data_1bzf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bzf _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.49 134.0 44.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.437 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 7.2 m-85 -104.76 153.99 20.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 tp -164.57 109.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 109.32 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.1 146.61 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.533 -0.729 . . . . 0.0 109.655 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.78 110.05 22.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.285 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -129.12 149.31 50.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.64 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -99.34 171.76 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 0.0 109.411 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.414 ' HB2' HH11 ' A' ' 9' ' ' ARG . 1.8 ptp180 -61.56 -19.53 62.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.641 -0.662 . . . . 0.0 109.806 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.53 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.16 37.0 93.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 5.5 tp -105.58 167.81 9.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.528 -0.983 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.406 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 2.6 pp -144.92 -26.19 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.487 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.59 -170.97 35.48 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -172.65 120.28 0.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.575 -0.956 . . . . 0.0 109.442 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.92 33.42 21.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.506 -0.746 . . . . 0.0 109.706 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.98 3.68 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -77.24 178.27 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.506 -0.996 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.7 mt -83.7 155.5 65.21 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.475 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -80.16 -30.92 1.92 Allowed 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 124.993 3.795 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 31.7 p90 -105.76 168.11 9.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.545 -0.722 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -115.19 107.61 15.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.675 . . . . 0.0 109.376 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -129.31 80.49 72.18 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.578 -0.701 . . . . 0.0 109.411 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.29 -40.05 16.46 Favored 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 125.162 3.908 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.67 -49.77 73.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.55 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -63.04 -31.35 72.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.32 -24.73 61.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -86.74 -23.83 25.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.505 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.0 t80 -75.02 -24.63 58.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 34' ' ' THR . 53.4 t80 -63.24 -44.98 93.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.576 -0.703 . . . . 0.0 109.472 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -63.6 -26.15 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.566 -0.709 . . . . 0.0 109.463 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.56 -28.34 33.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.548 -0.72 . . . . 0.0 109.419 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.404 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 17.3 mm100 -103.06 34.12 3.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 30' ' ' PHE . 22.1 p -140.59 -34.73 0.51 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.2 m -77.29 131.16 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.419 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.07 7.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -111.37 167.6 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.603 -0.939 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.8 mt -85.12 126.03 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 109.431 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.6 ttp -92.12 107.66 19.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.49 122.04 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.56 163.13 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.95 -164.28 39.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -82.28 -38.64 24.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.987 . . . . 0.0 109.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.44 -33.33 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.623 -0.673 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -79.42 -27.55 41.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 109.459 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -65.51 -58.35 6.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.02 -26.71 68.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -62.7 -21.85 66.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.722 . . . . 0.0 109.694 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -62.77 161.1 31.18 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.523 -0.736 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.17 -71.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 125.119 3.879 . . . . 0.0 109.901 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -115.77 75.74 0.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -78.39 156.48 78.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.04 166.86 75.92 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.423 1.223 . . . . 0.0 109.994 0.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.6 mt -90.09 118.03 68.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.736 . . . . 0.0 109.315 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.65 174.3 12.49 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 124.765 3.644 . . . . 0.0 109.969 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.48 27.03 16.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.63 -0.668 . . . . 0.0 109.641 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -177.41 155.0 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.499 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.2 m -76.39 144.7 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -120.48 96.91 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.593 -0.692 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -100.34 151.57 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.69 120.2 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.697 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.0 tp -96.61 117.61 31.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.598 -0.689 . . . . 0.0 109.458 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -151.05 144.14 24.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.569 -0.707 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -103.06 31.14 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -124.24 132.31 53.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.629 -0.669 . . . . 0.0 109.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.2 30.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.39 -30.69 5.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.589 -0.694 . . . . 0.0 109.513 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -66.58 142.56 57.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -137.58 142.45 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.91 117.65 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -84.04 122.1 28.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.716 -0.615 . . . . 0.0 109.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.68 41.59 12.67 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.41 145.4 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.99 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -83.07 97.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.564 -0.71 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 t -76.8 100.35 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.56 -0.713 . . . . 0.0 109.443 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -91.16 153.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -135.35 30.34 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.566 -0.708 . . . . 0.0 109.446 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -166.88 148.23 6.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.7 -33.33 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.94 -32.9 72.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.59 -36.07 80.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.65 -0.656 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.7 t -69.8 -39.78 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.436 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -76.84 -31.43 56.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.643 -0.661 . . . . 0.0 109.52 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.08 78.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -72.98 -33.66 65.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.21 68.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.21 -42.54 83.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.639 -0.663 . . . . 0.0 109.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.18 -27.84 68.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.507 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -119.33 89.93 41.14 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.713 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.63 -22.99 7.44 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 125.112 3.875 . . . . 0.0 109.922 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -68.15 -26.9 66.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.415 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -97.9 179.89 4.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -139.47 165.7 26.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.7 tp -96.59 128.75 43.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.501 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 t -132.08 133.57 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 96' ' ' ILE . 40.4 mm -104.07 124.46 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.69 -27.96 9.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.22 -179.57 38.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.87 -154.8 19.55 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.317 -1.696 . . . . 0.0 109.554 -0.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.84 -32.27 73.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.937 . . . . 0.0 109.486 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -71.04 -31.83 68.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.99 -36.0 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 96' ' ' ILE . 22.2 m-85 -63.21 -55.63 23.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.582 -0.699 . . . . 0.0 109.554 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -62.55 -21.38 65.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.626 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.93 -36.87 78.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 79' ' ' VAL . 69.5 m-85 -113.41 18.7 17.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -23.81 65.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 109.58 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.49 -45.42 59.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.08 38.84 1.12 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.607 -0.683 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -88.95 151.75 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -132.84 -61.85 0.83 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.6 m -93.55 159.82 15.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.433 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.406 HD12 ' CZ ' ' A' ' 136' ' ' PHE . 34.3 mt -140.17 95.77 2.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.4 mt -95.08 103.36 15.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.316 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -109.24 136.18 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.725 . . . . 0.0 109.452 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 m -107.39 102.95 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.388 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.9 146.49 26.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.78 132.1 51.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.623 -0.673 . . . . 0.0 109.272 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.88 -34.17 73.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.613 -0.679 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.86 130.59 27.95 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 t -79.82 139.85 37.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.58 -0.953 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -146.78 126.55 13.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.715 . . . . 0.0 109.506 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.05 146.52 26.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.36 -124.01 1.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -145.04 -30.08 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.61 -0.935 . . . . 0.0 109.49 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -100.79 142.45 32.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.705 . . . . 0.0 109.509 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -118.02 176.05 5.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.572 -0.705 . . . . 0.0 109.461 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.41 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.597 -0.689 . . . . 0.0 109.5 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.3 pt -69.37 163.68 56.08 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.562 -0.711 . . . . 0.0 109.516 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.88 102.35 1.45 Allowed 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 125.047 3.831 . . . . 0.0 109.851 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.24 144.74 26.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -81.15 85.62 6.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.692 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -71.74 -14.1 61.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.852 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.05 10.05 1.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.897 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.86 31.73 3.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 0.0 109.417 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.406 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 66.3 m-85 -141.47 174.13 10.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.399 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -147.44 137.35 22.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -71.1 156.56 39.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.746 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.73 -36.02 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.701 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.7 m -148.2 163.63 36.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.8 t -158.86 157.63 31.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -142.92 101.09 3.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.488 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -85.52 143.22 28.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.409 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.9 p -147.18 129.18 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.541 -0.725 . . . . 0.0 109.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -105.25 121.34 43.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.563 -0.711 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.32 -166.21 1.01 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.4 p -70.23 -39.63 74.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.596 -0.69 . . . . 0.0 109.61 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -105.35 137.84 19.38 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.647 -0.658 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -47.98 -45.54 24.66 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 C-N-CA 124.842 3.694 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.98 70.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.689 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.1 mt -81.07 20.83 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.6 m -91.37 137.99 31.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.409 ' CE1' HG12 ' A' ' 144' ' ' VAL . 34.5 p-80 -151.85 169.01 23.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.0 m -142.73 132.51 24.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -89.61 101.0 13.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.446 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 38.2 mt-10 -85.9 128.98 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.8 t -114.96 112.7 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.534 -0.729 . . . . 0.0 109.51 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.446 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 31.2 m95 -109.32 164.06 12.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -139.92 136.4 33.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.615 -0.678 . . . . 0.0 109.429 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 73.4 tttt . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.518 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.59 121.24 19.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.6 m-85 -91.62 149.24 21.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 tp -159.79 110.39 1.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.696 . . . . 0.0 109.401 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -143.77 147.99 34.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.749 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.23 111.88 23.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.538 -0.726 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -132.43 149.47 52.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.537 -0.727 . . . . 0.0 109.637 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -100.43 170.44 8.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.684 . . . . 0.0 109.458 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 11' ' ' GLY . 15.8 ptm180 -61.25 -17.32 52.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.785 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.72 14.4 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 109.846 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.41 36.89 93.76 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 4.9 tp -112.23 166.55 11.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.549 -0.971 . . . . 0.0 109.526 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 13' ' ' ILE . 32.2 pt -139.8 -29.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.73 -168.18 32.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -170.23 119.72 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.636 -0.92 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.95 29.81 19.36 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.566 -0.709 . . . . 0.0 109.742 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.89 -61.69 2.65 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -73.83 169.77 16.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.923 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.414 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 40.3 mt -84.84 155.92 61.3 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.616 -0.677 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.4 Cg_endo -79.52 -28.08 3.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.046 3.831 . . . . 0.0 109.958 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 37.1 p90 -106.77 167.67 9.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -118.57 93.53 4.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.557 -0.714 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 tp -114.97 80.73 6.99 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.27 -38.67 15.19 Favored 'Trans proline' 0 N--CA 1.507 2.273 0 C-N-CA 125.139 3.893 . . . . 0.0 110.25 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.7 -44.25 96.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.698 . . . . 0.0 109.59 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -64.24 -41.07 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.741 . . . . 0.0 109.436 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.02 -23.72 67.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -85.0 -29.48 24.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.631 -0.668 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -70.8 -25.75 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.458 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.34 -52.2 59.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.545 -0.722 . . . . 0.0 109.453 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.461 HH22 ' HZ2' ' A' ' 51' ' ' LYS . 11.2 ttm180 -68.32 2.09 2.51 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.601 -0.687 . . . . 0.0 110.022 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.15 12.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -0.832 . . . . 0.0 109.451 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -114.91 35.09 4.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.568 -0.707 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 p -132.91 -27.53 1.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.741 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.0 m -75.5 127.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.91 23.62 51.88 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.25 164.98 29.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.522 -0.987 . . . . 0.0 109.5 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -91.37 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.8 ttp -82.92 108.33 16.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.54 -0.725 . . . . 0.0 109.559 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -96.59 118.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.503 -0.748 . . . . 0.0 109.385 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.47 166.92 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 109.495 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.41 -160.71 36.59 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.7 -35.54 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.617 -0.931 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -69.5 -37.79 77.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -77.4 -27.23 52.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 32.1 t80 -65.51 -34.55 78.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.496 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -89.61 -24.03 21.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -62.91 -22.18 66.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.735 . . . . 0.0 109.601 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -62.73 159.8 41.23 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -72.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.093 3.862 . . . . 0.0 109.89 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HZ2' HH22 ' A' ' 31' ' ' ARG . 5.3 pttm -108.07 74.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.423 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 4.6 ptm180 -78.73 156.03 77.89 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.489 -0.757 . . . . 0.0 109.528 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.18 171.09 63.39 Favored 'Cis proline' 0 N--CA 1.507 2.317 0 O-C-N 123.407 1.214 . . . . 0.0 109.957 0.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.4 mt -94.58 115.39 65.25 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.55 -0.719 . . . . 0.0 109.332 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.0 -178.28 4.53 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.808 3.672 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 60.65 28.21 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -176.68 179.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.5 m -112.42 111.17 21.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.607 -0.683 . . . . 0.0 109.487 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 59' ' ' ASN . 1.5 m-80 -86.0 107.83 17.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.488 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 t -102.3 112.66 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.588 -0.695 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.4 t -95.71 125.16 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.453 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.4 tp -104.56 114.79 29.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.42 140.89 33.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -89.16 30.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -137.65 125.05 21.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.7 29.83 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.03 -37.46 6.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.601 -0.687 . . . . 0.0 109.55 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -70.83 143.7 51.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 109.518 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.75 101.45 3.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . . . -88.61 118.57 28.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -73.83 136.38 43.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.546 -0.722 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 37.43 57.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.99 145.93 18.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.973 . . . . 0.0 109.515 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.78 98.91 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 0.0 109.501 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -80.42 99.41 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.97 158.57 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.61 -0.681 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -138.8 29.82 2.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.548 -0.72 . . . . 0.0 109.454 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -167.85 148.75 5.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 106' ' ' PHE . 31.6 t -68.06 -31.69 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.612 -0.68 . . . . 0.0 109.475 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.53 -33.68 76.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.5 -0.75 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.41 75.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.683 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 t -67.81 -43.92 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -73.19 -30.13 63.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.486 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.68 83.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.597 -0.689 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -71.51 -34.02 69.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.5 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.0 -30.82 69.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.602 -0.686 . . . . 0.0 109.405 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -67.19 -34.63 77.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.534 -0.728 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.43 -36.58 76.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -120.92 87.26 42.88 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.45 20.22 0.98 Allowed 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.169 3.912 . . . . 0.0 109.952 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -100.96 -30.12 11.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -94.51 178.23 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.558 -0.713 . . . . 0.0 109.443 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -127.88 151.62 48.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.626 -0.671 . . . . 0.0 109.466 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.17 108.26 16.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.629 -0.669 . . . . 0.0 109.483 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -113.91 131.42 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.553 -0.717 . . . . 0.0 109.419 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.414 ' CG2' ' CD1' ' A' ' 103' ' ' PHE . 39.9 mm -98.28 125.68 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.707 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.13 -27.52 10.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.503 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 160.85 -179.94 36.0 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.29 -152.26 17.54 Favored Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.315 -1.697 . . . . 0.0 109.585 0.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.4 73.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.582 -0.952 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -70.85 -30.45 66.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.76 -34.89 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.563 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 22.1 m-85 -64.39 -56.79 11.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.713 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.6 m -62.53 -21.18 65.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.661 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.93 73.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.528 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.419 ' CE1' HG11 ' A' ' 79' ' ' VAL . 69.9 m-85 -113.1 17.24 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.526 -0.734 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -67.06 -23.17 65.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.521 -0.737 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -66.77 -45.44 78.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.516 -0.74 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.23 44.97 1.0 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.448 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -93.96 147.83 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 0.0 109.442 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -136.94 -68.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -84.65 120.04 25.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 mt -107.7 94.95 5.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.631 -0.668 . . . . 0.0 109.609 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 39.0 mt -91.33 115.51 28.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.645 -0.659 . . . . 0.0 109.343 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -124.31 138.71 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.705 . . . . 0.0 109.509 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.9 m -109.87 101.4 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.564 -0.71 . . . . 0.0 109.234 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -87.68 139.81 30.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 109.614 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.73 140.15 47.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.331 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.81 -33.27 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.05 139.06 25.45 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.2 m -86.91 143.13 27.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.516 -0.991 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -148.45 108.73 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -80.1 147.04 31.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.531 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.46 -126.77 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -141.79 -41.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.949 . . . . 0.0 109.482 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.8 m -90.52 126.98 36.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.509 -0.745 . . . . 0.0 109.435 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -104.53 172.22 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.82 145.09 24.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.462 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.4 pt -66.79 165.37 26.17 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.519 -0.738 . . . . 0.0 109.483 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.52 108.83 2.19 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 125.173 3.915 . . . . 0.0 109.961 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -98.67 145.22 27.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -86.09 87.15 7.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -69.88 -17.25 63.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.82 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.86 -27.19 69.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.477 -0.764 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -93.3 30.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -149.91 164.15 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -139.07 136.18 34.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.698 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -70.12 149.17 47.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.631 -0.668 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.6 -31.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.469 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -143.87 153.3 42.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.522 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.2 p -155.48 113.3 3.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.544 -0.723 . . . . 0.0 109.501 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 tpt85 -91.24 103.31 16.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.7 m -85.55 141.4 29.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.9 p -146.72 129.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.597 -0.69 . . . . 0.0 109.322 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -108.3 120.7 43.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.4 -166.04 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.3 p -71.17 -42.77 68.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.717 . . . . 0.0 109.588 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.18 137.75 19.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.573 -0.705 . . . . 0.0 109.428 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.87 -43.1 30.33 Favored 'Trans proline' 0 N--CA 1.508 2.333 0 C-N-CA 124.781 3.654 . . . . 0.0 110.126 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.48 73.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.565 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.9 mt -80.91 20.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.629 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.6 m -90.85 141.93 28.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 109.473 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.418 ' CE1' HG12 ' A' ' 144' ' ' VAL . 27.5 p-80 -158.12 167.29 30.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.496 -0.752 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -138.63 141.03 39.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.638 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.36 97.75 9.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.667 . . . . 0.0 109.467 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -81.36 139.46 35.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.45 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -124.97 107.29 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 31.4 m95 -103.97 165.13 11.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.685 . . . . 0.0 109.454 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -148.87 144.18 26.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.482 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.81 128.59 35.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 109.412 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.434 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 6.6 m-85 -95.8 160.06 14.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.562 -0.711 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 tp -170.86 108.92 0.32 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.698 . . . . 0.0 109.335 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.39 151.21 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.31 114.12 26.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -135.61 150.65 49.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -100.86 170.73 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.526 -0.734 . . . . 0.0 109.366 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -61.17 -17.85 55.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.579 -0.701 . . . . 0.0 109.887 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.72 14.05 0.89 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.501 -0.749 . . . . 0.0 109.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.16 39.01 97.1 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 tp -112.25 163.95 13.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.95 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.75 -27.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.518 -0.738 . . . . 0.0 109.514 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.16 -176.85 40.59 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -166.42 120.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.958 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.88 32.74 21.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -61.73 3.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -76.34 171.3 14.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.96 . . . . 0.0 109.493 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.4 HD23 ' CZ2' ' A' ' 21' ' ' TRP . 20.1 mt -84.8 155.85 61.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 9.8 Cg_endo -78.9 -26.99 5.0 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 125.069 3.846 . . . . 0.0 109.97 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.422 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 37.5 p90 -108.37 167.31 10.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -118.83 97.6 5.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.5 tp -118.63 80.09 16.77 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 109.428 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.28 -37.82 14.3 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 125.193 3.928 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -63.02 -43.51 98.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.505 -0.747 . . . . 0.0 109.503 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.4 -35.0 79.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.396 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.68 -25.3 63.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.67 -0.644 . . . . 0.0 109.516 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -83.8 -28.51 28.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.435 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.7 t80 -74.01 -25.53 59.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.541 -0.725 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -65.01 -45.82 83.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.452 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -65.69 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.85 56.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 41.5 mm-40 -99.59 32.27 2.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 109.506 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.5 p -139.55 -31.33 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.88 129.22 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.456 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.09 56.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -155.35 170.35 22.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.561 -0.964 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.1 mt -99.62 111.66 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.4 ttp -87.05 106.87 18.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.56 119.46 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.43 160.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.562 -0.711 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.34 -170.2 46.69 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.12 -33.71 59.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.598 -0.943 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -67.67 -47.32 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 109.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -70.1 -26.03 63.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.686 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -63.9 -43.54 95.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.573 -0.704 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.9 -22.96 33.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.531 -0.73 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t -62.97 -23.9 67.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.721 . . . . 0.0 109.621 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.98 160.23 48.93 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.725 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.83 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.124 3.882 . . . . 0.0 109.942 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -105.81 89.59 3.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.377 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 3.4 ptm180 -96.78 157.03 35.86 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.593 -0.692 . . . . 0.0 109.507 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.87 142.32 57.68 Favored 'Cis proline' 0 N--CA 1.509 2.4 0 O-C-N 123.325 1.171 . . . . 0.0 109.964 -0.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.3 mt -61.85 111.17 4.02 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.577 -0.702 . . . . 0.0 109.413 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.43 -178.05 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.732 3.621 . . . . 0.0 109.949 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 60.96 29.21 18.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.588 -0.695 . . . . 0.0 109.56 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -177.24 177.42 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -100.2 119.32 38.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -93.18 104.53 16.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.568 -0.707 . . . . 0.0 109.511 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -105.75 120.81 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.495 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -106.5 127.38 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.731 . . . . 0.0 109.408 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 tp -102.34 120.75 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.654 -0.654 . . . . 0.0 109.468 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.11 155.41 44.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.396 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -86.24 -61.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.617 -0.677 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.37 145.54 37.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.655 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.38 30.95 0.59 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.72 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.55 -31.3 19.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -69.58 124.75 24.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -104.56 131.56 51.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.66 -0.65 . . . . 0.0 109.374 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.76 112.32 8.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.507 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -90.47 142.93 27.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 34.74 61.03 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.49 141.93 15.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.955 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.11 96.92 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 t -73.55 96.57 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.6 m -91.23 160.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.717 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -137.53 29.74 2.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.581 -0.699 . . . . 0.0 109.495 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.65 146.39 2.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 106' ' ' PHE . 30.4 t -68.17 -32.92 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -33.83 75.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.485 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.19 -37.35 83.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.498 -0.751 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.9 t -69.03 -38.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.606 -0.684 . . . . 0.0 109.449 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -73.07 -30.75 63.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.74 86.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.61 -32.78 71.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.83 -31.03 68.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -65.64 -40.55 92.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -67.61 -32.13 72.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.546 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.82 89.75 42.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.59 -0.693 . . . . 0.0 109.521 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.08 -21.6 7.89 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 125.12 3.88 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 -26.74 67.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.545 -0.722 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.01 -179.99 5.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.576 -0.703 . . . . 0.0 109.427 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -138.16 144.81 40.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.2 tp -86.07 132.59 34.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -139.29 131.04 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 109.504 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 103' ' ' PHE . 40.6 mm -97.1 125.79 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.01 -25.13 10.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.504 -0.748 . . . . 0.0 109.474 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.29 -176.14 36.12 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.483 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.28 -152.4 9.12 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.259 -1.73 . . . . 0.0 109.546 0.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.84 82.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.946 . . . . 0.0 109.707 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -66.1 -23.05 66.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.61 -0.681 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.483 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.5 mm -77.31 -35.42 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.521 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 96' ' ' ILE . 25.5 m-85 -64.0 -50.39 68.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 109.507 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.06 -26.22 68.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.03 83.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.545 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.417 ' CE2' HG12 ' A' ' 79' ' ' VAL . 55.3 m-85 -103.02 11.8 36.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.513 -0.742 . . . . 0.0 109.951 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -71.54 -24.26 61.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.779 . . . . 0.0 109.526 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 -41.54 92.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.722 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -110.77 37.41 2.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.582 -0.699 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.434 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 8.9 p -79.72 151.89 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 0.0 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.2 -68.79 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.66 -0.65 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -88.68 163.03 15.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.459 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 136' ' ' PHE . 22.0 mt -142.19 89.74 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.9 mt -89.34 117.02 27.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.272 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -126.72 137.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.598 -0.689 . . . . 0.0 109.54 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.1 m -107.89 102.44 11.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.281 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -87.46 132.9 33.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.574 -0.704 . . . . 0.0 109.585 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.81 135.53 49.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.05 77.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.712 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 130.11 25.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 p -77.99 143.01 37.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.592 -0.946 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -147.99 113.32 5.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.51 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.65 149.63 25.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.532 -0.73 . . . . 0.0 109.442 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.25 -127.86 1.52 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.52 -32.64 0.58 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.633 -0.922 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -93.93 147.44 23.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.698 . . . . 0.0 109.574 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -128.07 173.05 10.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.7 tpt -98.01 151.09 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.496 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.5 pt -72.46 164.61 58.41 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.433 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.07 97.55 1.07 Allowed 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 125.106 3.87 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -88.11 137.71 32.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.708 . . . . 0.0 109.474 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -80.32 85.38 5.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.715 . . . . 0.0 109.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.92 -16.92 63.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.751 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.73 -24.91 67.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.745 . . . . 0.0 109.508 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.67 -29.44 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.415 ' CZ ' HD13 ' A' ' 113' ' ' LEU . 91.7 m-85 -87.89 169.56 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.563 -0.711 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.2 m -138.97 134.82 33.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.632 -0.668 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -69.16 148.62 49.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 -34.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.1 p -149.53 157.91 43.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -157.62 122.37 4.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.48 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.29 100.2 11.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 109.479 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.2 m -82.07 146.48 29.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.699 . . . . 0.0 109.486 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -148.88 131.24 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.625 -0.672 . . . . 0.0 109.315 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -111.88 118.4 35.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 0.0 109.49 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.46 -174.25 4.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.551 -0.718 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.5 p -63.31 -44.06 96.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -89.34 156.13 48.55 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.145 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.76 -22.03 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 124.827 3.685 . . . . 0.0 109.943 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.28 -23.39 30.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.548 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -89.28 18.97 4.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.605 -0.684 . . . . 0.0 109.708 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.8 m -85.6 141.88 29.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -158.48 168.26 27.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.0 m -136.93 134.84 37.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.638 -0.664 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.55 91.2 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.579 -0.701 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -71.79 145.28 48.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.685 . . . . 0.0 109.418 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.0 t -133.56 104.3 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.659 . . . . 0.0 109.497 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.6 m95 -101.34 168.25 9.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -144.78 140.55 28.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.618 -0.676 . . . . 0.0 109.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 109.449 179.954 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.62 103.23 11.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.445 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.5 m-85 -72.73 140.65 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.436 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.9 tp -154.42 111.87 3.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.305 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -142.79 141.88 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.585 -0.697 . . . . 0.0 109.757 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.21 110.5 21.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.577 -0.702 . . . . 0.0 109.294 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -130.26 150.72 51.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.698 . . . . 0.0 109.676 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -98.9 169.66 9.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -60.93 -17.47 51.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.42 0.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.589 -0.694 . . . . 0.0 109.759 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 33.8 87.19 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 tp -109.45 164.0 12.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.947 . . . . 0.0 109.537 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.0 pt -137.94 -30.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.532 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.82 -176.96 39.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -162.54 124.59 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.969 . . . . 0.0 109.431 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.89 29.77 19.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 109.694 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.25 -64.13 1.67 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -75.42 -179.51 4.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.581 -0.952 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.3 mt -88.74 155.96 50.22 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.425 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -80.12 -26.93 3.99 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.994 3.796 . . . . 0.0 109.887 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.419 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 35.8 p90 -108.09 170.89 7.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.562 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -122.54 100.2 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.673 -0.642 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -121.3 82.47 38.65 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.623 -0.673 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -45.22 -39.04 15.35 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 125.142 3.894 . . . . 0.0 110.253 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.9 -49.7 73.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -63.35 -29.52 70.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.71 -23.45 60.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.554 -0.716 . . . . 0.0 109.595 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -88.4 -26.38 22.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.447 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -70.41 -25.9 63.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.568 -0.707 . . . . 0.0 109.464 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -63.19 -46.82 85.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.595 -0.691 . . . . 0.0 109.456 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -63.51 -29.87 71.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.707 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.54 -30.24 57.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.516 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -99.18 33.74 2.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.9 p -142.65 -32.49 0.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.426 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.98 126.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.69 . . . . 0.0 109.502 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.32 34.53 25.83 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -155.84 171.35 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.949 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.68 98.53 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.597 -0.689 . . . . 0.0 109.419 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -70.03 132.23 45.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 t -137.2 118.91 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.581 -0.699 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.82 179.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.38 -168.34 41.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -80.69 -39.59 26.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -73.86 -32.31 63.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -76.23 -30.48 57.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CE2' ' HD2' ' A' ' 52' ' ' ARG . 27.9 t80 -64.27 -58.4 6.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.511 -0.743 . . . . 0.0 109.428 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -64.52 -15.65 61.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.535 -0.728 . . . . 0.0 109.793 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -62.4 -28.73 69.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.775 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -66.61 162.69 48.47 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.72 -69.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 125.129 3.886 . . . . 0.0 109.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -104.86 143.41 33.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.472 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HD2' ' CE2' ' A' ' 46' ' ' TYR . 21.3 mtm105 -144.82 161.96 40.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.73 148.54 76.11 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.449 1.236 . . . . 0.0 109.894 -0.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.46 ' HB2' HD22 ' A' ' 59' ' ' ASN . 75.0 mt -62.17 111.33 4.41 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.559 -0.713 . . . . 0.0 109.444 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.62 174.03 12.29 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.873 3.715 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 61.73 24.87 14.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.543 -0.723 . . . . 0.0 109.606 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -177.18 148.45 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.688 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -79.21 126.27 30.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.499 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' A' ' 54' ' ' LEU . 1.4 m-80 -100.2 117.61 34.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.54 -0.725 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -114.31 146.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.621 -0.675 . . . . 0.0 109.45 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.38 118.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.493 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 tp -97.56 107.03 19.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.72 . . . . 0.0 109.475 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -137.71 155.59 48.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.686 . . . . 0.0 109.464 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -98.41 -30.67 12.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.27 124.46 25.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -84.03 29.9 0.54 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.618 -0.676 . . . . 0.0 109.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -102.4 -34.79 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -71.96 140.45 49.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -144.18 104.19 4.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.476 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.82 118.37 27.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -79.24 123.88 27.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.549 -0.72 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.5 37.44 10.75 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.4 144.95 19.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 109.534 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.74 93.23 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 t -77.11 102.11 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.401 ' H ' HG21 ' A' ' 76' ' ' VAL . 27.9 m -97.68 155.05 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -135.01 29.33 3.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.63 -0.669 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -159.77 141.65 13.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.627 -0.671 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.8 t -67.6 -34.31 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.544 -0.723 . . . . 0.0 109.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.83 67.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.58 80.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.592 -0.693 . . . . 0.0 109.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t -68.15 -40.23 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.442 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.66 -31.91 65.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.721 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.46 -34.9 78.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.66 -0.65 . . . . 0.0 109.565 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -69.48 -35.21 75.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 109.488 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -68.27 -34.54 76.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.706 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -69.63 -32.4 71.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -120.6 87.95 42.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.685 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.39 20.1 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 125.116 3.878 . . . . 0.0 109.939 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.66 -30.02 12.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.565 -0.71 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.68 178.41 4.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.595 -0.691 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -127.02 155.8 42.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.624 -0.673 . . . . 0.0 109.452 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.8 tp -81.46 123.0 28.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.559 -0.713 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -124.64 120.07 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.409 HG21 ' CE1' ' A' ' 103' ' ' PHE . 41.3 mm -97.67 125.25 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -104.7 -24.82 12.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.17 -175.86 40.2 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.493 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.06 -155.72 22.16 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.283 -1.716 . . . . 0.0 109.588 -0.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.42 75.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.647 -0.914 . . . . 0.0 109.525 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.12 -28.18 62.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.557 -0.715 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.493 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -71.72 -37.61 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.696 . . . . 0.0 109.56 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.409 ' CE1' HG21 ' A' ' 96' ' ' ILE . 30.3 m-85 -63.02 -47.57 82.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.607 -0.683 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.5 m -63.07 -24.47 67.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.538 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.77 60.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' HG12 ' A' ' 79' ' ' VAL . 58.8 m-85 -103.97 21.05 17.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.583 -0.698 . . . . 0.0 109.646 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -23.59 53.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.498 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.82 18.7 0.58 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.499 -0.751 . . . . 0.0 109.745 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -160.08 38.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.416 -0.803 . . . . 0.0 109.419 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.445 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -93.56 152.84 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.87 -45.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 109.396 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.5 m -106.54 122.61 46.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.669 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.404 HD11 ' CD1' ' A' ' 136' ' ' PHE . 30.8 mt -108.57 101.48 10.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.646 -0.658 . . . . 0.0 109.626 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.7 mt -102.47 106.31 17.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -114.3 140.1 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.505 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -110.4 100.97 9.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -84.62 144.3 28.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.566 -0.708 . . . . 0.0 109.58 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -119.65 136.06 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.78 -35.54 77.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.437 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.23 126.79 13.64 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.6 p -79.75 143.2 34.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.569 -0.959 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -148.01 112.4 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.602 -0.686 . . . . 0.0 109.43 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.38 149.24 31.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.626 -0.671 . . . . 0.0 109.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.02 -129.29 1.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.56 -29.03 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.6 m -98.38 145.99 26.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HZ3' ' HB2' ' A' ' 127' ' ' LYS . 9.9 mtmp? -127.49 170.68 12.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.605 -0.684 . . . . 0.0 109.516 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.3 tpt -93.15 151.9 19.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.4 pt -72.45 164.64 58.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.674 . . . . 0.0 109.508 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.03 93.41 1.06 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.168 3.912 . . . . 0.0 109.914 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 71.7 mt -80.51 144.56 32.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -84.82 85.79 7.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.405 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -71.48 -7.84 50.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.57 -31.82 72.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.357 -0.84 . . . . 0.0 109.587 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.63 32.35 2.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.404 ' CD1' HD11 ' A' ' 113' ' ' LEU . 27.6 m-85 -138.9 169.5 17.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.434 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -150.15 147.06 27.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.547 -0.721 . . . . 0.0 109.446 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -86.08 116.41 24.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.41 -35.42 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -149.89 172.95 14.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.67 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t -165.78 123.51 1.5 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.459 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -100.66 105.5 16.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.5 m -86.87 152.25 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 109.395 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -154.87 133.06 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.16 123.19 49.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.94 -174.3 5.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.9 p -63.3 -40.55 97.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.634 -0.667 . . . . 0.0 109.451 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -91.97 155.0 43.53 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -77.87 -24.68 8.31 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.887 3.725 . . . . 0.0 109.865 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.63 -23.25 31.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.536 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.0 mt -88.4 20.29 3.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.7 m -82.51 144.68 30.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.367 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.41 ' CE1' HG12 ' A' ' 144' ' ' VAL . 30.1 p-80 -158.54 162.74 37.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.727 . . . . 0.0 109.615 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -135.46 137.54 42.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.671 -0.643 . . . . 0.0 109.443 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.77 98.45 11.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.509 -0.744 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.44 134.28 35.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.448 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.1 t -123.84 99.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.2 m95 -97.5 164.46 12.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.579 -0.701 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -140.38 145.49 37.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.447 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.5 132.32 29.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 7.0 m-85 -97.07 162.56 13.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 tp -171.18 107.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 109.269 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -141.75 147.66 37.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.524 -0.735 . . . . 0.0 109.711 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.84 115.18 26.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.588 -0.695 . . . . 0.0 109.179 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -136.21 151.99 50.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.685 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -101.74 170.38 8.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.59 -0.694 . . . . 0.0 109.373 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 11' ' ' GLY . 8.7 ptm180 -60.89 -17.48 50.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 109.946 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.94 14.33 0.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.718 . . . . 0.0 109.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.19 36.66 93.3 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 5.7 tp -112.26 164.4 13.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.916 . . . . 0.0 109.578 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.404 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 31.6 pt -138.69 -29.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.17 -165.92 27.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -173.8 122.46 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.959 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 57.9 35.01 24.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.624 -0.673 . . . . 0.0 109.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -62.81 3.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -76.17 171.95 13.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.564 -0.962 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.65 157.89 54.68 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.97 -27.18 3.96 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.03 3.82 . . . . 0.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.422 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 37.0 p90 -108.37 163.35 13.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.513 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -115.55 89.59 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.8 tp -107.7 79.57 0.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.68 -37.96 16.48 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 125.114 3.876 . . . . 0.0 110.251 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.79 -45.8 90.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.554 -0.716 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -62.71 -38.99 92.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 0.0 109.442 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.82 -24.0 67.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.668 . . . . 0.0 109.468 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -83.7 -27.84 28.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.625 -0.672 . . . . 0.0 109.48 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -76.76 -26.04 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -67.02 -45.31 77.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.453 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -64.76 -29.43 70.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.74 -28.74 44.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -101.44 33.5 2.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.506 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.5 p -137.69 -33.76 0.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 109.467 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.4 ' H ' HG21 ' A' ' 35' ' ' VAL . 27.6 m -79.73 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.576 -0.703 . . . . 0.0 109.47 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -29.49 12.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 165.17 12.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.545 -0.973 . . . . 0.0 109.495 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 38' ' ' ILE . 58.5 mt -80.84 121.85 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.62 -0.675 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.8 ttp -90.88 107.33 19.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.602 -0.686 . . . . 0.0 109.517 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -96.48 124.47 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.62 -0.675 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.82 166.07 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.02 -169.24 44.47 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -77.7 -34.18 52.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.565 -0.962 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.78 -45.14 72.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.7 m -71.07 -25.94 62.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.695 . . . . 0.0 109.533 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -63.96 -38.73 92.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -87.75 -20.24 26.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.4 m -62.78 -25.58 68.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.621 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -66.58 160.6 66.19 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.62 -0.675 . . . . 0.0 109.412 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.29 -73.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.125 3.883 . . . . 0.0 109.821 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -103.51 92.32 4.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.404 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 3.8 ptm180 -99.25 154.53 37.25 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.97 151.07 83.46 Favored 'Cis proline' 0 N--CA 1.51 2.463 0 O-C-N 123.309 1.163 . . . . 0.0 109.952 -0.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.8 mt -69.25 123.84 89.17 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.653 . . . . 0.0 109.289 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.28 176.85 9.25 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.676 3.584 . . . . 0.0 109.937 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.04 28.66 18.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.585 -0.697 . . . . 0.0 109.729 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.28 170.52 2.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.548 -0.72 . . . . 0.0 109.496 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 m -105.93 118.76 37.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.597 -0.689 . . . . 0.0 109.514 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 59' ' ' ASN . 1.5 m-80 -85.73 101.54 12.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -99.22 100.38 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.429 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -86.42 135.99 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 tp -110.51 113.7 26.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.676 . . . . 0.0 109.498 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.59 145.53 36.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.641 -0.662 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.21 -26.87 14.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -70.43 136.9 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.654 -0.654 . . . . 0.0 109.44 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.1 29.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.728 . . . . 0.0 109.508 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -111.44 -28.81 8.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.592 -0.693 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.34 140.87 58.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.536 -0.727 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -140.86 104.55 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.51 126.06 42.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 0.0 109.549 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -92.03 131.93 36.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.11 39.89 62.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.52 141.58 17.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.627 -0.926 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.7 95.62 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.611 -0.681 . . . . 0.0 109.448 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.8 t -81.47 98.39 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 109.45 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.76 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.653 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -140.73 30.68 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -169.14 142.74 2.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.06 -35.04 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.18 -31.25 69.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -35.93 80.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.0 t -68.45 -38.37 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.476 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -69.24 -31.31 69.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.602 -0.686 . . . . 0.0 109.491 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.9 -36.83 83.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.683 -0.636 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -69.58 -31.69 70.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.673 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.23 -27.13 60.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 109.429 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -64.21 -44.31 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.618 -0.676 . . . . 0.0 109.519 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.77 -30.27 70.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.578 -0.701 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -119.16 89.98 40.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.663 -0.648 . . . . 0.0 109.455 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -22.08 7.51 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.118 3.879 . . . . 0.0 109.874 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.67 -27.24 67.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 109.415 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -95.22 -180.0 4.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -138.44 169.3 18.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.532 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 tt -104.02 121.58 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.646 -0.659 . . . . 0.0 109.497 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.5 t -122.3 133.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.458 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.419 HG23 ' CD1' ' A' ' 103' ' ' PHE . 40.3 mm -102.24 120.68 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.56 -25.45 10.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.675 . . . . 0.0 109.489 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.64 -178.37 38.42 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.436 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.83 -153.21 18.79 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.223 -1.751 . . . . 0.0 109.565 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.51 73.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.949 . . . . 0.0 109.502 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.36 -27.71 60.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.436 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.9 mm -76.07 -34.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.713 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CD1' HG23 ' A' ' 96' ' ' ILE . 21.3 m-85 -63.04 -52.37 63.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.527 ' H ' ' HG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -64.9 -23.42 67.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.531 -0.731 . . . . 0.0 109.548 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.57 77.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -104.28 14.4 30.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.559 -0.713 . . . . 0.0 109.908 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -70.05 -24.68 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.802 . . . . 0.0 109.53 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.37 -44.21 79.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -101.42 38.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.644 -0.66 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 8.6 p -83.97 147.6 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.688 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.38 -63.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.591 -0.693 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.49 164.12 13.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 136' ' ' PHE . 41.8 mt -143.15 93.22 2.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.1 mt -91.71 114.16 26.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.413 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -122.05 138.18 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.551 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.3 m -109.31 98.17 7.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.642 -0.661 . . . . 0.0 109.282 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -84.0 134.11 34.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.95 142.65 36.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.622 -0.674 . . . . 0.0 109.314 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.53 -38.76 65.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.505 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.64 136.44 26.07 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.6 p -85.67 145.79 27.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 109.476 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -147.82 122.69 9.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.584 -0.698 . . . . 0.0 109.448 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -81.68 161.2 23.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.608 -0.683 . . . . 0.0 109.519 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.79 -134.87 1.71 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -142.1 -34.58 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.984 . . . . 0.0 109.449 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 m -95.82 143.08 27.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -122.26 173.68 7.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.605 -0.684 . . . . 0.0 109.403 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -93.3 152.02 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.536 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.6 pt -73.58 164.06 63.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.627 -0.671 . . . . 0.0 109.511 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.11 99.53 1.19 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.137 3.891 . . . . 0.0 109.878 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.42 144.52 27.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.63 -0.669 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.5 83.21 3.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.405 ' C ' ' H ' ' A' ' 135' ' ' ASP . 94.7 m95 -71.89 -18.58 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.654 . . . . 0.0 109.693 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.04 10.07 1.34 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.488 -0.758 . . . . 0.0 110.017 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 133' ' ' TRP . 20.5 m-20 -123.93 -31.75 3.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.498 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.406 ' CE2' HD12 ' A' ' 113' ' ' LEU . 86.1 m-85 -81.27 173.59 12.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.541 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.5 m -142.34 121.06 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.622 -0.674 . . . . 0.0 109.514 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -66.75 154.74 39.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.566 -0.709 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.5 -34.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 0.0 109.481 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.8 t -148.94 165.97 29.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 109.479 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 t -158.76 119.86 3.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.7 ttt-85 -93.14 108.65 20.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 m -90.76 143.07 27.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -144.88 134.61 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.52 120.06 40.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.591 -0.693 . . . . 0.0 109.434 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -81.49 -173.19 4.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.71 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.0 p -63.29 -41.37 98.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.584 -0.698 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.23 154.96 44.84 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.576 -0.703 . . . . 0.0 109.23 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.52 -25.79 7.79 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.819 3.679 . . . . 0.0 109.844 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -22.81 31.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -87.39 18.92 3.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.3 p -85.23 146.62 26.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.403 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -159.13 171.56 19.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.644 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.7 m -140.76 133.43 28.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.686 -0.634 . . . . 0.0 109.371 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -89.6 97.4 11.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.13 143.7 37.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.429 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.7 t -128.49 104.81 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 109.532 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.414 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 28.3 m95 -102.79 166.72 10.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -144.42 138.5 27.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.616 -0.677 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.5 tttt . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.14 122.17 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.55 -0.719 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.7 m-85 -93.75 151.72 19.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.641 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -163.15 110.92 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.592 -0.693 . . . . 0.0 109.331 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -141.85 140.01 32.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.517 -0.739 . . . . 0.0 109.743 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.94 109.4 20.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -130.0 147.24 51.73 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.678 . . . . 0.0 109.616 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -94.68 170.16 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.617 -0.677 . . . . 0.0 109.43 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -60.84 -18.12 53.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 109.897 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.61 14.92 0.9 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.73 . . . . 0.0 109.801 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.03 36.41 92.84 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 6.8 tp -108.83 167.6 9.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.966 . . . . 0.0 109.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.476 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 30.3 pt -142.65 -30.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.25 -169.44 22.6 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -175.21 116.22 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.614 -0.933 . . . . 0.0 109.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.94 35.62 21.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.478 -0.764 . . . . 0.0 109.699 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.68 -61.11 4.42 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -79.18 170.95 15.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.525 -0.985 . . . . 0.0 109.471 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.4 mt -80.37 156.55 73.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.432 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -80.25 -27.44 3.59 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.061 3.84 . . . . 0.0 109.945 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 33.0 p90 -108.82 163.61 13.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 0.0 109.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -116.25 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.1 tp -107.29 80.44 0.87 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.601 -0.687 . . . . 0.0 109.47 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -45.76 -37.53 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 125.061 3.841 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.7 -45.91 90.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -62.85 -37.28 86.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.642 -0.661 . . . . 0.0 109.465 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.22 -24.21 67.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.51 -0.744 . . . . 0.0 109.506 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -85.3 -28.93 24.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -74.87 -26.72 59.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.478 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -66.63 -45.1 80.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HA ' ' HG1' ' A' ' 34' ' ' THR . 38.7 ttp180 -65.93 -31.66 72.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.71 . . . . 0.0 109.482 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.35 59.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.481 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -96.26 31.35 2.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.542 -0.724 . . . . 0.0 109.439 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.442 ' HG1' ' HA ' ' A' ' 31' ' ' ARG . 10.4 p -136.84 -35.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 129.63 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.671 . . . . 0.0 109.501 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.78 -27.56 18.4 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER -110.6 178.94 4.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.1 mt -98.05 122.84 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 56.7 ttp -88.54 102.25 14.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.54 -0.725 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 t -94.78 115.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.498 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.82 166.35 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.53 -170.18 46.65 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -79.64 -33.16 41.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.976 . . . . 0.0 109.5 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -71.63 -33.91 69.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.1 m -81.14 -30.84 34.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -66.99 -29.24 69.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.445 -0.785 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.89 -18.23 24.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.7 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.4 p -62.46 -24.38 67.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.645 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -65.21 160.77 54.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.69 -68.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.14 3.893 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.85 127.0 51.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtp-105 -123.14 157.43 60.92 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.489 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.55 -166.78 5.47 Favored 'Cis proline' 0 N--CA 1.509 2.416 0 O-C-N 123.4 1.211 . . . . 0.0 109.941 -0.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.34 96.17 38.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.515 -0.741 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -72.33 -177.7 2.86 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.656 3.57 . . . . 0.0 109.755 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 61.59 25.49 15.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 109.534 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -176.3 177.32 1.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -96.61 130.91 43.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -102.28 100.47 10.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.591 -0.693 . . . . 0.0 109.477 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 t -110.66 107.01 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.738 . . . . 0.0 109.386 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -98.97 136.92 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.632 -0.667 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.6 tp -102.47 125.98 49.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.719 . . . . 0.0 109.43 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -153.18 142.24 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -88.62 -42.22 12.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -71.79 133.28 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -85.93 30.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -101.19 -35.11 9.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -69.18 148.58 49.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.579 -0.7 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -147.18 152.98 39.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.689 . . . . 0.0 109.442 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.78 138.67 41.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.716 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -86.42 121.62 29.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 109.455 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.2 48.43 25.47 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.45 140.44 15.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.914 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -82.18 100.49 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 109.387 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -79.47 98.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.568 -0.708 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -87.67 164.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.645 -0.659 . . . . 0.0 109.459 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -138.09 29.99 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -171.94 143.22 1.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.5 t -66.82 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.551 -0.718 . . . . 0.0 109.418 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.53 76.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 109.48 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.32 77.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t -67.99 -37.47 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -74.6 -30.42 61.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.546 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.32 90.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.49 -33.34 72.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.3 62.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.0 109.592 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -64.61 -46.23 83.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -65.0 -26.99 68.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -119.16 90.15 41.07 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.57 -0.707 . . . . 0.0 109.48 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -24.03 6.65 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.122 3.881 . . . . 0.0 109.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.38 -25.35 62.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.623 -0.673 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -96.56 131.8 42.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' H ' ' HG3' ' A' ' 37' ' ' LYS . 6.1 mm-40 -95.67 152.78 18.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.576 -0.702 . . . . 0.0 109.539 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tp -88.73 137.73 32.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.63 -0.669 . . . . 0.0 109.426 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.3 123.54 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.644 -0.66 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.411 HG21 ' CE1' ' A' ' 103' ' ' PHE . 41.2 mm -93.75 119.83 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -101.69 -29.78 11.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.534 -0.729 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.25 -174.06 40.3 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.419 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.94 -154.53 19.11 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.379 -1.659 . . . . 0.0 109.555 0.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.55 -31.41 71.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.649 -0.912 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.79 -28.07 61.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.419 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.7 mm -74.37 -36.5 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.63 -0.669 . . . . 0.0 109.51 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.416 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 27.8 m-85 -63.3 -48.11 79.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.676 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.76 73.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -102.26 11.81 37.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 109.887 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -67.65 -31.89 72.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.511 -0.743 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -78.86 17.94 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.548 -0.72 . . . . 0.0 109.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -160.08 38.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.448 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -95.37 145.91 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.06 -53.14 1.74 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.578 -0.701 . . . . 0.0 109.357 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -103.37 160.84 14.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.697 . . . . 0.0 109.374 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.414 HD12 ' CE2' ' A' ' 136' ' ' PHE . 30.4 mt -139.45 98.49 3.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.728 . . . . 0.0 109.604 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.8 mt -98.49 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.625 -0.672 . . . . 0.0 109.314 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.413 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -115.05 136.77 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 0.0 109.518 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -107.7 103.32 12.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.636 -0.665 . . . . 0.0 109.278 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -87.54 143.54 27.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.52 -0.737 . . . . 0.0 109.616 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.39 133.9 55.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.638 -0.663 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.91 78.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.674 . . . . 0.0 109.487 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.29 123.93 9.63 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -76.82 143.93 39.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.633 -0.922 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -148.32 117.39 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.466 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.53 145.77 27.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.16 -128.3 2.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -140.71 -36.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.542 -0.975 . . . . 0.0 109.56 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -95.22 142.09 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.576 -0.702 . . . . 0.0 109.553 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.12 173.0 7.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.616 -0.677 . . . . 0.0 109.455 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -92.91 153.52 18.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -73.58 163.74 66.19 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.18 96.19 1.02 Allowed 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 125.135 3.89 . . . . 0.0 110.007 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.93 137.0 33.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.495 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -78.73 87.26 4.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.579 -0.701 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -68.39 -16.93 64.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.619 -0.676 . . . . 0.0 109.78 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.55 -26.22 68.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.44 29.78 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.414 ' CE2' HD12 ' A' ' 113' ' ' LEU . 45.9 m-85 -142.97 175.35 9.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.598 -0.689 . . . . 0.0 109.455 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.47 135.42 17.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.652 -0.655 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -70.92 158.03 37.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.675 -0.64 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.15 -32.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.726 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.3 p -157.74 155.5 30.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 p -149.51 122.08 8.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -99.16 105.59 17.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.3 m -84.94 142.78 29.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.56 -0.712 . . . . 0.0 109.441 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.414 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -145.14 129.89 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.659 -0.651 . . . . 0.0 109.377 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -105.92 121.07 43.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.433 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -80.32 -165.82 0.93 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.64 -39.42 64.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -101.92 138.05 19.69 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 109.418 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.66 -46.29 24.67 Favored 'Trans proline' 0 N--CA 1.505 2.202 0 C-N-CA 124.748 3.632 . . . . 0.0 110.08 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.59 69.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.518 -0.739 . . . . 0.0 109.668 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.0 18.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.733 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.1 m -87.55 140.0 29.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 109.314 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.414 ' CE1' HG12 ' A' ' 144' ' ' VAL . 34.1 p-80 -154.75 162.24 41.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.599 -0.688 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.4 m -134.46 135.51 42.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.705 . . . . 0.0 109.454 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -90.78 93.89 9.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -76.74 137.8 39.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.585 -0.697 . . . . 0.0 109.473 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 t -124.71 115.74 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.583 -0.698 . . . . 0.0 109.453 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -113.17 170.03 8.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.469 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -148.89 141.06 23.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.577 -0.702 . . . . 0.0 109.394 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.9 tttm . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.48 99.72 7.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.432 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 5.6 m-85 -76.11 131.43 39.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -147.41 113.67 5.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.347 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.3 p90 -143.38 147.12 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 109.746 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.85 114.18 26.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -133.95 150.2 51.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.491 -0.755 . . . . 0.0 109.636 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -98.63 171.44 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 11' ' ' GLY . 7.2 ptp180 -61.13 -19.85 61.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.803 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.66 15.05 0.88 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 109.754 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 61.89 38.54 96.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 tp -106.14 166.25 10.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 13' ' ' ILE . 31.3 pt -145.89 -29.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.467 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.11 -176.2 27.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -175.26 115.88 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.547 -0.972 . . . . 0.0 109.514 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.09 21.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.52 -0.737 . . . . 0.0 109.679 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.45 5.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -77.94 176.45 9.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.8 mt -77.05 157.87 80.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.38 -33.79 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 125.089 3.859 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.411 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.8 p90 -108.16 -170.59 1.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.688 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -136.53 86.89 2.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 109.446 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.6 tp -109.36 82.13 1.97 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -45.31 -38.55 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 125.172 3.915 . . . . 0.0 110.269 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -62.69 -40.19 96.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.538 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -66.05 -33.19 75.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.693 . . . . 0.0 109.407 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.1 -24.72 63.26 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.66 -29.56 27.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.633 -0.667 . . . . 0.0 109.399 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.32 -25.4 57.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -65.84 -45.74 81.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.656 -0.653 . . . . 0.0 109.449 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -65.28 -30.87 71.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.53 -30.98 57.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.523 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -97.82 32.66 2.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.432 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 p -140.29 -34.1 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.488 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.27 128.19 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.622 -0.673 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 31.97 27.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -156.54 172.3 18.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.951 . . . . 0.0 109.481 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -90.47 112.81 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.649 -0.657 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -81.51 105.01 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.484 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.0 t -113.19 123.77 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.481 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.3 m -137.74 -175.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.435 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.6 -164.89 31.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -82.84 -41.28 19.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.625 -0.926 . . . . 0.0 109.492 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -70.2 -33.15 71.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.413 ' HA ' ' HG ' ' A' ' 48' ' ' SER . 18.1 m -76.41 -29.41 57.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.461 ' HH ' ' HB3' ' A' ' 53' ' ' PRO . 33.8 t80 -67.12 -35.59 80.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.523 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -83.06 -25.27 32.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.677 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.413 ' HG ' ' HA ' ' A' ' 45' ' ' THR . 80.9 p -62.91 -22.64 66.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.567 -0.708 . . . . 0.0 109.611 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.72 164.2 13.2 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.507 -0.746 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -80.91 -73.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.11 3.874 . . . . 0.0 109.949 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -114.33 103.78 11.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.547 -0.721 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.91 156.63 39.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.696 . . . . 0.0 109.415 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HB3' ' HH ' ' A' ' 46' ' ' TYR . 9.8 Cg_endo -81.25 169.69 65.48 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.397 1.209 . . . . 0.0 110.004 -0.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.5 mt -89.76 113.09 55.55 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.36 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.46 -178.87 4.95 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 124.659 3.572 . . . . 0.0 109.918 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 61.54 24.29 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.546 -0.721 . . . . 0.0 109.704 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -176.61 174.41 1.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.573 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -91.64 131.28 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.539 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -98.91 105.22 17.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.8 144.23 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.2 t -134.45 124.12 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -97.79 117.15 31.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.538 -0.726 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -155.43 137.8 14.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -93.12 29.43 1.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.514 -0.741 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -110.24 123.79 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -86.17 30.13 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.674 -0.641 . . . . 0.0 109.407 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -124.47 -33.39 3.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -69.13 147.29 51.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.61 -0.681 . . . . 0.0 109.508 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -146.14 156.72 43.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.23 132.22 31.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.649 -0.657 . . . . 0.0 109.491 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -87.55 119.42 27.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.21 42.59 18.66 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.41 133.33 8.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.971 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -74.32 103.57 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.634 -0.666 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.13 103.28 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.578 -0.702 . . . . 0.0 109.441 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.4 m -89.98 154.88 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.678 -0.639 . . . . 0.0 109.509 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -136.16 29.52 3.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.451 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -164.88 149.34 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.441 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.414 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.0 -33.41 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.48 70.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.654 . . . . 0.0 109.529 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.42 77.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.55 -42.77 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.32 -29.27 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.616 -0.677 . . . . 0.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.83 92.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.717 . . . . 0.0 109.478 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -66.44 -42.76 87.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.13 -24.97 65.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.661 . . . . 0.0 109.51 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -41.15 97.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.592 -0.692 . . . . 0.0 109.463 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -69.47 -31.02 69.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -119.24 89.75 40.46 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.606 -0.684 . . . . 0.0 109.489 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.32 -22.71 6.77 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 125.138 3.892 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.84 -25.9 66.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.475 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -92.92 -179.93 5.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -138.76 148.56 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.669 . . . . 0.0 109.487 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.24 108.11 12.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.622 -0.673 . . . . 0.0 109.457 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.38 112.92 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.631 -0.668 . . . . 0.0 109.464 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.4 mm -91.97 122.27 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 109.36 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -101.38 -28.87 12.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.529 -0.732 . . . . 0.0 109.522 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.13 -175.83 40.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.92 -151.75 12.87 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.362 -1.669 . . . . 0.0 109.613 -0.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.94 -26.22 62.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -74.78 -23.69 58.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -80.32 -38.33 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.483 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -62.75 -48.5 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 0.0 109.396 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 t -63.6 -33.04 74.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.594 -0.691 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE1' HG12 ' A' ' 79' ' ' VAL . 45.8 m-85 -122.32 21.33 10.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.714 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 109' ' ' ASP . 19.4 pttt -63.48 -32.83 74.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.441 -0.787 . . . . 0.0 109.586 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -81.09 31.0 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.725 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 107' ' ' LYS . 5.6 m-20 -160.08 32.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.733 . . . . 0.0 109.408 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.432 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -99.22 145.63 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.319 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -128.0 -55.83 1.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.583 -0.698 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -103.69 106.86 17.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.377 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.408 HD12 ' CE2' ' A' ' 136' ' ' PHE . 24.5 mt -90.44 100.94 13.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.568 -0.707 . . . . 0.0 109.592 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.5 mt -99.23 105.98 18.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.719 . . . . 0.0 109.21 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -111.32 136.05 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.613 -0.679 . . . . 0.0 109.523 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -108.62 97.49 7.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.652 . . . . 0.0 109.248 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -85.43 139.79 31.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.632 -0.668 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 135.07 54.4 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.84 -33.31 73.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.556 -0.715 . . . . 0.0 109.472 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.88 124.42 14.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.7 t -70.25 140.83 52.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.59 -0.947 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -148.38 107.2 3.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.422 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.72 146.33 28.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.02 -123.3 1.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -143.42 -49.87 0.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.975 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.4 m -81.64 141.09 33.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.632 -0.667 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -118.46 172.94 7.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.416 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -94.47 146.97 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.47 164.69 42.01 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.469 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.29 99.96 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.113 3.876 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.39 138.07 32.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -77.74 84.81 4.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -67.23 -17.53 64.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.6 -0.688 . . . . 0.0 109.772 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -26.0 68.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.765 . . . . 0.0 109.519 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.81 30.32 2.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.718 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.408 ' CE2' HD12 ' A' ' 113' ' ' LEU . 68.0 m-85 -145.35 177.16 9.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.515 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 m -153.54 131.41 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -72.13 115.82 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 109.475 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.412 ' H ' HG21 ' A' ' 139' ' ' VAL . 27.4 m -95.1 -36.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.2 p -154.79 179.16 9.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.1 t -165.2 159.48 17.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -133.41 100.8 4.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.0 m -81.75 152.95 26.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.536 -0.727 . . . . 0.0 109.423 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.405 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -156.17 127.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.309 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.39 121.99 44.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.58 -165.61 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.3 p -72.35 -36.38 68.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.603 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -106.13 137.88 19.52 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.86 -48.19 16.75 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 124.822 3.682 . . . . 0.0 110.076 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.83 69.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.5 mt -80.38 20.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.629 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 m -91.98 136.97 32.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.525 -0.734 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.405 ' CE1' HG12 ' A' ' 144' ' ' VAL . 31.6 p-80 -151.93 169.55 22.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.697 . . . . 0.0 109.602 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.1 m -139.76 137.74 35.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.541 -0.724 . . . . 0.0 109.451 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -95.32 94.75 8.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.468 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 23.4 mt-10 -76.24 128.84 35.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.2 t -112.9 102.91 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.502 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.468 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 42.4 m95 -101.41 163.45 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -140.14 145.96 38.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.4 tttt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.602 -0.686 . . . . 0.0 109.489 179.936 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.92 127.65 34.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.7 m-85 -101.99 137.35 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 tp -149.87 111.69 4.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.602 -0.686 . . . . 0.0 109.331 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.2 p90 -142.04 151.52 42.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.711 . . . . 0.0 109.73 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 112.08 24.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -132.33 150.17 52.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.569 -0.707 . . . . 0.0 109.638 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.46 171.78 7.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -61.37 -18.69 59.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.618 -0.676 . . . . 0.0 109.763 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.37 15.14 0.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.518 -0.739 . . . . 0.0 109.775 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 37.57 94.64 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 7.1 tp -107.39 167.25 10.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.621 -0.929 . . . . 0.0 109.553 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 13' ' ' ILE . 31.7 pt -141.74 -30.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.575 -0.703 . . . . 0.0 109.519 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.0 28.74 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -173.28 115.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.462 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 33.83 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.466 -0.771 . . . . 0.0 109.723 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 -61.45 3.74 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -74.96 170.61 15.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -1.02 . . . . 0.0 109.455 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 24.0 mt -79.89 157.21 74.27 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.571 -0.706 . . . . 0.0 109.46 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.91 -30.52 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 125.018 3.812 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 35.0 p90 -105.88 -171.38 1.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.547 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -138.42 103.02 4.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.705 -0.622 . . . . 0.0 109.431 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -124.58 81.02 60.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.587 -0.695 . . . . 0.0 109.516 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.23 -39.09 20.74 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 125.117 3.878 . . . . 0.0 110.154 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.98 -52.16 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.614 -0.679 . . . . 0.0 109.525 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.95 -36.54 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.75 -24.26 67.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.455 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -85.62 -29.91 23.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -65.44 -23.96 67.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.516 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CE2' HG22 ' A' ' 34' ' ' THR . 59.6 t80 -63.15 -46.5 86.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -65.15 -25.33 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.459 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.24 -26.57 39.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -107.47 36.38 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.709 . . . . 0.0 109.475 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.409 HG22 ' CE2' ' A' ' 30' ' ' PHE . 15.0 p -138.38 -35.04 0.62 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.482 -0.761 . . . . 0.0 109.487 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.4 ' N ' HH12 ' A' ' 57' ' ' ARG . 28.0 m -67.36 126.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.8 38.61 23.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -153.97 168.53 26.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.917 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 38' ' ' ILE . 60.5 mt -93.47 104.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -78.87 117.47 20.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 t -125.13 120.19 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.669 -0.644 . . . . 0.0 109.418 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.1 m -136.08 173.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.81 -167.21 42.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -84.05 -36.36 23.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.485 -1.009 . . . . 0.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -68.16 -31.81 71.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.444 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -82.41 -27.65 31.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -64.93 -35.7 82.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 109.487 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.27 -25.87 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.7 m -67.13 -15.36 63.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.664 -0.648 . . . . 0.0 109.759 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -61.77 161.39 21.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 109.576 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 125.101 3.867 . . . . 0.0 109.987 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.6 73.57 0.92 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -72.78 157.36 88.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.58 172.7 55.23 Favored 'Cis proline' 0 N--CA 1.509 2.43 0 O-C-N 123.332 1.175 . . . . 0.0 110.035 0.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB2' HD22 ' A' ' 59' ' ' ASN . 39.2 mt -97.8 110.75 56.73 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.589 -0.694 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -76.79 178.11 8.02 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.733 3.622 . . . . 0.0 109.866 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.39 29.59 18.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.58 -0.7 . . . . 0.0 109.68 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.4 HH12 ' N ' ' A' ' 35' ' ' VAL . 1.4 ptp180 -177.1 178.91 1.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 m -105.91 119.38 39.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.45 HD22 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -96.16 111.45 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.6 t -112.92 140.73 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 109.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 t -125.26 124.78 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.3 tp -99.78 109.7 22.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.51 -0.744 . . . . 0.0 109.487 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 t -139.93 142.54 36.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.562 -0.712 . . . . 0.0 109.474 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 64' ' ' HIS . 10.6 p80 -93.86 31.6 1.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.665 -0.647 . . . . 0.0 109.568 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.9 128.64 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.584 -0.698 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -88.89 29.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.41 -33.03 6.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -69.63 152.18 45.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -152.3 110.11 3.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.727 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 75' ' ' VAL . . . -98.1 125.18 42.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.618 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -80.57 133.05 35.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.639 -0.663 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.32 37.81 70.87 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.76 133.26 9.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.609 -0.936 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -73.52 99.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.578 -0.701 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 70' ' ' ALA . 29.9 t -79.35 102.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.708 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.12 159.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 0.0 109.455 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -139.35 29.98 2.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -164.26 144.93 8.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 106' ' ' PHE . 29.4 t -68.2 -33.68 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.0 109.511 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.28 70.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 109.49 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.48 81.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.647 -0.658 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.4 t -68.42 -35.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.392 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.45 -33.02 62.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.41 70.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -71.31 -37.26 71.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.706 . . . . 0.0 109.419 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.03 -26.27 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.711 . . . . 0.0 109.526 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -70.22 -38.54 75.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.77 -24.68 65.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -115.74 93.42 37.39 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.622 -0.674 . . . . 0.0 109.483 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.99 -19.96 13.43 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 124.838 3.692 . . . . 0.0 109.957 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -81.44 -25.0 36.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.54 -0.725 . . . . 0.0 109.496 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.15 179.99 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.517 -0.739 . . . . 0.0 109.492 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -142.37 148.18 37.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 tt -80.65 123.32 28.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.556 -0.715 . . . . 0.0 109.466 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -128.59 129.46 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -102.55 129.75 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.57 -24.09 11.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 109.599 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.76 -178.34 40.56 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.486 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.66 -155.22 19.96 Favored Glycine 0 N--CA 1.5 2.92 0 O-C-N 120.321 -1.693 . . . . 0.0 109.518 0.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.93 75.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -72.88 -25.44 61.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.531 -0.731 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.486 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.7 mm -74.61 -36.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.45 -49.9 71.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.511 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.2 t -62.88 -34.82 78.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.534 -0.729 . . . . 0.0 109.595 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.42 76.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.644 -0.66 . . . . 0.0 109.688 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' HG12 ' A' ' 79' ' ' VAL . 41.8 m-85 -105.47 13.6 29.92 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.532 -0.73 . . . . 0.0 109.847 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -23.57 56.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.478 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -65.01 -22.22 66.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.649 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -130.3 41.43 3.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.53 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -86.05 156.98 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.416 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -136.54 -69.08 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 m -84.92 159.9 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.5 mt -142.01 96.27 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.632 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.5 mt -97.82 110.48 23.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.245 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -117.6 141.0 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.625 -0.672 . . . . 0.0 109.537 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -111.12 102.17 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.597 -0.689 . . . . 0.0 109.346 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -85.22 151.28 24.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.6 133.81 48.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 109.279 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.51 -30.87 68.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.586 -0.696 . . . . 0.0 109.51 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.02 128.05 11.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.6 p -79.53 141.44 36.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.53 -0.982 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -148.63 128.28 13.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.677 . . . . 0.0 109.457 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.8 163.46 14.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.83 -138.38 2.44 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.69 10.04 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.96 . . . . 0.0 109.865 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.4 m -147.28 130.39 16.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.386 -0.821 . . . . 0.0 109.5 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -105.88 176.52 5.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.593 -0.692 . . . . 0.0 109.399 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.424 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -93.33 148.31 22.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.473 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.6 pt -66.83 165.57 25.04 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.536 -0.728 . . . . 0.0 109.477 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.18 109.32 2.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.11 3.873 . . . . 0.0 109.994 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.45 139.81 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.565 -0.709 . . . . 0.0 109.501 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 83.57 4.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.52 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.18 -20.02 64.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -62.72 -23.6 67.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.527 -0.733 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -97.78 28.73 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -142.16 174.23 10.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.2 m -149.62 136.41 19.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.554 -0.716 . . . . 0.0 109.526 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -70.39 155.96 39.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.636 -0.665 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.61 -32.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.677 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 t -147.89 146.0 28.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.455 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -144.81 110.42 5.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -95.32 102.68 14.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.423 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.1 m -86.06 147.14 26.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.541 -0.725 . . . . 0.0 109.466 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -152.89 133.7 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.299 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.94 123.87 49.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.47 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -80.43 -165.1 0.8 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 p -71.47 -38.56 71.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.649 -0.657 . . . . 0.0 109.58 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -105.03 137.65 19.28 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.06 -46.19 22.98 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 124.815 3.677 . . . . 0.0 110.069 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.15 68.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.612 -0.68 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.55 19.9 0.97 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.704 . . . . 0.0 109.677 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 50.6 m -87.54 140.73 29.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.275 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.415 ' CE1' HG12 ' A' ' 144' ' ' VAL . 32.3 p-80 -152.63 167.27 29.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -140.57 130.52 24.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.594 -0.692 . . . . 0.0 109.434 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.46 93.81 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.54 139.37 38.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.423 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.6 t -128.81 113.51 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -111.71 166.38 11.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.508 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -142.94 143.06 31.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 41.4 tttt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.35 103.39 5.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.497 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 5.8 m-85 -75.42 141.29 43.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 tp -153.42 112.53 3.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 0.0 109.299 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 8.9 p90 -145.38 146.49 31.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.528 -0.733 . . . . 0.0 109.756 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 115.5 29.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 109.323 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -133.86 161.32 35.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -108.72 169.64 8.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.643 -0.661 . . . . 0.0 109.406 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HB2' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -60.8 -15.86 34.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.61 -0.681 . . . . 0.0 109.88 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 15.02 0.84 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 109.763 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.59 86.17 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 tp -117.21 151.55 36.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -120.48 -41.36 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.577 -0.702 . . . . 0.0 109.558 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.87 -170.13 27.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -163.04 124.19 2.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.928 . . . . 0.0 109.454 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.91 32.66 21.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.542 -0.724 . . . . 0.0 109.717 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 -62.5 3.55 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -73.2 173.19 9.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.965 . . . . 0.0 109.499 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 mt -93.4 155.54 40.77 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.533 -0.73 . . . . 0.0 109.469 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -79.96 -24.92 5.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 125.045 3.83 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 30.4 p90 -106.72 163.13 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.624 -0.672 . . . . 0.0 109.574 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -115.55 100.96 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.677 -0.64 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.6 tp -119.68 80.27 23.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.613 -0.679 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.91 -37.36 16.87 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 125.133 3.889 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.93 -46.88 85.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.53 -0.731 . . . . 0.0 109.57 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -62.83 -37.61 87.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 109.484 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.59 -23.94 67.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.725 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -86.97 -29.7 21.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.565 -0.709 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -73.36 -24.43 60.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.528 -0.733 . . . . 0.0 109.547 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.33 -45.35 91.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttp-105 -64.84 -29.29 70.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.477 -0.764 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.84 -29.09 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -101.13 34.91 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.704 . . . . 0.0 109.46 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.0 p -141.67 -34.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.508 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.98 126.82 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.639 -0.663 . . . . 0.0 109.456 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.35 35.14 24.13 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -156.94 166.48 33.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.581 -0.952 . . . . 0.0 109.441 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.3 mt -90.66 103.36 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.546 -0.721 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -71.96 131.48 43.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 t -135.55 116.04 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.86 -177.57 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.659 -0.65 . . . . 0.0 109.458 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 -174.06 43.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -76.17 -38.33 56.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.936 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -69.07 -41.87 76.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 m -69.97 -26.45 64.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.35 -46.03 85.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.534 -0.728 . . . . 0.0 109.487 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.86 -23.96 36.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.515 -0.741 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -62.83 -21.13 65.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -62.07 161.35 24.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.493 -0.755 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 125.103 3.869 . . . . 0.0 109.886 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -108.55 91.98 3.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.623 -0.673 . . . . 0.0 109.488 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -99.76 157.3 34.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.723 . . . . 0.0 109.458 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.5 159.06 85.8 Favored 'Cis proline' 0 N--CA 1.509 2.386 0 O-C-N 123.384 1.202 . . . . 0.0 109.953 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.98 114.17 46.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.15 179.31 6.57 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.761 3.64 . . . . 0.0 109.947 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 61.05 29.64 19.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.612 -0.68 . . . . 0.0 109.662 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.03 173.55 1.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 m -93.98 118.94 32.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -89.71 99.17 12.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.8 t -107.11 143.35 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.62 125.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.8 tp -95.9 112.46 24.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.615 -0.678 . . . . 0.0 109.541 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -140.26 150.78 44.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.574 -0.704 . . . . 0.0 109.401 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -91.24 -34.14 15.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -76.15 123.73 26.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.611 -0.68 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -83.52 29.59 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -100.46 -34.75 9.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 109.5 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -69.35 136.33 51.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.702 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -141.54 104.52 4.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.728 . . . . 0.0 109.48 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.36 119.71 26.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.551 -0.718 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -70.85 127.25 31.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.41 38.66 24.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.66 146.81 19.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.598 -0.942 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.28 98.03 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.8 t -77.19 98.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.478 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -85.13 156.86 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -136.78 30.0 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.507 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -169.8 148.82 3.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.416 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.2 t -68.34 -34.13 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.88 -31.05 67.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.681 . . . . 0.0 109.46 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.22 -37.29 83.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.542 -0.724 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 t -69.59 -40.7 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 109.379 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -72.54 -29.54 63.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.88 84.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.633 -0.667 . . . . 0.0 109.515 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.28 -40.44 81.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.737 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.71 68.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.39 -36.59 83.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.573 -0.704 . . . . 0.0 109.492 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.9 -27.77 61.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.679 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -119.61 88.05 38.24 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.36 20.21 0.97 Allowed 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.133 3.888 . . . . 0.0 109.967 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -106.86 -31.7 8.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -94.48 178.54 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.556 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -133.03 153.86 51.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.491 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.1 tp -84.64 133.63 34.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.712 . . . . 0.0 109.475 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.6 t -134.47 114.45 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.407 HG23 ' CE1' ' A' ' 103' ' ' PHE . 41.0 mm -91.48 127.39 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.494 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.74 -24.51 10.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.579 -0.701 . . . . 0.0 109.517 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.3 -179.67 36.58 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.53 -155.47 20.18 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 120.287 -1.714 . . . . 0.0 109.583 0.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.45 72.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.572 -0.957 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -69.88 -31.09 68.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.511 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.14 -37.7 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.524 -0.735 . . . . 0.0 109.528 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.407 ' CE1' HG23 ' A' ' 96' ' ' ILE . 25.6 m-85 -62.88 -46.1 89.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.557 -0.715 . . . . 0.0 109.483 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -21.78 65.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.581 -0.7 . . . . 0.0 109.605 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.87 -37.1 62.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.416 ' CE1' HG12 ' A' ' 79' ' ' VAL . 73.9 m-85 -106.4 14.78 26.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.695 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -29.75 66.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.772 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.2 -27.24 69.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.07 58.86 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -105.2 151.69 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -135.29 -68.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 127.51 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 136' ' ' PHE . 37.2 mt -111.7 87.76 2.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.6 mt -89.27 121.78 31.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.527 -0.733 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -134.49 145.09 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.647 -0.658 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -111.39 107.86 17.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.234 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -88.65 128.79 35.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.3 141.2 37.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.84 62.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.1 137.46 24.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -87.4 143.49 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.533 -0.981 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.46 124.42 14.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.638 -0.664 . . . . 0.0 109.419 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.9 140.03 30.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.514 -0.741 . . . . 0.0 109.474 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.04 -131.65 2.3 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -144.11 -27.31 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.961 . . . . 0.0 109.476 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -94.21 118.64 31.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.571 -0.706 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -103.31 166.39 10.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.38 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.413 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -92.94 144.36 25.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.634 -0.666 . . . . 0.0 109.411 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.1 pt -66.13 164.63 27.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.523 -0.736 . . . . 0.0 109.493 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.37 104.34 1.62 Allowed 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 125.109 3.873 . . . . 0.0 109.896 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.76 86.92 6.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 0.0 109.488 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -68.58 -17.76 64.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.648 -0.658 . . . . 0.0 109.707 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.45 -29.48 70.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.586 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.32 29.45 1.68 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.605 -0.684 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 113' ' ' LEU . 34.0 m-85 -140.61 173.75 11.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.523 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -146.08 135.95 23.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -72.15 156.24 39.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.52 -31.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.619 -0.675 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -147.2 154.09 40.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.561 -0.712 . . . . 0.0 109.383 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -158.03 109.75 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -93.09 107.3 19.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.644 -0.66 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.4 m -85.62 150.08 24.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.488 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.74 126.27 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -103.6 118.26 36.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.668 . . . . 0.0 109.415 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.12 -166.03 0.96 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.7 p -73.68 -43.25 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.695 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -103.1 137.82 19.37 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.318 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -46.38 -42.16 22.64 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 124.878 3.719 . . . . 0.0 110.184 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.16 85.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.3 mt -76.27 12.64 1.13 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.632 -0.667 . . . . 0.0 109.902 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.2 m -87.14 137.2 32.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.484 -0.76 . . . . 0.0 109.349 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -155.6 175.05 14.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.64 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.0 m -141.83 137.82 31.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.375 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.58 95.71 9.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.679 -0.638 . . . . 0.0 109.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.86 146.41 37.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.5 t -138.76 102.86 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.694 . . . . 0.0 109.478 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 27.9 m95 -104.46 162.53 13.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.563 -0.71 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -148.64 143.42 26.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.716 . . . . 0.0 109.462 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.461 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.76 103.73 5.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.498 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.7 m-85 -78.53 147.53 33.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.631 -0.668 . . . . 0.0 109.43 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.7 tp -158.84 111.23 2.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.564 -0.71 . . . . 0.0 109.239 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.39 143.95 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.777 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.87 116.16 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.656 . . . . 0.0 109.281 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -135.39 156.31 49.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -104.4 171.14 7.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.419 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.04 -20.16 62.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.852 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.47 14.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.765 . . . . 0.0 109.756 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.86 40.12 98.42 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.5 tp -108.93 162.64 14.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.545 -0.974 . . . . 0.0 109.577 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.3 pt -142.85 -29.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.69 . . . . 0.0 109.491 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.89 -175.62 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -174.66 116.33 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.564 -0.962 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.95 34.2 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 0.0 109.662 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -61.42 3.92 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -80.05 -175.95 5.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.622 -0.928 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.9 mt -86.08 156.88 57.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 109.461 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.7 Cg_endo -80.35 -31.15 1.74 Allowed 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 125.049 3.832 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 29.3 p90 -106.91 170.2 8.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.673 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.5 88.2 2.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.482 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.3 tp -107.24 80.5 0.86 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.04 -37.36 17.48 Favored 'Trans proline' 0 N--CA 1.506 2.234 0 C-N-CA 125.056 3.838 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -62.94 -44.89 94.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -63.03 -38.71 92.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.607 -0.683 . . . . 0.0 109.423 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.89 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -88.3 -28.83 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.695 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -73.02 -25.66 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.404 ' CE2' HG22 ' A' ' 34' ' ' THR . 59.2 t80 -64.48 -44.73 90.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -66.7 -26.23 66.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.85 -29.86 50.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.561 -0.712 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -102.61 36.25 2.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.704 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.404 HG22 ' CE2' ' A' ' 30' ' ' PHE . 20.5 p -144.68 -28.96 0.47 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.584 -0.698 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.95 128.59 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.17 32.94 46.52 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -156.35 165.26 36.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.939 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.3 107.69 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.392 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.2 ttp -82.63 104.16 12.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.455 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.87 126.84 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.533 -0.729 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.75 164.55 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.662 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.65 -161.01 36.87 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -84.78 -36.6 21.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.568 -0.96 . . . . 0.0 109.45 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -69.6 -37.25 76.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.525 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -75.9 -29.7 58.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 32.2 t80 -66.8 -33.69 76.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.489 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -82.19 -23.04 35.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -63.14 -27.78 69.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -65.24 163.53 30.95 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.736 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.2 -66.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.175 3.917 . . . . 0.0 109.894 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HZ2' ' HB3' ' A' ' 51' ' ' LYS . 4.4 mtpm? -121.02 103.19 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.618 -0.676 . . . . 0.0 109.44 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -94.07 154.19 40.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.0 109.45 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.69 164.57 78.54 Favored 'Cis proline' 0 N--CA 1.508 2.364 0 O-C-N 123.467 1.246 . . . . 0.0 109.844 -0.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.61 128.35 69.7 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.556 -0.715 . . . . 0.0 109.297 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.62 172.09 14.83 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 124.798 3.665 . . . . 0.0 109.965 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 61.37 27.75 17.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.574 -0.704 . . . . 0.0 109.8 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -177.2 178.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -105.27 147.29 28.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.62 -0.675 . . . . 0.0 109.519 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -114.92 97.89 6.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -102.67 101.81 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.58 -0.7 . . . . 0.0 109.489 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 120.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.608 -0.682 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.2 tp -101.51 106.4 17.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.425 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -138.86 151.71 47.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.713 . . . . 0.0 109.519 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 65' ' ' GLN . 9.5 p-80 -97.02 -29.69 13.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.66 -0.65 . . . . 0.0 109.512 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.406 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 11.5 tt0 -72.68 124.25 24.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.624 -0.672 . . . . 0.0 109.458 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -82.8 30.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.722 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -34.85 9.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.736 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.75 143.98 45.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.638 -0.664 . . . . 0.0 109.462 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -145.58 101.92 3.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.627 -0.67 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.19 119.95 30.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.612 -0.68 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -83.0 136.27 34.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.458 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.88 39.07 39.82 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.43 155.8 29.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.965 . . . . 0.0 109.52 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.94 95.75 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.611 -0.681 . . . . 0.0 109.483 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -80.28 100.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.541 -0.724 . . . . 0.0 109.437 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -98.7 160.34 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.663 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -139.65 30.76 2.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.628 -0.67 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -165.68 146.91 7.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.566 -0.709 . . . . 0.0 109.436 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -68.39 -34.1 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.697 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -32.31 72.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.28 -37.05 82.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.602 -0.686 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.9 t -67.68 -38.34 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.475 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.39 -32.31 66.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.683 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.37 91.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.497 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -68.26 -36.48 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.574 -0.704 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.46 70.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -66.99 -42.79 84.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.33 5.72 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 109.943 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -144.2 87.87 7.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.492 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.11 -23.6 6.35 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.113 3.876 . . . . 0.0 109.856 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.48 -24.91 61.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -100.67 178.58 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.58 -0.7 . . . . 0.0 109.481 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -136.91 172.98 12.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.94 130.16 51.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.511 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.63 129.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.549 -0.719 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -98.53 124.42 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.699 . . . . 0.0 109.425 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.6 -24.24 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.634 -0.666 . . . . 0.0 109.542 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.36 -176.46 37.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.492 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.93 -155.12 14.61 Favored Glycine 0 N--CA 1.5 2.904 0 O-C-N 120.235 -1.744 . . . . 0.0 109.589 0.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.9 76.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.565 -0.962 . . . . 0.0 109.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -73.37 -27.74 61.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.492 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -72.62 -35.61 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.545 -0.722 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 96' ' ' ILE . 27.2 m-85 -63.8 -51.58 64.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.501 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.423 ' H ' ' HG1' ' A' ' 104' ' ' THR . 3.3 m -62.44 -22.65 66.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.58 -49.85 43.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.545 -0.722 . . . . 0.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 79' ' ' VAL . 70.5 m-85 -93.17 13.93 19.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.528 -0.732 . . . . 0.0 109.906 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -67.22 -23.1 65.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.745 . . . . 0.0 109.591 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.53 14.99 0.87 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.541 -0.724 . . . . 0.0 109.839 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.17 38.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.457 -0.777 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.441 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.44 154.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.52 -0.737 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -138.45 -60.06 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.513 -0.742 . . . . 0.0 109.418 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -97.1 111.39 23.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 mt -96.13 96.38 8.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.55 -0.719 . . . . 0.0 109.586 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.5 mt -93.39 116.46 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.589 -0.694 . . . . 0.0 109.287 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.413 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -124.94 141.45 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.705 . . . . 0.0 109.455 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 m -109.49 100.46 9.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.631 -0.668 . . . . 0.0 109.26 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -83.73 133.78 34.78 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.641 -0.662 . . . . 0.0 109.657 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.16 135.92 50.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.3 -37.03 74.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.562 -0.711 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.63 124.88 16.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.8 p -77.69 148.21 35.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.969 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -148.27 128.25 13.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 0.0 109.459 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -86.12 148.59 25.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.28 -137.6 2.47 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -145.31 -33.02 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.652 -0.911 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.6 m -92.07 124.2 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -106.35 168.76 8.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.412 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -90.96 147.77 22.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.2 pt -67.73 165.07 33.98 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.42 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 104.7 1.71 Allowed 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 125.138 3.892 . . . . 0.0 109.978 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.5 mt -94.38 133.52 37.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -77.47 85.24 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.602 -0.686 . . . . 0.0 109.469 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.36 -14.21 62.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.582 -0.698 . . . . 0.0 109.815 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.34 -27.14 68.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.78 30.08 2.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.543 -0.723 . . . . 0.0 109.416 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -144.95 172.11 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.665 -0.647 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -146.8 131.81 18.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.607 -0.683 . . . . 0.0 109.49 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -74.01 120.51 19.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.554 -0.716 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.405 ' H ' HG21 ' A' ' 139' ' ' VAL . 27.1 m -97.08 -34.29 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.651 -0.656 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.1 p -164.12 163.73 22.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.659 -0.65 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.8 p -150.8 133.94 16.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -99.6 113.67 26.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.692 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.8 m -90.57 150.74 21.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 109.482 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -154.07 128.6 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.379 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -107.32 120.46 42.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.579 -0.7 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -80.43 -165.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.8 p -73.9 -39.29 63.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.593 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.66 137.58 19.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.77 -47.32 18.87 Favored 'Trans proline' 0 N--CA 1.507 2.267 0 C-N-CA 124.744 3.629 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.25 70.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.607 -0.683 . . . . 0.0 109.68 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.6 mt -79.47 18.42 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 109.66 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.3 m -91.64 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.715 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -153.08 168.51 25.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.574 -0.704 . . . . 0.0 109.596 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.5 m -135.54 135.85 40.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.562 -0.711 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -90.16 97.86 11.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.07 143.42 32.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.53 -0.731 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 t -132.4 107.56 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.424 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 30.2 m95 -105.51 169.28 8.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -147.73 145.14 28.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.507 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.3 tttt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.715 . . . . 0.0 109.451 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.02 116.4 16.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.8 m-85 -90.25 157.74 17.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.68 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 tp -169.51 109.65 0.44 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.371 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.412 ' N ' ' CE3' ' A' ' 5' ' ' TRP . 9.2 p90 -140.93 140.29 34.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.564 -0.71 . . . . 0.0 109.68 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.11 111.11 22.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.284 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.5 153.31 48.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.16 170.91 7.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 11' ' ' GLY . 5.5 ptp180 -60.54 -20.08 59.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.508 -0.745 . . . . 0.0 109.851 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.37 14.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.491 -0.755 . . . . 0.0 109.784 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 61.77 38.11 95.41 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 5.2 tp -108.82 168.14 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.944 . . . . 0.0 109.549 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 13' ' ' ILE . 30.9 pt -144.1 -29.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.722 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.61 -172.38 26.71 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.59 115.53 0.3 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.585 -0.95 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.07 32.19 20.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.569 -0.707 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.1 -61.38 3.33 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -78.78 171.93 14.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.594 -0.945 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 25.4 mt -79.7 154.49 75.95 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.554 -0.716 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.75 -29.86 2.62 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.932 3.754 . . . . 0.0 109.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.419 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 34.2 p90 -106.34 -177.65 3.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.698 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -134.87 97.89 3.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 tp -118.71 80.25 17.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.499 -0.751 . . . . 0.0 109.486 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -45.78 -40.02 19.04 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 C-N-CA 125.13 3.887 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.45 -43.99 97.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 109.624 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.15 -38.72 88.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.577 -0.702 . . . . 0.0 109.409 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.45 -23.9 67.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.516 -0.74 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -82.3 -29.24 31.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -72.14 -26.92 62.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 109.422 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.527 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.405 ' HD3' HH12 ' A' ' 57' ' ' ARG . 10.5 tpp85 -63.71 -28.26 69.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.584 -0.697 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.39 -28.13 34.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -101.57 34.95 2.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.404 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.6 p -137.66 -34.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.404 ' H ' HG21 ' A' ' 35' ' ' VAL . 27.3 m -80.59 128.59 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.484 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.96 -31.01 9.14 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -113.92 164.15 14.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 38' ' ' ILE . 58.6 mt -79.83 122.03 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.51 -0.744 . . . . 0.0 109.377 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.3 ttp -91.28 105.63 17.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.442 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 t -94.26 130.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.433 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 m -146.77 164.33 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.6 -0.688 . . . . 0.0 109.502 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.82 -163.8 38.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -84.34 -36.37 22.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.974 . . . . 0.0 109.553 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.1 ttp85 -68.08 -37.84 81.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.412 ' HA ' ' HG ' ' A' ' 48' ' ' SER . 6.9 m -75.81 -28.93 58.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 0.0 109.501 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -36.43 83.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.66 -26.16 26.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.412 ' HG ' ' HA ' ' A' ' 45' ' ' THR . 96.7 p -63.93 -19.51 65.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.13 161.21 25.4 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.11 -71.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.162 3.908 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -115.21 94.77 4.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.64 -0.662 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -98.0 157.27 34.84 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.78 147.22 73.88 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 O-C-N 123.347 1.183 . . . . 0.0 110.007 0.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.433 ' HB2' HD22 ' A' ' 59' ' ' ASN . 74.9 mt -69.62 113.63 18.57 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.353 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.11 179.38 6.5 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.766 3.644 . . . . 0.0 109.899 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 61.28 26.39 16.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.459 -0.776 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.405 HH12 ' HD3' ' A' ' 31' ' ' ARG . 11.6 ptp180 -176.63 176.91 1.48 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.534 -0.729 . . . . 0.0 109.462 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -107.29 121.66 45.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.433 HD22 ' HB2' ' A' ' 54' ' ' LEU . 2.2 m-80 -97.57 111.53 23.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.9 t -107.08 112.48 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.45 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -95.95 128.27 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.66 119.3 38.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -152.22 133.94 14.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.651 -0.656 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -92.37 30.52 1.47 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.729 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -111.15 130.41 55.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.698 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.04 31.61 0.78 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.683 . . . . 0.0 109.427 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -131.13 -25.81 2.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.671 . . . . 0.0 109.448 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -64.49 145.34 56.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.488 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.22 140.09 35.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.63 -0.669 . . . . 0.0 109.469 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.83 122.85 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.66 135.0 33.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.635 -0.666 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.71 36.68 67.01 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.67 138.35 14.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.566 -0.961 . . . . 0.0 109.468 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.4 94.58 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.596 -0.69 . . . . 0.0 109.444 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 t -74.86 100.41 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.556 -0.715 . . . . 0.0 109.449 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.82 155.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.565 -0.709 . . . . 0.0 109.521 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -136.31 29.96 2.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.97 152.1 2.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.658 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.32 -33.8 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -31.13 69.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.567 -0.708 . . . . 0.0 109.501 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.21 79.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.633 -0.667 . . . . 0.0 109.476 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.4 t -69.14 -42.56 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -71.23 -29.02 64.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.76 86.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -69.55 -35.96 75.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.31 -26.52 64.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.472 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -64.36 -43.91 93.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.56 -0.712 . . . . 0.0 109.467 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.98 -30.38 69.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.592 -0.692 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -119.71 89.9 42.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.09 -23.21 6.69 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 125.024 3.816 . . . . 0.0 109.96 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -68.75 -25.77 64.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.91 -179.91 5.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -138.15 161.81 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.579 -0.701 . . . . 0.0 109.518 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.8 tp -99.6 133.29 44.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.561 -0.712 . . . . 0.0 109.476 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.0 136.32 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.419 HG23 ' CD1' ' A' ' 103' ' ' PHE . 40.7 mm -102.24 120.02 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.25 -26.59 10.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.486 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.26 -176.71 38.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.44 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.41 -153.18 14.12 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 120.361 -1.67 . . . . 0.0 109.604 0.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.24 -32.38 73.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.605 -0.938 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.28 -27.74 60.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.44 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.6 mm -74.88 -34.75 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CD1' HG23 ' A' ' 96' ' ' ILE . 23.6 m-85 -63.48 -54.29 38.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.448 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 m -63.16 -24.59 67.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.76 76.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 79' ' ' VAL . 49.8 m-85 -106.14 13.13 29.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.581 -0.699 . . . . 0.0 109.84 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -71.32 -25.41 62.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 0.0 109.549 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.93 13.83 0.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.65 -0.657 . . . . 0.0 109.857 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.09 36.83 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.448 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.28 149.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -126.27 -49.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 m -107.49 158.24 17.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.8 mt -137.23 104.84 5.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 44.4 mt -103.55 105.06 15.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.497 -0.752 . . . . 0.0 109.308 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.411 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.8 p -111.81 136.32 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 109.495 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -108.3 99.85 9.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -83.37 149.04 26.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.637 -0.665 . . . . 0.0 109.5 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.54 132.14 52.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.605 -0.684 . . . . 0.0 109.305 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.22 77.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.555 -0.715 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.85 128.75 17.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 p -83.69 141.94 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.627 -0.925 . . . . 0.0 109.436 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -145.88 126.27 14.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.717 . . . . 0.0 109.39 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -89.16 148.04 23.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 109.508 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.39 -136.03 2.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -138.4 -31.44 0.75 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.92 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -97.7 143.2 28.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -122.87 176.96 5.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.58 -0.7 . . . . 0.0 109.486 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.8 tpt -97.92 152.56 19.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.556 -0.715 . . . . 0.0 109.468 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.9 pt -72.0 163.41 67.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.677 -0.639 . . . . 0.0 109.525 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.14 96.87 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 125.162 3.908 . . . . 0.0 109.91 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.1 mt -85.96 134.9 33.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.705 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -79.97 86.59 5.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.528 -0.733 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -67.32 -14.84 63.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.562 -0.711 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.26 -27.65 69.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.452 -0.78 . . . . 0.0 109.509 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.65 29.57 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.557 -0.715 . . . . 0.0 109.449 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -142.08 179.79 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.528 -0.732 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 m -153.88 139.45 17.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 0.0 109.487 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -77.85 156.45 30.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.696 . . . . 0.0 109.509 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.09 -32.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -151.65 153.14 33.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.7 p -150.15 122.45 8.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 109.5 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -97.3 98.86 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 0.0 109.472 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m -84.15 139.86 32.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.602 -0.686 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -148.51 136.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.9 123.87 50.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.677 . . . . 0.0 109.419 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -79.96 -165.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.1 p -72.67 -40.79 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.548 -0.72 . . . . 0.0 109.638 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -100.63 138.13 20.04 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.684 . . . . 0.0 109.494 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.52 -46.48 23.58 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 124.717 3.611 . . . . 0.0 109.983 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.69 -27.66 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.733 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.1 mt -79.98 18.36 0.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.9 m -86.61 143.71 27.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.403 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.412 ' CE1' HG11 ' A' ' 144' ' ' VAL . 27.8 p-80 -155.9 163.82 39.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.672 . . . . 0.0 109.547 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.2 m -137.69 134.55 35.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 109.472 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.38 96.39 10.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -81.99 136.66 35.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.54 -0.725 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.8 t -125.47 109.07 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.0 m95 -103.88 169.26 8.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -143.57 140.61 30.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 48.2 tttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.493 -0.754 . . . . 0.0 109.467 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.86 95.67 3.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.447 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.6 m-85 -68.38 134.05 49.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.9 tp -148.53 113.03 5.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.373 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -143.98 145.47 32.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.499 -0.751 . . . . 0.0 109.711 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.64 107.27 19.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 0.0 109.26 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -127.1 157.7 38.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.643 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -97.65 170.08 9.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -61.23 -17.54 53.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.67 14.17 0.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.728 . . . . 0.0 109.865 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.11 39.21 97.33 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.02 151.51 47.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.624 -0.927 . . . . 0.0 109.413 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 13' ' ' ILE . 30.5 pt -111.39 -32.02 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.649 -0.657 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.02 -150.29 18.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -169.99 147.59 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.61 -0.935 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.63 8.11 1.62 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.22 -48.77 1.54 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -72.15 165.73 23.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.494 -1.004 . . . . 0.0 109.566 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.438 ' CD2' ' CZ2' ' A' ' 21' ' ' TRP . 13.6 mt -87.35 147.7 42.8 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.678 . . . . 0.0 109.52 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -82.01 -31.81 0.92 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 124.987 3.791 . . . . 0.0 109.767 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.438 ' CZ2' ' CD2' ' A' ' 19' ' ' LEU . 26.3 p90 -101.26 157.36 16.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.727 -0.608 . . . . 0.0 109.497 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -106.09 98.13 7.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.5 tp -121.04 79.8 34.06 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.424 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.47 -39.03 16.66 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 125.142 3.894 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.95 -42.55 99.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.692 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -68.02 -29.78 68.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.471 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.567 -0.708 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -84.8 -29.71 25.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 18.2 t80 -71.09 -27.0 63.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -65.17 -45.58 84.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.624 -0.672 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HA ' ' HG1' ' A' ' 34' ' ' THR . 68.0 ttt180 -66.15 -30.05 70.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.505 -0.747 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.98 -31.53 56.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.2 mm100 -97.07 32.32 2.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.55 -0.719 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.434 ' HG1' ' HA ' ' A' ' 31' ' ' ARG . 12.5 p -137.89 -34.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.449 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -69.25 125.91 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.64 -0.663 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.87 34.89 23.35 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -152.69 174.38 14.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.591 -0.946 . . . . 0.0 109.416 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.77 100.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 109.401 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.7 tmm? -71.81 131.79 43.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 109.451 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -135.25 117.98 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.499 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.43 -173.3 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.524 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.97 -173.89 29.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -76.28 -35.31 58.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.61 -0.935 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -69.71 -39.39 76.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 m -76.33 -27.24 56.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.433 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -63.34 -39.82 95.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -87.34 -22.93 24.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.632 -0.668 . . . . 0.0 109.594 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 m -62.87 -22.66 66.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -62.1 162.22 19.39 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.542 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -73.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.159 3.906 . . . . 0.0 109.897 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.47 90.42 3.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.439 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt85 -93.66 157.13 38.83 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.644 -0.66 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.8 -174.79 15.18 Favored 'Cis proline' 0 N--CA 1.508 2.353 0 O-C-N 123.447 1.235 . . . . 0.0 110.035 0.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.65 105.99 52.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 109.374 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -75.05 -178.7 4.37 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 124.602 3.534 . . . . 0.0 109.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.55 23.41 13.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -176.27 175.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.435 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -95.84 143.89 26.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.46 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -116.9 117.62 30.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.47 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.07 103.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 t -91.64 136.45 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.3 tp -104.04 115.22 30.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -143.11 146.92 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.691 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -93.58 -35.16 13.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -73.46 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.639 -0.663 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.16 30.1 0.54 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.71 -35.75 8.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -71.31 139.6 49.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.532 -0.73 . . . . 0.0 109.477 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -142.67 100.13 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.42 117.69 24.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.9 131.63 42.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 38.85 34.6 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.74 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.555 -0.968 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 t -75.09 98.27 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.84 99.06 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.46 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.11 164.93 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.482 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -141.46 27.93 1.86 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.44 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -174.9 153.42 1.69 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.68 -30.84 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.641 -0.662 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.99 69.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.649 -0.657 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.49 58.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.517 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 t -68.18 -46.35 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.493 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -71.72 -28.84 63.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.83 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.644 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -72.44 -33.7 67.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.87 -30.9 68.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -66.84 -40.75 88.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -67.27 -30.3 70.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.469 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -119.84 89.87 42.68 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.22 -22.43 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.196 3.93 . . . . 0.0 109.947 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -66.98 -26.6 66.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.52 -0.738 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -96.22 -179.86 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.514 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -137.53 154.63 49.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.43 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -86.65 141.33 29.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.586 -0.696 . . . . 0.0 109.445 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -146.93 118.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.55 -0.719 . . . . 0.0 109.488 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 96' ' ' ILE . 41.7 mm -91.76 125.88 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.465 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -100.93 -34.93 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.97 -178.45 39.37 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.01 -152.26 16.81 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 120.356 -1.673 . . . . 0.0 109.529 0.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.14 65.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.948 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -69.62 -33.44 72.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -75.3 -38.54 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.537 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.415 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 28.9 m-85 -63.08 -51.51 66.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -62.87 -23.98 67.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.603 -0.686 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.18 61.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 79' ' ' VAL . 57.3 m-85 -111.74 17.36 19.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.695 -0.628 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -27.0 65.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.82 18.69 0.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.55 -0.719 . . . . 0.0 109.703 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.15 36.32 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.447 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -91.39 150.76 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.505 -0.747 . . . . 0.0 109.366 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -132.36 -55.97 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.413 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 m -102.06 125.66 48.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.706 . . . . 0.0 109.375 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.9 mt -108.71 96.55 6.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.605 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.13 105.7 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 109.298 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -111.85 143.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.631 -0.668 . . . . 0.0 109.505 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.8 m -117.69 99.58 7.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.251 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 mtt85 -85.19 141.67 29.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.01 138.72 49.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.611 -0.681 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.92 72.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.602 -0.686 . . . . 0.0 109.433 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.34 132.48 13.4 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.6 m -85.32 142.52 29.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.966 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -143.13 135.24 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -97.68 155.29 17.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.541 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.69 -139.54 2.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.58 -26.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.8 m -97.82 116.83 30.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -100.77 167.71 10.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.448 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -85.65 149.97 24.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.468 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.39 164.78 58.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.608 -0.683 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 101.79 1.37 Allowed 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 125.104 3.87 . . . . 0.0 109.871 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.19 157.25 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.64 86.55 7.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -73.45 -17.5 61.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.783 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.19 9.88 1.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.541 -0.724 . . . . 0.0 109.848 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -132.34 29.16 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.732 . . . . 0.0 109.392 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -144.33 178.82 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.606 -0.684 . . . . 0.0 109.507 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.4 m -151.69 138.71 19.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.631 -0.668 . . . . 0.0 109.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -79.69 120.59 24.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.45 -32.93 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.549 -0.719 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.8 t -150.73 176.0 11.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -163.48 116.61 1.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 109.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -95.09 108.2 20.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.546 -0.721 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 m -92.33 144.58 25.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -146.83 127.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -101.89 119.13 38.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.07 -168.66 1.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.59 -0.694 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.3 p -72.18 -43.07 65.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.588 -0.695 . . . . 0.0 109.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -101.77 137.85 19.67 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.41 -48.38 11.76 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 124.996 3.797 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.09 78.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.572 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.2 mt -72.06 6.31 2.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 109.868 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.0 m -80.67 146.19 31.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.36 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.415 ' CE1' HG12 ' A' ' 144' ' ' VAL . 32.4 p-80 -160.79 167.87 25.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.569 -0.707 . . . . 0.0 109.55 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.0 m -140.13 139.34 35.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.578 -0.701 . . . . 0.0 109.335 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.52 99.38 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.468 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.9 mt-10 -80.9 130.97 35.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.475 -0.766 . . . . 0.0 109.438 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -115.16 103.53 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.695 . . . . 0.0 109.45 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.468 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 34.1 m95 -101.01 165.26 11.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.511 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -147.57 145.3 29.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.565 -0.71 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 56.9 tttt . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.519 179.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.5 133.15 34.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.548 -0.72 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.443 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.7 m-85 -100.95 160.87 14.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.701 . . . . 0.0 109.437 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 tp -169.55 109.06 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.68 . . . . 0.0 109.35 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.3 p90 -140.91 146.66 37.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.4 112.22 24.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -132.61 149.85 52.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.58 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -99.13 170.8 8.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -61.3 -18.7 59.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.818 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.46 15.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.445 -0.784 . . . . 0.0 109.858 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.37 35.32 91.5 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 5.9 tp -107.34 167.12 10.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.436 HD11 HG22 ' A' ' 13' ' ' ILE . 31.2 pt -141.86 -30.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.521 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.43 -167.41 27.06 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -172.49 121.22 0.42 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.627 -0.925 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 57.99 34.0 23.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.706 . . . . 0.0 109.923 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.92 -63.69 2.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -76.26 177.46 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.54 -0.977 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.4 mt -84.94 156.9 60.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.576 -0.703 . . . . 0.0 109.494 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.26 -28.38 3.05 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 125.055 3.836 . . . . 0.0 109.923 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 33.3 p90 -108.09 176.02 5.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -126.55 98.85 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.693 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.8 tp -118.23 80.44 15.69 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 109.51 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -45.88 -37.74 17.21 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 125.051 3.834 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.63 -45.51 92.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -63.09 -39.66 95.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.474 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.77 -23.62 67.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -86.07 -28.54 24.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.365 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.432 ' CZ ' ' NE2' ' A' ' 33' ' ' GLN . 20.6 t80 -71.67 -26.51 62.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.672 . . . . 0.0 109.476 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -65.27 -46.33 80.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.547 -0.72 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -71.09 2.72 4.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.643 . . . . 0.0 109.994 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.02 -33.06 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.831 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.432 ' NE2' ' CZ ' ' A' ' 29' ' ' TYR . 3.5 mp0 -107.99 30.46 6.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 p -126.63 -30.59 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.483 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.13 134.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.573 -0.704 . . . . 0.0 109.445 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.18 34.29 64.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -156.92 165.78 35.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.954 . . . . 0.0 109.511 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.8 mt -92.51 111.61 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.594 -0.691 . . . . 0.0 109.465 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.0 ttp -87.83 111.7 21.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.0 t -98.87 122.48 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.42 161.54 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.652 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.81 -177.61 52.03 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -72.35 -38.36 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.457 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.8 mtm-85 -68.23 -34.08 75.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -78.68 -28.82 45.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.579 -0.701 . . . . 0.0 109.459 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 35.7 t80 -68.17 -29.22 68.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.541 -0.725 . . . . 0.0 109.496 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -85.8 -24.62 26.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.537 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p -63.6 -25.34 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.635 -0.666 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -63.98 161.26 40.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.542 -0.724 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.81 -61.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.084 3.856 . . . . 0.0 109.878 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -126.37 77.01 1.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.394 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' H ' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -79.87 150.73 72.69 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 0.0 109.588 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.41 161.64 87.09 Favored 'Cis proline' 0 N--CA 1.51 2.466 0 O-C-N 123.445 1.234 . . . . 0.0 109.859 0.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.5 mt -78.53 142.93 62.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -80.58 162.62 21.78 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 124.914 3.742 . . . . 0.0 110.037 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.08 28.46 18.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.544 -0.723 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -177.83 146.36 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.555 -0.715 . . . . 0.0 109.629 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -78.43 152.42 32.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.589 -0.694 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -123.79 97.67 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.695 . . . . 0.0 109.5 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -91.62 149.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -136.03 120.72 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.445 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.1 tp -96.21 119.52 34.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 109.492 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.37 146.07 36.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -100.57 31.21 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -150.95 137.17 18.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.635 -0.666 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -87.74 32.19 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -95.14 -38.04 10.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.668 -0.645 . . . . 0.0 109.475 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -73.56 158.18 35.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -151.73 101.52 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.45 115.33 27.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.544 -0.722 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -80.36 124.5 28.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.63 -0.669 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.82 40.38 12.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.47 153.82 29.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.598 -0.942 . . . . 0.0 109.558 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -86.29 94.29 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.586 -0.696 . . . . 0.0 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.4 t -75.55 103.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.63 -0.669 . . . . 0.0 109.444 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -96.57 157.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.519 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -135.95 30.68 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -169.98 146.46 3.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -67.95 -32.37 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.638 -0.664 . . . . 0.0 109.476 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.79 70.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.738 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.46 -35.21 78.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 t -68.45 -33.31 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.45 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.15 -31.22 39.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.661 -0.649 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.46 67.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.458 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.53 -25.32 22.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.635 -0.665 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.17 -33.18 50.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.83 -31.51 72.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.546 -0.721 . . . . 0.0 109.5 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.36 -26.12 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.674 -0.641 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.37 90.28 42.01 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.465 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.25 -22.46 8.33 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.077 3.852 . . . . 0.0 109.95 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.94 -27.18 65.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -96.99 -179.99 4.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -138.02 150.68 47.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 tp -88.08 130.2 35.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.6 t -128.83 129.86 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.525 -0.734 . . . . 0.0 109.435 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 103' ' ' PHE . 40.9 mm -96.64 116.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.613 -0.68 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -104.08 -29.97 10.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.66 -175.51 39.06 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.05 -151.86 11.02 Favored Glycine 0 N--CA 1.5 2.902 0 O-C-N 120.298 -1.707 . . . . 0.0 109.567 -0.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.12 -30.64 69.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.606 -0.938 . . . . 0.0 109.483 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.73 -27.56 60.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 0.0 109.425 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -77.26 -33.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 96' ' ' ILE . 20.0 m-85 -63.38 -58.19 7.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.483 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.432 ' H ' ' HG1' ' A' ' 104' ' ' THR . 1.9 m -62.91 -21.92 66.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.596 -0.69 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.55 -29.13 64.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 79' ' ' VAL . 54.5 m-85 -117.35 16.55 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.707 . . . . 0.0 109.778 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -23.03 63.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.636 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.05 -39.01 83.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.569 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.8 41.28 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.443 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -91.17 151.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.748 . . . . 0.0 109.315 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -134.57 -66.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.581 -0.699 . . . . 0.0 109.441 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -90.03 161.92 15.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.41 HD12 ' CE2' ' A' ' 136' ' ' PHE . 59.3 mt -140.78 96.85 3.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.557 -0.714 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.69 104.44 16.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.322 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.0 p -111.23 137.43 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.2 m -109.19 99.16 8.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.337 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -85.07 139.62 31.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.04 140.05 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.294 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.28 -34.33 68.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.575 -0.703 . . . . 0.0 109.487 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.67 128.77 18.26 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.2 t -77.35 137.33 38.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.632 -0.923 . . . . 0.0 109.493 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -144.09 117.78 9.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.608 -0.683 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -93.06 145.29 24.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.461 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.8 -120.21 1.52 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.06 -36.35 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.674 -0.898 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 m -93.14 144.38 25.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.625 -0.672 . . . . 0.0 109.584 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -122.78 176.42 5.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.692 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -91.74 150.95 20.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.695 . . . . 0.0 109.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.9 pt -73.67 165.55 52.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.705 . . . . 0.0 109.456 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.95 92.72 1.09 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.123 3.882 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -77.87 149.73 34.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.595 -0.69 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -81.63 81.83 7.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -70.14 -13.92 62.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 9.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.386 -0.821 . . . . 0.0 109.904 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -136.82 30.26 2.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.41 ' CE2' HD12 ' A' ' 113' ' ' LEU . 60.2 m-85 -139.41 177.03 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.711 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -153.69 143.56 21.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.659 -0.651 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -76.22 157.04 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.582 -0.699 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.29 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.502 -0.749 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 t -147.13 159.52 43.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.632 -0.667 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.9 t -157.12 111.06 2.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.68 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -95.88 106.82 19.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.0 m -90.19 143.37 26.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -147.29 131.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -109.39 121.85 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.687 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.33 -171.59 3.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.9 p -63.2 -45.05 93.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.313 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.46 158.91 42.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -78.81 -23.09 8.4 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 124.915 3.743 . . . . 0.0 109.819 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.76 -23.02 29.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.513 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 mt -86.01 16.84 3.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.715 . . . . 0.0 109.817 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.0 m -82.62 146.25 29.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.447 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -160.26 166.45 29.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 109.544 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.6 m -138.67 138.65 37.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.586 -0.696 . . . . 0.0 109.42 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -93.69 92.19 7.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.471 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 39.0 mm-40 -74.43 126.23 30.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -110.89 112.15 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.484 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.471 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 33.4 m95 -109.22 168.34 9.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -147.1 141.08 25.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.698 . . . . 0.0 109.452 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.466 ' H2 ' ' HG1' ' A' ' 1' ' ' THR . 8.4 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.31 113.27 13.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.558 -0.714 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.5 m-85 -86.92 153.39 21.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.6 tp -163.28 109.85 1.16 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 0.0 109.359 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.418 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.3 p90 -141.2 146.12 36.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.546 -0.721 . . . . 0.0 109.708 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.78 113.04 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.587 -0.696 . . . . 0.0 109.245 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -131.87 152.45 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.543 -0.723 . . . . 0.0 109.66 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -102.97 171.21 7.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLY . 3.5 ptm85 -60.92 -19.45 60.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.554 -0.716 . . . . 0.0 109.808 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.45 14.86 0.88 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.491 -0.756 . . . . 0.0 109.736 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.17 36.89 93.63 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.65 167.33 9.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.936 . . . . 0.0 109.473 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.3 pt -142.57 -29.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.15 -176.56 44.46 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -164.19 124.1 2.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.942 . . . . 0.0 109.53 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 29.18 18.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.517 -0.739 . . . . 0.0 109.754 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -62.42 2.51 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -72.4 -179.78 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.94 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 25.7 mt -91.4 157.83 41.76 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.464 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.34 -30.24 2.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.063 3.842 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.419 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 34.9 p90 -105.44 -175.45 2.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.585 -0.697 . . . . 0.0 109.527 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -134.28 103.06 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.361 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.8 tp -124.74 82.39 60.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.44 -38.78 16.22 Favored 'Trans proline' 0 N--CA 1.508 2.329 0 C-N-CA 125.066 3.844 . . . . 0.0 110.21 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.79 -47.37 83.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.472 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -64.47 -28.95 70.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.512 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -72.72 -23.69 60.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.587 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -87.18 -27.83 22.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.581 -0.7 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -69.68 -28.44 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -67.59 -45.7 74.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.402 ' HA ' ' HG1' ' A' ' 34' ' ' THR . 18.2 ttm180 -67.12 -26.25 66.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.65 -0.656 . . . . 0.0 109.46 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.7 -28.07 40.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.549 -0.719 . . . . 0.0 109.462 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -104.72 35.71 2.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.402 ' HG1' ' HA ' ' A' ' 31' ' ' ARG . 13.9 p -139.26 -27.01 0.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.694 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.29 124.26 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.64 . . . . 0.0 109.501 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 37.84 61.54 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -146.93 164.12 33.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.529 -0.983 . . . . 0.0 109.534 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.451 HG22 HD11 ' A' ' 38' ' ' ILE . 58.9 mt -94.1 103.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.432 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.3 ttp -86.49 105.17 16.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.64 -0.663 . . . . 0.0 109.481 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 t -94.24 124.54 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.5 166.26 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 109.489 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.31 -164.25 40.08 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -81.85 -37.49 26.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.62 -0.929 . . . . 0.0 109.441 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -66.99 -42.3 85.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.643 -0.66 . . . . 0.0 109.486 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -72.27 -26.11 61.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.612 -0.68 . . . . 0.0 109.456 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -64.32 -41.3 96.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.442 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -85.37 -21.18 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.63 -0.668 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -62.71 -24.26 67.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.739 . . . . 0.0 109.608 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -62.83 161.06 31.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.98 -72.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.194 3.929 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -107.36 94.46 5.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -99.01 157.18 34.55 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.77 153.46 83.03 Favored 'Cis proline' 0 N--CA 1.508 2.35 0 O-C-N 123.37 1.195 . . . . 0.0 109.967 0.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.45 114.06 34.78 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.636 -0.665 . . . . 0.0 109.282 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.28 -179.16 5.17 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 124.791 3.66 . . . . 0.0 109.906 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 60.81 32.13 20.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.714 . . . . 0.0 109.666 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -177.11 -171.59 0.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.764 . . . . 0.0 109.544 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -118.06 113.09 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.601 -0.687 . . . . 0.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 59' ' ' ASN . 1.5 m-80 -83.49 103.67 13.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 0.0 109.417 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.62 92.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.582 -0.699 . . . . 0.0 109.461 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -79.66 136.86 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.6 tp -108.65 109.75 21.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.677 -0.64 . . . . 0.0 109.499 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -137.51 151.69 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.449 ' CD2' ' H ' ' A' ' 64' ' ' HIS . 9.3 p80 -95.76 -33.9 12.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -77.22 128.81 35.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -85.16 30.36 0.6 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.714 . . . . 0.0 109.522 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -98.43 -36.37 9.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.692 . . . . 0.0 109.579 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -71.04 146.76 49.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -143.96 103.4 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.33 117.61 26.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -74.62 127.37 32.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.63 -0.669 . . . . 0.0 109.487 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.28 38.06 35.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.8 144.47 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.958 . . . . 0.0 109.417 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -79.69 104.45 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.6 t -85.65 94.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.555 -0.715 . . . . 0.0 109.414 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.6 171.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -143.95 29.96 1.33 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.493 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -171.22 142.86 1.81 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.559 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.5 t -66.55 -33.64 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.85 74.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.659 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.02 79.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.627 -0.671 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.06 -40.25 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.455 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.89 -29.55 66.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.42 77.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.665 . . . . 0.0 109.529 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -72.39 -34.14 67.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.513 -0.742 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.79 -30.49 68.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -65.81 -40.4 91.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -65.69 -29.63 70.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.619 -0.676 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -118.99 90.06 40.33 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.01 -23.54 6.52 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.061 3.841 . . . . 0.0 109.828 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.56 -25.31 63.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.676 -0.64 . . . . 0.0 109.495 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 1.4 tp60 -94.6 179.85 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 28.4 mt-10 -136.52 155.61 49.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.598 -0.689 . . . . 0.0 109.468 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -97.4 147.81 23.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.606 -0.684 . . . . 0.0 109.462 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -145.92 139.12 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.585 -0.697 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.419 HG23 ' CD1' ' A' ' 103' ' ' PHE . 40.9 mm -105.21 120.55 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.429 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -101.97 -29.1 12.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 109.415 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 156.67 -174.41 34.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.97 -150.14 9.06 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.266 -1.726 . . . . 0.0 109.58 -0.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.17 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.962 . . . . 0.0 109.53 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.51 -28.06 65.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.601 -0.687 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -79.44 -36.12 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CD1' HG23 ' A' ' 96' ' ' ILE . 22.4 m-85 -63.3 -52.96 59.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.478 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.13 -28.04 69.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.61 -0.681 . . . . 0.0 109.535 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.46 79.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.679 . . . . 0.0 109.534 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.61 8.78 41.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.503 -0.748 . . . . 0.0 109.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -66.07 -30.67 71.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.56 14.45 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.0 109.873 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -160.1 37.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.741 . . . . 0.0 109.402 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.448 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -95.77 153.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.596 -0.69 . . . . 0.0 109.442 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -130.94 -52.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -102.29 158.69 16.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.675 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.8 mt -139.49 107.7 5.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.8 mt -104.66 102.51 12.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.242 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.418 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -108.27 137.92 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.526 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -109.09 99.82 9.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -81.98 147.66 29.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.712 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -126.33 131.92 51.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.554 -0.716 . . . . 0.0 109.277 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.69 71.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.464 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.8 127.47 13.48 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.4 p -79.16 140.66 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.934 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -147.95 129.53 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.462 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -99.35 151.03 21.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.535 -0.728 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.56 -122.38 1.32 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -146.27 -36.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.599 -0.942 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.2 m -99.42 135.74 40.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -110.32 179.95 3.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.415 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.15 144.73 25.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 109.548 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.8 pt -67.27 163.5 45.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.632 -0.668 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.79 94.85 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 125.137 3.891 . . . . 0.0 109.945 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.1 mt -77.91 147.29 35.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.523 -0.736 . . . . 0.0 109.388 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -79.67 86.75 5.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.4 ' C ' ' H ' ' A' ' 135' ' ' ASP . 95.1 m95 -73.94 -11.76 60.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.953 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.01 10.11 1.31 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 133' ' ' TRP . 2.3 m-20 -138.56 30.73 2.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -143.21 176.96 8.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.3 m -156.69 140.14 15.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -81.95 120.87 25.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.567 -0.708 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.02 -35.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.724 . . . . 0.0 109.51 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.4 p -148.64 170.26 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.1 p -157.49 113.64 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.36 104.1 16.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.538 -0.726 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.3 m -86.02 147.09 26.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -151.74 132.49 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.586 -0.696 . . . . 0.0 109.38 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -107.6 128.91 54.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.81 -166.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -69.96 -39.0 76.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -105.38 137.7 19.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.42 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -48.53 -43.7 32.44 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 124.775 3.65 . . . . 0.0 110.059 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.88 -29.06 69.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.537 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.7 mt -80.71 21.2 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.6 m -89.06 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.418 ' CE1' HG12 ' A' ' 144' ' ' VAL . 34.6 p-80 -153.76 168.23 26.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.4 m -141.67 128.25 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -84.52 95.83 8.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.439 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 25.7 mt-10 -81.12 130.4 35.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 t -117.6 106.06 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.5 m95 -100.48 166.81 10.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.721 . . . . 0.0 109.481 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -142.49 147.14 35.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttm . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.695 . . . . 0.0 109.501 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.37 20.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.8 m-85 -87.92 135.03 33.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.587 -0.696 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 tp -150.08 112.91 4.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.722 . . . . 0.0 109.467 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.416 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -144.23 138.79 28.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.536 -0.727 . . . . 0.0 109.735 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.84 111.19 22.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -129.75 157.64 41.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.515 -0.74 . . . . 0.0 109.68 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -101.32 168.44 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.559 -0.713 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -60.77 -23.88 65.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 109.713 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.71 -1.44 3.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.636 -0.665 . . . . 0.0 109.907 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.75 44.79 19.1 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 tp -124.55 152.32 43.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.562 -0.963 . . . . 0.0 109.53 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -128.01 -33.87 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.569 -0.707 . . . . 0.0 109.81 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' H ' HD12 ' A' ' 13' ' ' ILE . . . -146.01 178.84 23.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -172.03 116.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.624 -0.927 . . . . 0.0 109.543 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.86 31.18 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.507 -0.745 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.55 -59.57 4.04 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -81.95 179.99 7.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.598 -0.943 . . . . 0.0 109.503 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 20.2 mt -88.57 155.1 51.09 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.0 109.4 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.28 -29.46 3.1 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 124.946 3.764 . . . . 0.0 109.892 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 37.5 p90 -105.06 167.24 9.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.639 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -123.37 83.77 2.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 109.394 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.2 tp -106.76 81.4 0.88 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.538 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -45.01 -39.06 14.24 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 125.262 3.974 . . . . 0.0 110.22 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.91 -38.33 90.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.446 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.91 -32.32 69.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.528 -0.732 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.3 mt -72.47 -24.23 61.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.737 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -82.15 -30.32 31.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.593 -0.692 . . . . 0.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -70.47 -25.11 63.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.571 -0.705 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -63.39 -45.43 91.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.584 -0.698 . . . . 0.0 109.401 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -64.45 -28.71 69.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -28.71 46.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.527 -0.733 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -101.96 33.65 2.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.541 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.8 p -140.05 -34.45 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.59 126.04 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.557 -0.714 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.53 36.8 25.45 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -154.49 175.29 13.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.654 -0.909 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 99.97 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.557 -0.714 . . . . 0.0 109.415 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -72.62 125.77 28.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.486 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -132.55 118.55 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.35 -176.17 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.87 -169.39 33.74 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -80.01 -35.69 36.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.929 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -70.22 -40.86 74.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 m -73.1 -26.08 61.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -63.67 -45.09 91.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.629 -0.67 . . . . 0.0 109.502 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -77.48 -23.31 50.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.626 -0.671 . . . . 0.0 109.568 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.9 m -63.05 -24.16 67.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.509 -0.745 . . . . 0.0 109.607 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.43 160.59 58.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.583 -0.698 . . . . 0.0 109.471 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.96 -72.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 125.075 3.85 . . . . 0.0 109.955 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -109.22 94.81 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -99.54 157.26 34.3 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.75 154.09 83.61 Favored 'Cis proline' 0 N--CA 1.509 2.419 0 O-C-N 123.313 1.165 . . . . 0.0 109.923 0.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.2 mt -73.88 115.61 44.0 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.642 -0.661 . . . . 0.0 109.277 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.96 178.86 7.04 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 124.741 3.627 . . . . 0.0 109.934 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 61.34 29.32 18.52 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.595 -0.69 . . . . 0.0 109.608 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.0 167.61 2.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.702 . . . . 0.0 109.465 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -88.26 117.06 26.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -91.85 101.61 14.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.22 145.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -134.93 116.43 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.587 -0.696 . . . . 0.0 109.417 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.5 tp -96.2 119.54 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.573 -0.705 . . . . 0.0 109.485 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.51 152.61 48.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.454 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -93.79 -37.24 11.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.529 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -72.34 133.64 45.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 109.46 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -88.48 29.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -102.6 -38.61 7.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.53 141.41 48.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.681 -0.637 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -149.91 101.52 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.604 -0.685 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.88 115.02 20.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -76.84 135.01 38.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.43 35.09 34.07 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.16 147.81 19.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.553 -0.969 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.66 94.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -96.8 124.4 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 109.426 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.23 174.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.682 . . . . 0.0 109.514 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -138.86 31.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -153.67 143.69 22.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -66.96 -32.76 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.718 . . . . 0.0 109.442 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.62 -34.15 76.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.715 . . . . 0.0 109.44 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.97 90.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 t -66.83 -39.37 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.453 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.63 -28.55 63.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.48 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.18 90.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 0.0 109.533 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -69.36 -37.42 77.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.541 -0.725 . . . . 0.0 109.45 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.3 68.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.595 -0.69 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -67.18 -43.74 81.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -65.46 -28.84 69.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -119.42 90.02 41.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.77 -20.59 9.01 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.14 3.893 . . . . 0.0 109.944 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.12 -28.31 69.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.479 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -105.55 165.54 11.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.6 -0.687 . . . . 0.0 109.498 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -122.01 143.66 49.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.18 132.93 48.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 t -135.31 120.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -96.09 140.64 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 109.438 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.78 -36.1 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.705 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.17 179.58 36.89 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 -155.44 28.06 Favored Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.335 -1.685 . . . . 0.0 109.591 0.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.78 -23.43 67.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.649 -0.912 . . . . 0.0 109.669 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.05 -38.55 75.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.1 mm -72.14 -39.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.552 -0.718 . . . . 0.0 109.585 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 29.1 m-85 -62.93 -41.69 99.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.552 -0.717 . . . . 0.0 109.415 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.74 -19.06 62.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.669 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.15 -25.8 47.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.554 -0.716 . . . . 0.0 109.544 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 79' ' ' VAL . 82.1 m-85 -124.53 19.85 8.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.584 -0.698 . . . . 0.0 109.748 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -63.41 -29.99 71.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 109.625 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -80.85 26.02 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.617 -0.677 . . . . 0.0 109.73 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -159.99 34.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -91.68 150.66 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.49 -0.756 . . . . 0.0 109.436 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -132.35 -58.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.683 -0.636 . . . . 0.0 109.307 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -102.22 112.04 24.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.569 -0.707 . . . . 0.0 109.353 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.404 HD12 ' CE2' ' A' ' 136' ' ' PHE . 30.0 mt -94.64 99.26 11.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 20.0 mt -100.63 104.41 15.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.667 . . . . 0.0 109.22 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -112.38 143.65 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.602 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.0 m -113.5 99.98 8.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -83.64 142.12 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.682 . . . . 0.0 109.611 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.1 131.54 56.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.685 . . . . 0.0 109.243 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.47 75.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.41 9.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 p -76.92 142.89 39.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.443 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -147.82 109.44 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.33 153.19 28.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.12 -126.2 1.29 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.55 -46.9 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.907 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.2 m -85.8 139.84 30.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 109.515 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -116.54 160.72 20.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.634 . . . . 0.0 109.457 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.61 147.61 37.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.546 -0.721 . . . . 0.0 109.476 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.7 pt -70.37 163.83 59.13 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.695 . . . . 0.0 109.479 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.34 101.03 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.139 3.893 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.3 153.08 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.686 . . . . 0.0 109.485 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.2 88.52 7.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 109.461 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -73.9 -15.16 61.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.0 109.82 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.95 9.86 1.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 109.933 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -134.48 30.62 3.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.823 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.404 ' CE2' HD12 ' A' ' 113' ' ' LEU . 60.9 m-85 -140.59 179.59 6.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -150.77 134.29 16.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.638 -0.664 . . . . 0.0 109.43 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -78.63 118.55 20.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -95.25 -33.56 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.6 m -157.47 174.28 15.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 t -161.69 122.73 2.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -95.67 107.22 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.7 m -90.13 149.52 22.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 109.427 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.417 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.7 p -154.43 129.57 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.363 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -107.73 120.79 43.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.533 -0.73 . . . . 0.0 109.479 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.19 -165.97 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.589 -0.695 . . . . 0.0 109.519 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.6 p -71.52 -39.19 70.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.599 -0.688 . . . . 0.0 109.525 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -105.63 137.59 19.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.547 -0.721 . . . . 0.0 109.41 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.99 -44.84 26.74 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 C-N-CA 124.762 3.641 . . . . 0.0 110.072 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.15 71.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.718 . . . . 0.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.3 mt -80.78 20.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.682 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.2 m -92.33 142.06 27.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.36 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.417 ' CE1' HG12 ' A' ' 144' ' ' VAL . 31.6 p-80 -156.93 166.62 32.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.5 m -138.33 133.44 33.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.91 92.97 9.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.06 139.84 44.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 0.0 109.414 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.8 t -128.91 106.74 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.597 -0.69 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.1 m95 -106.83 168.56 9.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -145.21 142.31 29.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.32 100.68 7.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 5.8 m-85 -71.66 139.03 49.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.6 tp -153.91 113.38 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.324 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 p90 -146.05 151.01 37.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.736 . . . . 0.0 109.909 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.59 118.24 36.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.282 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -138.04 152.81 49.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.48 -0.762 . . . . 0.0 109.588 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.38 171.07 7.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 109.498 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLY . 5.9 ptp180 -61.1 -19.05 61.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.604 -0.685 . . . . 0.0 109.864 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -76.61 13.95 0.89 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.493 -0.754 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.24 39.63 97.95 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 tp -112.02 165.79 11.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.624 -0.927 . . . . 0.0 109.485 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 pt -142.21 -30.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.577 -0.702 . . . . 0.0 109.545 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.18 -169.43 30.75 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -172.13 117.78 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.631 -0.923 . . . . 0.0 109.44 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.0 21.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.577 -0.702 . . . . 0.0 109.613 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.68 -61.74 4.08 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -76.89 166.56 23.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.6 mt -79.91 157.54 73.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.662 -0.649 . . . . 0.0 109.439 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -80.24 -27.98 3.28 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.08 3.853 . . . . 0.0 109.971 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.421 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 35.4 p90 -108.25 -179.29 3.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.534 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -131.34 102.35 5.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.7 tp -121.51 80.16 38.39 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.606 -0.684 . . . . 0.0 109.433 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.63 -37.6 15.77 Favored 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 125.167 3.912 . . . . 0.0 110.178 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -62.89 -42.79 99.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.562 -0.711 . . . . 0.0 109.509 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -65.42 -38.1 88.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.622 -0.674 . . . . 0.0 109.38 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.35 -24.42 67.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.579 -0.7 . . . . 0.0 109.519 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -83.63 -30.82 26.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.614 -0.679 . . . . 0.0 109.407 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.411 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 19.0 t80 -73.83 -25.62 60.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -63.42 -45.74 89.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.51 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -63.58 -30.12 71.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.624 -0.672 . . . . 0.0 109.44 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.83 -29.21 50.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 76.5 mm-40 -100.77 32.54 3.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.3 p -136.82 -35.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.588 -0.695 . . . . 0.0 109.54 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.42 128.86 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.705 . . . . 0.0 109.496 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.88 -25.75 26.36 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.36 -170.58 1.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.927 . . . . 0.0 109.511 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -103.99 112.05 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.459 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.7 tmm? -73.72 110.99 8.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 109.459 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.26 122.88 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.713 . . . . 0.0 109.464 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 m -136.66 178.05 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.94 -177.58 34.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -70.36 -39.58 74.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.963 . . . . 0.0 109.416 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -68.94 -40.53 78.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.616 -0.678 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -72.46 -25.72 61.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.31 -44.49 87.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.661 -0.65 . . . . 0.0 109.462 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -77.33 -26.84 52.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.1 p -62.67 -21.79 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.64 -0.663 . . . . 0.0 109.697 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -62.45 162.96 16.37 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -81.22 -74.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 125.227 3.952 . . . . 0.0 110.037 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -113.7 82.65 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.465 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -84.42 157.24 62.01 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.371 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.87 152.14 76.88 Favored 'Cis proline' 0 N--CA 1.509 2.383 0 O-C-N 123.415 1.219 . . . . 0.0 109.995 0.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.4 113.86 26.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.707 . . . . 0.0 109.27 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.44 179.24 6.68 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.761 3.641 . . . . 0.0 109.942 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 61.03 32.03 19.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.525 -0.734 . . . . 0.0 109.64 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.29 -178.62 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.7 m -100.98 119.83 39.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 109.339 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -94.24 117.16 29.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.653 -0.654 . . . . 0.0 109.484 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -125.83 143.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.59 -0.693 . . . . 0.0 109.398 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 t -127.97 132.62 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.602 -0.686 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.8 tp -104.2 112.02 24.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -137.88 153.5 49.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.7 . . . . 0.0 109.464 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -89.68 -47.82 7.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 0.0 109.548 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -72.74 157.97 36.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.604 -0.685 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -102.45 8.11 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.593 -0.692 . . . . 0.0 109.859 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.99 -28.01 57.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.28 153.56 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.492 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -143.72 143.59 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.601 -0.687 . . . . 0.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.0 125.4 24.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -87.6 123.39 32.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.16 41.6 59.77 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.42 148.84 26.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.617 -0.931 . . . . 0.0 109.458 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.64 99.63 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 t -75.88 97.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.652 -0.655 . . . . 0.0 109.467 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.19 162.98 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -140.07 30.39 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.41 146.48 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.607 -0.683 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.409 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.6 t -68.18 -33.36 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.528 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.53 70.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.506 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.39 80.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.54 -0.725 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.4 t -69.13 -36.57 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.645 -0.659 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.6 -30.34 64.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.75 -36.92 83.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.83 -38.75 83.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.581 -0.7 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.51 -24.49 64.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -63.87 -43.73 95.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -67.45 -29.11 68.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -120.77 89.76 45.58 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.13 -23.53 6.38 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.165 3.91 . . . . 0.0 109.86 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.57 -24.92 64.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.536 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -90.44 179.97 5.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -138.31 154.06 49.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tt -91.16 109.58 20.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -110.62 122.6 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 96' ' ' ILE . 41.7 mm -97.3 127.76 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.57 -23.44 11.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.599 -0.688 . . . . 0.0 109.578 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.38 -177.05 40.88 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.464 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -80.5 -157.0 14.34 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.341 -1.682 . . . . 0.0 109.54 -0.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.56 87.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.588 -0.948 . . . . 0.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.31 -26.29 66.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.548 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.5 mm -74.88 -32.17 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.6 -0.688 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.68 -42.65 81.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -69.89 -35.09 74.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.581 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.77 88.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.664 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.409 ' CE1' HG12 ' A' ' 79' ' ' VAL . 33.6 m-85 -95.14 3.49 54.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.461 ' HZ3' ' HB2' ' A' ' 132' ' ' ASN . 5.6 tmtt? -70.8 -22.72 62.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.568 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -62.93 -23.87 67.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.71 58.97 1.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -105.98 149.51 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -130.37 -50.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -95.2 142.72 27.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.589 -0.694 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 mt -129.52 87.15 2.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.573 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.37 123.97 34.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.347 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.413 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -135.59 147.28 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 0.0 109.543 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.5 m -113.51 105.95 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.64 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -88.27 127.97 35.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.44 133.66 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 109.387 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.58 63.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 0.0 109.425 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.04 129.06 12.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 p -78.05 143.69 37.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.988 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -148.45 125.79 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.634 -0.667 . . . . 0.0 109.517 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.57 160.77 16.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.37 -132.17 1.32 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -143.83 -41.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.664 -0.903 . . . . 0.0 109.451 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.2 m -89.46 134.94 33.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.518 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -113.33 173.39 6.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.419 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.84 143.56 26.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.485 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.2 pt -67.34 164.62 35.61 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.564 -0.71 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.4 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.147 3.898 . . . . 0.0 109.883 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.66 155.15 18.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.461 ' HB2' ' HZ3' ' A' ' 107' ' ' LYS . 5.4 t-20 -87.04 85.34 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.588 -0.695 . . . . 0.0 109.418 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -74.64 -15.17 60.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.669 -0.644 . . . . 0.0 109.871 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.09 9.97 1.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.513 -0.742 . . . . 0.0 109.877 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -134.05 29.7 3.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -141.13 176.01 9.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -150.39 134.24 16.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 109.42 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.409 ' HB2' ' HZ1' ' A' ' 138' ' ' LYS . 2.1 ttmp? -70.65 153.19 43.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.553 -0.717 . . . . 0.0 109.498 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.09 -31.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.612 -0.68 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.2 m -139.33 144.01 38.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -143.84 99.09 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -86.71 97.56 10.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.708 . . . . 0.0 109.462 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 m -77.2 147.87 36.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.54 129.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.351 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.75 120.65 42.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.736 . . . . 0.0 109.477 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.08 -165.9 0.93 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.7 p -74.89 -41.96 58.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.22 137.8 20.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.733 . . . . 0.0 109.434 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.65 -48.45 15.69 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 124.804 3.669 . . . . 0.0 110.143 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.88 70.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.658 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.32 15.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.788 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.0 m -86.58 139.36 30.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.339 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -156.01 173.25 17.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.571 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.3 m -139.23 135.56 34.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.417 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -86.46 92.13 8.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.46 147.52 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 t -139.05 99.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.461 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -94.59 166.19 12.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.395 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -148.84 141.34 24.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.1 tttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 179.989 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.82 124.31 20.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.71 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.6 m-85 -94.86 152.77 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.561 -0.712 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 tp -163.2 110.05 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.33 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.0 p90 -144.78 150.1 36.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.75 117.3 31.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 109.223 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -138.48 152.8 48.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.723 . . . . 0.0 109.691 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -104.07 170.99 7.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.68 -17.38 55.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.805 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.85 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.36 38.22 95.91 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 tp -113.03 163.97 14.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.551 -0.97 . . . . 0.0 109.493 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.16 -30.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.49 -166.87 27.29 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HZ2' ' HB3' ' A' ' 15' ' ' LYS . 5.2 ttpm? -171.79 118.2 0.42 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.902 . . . . 0.0 109.501 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 59.98 32.24 21.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.72 -62.8 2.63 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -75.35 172.84 11.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.615 -0.932 . . . . 0.0 109.454 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.413 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 31.1 mt -85.18 156.36 60.12 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.84 -26.66 4.4 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 125.021 3.814 . . . . 0.0 109.944 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 36.4 p90 -108.77 167.74 9.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.511 -0.743 . . . . 0.0 109.491 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -117.57 101.31 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.61 -0.682 . . . . 0.0 109.45 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.1 tp -121.38 80.41 37.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.59 -38.99 17.29 Favored 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 125.171 3.914 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.48 -41.35 98.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.625 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -65.87 -36.99 84.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.15 -23.25 64.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -86.1 -28.23 24.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.65 -0.656 . . . . 0.0 109.461 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.8 t80 -75.23 -25.49 58.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.507 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.82 -48.98 74.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -65.66 -25.7 67.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.566 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.08 -25.72 43.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.542 -0.724 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.0 mm100 -109.07 36.77 2.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.6 p -142.06 -29.3 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.32 132.49 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.592 -0.692 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.37 34.82 60.39 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -155.98 164.31 38.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.532 -0.981 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.87 117.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.44 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.6 ttp -97.6 108.34 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 t -93.67 120.08 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 109.428 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.47 161.78 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.512 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.73 -162.85 37.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 ptt85 -83.55 -35.8 24.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.956 . . . . 0.0 109.428 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -69.59 -38.66 77.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.697 -0.627 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.401 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 10.7 m -74.14 -28.64 61.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.483 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.49 -58.44 7.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -66.32 -21.58 66.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.586 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.6 m -63.1 -29.36 70.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.743 . . . . 0.0 109.543 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CZ ' HG21 ' A' ' 45' ' ' THR . 35.7 m-85 -64.83 161.64 44.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.86 -73.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 125.126 3.884 . . . . 0.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -107.03 95.57 5.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.625 -0.672 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -101.23 157.32 33.89 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.641 -0.662 . . . . 0.0 109.443 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.27 145.7 72.09 Favored 'Cis proline' 0 N--CA 1.508 2.365 0 O-C-N 123.385 1.203 . . . . 0.0 109.903 0.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.2 mt -62.59 116.1 21.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.289 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.92 178.47 7.51 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 124.762 3.641 . . . . 0.0 109.929 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 61.02 29.44 18.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.516 -0.74 . . . . 0.0 109.638 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.11 -169.27 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.706 . . . . 0.0 109.527 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -118.06 130.19 56.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.525 -0.735 . . . . 0.0 109.437 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -107.61 100.56 9.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.491 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -99.55 105.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.56 -0.713 . . . . 0.0 109.449 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.42 122.05 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.3 tp -101.38 118.16 36.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.624 -0.673 . . . . 0.0 109.534 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -144.32 154.37 42.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -95.11 -38.87 10.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.579 -0.7 . . . . 0.0 109.479 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -72.1 131.61 43.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.613 -0.68 . . . . 0.0 109.433 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.97 30.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -103.21 -33.21 9.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -69.69 143.3 53.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -142.14 146.09 34.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.69 . . . . 0.0 109.48 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.98 124.31 20.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -83.0 130.21 35.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.38 38.85 37.57 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.74 139.4 12.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.991 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -77.37 104.46 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.61 100.71 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -102.47 -176.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -142.93 30.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.489 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -161.06 142.54 11.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 t -65.18 -31.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.06 -34.54 78.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.05 81.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.643 -0.661 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.73 -41.22 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.42 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -71.94 -30.07 64.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.603 -0.686 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.42 87.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.71 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -71.44 -33.03 69.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.583 -0.698 . . . . 0.0 109.521 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.32 -29.98 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -66.42 -42.45 87.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.517 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -66.54 -28.41 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -119.21 90.01 40.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.643 -0.66 . . . . 0.0 109.453 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 -23.67 6.51 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 125.103 3.869 . . . . 0.0 109.843 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.58 -26.4 66.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -102.44 133.67 47.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -92.29 151.63 20.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.71 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 tp -87.43 143.93 26.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.555 -0.716 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -144.43 130.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.431 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG23 ' CD1' ' A' ' 103' ' ' PHE . 40.1 mm -94.65 125.36 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.94 -28.32 9.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.522 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.402 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 161.81 -177.57 38.01 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.85 -154.73 16.48 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.361 -1.67 . . . . 0.0 109.6 -0.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.58 78.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.953 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -75.09 -30.51 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 96' ' ' ILE . 18.4 m-85 -68.78 -50.65 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -64.21 -23.16 67.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.615 -0.678 . . . . 0.0 109.558 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.32 -52.11 37.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.6 -0.688 . . . . 0.0 109.615 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -86.46 6.16 31.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.567 -0.708 . . . . 0.0 110.037 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -66.04 -23.55 66.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -68.37 -42.43 79.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.598 -0.689 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.73 38.19 2.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.611 -0.68 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -79.97 152.76 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.583 -0.698 . . . . 0.0 109.342 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.15 -68.87 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.692 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -85.57 161.44 19.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.635 -0.665 . . . . 0.0 109.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.41 ' CD1' ' CE2' ' A' ' 136' ' ' PHE . 23.7 mt -141.63 88.32 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.549 -0.719 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.0 mt -89.44 120.65 30.95 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -132.63 142.77 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.7 m -109.98 103.17 11.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 0.0 109.329 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -85.71 132.22 34.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.0 109.603 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.9 132.73 53.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.371 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.9 -31.68 72.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.439 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.98 131.95 14.65 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.5 p -85.15 142.01 29.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.605 -0.938 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -144.86 126.26 14.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.604 -0.685 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -90.01 146.42 24.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.76 -128.89 2.02 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -143.62 -34.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.995 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.9 m -98.68 127.89 44.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 109.55 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -104.81 170.86 7.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.23 145.35 25.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.0 pt -66.91 164.78 31.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.505 -0.747 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.23 109.23 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.105 3.87 . . . . 0.0 109.891 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.08 149.42 21.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -84.46 86.35 7.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -73.36 -16.95 61.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.632 -0.668 . . . . 0.0 109.768 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.08 9.83 1.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.961 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -131.87 28.42 4.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' A' ' 113' ' ' LEU . 54.5 m-85 -138.48 179.86 6.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.45 122.01 7.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.505 -0.747 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -70.25 121.3 17.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.11 -37.4 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.478 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.4 p -158.62 169.33 24.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.545 -0.722 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 81.4 p -158.35 129.63 6.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.607 -0.683 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -97.18 116.24 29.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.685 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.4 m -93.95 152.08 19.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.36 130.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -102.38 123.22 45.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.511 -0.743 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.45 -165.95 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.7 p -73.99 -39.9 63.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 0.0 109.604 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -99.85 137.57 20.19 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.25 -39.88 34.9 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 124.773 3.649 . . . . 0.0 110.015 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.07 -29.58 60.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.693 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.84 8.36 2.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.566 -0.709 . . . . 0.0 109.981 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.3 p -78.45 159.0 28.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.476 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -171.97 170.74 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.539 -0.725 . . . . 0.0 109.603 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.9 m -140.44 133.84 29.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -86.64 95.95 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 109.383 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -78.14 144.41 36.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.627 -0.671 . . . . 0.0 109.483 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 t -133.65 99.55 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 31.5 m95 -96.86 166.95 11.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.615 -0.678 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -146.0 138.82 25.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.4 tttp . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.715 . . . . 0.0 109.405 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.28 107.05 14.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.7 m-85 -80.98 155.97 26.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.624 -0.673 . . . . 0.0 109.416 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.5 tp -168.78 121.56 0.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 44.0 p90 -147.31 130.1 16.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.508 -0.745 . . . . 0.0 109.584 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.91 109.77 18.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.266 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 6.6 pt20 -131.26 160.87 33.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.704 . . . . 0.0 109.72 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -109.86 169.45 8.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.672 -0.642 . . . . 0.0 109.465 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -60.72 -17.56 49.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.57 15.26 0.83 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.715 . . . . 0.0 109.798 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.25 33.75 87.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.8 tp -113.69 161.31 17.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.638 -0.919 . . . . 0.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.1 pt -134.21 -30.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.46 -174.45 38.5 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -166.38 124.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.91 32.48 21.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 109.752 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.19 -61.71 3.93 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -74.97 174.77 8.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.586 -0.949 . . . . 0.0 109.5 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 47.8 mt -89.7 156.02 47.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 109.426 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -79.59 -26.55 4.7 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 124.955 3.77 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 36.7 p90 -108.59 165.76 11.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -115.13 101.5 9.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -122.76 79.23 48.87 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.84 -38.01 17.35 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 125.165 3.91 . . . . 0.0 110.197 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.83 -46.51 87.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.559 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -64.19 -36.9 85.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.59 -24.99 67.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.664 . . . . 0.0 109.459 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -84.12 -29.35 26.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.605 -0.685 . . . . 0.0 109.437 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -71.73 -28.12 63.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.584 -0.697 . . . . 0.0 109.4 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -67.62 -44.96 76.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.554 -0.716 . . . . 0.0 109.518 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -66.0 -31.0 71.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -30.94 60.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.693 . . . . 0.0 109.437 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -97.9 33.25 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.3 p -139.55 -30.03 0.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.608 -0.682 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.63 128.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.38 69.94 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -145.67 165.79 27.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.565 -0.962 . . . . 0.0 109.449 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.8 mt -92.11 101.0 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.7 ttp -80.7 103.33 10.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.555 -0.715 . . . . 0.0 109.457 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.85 121.43 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.24 168.33 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.624 -0.673 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.67 -165.28 39.38 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -78.87 -43.49 24.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.936 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.493 HH22 HE21 ' A' ' 101' ' ' GLN . 10.8 ptp85 -68.73 -30.99 69.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 0.0 109.461 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -79.91 -29.15 39.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.68 -31.81 72.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.629 -0.669 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -94.18 -18.07 22.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.694 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -62.26 -23.43 66.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -66.43 159.77 70.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.15 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.066 3.844 . . . . 0.0 109.953 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.92 112.8 24.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.498 -0.751 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -108.46 158.64 33.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.518 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.69 -165.51 4.57 Favored 'Cis proline' 0 N--CA 1.509 2.382 0 O-C-N 123.372 1.196 . . . . 0.0 109.897 -0.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HB2' HD22 ' A' ' 59' ' ' ASN . 87.9 mt -114.97 94.4 38.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.585 -0.697 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -74.97 -175.89 2.59 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 124.819 3.679 . . . . 0.0 109.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 61.51 27.93 17.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.77 . . . . 0.0 109.52 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.23 -169.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -119.39 115.23 23.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.583 -0.698 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.454 HD22 ' HB2' ' A' ' 54' ' ' LEU . 1.7 m-80 -92.77 103.79 16.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.722 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -104.62 99.94 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.481 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.3 t -87.03 123.89 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.4 tp -101.11 115.83 31.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.651 -0.656 . . . . 0.0 109.502 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -145.98 146.61 31.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.705 -0.622 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -101.43 31.54 3.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.585 -0.697 . . . . 0.0 109.562 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -134.2 126.51 30.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -85.1 29.53 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.17 -35.65 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 109.515 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -69.55 157.76 36.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.62 -0.675 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -147.52 140.89 25.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.527 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.5 11.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.584 -0.698 . . . . 0.0 109.475 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -84.83 133.68 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.581 -0.7 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.74 41.21 35.13 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.02 159.82 36.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.928 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -94.07 94.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.612 -0.68 . . . . 0.0 109.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 t -79.01 99.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.363 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -97.21 159.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.458 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -139.23 28.68 2.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.695 . . . . 0.0 109.511 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -161.49 147.56 14.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.466 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.412 HG12 ' CE1' ' A' ' 106' ' ' PHE . 31.3 t -67.81 -33.64 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.722 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.31 73.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.653 -0.655 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.08 79.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 t -67.2 -46.57 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.591 -0.693 . . . . 0.0 109.463 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.91 -27.27 63.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.672 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.29 -36.89 85.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.558 -0.714 . . . . 0.0 109.437 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.21 -34.29 68.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 109.525 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.21 67.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -65.55 -42.39 91.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.22 -29.84 70.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.579 -0.7 . . . . 0.0 109.543 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -119.74 89.86 42.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.58 -0.7 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.99 -23.16 6.85 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.148 3.899 . . . . 0.0 109.943 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.07 -26.42 65.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.49 172.49 7.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -130.94 169.13 16.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tp -93.58 131.94 38.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -128.03 127.12 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.463 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 103' ' ' PHE . 40.0 mm -103.41 118.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.54 -25.37 11.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.498 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.74 -179.04 40.83 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.85 -157.08 28.5 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.328 -1.689 . . . . 0.0 109.542 -0.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.97 -30.53 71.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.623 -0.928 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.493 HE21 HH22 ' A' ' 44' ' ' ARG . 46.0 mt-30 -73.24 -32.76 64.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.441 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -70.28 -36.87 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.552 -0.717 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 96' ' ' ILE . 25.5 m-85 -63.77 -56.65 13.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -62.47 -16.05 53.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.604 -0.685 . . . . 0.0 109.83 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.42 -23.23 32.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.412 ' CE1' HG12 ' A' ' 79' ' ' VAL . 35.4 m-85 -121.06 18.12 11.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.809 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -66.27 -31.36 72.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.554 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.0 26.65 0.42 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.694 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.05 34.13 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.542 -0.724 . . . . 0.0 109.485 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -102.23 159.37 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -141.83 -50.43 0.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.674 -0.641 . . . . 0.0 109.345 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -105.75 109.28 21.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 0.0 109.335 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.1 mt -93.61 110.26 21.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.585 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.8 mt -105.74 101.96 11.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.596 -0.69 . . . . 0.0 109.298 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -107.71 132.74 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.669 -0.645 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.406 HG22 ' CE1' ' A' ' 155' ' ' TYR . 20.5 m -106.91 96.51 6.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.564 -0.71 . . . . 0.0 109.244 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -82.39 150.16 27.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.648 -0.658 . . . . 0.0 109.704 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.35 142.39 50.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.634 -0.666 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.69 -34.83 62.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.556 -0.715 . . . . 0.0 109.453 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.41 136.29 22.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.9 p -86.7 143.63 27.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.994 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -144.92 138.62 27.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.3 152.96 18.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.546 -0.721 . . . . 0.0 109.52 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.97 -128.76 1.04 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.05 -34.37 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.946 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -89.85 149.52 22.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.624 -0.673 . . . . 0.0 109.521 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -130.89 167.85 18.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 11.4 tpt -88.14 151.57 22.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.54 -0.725 . . . . 0.0 109.479 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.3 pt -76.06 163.62 65.47 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.595 -0.69 . . . . 0.0 109.509 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.16 104.78 1.69 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.172 3.915 . . . . 0.0 109.902 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.2 mt -97.43 144.5 27.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.16 88.44 7.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -67.15 -14.97 63.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.575 -0.703 . . . . 0.0 109.831 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.58 -26.02 68.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.478 -0.764 . . . . 0.0 109.531 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.65 30.46 2.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -143.84 171.3 14.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.533 -0.73 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.9 m -144.34 136.38 26.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.545 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -74.12 150.26 40.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.38 -35.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.56 -0.712 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -142.37 165.64 26.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.6 t -164.43 119.65 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.48 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -99.56 106.07 18.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.528 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 m -93.14 141.05 28.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.671 . . . . 0.0 109.42 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.402 ' CG1' ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -150.32 135.03 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.94 125.4 54.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.2 -165.94 0.95 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.4 p -70.85 -38.32 73.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.554 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.26 137.71 19.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.598 -0.689 . . . . 0.0 109.37 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.74 -44.14 27.21 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 124.829 3.686 . . . . 0.0 110.065 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.32 72.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.68 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.2 mt -80.74 21.1 0.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.569 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 38.0 m -91.74 142.67 27.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.39 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.402 ' NE2' ' CG1' ' A' ' 144' ' ' VAL . 35.9 p-80 -155.45 168.95 25.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -141.95 131.35 23.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 109.419 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.406 ' CE1' HG22 ' A' ' 116' ' ' THR . 99.7 m-85 -91.12 95.21 9.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.732 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.457 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 22.5 mt-10 -78.2 130.76 36.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.608 -0.683 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.1 t -115.39 110.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.457 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 36.8 m95 -108.48 165.67 11.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.584 -0.698 . . . . 0.0 109.458 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -143.36 138.87 29.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.651 -0.656 . . . . 0.0 109.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.407 ' H2 ' ' HG1' ' A' ' 1' ' ' THR . 6.3 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.47 130.96 23.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 7.7 m-85 -96.37 162.14 13.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.733 . . . . 0.0 109.479 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.6 tp -168.97 107.33 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.597 -0.689 . . . . 0.0 109.301 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.04 143.14 31.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.55 -0.719 . . . . 0.0 109.811 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.09 112.5 24.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.648 -0.658 . . . . 0.0 109.245 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -134.16 149.79 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -98.7 170.17 8.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.499 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -60.96 -17.26 50.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.558 -0.714 . . . . 0.0 109.943 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -76.83 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.493 -0.754 . . . . 0.0 109.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.21 36.43 92.99 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 tp -111.59 162.36 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 13' ' ' ILE . 32.3 pt -137.13 -30.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.508 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.12 -172.8 34.74 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -168.98 124.96 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.933 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.08 28.04 17.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.01 -63.55 1.47 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -75.45 -171.65 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.602 -0.94 . . . . 0.0 109.468 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 31.5 mt -92.58 156.89 40.81 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.58 -0.7 . . . . 0.0 109.423 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.1 Cg_endo -80.22 -28.67 2.91 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.015 3.81 . . . . 0.0 109.882 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 36.7 p90 -106.75 -172.27 2.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -138.65 94.8 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.614 -0.679 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.3 tp -116.12 83.36 12.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.56 -38.34 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.123 3.882 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.99 -40.97 99.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -69.25 -28.4 66.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.457 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.24 -23.47 57.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.621 -0.674 . . . . 0.0 109.542 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -86.82 -28.87 22.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.729 . . . . 0.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -71.04 -27.08 63.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -64.35 -47.8 77.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.627 -0.67 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -66.6 -5.27 10.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.611 -0.681 . . . . 0.0 109.974 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.08 -34.47 12.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.512 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -106.28 35.48 2.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.466 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.6 p -133.37 -32.8 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.527 -0.733 . . . . 0.0 109.493 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.7 129.58 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 37.3 57.15 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -155.15 164.94 38.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.484 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -92.37 110.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.3 ttp -88.81 107.6 19.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -94.57 119.42 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.468 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.95 164.49 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.718 . . . . 0.0 109.5 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.38 -165.36 40.42 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtm105 -80.52 -38.43 29.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.95 . . . . 0.0 109.471 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -70.05 -32.98 71.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.58 -0.7 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 m -79.17 -28.5 42.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.465 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.65 -34.19 77.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.471 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -86.7 -25.48 24.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -62.89 -23.23 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -62.92 162.83 19.18 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.18 -63.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.125 3.883 . . . . 0.0 109.922 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -124.12 111.55 16.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.543 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -108.52 157.37 36.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.405 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.83 146.51 72.18 Favored 'Cis proline' 0 N--CA 1.508 2.36 0 O-C-N 123.396 1.208 . . . . 0.0 109.982 0.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.447 ' HB2' HD22 ' A' ' 59' ' ' ASN . 68.6 mt -67.51 112.93 11.61 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.368 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -78.24 179.91 6.06 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 124.793 3.662 . . . . 0.0 109.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 61.22 27.65 17.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.665 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -177.13 -173.32 0.45 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.493 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -116.16 120.11 37.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.711 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.447 HD22 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -95.53 107.72 19.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.668 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.1 116.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.424 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -102.1 122.7 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.606 -0.684 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 tp -99.22 110.93 23.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.74 142.82 31.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -97.65 30.98 2.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -125.81 138.39 53.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.71 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.75 29.84 2.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.31 -40.18 5.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.611 -0.681 . . . . 0.0 109.454 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -73.17 136.98 44.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -141.48 102.88 4.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.75 117.43 23.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -76.92 133.28 39.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.571 -0.705 . . . . 0.0 109.424 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 37.52 59.55 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.47 142.83 19.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.965 . . . . 0.0 109.494 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -75.4 95.96 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.0 t -80.22 102.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.528 -0.732 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.33 158.7 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.488 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -139.68 29.56 2.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.693 . . . . 0.0 109.459 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -162.18 147.29 12.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 106' ' ' PHE . 31.1 t -67.97 -35.3 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.454 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.58 70.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.53 81.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.473 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.0 t -68.34 -40.72 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -75.67 -30.24 59.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -36.96 84.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.56 -41.92 75.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.622 -0.674 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 109.48 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -65.12 -45.31 85.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.57 -0.706 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -67.48 -27.08 66.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.469 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.82 89.82 39.02 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.678 . . . . 0.0 109.463 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.93 -23.14 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 125.06 3.84 . . . . 0.0 109.893 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.69 -26.79 66.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -91.27 179.94 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.34 150.64 46.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.7 tp -93.67 126.4 38.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 t -133.16 127.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.716 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG21 ' CE1' ' A' ' 103' ' ' PHE . 39.7 mm -91.42 127.64 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.85 -23.83 10.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.562 -0.711 . . . . 0.0 109.59 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.92 -178.15 37.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.493 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -82.6 -154.37 14.92 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 120.389 -1.654 . . . . 0.0 109.587 -0.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.53 77.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.579 -0.954 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -73.15 -27.2 61.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.493 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -73.94 -35.44 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.723 . . . . 0.0 109.479 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 96' ' ' ILE . 24.1 m-85 -63.26 -53.71 48.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -62.71 -21.98 66.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.59 -0.694 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.91 -30.84 67.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.741 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CE1' HG11 ' A' ' 79' ' ' VAL . 59.9 m-85 -116.06 16.89 16.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -22.85 64.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.651 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -70.19 -45.51 66.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -97.04 40.3 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.456 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 9.0 p -89.38 143.95 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -128.53 -65.63 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.668 . . . . 0.0 109.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.5 m -89.86 164.58 14.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 33.4 mt -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.564 -0.71 . . . . 0.0 109.58 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.9 mt -91.21 104.25 16.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -115.47 137.99 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -107.77 102.69 11.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.68 . . . . 0.0 109.336 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mmm-85 -88.23 135.22 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.99 140.69 42.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.69 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.62 -29.63 61.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.416 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.93 126.08 8.65 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 p -72.57 143.25 48.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.939 . . . . 0.0 109.452 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -148.98 121.55 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 109.432 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -96.51 149.25 21.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.54 -120.78 1.13 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -145.95 -33.94 0.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.631 -0.923 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.2 m -93.9 146.28 24.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -125.53 174.32 8.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.6 tpt -97.55 152.14 19.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.2 pt -74.67 163.9 65.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.14 94.18 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.115 3.876 . . . . 0.0 109.873 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.57 154.28 28.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.6 -0.688 . . . . 0.0 109.486 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -87.14 86.08 7.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.587 -0.696 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.401 ' C ' ' H ' ' A' ' 135' ' ' ASP . 96.7 m95 -71.47 -18.49 62.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.6 -0.688 . . . . 0.0 109.725 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -74.12 10.08 1.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 133' ' ' TRP . 9.2 t70 -132.68 29.62 4.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.0 109.472 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -138.95 -180.0 6.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.629 -0.669 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -148.59 125.5 11.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 109.441 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -78.44 126.36 30.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.07 -35.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.612 -0.68 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.2 t -162.31 -177.79 5.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 98.3 p -163.88 132.56 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -95.73 100.74 12.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.4 m -82.72 148.79 27.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.58 131.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.313 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -108.36 120.22 41.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.451 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.01 -165.3 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 p -72.99 -42.96 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.61 -0.681 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -100.01 137.97 20.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.4 -47.62 17.19 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 124.832 3.688 . . . . 0.0 110.092 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.02 70.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.569 -0.707 . . . . 0.0 109.664 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.8 mt -78.82 17.58 0.7 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 109.741 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.5 m -90.54 144.36 25.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.755 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -159.68 170.14 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.56 -0.712 . . . . 0.0 109.574 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.5 m -139.92 135.66 33.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.39 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -91.32 92.02 8.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.564 -0.71 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.463 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 44.0 mt-10 -77.1 128.36 34.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.544 -0.722 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.8 t -114.76 99.49 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.463 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 35.5 m95 -95.03 164.31 12.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.7 . . . . 0.0 109.445 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -148.66 136.11 20.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.0 tttt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.724 . . . . 0.0 109.45 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.73 127.76 33.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.557 -0.714 . . . . 0.0 109.467 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.445 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.5 m-85 -100.18 143.93 29.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.532 -0.73 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.4 ' CD1' ' CB ' ' A' ' 114' ' ' LEU . 7.7 tp -156.59 111.51 2.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.33 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.93 141.22 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.545 -0.722 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.97 112.81 24.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.207 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.89 157.82 44.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -107.53 170.01 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 109.46 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -60.89 -18.31 55.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.551 -0.718 . . . . 0.0 109.871 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.42 15.09 0.82 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.77 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 35.77 91.9 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 tp -111.34 162.01 15.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.978 . . . . 0.0 109.535 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 13' ' ' ILE . 31.9 pt -136.28 -30.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.493 -0.754 . . . . 0.0 109.58 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.34 -170.28 31.04 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -168.8 117.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.584 -0.951 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.1 30.74 20.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.698 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.83 -61.85 2.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -75.03 165.15 25.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.975 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -78.09 156.9 79.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.721 . . . . 0.0 109.421 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.7 Cg_endo -80.34 -28.58 2.88 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 124.996 3.797 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.421 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 34.2 p90 -107.53 -170.94 1.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -140.68 96.96 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -117.09 81.11 12.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.76 -40.85 19.59 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 125.095 3.863 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -62.48 -52.25 64.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 109.63 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.1 -35.94 81.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.0 mt -63.12 -23.8 67.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.539 -0.726 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -85.52 -29.16 24.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 12.4 t80 -64.78 -25.72 68.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.647 -0.658 . . . . 0.0 109.528 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.64 -46.05 84.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.591 -0.693 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -65.12 -31.84 73.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 109.465 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.93 -29.03 58.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.565 -0.709 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 22.4 mm100 -100.4 34.17 2.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.4 p -140.46 -34.87 0.51 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.581 -0.699 . . . . 0.0 109.525 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -70.98 124.94 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.687 -0.633 . . . . 0.0 109.508 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.21 34.4 20.73 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.442 ' HZ1' ' HB2' ' A' ' 93' ' ' GLU . 44.2 mttm -156.29 168.23 27.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.498 -1.001 . . . . 0.0 109.516 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.5 mt -90.54 104.61 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.649 -0.657 . . . . 0.0 109.469 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -77.22 120.58 22.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 t -126.81 122.57 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.524 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 m -135.12 -174.28 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.79 -170.33 26.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -77.59 -40.01 43.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.525 -0.985 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.19 -36.3 74.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.638 -0.664 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -73.09 -28.12 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -63.7 -47.45 81.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HA ' HH21 ' A' ' 52' ' ' ARG . 25.1 mt-10 -71.97 -25.73 61.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -62.51 -21.64 65.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.571 -0.705 . . . . 0.0 109.587 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -62.44 164.37 11.87 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.03 -65.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.167 3.911 . . . . 0.0 110.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -128.33 103.97 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.523 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -88.92 157.38 48.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.653 . . . . 0.0 109.421 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.35 -168.95 7.07 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.361 1.19 . . . . 0.0 110.035 0.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.2 mt -112.96 96.32 37.76 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.421 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -69.54 176.48 6.54 Favored 'Trans proline' 0 N--CA 1.505 2.206 0 C-N-CA 124.592 3.528 . . . . 0.0 109.831 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 62.04 21.79 12.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.533 -0.729 . . . . 0.0 109.639 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -177.52 156.6 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.72 . . . . 0.0 109.458 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -79.46 152.36 30.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 109.54 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -130.32 114.76 16.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -116.52 103.98 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.654 -0.654 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.6 123.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 tp -94.99 108.69 20.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.416 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.418 HG21 ' CE1' ' A' ' 77' ' ' HIS . 3.9 t -136.56 152.8 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.46 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -104.44 -22.73 13.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.69 -0.631 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.88 134.31 48.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.686 . . . . 0.0 109.419 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.38 31.9 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.637 -0.664 . . . . 0.0 109.455 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -121.56 -30.6 4.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -67.79 144.44 55.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.742 . . . . 0.0 109.395 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -147.97 102.67 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.524 -0.735 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.42 117.96 25.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -78.19 133.77 37.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.685 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.69 35.95 44.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -159.22 151.48 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.611 -0.934 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -81.38 95.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.72 . . . . 0.0 109.439 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -76.7 97.72 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.55 170.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.579 -0.701 . . . . 0.0 109.501 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.418 ' CE1' HG21 ' A' ' 63' ' ' THR . 75.9 m-70 -146.15 30.23 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -168.3 144.7 3.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 t -66.48 -33.2 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.84 74.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.64 -0.662 . . . . 0.0 109.469 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.19 -35.63 78.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.629 -0.669 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.3 t -67.11 -42.28 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.635 -0.666 . . . . 0.0 109.519 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -68.94 -29.63 67.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.47 82.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.09 -33.62 72.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.57 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.641 -0.662 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.88 -40.93 92.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -67.36 -31.12 71.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -120.19 90.03 44.07 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.12 -22.98 6.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.104 3.869 . . . . 0.0 109.893 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.33 -25.29 64.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.718 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -103.72 141.09 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.442 ' HB2' ' HZ1' ' A' ' 37' ' ' LYS . 36.9 mt-10 -97.36 164.79 12.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.629 -0.669 . . . . 0.0 109.478 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.6 tp -93.17 132.1 37.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.53 -0.731 . . . . 0.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -134.5 126.81 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.458 HG22 HD11 ' A' ' 96' ' ' ILE . 41.1 mm -99.67 127.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.672 -0.643 . . . . 0.0 109.429 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.5 -22.36 12.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.586 -0.696 . . . . 0.0 109.611 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.3 -176.51 39.48 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.495 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.98 -154.23 18.49 Favored Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.353 -1.675 . . . . 0.0 109.533 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.9 77.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 109.502 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -72.49 -26.01 61.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.581 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.495 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -74.68 -36.56 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.555 -0.716 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -63.21 -51.0 68.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 m -63.17 -24.31 67.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.704 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.49 75.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.678 . . . . 0.0 109.487 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -102.13 12.62 36.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.606 -0.684 . . . . 0.0 109.759 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -70.75 -28.75 64.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.464 -0.773 . . . . 0.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -65.65 -31.6 72.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.715 . . . . 0.0 109.569 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -119.49 37.95 4.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.49 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.445 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -84.78 156.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.34 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.25 -68.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.597 -0.689 . . . . 0.0 109.482 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -88.55 161.9 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 136' ' ' PHE . 26.9 mt -143.5 92.38 2.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.634 -0.666 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.4 ' CB ' ' CD1' ' A' ' 4' ' ' LEU . 50.8 mt -90.52 112.53 24.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.0 109.401 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -118.69 133.51 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.426 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -104.94 96.7 6.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.697 . . . . 0.0 109.321 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -82.42 138.73 34.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.7 . . . . 0.0 109.578 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.8 134.55 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.41 87.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.533 -0.729 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.78 126.22 23.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.2 p -79.29 143.44 35.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.947 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -145.83 128.61 16.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.581 -0.699 . . . . 0.0 109.506 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.82 153.58 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.718 . . . . 0.0 109.495 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.64 -135.49 1.96 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -30.39 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -94.54 143.51 26.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 109.553 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.66 168.95 13.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.639 -0.663 . . . . 0.0 109.485 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.4 tpt -93.38 152.4 19.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.512 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -71.83 164.4 58.73 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.618 -0.677 . . . . 0.0 109.502 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 95.2 1.0 Allowed 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 125.165 3.91 . . . . 0.0 109.889 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.67 138.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.655 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -81.15 84.15 6.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.429 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -67.83 -15.92 63.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.785 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.48 -25.93 68.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.46 -33.95 20.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.662 -0.649 . . . . 0.0 109.443 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.417 ' CD2' HD11 ' A' ' 113' ' ' LEU . 96.3 m-85 -84.29 166.56 17.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.8 m -136.45 131.63 34.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -71.65 113.6 8.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.678 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.46 -38.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 109.494 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.1 m -153.37 166.37 32.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.563 -0.711 . . . . 0.0 109.494 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.9 p -160.8 134.24 6.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.583 -0.698 . . . . 0.0 109.44 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -100.41 113.4 26.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.9 m -94.81 142.39 27.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.697 . . . . 0.0 109.489 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -151.1 147.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.697 . . . . 0.0 109.352 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.27 132.76 48.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.441 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.58 -171.38 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -64.25 -34.96 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.649 . . . . 0.0 109.45 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -95.89 152.96 39.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.68 . . . . 0.0 109.293 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.08 -22.52 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.858 3.705 . . . . 0.0 109.909 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.93 -23.25 27.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.548 -0.72 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.8 mt -84.2 -1.32 54.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.503 -0.748 . . . . 0.0 109.99 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.7 m -63.35 146.07 54.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.485 -0.759 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -157.79 165.31 35.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.65 -0.656 . . . . 0.0 109.483 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.3 m -137.57 133.87 34.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.45 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -91.66 94.44 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.91 139.16 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.8 t -126.46 103.86 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.523 -0.736 . . . . 0.0 109.536 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -99.78 165.3 11.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -144.63 138.0 27.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 tttp . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.726 . . . . 0.0 109.483 -179.981 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.9 108.33 7.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 0.0 109.416 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.445 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.1 m-85 -84.44 123.88 30.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.438 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tp -138.58 112.97 8.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.573 -0.705 . . . . 0.0 109.274 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.414 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -142.25 140.53 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 0.0 109.801 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.58 112.47 23.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.527 -0.733 . . . . 0.0 109.287 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.23 152.88 51.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.509 -0.744 . . . . 0.0 109.717 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -102.85 170.41 8.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLY . 11.5 ptm180 -60.78 -18.44 55.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.626 -0.671 . . . . 0.0 109.896 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 14.22 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.501 -0.749 . . . . 0.0 109.838 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.28 37.05 93.94 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 4.6 tp -111.48 165.88 11.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.956 . . . . 0.0 109.487 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.448 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 2.5 pp -138.14 -41.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.506 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.67 -179.31 37.95 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -162.11 125.92 3.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.947 . . . . 0.0 109.471 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 59.75 30.8 20.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.534 -0.729 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.57 -60.49 4.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -75.22 168.17 20.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.951 . . . . 0.0 109.503 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 25.0 mt -81.74 156.4 70.33 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.21 -29.39 2.56 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.012 3.808 . . . . 0.0 109.847 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 32.8 p90 -107.25 173.85 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 109.521 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -124.05 106.06 10.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 tp -126.77 81.18 69.51 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.24 -39.36 15.71 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 125.213 3.942 . . . . 0.0 110.253 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.92 -47.17 84.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.516 -0.74 . . . . 0.0 109.491 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -64.58 -31.46 72.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.71 . . . . 0.0 109.496 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.75 -24.44 63.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -86.65 -29.68 22.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.468 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -69.81 -24.43 63.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.612 -0.68 . . . . 0.0 109.536 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -63.35 -45.82 89.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -65.2 -29.21 70.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.525 -0.734 . . . . 0.0 109.461 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.52 -29.39 56.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.358 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -100.74 34.8 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -143.33 -35.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.634 -0.666 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.66 124.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.496 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.31 33.96 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -156.32 166.93 32.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.954 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.63 99.68 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.343 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -72.57 134.39 45.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 t -138.32 117.8 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.579 -0.701 . . . . 0.0 109.46 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.67 -174.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.558 -0.714 . . . . 0.0 109.427 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.93 -168.32 32.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -81.78 -34.32 30.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -71.29 -38.52 71.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.597 -0.689 . . . . 0.0 109.399 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -75.43 -27.68 59.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 40.3 t80 -64.89 -42.4 94.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -75.09 -23.3 57.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.4 m -63.24 -26.13 68.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.89 161.66 44.67 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.72 -61.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.082 3.855 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -125.55 103.14 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.449 ' H ' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -104.73 154.79 38.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.439 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.6 154.71 88.74 Favored 'Cis proline' 0 N--CA 1.508 2.362 0 O-C-N 123.388 1.204 . . . . 0.0 109.827 0.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.1 mt -72.73 131.26 84.42 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -80.11 170.25 16.64 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.687 3.591 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.04 27.31 17.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -177.47 155.1 1.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.525 -0.734 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -84.92 134.22 34.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -105.6 105.08 14.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.546 -0.721 . . . . 0.0 109.465 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.9 147.54 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.435 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 t -137.15 119.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 109.476 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.7 tp -98.95 116.84 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.06 140.02 39.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.401 ' CD2' ' HG3' ' A' ' 65' ' ' GLN . 12.4 p-80 -81.63 -27.33 34.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.561 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.401 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 59.4 mt-30 -71.51 137.51 48.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.649 -0.657 . . . . 0.0 109.426 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -94.28 31.69 1.67 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.686 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -121.79 -31.37 3.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.536 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -67.94 138.7 56.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -144.47 158.57 43.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.632 -0.667 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' H ' HG23 ' A' ' 75' ' ' VAL . . . -137.59 129.67 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -84.53 136.5 33.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.583 -0.698 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.7 36.8 75.98 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.91 158.82 38.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.599 -0.942 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 t -95.06 92.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.613 -0.679 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 70' ' ' ALA . 29.1 t -74.4 104.83 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.474 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.7 153.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.493 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -136.14 28.41 3.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -161.27 149.55 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.708 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.414 HG11 ' CE1' ' A' ' 106' ' ' PHE . 31.0 t -68.92 -35.24 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.555 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.99 65.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.572 -0.705 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.99 86.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.9 t -68.15 -45.08 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.525 -0.735 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.95 -29.25 66.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.628 -0.67 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.01 82.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.4 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -71.33 -33.94 70.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.606 -0.684 . . . . 0.0 109.455 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.29 67.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.596 -0.69 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -65.92 -39.35 90.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.661 -0.65 . . . . 0.0 109.502 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.8 -32.11 72.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.523 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -121.71 89.49 47.72 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 -22.36 7.02 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.094 3.863 . . . . 0.0 109.891 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -65.53 -26.49 67.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -97.95 179.16 4.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.659 -0.65 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -137.32 150.1 47.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.3 tp -76.31 134.98 39.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.577 -0.702 . . . . 0.0 109.473 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.24 122.8 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.581 -0.7 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 96' ' ' ILE . 41.3 mm -97.02 142.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.641 . . . . 0.0 109.402 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -121.28 -30.95 4.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.713 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.56 178.78 37.5 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.86 -151.9 20.87 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.364 -1.668 . . . . 0.0 109.534 0.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.52 -26.51 65.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.963 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -68.94 -31.97 71.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 109.541 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.2 -40.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.689 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 31.3 m-85 -63.06 -47.18 84.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.96 -23.59 66.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.554 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.75 -29.6 51.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE1' HG11 ' A' ' 79' ' ' VAL . 43.7 m-85 -114.5 20.26 15.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -63.1 -36.74 84.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.605 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -81.11 29.72 0.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.603 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -160.01 33.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.585 -0.697 . . . . 0.0 109.486 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.445 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.1 p -94.7 153.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.714 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.58 -61.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.308 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -96.42 111.75 23.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.603 -0.686 . . . . 0.0 109.342 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.1 mt -95.66 98.43 10.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.573 -0.705 . . . . 0.0 109.626 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.3 mt -99.21 104.48 16.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 109.214 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.414 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -111.57 140.79 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.598 -0.689 . . . . 0.0 109.565 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.6 m -110.17 97.7 7.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 109.245 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -80.44 151.13 29.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mp -127.53 136.16 51.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.242 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.72 -32.77 71.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.05 128.88 10.25 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.7 p -81.38 144.44 31.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -147.27 121.74 9.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.619 -0.676 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.99 149.8 27.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.705 . . . . 0.0 109.522 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.05 -141.26 3.42 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.7 -30.76 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.558 -0.966 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.1 m -102.97 130.22 49.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.581 -0.699 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -108.43 175.23 5.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.573 -0.704 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -93.93 152.47 18.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.6 pt -75.19 164.29 62.2 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.78 98.08 1.11 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.178 3.919 . . . . 0.0 109.844 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.85 145.32 27.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.612 -0.68 . . . . 0.0 109.507 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -85.07 87.03 7.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.614 -0.679 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -73.26 -9.94 59.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.58 -31.26 72.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.4 36.7 1.44 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -143.28 167.81 21.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.536 -0.728 . . . . 0.0 109.452 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -144.76 145.84 31.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 109.45 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -75.28 152.66 38.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.28 -32.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -149.6 154.92 39.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 t -157.1 110.49 2.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.585 -0.697 . . . . 0.0 109.498 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -100.68 110.88 23.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.6 m -92.07 146.43 23.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.671 . . . . 0.0 109.402 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -150.47 132.1 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.552 -0.717 . . . . 0.0 109.329 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -107.61 123.47 48.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.685 . . . . 0.0 109.478 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.35 -165.52 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.583 -0.698 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -71.19 -39.55 71.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.89 137.7 19.36 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.551 -0.718 . . . . 0.0 109.408 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.39 -46.64 22.62 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 124.755 3.637 . . . . 0.0 110.052 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.92 69.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.73 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -80.2 20.53 0.66 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.711 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.7 m -89.45 141.32 28.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.408 -0.807 . . . . 0.0 109.354 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.418 ' CE1' HG12 ' A' ' 144' ' ' VAL . 34.9 p-80 -152.87 164.88 37.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.559 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.7 m -137.73 132.63 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.15 93.03 9.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.623 -0.673 . . . . 0.0 109.483 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.46 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 56.0 mm-40 -78.51 130.76 36.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.2 t -119.94 112.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.582 -0.699 . . . . 0.0 109.475 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.46 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.9 m95 -110.84 157.5 19.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.518 -0.739 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -141.38 143.06 33.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.3 tttp . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.603 -0.685 . . . . 0.0 109.489 -179.989 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.05 101.45 8.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.7 m-85 -74.73 126.89 31.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.513 -0.742 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.3 tp -140.11 112.99 8.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 109.313 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.407 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.7 p90 -142.67 141.92 31.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 0.0 109.731 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.81 112.53 24.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.576 -0.702 . . . . 0.0 109.213 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.13 149.42 52.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.607 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -97.41 170.14 9.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.619 -0.676 . . . . 0.0 109.452 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.55 -18.58 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.872 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.38 15.4 0.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 0.0 109.855 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.1 34.38 88.83 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 4.5 tp -107.54 165.25 11.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.596 -0.944 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 13' ' ' ILE . 31.8 pt -138.61 -29.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.476 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.71 -168.85 33.05 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -174.43 124.35 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.49 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 60.03 33.56 21.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.51 -0.744 . . . . 0.0 109.735 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.35 4.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -76.03 176.11 8.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.548 -0.972 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.409 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 19.3 mt -86.92 156.59 55.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.707 . . . . 0.0 109.41 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -80.59 -31.51 1.5 Allowed 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.0 3.8 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 31.4 p90 -104.96 167.11 9.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.56 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -117.79 100.27 7.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.606 -0.684 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.7 tp -122.02 81.76 43.44 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.25 -38.89 15.38 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 125.181 3.92 . . . . 0.0 110.307 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.78 -41.34 99.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.528 -0.732 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.63 -31.58 72.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.642 -0.661 . . . . 0.0 109.422 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.05 -23.7 61.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.589 -0.695 . . . . 0.0 109.531 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -86.81 -29.8 22.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.567 -0.708 . . . . 0.0 109.452 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -70.97 -25.94 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -65.42 -45.23 84.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.661 . . . . 0.0 109.446 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -64.98 -29.3 70.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.475 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.69 51.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.642 -0.661 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -97.77 33.13 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.3 p -137.37 -34.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.6 m -68.62 126.17 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.557 -0.714 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 36.28 23.58 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -153.24 166.21 33.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.521 -0.988 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.42 102.0 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.598 -0.689 . . . . 0.0 109.447 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.1 tmm? -70.38 125.72 27.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.58 -0.7 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 t -131.9 115.5 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.631 -0.668 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.7 m -135.45 -177.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.702 . . . . 0.0 109.458 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.3 -178.62 35.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -72.27 -31.86 66.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.576 -0.955 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.22 -48.23 62.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -68.64 -25.95 65.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -68.54 -33.92 74.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.708 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.14 -26.15 19.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 t -74.9 10.11 1.59 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -81.76 166.42 37.7 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.83 -73.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.103 3.868 . . . . 0.0 109.968 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -118.23 71.94 0.85 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.55 -0.719 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -72.19 156.82 90.25 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.12 -175.86 17.48 Favored 'Cis proline' 0 N--CA 1.508 2.378 0 O-C-N 123.377 1.198 . . . . 0.0 109.946 0.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.415 ' HB2' HD22 ' A' ' 59' ' ' ASN . 84.2 mt -107.73 104.25 52.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -74.56 179.83 5.55 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 124.645 3.564 . . . . 0.0 109.813 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.95 28.06 17.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.572 -0.705 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -176.1 178.76 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.416 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 m -98.47 117.47 32.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.464 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.415 HD22 ' HB2' ' A' ' 54' ' ' LEU . 21.3 m120 -88.78 105.99 18.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -114.9 141.37 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 109.438 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -131.94 123.49 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.2 tp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.523 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.65 140.13 34.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.63 -0.669 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -94.74 29.74 2.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -147.56 142.46 26.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 109.442 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -88.65 30.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.703 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.57 -35.15 9.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -77.18 134.57 38.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.515 -0.74 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -146.29 116.41 7.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.47 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' H ' HG23 ' A' ' 75' ' ' VAL . . . -106.68 131.98 53.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.473 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -84.66 138.42 32.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.562 -0.711 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.17 38.05 59.36 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.5 144.25 16.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.529 -0.983 . . . . 0.0 109.553 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -79.84 95.66 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.587 -0.696 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 70' ' ' ALA . 30.0 t -79.99 106.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.88 150.82 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -131.65 30.03 4.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.679 . . . . 0.0 109.464 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -163.87 144.55 8.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.454 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.406 HG12 ' CE1' ' A' ' 106' ' ' PHE . 29.8 t -67.57 -32.95 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.585 -0.697 . . . . 0.0 109.476 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -32.96 72.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.667 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.86 75.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.0 t -69.19 -44.14 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.42 -30.2 65.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.565 -0.71 . . . . 0.0 109.426 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.15 79.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.681 -0.637 . . . . 0.0 109.474 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -71.3 -33.45 69.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.553 -0.717 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.47 -31.16 65.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.92 -45.91 69.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.594 -0.692 . . . . 0.0 109.484 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -66.19 -26.79 67.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.552 -0.717 . . . . 0.0 109.509 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -118.94 89.75 39.38 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 -22.49 6.98 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.126 3.884 . . . . 0.0 109.984 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -65.82 -26.02 67.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.603 -0.686 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -104.24 179.46 4.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.512 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -140.36 150.61 44.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.653 -0.654 . . . . 0.0 109.462 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.6 tp -75.28 137.84 41.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 109.486 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -144.24 116.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.656 -0.652 . . . . 0.0 109.473 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 96' ' ' ILE . 40.5 mm -91.74 128.73 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.698 . . . . 0.0 109.379 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.13 -31.03 8.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.86 178.83 38.49 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.52 -151.71 21.81 Favored Glycine 0 N--CA 1.499 2.855 0 O-C-N 120.362 -1.67 . . . . 0.0 109.632 0.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.5 68.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.965 . . . . 0.0 109.519 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -70.51 -30.6 67.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -76.01 -37.75 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.533 -0.729 . . . . 0.0 109.494 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.411 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 28.9 m-85 -63.64 -50.02 70.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.399 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 -24.92 68.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.656 -0.653 . . . . 0.0 109.497 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.19 69.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.406 ' CE1' HG12 ' A' ' 79' ' ' VAL . 77.6 m-85 -116.44 19.28 14.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -27.74 65.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.69 20.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.695 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -160.09 36.85 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.546 -0.721 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.441 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -96.99 141.31 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.589 -0.695 . . . . 0.0 109.473 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -122.03 -47.46 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.384 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.7 m -100.9 152.62 20.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.391 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.0 mt -136.12 96.95 3.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.624 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.2 mt -100.49 109.3 21.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.722 . . . . 0.0 109.292 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.407 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -119.23 141.98 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.0 m -109.21 103.08 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.58 -0.7 . . . . 0.0 109.267 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -88.22 138.88 31.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.702 . . . . 0.0 109.561 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.63 141.47 47.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.291 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.94 -32.35 63.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.503 -0.748 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.74 133.73 19.52 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.0 m -82.7 142.29 31.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.62 -0.929 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -148.04 119.22 7.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.668 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -87.53 145.23 26.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.586 -0.697 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.72 -127.68 2.36 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -143.19 -32.59 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.951 . . . . 0.0 109.438 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.3 m -105.1 136.94 43.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -113.14 175.5 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.605 -0.684 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.6 tpt -92.13 152.61 19.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.528 -0.732 . . . . 0.0 109.558 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 pt -72.55 164.75 57.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.71 98.38 1.14 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 125.112 3.875 . . . . 0.0 109.919 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.56 147.0 26.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -84.45 84.81 7.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.558 -0.714 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -67.83 -19.31 65.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.718 . . . . 0.0 109.684 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -24.97 67.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -97.42 29.35 3.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -143.57 175.2 10.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -149.47 144.28 26.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -84.43 114.75 22.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.47 -34.0 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.523 -0.736 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -155.41 171.45 19.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.726 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 t -164.51 127.64 2.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -98.7 111.91 24.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.556 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 m -91.29 145.38 24.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -149.24 125.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.509 -0.744 . . . . 0.0 109.345 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -104.79 121.32 43.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.61 -0.681 . . . . 0.0 109.436 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.56 -165.11 0.81 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.3 p -73.32 -40.7 64.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.723 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -103.45 137.58 19.29 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.61 -44.34 26.11 Favored 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 124.826 3.684 . . . . 0.0 110.093 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.7 71.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.631 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.97 19.43 1.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 109.66 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.4 m -91.13 134.29 34.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.543 -0.723 . . . . 0.0 109.437 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.41 ' CE1' HG12 ' A' ' 144' ' ' VAL . 37.4 p-80 -150.01 167.23 27.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -137.32 136.48 38.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -89.44 95.45 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.446 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.6 mt-10 -76.67 135.6 39.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.552 -0.717 . . . . 0.0 109.453 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.9 t -126.19 97.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.565 -0.709 . . . . 0.0 109.511 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.446 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 30.5 m95 -96.46 163.0 13.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.637 -0.664 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -143.31 144.77 32.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.62 -0.675 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 0.0 109.461 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.49 134.0 44.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.437 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 7.2 m-85 -104.76 153.99 20.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 tp -164.57 109.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 109.32 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.1 146.61 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.533 -0.729 . . . . 0.0 109.655 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.78 110.05 22.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.285 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -129.12 149.31 50.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.64 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -99.34 171.76 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 0.0 109.411 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.414 ' HB2' HH11 ' A' ' 9' ' ' ARG . 1.8 ptp180 -61.56 -19.53 62.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.641 -0.662 . . . . 0.0 109.806 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.53 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.16 37.0 93.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 5.5 tp -105.58 167.81 9.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.528 -0.983 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.406 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 2.6 pp -144.92 -26.19 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.487 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.59 -170.97 35.48 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -172.65 120.28 0.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.575 -0.956 . . . . 0.0 109.442 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.92 33.42 21.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.506 -0.746 . . . . 0.0 109.706 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.98 3.68 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -77.24 178.27 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.506 -0.996 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.7 mt -83.7 155.5 65.21 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.475 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -80.16 -30.92 1.92 Allowed 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 124.993 3.795 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 31.7 p90 -105.76 168.11 9.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.545 -0.722 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -115.19 107.61 15.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.675 . . . . 0.0 109.376 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.0 tp -129.31 80.49 72.18 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.578 -0.701 . . . . 0.0 109.411 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.29 -40.05 16.46 Favored 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 125.162 3.908 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.67 -49.77 73.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.55 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -63.04 -31.35 72.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.32 -24.73 61.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -86.74 -23.83 25.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.505 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.0 t80 -75.02 -24.63 58.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 34' ' ' THR . 53.4 t80 -63.24 -44.98 93.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.576 -0.703 . . . . 0.0 109.472 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -63.6 -26.15 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.566 -0.709 . . . . 0.0 109.463 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.56 -28.34 33.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.548 -0.72 . . . . 0.0 109.419 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.404 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 17.3 mm100 -103.06 34.12 3.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 30' ' ' PHE . 22.1 p -140.59 -34.73 0.51 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.2 m -77.29 131.16 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.419 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.07 7.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -111.37 167.6 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.603 -0.939 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.8 mt -85.12 126.03 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 109.431 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.6 ttp -92.12 107.66 19.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.49 122.04 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.56 163.13 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.95 -164.28 39.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -82.28 -38.64 24.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.987 . . . . 0.0 109.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.44 -33.33 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.623 -0.673 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -79.42 -27.55 41.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 109.459 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -65.51 -58.35 6.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.02 -26.71 68.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -62.7 -21.85 66.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.722 . . . . 0.0 109.694 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -62.77 161.1 31.18 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.523 -0.736 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.17 -71.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 125.119 3.879 . . . . 0.0 109.901 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -115.77 75.74 0.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -78.39 156.48 78.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.04 166.86 75.92 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.423 1.223 . . . . 0.0 109.994 0.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.6 mt -90.09 118.03 68.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.736 . . . . 0.0 109.315 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.65 174.3 12.49 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 124.765 3.644 . . . . 0.0 109.969 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.48 27.03 16.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.63 -0.668 . . . . 0.0 109.641 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -177.41 155.0 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.499 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.2 m -76.39 144.7 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -120.48 96.91 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.593 -0.692 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -100.34 151.57 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.69 120.2 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.697 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.0 tp -96.61 117.61 31.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.598 -0.689 . . . . 0.0 109.458 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -151.05 144.14 24.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.569 -0.707 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -103.06 31.14 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -124.24 132.31 53.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.629 -0.669 . . . . 0.0 109.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.2 30.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.39 -30.69 5.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.589 -0.694 . . . . 0.0 109.513 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -66.58 142.56 57.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -137.58 142.45 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.91 117.65 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -84.04 122.1 28.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.716 -0.615 . . . . 0.0 109.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.68 41.59 12.67 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.41 145.4 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.99 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -83.07 97.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.564 -0.71 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 t -76.8 100.35 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.56 -0.713 . . . . 0.0 109.443 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -91.16 153.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -135.35 30.34 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.566 -0.708 . . . . 0.0 109.446 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -166.88 148.23 6.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.7 -33.33 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.94 -32.9 72.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.59 -36.07 80.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.65 -0.656 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.7 t -69.8 -39.78 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.436 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -76.84 -31.43 56.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.643 -0.661 . . . . 0.0 109.52 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.08 78.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -72.98 -33.66 65.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.21 68.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.21 -42.54 83.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.639 -0.663 . . . . 0.0 109.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.18 -27.84 68.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.507 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -119.33 89.93 41.14 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.713 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.63 -22.99 7.44 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 125.112 3.875 . . . . 0.0 109.922 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -68.15 -26.9 66.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.415 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -97.9 179.89 4.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -139.47 165.7 26.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.7 tp -96.59 128.75 43.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.501 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 t -132.08 133.57 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 96' ' ' ILE . 40.4 mm -104.07 124.46 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.69 -27.96 9.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.22 -179.57 38.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.87 -154.8 19.55 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.317 -1.696 . . . . 0.0 109.554 -0.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.84 -32.27 73.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.937 . . . . 0.0 109.486 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -71.04 -31.83 68.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.99 -36.0 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 96' ' ' ILE . 22.2 m-85 -63.21 -55.63 23.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.582 -0.699 . . . . 0.0 109.554 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -62.55 -21.38 65.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.626 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.93 -36.87 78.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 79' ' ' VAL . 69.5 m-85 -113.41 18.7 17.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -23.81 65.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 109.58 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.49 -45.42 59.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.08 38.84 1.12 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.607 -0.683 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -88.95 151.75 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -132.84 -61.85 0.83 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.6 m -93.55 159.82 15.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.433 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.406 HD12 ' CZ ' ' A' ' 136' ' ' PHE . 34.3 mt -140.17 95.77 2.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.4 mt -95.08 103.36 15.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.316 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -109.24 136.18 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.725 . . . . 0.0 109.452 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 m -107.39 102.95 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.388 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.9 146.49 26.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.78 132.1 51.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.623 -0.673 . . . . 0.0 109.272 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.88 -34.17 73.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.613 -0.679 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.86 130.59 27.95 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 t -79.82 139.85 37.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.58 -0.953 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -146.78 126.55 13.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.715 . . . . 0.0 109.506 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.05 146.52 26.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.36 -124.01 1.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -145.04 -30.08 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.61 -0.935 . . . . 0.0 109.49 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -100.79 142.45 32.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.705 . . . . 0.0 109.509 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -118.02 176.05 5.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.572 -0.705 . . . . 0.0 109.461 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.41 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.597 -0.689 . . . . 0.0 109.5 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.3 pt -69.37 163.68 56.08 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.562 -0.711 . . . . 0.0 109.516 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.88 102.35 1.45 Allowed 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 125.047 3.831 . . . . 0.0 109.851 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.24 144.74 26.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -81.15 85.62 6.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.692 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -71.74 -14.1 61.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.852 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.05 10.05 1.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.897 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.86 31.73 3.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 0.0 109.417 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.406 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 66.3 m-85 -141.47 174.13 10.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.399 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -147.44 137.35 22.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -71.1 156.56 39.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.746 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.73 -36.02 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.701 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.7 m -148.2 163.63 36.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.8 t -158.86 157.63 31.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -142.92 101.09 3.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.488 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -85.52 143.22 28.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.409 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.9 p -147.18 129.18 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.541 -0.725 . . . . 0.0 109.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -105.25 121.34 43.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.563 -0.711 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.32 -166.21 1.01 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.4 p -70.23 -39.63 74.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.596 -0.69 . . . . 0.0 109.61 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -105.35 137.84 19.38 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.647 -0.658 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -47.98 -45.54 24.66 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 C-N-CA 124.842 3.694 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.98 70.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.689 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.1 mt -81.07 20.83 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.6 m -91.37 137.99 31.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.409 ' CE1' HG12 ' A' ' 144' ' ' VAL . 34.5 p-80 -151.85 169.01 23.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.0 m -142.73 132.51 24.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -89.61 101.0 13.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.446 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 38.2 mt-10 -85.9 128.98 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.8 t -114.96 112.7 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.534 -0.729 . . . . 0.0 109.51 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.446 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 31.2 m95 -109.32 164.06 12.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.0 mm-40 -139.92 136.4 33.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.615 -0.678 . . . . 0.0 109.429 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -72.78 140.35 47.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.518 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -141.65 127.46 19.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.607 -0.683 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.432 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.401 ' C17' HN52 ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.59 121.24 19.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.6 m-85 -91.62 149.24 21.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 tp -159.79 110.39 1.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.696 . . . . 0.0 109.401 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -143.77 147.99 34.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.749 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.23 111.88 23.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.538 -0.726 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -132.43 149.47 52.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.537 -0.727 . . . . 0.0 109.637 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -100.43 170.44 8.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.684 . . . . 0.0 109.458 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 11' ' ' GLY . 15.8 ptm180 -61.25 -17.32 52.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.785 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.72 14.4 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 109.846 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.41 36.89 93.76 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 4.9 tp -112.23 166.55 11.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.549 -0.971 . . . . 0.0 109.526 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 13' ' ' ILE . 32.2 pt -139.8 -29.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.73 -168.18 32.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -170.23 119.72 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.636 -0.92 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.95 29.81 19.36 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.566 -0.709 . . . . 0.0 109.742 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.89 -61.69 2.65 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -73.83 169.77 16.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.923 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.414 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 40.3 mt -84.84 155.92 61.3 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.616 -0.677 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.4 Cg_endo -79.52 -28.08 3.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.046 3.831 . . . . 0.0 109.958 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 37.1 p90 -106.77 167.67 9.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -118.57 93.53 4.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.557 -0.714 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 tp -114.97 80.73 6.99 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.27 -38.67 15.19 Favored 'Trans proline' 0 N--CA 1.507 2.273 0 C-N-CA 125.139 3.893 . . . . 0.0 110.25 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.7 -44.25 96.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.698 . . . . 0.0 109.59 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -64.24 -41.07 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.741 . . . . 0.0 109.436 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.02 -23.72 67.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -85.0 -29.48 24.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.631 -0.668 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -70.8 -25.75 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.458 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.34 -52.2 59.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.545 -0.722 . . . . 0.0 109.453 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.461 HH22 ' HZ2' ' A' ' 51' ' ' LYS . 11.2 ttm180 -68.32 2.09 2.51 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.601 -0.687 . . . . 0.0 110.022 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.15 12.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -0.832 . . . . 0.0 109.451 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -114.91 35.09 4.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.568 -0.707 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 p -132.91 -27.53 1.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.741 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.0 m -75.5 127.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.91 23.62 51.88 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.25 164.98 29.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.522 -0.987 . . . . 0.0 109.5 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -91.37 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.8 ttp -82.92 108.33 16.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.54 -0.725 . . . . 0.0 109.559 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.0 t -96.59 118.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.503 -0.748 . . . . 0.0 109.385 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 m -131.47 166.92 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 109.495 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.41 -160.71 36.59 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.7 -35.54 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.617 -0.931 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -69.5 -37.79 77.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -77.4 -27.23 52.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 32.1 t80 -65.51 -34.55 78.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.496 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -89.61 -24.03 21.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -62.91 -22.18 66.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.735 . . . . 0.0 109.601 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -62.73 159.8 41.23 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -72.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.093 3.862 . . . . 0.0 109.89 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HZ2' HH22 ' A' ' 31' ' ' ARG . 5.3 pttm -108.07 74.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.423 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 4.6 ptm180 -78.73 156.03 77.89 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.489 -0.757 . . . . 0.0 109.528 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.18 171.09 63.39 Favored 'Cis proline' 0 N--CA 1.507 2.317 0 O-C-N 123.407 1.214 . . . . 0.0 109.957 0.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.4 mt -94.58 115.39 65.25 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.55 -0.719 . . . . 0.0 109.332 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.0 -178.28 4.53 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.808 3.672 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 60.65 28.21 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -176.68 179.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.5 m -112.42 111.17 21.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.607 -0.683 . . . . 0.0 109.487 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 59' ' ' ASN . 1.5 m-80 -86.0 107.83 17.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.488 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 t -102.3 112.66 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.588 -0.695 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.4 t -95.71 125.16 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.453 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.4 tp -104.56 114.79 29.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.42 140.89 33.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -89.16 30.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -137.65 125.05 21.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.7 29.83 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.03 -37.46 6.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.601 -0.687 . . . . 0.0 109.55 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -70.83 143.7 51.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 109.518 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.75 101.45 3.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . . . -88.61 118.57 28.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -73.83 136.38 43.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.546 -0.722 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 37.43 57.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.99 145.93 18.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.973 . . . . 0.0 109.515 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.78 98.91 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 0.0 109.501 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -80.42 99.41 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.97 158.57 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.61 -0.681 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -138.8 29.82 2.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.548 -0.72 . . . . 0.0 109.454 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -167.85 148.75 5.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 106' ' ' PHE . 31.6 t -68.06 -31.69 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.612 -0.68 . . . . 0.0 109.475 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.53 -33.68 76.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.5 -0.75 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.41 75.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.683 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 t -67.81 -43.92 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -73.19 -30.13 63.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.486 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.68 83.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.597 -0.689 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -71.51 -34.02 69.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.5 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.0 -30.82 69.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.602 -0.686 . . . . 0.0 109.405 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -67.19 -34.63 77.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.534 -0.728 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.43 -36.58 76.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -120.92 87.26 42.88 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.45 20.22 0.98 Allowed 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.169 3.912 . . . . 0.0 109.952 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -100.96 -30.12 11.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -94.51 178.23 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.558 -0.713 . . . . 0.0 109.443 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -127.88 151.62 48.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.626 -0.671 . . . . 0.0 109.466 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.17 108.26 16.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.629 -0.669 . . . . 0.0 109.483 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -113.91 131.42 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.553 -0.717 . . . . 0.0 109.419 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' CG2' ' CD1' ' A' ' 103' ' ' PHE . 39.9 mm -98.28 125.68 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.707 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.13 -27.52 10.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.503 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 160.85 -179.94 36.0 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.29 -152.26 17.54 Favored Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.315 -1.697 . . . . 0.0 109.585 0.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.4 73.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.582 -0.952 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -70.85 -30.45 66.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.76 -34.89 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.563 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 22.1 m-85 -64.39 -56.79 11.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.713 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.6 m -62.53 -21.18 65.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.661 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.93 73.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.528 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.419 ' CE1' HG11 ' A' ' 79' ' ' VAL . 69.9 m-85 -113.1 17.24 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.526 -0.734 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -67.06 -23.17 65.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.521 -0.737 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -66.77 -45.44 78.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.516 -0.74 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.23 44.97 1.0 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.448 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -93.96 147.83 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 0.0 109.442 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -136.94 -68.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -84.65 120.04 25.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 mt -107.7 94.95 5.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.631 -0.668 . . . . 0.0 109.609 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 39.0 mt -91.33 115.51 28.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.645 -0.659 . . . . 0.0 109.343 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -124.31 138.71 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.705 . . . . 0.0 109.509 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.9 m -109.87 101.4 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.564 -0.71 . . . . 0.0 109.234 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -87.68 139.81 30.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 109.614 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.73 140.15 47.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.331 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.81 -33.27 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.05 139.06 25.45 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.2 m -86.91 143.13 27.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.516 -0.991 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -148.45 108.73 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -80.1 147.04 31.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.531 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.46 -126.77 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -141.79 -41.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.949 . . . . 0.0 109.482 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.8 m -90.52 126.98 36.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.509 -0.745 . . . . 0.0 109.435 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -104.53 172.22 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.82 145.09 24.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.462 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.4 pt -66.79 165.37 26.17 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.519 -0.738 . . . . 0.0 109.483 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.52 108.83 2.19 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 125.173 3.915 . . . . 0.0 109.961 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -98.67 145.22 27.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -86.09 87.15 7.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -69.88 -17.25 63.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.82 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.86 -27.19 69.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.477 -0.764 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -93.3 30.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -149.91 164.15 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -139.07 136.18 34.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.698 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -70.12 149.17 47.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.631 -0.668 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.6 -31.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.469 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -143.87 153.3 42.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.522 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.2 p -155.48 113.3 3.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.544 -0.723 . . . . 0.0 109.501 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 tpt85 -91.24 103.31 16.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.7 m -85.55 141.4 29.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.9 p -146.72 129.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.597 -0.69 . . . . 0.0 109.322 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -108.3 120.7 43.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.4 -166.04 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.3 p -71.17 -42.77 68.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.717 . . . . 0.0 109.588 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.18 137.75 19.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.573 -0.705 . . . . 0.0 109.428 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.87 -43.1 30.33 Favored 'Trans proline' 0 N--CA 1.508 2.333 0 C-N-CA 124.781 3.654 . . . . 0.0 110.126 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.48 73.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.565 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 47.9 mt -80.91 20.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.629 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.6 m -90.85 141.93 28.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 109.473 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.418 ' CE1' HG12 ' A' ' 144' ' ' VAL . 27.5 p-80 -158.12 167.29 30.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.496 -0.752 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -138.63 141.03 39.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.638 . . . . 0.0 109.417 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.36 97.75 9.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.667 . . . . 0.0 109.467 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -81.36 139.46 35.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.45 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -124.97 107.29 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.412 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 31.4 m95 -103.97 165.13 11.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.685 . . . . 0.0 109.454 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -148.87 144.18 26.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.482 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -69.01 113.81 6.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -146.89 139.25 24.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.632 -0.667 . . . . 0.0 109.507 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.504 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.401 HN51 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.81 128.59 35.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 109.412 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.434 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 6.6 m-85 -95.8 160.06 14.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.562 -0.711 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 tp -170.86 108.92 0.32 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.698 . . . . 0.0 109.335 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.39 151.21 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.31 114.12 26.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -135.61 150.65 49.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -100.86 170.73 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.526 -0.734 . . . . 0.0 109.366 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -61.17 -17.85 55.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.579 -0.701 . . . . 0.0 109.887 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.72 14.05 0.89 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.501 -0.749 . . . . 0.0 109.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.16 39.01 97.1 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 tp -112.25 163.95 13.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.95 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.75 -27.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.518 -0.738 . . . . 0.0 109.514 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.16 -176.85 40.59 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -166.42 120.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.958 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.88 32.74 21.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -61.73 3.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -76.34 171.3 14.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.96 . . . . 0.0 109.493 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.4 HD23 ' CZ2' ' A' ' 21' ' ' TRP . 20.1 mt -84.8 155.85 61.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 9.8 Cg_endo -78.9 -26.99 5.0 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 125.069 3.846 . . . . 0.0 109.97 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.422 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 37.5 p90 -108.37 167.31 10.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -118.83 97.6 5.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.5 tp -118.63 80.09 16.77 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 109.428 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.28 -37.82 14.3 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 125.193 3.928 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -63.02 -43.51 98.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.505 -0.747 . . . . 0.0 109.503 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.4 -35.0 79.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.396 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.68 -25.3 63.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.67 -0.644 . . . . 0.0 109.516 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -83.8 -28.51 28.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.435 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.7 t80 -74.01 -25.53 59.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.541 -0.725 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -65.01 -45.82 83.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.452 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -65.69 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.85 56.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 41.5 mm-40 -99.59 32.27 2.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 109.506 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.5 p -139.55 -31.33 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -67.88 129.22 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.456 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.09 56.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -155.35 170.35 22.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.561 -0.964 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.1 mt -99.62 111.66 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.4 ttp -87.05 106.87 18.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.56 119.46 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.43 160.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.562 -0.711 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.34 -170.2 46.69 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.12 -33.71 59.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.598 -0.943 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -67.67 -47.32 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 109.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -70.1 -26.03 63.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.686 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -63.9 -43.54 95.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.573 -0.704 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.9 -22.96 33.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.531 -0.73 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t -62.97 -23.9 67.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.721 . . . . 0.0 109.621 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.98 160.23 48.93 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.725 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.83 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.124 3.882 . . . . 0.0 109.942 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -105.81 89.59 3.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.377 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 3.4 ptm180 -96.78 157.03 35.86 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.593 -0.692 . . . . 0.0 109.507 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.87 142.32 57.68 Favored 'Cis proline' 0 N--CA 1.509 2.4 0 O-C-N 123.325 1.171 . . . . 0.0 109.964 -0.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.3 mt -61.85 111.17 4.02 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.577 -0.702 . . . . 0.0 109.413 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.43 -178.05 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.732 3.621 . . . . 0.0 109.949 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 60.96 29.21 18.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.588 -0.695 . . . . 0.0 109.56 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -177.24 177.42 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -100.2 119.32 38.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -93.18 104.53 16.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.568 -0.707 . . . . 0.0 109.511 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 t -105.75 120.81 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.495 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -106.5 127.38 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.731 . . . . 0.0 109.408 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 tp -102.34 120.75 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.654 -0.654 . . . . 0.0 109.468 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.11 155.41 44.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.396 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -86.24 -61.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.617 -0.677 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.37 145.54 37.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.655 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.38 30.95 0.59 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.72 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.55 -31.3 19.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -69.58 124.75 24.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -104.56 131.56 51.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.66 -0.65 . . . . 0.0 109.374 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.76 112.32 8.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.507 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -90.47 142.93 27.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 34.74 61.03 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.49 141.93 15.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.955 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.11 96.92 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 t -73.55 96.57 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.6 m -91.23 160.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.717 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -137.53 29.74 2.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.581 -0.699 . . . . 0.0 109.495 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.65 146.39 2.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 106' ' ' PHE . 30.4 t -68.17 -32.92 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -33.83 75.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.485 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.19 -37.35 83.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.498 -0.751 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.9 t -69.03 -38.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.606 -0.684 . . . . 0.0 109.449 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -73.07 -30.75 63.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.74 86.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.61 -32.78 71.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.83 -31.03 68.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -65.64 -40.55 92.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -67.61 -32.13 72.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.546 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.82 89.75 42.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.59 -0.693 . . . . 0.0 109.521 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.08 -21.6 7.89 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 125.12 3.88 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 -26.74 67.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.545 -0.722 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.01 -179.99 5.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.576 -0.703 . . . . 0.0 109.427 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -138.16 144.81 40.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.2 tp -86.07 132.59 34.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -139.29 131.04 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 109.504 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 103' ' ' PHE . 40.6 mm -97.1 125.79 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.01 -25.13 10.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.504 -0.748 . . . . 0.0 109.474 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.29 -176.14 36.12 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.483 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.28 -152.4 9.12 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.259 -1.73 . . . . 0.0 109.546 0.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.84 82.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.946 . . . . 0.0 109.707 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -66.1 -23.05 66.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.61 -0.681 . . . . 0.0 109.765 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.483 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.5 mm -77.31 -35.42 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.521 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 96' ' ' ILE . 25.5 m-85 -64.0 -50.39 68.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 109.507 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.06 -26.22 68.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.03 83.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.545 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.417 ' CE2' HG12 ' A' ' 79' ' ' VAL . 55.3 m-85 -103.02 11.8 36.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.513 -0.742 . . . . 0.0 109.951 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -71.54 -24.26 61.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.779 . . . . 0.0 109.526 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 -41.54 92.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.722 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -110.77 37.41 2.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.582 -0.699 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.434 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 8.9 p -79.72 151.89 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 0.0 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.2 -68.79 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.66 -0.65 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -88.68 163.03 15.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.459 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 136' ' ' PHE . 22.0 mt -142.19 89.74 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.9 mt -89.34 117.02 27.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.272 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -126.72 137.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.598 -0.689 . . . . 0.0 109.54 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.1 m -107.89 102.44 11.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.281 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -87.46 132.9 33.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.574 -0.704 . . . . 0.0 109.585 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.81 135.53 49.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.05 77.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.712 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 130.11 25.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 p -77.99 143.01 37.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.592 -0.946 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -147.99 113.32 5.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.51 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.65 149.63 25.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.532 -0.73 . . . . 0.0 109.442 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.25 -127.86 1.52 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.52 -32.64 0.58 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.633 -0.922 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -93.93 147.44 23.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.698 . . . . 0.0 109.574 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -128.07 173.05 10.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.7 tpt -98.01 151.09 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.496 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.5 pt -72.46 164.61 58.41 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.433 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.07 97.55 1.07 Allowed 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 125.106 3.87 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -88.11 137.71 32.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.708 . . . . 0.0 109.474 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -80.32 85.38 5.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.715 . . . . 0.0 109.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.92 -16.92 63.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.751 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.73 -24.91 67.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.745 . . . . 0.0 109.508 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.67 -29.44 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.415 ' CZ ' HD13 ' A' ' 113' ' ' LEU . 91.7 m-85 -87.89 169.56 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.563 -0.711 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.2 m -138.97 134.82 33.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.632 -0.668 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -69.16 148.62 49.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 -34.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.1 p -149.53 157.91 43.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -157.62 122.37 4.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.48 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.29 100.2 11.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 109.479 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.2 m -82.07 146.48 29.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.699 . . . . 0.0 109.486 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -148.88 131.24 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.625 -0.672 . . . . 0.0 109.315 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -111.88 118.4 35.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 0.0 109.49 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.46 -174.25 4.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.551 -0.718 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.5 p -63.31 -44.06 96.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -89.34 156.13 48.55 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.145 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.76 -22.03 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 124.827 3.685 . . . . 0.0 109.943 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.28 -23.39 30.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.548 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -89.28 18.97 4.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.605 -0.684 . . . . 0.0 109.708 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 16.8 m -85.6 141.88 29.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -158.48 168.26 27.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.0 m -136.93 134.84 37.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.638 -0.664 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.55 91.2 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.579 -0.701 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -71.79 145.28 48.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.685 . . . . 0.0 109.418 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.0 t -133.56 104.3 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.659 . . . . 0.0 109.497 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.6 m95 -101.34 168.25 9.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -144.78 140.55 28.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.618 -0.676 . . . . 0.0 109.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -69.87 108.51 4.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -152.55 151.56 30.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.568 -0.707 . . . . 0.0 109.457 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.469 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.62 103.23 11.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.445 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.5 m-85 -72.73 140.65 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.436 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.9 tp -154.42 111.87 3.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.305 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -142.79 141.88 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.585 -0.697 . . . . 0.0 109.757 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.21 110.5 21.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.577 -0.702 . . . . 0.0 109.294 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -130.26 150.72 51.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.698 . . . . 0.0 109.676 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -98.9 169.66 9.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -60.93 -17.47 51.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.42 0.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.589 -0.694 . . . . 0.0 109.759 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 33.8 87.19 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 tp -109.45 164.0 12.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.947 . . . . 0.0 109.537 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.0 pt -137.94 -30.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.532 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.82 -176.96 39.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -162.54 124.59 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.969 . . . . 0.0 109.431 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.89 29.77 19.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 109.694 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.25 -64.13 1.67 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -75.42 -179.51 4.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.581 -0.952 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.3 mt -88.74 155.96 50.22 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.425 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -80.12 -26.93 3.99 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.994 3.796 . . . . 0.0 109.887 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.419 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 35.8 p90 -108.09 170.89 7.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.562 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -122.54 100.2 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.673 -0.642 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -121.3 82.47 38.65 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.623 -0.673 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -45.22 -39.04 15.35 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 125.142 3.894 . . . . 0.0 110.253 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.9 -49.7 73.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -63.35 -29.52 70.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.71 -23.45 60.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.554 -0.716 . . . . 0.0 109.595 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -88.4 -26.38 22.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.447 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -70.41 -25.9 63.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.568 -0.707 . . . . 0.0 109.464 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD2' H213 ' A' ' 170' ' ' TMQ . 60.9 t80 -63.19 -46.82 85.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.595 -0.691 . . . . 0.0 109.456 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttt-85 -63.51 -29.87 71.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.707 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.54 -30.24 57.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.516 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -99.18 33.74 2.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.9 p -142.65 -32.49 0.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.426 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.98 126.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.69 . . . . 0.0 109.502 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.32 34.53 25.83 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -155.84 171.35 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.949 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.68 98.53 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.597 -0.689 . . . . 0.0 109.419 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -70.03 132.23 45.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 t -137.2 118.91 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.581 -0.699 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.82 179.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.38 -168.34 41.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -80.69 -39.59 26.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -73.86 -32.31 63.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -76.23 -30.48 57.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CE2' ' HD2' ' A' ' 52' ' ' ARG . 27.9 t80 -64.27 -58.4 6.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.511 -0.743 . . . . 0.0 109.428 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -64.52 -15.65 61.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.535 -0.728 . . . . 0.0 109.793 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -62.4 -28.73 69.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.775 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -66.61 162.69 48.47 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.72 -69.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 125.129 3.886 . . . . 0.0 109.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -104.86 143.41 33.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.472 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HD2' ' CE2' ' A' ' 46' ' ' TYR . 21.3 mtm105 -144.82 161.96 40.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.73 148.54 76.11 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.449 1.236 . . . . 0.0 109.894 -0.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.46 ' HB2' HD22 ' A' ' 59' ' ' ASN . 75.0 mt -62.17 111.33 4.41 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.559 -0.713 . . . . 0.0 109.444 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.62 174.03 12.29 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.873 3.715 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 61.73 24.87 14.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.543 -0.723 . . . . 0.0 109.606 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -177.18 148.45 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.688 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -79.21 126.27 30.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.499 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' A' ' 54' ' ' LEU . 1.4 m-80 -100.2 117.61 34.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.54 -0.725 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -114.31 146.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.621 -0.675 . . . . 0.0 109.45 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.38 118.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.493 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 tp -97.56 107.03 19.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.72 . . . . 0.0 109.475 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -137.71 155.59 48.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.686 . . . . 0.0 109.464 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -98.41 -30.67 12.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.27 124.46 25.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -84.03 29.9 0.54 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.618 -0.676 . . . . 0.0 109.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -102.4 -34.79 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -71.96 140.45 49.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -144.18 104.19 4.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.476 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.82 118.37 27.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -79.24 123.88 27.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.549 -0.72 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.5 37.44 10.75 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.4 144.95 19.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 109.534 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.74 93.23 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.9 t -77.11 102.11 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.401 ' H ' HG21 ' A' ' 76' ' ' VAL . 27.9 m -97.68 155.05 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -135.01 29.33 3.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.63 -0.669 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -159.77 141.65 13.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.627 -0.671 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.8 t -67.6 -34.31 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.544 -0.723 . . . . 0.0 109.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.83 67.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.58 80.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.592 -0.693 . . . . 0.0 109.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t -68.15 -40.23 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.442 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.66 -31.91 65.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.721 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.46 -34.9 78.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.66 -0.65 . . . . 0.0 109.565 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -69.48 -35.21 75.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 109.488 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -68.27 -34.54 76.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.706 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -69.63 -32.4 71.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -120.6 87.95 42.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.685 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.39 20.1 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 125.116 3.878 . . . . 0.0 109.939 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.66 -30.02 12.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.565 -0.71 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.68 178.41 4.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.595 -0.691 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -127.02 155.8 42.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.624 -0.673 . . . . 0.0 109.452 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.8 tp -81.46 123.0 28.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.559 -0.713 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -124.64 120.07 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.409 HG21 ' CE1' ' A' ' 103' ' ' PHE . 41.3 mm -97.67 125.25 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -104.7 -24.82 12.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.17 -175.86 40.2 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.493 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.06 -155.72 22.16 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.283 -1.716 . . . . 0.0 109.588 -0.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.42 75.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.647 -0.914 . . . . 0.0 109.525 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.12 -28.18 62.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.557 -0.715 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.493 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -71.72 -37.61 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.696 . . . . 0.0 109.56 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.409 ' CE1' HG21 ' A' ' 96' ' ' ILE . 30.3 m-85 -63.02 -47.57 82.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.607 -0.683 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.5 m -63.07 -24.47 67.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.538 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.77 60.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' HG12 ' A' ' 79' ' ' VAL . 58.8 m-85 -103.97 21.05 17.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.583 -0.698 . . . . 0.0 109.646 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -23.59 53.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.498 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.82 18.7 0.58 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.499 -0.751 . . . . 0.0 109.745 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -160.08 38.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.416 -0.803 . . . . 0.0 109.419 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.445 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -93.56 152.84 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.87 -45.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 109.396 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.5 m -106.54 122.61 46.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.669 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.404 HD11 ' CD1' ' A' ' 136' ' ' PHE . 30.8 mt -108.57 101.48 10.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.646 -0.658 . . . . 0.0 109.626 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.7 mt -102.47 106.31 17.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -114.3 140.1 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.505 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -110.4 100.97 9.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -84.62 144.3 28.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.566 -0.708 . . . . 0.0 109.58 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -119.65 136.06 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.78 -35.54 77.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.437 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.23 126.79 13.64 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.6 p -79.75 143.2 34.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.569 -0.959 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -148.01 112.4 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.602 -0.686 . . . . 0.0 109.43 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.38 149.24 31.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.626 -0.671 . . . . 0.0 109.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.02 -129.29 1.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.56 -29.03 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.6 m -98.38 145.99 26.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HZ3' ' HB2' ' A' ' 127' ' ' LYS . 9.9 mtmp? -127.49 170.68 12.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.605 -0.684 . . . . 0.0 109.516 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.3 tpt -93.15 151.9 19.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.4 pt -72.45 164.64 58.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.674 . . . . 0.0 109.508 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.03 93.41 1.06 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.168 3.912 . . . . 0.0 109.914 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 71.7 mt -80.51 144.56 32.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -84.82 85.79 7.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.405 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -71.48 -7.84 50.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.57 -31.82 72.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.357 -0.84 . . . . 0.0 109.587 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.63 32.35 2.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.404 ' CD1' HD11 ' A' ' 113' ' ' LEU . 27.6 m-85 -138.9 169.5 17.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.434 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -150.15 147.06 27.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.547 -0.721 . . . . 0.0 109.446 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -86.08 116.41 24.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.41 -35.42 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -149.89 172.95 14.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.67 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t -165.78 123.51 1.5 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.459 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -100.66 105.5 16.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.5 m -86.87 152.25 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 109.395 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -154.87 133.06 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.16 123.19 49.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.94 -174.3 5.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.9 p -63.3 -40.55 97.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.634 -0.667 . . . . 0.0 109.451 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -91.97 155.0 43.53 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -77.87 -24.68 8.31 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.887 3.725 . . . . 0.0 109.865 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.63 -23.25 31.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.536 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.0 mt -88.4 20.29 3.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.7 m -82.51 144.68 30.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.367 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.41 ' CE1' HG12 ' A' ' 144' ' ' VAL . 30.1 p-80 -158.54 162.74 37.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.727 . . . . 0.0 109.615 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -135.46 137.54 42.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.671 -0.643 . . . . 0.0 109.443 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.77 98.45 11.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.509 -0.744 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.44 134.28 35.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.448 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.1 t -123.84 99.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.2 m95 -97.5 164.46 12.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.579 -0.701 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -140.38 145.49 37.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -67.07 115.64 7.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.447 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -152.81 151.91 30.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.563 -0.711 . . . . 0.0 109.469 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.489 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.416 H213 ' CD2' ' A' ' 30' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.5 132.32 29.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 7.0 m-85 -97.07 162.56 13.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.9 tp -171.18 107.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 109.269 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -141.75 147.66 37.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.524 -0.735 . . . . 0.0 109.711 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.84 115.18 26.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.588 -0.695 . . . . 0.0 109.179 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -136.21 151.99 50.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.685 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -101.74 170.38 8.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.59 -0.694 . . . . 0.0 109.373 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 11' ' ' GLY . 8.7 ptm180 -60.89 -17.48 50.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 109.946 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.94 14.33 0.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.718 . . . . 0.0 109.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.19 36.66 93.3 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 5.7 tp -112.26 164.4 13.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.916 . . . . 0.0 109.578 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.404 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 31.6 pt -138.69 -29.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.17 -165.92 27.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -173.8 122.46 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.959 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 57.9 35.01 24.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.624 -0.673 . . . . 0.0 109.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -62.81 3.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -76.17 171.95 13.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.564 -0.962 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.65 157.89 54.68 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.97 -27.18 3.96 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.03 3.82 . . . . 0.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.422 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 37.0 p90 -108.37 163.35 13.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.513 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -115.55 89.59 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.8 tp -107.7 79.57 0.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.68 -37.96 16.48 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 125.114 3.876 . . . . 0.0 110.251 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.79 -45.8 90.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.554 -0.716 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -62.71 -38.99 92.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 0.0 109.442 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.82 -24.0 67.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.668 . . . . 0.0 109.468 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -83.7 -27.84 28.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.625 -0.672 . . . . 0.0 109.48 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -76.76 -26.04 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -67.02 -45.31 77.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.453 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -64.76 -29.43 70.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.74 -28.74 44.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -101.44 33.5 2.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.506 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.5 p -137.69 -33.76 0.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 109.467 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.4 ' H ' HG21 ' A' ' 35' ' ' VAL . 27.6 m -79.73 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.576 -0.703 . . . . 0.0 109.47 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -29.49 12.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 165.17 12.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.545 -0.973 . . . . 0.0 109.495 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 38' ' ' ILE . 58.5 mt -80.84 121.85 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.62 -0.675 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.8 ttp -90.88 107.33 19.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.602 -0.686 . . . . 0.0 109.517 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -96.48 124.47 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.62 -0.675 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.82 166.07 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.02 -169.24 44.47 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -77.7 -34.18 52.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.565 -0.962 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.78 -45.14 72.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.7 m -71.07 -25.94 62.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.695 . . . . 0.0 109.533 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -63.96 -38.73 92.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -87.75 -20.24 26.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.4 m -62.78 -25.58 68.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.621 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -66.58 160.6 66.19 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.62 -0.675 . . . . 0.0 109.412 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.29 -73.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.125 3.883 . . . . 0.0 109.821 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -103.51 92.32 4.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 3.8 ptm180 -99.25 154.53 37.25 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.97 151.07 83.46 Favored 'Cis proline' 0 N--CA 1.51 2.463 0 O-C-N 123.309 1.163 . . . . 0.0 109.952 -0.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.8 mt -69.25 123.84 89.17 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.653 . . . . 0.0 109.289 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.28 176.85 9.25 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.676 3.584 . . . . 0.0 109.937 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.04 28.66 18.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.585 -0.697 . . . . 0.0 109.729 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.28 170.52 2.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.548 -0.72 . . . . 0.0 109.496 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 m -105.93 118.76 37.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.597 -0.689 . . . . 0.0 109.514 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 59' ' ' ASN . 1.5 m-80 -85.73 101.54 12.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -99.22 100.38 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.429 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -86.42 135.99 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 tp -110.51 113.7 26.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.676 . . . . 0.0 109.498 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.59 145.53 36.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.641 -0.662 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.21 -26.87 14.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -70.43 136.9 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.654 -0.654 . . . . 0.0 109.44 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.1 29.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.728 . . . . 0.0 109.508 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -111.44 -28.81 8.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.592 -0.693 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.34 140.87 58.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.536 -0.727 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -140.86 104.55 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.51 126.06 42.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 0.0 109.549 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -92.03 131.93 36.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.11 39.89 62.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.52 141.58 17.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.627 -0.926 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.7 95.62 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.611 -0.681 . . . . 0.0 109.448 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.8 t -81.47 98.39 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 109.45 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.76 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.653 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -140.73 30.68 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -169.14 142.74 2.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.06 -35.04 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.18 -31.25 69.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -35.93 80.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.0 t -68.45 -38.37 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.476 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -69.24 -31.31 69.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.602 -0.686 . . . . 0.0 109.491 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.9 -36.83 83.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.683 -0.636 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -69.58 -31.69 70.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.673 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.23 -27.13 60.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 109.429 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -64.21 -44.31 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.618 -0.676 . . . . 0.0 109.519 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.77 -30.27 70.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.578 -0.701 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -119.16 89.98 40.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.663 -0.648 . . . . 0.0 109.455 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -22.08 7.51 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.118 3.879 . . . . 0.0 109.874 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.67 -27.24 67.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 109.415 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -95.22 -180.0 4.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -138.44 169.3 18.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.532 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 tt -104.02 121.58 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.646 -0.659 . . . . 0.0 109.497 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.5 t -122.3 133.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.458 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.419 HG23 ' CD1' ' A' ' 103' ' ' PHE . 40.3 mm -102.24 120.68 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.56 -25.45 10.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.675 . . . . 0.0 109.489 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.64 -178.37 38.42 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.436 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.83 -153.21 18.79 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.223 -1.751 . . . . 0.0 109.565 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.51 73.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.949 . . . . 0.0 109.502 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.36 -27.71 60.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.436 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.9 mm -76.07 -34.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.713 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CD1' HG23 ' A' ' 96' ' ' ILE . 21.3 m-85 -63.04 -52.37 63.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.527 ' H ' ' HG1' ' A' ' 104' ' ' THR . 0.6 OUTLIER -64.9 -23.42 67.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.531 -0.731 . . . . 0.0 109.548 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.57 77.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -104.28 14.4 30.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.559 -0.713 . . . . 0.0 109.908 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -70.05 -24.68 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.802 . . . . 0.0 109.53 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.37 -44.21 79.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -101.42 38.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.644 -0.66 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 8.6 p -83.97 147.6 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.688 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.38 -63.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.591 -0.693 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.49 164.12 13.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 136' ' ' PHE . 41.8 mt -143.15 93.22 2.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.1 mt -91.71 114.16 26.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.413 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -122.05 138.18 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.551 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.3 m -109.31 98.17 7.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.642 -0.661 . . . . 0.0 109.282 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -84.0 134.11 34.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.95 142.65 36.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.622 -0.674 . . . . 0.0 109.314 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.53 -38.76 65.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.505 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.64 136.44 26.07 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.6 p -85.67 145.79 27.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 109.476 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -147.82 122.69 9.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.584 -0.698 . . . . 0.0 109.448 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -81.68 161.2 23.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.608 -0.683 . . . . 0.0 109.519 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.79 -134.87 1.71 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -142.1 -34.58 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.984 . . . . 0.0 109.449 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 m -95.82 143.08 27.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -122.26 173.68 7.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.605 -0.684 . . . . 0.0 109.403 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -93.3 152.02 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.536 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.6 pt -73.58 164.06 63.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.627 -0.671 . . . . 0.0 109.511 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.11 99.53 1.19 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.137 3.891 . . . . 0.0 109.878 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.42 144.52 27.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.63 -0.669 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.5 83.21 3.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.405 ' C ' ' H ' ' A' ' 135' ' ' ASP . 94.7 m95 -71.89 -18.58 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.654 . . . . 0.0 109.693 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.04 10.07 1.34 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.488 -0.758 . . . . 0.0 110.017 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 133' ' ' TRP . 20.5 m-20 -123.93 -31.75 3.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.498 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.406 ' CE2' HD12 ' A' ' 113' ' ' LEU . 86.1 m-85 -81.27 173.59 12.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.541 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.5 m -142.34 121.06 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.622 -0.674 . . . . 0.0 109.514 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -66.75 154.74 39.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.566 -0.709 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.5 -34.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 0.0 109.481 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.8 t -148.94 165.97 29.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 109.479 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 t -158.76 119.86 3.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.7 ttt-85 -93.14 108.65 20.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 m -90.76 143.07 27.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -144.88 134.61 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.52 120.06 40.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.591 -0.693 . . . . 0.0 109.434 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -81.49 -173.19 4.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.71 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.0 p -63.29 -41.37 98.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.584 -0.698 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.23 154.96 44.84 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.576 -0.703 . . . . 0.0 109.23 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.52 -25.79 7.79 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.819 3.679 . . . . 0.0 109.844 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -22.81 31.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -87.39 18.92 3.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.3 p -85.23 146.62 26.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.403 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -159.13 171.56 19.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.644 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.7 m -140.76 133.43 28.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.686 -0.634 . . . . 0.0 109.371 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -89.6 97.4 11.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.13 143.7 37.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.429 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.7 t -128.49 104.81 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 109.532 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.414 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 28.3 m95 -102.79 166.72 10.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -144.42 138.5 27.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.616 -0.677 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -73.93 106.15 5.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -159.36 154.74 25.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.588 -0.695 . . . . 0.0 109.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.485 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.14 122.17 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.55 -0.719 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.7 m-85 -93.75 151.72 19.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.641 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -163.15 110.92 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.592 -0.693 . . . . 0.0 109.331 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -141.85 140.01 32.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.517 -0.739 . . . . 0.0 109.743 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.94 109.4 20.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -130.0 147.24 51.73 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.678 . . . . 0.0 109.616 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -94.68 170.16 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.617 -0.677 . . . . 0.0 109.43 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -60.84 -18.12 53.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 109.897 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.61 14.92 0.9 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.73 . . . . 0.0 109.801 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.03 36.41 92.84 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 6.8 tp -108.83 167.6 9.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.966 . . . . 0.0 109.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.476 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 30.3 pt -142.65 -30.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.25 -169.44 22.6 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -175.21 116.22 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.614 -0.933 . . . . 0.0 109.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.94 35.62 21.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.478 -0.764 . . . . 0.0 109.699 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.68 -61.11 4.42 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -79.18 170.95 15.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.525 -0.985 . . . . 0.0 109.471 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.4 mt -80.37 156.55 73.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.432 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.417 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -80.25 -27.44 3.59 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.061 3.84 . . . . 0.0 109.945 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 33.0 p90 -108.82 163.61 13.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 0.0 109.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -116.25 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.1 tp -107.29 80.44 0.87 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.601 -0.687 . . . . 0.0 109.47 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -45.76 -37.53 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 125.061 3.841 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.7 -45.91 90.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -62.85 -37.28 86.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.642 -0.661 . . . . 0.0 109.465 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.22 -24.21 67.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.51 -0.744 . . . . 0.0 109.506 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -85.3 -28.93 24.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -74.87 -26.72 59.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.478 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -66.63 -45.1 80.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HA ' ' HG1' ' A' ' 34' ' ' THR . 38.7 ttp180 -65.93 -31.66 72.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.71 . . . . 0.0 109.482 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.35 59.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.481 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -96.26 31.35 2.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.542 -0.724 . . . . 0.0 109.439 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.442 ' HG1' ' HA ' ' A' ' 31' ' ' ARG . 10.4 p -136.84 -35.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 129.63 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.671 . . . . 0.0 109.501 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.78 -27.56 18.4 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER -110.6 178.94 4.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.1 mt -98.05 122.84 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 56.7 ttp -88.54 102.25 14.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.54 -0.725 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 t -94.78 115.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.498 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.82 166.35 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.493 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.53 -170.18 46.65 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -79.64 -33.16 41.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.976 . . . . 0.0 109.5 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -71.63 -33.91 69.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.1 m -81.14 -30.84 34.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -66.99 -29.24 69.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.445 -0.785 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.89 -18.23 24.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.7 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.4 p -62.46 -24.38 67.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.645 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -65.21 160.77 54.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.69 -68.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.14 3.893 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.85 127.0 51.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtp-105 -123.14 157.43 60.92 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.489 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.55 -166.78 5.47 Favored 'Cis proline' 0 N--CA 1.509 2.416 0 O-C-N 123.4 1.211 . . . . 0.0 109.941 -0.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.34 96.17 38.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.515 -0.741 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -72.33 -177.7 2.86 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.656 3.57 . . . . 0.0 109.755 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 61.59 25.49 15.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 109.534 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -176.3 177.32 1.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 m -96.61 130.91 43.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -102.28 100.47 10.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.591 -0.693 . . . . 0.0 109.477 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 t -110.66 107.01 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.738 . . . . 0.0 109.386 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -98.97 136.92 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.632 -0.667 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.6 tp -102.47 125.98 49.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.719 . . . . 0.0 109.43 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -153.18 142.24 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -88.62 -42.22 12.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -71.79 133.28 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -85.93 30.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -101.19 -35.11 9.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -69.18 148.58 49.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.579 -0.7 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -147.18 152.98 39.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.689 . . . . 0.0 109.442 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.78 138.67 41.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.716 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -86.42 121.62 29.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 109.455 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.2 48.43 25.47 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.45 140.44 15.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.914 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -82.18 100.49 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 109.387 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -79.47 98.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.568 -0.708 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -87.67 164.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.645 -0.659 . . . . 0.0 109.459 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -138.09 29.99 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -171.94 143.22 1.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.5 t -66.82 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.551 -0.718 . . . . 0.0 109.418 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.53 76.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 109.48 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.32 77.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 t -67.99 -37.47 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -74.6 -30.42 61.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.546 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.32 90.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.49 -33.34 72.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.3 62.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.0 109.592 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -64.61 -46.23 83.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -65.0 -26.99 68.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -119.16 90.15 41.07 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.57 -0.707 . . . . 0.0 109.48 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -24.03 6.65 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.122 3.881 . . . . 0.0 109.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.38 -25.35 62.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.623 -0.673 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -96.56 131.8 42.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' H ' ' HG3' ' A' ' 37' ' ' LYS . 6.1 mm-40 -95.67 152.78 18.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.576 -0.702 . . . . 0.0 109.539 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tp -88.73 137.73 32.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.63 -0.669 . . . . 0.0 109.426 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.3 123.54 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.644 -0.66 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.411 HG21 ' CE1' ' A' ' 103' ' ' PHE . 41.2 mm -93.75 119.83 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -101.69 -29.78 11.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.534 -0.729 . . . . 0.0 109.526 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.25 -174.06 40.3 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.419 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.94 -154.53 19.11 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.379 -1.659 . . . . 0.0 109.555 0.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.55 -31.41 71.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.649 -0.912 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.79 -28.07 61.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.419 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.7 mm -74.37 -36.5 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.63 -0.669 . . . . 0.0 109.51 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.416 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 27.8 m-85 -63.3 -48.11 79.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.676 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.76 73.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -102.26 11.81 37.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 109.887 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -67.65 -31.89 72.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.511 -0.743 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -78.86 17.94 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.548 -0.72 . . . . 0.0 109.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -160.08 38.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.448 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -95.37 145.91 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.06 -53.14 1.74 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.578 -0.701 . . . . 0.0 109.357 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -103.37 160.84 14.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.697 . . . . 0.0 109.374 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.414 HD12 ' CE2' ' A' ' 136' ' ' PHE . 30.4 mt -139.45 98.49 3.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.728 . . . . 0.0 109.604 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.8 mt -98.49 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.625 -0.672 . . . . 0.0 109.314 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.413 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -115.05 136.77 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 0.0 109.518 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -107.7 103.32 12.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.636 -0.665 . . . . 0.0 109.278 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -87.54 143.54 27.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.52 -0.737 . . . . 0.0 109.616 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.39 133.9 55.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.638 -0.663 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.91 78.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.674 . . . . 0.0 109.487 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.29 123.93 9.63 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -76.82 143.93 39.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.633 -0.922 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -148.32 117.39 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.466 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.53 145.77 27.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.16 -128.3 2.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -140.71 -36.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.542 -0.975 . . . . 0.0 109.56 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -95.22 142.09 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.576 -0.702 . . . . 0.0 109.553 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.12 173.0 7.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.616 -0.677 . . . . 0.0 109.455 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -92.91 153.52 18.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -73.58 163.74 66.19 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.18 96.19 1.02 Allowed 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 125.135 3.89 . . . . 0.0 110.007 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.93 137.0 33.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.495 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -78.73 87.26 4.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.579 -0.701 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -68.39 -16.93 64.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.619 -0.676 . . . . 0.0 109.78 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.55 -26.22 68.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.44 29.78 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.414 ' CE2' HD12 ' A' ' 113' ' ' LEU . 45.9 m-85 -142.97 175.35 9.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.598 -0.689 . . . . 0.0 109.455 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.47 135.42 17.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.652 -0.655 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -70.92 158.03 37.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.675 -0.64 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.15 -32.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.726 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.3 p -157.74 155.5 30.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 p -149.51 122.08 8.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -99.16 105.59 17.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.3 m -84.94 142.78 29.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.56 -0.712 . . . . 0.0 109.441 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.414 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -145.14 129.89 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.659 -0.651 . . . . 0.0 109.377 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -105.92 121.07 43.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.433 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -80.32 -165.82 0.93 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.64 -39.42 64.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -101.92 138.05 19.69 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 109.418 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.66 -46.29 24.67 Favored 'Trans proline' 0 N--CA 1.505 2.202 0 C-N-CA 124.748 3.632 . . . . 0.0 110.08 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.59 69.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.518 -0.739 . . . . 0.0 109.668 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.0 18.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.733 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.1 m -87.55 140.0 29.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 109.314 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.414 ' CE1' HG12 ' A' ' 144' ' ' VAL . 34.1 p-80 -154.75 162.24 41.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.599 -0.688 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.4 m -134.46 135.51 42.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.705 . . . . 0.0 109.454 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -90.78 93.89 9.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -76.74 137.8 39.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.585 -0.697 . . . . 0.0 109.473 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 t -124.71 115.74 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.583 -0.698 . . . . 0.0 109.453 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -113.17 170.03 8.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.469 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -148.89 141.06 23.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.577 -0.702 . . . . 0.0 109.394 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -72.18 116.23 12.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -160.57 102.87 1.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.662 -0.649 . . . . 0.0 109.484 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.498 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.4 HN51 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.48 99.72 7.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.432 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 5.6 m-85 -76.11 131.43 39.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -147.41 113.67 5.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.347 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.3 p90 -143.38 147.12 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 109.746 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.85 114.18 26.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -133.95 150.2 51.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.491 -0.755 . . . . 0.0 109.636 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -98.63 171.44 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 11' ' ' GLY . 7.2 ptp180 -61.13 -19.85 61.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.803 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.66 15.05 0.88 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 109.754 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 61.89 38.54 96.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 tp -106.14 166.25 10.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 13' ' ' ILE . 31.3 pt -145.89 -29.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.467 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.11 -176.2 27.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -175.26 115.88 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.547 -0.972 . . . . 0.0 109.514 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.09 21.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.52 -0.737 . . . . 0.0 109.679 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.45 5.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -77.94 176.45 9.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.8 mt -77.05 157.87 80.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.38 -33.79 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 125.089 3.859 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.411 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.8 p90 -108.16 -170.59 1.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.688 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -136.53 86.89 2.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 109.446 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.6 tp -109.36 82.13 1.97 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -45.31 -38.55 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 125.172 3.915 . . . . 0.0 110.269 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -62.69 -40.19 96.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.538 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -66.05 -33.19 75.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.693 . . . . 0.0 109.407 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.1 -24.72 63.26 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.66 -29.56 27.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.633 -0.667 . . . . 0.0 109.399 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.32 -25.4 57.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -65.84 -45.74 81.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.656 -0.653 . . . . 0.0 109.449 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -65.28 -30.87 71.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.53 -30.98 57.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.523 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -97.82 32.66 2.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.432 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 p -140.29 -34.1 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.488 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.27 128.19 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.622 -0.673 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 31.97 27.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -156.54 172.3 18.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.951 . . . . 0.0 109.481 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -90.47 112.81 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.649 -0.657 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -81.51 105.01 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.484 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.0 t -113.19 123.77 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.481 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.3 m -137.74 -175.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.435 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.6 -164.89 31.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -82.84 -41.28 19.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.625 -0.926 . . . . 0.0 109.492 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -70.2 -33.15 71.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.413 ' HA ' ' HG ' ' A' ' 48' ' ' SER . 18.1 m -76.41 -29.41 57.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.461 ' HH ' ' HB3' ' A' ' 53' ' ' PRO . 33.8 t80 -67.12 -35.59 80.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.523 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -83.06 -25.27 32.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.677 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.413 ' HG ' ' HA ' ' A' ' 45' ' ' THR . 80.9 p -62.91 -22.64 66.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.567 -0.708 . . . . 0.0 109.611 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.72 164.2 13.2 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.507 -0.746 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -80.91 -73.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.11 3.874 . . . . 0.0 109.949 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -114.33 103.78 11.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.547 -0.721 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.91 156.63 39.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.696 . . . . 0.0 109.415 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HB3' ' HH ' ' A' ' 46' ' ' TYR . 9.8 Cg_endo -81.25 169.69 65.48 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.397 1.209 . . . . 0.0 110.004 -0.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.5 mt -89.76 113.09 55.55 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.36 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.46 -178.87 4.95 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 124.659 3.572 . . . . 0.0 109.918 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 61.54 24.29 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.546 -0.721 . . . . 0.0 109.704 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -176.61 174.41 1.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.573 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -91.64 131.28 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.539 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -98.91 105.22 17.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.8 144.23 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.2 t -134.45 124.12 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -97.79 117.15 31.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.538 -0.726 . . . . 0.0 109.511 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -155.43 137.8 14.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -93.12 29.43 1.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.514 -0.741 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -110.24 123.79 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -86.17 30.13 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.674 -0.641 . . . . 0.0 109.407 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -124.47 -33.39 3.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -69.13 147.29 51.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.61 -0.681 . . . . 0.0 109.508 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -146.14 156.72 43.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.23 132.22 31.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.649 -0.657 . . . . 0.0 109.491 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -87.55 119.42 27.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.21 42.59 18.66 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.41 133.33 8.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.971 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -74.32 103.57 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.634 -0.666 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.13 103.28 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.578 -0.702 . . . . 0.0 109.441 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.4 m -89.98 154.88 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.678 -0.639 . . . . 0.0 109.509 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -136.16 29.52 3.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.451 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -164.88 149.34 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.441 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.414 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.0 -33.41 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.48 70.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.654 . . . . 0.0 109.529 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.42 77.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.55 -42.77 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.32 -29.27 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.616 -0.677 . . . . 0.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.83 92.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.717 . . . . 0.0 109.478 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -66.44 -42.76 87.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.13 -24.97 65.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.661 . . . . 0.0 109.51 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -41.15 97.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.592 -0.692 . . . . 0.0 109.463 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -69.47 -31.02 69.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -119.24 89.75 40.46 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.606 -0.684 . . . . 0.0 109.489 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.32 -22.71 6.77 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 125.138 3.892 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.84 -25.9 66.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.475 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -92.92 -179.93 5.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -138.76 148.56 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.669 . . . . 0.0 109.487 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.8 tp -79.24 108.11 12.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.622 -0.673 . . . . 0.0 109.457 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.38 112.92 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.631 -0.668 . . . . 0.0 109.464 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.4 mm -91.97 122.27 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 109.36 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -101.38 -28.87 12.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.529 -0.732 . . . . 0.0 109.522 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.13 -175.83 40.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.92 -151.75 12.87 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.362 -1.669 . . . . 0.0 109.613 -0.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.94 -26.22 62.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -74.78 -23.69 58.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -80.32 -38.33 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.483 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -62.75 -48.5 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 0.0 109.396 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 t -63.6 -33.04 74.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.594 -0.691 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE1' HG12 ' A' ' 79' ' ' VAL . 45.8 m-85 -122.32 21.33 10.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.714 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 109' ' ' ASP . 19.4 pttt -63.48 -32.83 74.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.441 -0.787 . . . . 0.0 109.586 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -81.09 31.0 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.725 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 107' ' ' LYS . 5.6 m-20 -160.08 32.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.733 . . . . 0.0 109.408 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.432 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -99.22 145.63 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.319 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -128.0 -55.83 1.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.583 -0.698 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -103.69 106.86 17.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.377 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.408 HD12 ' CE2' ' A' ' 136' ' ' PHE . 24.5 mt -90.44 100.94 13.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.568 -0.707 . . . . 0.0 109.592 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.5 mt -99.23 105.98 18.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.719 . . . . 0.0 109.21 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -111.32 136.05 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.613 -0.679 . . . . 0.0 109.523 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -108.62 97.49 7.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.652 . . . . 0.0 109.248 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -85.43 139.79 31.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.632 -0.668 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 135.07 54.4 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.84 -33.31 73.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.556 -0.715 . . . . 0.0 109.472 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.88 124.42 14.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.7 t -70.25 140.83 52.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.59 -0.947 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -148.38 107.2 3.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.422 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.72 146.33 28.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.02 -123.3 1.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -143.42 -49.87 0.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.975 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.4 m -81.64 141.09 33.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.632 -0.667 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -118.46 172.94 7.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.416 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -94.47 146.97 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.47 164.69 42.01 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.469 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.29 99.96 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.113 3.876 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.39 138.07 32.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -77.74 84.81 4.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -67.23 -17.53 64.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.6 -0.688 . . . . 0.0 109.772 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -26.0 68.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.765 . . . . 0.0 109.519 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.81 30.32 2.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.718 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.408 ' CE2' HD12 ' A' ' 113' ' ' LEU . 68.0 m-85 -145.35 177.16 9.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.515 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 m -153.54 131.41 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -72.13 115.82 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 109.475 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.412 ' H ' HG21 ' A' ' 139' ' ' VAL . 27.4 m -95.1 -36.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.498 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.2 p -154.79 179.16 9.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.1 t -165.2 159.48 17.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -133.41 100.8 4.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.0 m -81.75 152.95 26.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.536 -0.727 . . . . 0.0 109.423 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.405 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -156.17 127.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.309 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.39 121.99 44.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.58 -165.61 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.3 p -72.35 -36.38 68.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.603 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -106.13 137.88 19.52 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.86 -48.19 16.75 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 124.822 3.682 . . . . 0.0 110.076 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.83 69.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.5 mt -80.38 20.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.629 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 m -91.98 136.97 32.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.525 -0.734 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.405 ' CE1' HG12 ' A' ' 144' ' ' VAL . 31.6 p-80 -151.93 169.55 22.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.697 . . . . 0.0 109.602 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.1 m -139.76 137.74 35.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.541 -0.724 . . . . 0.0 109.451 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -95.32 94.75 8.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.468 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 23.4 mt-10 -76.24 128.84 35.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.2 t -112.9 102.91 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.502 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.468 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 42.4 m95 -101.41 163.45 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -140.14 145.96 38.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -66.71 116.33 7.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.602 -0.686 . . . . 0.0 109.489 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -165.22 114.52 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.678 . . . . 0.0 109.455 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.475 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.401 ' C17' HN52 ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.92 127.65 34.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.7 m-85 -101.99 137.35 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 tp -149.87 111.69 4.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.602 -0.686 . . . . 0.0 109.331 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.2 p90 -142.04 151.52 42.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.711 . . . . 0.0 109.73 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 112.08 24.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -132.33 150.17 52.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.569 -0.707 . . . . 0.0 109.638 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.46 171.78 7.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -61.37 -18.69 59.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.618 -0.676 . . . . 0.0 109.763 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.37 15.14 0.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.518 -0.739 . . . . 0.0 109.775 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 37.57 94.64 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 7.1 tp -107.39 167.25 10.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.621 -0.929 . . . . 0.0 109.553 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 13' ' ' ILE . 31.7 pt -141.74 -30.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.575 -0.703 . . . . 0.0 109.519 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.0 28.74 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -173.28 115.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.462 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 33.83 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.466 -0.771 . . . . 0.0 109.723 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 -61.45 3.74 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -74.96 170.61 15.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -1.02 . . . . 0.0 109.455 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 24.0 mt -79.89 157.21 74.27 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.571 -0.706 . . . . 0.0 109.46 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.91 -30.52 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 125.018 3.812 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 35.0 p90 -105.88 -171.38 1.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.547 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -138.42 103.02 4.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.705 -0.622 . . . . 0.0 109.431 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.8 tp -124.58 81.02 60.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.587 -0.695 . . . . 0.0 109.516 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.23 -39.09 20.74 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 125.117 3.878 . . . . 0.0 110.154 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.98 -52.16 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.614 -0.679 . . . . 0.0 109.525 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.95 -36.54 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.75 -24.26 67.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.455 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -85.62 -29.91 23.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -65.44 -23.96 67.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.516 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.41 ' CD2' H211 ' A' ' 170' ' ' TMQ . 59.6 t80 -63.15 -46.5 86.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -65.15 -25.33 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.459 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.24 -26.57 39.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -107.47 36.38 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.709 . . . . 0.0 109.475 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.409 HG22 ' CE2' ' A' ' 30' ' ' PHE . 15.0 p -138.38 -35.04 0.62 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.482 -0.761 . . . . 0.0 109.487 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.4 ' N ' HH12 ' A' ' 57' ' ' ARG . 28.0 m -67.36 126.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.8 38.61 23.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -153.97 168.53 26.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.917 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 38' ' ' ILE . 60.5 mt -93.47 104.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -78.87 117.47 20.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 t -125.13 120.19 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.669 -0.644 . . . . 0.0 109.418 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.1 m -136.08 173.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.81 -167.21 42.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -84.05 -36.36 23.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.485 -1.009 . . . . 0.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -68.16 -31.81 71.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.444 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -82.41 -27.65 31.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -64.93 -35.7 82.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 109.487 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.27 -25.87 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.7 m -67.13 -15.36 63.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.664 -0.648 . . . . 0.0 109.759 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -61.77 161.39 21.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 109.576 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 125.101 3.867 . . . . 0.0 109.987 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.6 73.57 0.92 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -72.78 157.36 88.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.58 172.7 55.23 Favored 'Cis proline' 0 N--CA 1.509 2.43 0 O-C-N 123.332 1.175 . . . . 0.0 110.035 0.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB2' HD22 ' A' ' 59' ' ' ASN . 39.2 mt -97.8 110.75 56.73 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.589 -0.694 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -76.79 178.11 8.02 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.733 3.622 . . . . 0.0 109.866 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.39 29.59 18.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.58 -0.7 . . . . 0.0 109.68 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.4 HH12 ' N ' ' A' ' 35' ' ' VAL . 1.4 ptp180 -177.1 178.91 1.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 m -105.91 119.38 39.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.45 HD22 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -96.16 111.45 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.6 t -112.92 140.73 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 109.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 t -125.26 124.78 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.3 tp -99.78 109.7 22.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.51 -0.744 . . . . 0.0 109.487 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 t -139.93 142.54 36.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.562 -0.712 . . . . 0.0 109.474 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 64' ' ' HIS . 10.6 p80 -93.86 31.6 1.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.665 -0.647 . . . . 0.0 109.568 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.9 128.64 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.584 -0.698 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -88.89 29.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.41 -33.03 6.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -69.63 152.18 45.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -152.3 110.11 3.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.727 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 75' ' ' VAL . . . -98.1 125.18 42.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.618 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -80.57 133.05 35.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.639 -0.663 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.32 37.81 70.87 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.76 133.26 9.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.609 -0.936 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -73.52 99.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.578 -0.701 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 70' ' ' ALA . 29.9 t -79.35 102.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.708 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.12 159.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 0.0 109.455 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -139.35 29.98 2.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -164.26 144.93 8.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 106' ' ' PHE . 29.4 t -68.2 -33.68 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.0 109.511 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.28 70.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 109.49 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.48 81.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.647 -0.658 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.4 t -68.42 -35.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.392 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.45 -33.02 62.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.41 70.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -71.31 -37.26 71.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.706 . . . . 0.0 109.419 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.03 -26.27 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.711 . . . . 0.0 109.526 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -70.22 -38.54 75.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.77 -24.68 65.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -115.74 93.42 37.39 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.622 -0.674 . . . . 0.0 109.483 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.99 -19.96 13.43 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 124.838 3.692 . . . . 0.0 109.957 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -81.44 -25.0 36.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.54 -0.725 . . . . 0.0 109.496 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.15 179.99 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.517 -0.739 . . . . 0.0 109.492 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -142.37 148.18 37.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.1 tt -80.65 123.32 28.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.556 -0.715 . . . . 0.0 109.466 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -128.59 129.46 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -102.55 129.75 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.57 -24.09 11.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 109.599 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.76 -178.34 40.56 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.486 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.66 -155.22 19.96 Favored Glycine 0 N--CA 1.5 2.92 0 O-C-N 120.321 -1.693 . . . . 0.0 109.518 0.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.93 75.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -72.88 -25.44 61.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.531 -0.731 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.486 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.7 mm -74.61 -36.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.45 -49.9 71.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.511 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.2 t -62.88 -34.82 78.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.534 -0.729 . . . . 0.0 109.595 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.42 76.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.644 -0.66 . . . . 0.0 109.688 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' HG12 ' A' ' 79' ' ' VAL . 41.8 m-85 -105.47 13.6 29.92 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.532 -0.73 . . . . 0.0 109.847 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -23.57 56.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.478 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -65.01 -22.22 66.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.649 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -130.3 41.43 3.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.53 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -86.05 156.98 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.416 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -136.54 -69.08 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 m -84.92 159.9 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.5 mt -142.01 96.27 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.632 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.5 mt -97.82 110.48 23.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.245 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -117.6 141.0 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.625 -0.672 . . . . 0.0 109.537 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -111.12 102.17 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.597 -0.689 . . . . 0.0 109.346 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -85.22 151.28 24.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.6 133.81 48.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 109.279 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.51 -30.87 68.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.586 -0.696 . . . . 0.0 109.51 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.02 128.05 11.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.6 p -79.53 141.44 36.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.53 -0.982 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -148.63 128.28 13.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.677 . . . . 0.0 109.457 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.8 163.46 14.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.83 -138.38 2.44 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.69 10.04 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.96 . . . . 0.0 109.865 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.4 m -147.28 130.39 16.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.386 -0.821 . . . . 0.0 109.5 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -105.88 176.52 5.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.593 -0.692 . . . . 0.0 109.399 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.424 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -93.33 148.31 22.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.473 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.6 pt -66.83 165.57 25.04 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.536 -0.728 . . . . 0.0 109.477 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.18 109.32 2.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.11 3.873 . . . . 0.0 109.994 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.45 139.81 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.565 -0.709 . . . . 0.0 109.501 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 83.57 4.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.52 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.18 -20.02 64.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -62.72 -23.6 67.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.527 -0.733 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -97.78 28.73 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -142.16 174.23 10.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.2 m -149.62 136.41 19.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.554 -0.716 . . . . 0.0 109.526 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -70.39 155.96 39.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.636 -0.665 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.61 -32.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.677 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 t -147.89 146.0 28.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.455 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -144.81 110.42 5.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -95.32 102.68 14.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.423 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.1 m -86.06 147.14 26.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.541 -0.725 . . . . 0.0 109.466 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -152.89 133.7 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.299 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.94 123.87 49.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.47 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -80.43 -165.1 0.8 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 p -71.47 -38.56 71.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.649 -0.657 . . . . 0.0 109.58 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -105.03 137.65 19.28 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.06 -46.19 22.98 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 124.815 3.677 . . . . 0.0 110.069 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.15 68.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.612 -0.68 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.55 19.9 0.97 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.704 . . . . 0.0 109.677 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 50.6 m -87.54 140.73 29.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.275 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.415 ' CE1' HG12 ' A' ' 144' ' ' VAL . 32.3 p-80 -152.63 167.27 29.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -140.57 130.52 24.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.594 -0.692 . . . . 0.0 109.434 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.46 93.81 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.54 139.37 38.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.423 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.6 t -128.81 113.51 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -111.71 166.38 11.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.508 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -142.94 143.06 31.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -68.01 127.52 33.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -150.53 147.0 26.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.496 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.41 H211 ' CD2' ' A' ' 30' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.35 103.39 5.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.497 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 5.8 m-85 -75.42 141.29 43.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 tp -153.42 112.53 3.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 0.0 109.299 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 8.9 p90 -145.38 146.49 31.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.528 -0.733 . . . . 0.0 109.756 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 115.5 29.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 109.323 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -133.86 161.32 35.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -108.72 169.64 8.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.643 -0.661 . . . . 0.0 109.406 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HB2' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -60.8 -15.86 34.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.61 -0.681 . . . . 0.0 109.88 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 15.02 0.84 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 109.763 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.59 86.17 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.3 tp -117.21 151.55 36.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -120.48 -41.36 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.577 -0.702 . . . . 0.0 109.558 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -162.87 -170.13 27.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -163.04 124.19 2.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.928 . . . . 0.0 109.454 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.91 32.66 21.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.542 -0.724 . . . . 0.0 109.717 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 -62.5 3.55 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -73.2 173.19 9.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.965 . . . . 0.0 109.499 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 mt -93.4 155.54 40.77 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.533 -0.73 . . . . 0.0 109.469 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -79.96 -24.92 5.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 125.045 3.83 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 30.4 p90 -106.72 163.13 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.624 -0.672 . . . . 0.0 109.574 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -115.55 100.96 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.677 -0.64 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.6 tp -119.68 80.27 23.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.613 -0.679 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.91 -37.36 16.87 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 125.133 3.889 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.93 -46.88 85.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.53 -0.731 . . . . 0.0 109.57 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -62.83 -37.61 87.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 109.484 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.59 -23.94 67.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.725 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -86.97 -29.7 21.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.565 -0.709 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -73.36 -24.43 60.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.528 -0.733 . . . . 0.0 109.547 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.33 -45.35 91.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttp-105 -64.84 -29.29 70.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.477 -0.764 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.84 -29.09 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -101.13 34.91 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.704 . . . . 0.0 109.46 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.0 p -141.67 -34.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.508 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.98 126.82 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.639 -0.663 . . . . 0.0 109.456 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.35 35.14 24.13 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -156.94 166.48 33.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.581 -0.952 . . . . 0.0 109.441 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.3 mt -90.66 103.36 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.546 -0.721 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -71.96 131.48 43.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 t -135.55 116.04 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.86 -177.57 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.659 -0.65 . . . . 0.0 109.458 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 -174.06 43.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -76.17 -38.33 56.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.936 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -69.07 -41.87 76.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 m -69.97 -26.45 64.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.35 -46.03 85.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.534 -0.728 . . . . 0.0 109.487 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.86 -23.96 36.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.515 -0.741 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -62.83 -21.13 65.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -62.07 161.35 24.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.493 -0.755 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 125.103 3.869 . . . . 0.0 109.886 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -108.55 91.98 3.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.623 -0.673 . . . . 0.0 109.488 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -99.76 157.3 34.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.723 . . . . 0.0 109.458 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.5 159.06 85.8 Favored 'Cis proline' 0 N--CA 1.509 2.386 0 O-C-N 123.384 1.202 . . . . 0.0 109.953 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.98 114.17 46.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.15 179.31 6.57 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.761 3.64 . . . . 0.0 109.947 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 61.05 29.64 19.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.612 -0.68 . . . . 0.0 109.662 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.03 173.55 1.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 m -93.98 118.94 32.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -89.71 99.17 12.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.8 t -107.11 143.35 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.62 125.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.8 tp -95.9 112.46 24.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.615 -0.678 . . . . 0.0 109.541 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -140.26 150.78 44.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.574 -0.704 . . . . 0.0 109.401 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -91.24 -34.14 15.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -76.15 123.73 26.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.611 -0.68 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -83.52 29.59 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -100.46 -34.75 9.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 109.5 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -69.35 136.33 51.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.702 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -141.54 104.52 4.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.728 . . . . 0.0 109.48 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.36 119.71 26.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.551 -0.718 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -70.85 127.25 31.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.41 38.66 24.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.66 146.81 19.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.598 -0.942 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.28 98.03 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.8 t -77.19 98.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.478 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -85.13 156.86 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -136.78 30.0 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.507 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -169.8 148.82 3.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.416 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.2 t -68.34 -34.13 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.88 -31.05 67.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.681 . . . . 0.0 109.46 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.22 -37.29 83.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.542 -0.724 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 t -69.59 -40.7 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 109.379 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -72.54 -29.54 63.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.88 84.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.633 -0.667 . . . . 0.0 109.515 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.28 -40.44 81.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.737 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.71 68.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.39 -36.59 83.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.573 -0.704 . . . . 0.0 109.492 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.9 -27.77 61.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.679 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -119.61 88.05 38.24 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.36 20.21 0.97 Allowed 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.133 3.888 . . . . 0.0 109.967 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -106.86 -31.7 8.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -94.48 178.54 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.556 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -133.03 153.86 51.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.491 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.1 tp -84.64 133.63 34.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.712 . . . . 0.0 109.475 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.6 t -134.47 114.45 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.407 HG23 ' CE1' ' A' ' 103' ' ' PHE . 41.0 mm -91.48 127.39 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.494 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.74 -24.51 10.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.579 -0.701 . . . . 0.0 109.517 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.3 -179.67 36.58 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.53 -155.47 20.18 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 120.287 -1.714 . . . . 0.0 109.583 0.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.45 72.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.572 -0.957 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -69.88 -31.09 68.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.511 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.14 -37.7 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.524 -0.735 . . . . 0.0 109.528 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.407 ' CE1' HG23 ' A' ' 96' ' ' ILE . 25.6 m-85 -62.88 -46.1 89.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.557 -0.715 . . . . 0.0 109.483 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -21.78 65.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.581 -0.7 . . . . 0.0 109.605 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.87 -37.1 62.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.416 ' CE1' HG12 ' A' ' 79' ' ' VAL . 73.9 m-85 -106.4 14.78 26.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.695 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -29.75 66.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.772 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.2 -27.24 69.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.07 58.86 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -105.2 151.69 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -135.29 -68.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 127.51 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 136' ' ' PHE . 37.2 mt -111.7 87.76 2.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.6 mt -89.27 121.78 31.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.527 -0.733 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -134.49 145.09 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.647 -0.658 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -111.39 107.86 17.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.234 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -88.65 128.79 35.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.3 141.2 37.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.84 62.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.1 137.46 24.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -87.4 143.49 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.533 -0.981 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.46 124.42 14.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.638 -0.664 . . . . 0.0 109.419 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.9 140.03 30.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.514 -0.741 . . . . 0.0 109.474 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.04 -131.65 2.3 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -144.11 -27.31 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.961 . . . . 0.0 109.476 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -94.21 118.64 31.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.571 -0.706 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -103.31 166.39 10.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.38 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.413 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -92.94 144.36 25.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.634 -0.666 . . . . 0.0 109.411 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.1 pt -66.13 164.63 27.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.523 -0.736 . . . . 0.0 109.493 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.37 104.34 1.62 Allowed 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 125.109 3.873 . . . . 0.0 109.896 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.76 86.92 6.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 0.0 109.488 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -68.58 -17.76 64.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.648 -0.658 . . . . 0.0 109.707 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.45 -29.48 70.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.586 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.32 29.45 1.68 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.605 -0.684 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.414 ' CD1' HD13 ' A' ' 113' ' ' LEU . 34.0 m-85 -140.61 173.75 11.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.523 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -146.08 135.95 23.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -72.15 156.24 39.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.52 -31.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.619 -0.675 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -147.2 154.09 40.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.561 -0.712 . . . . 0.0 109.383 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -158.03 109.75 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -93.09 107.3 19.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.644 -0.66 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.4 m -85.62 150.08 24.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.488 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.74 126.27 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -103.6 118.26 36.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.668 . . . . 0.0 109.415 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.12 -166.03 0.96 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.7 p -73.68 -43.25 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.695 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -103.1 137.82 19.37 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.318 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -46.38 -42.16 22.64 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 124.878 3.719 . . . . 0.0 110.184 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.16 85.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.3 mt -76.27 12.64 1.13 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.632 -0.667 . . . . 0.0 109.902 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 21.2 m -87.14 137.2 32.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.484 -0.76 . . . . 0.0 109.349 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -155.6 175.05 14.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.64 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.0 m -141.83 137.82 31.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.375 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.58 95.71 9.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.679 -0.638 . . . . 0.0 109.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.86 146.41 37.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.5 t -138.76 102.86 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.694 . . . . 0.0 109.478 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.45 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 27.9 m95 -104.46 162.53 13.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.563 -0.71 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -148.64 143.42 26.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.716 . . . . 0.0 109.462 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -69.34 110.7 4.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -153.33 98.21 2.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.453 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.4 HN51 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.76 103.73 5.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.498 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.7 m-85 -78.53 147.53 33.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.631 -0.668 . . . . 0.0 109.43 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.7 tp -158.84 111.23 2.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.564 -0.71 . . . . 0.0 109.239 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.39 143.95 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.777 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.87 116.16 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.656 . . . . 0.0 109.281 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -135.39 156.31 49.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -104.4 171.14 7.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.419 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.04 -20.16 62.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.852 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.47 14.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.765 . . . . 0.0 109.756 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.86 40.12 98.42 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.5 tp -108.93 162.64 14.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.545 -0.974 . . . . 0.0 109.577 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.3 pt -142.85 -29.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.69 . . . . 0.0 109.491 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.89 -175.62 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -174.66 116.33 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.564 -0.962 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.95 34.2 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 0.0 109.662 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -61.42 3.92 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -80.05 -175.95 5.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.622 -0.928 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.9 mt -86.08 156.88 57.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 109.461 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.7 Cg_endo -80.35 -31.15 1.74 Allowed 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 125.049 3.832 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 29.3 p90 -106.91 170.2 8.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.673 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.5 88.2 2.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.482 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.3 tp -107.24 80.5 0.86 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.04 -37.36 17.48 Favored 'Trans proline' 0 N--CA 1.506 2.234 0 C-N-CA 125.056 3.838 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -62.94 -44.89 94.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -63.03 -38.71 92.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.607 -0.683 . . . . 0.0 109.423 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.89 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -88.3 -28.83 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.695 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -73.02 -25.66 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.404 ' CE2' HG22 ' A' ' 34' ' ' THR . 59.2 t80 -64.48 -44.73 90.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -66.7 -26.23 66.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.85 -29.86 50.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.561 -0.712 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -102.61 36.25 2.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.704 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.404 HG22 ' CE2' ' A' ' 30' ' ' PHE . 20.5 p -144.68 -28.96 0.47 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.584 -0.698 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.95 128.59 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.17 32.94 46.52 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -156.35 165.26 36.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.939 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.3 107.69 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.392 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.2 ttp -82.63 104.16 12.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.455 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.87 126.84 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.533 -0.729 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.75 164.55 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.662 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.65 -161.01 36.87 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -84.78 -36.6 21.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.568 -0.96 . . . . 0.0 109.45 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -69.6 -37.25 76.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.525 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -75.9 -29.7 58.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 32.2 t80 -66.8 -33.69 76.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.489 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -82.19 -23.04 35.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -63.14 -27.78 69.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -65.24 163.53 30.95 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.736 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.2 -66.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.175 3.917 . . . . 0.0 109.894 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HZ2' ' HB3' ' A' ' 51' ' ' LYS . 4.4 mtpm? -121.02 103.19 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.618 -0.676 . . . . 0.0 109.44 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -94.07 154.19 40.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.0 109.45 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.69 164.57 78.54 Favored 'Cis proline' 0 N--CA 1.508 2.364 0 O-C-N 123.467 1.246 . . . . 0.0 109.844 -0.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.61 128.35 69.7 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.556 -0.715 . . . . 0.0 109.297 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.62 172.09 14.83 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 124.798 3.665 . . . . 0.0 109.965 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 61.37 27.75 17.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.574 -0.704 . . . . 0.0 109.8 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -177.2 178.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -105.27 147.29 28.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.62 -0.675 . . . . 0.0 109.519 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -114.92 97.89 6.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -102.67 101.81 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.58 -0.7 . . . . 0.0 109.489 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 120.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.608 -0.682 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.2 tp -101.51 106.4 17.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.425 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -138.86 151.71 47.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.713 . . . . 0.0 109.519 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 65' ' ' GLN . 9.5 p-80 -97.02 -29.69 13.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.66 -0.65 . . . . 0.0 109.512 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.406 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 11.5 tt0 -72.68 124.25 24.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.624 -0.672 . . . . 0.0 109.458 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -82.8 30.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.722 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -34.85 9.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.736 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.75 143.98 45.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.638 -0.664 . . . . 0.0 109.462 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -145.58 101.92 3.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.627 -0.67 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.19 119.95 30.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.612 -0.68 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -83.0 136.27 34.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.458 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.88 39.07 39.82 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.43 155.8 29.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.965 . . . . 0.0 109.52 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.94 95.75 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.611 -0.681 . . . . 0.0 109.483 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -80.28 100.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.541 -0.724 . . . . 0.0 109.437 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -98.7 160.34 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.663 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -139.65 30.76 2.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.628 -0.67 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -165.68 146.91 7.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.566 -0.709 . . . . 0.0 109.436 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -68.39 -34.1 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.697 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -32.31 72.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.28 -37.05 82.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.602 -0.686 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.9 t -67.68 -38.34 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.475 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.39 -32.31 66.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.683 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.37 91.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.497 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -68.26 -36.48 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.574 -0.704 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.46 70.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -66.99 -42.79 84.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.33 5.72 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 109.943 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -144.2 87.87 7.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.492 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.11 -23.6 6.35 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.113 3.876 . . . . 0.0 109.856 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.48 -24.91 61.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -100.67 178.58 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.58 -0.7 . . . . 0.0 109.481 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -136.91 172.98 12.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.94 130.16 51.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.511 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.63 129.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.549 -0.719 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -98.53 124.42 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.699 . . . . 0.0 109.425 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.6 -24.24 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.634 -0.666 . . . . 0.0 109.542 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.36 -176.46 37.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.492 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.93 -155.12 14.61 Favored Glycine 0 N--CA 1.5 2.904 0 O-C-N 120.235 -1.744 . . . . 0.0 109.589 0.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.9 76.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.565 -0.962 . . . . 0.0 109.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -73.37 -27.74 61.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.492 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -72.62 -35.61 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.545 -0.722 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 96' ' ' ILE . 27.2 m-85 -63.8 -51.58 64.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.501 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.423 ' H ' ' HG1' ' A' ' 104' ' ' THR . 3.3 m -62.44 -22.65 66.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.58 -49.85 43.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.545 -0.722 . . . . 0.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 79' ' ' VAL . 70.5 m-85 -93.17 13.93 19.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.528 -0.732 . . . . 0.0 109.906 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -67.22 -23.1 65.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.745 . . . . 0.0 109.591 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.53 14.99 0.87 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.541 -0.724 . . . . 0.0 109.839 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.17 38.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.457 -0.777 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.441 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.44 154.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.52 -0.737 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -138.45 -60.06 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.513 -0.742 . . . . 0.0 109.418 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -97.1 111.39 23.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 mt -96.13 96.38 8.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.55 -0.719 . . . . 0.0 109.586 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 27.5 mt -93.39 116.46 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.589 -0.694 . . . . 0.0 109.287 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.413 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -124.94 141.45 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.705 . . . . 0.0 109.455 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 m -109.49 100.46 9.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.631 -0.668 . . . . 0.0 109.26 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -83.73 133.78 34.78 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.641 -0.662 . . . . 0.0 109.657 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.16 135.92 50.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.3 -37.03 74.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.562 -0.711 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.63 124.88 16.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.8 p -77.69 148.21 35.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.969 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -148.27 128.25 13.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 0.0 109.459 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -86.12 148.59 25.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.28 -137.6 2.47 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -145.31 -33.02 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.652 -0.911 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.6 m -92.07 124.2 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -106.35 168.76 8.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.412 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -90.96 147.77 22.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.2 pt -67.73 165.07 33.98 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.42 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 104.7 1.71 Allowed 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 125.138 3.892 . . . . 0.0 109.978 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.5 mt -94.38 133.52 37.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -77.47 85.24 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.602 -0.686 . . . . 0.0 109.469 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.36 -14.21 62.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.582 -0.698 . . . . 0.0 109.815 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.34 -27.14 68.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.78 30.08 2.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.543 -0.723 . . . . 0.0 109.416 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -144.95 172.11 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.665 -0.647 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -146.8 131.81 18.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.607 -0.683 . . . . 0.0 109.49 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -74.01 120.51 19.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.554 -0.716 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.405 ' H ' HG21 ' A' ' 139' ' ' VAL . 27.1 m -97.08 -34.29 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.651 -0.656 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.1 p -164.12 163.73 22.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.659 -0.65 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.8 p -150.8 133.94 16.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -99.6 113.67 26.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.692 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.8 m -90.57 150.74 21.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 109.482 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -154.07 128.6 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.379 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -107.32 120.46 42.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.579 -0.7 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -80.43 -165.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.8 p -73.9 -39.29 63.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.593 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.66 137.58 19.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.77 -47.32 18.87 Favored 'Trans proline' 0 N--CA 1.507 2.267 0 C-N-CA 124.744 3.629 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.25 70.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.607 -0.683 . . . . 0.0 109.68 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.6 mt -79.47 18.42 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 109.66 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.3 m -91.64 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.715 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -153.08 168.51 25.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.574 -0.704 . . . . 0.0 109.596 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.5 m -135.54 135.85 40.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.562 -0.711 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -90.16 97.86 11.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.07 143.42 32.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.53 -0.731 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 t -132.4 107.56 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.424 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 30.2 m95 -105.51 169.28 8.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -147.73 145.14 28.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.507 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -67.8 129.68 40.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.715 . . . . 0.0 109.451 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -144.78 148.41 34.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.629 -0.669 . . . . 0.0 109.566 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.497 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.401 HN51 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.02 116.4 16.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.8 m-85 -90.25 157.74 17.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.68 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 tp -169.51 109.65 0.44 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.371 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.412 ' N ' ' CE3' ' A' ' 5' ' ' TRP . 9.2 p90 -140.93 140.29 34.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.564 -0.71 . . . . 0.0 109.68 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.11 111.11 22.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.284 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.5 153.31 48.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.16 170.91 7.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 11' ' ' GLY . 5.5 ptp180 -60.54 -20.08 59.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.508 -0.745 . . . . 0.0 109.851 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.37 14.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.491 -0.755 . . . . 0.0 109.784 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 61.77 38.11 95.41 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 5.2 tp -108.82 168.14 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.944 . . . . 0.0 109.549 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 13' ' ' ILE . 30.9 pt -144.1 -29.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.722 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.61 -172.38 26.71 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.59 115.53 0.3 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.585 -0.95 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.07 32.19 20.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.569 -0.707 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.1 -61.38 3.33 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -78.78 171.93 14.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.594 -0.945 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 25.4 mt -79.7 154.49 75.95 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.554 -0.716 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.75 -29.86 2.62 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.932 3.754 . . . . 0.0 109.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.419 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 34.2 p90 -106.34 -177.65 3.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.698 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -134.87 97.89 3.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 tp -118.71 80.25 17.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.499 -0.751 . . . . 0.0 109.486 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -45.78 -40.02 19.04 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 C-N-CA 125.13 3.887 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.45 -43.99 97.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 109.624 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.15 -38.72 88.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.577 -0.702 . . . . 0.0 109.409 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.45 -23.9 67.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.516 -0.74 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -82.3 -29.24 31.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -72.14 -26.92 62.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 109.422 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CD2' ' C21' ' A' ' 170' ' ' TMQ . 46.8 t80 -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' HD3' HH12 ' A' ' 57' ' ' ARG . 10.5 tpp85 -63.71 -28.26 69.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.584 -0.697 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.39 -28.13 34.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -101.57 34.95 2.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.404 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.6 p -137.66 -34.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.404 ' H ' HG21 ' A' ' 35' ' ' VAL . 27.3 m -80.59 128.59 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.484 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.96 -31.01 9.14 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -113.92 164.15 14.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 38' ' ' ILE . 58.6 mt -79.83 122.03 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.51 -0.744 . . . . 0.0 109.377 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.3 ttp -91.28 105.63 17.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.442 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 t -94.26 130.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.433 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 m -146.77 164.33 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.6 -0.688 . . . . 0.0 109.502 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.82 -163.8 38.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -84.34 -36.37 22.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.974 . . . . 0.0 109.553 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.1 ttp85 -68.08 -37.84 81.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.412 ' HA ' ' HG ' ' A' ' 48' ' ' SER . 6.9 m -75.81 -28.93 58.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 0.0 109.501 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -36.43 83.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.66 -26.16 26.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.412 ' HG ' ' HA ' ' A' ' 45' ' ' THR . 96.7 p -63.93 -19.51 65.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.13 161.21 25.4 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.11 -71.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.162 3.908 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -115.21 94.77 4.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.64 -0.662 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -98.0 157.27 34.84 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.78 147.22 73.88 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 O-C-N 123.347 1.183 . . . . 0.0 110.007 0.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.433 ' HB2' HD22 ' A' ' 59' ' ' ASN . 74.9 mt -69.62 113.63 18.57 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.353 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.11 179.38 6.5 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.766 3.644 . . . . 0.0 109.899 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 61.28 26.39 16.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.459 -0.776 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.405 HH12 ' HD3' ' A' ' 31' ' ' ARG . 11.6 ptp180 -176.63 176.91 1.48 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.534 -0.729 . . . . 0.0 109.462 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -107.29 121.66 45.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.433 HD22 ' HB2' ' A' ' 54' ' ' LEU . 2.2 m-80 -97.57 111.53 23.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.9 t -107.08 112.48 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.45 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -95.95 128.27 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.66 119.3 38.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -152.22 133.94 14.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.651 -0.656 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -92.37 30.52 1.47 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.729 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -111.15 130.41 55.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.698 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.04 31.61 0.78 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.683 . . . . 0.0 109.427 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -131.13 -25.81 2.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.671 . . . . 0.0 109.448 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -64.49 145.34 56.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.488 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.22 140.09 35.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.63 -0.669 . . . . 0.0 109.469 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.83 122.85 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.66 135.0 33.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.635 -0.666 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.71 36.68 67.01 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.67 138.35 14.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.566 -0.961 . . . . 0.0 109.468 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.4 94.58 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.596 -0.69 . . . . 0.0 109.444 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.5 t -74.86 100.41 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.556 -0.715 . . . . 0.0 109.449 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.82 155.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.565 -0.709 . . . . 0.0 109.521 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -136.31 29.96 2.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.97 152.1 2.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.658 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.32 -33.8 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -31.13 69.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.567 -0.708 . . . . 0.0 109.501 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.21 79.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.633 -0.667 . . . . 0.0 109.476 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.4 t -69.14 -42.56 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -71.23 -29.02 64.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.76 86.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -69.55 -35.96 75.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.31 -26.52 64.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.472 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -64.36 -43.91 93.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.56 -0.712 . . . . 0.0 109.467 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.98 -30.38 69.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.592 -0.692 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -119.71 89.9 42.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.09 -23.21 6.69 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 125.024 3.816 . . . . 0.0 109.96 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -68.75 -25.77 64.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.91 -179.91 5.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -138.15 161.81 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.579 -0.701 . . . . 0.0 109.518 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.8 tp -99.6 133.29 44.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.561 -0.712 . . . . 0.0 109.476 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.0 136.32 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.419 HG23 ' CD1' ' A' ' 103' ' ' PHE . 40.7 mm -102.24 120.02 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.25 -26.59 10.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.486 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.26 -176.71 38.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.41 -153.18 14.12 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 120.361 -1.67 . . . . 0.0 109.604 0.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.24 -32.38 73.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.605 -0.938 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.28 -27.74 60.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.44 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.6 mm -74.88 -34.75 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CD1' HG23 ' A' ' 96' ' ' ILE . 23.6 m-85 -63.48 -54.29 38.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.448 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 m -63.16 -24.59 67.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.76 76.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 79' ' ' VAL . 49.8 m-85 -106.14 13.13 29.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.581 -0.699 . . . . 0.0 109.84 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -71.32 -25.41 62.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 0.0 109.549 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.93 13.83 0.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.65 -0.657 . . . . 0.0 109.857 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.09 36.83 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.448 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.28 149.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -126.27 -49.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 m -107.49 158.24 17.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.8 mt -137.23 104.84 5.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 44.4 mt -103.55 105.06 15.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.497 -0.752 . . . . 0.0 109.308 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.411 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.8 p -111.81 136.32 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 109.495 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -108.3 99.85 9.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -83.37 149.04 26.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.637 -0.665 . . . . 0.0 109.5 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.54 132.14 52.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.605 -0.684 . . . . 0.0 109.305 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.22 77.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.555 -0.715 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.85 128.75 17.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 p -83.69 141.94 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.627 -0.925 . . . . 0.0 109.436 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -145.88 126.27 14.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.717 . . . . 0.0 109.39 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -89.16 148.04 23.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 109.508 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.39 -136.03 2.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -138.4 -31.44 0.75 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.92 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -97.7 143.2 28.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -122.87 176.96 5.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.58 -0.7 . . . . 0.0 109.486 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.8 tpt -97.92 152.56 19.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.556 -0.715 . . . . 0.0 109.468 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.9 pt -72.0 163.41 67.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.677 -0.639 . . . . 0.0 109.525 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.14 96.87 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 125.162 3.908 . . . . 0.0 109.91 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.1 mt -85.96 134.9 33.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.705 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -79.97 86.59 5.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.528 -0.733 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -67.32 -14.84 63.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.562 -0.711 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.26 -27.65 69.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.452 -0.78 . . . . 0.0 109.509 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.65 29.57 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.557 -0.715 . . . . 0.0 109.449 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -142.08 179.79 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.528 -0.732 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.548 ' HG1' ' HZ3' ' A' ' 161' ' ' LYS . 10.9 m -153.88 139.45 17.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 0.0 109.487 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -77.85 156.45 30.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.696 . . . . 0.0 109.509 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.09 -32.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -151.65 153.14 33.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.7 p -150.15 122.45 8.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 109.5 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -97.3 98.86 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 0.0 109.472 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m -84.15 139.86 32.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.602 -0.686 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -148.51 136.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.9 123.87 50.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.677 . . . . 0.0 109.419 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -79.96 -165.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.1 p -72.67 -40.79 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.548 -0.72 . . . . 0.0 109.638 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -100.63 138.13 20.04 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.684 . . . . 0.0 109.494 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.52 -46.48 23.58 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 124.717 3.611 . . . . 0.0 109.983 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.69 -27.66 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.733 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.1 mt -79.98 18.36 0.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.9 m -86.61 143.71 27.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.403 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.412 ' CE1' HG11 ' A' ' 144' ' ' VAL . 27.8 p-80 -155.9 163.82 39.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.672 . . . . 0.0 109.547 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.2 m -137.69 134.55 35.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 109.472 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.38 96.39 10.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -81.99 136.66 35.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.54 -0.725 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.8 t -125.47 109.07 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.0 m95 -103.88 169.26 8.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -143.57 140.61 30.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -81.67 131.77 35.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.493 -0.754 . . . . 0.0 109.467 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.548 ' HZ3' ' HG1' ' A' ' 137' ' ' THR . 0.6 OUTLIER -144.56 179.0 7.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -0.76 . . . . 0.0 109.506 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.456 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.438 ' C21' ' CD2' ' A' ' 30' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.86 95.67 3.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.447 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.6 m-85 -68.38 134.05 49.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.9 tp -148.53 113.03 5.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.373 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -143.98 145.47 32.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.499 -0.751 . . . . 0.0 109.711 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.64 107.27 19.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 0.0 109.26 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -127.1 157.7 38.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.643 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -97.65 170.08 9.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -61.23 -17.54 53.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.67 14.17 0.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.728 . . . . 0.0 109.865 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.11 39.21 97.33 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.02 151.51 47.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.624 -0.927 . . . . 0.0 109.413 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 13' ' ' ILE . 30.5 pt -111.39 -32.02 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.649 -0.657 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.02 -150.29 18.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -169.99 147.59 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.61 -0.935 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.63 8.11 1.62 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.22 -48.77 1.54 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -72.15 165.73 23.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.494 -1.004 . . . . 0.0 109.566 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.438 ' CD2' ' CZ2' ' A' ' 21' ' ' TRP . 13.6 mt -87.35 147.7 42.8 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.678 . . . . 0.0 109.52 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -82.01 -31.81 0.92 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 124.987 3.791 . . . . 0.0 109.767 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.438 ' CZ2' ' CD2' ' A' ' 19' ' ' LEU . 26.3 p90 -101.26 157.36 16.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.727 -0.608 . . . . 0.0 109.497 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -106.09 98.13 7.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.5 tp -121.04 79.8 34.06 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.424 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.47 -39.03 16.66 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 125.142 3.894 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.95 -42.55 99.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.692 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -68.02 -29.78 68.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.471 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.567 -0.708 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -84.8 -29.71 25.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 18.2 t80 -71.09 -27.0 63.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -65.17 -45.58 84.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.624 -0.672 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HA ' ' HG1' ' A' ' 34' ' ' THR . 68.0 ttt180 -66.15 -30.05 70.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.505 -0.747 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.98 -31.53 56.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.2 mm100 -97.07 32.32 2.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.55 -0.719 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.434 ' HG1' ' HA ' ' A' ' 31' ' ' ARG . 12.5 p -137.89 -34.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.449 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -69.25 125.91 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.64 -0.663 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.87 34.89 23.35 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -152.69 174.38 14.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.591 -0.946 . . . . 0.0 109.416 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.77 100.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 109.401 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.7 tmm? -71.81 131.79 43.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 109.451 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -135.25 117.98 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.499 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.43 -173.3 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.524 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.97 -173.89 29.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -76.28 -35.31 58.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.61 -0.935 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -69.71 -39.39 76.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 m -76.33 -27.24 56.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.433 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -63.34 -39.82 95.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -87.34 -22.93 24.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.632 -0.668 . . . . 0.0 109.594 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 m -62.87 -22.66 66.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -62.1 162.22 19.39 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.542 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -73.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.159 3.906 . . . . 0.0 109.897 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.47 90.42 3.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.439 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt85 -93.66 157.13 38.83 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.644 -0.66 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.8 -174.79 15.18 Favored 'Cis proline' 0 N--CA 1.508 2.353 0 O-C-N 123.447 1.235 . . . . 0.0 110.035 0.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.65 105.99 52.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 109.374 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -75.05 -178.7 4.37 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 124.602 3.534 . . . . 0.0 109.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.55 23.41 13.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -176.27 175.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.435 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -95.84 143.89 26.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.46 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -116.9 117.62 30.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.47 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.07 103.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 t -91.64 136.45 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.3 tp -104.04 115.22 30.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -143.11 146.92 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.691 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -93.58 -35.16 13.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -73.46 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.639 -0.663 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.16 30.1 0.54 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.71 -35.75 8.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -71.31 139.6 49.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.532 -0.73 . . . . 0.0 109.477 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -142.67 100.13 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.42 117.69 24.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.9 131.63 42.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 38.85 34.6 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.74 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.555 -0.968 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 t -75.09 98.27 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.84 99.06 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.46 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.11 164.93 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.482 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -141.46 27.93 1.86 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.44 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -174.9 153.42 1.69 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.68 -30.84 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.641 -0.662 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.99 69.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.649 -0.657 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.49 58.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.517 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 t -68.18 -46.35 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.493 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -71.72 -28.84 63.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.83 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.644 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -72.44 -33.7 67.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.87 -30.9 68.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -66.84 -40.75 88.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -67.27 -30.3 70.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.469 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -119.84 89.87 42.68 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.22 -22.43 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.196 3.93 . . . . 0.0 109.947 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -66.98 -26.6 66.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.52 -0.738 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -96.22 -179.86 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.514 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -137.53 154.63 49.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.43 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -86.65 141.33 29.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.586 -0.696 . . . . 0.0 109.445 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -146.93 118.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.55 -0.719 . . . . 0.0 109.488 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 96' ' ' ILE . 41.7 mm -91.76 125.88 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.465 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -100.93 -34.93 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.97 -178.45 39.37 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.01 -152.26 16.81 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 120.356 -1.673 . . . . 0.0 109.529 0.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.14 65.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.948 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -69.62 -33.44 72.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -75.3 -38.54 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.537 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.415 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 28.9 m-85 -63.08 -51.51 66.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -62.87 -23.98 67.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.603 -0.686 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.18 61.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 79' ' ' VAL . 57.3 m-85 -111.74 17.36 19.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.695 -0.628 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -27.0 65.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.82 18.69 0.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.55 -0.719 . . . . 0.0 109.703 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.15 36.32 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.447 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -91.39 150.76 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.505 -0.747 . . . . 0.0 109.366 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -132.36 -55.97 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.413 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 m -102.06 125.66 48.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.706 . . . . 0.0 109.375 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.9 mt -108.71 96.55 6.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.605 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.13 105.7 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 109.298 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -111.85 143.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.631 -0.668 . . . . 0.0 109.505 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.8 m -117.69 99.58 7.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.251 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 mtt85 -85.19 141.67 29.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.01 138.72 49.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.611 -0.681 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.92 72.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.602 -0.686 . . . . 0.0 109.433 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.34 132.48 13.4 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.6 m -85.32 142.52 29.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.966 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -143.13 135.24 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -97.68 155.29 17.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.541 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.69 -139.54 2.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.58 -26.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.8 m -97.82 116.83 30.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -100.77 167.71 10.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.448 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -85.65 149.97 24.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.468 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.39 164.78 58.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.608 -0.683 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 101.79 1.37 Allowed 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 125.104 3.87 . . . . 0.0 109.871 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.19 157.25 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.64 86.55 7.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -73.45 -17.5 61.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.783 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.19 9.88 1.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.541 -0.724 . . . . 0.0 109.848 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -132.34 29.16 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.732 . . . . 0.0 109.392 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -144.33 178.82 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.606 -0.684 . . . . 0.0 109.507 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.4 m -151.69 138.71 19.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.631 -0.668 . . . . 0.0 109.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -79.69 120.59 24.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.45 -32.93 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.549 -0.719 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.8 t -150.73 176.0 11.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -163.48 116.61 1.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 109.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -95.09 108.2 20.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.546 -0.721 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 m -92.33 144.58 25.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -146.83 127.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -101.89 119.13 38.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.07 -168.66 1.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.59 -0.694 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.3 p -72.18 -43.07 65.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.588 -0.695 . . . . 0.0 109.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -101.77 137.85 19.67 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.41 -48.38 11.76 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 124.996 3.797 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.09 78.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.572 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.2 mt -72.06 6.31 2.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 109.868 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.0 m -80.67 146.19 31.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.36 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.415 ' CE1' HG12 ' A' ' 144' ' ' VAL . 32.4 p-80 -160.79 167.87 25.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.569 -0.707 . . . . 0.0 109.55 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.0 m -140.13 139.34 35.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.578 -0.701 . . . . 0.0 109.335 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.52 99.38 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.468 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.9 mt-10 -80.9 130.97 35.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.475 -0.766 . . . . 0.0 109.438 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -115.16 103.53 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.695 . . . . 0.0 109.45 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.468 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 34.1 m95 -101.01 165.26 11.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.511 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -147.57 145.3 29.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.565 -0.71 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -71.11 104.36 3.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.519 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -138.06 123.28 19.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.548 -0.72 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.431 -179.971 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.5 133.15 34.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.548 -0.72 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.443 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.7 m-85 -100.95 160.87 14.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.701 . . . . 0.0 109.437 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.9 tp -169.55 109.06 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.68 . . . . 0.0 109.35 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.3 p90 -140.91 146.66 37.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.4 112.22 24.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -132.61 149.85 52.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.58 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -99.13 170.8 8.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -61.3 -18.7 59.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.818 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.46 15.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.445 -0.784 . . . . 0.0 109.858 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.37 35.32 91.5 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 5.9 tp -107.34 167.12 10.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.436 HD11 HG22 ' A' ' 13' ' ' ILE . 31.2 pt -141.86 -30.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.521 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.43 -167.41 27.06 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -172.49 121.22 0.42 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.627 -0.925 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 57.99 34.0 23.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.706 . . . . 0.0 109.923 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.92 -63.69 2.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -76.26 177.46 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.54 -0.977 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.4 mt -84.94 156.9 60.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.576 -0.703 . . . . 0.0 109.494 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.26 -28.38 3.05 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 125.055 3.836 . . . . 0.0 109.923 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 33.3 p90 -108.09 176.02 5.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -126.55 98.85 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.693 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.8 tp -118.23 80.44 15.69 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 109.51 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -45.88 -37.74 17.21 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 125.051 3.834 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.63 -45.51 92.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -63.09 -39.66 95.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.474 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.77 -23.62 67.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -86.07 -28.54 24.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.365 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' CZ ' ' NE2' ' A' ' 33' ' ' GLN . 20.6 t80 -71.67 -26.51 62.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.672 . . . . 0.0 109.476 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -65.27 -46.33 80.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.547 -0.72 . . . . 0.0 109.502 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -71.09 2.72 4.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.643 . . . . 0.0 109.994 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.02 -33.06 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.831 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.432 ' NE2' ' CZ ' ' A' ' 29' ' ' TYR . 3.5 mp0 -107.99 30.46 6.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 p -126.63 -30.59 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.483 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.13 134.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.573 -0.704 . . . . 0.0 109.445 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.18 34.29 64.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -156.92 165.78 35.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.954 . . . . 0.0 109.511 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.8 mt -92.51 111.61 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.594 -0.691 . . . . 0.0 109.465 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.0 ttp -87.83 111.7 21.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.0 t -98.87 122.48 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.42 161.54 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.652 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.81 -177.61 52.03 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -72.35 -38.36 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.457 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.8 mtm-85 -68.23 -34.08 75.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -78.68 -28.82 45.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.579 -0.701 . . . . 0.0 109.459 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 35.7 t80 -68.17 -29.22 68.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.541 -0.725 . . . . 0.0 109.496 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -85.8 -24.62 26.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.537 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p -63.6 -25.34 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.635 -0.666 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -63.98 161.26 40.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.542 -0.724 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.81 -61.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.084 3.856 . . . . 0.0 109.878 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -126.37 77.01 1.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.394 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' H ' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -79.87 150.73 72.69 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 0.0 109.588 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.41 161.64 87.09 Favored 'Cis proline' 0 N--CA 1.51 2.466 0 O-C-N 123.445 1.234 . . . . 0.0 109.859 0.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.5 mt -78.53 142.93 62.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -80.58 162.62 21.78 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 124.914 3.742 . . . . 0.0 110.037 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.08 28.46 18.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.544 -0.723 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -177.83 146.36 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.555 -0.715 . . . . 0.0 109.629 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -78.43 152.42 32.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.589 -0.694 . . . . 0.0 109.455 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -123.79 97.67 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.695 . . . . 0.0 109.5 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -91.62 149.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -136.03 120.72 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.445 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.1 tp -96.21 119.52 34.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 109.492 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.37 146.07 36.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -100.57 31.21 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -150.95 137.17 18.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.635 -0.666 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -87.74 32.19 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -95.14 -38.04 10.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.668 -0.645 . . . . 0.0 109.475 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -73.56 158.18 35.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -151.73 101.52 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.45 115.33 27.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.544 -0.722 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -80.36 124.5 28.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.63 -0.669 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.82 40.38 12.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.47 153.82 29.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.598 -0.942 . . . . 0.0 109.558 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -86.29 94.29 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.586 -0.696 . . . . 0.0 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.4 t -75.55 103.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.63 -0.669 . . . . 0.0 109.444 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -96.57 157.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.519 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -135.95 30.68 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -169.98 146.46 3.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -67.95 -32.37 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.638 -0.664 . . . . 0.0 109.476 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.79 70.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.738 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.46 -35.21 78.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 t -68.45 -33.31 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.45 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.15 -31.22 39.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.661 -0.649 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.46 67.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.458 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.53 -25.32 22.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.635 -0.665 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.17 -33.18 50.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.83 -31.51 72.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.546 -0.721 . . . . 0.0 109.5 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.36 -26.12 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.674 -0.641 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.37 90.28 42.01 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.465 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.25 -22.46 8.33 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.077 3.852 . . . . 0.0 109.95 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.94 -27.18 65.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -96.99 -179.99 4.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -138.02 150.68 47.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 tp -88.08 130.2 35.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.6 t -128.83 129.86 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.525 -0.734 . . . . 0.0 109.435 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 103' ' ' PHE . 40.9 mm -96.64 116.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.613 -0.68 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -104.08 -29.97 10.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.66 -175.51 39.06 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.05 -151.86 11.02 Favored Glycine 0 N--CA 1.5 2.902 0 O-C-N 120.298 -1.707 . . . . 0.0 109.567 -0.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.12 -30.64 69.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.606 -0.938 . . . . 0.0 109.483 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.73 -27.56 60.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 0.0 109.425 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -77.26 -33.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 96' ' ' ILE . 20.0 m-85 -63.38 -58.19 7.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.483 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.432 ' H ' ' HG1' ' A' ' 104' ' ' THR . 1.9 m -62.91 -21.92 66.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.596 -0.69 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.55 -29.13 64.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 79' ' ' VAL . 54.5 m-85 -117.35 16.55 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.707 . . . . 0.0 109.778 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -23.03 63.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.636 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.05 -39.01 83.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.569 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.8 41.28 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.443 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -91.17 151.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.748 . . . . 0.0 109.315 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -134.57 -66.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.581 -0.699 . . . . 0.0 109.441 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -90.03 161.92 15.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.41 HD12 ' CE2' ' A' ' 136' ' ' PHE . 59.3 mt -140.78 96.85 3.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.557 -0.714 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.69 104.44 16.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.322 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.0 p -111.23 137.43 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.2 m -109.19 99.16 8.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.337 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -85.07 139.62 31.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.04 140.05 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.294 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.28 -34.33 68.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.575 -0.703 . . . . 0.0 109.487 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.67 128.77 18.26 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.2 t -77.35 137.33 38.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.632 -0.923 . . . . 0.0 109.493 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -144.09 117.78 9.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.608 -0.683 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -93.06 145.29 24.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.461 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.8 -120.21 1.52 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.06 -36.35 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.674 -0.898 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 m -93.14 144.38 25.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.625 -0.672 . . . . 0.0 109.584 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -122.78 176.42 5.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.692 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -91.74 150.95 20.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.695 . . . . 0.0 109.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.9 pt -73.67 165.55 52.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.705 . . . . 0.0 109.456 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.95 92.72 1.09 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.123 3.882 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -77.87 149.73 34.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.595 -0.69 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -81.63 81.83 7.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -70.14 -13.92 62.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 9.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.386 -0.821 . . . . 0.0 109.904 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -136.82 30.26 2.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.41 ' CE2' HD12 ' A' ' 113' ' ' LEU . 60.2 m-85 -139.41 177.03 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.711 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -153.69 143.56 21.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.659 -0.651 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -76.22 157.04 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.582 -0.699 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.29 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.502 -0.749 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 t -147.13 159.52 43.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.632 -0.667 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.9 t -157.12 111.06 2.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.68 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -95.88 106.82 19.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.0 m -90.19 143.37 26.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -147.29 131.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -109.39 121.85 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.687 . . . . 0.0 109.48 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.33 -171.59 3.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.9 p -63.2 -45.05 93.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.313 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.46 158.91 42.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -78.81 -23.09 8.4 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 124.915 3.743 . . . . 0.0 109.819 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.76 -23.02 29.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.513 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 mt -86.01 16.84 3.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.715 . . . . 0.0 109.817 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.0 m -82.62 146.25 29.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.447 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -160.26 166.45 29.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 109.544 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.6 m -138.67 138.65 37.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.586 -0.696 . . . . 0.0 109.42 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -93.69 92.19 7.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.471 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 39.0 mm-40 -74.43 126.23 30.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -110.89 112.15 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.484 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.471 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 33.4 m95 -109.22 168.34 9.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -147.1 141.08 25.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.698 . . . . 0.0 109.452 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -66.47 124.81 23.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.46 ' HZ1' ' CB ' ' A' ' 161' ' ' LYS . 6.8 ttpm? -153.54 144.02 22.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.592 -0.692 . . . . 0.0 109.434 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.434 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.403 ' C17' HN52 ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.466 ' H2 ' ' HG1' ' A' ' 1' ' ' THR . 8.4 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.31 113.27 13.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.558 -0.714 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.5 m-85 -86.92 153.39 21.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.6 tp -163.28 109.85 1.16 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 0.0 109.359 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.418 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.3 p90 -141.2 146.12 36.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.546 -0.721 . . . . 0.0 109.708 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.78 113.04 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.587 -0.696 . . . . 0.0 109.245 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -131.87 152.45 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.543 -0.723 . . . . 0.0 109.66 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -102.97 171.21 7.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLY . 3.5 ptm85 -60.92 -19.45 60.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.554 -0.716 . . . . 0.0 109.808 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.45 14.86 0.88 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.491 -0.756 . . . . 0.0 109.736 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.17 36.89 93.63 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.65 167.33 9.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.936 . . . . 0.0 109.473 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.3 pt -142.57 -29.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.15 -176.56 44.46 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -164.19 124.1 2.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.942 . . . . 0.0 109.53 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 29.18 18.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.517 -0.739 . . . . 0.0 109.754 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -62.42 2.51 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -72.4 -179.78 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.94 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 25.7 mt -91.4 157.83 41.76 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.464 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.419 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.34 -30.24 2.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.063 3.842 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.419 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 34.9 p90 -105.44 -175.45 2.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.585 -0.697 . . . . 0.0 109.527 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -134.28 103.06 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.361 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.8 tp -124.74 82.39 60.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.44 -38.78 16.22 Favored 'Trans proline' 0 N--CA 1.508 2.329 0 C-N-CA 125.066 3.844 . . . . 0.0 110.21 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.79 -47.37 83.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.472 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -64.47 -28.95 70.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.512 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -72.72 -23.69 60.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.587 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -87.18 -27.83 22.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.581 -0.7 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -69.68 -28.44 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -67.59 -45.7 74.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.402 ' HA ' ' HG1' ' A' ' 34' ' ' THR . 18.2 ttm180 -67.12 -26.25 66.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.65 -0.656 . . . . 0.0 109.46 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.7 -28.07 40.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.549 -0.719 . . . . 0.0 109.462 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -104.72 35.71 2.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.402 ' HG1' ' HA ' ' A' ' 31' ' ' ARG . 13.9 p -139.26 -27.01 0.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.694 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.29 124.26 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.64 . . . . 0.0 109.501 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 37.84 61.54 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -146.93 164.12 33.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.529 -0.983 . . . . 0.0 109.534 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.451 HG22 HD11 ' A' ' 38' ' ' ILE . 58.9 mt -94.1 103.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.432 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 46.3 ttp -86.49 105.17 16.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.64 -0.663 . . . . 0.0 109.481 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 t -94.24 124.54 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.5 166.26 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 109.489 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.31 -164.25 40.08 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -81.85 -37.49 26.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.62 -0.929 . . . . 0.0 109.441 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -66.99 -42.3 85.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.643 -0.66 . . . . 0.0 109.486 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -72.27 -26.11 61.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.612 -0.68 . . . . 0.0 109.456 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -64.32 -41.3 96.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.442 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -85.37 -21.18 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.63 -0.668 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -62.71 -24.26 67.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.739 . . . . 0.0 109.608 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -62.83 161.06 31.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.98 -72.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.194 3.929 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -107.36 94.46 5.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -99.01 157.18 34.55 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.77 153.46 83.03 Favored 'Cis proline' 0 N--CA 1.508 2.35 0 O-C-N 123.37 1.195 . . . . 0.0 109.967 0.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.45 114.06 34.78 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.636 -0.665 . . . . 0.0 109.282 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.28 -179.16 5.17 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 124.791 3.66 . . . . 0.0 109.906 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 60.81 32.13 20.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.714 . . . . 0.0 109.666 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -177.11 -171.59 0.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.764 . . . . 0.0 109.544 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -118.06 113.09 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.601 -0.687 . . . . 0.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 59' ' ' ASN . 1.5 m-80 -83.49 103.67 13.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 0.0 109.417 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.62 92.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.582 -0.699 . . . . 0.0 109.461 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -79.66 136.86 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.6 tp -108.65 109.75 21.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.677 -0.64 . . . . 0.0 109.499 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -137.51 151.69 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.449 ' CD2' ' H ' ' A' ' 64' ' ' HIS . 9.3 p80 -95.76 -33.9 12.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -77.22 128.81 35.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -85.16 30.36 0.6 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.714 . . . . 0.0 109.522 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -98.43 -36.37 9.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.692 . . . . 0.0 109.579 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -71.04 146.76 49.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -143.96 103.4 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.33 117.61 26.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -74.62 127.37 32.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.63 -0.669 . . . . 0.0 109.487 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.28 38.06 35.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.8 144.47 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.958 . . . . 0.0 109.417 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -79.69 104.45 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.6 t -85.65 94.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.555 -0.715 . . . . 0.0 109.414 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.6 171.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -143.95 29.96 1.33 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.493 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -171.22 142.86 1.81 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.559 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.5 t -66.55 -33.64 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.85 74.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.659 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.02 79.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.627 -0.671 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.06 -40.25 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.455 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.89 -29.55 66.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.42 77.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.665 . . . . 0.0 109.529 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -72.39 -34.14 67.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.513 -0.742 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.79 -30.49 68.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -65.81 -40.4 91.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -65.69 -29.63 70.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.619 -0.676 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -118.99 90.06 40.33 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.01 -23.54 6.52 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.061 3.841 . . . . 0.0 109.828 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.56 -25.31 63.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.676 -0.64 . . . . 0.0 109.495 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 1.4 tp60 -94.6 179.85 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 28.4 mt-10 -136.52 155.61 49.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.598 -0.689 . . . . 0.0 109.468 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -97.4 147.81 23.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.606 -0.684 . . . . 0.0 109.462 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -145.92 139.12 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.585 -0.697 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.419 HG23 ' CD1' ' A' ' 103' ' ' PHE . 40.9 mm -105.21 120.55 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.429 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -101.97 -29.1 12.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 109.415 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 156.67 -174.41 34.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.97 -150.14 9.06 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.266 -1.726 . . . . 0.0 109.58 -0.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.17 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.962 . . . . 0.0 109.53 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.51 -28.06 65.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.601 -0.687 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -79.44 -36.12 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CD1' HG23 ' A' ' 96' ' ' ILE . 22.4 m-85 -63.3 -52.96 59.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.478 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.13 -28.04 69.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.61 -0.681 . . . . 0.0 109.535 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.46 79.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.679 . . . . 0.0 109.534 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.61 8.78 41.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.503 -0.748 . . . . 0.0 109.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -66.07 -30.67 71.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.56 14.45 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.0 109.873 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -160.1 37.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.741 . . . . 0.0 109.402 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.448 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -95.77 153.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.596 -0.69 . . . . 0.0 109.442 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -130.94 -52.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -102.29 158.69 16.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.675 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.8 mt -139.49 107.7 5.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.8 mt -104.66 102.51 12.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.242 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.418 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -108.27 137.92 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.526 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -109.09 99.82 9.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -81.98 147.66 29.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.712 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -126.33 131.92 51.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.554 -0.716 . . . . 0.0 109.277 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.69 71.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.464 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.8 127.47 13.48 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.4 p -79.16 140.66 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.934 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -147.95 129.53 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.462 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -99.35 151.03 21.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.535 -0.728 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.56 -122.38 1.32 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -146.27 -36.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.599 -0.942 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.2 m -99.42 135.74 40.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -110.32 179.95 3.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.415 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.15 144.73 25.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 109.548 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.8 pt -67.27 163.5 45.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.632 -0.668 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.79 94.85 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 125.137 3.891 . . . . 0.0 109.945 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.1 mt -77.91 147.29 35.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.523 -0.736 . . . . 0.0 109.388 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -79.67 86.75 5.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.4 ' C ' ' H ' ' A' ' 135' ' ' ASP . 95.1 m95 -73.94 -11.76 60.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.953 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.01 10.11 1.31 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 133' ' ' TRP . 2.3 m-20 -138.56 30.73 2.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -143.21 176.96 8.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.3 m -156.69 140.14 15.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -81.95 120.87 25.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.567 -0.708 . . . . 0.0 109.492 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.02 -35.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.724 . . . . 0.0 109.51 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.4 p -148.64 170.26 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.1 p -157.49 113.64 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.36 104.1 16.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.538 -0.726 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.3 m -86.02 147.09 26.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -151.74 132.49 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.586 -0.696 . . . . 0.0 109.38 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -107.6 128.91 54.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.81 -166.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -69.96 -39.0 76.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -105.38 137.7 19.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.42 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -48.53 -43.7 32.44 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 124.775 3.65 . . . . 0.0 110.059 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.88 -29.06 69.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.537 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.7 mt -80.71 21.2 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.6 m -89.06 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.418 ' CE1' HG12 ' A' ' 144' ' ' VAL . 34.6 p-80 -153.76 168.23 26.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.4 m -141.67 128.25 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -84.52 95.83 8.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.439 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 25.7 mt-10 -81.12 130.4 35.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 t -117.6 106.06 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.5 m95 -100.48 166.81 10.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.721 . . . . 0.0 109.481 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -142.49 147.14 35.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -66.4 99.84 0.59 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.695 . . . . 0.0 109.501 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -157.79 113.85 2.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.492 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.37 20.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.8 m-85 -87.92 135.03 33.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.587 -0.696 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 tp -150.08 112.91 4.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.722 . . . . 0.0 109.467 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.416 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -144.23 138.79 28.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.536 -0.727 . . . . 0.0 109.735 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.84 111.19 22.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -129.75 157.64 41.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.515 -0.74 . . . . 0.0 109.68 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -101.32 168.44 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.559 -0.713 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -60.77 -23.88 65.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 109.713 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.71 -1.44 3.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.636 -0.665 . . . . 0.0 109.907 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.75 44.79 19.1 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 tp -124.55 152.32 43.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.562 -0.963 . . . . 0.0 109.53 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -128.01 -33.87 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.569 -0.707 . . . . 0.0 109.81 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' H ' HD12 ' A' ' 13' ' ' ILE . . . -146.01 178.84 23.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -172.03 116.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.624 -0.927 . . . . 0.0 109.543 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.86 31.18 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.507 -0.745 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.55 -59.57 4.04 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -81.95 179.99 7.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.598 -0.943 . . . . 0.0 109.503 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.408 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 20.2 mt -88.57 155.1 51.09 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.0 109.4 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.28 -29.46 3.1 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 124.946 3.764 . . . . 0.0 109.892 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 37.5 p90 -105.06 167.24 9.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.639 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -123.37 83.77 2.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 109.394 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.2 tp -106.76 81.4 0.88 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.538 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -45.01 -39.06 14.24 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 125.262 3.974 . . . . 0.0 110.22 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.91 -38.33 90.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.446 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.91 -32.32 69.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.528 -0.732 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.3 mt -72.47 -24.23 61.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.737 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -82.15 -30.32 31.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.593 -0.692 . . . . 0.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -70.47 -25.11 63.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.571 -0.705 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -63.39 -45.43 91.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.584 -0.698 . . . . 0.0 109.401 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -64.45 -28.71 69.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -28.71 46.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.527 -0.733 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -101.96 33.65 2.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.541 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.8 p -140.05 -34.45 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.59 126.04 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.557 -0.714 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.53 36.8 25.45 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -154.49 175.29 13.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.654 -0.909 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 99.97 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.557 -0.714 . . . . 0.0 109.415 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -72.62 125.77 28.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.486 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -132.55 118.55 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.35 -176.17 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.87 -169.39 33.74 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -80.01 -35.69 36.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.929 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -70.22 -40.86 74.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 m -73.1 -26.08 61.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -63.67 -45.09 91.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.629 -0.67 . . . . 0.0 109.502 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -77.48 -23.31 50.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.626 -0.671 . . . . 0.0 109.568 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.9 m -63.05 -24.16 67.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.509 -0.745 . . . . 0.0 109.607 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.43 160.59 58.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.583 -0.698 . . . . 0.0 109.471 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.96 -72.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 125.075 3.85 . . . . 0.0 109.955 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -109.22 94.81 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -99.54 157.26 34.3 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.75 154.09 83.61 Favored 'Cis proline' 0 N--CA 1.509 2.419 0 O-C-N 123.313 1.165 . . . . 0.0 109.923 0.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.2 mt -73.88 115.61 44.0 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.642 -0.661 . . . . 0.0 109.277 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.96 178.86 7.04 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 124.741 3.627 . . . . 0.0 109.934 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 61.34 29.32 18.52 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.595 -0.69 . . . . 0.0 109.608 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.0 167.61 2.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.702 . . . . 0.0 109.465 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 m -88.26 117.06 26.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -91.85 101.61 14.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.22 145.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -134.93 116.43 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.587 -0.696 . . . . 0.0 109.417 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.5 tp -96.2 119.54 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.573 -0.705 . . . . 0.0 109.485 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.51 152.61 48.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.454 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -93.79 -37.24 11.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.529 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -72.34 133.64 45.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 109.46 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -88.48 29.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -102.6 -38.61 7.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.53 141.41 48.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.681 -0.637 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -149.91 101.52 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.604 -0.685 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.88 115.02 20.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -76.84 135.01 38.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.43 35.09 34.07 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.16 147.81 19.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.553 -0.969 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.66 94.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -96.8 124.4 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 109.426 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.23 174.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.682 . . . . 0.0 109.514 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -138.86 31.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -153.67 143.69 22.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -66.96 -32.76 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.718 . . . . 0.0 109.442 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.62 -34.15 76.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.715 . . . . 0.0 109.44 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.97 90.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 t -66.83 -39.37 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.453 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.63 -28.55 63.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.48 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.18 90.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 0.0 109.533 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -69.36 -37.42 77.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.541 -0.725 . . . . 0.0 109.45 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.3 68.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.595 -0.69 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -67.18 -43.74 81.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -65.46 -28.84 69.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -119.42 90.02 41.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.77 -20.59 9.01 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.14 3.893 . . . . 0.0 109.944 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.12 -28.31 69.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.479 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -105.55 165.54 11.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.6 -0.687 . . . . 0.0 109.498 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -122.01 143.66 49.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.18 132.93 48.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 t -135.31 120.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -96.09 140.64 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 109.438 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.78 -36.1 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.705 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.17 179.58 36.89 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 -155.44 28.06 Favored Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.335 -1.685 . . . . 0.0 109.591 0.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.78 -23.43 67.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.649 -0.912 . . . . 0.0 109.669 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.05 -38.55 75.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.1 mm -72.14 -39.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.552 -0.718 . . . . 0.0 109.585 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 29.1 m-85 -62.93 -41.69 99.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.552 -0.717 . . . . 0.0 109.415 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.74 -19.06 62.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.669 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.15 -25.8 47.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.554 -0.716 . . . . 0.0 109.544 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 79' ' ' VAL . 82.1 m-85 -124.53 19.85 8.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.584 -0.698 . . . . 0.0 109.748 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -63.41 -29.99 71.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 109.625 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -80.85 26.02 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.617 -0.677 . . . . 0.0 109.73 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -159.99 34.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -91.68 150.66 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.49 -0.756 . . . . 0.0 109.436 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -132.35 -58.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.683 -0.636 . . . . 0.0 109.307 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -102.22 112.04 24.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.569 -0.707 . . . . 0.0 109.353 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.404 HD12 ' CE2' ' A' ' 136' ' ' PHE . 30.0 mt -94.64 99.26 11.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 20.0 mt -100.63 104.41 15.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.667 . . . . 0.0 109.22 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -112.38 143.65 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.602 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.0 m -113.5 99.98 8.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -83.64 142.12 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.682 . . . . 0.0 109.611 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.1 131.54 56.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.685 . . . . 0.0 109.243 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.47 75.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.41 9.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 p -76.92 142.89 39.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.443 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -147.82 109.44 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.33 153.19 28.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.12 -126.2 1.29 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.55 -46.9 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.907 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.2 m -85.8 139.84 30.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 109.515 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -116.54 160.72 20.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.634 . . . . 0.0 109.457 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.61 147.61 37.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.546 -0.721 . . . . 0.0 109.476 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.7 pt -70.37 163.83 59.13 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.695 . . . . 0.0 109.479 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.34 101.03 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.139 3.893 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.3 153.08 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.686 . . . . 0.0 109.485 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.2 88.52 7.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 109.461 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -73.9 -15.16 61.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.0 109.82 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.95 9.86 1.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 109.933 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -134.48 30.62 3.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.823 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.404 ' CE2' HD12 ' A' ' 113' ' ' LEU . 60.9 m-85 -140.59 179.59 6.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -150.77 134.29 16.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.638 -0.664 . . . . 0.0 109.43 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -78.63 118.55 20.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -95.25 -33.56 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.6 m -157.47 174.28 15.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 t -161.69 122.73 2.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -95.67 107.22 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.7 m -90.13 149.52 22.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 109.427 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.417 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.7 p -154.43 129.57 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.363 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -107.73 120.79 43.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.533 -0.73 . . . . 0.0 109.479 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.19 -165.97 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.589 -0.695 . . . . 0.0 109.519 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.6 p -71.52 -39.19 70.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.599 -0.688 . . . . 0.0 109.525 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -105.63 137.59 19.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.547 -0.721 . . . . 0.0 109.41 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.99 -44.84 26.74 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 C-N-CA 124.762 3.641 . . . . 0.0 110.072 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.15 71.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.718 . . . . 0.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.3 mt -80.78 20.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.682 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.2 m -92.33 142.06 27.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.36 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.417 ' CE1' HG12 ' A' ' 144' ' ' VAL . 31.6 p-80 -156.93 166.62 32.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.5 m -138.33 133.44 33.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.91 92.97 9.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.06 139.84 44.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 0.0 109.414 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.8 t -128.91 106.74 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.597 -0.69 . . . . 0.0 109.506 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.1 m95 -106.83 168.56 9.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -145.21 142.31 29.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.79 122.02 19.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -141.42 136.2 31.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.566 -0.709 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.445 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.32 100.68 7.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 5.8 m-85 -71.66 139.03 49.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.6 tp -153.91 113.38 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.324 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 p90 -146.05 151.01 37.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.736 . . . . 0.0 109.909 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.59 118.24 36.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.282 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -138.04 152.81 49.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.48 -0.762 . . . . 0.0 109.588 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.38 171.07 7.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 109.498 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLY . 5.9 ptp180 -61.1 -19.05 61.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.604 -0.685 . . . . 0.0 109.864 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -76.61 13.95 0.89 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.493 -0.754 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.24 39.63 97.95 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 tp -112.02 165.79 11.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.624 -0.927 . . . . 0.0 109.485 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 pt -142.21 -30.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.577 -0.702 . . . . 0.0 109.545 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.18 -169.43 30.75 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -172.13 117.78 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.631 -0.923 . . . . 0.0 109.44 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.0 21.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.577 -0.702 . . . . 0.0 109.613 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.68 -61.74 4.08 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -76.89 166.56 23.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.6 mt -79.91 157.54 73.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.662 -0.649 . . . . 0.0 109.439 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -80.24 -27.98 3.28 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.08 3.853 . . . . 0.0 109.971 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.421 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 35.4 p90 -108.25 -179.29 3.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.534 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -131.34 102.35 5.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.7 tp -121.51 80.16 38.39 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.606 -0.684 . . . . 0.0 109.433 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.63 -37.6 15.77 Favored 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 125.167 3.912 . . . . 0.0 110.178 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -62.89 -42.79 99.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.562 -0.711 . . . . 0.0 109.509 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -65.42 -38.1 88.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.622 -0.674 . . . . 0.0 109.38 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.35 -24.42 67.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.579 -0.7 . . . . 0.0 109.519 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -83.63 -30.82 26.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.614 -0.679 . . . . 0.0 109.407 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.411 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 19.0 t80 -73.83 -25.62 60.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -63.42 -45.74 89.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.51 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -63.58 -30.12 71.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.624 -0.672 . . . . 0.0 109.44 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.83 -29.21 50.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 76.5 mm-40 -100.77 32.54 3.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.3 p -136.82 -35.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.588 -0.695 . . . . 0.0 109.54 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.42 128.86 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.705 . . . . 0.0 109.496 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.88 -25.75 26.36 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.36 -170.58 1.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.927 . . . . 0.0 109.511 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -103.99 112.05 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.459 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.7 tmm? -73.72 110.99 8.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 109.459 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.26 122.88 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.713 . . . . 0.0 109.464 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 m -136.66 178.05 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.94 -177.58 34.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -70.36 -39.58 74.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.963 . . . . 0.0 109.416 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -68.94 -40.53 78.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.616 -0.678 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -72.46 -25.72 61.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.31 -44.49 87.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.661 -0.65 . . . . 0.0 109.462 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -77.33 -26.84 52.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.1 p -62.67 -21.79 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.64 -0.663 . . . . 0.0 109.697 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -62.45 162.96 16.37 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -81.22 -74.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 125.227 3.952 . . . . 0.0 110.037 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -113.7 82.65 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.465 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -84.42 157.24 62.01 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.371 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.87 152.14 76.88 Favored 'Cis proline' 0 N--CA 1.509 2.383 0 O-C-N 123.415 1.219 . . . . 0.0 109.995 0.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.4 113.86 26.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.707 . . . . 0.0 109.27 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.44 179.24 6.68 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.761 3.641 . . . . 0.0 109.942 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 61.03 32.03 19.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.525 -0.734 . . . . 0.0 109.64 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.29 -178.62 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.7 m -100.98 119.83 39.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 109.339 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -94.24 117.16 29.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.653 -0.654 . . . . 0.0 109.484 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -125.83 143.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.59 -0.693 . . . . 0.0 109.398 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 t -127.97 132.62 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.602 -0.686 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.8 tp -104.2 112.02 24.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -137.88 153.5 49.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.7 . . . . 0.0 109.464 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -89.68 -47.82 7.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 0.0 109.548 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -72.74 157.97 36.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.604 -0.685 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -102.45 8.11 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.593 -0.692 . . . . 0.0 109.859 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.99 -28.01 57.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.28 153.56 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.492 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -143.72 143.59 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.601 -0.687 . . . . 0.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.0 125.4 24.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -87.6 123.39 32.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.16 41.6 59.77 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -154.42 148.84 26.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.617 -0.931 . . . . 0.0 109.458 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.64 99.63 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 t -75.88 97.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.652 -0.655 . . . . 0.0 109.467 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.19 162.98 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -140.07 30.39 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.41 146.48 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.607 -0.683 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.409 HG12 ' CE1' ' A' ' 106' ' ' PHE . 30.6 t -68.18 -33.36 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.528 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.53 70.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.506 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.39 80.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.54 -0.725 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.4 t -69.13 -36.57 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.645 -0.659 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.6 -30.34 64.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.75 -36.92 83.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.83 -38.75 83.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.581 -0.7 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.51 -24.49 64.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -63.87 -43.73 95.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -67.45 -29.11 68.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -120.77 89.76 45.58 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.13 -23.53 6.38 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.165 3.91 . . . . 0.0 109.86 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.57 -24.92 64.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.536 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -90.44 179.97 5.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -138.31 154.06 49.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tt -91.16 109.58 20.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -110.62 122.6 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 96' ' ' ILE . 41.7 mm -97.3 127.76 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.57 -23.44 11.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.599 -0.688 . . . . 0.0 109.578 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.38 -177.05 40.88 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.464 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -80.5 -157.0 14.34 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.341 -1.682 . . . . 0.0 109.54 -0.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.56 87.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.588 -0.948 . . . . 0.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.31 -26.29 66.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.548 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.464 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.5 mm -74.88 -32.17 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.6 -0.688 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.68 -42.65 81.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -69.89 -35.09 74.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.581 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.77 88.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.664 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.409 ' CE1' HG12 ' A' ' 79' ' ' VAL . 33.6 m-85 -95.14 3.49 54.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.461 ' HZ3' ' HB2' ' A' ' 132' ' ' ASN . 5.6 tmtt? -70.8 -22.72 62.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.568 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -62.93 -23.87 67.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.71 58.97 1.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -105.98 149.51 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -130.37 -50.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -95.2 142.72 27.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.589 -0.694 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 mt -129.52 87.15 2.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.573 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.37 123.97 34.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.347 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.413 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -135.59 147.28 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 0.0 109.543 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.5 m -113.51 105.95 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.64 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -88.27 127.97 35.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.44 133.66 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 109.387 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.58 63.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 0.0 109.425 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.04 129.06 12.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 p -78.05 143.69 37.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.988 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -148.45 125.79 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.634 -0.667 . . . . 0.0 109.517 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.57 160.77 16.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.37 -132.17 1.32 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -143.83 -41.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.664 -0.903 . . . . 0.0 109.451 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.2 m -89.46 134.94 33.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.518 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -113.33 173.39 6.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.419 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.84 143.56 26.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.485 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.2 pt -67.34 164.62 35.61 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.564 -0.71 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.4 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.147 3.898 . . . . 0.0 109.883 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.66 155.15 18.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.461 ' HB2' ' HZ3' ' A' ' 107' ' ' LYS . 5.4 t-20 -87.04 85.34 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.588 -0.695 . . . . 0.0 109.418 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -74.64 -15.17 60.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.669 -0.644 . . . . 0.0 109.871 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.09 9.97 1.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.513 -0.742 . . . . 0.0 109.877 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -134.05 29.7 3.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -141.13 176.01 9.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -150.39 134.24 16.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 109.42 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.409 ' HB2' ' HZ1' ' A' ' 138' ' ' LYS . 2.1 ttmp? -70.65 153.19 43.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.553 -0.717 . . . . 0.0 109.498 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.09 -31.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.612 -0.68 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.2 m -139.33 144.01 38.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -143.84 99.09 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -86.71 97.56 10.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.708 . . . . 0.0 109.462 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 m -77.2 147.87 36.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.54 129.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.351 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.75 120.65 42.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.736 . . . . 0.0 109.477 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.08 -165.9 0.93 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.7 p -74.89 -41.96 58.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.22 137.8 20.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.733 . . . . 0.0 109.434 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.65 -48.45 15.69 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 124.804 3.669 . . . . 0.0 110.143 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.88 70.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.658 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.32 15.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.788 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.0 m -86.58 139.36 30.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.339 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -156.01 173.25 17.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.571 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.3 m -139.23 135.56 34.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.417 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -86.46 92.13 8.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.46 147.52 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 t -139.05 99.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.461 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -94.59 166.19 12.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.395 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -148.84 141.34 24.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -63.22 133.48 54.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -140.01 157.16 46.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.484 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.457 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.402 ' C17' HN52 ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.82 124.31 20.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.71 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.6 m-85 -94.86 152.77 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.561 -0.712 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 tp -163.2 110.05 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.33 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.0 p90 -144.78 150.1 36.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.75 117.3 31.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 109.223 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -138.48 152.8 48.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.723 . . . . 0.0 109.691 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -104.07 170.99 7.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.68 -17.38 55.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.805 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.85 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.36 38.22 95.91 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 tp -113.03 163.97 14.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.551 -0.97 . . . . 0.0 109.493 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.7 pt -138.16 -30.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.49 -166.87 27.29 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HZ2' ' HB3' ' A' ' 15' ' ' LYS . 5.2 ttpm? -171.79 118.2 0.42 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.902 . . . . 0.0 109.501 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 59.98 32.24 21.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.72 -62.8 2.63 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -75.35 172.84 11.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.615 -0.932 . . . . 0.0 109.454 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.413 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 31.1 mt -85.18 156.36 60.12 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.84 -26.66 4.4 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 125.021 3.814 . . . . 0.0 109.944 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 36.4 p90 -108.77 167.74 9.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.511 -0.743 . . . . 0.0 109.491 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -117.57 101.31 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.61 -0.682 . . . . 0.0 109.45 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.1 tp -121.38 80.41 37.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.59 -38.99 17.29 Favored 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 125.171 3.914 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.48 -41.35 98.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.625 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -65.87 -36.99 84.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.15 -23.25 64.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -86.1 -28.23 24.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.65 -0.656 . . . . 0.0 109.461 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.8 t80 -75.23 -25.49 58.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.507 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.82 -48.98 74.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -65.66 -25.7 67.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.566 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.08 -25.72 43.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.542 -0.724 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.0 mm100 -109.07 36.77 2.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.6 p -142.06 -29.3 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.32 132.49 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.592 -0.692 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.37 34.82 60.39 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -155.98 164.31 38.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.532 -0.981 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.87 117.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.44 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.6 ttp -97.6 108.34 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 t -93.67 120.08 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 109.428 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.47 161.78 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.512 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.73 -162.85 37.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 ptt85 -83.55 -35.8 24.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.956 . . . . 0.0 109.428 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -69.59 -38.66 77.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.697 -0.627 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.401 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 10.7 m -74.14 -28.64 61.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.483 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.49 -58.44 7.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -66.32 -21.58 66.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.586 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.6 m -63.1 -29.36 70.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.743 . . . . 0.0 109.543 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CZ ' HG21 ' A' ' 45' ' ' THR . 35.7 m-85 -64.83 161.64 44.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.86 -73.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 125.126 3.884 . . . . 0.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -107.03 95.57 5.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.625 -0.672 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -101.23 157.32 33.89 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.641 -0.662 . . . . 0.0 109.443 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.27 145.7 72.09 Favored 'Cis proline' 0 N--CA 1.508 2.365 0 O-C-N 123.385 1.203 . . . . 0.0 109.903 0.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.2 mt -62.59 116.1 21.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.289 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.92 178.47 7.51 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 124.762 3.641 . . . . 0.0 109.929 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 61.02 29.44 18.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.516 -0.74 . . . . 0.0 109.638 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.11 -169.27 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.706 . . . . 0.0 109.527 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -118.06 130.19 56.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.525 -0.735 . . . . 0.0 109.437 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -107.61 100.56 9.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.491 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -99.55 105.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.56 -0.713 . . . . 0.0 109.449 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.42 122.05 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.3 tp -101.38 118.16 36.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.624 -0.673 . . . . 0.0 109.534 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -144.32 154.37 42.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.479 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -95.11 -38.87 10.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.579 -0.7 . . . . 0.0 109.479 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -72.1 131.61 43.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.613 -0.68 . . . . 0.0 109.433 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.97 30.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -103.21 -33.21 9.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -69.69 143.3 53.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -142.14 146.09 34.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.69 . . . . 0.0 109.48 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.98 124.31 20.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -83.0 130.21 35.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.38 38.85 37.57 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.74 139.4 12.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.991 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -77.37 104.46 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.61 100.71 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -102.47 -176.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -142.93 30.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.489 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -161.06 142.54 11.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 t -65.18 -31.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.06 -34.54 78.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.05 81.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.643 -0.661 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.73 -41.22 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.42 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -71.94 -30.07 64.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.603 -0.686 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.42 87.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.71 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -71.44 -33.03 69.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.583 -0.698 . . . . 0.0 109.521 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.32 -29.98 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -66.42 -42.45 87.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.517 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -66.54 -28.41 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -119.21 90.01 40.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.643 -0.66 . . . . 0.0 109.453 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 -23.67 6.51 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 125.103 3.869 . . . . 0.0 109.843 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.58 -26.4 66.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -102.44 133.67 47.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -92.29 151.63 20.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.71 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 tp -87.43 143.93 26.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.555 -0.716 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -144.43 130.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.431 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG23 ' CD1' ' A' ' 103' ' ' PHE . 40.1 mm -94.65 125.36 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.94 -28.32 9.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.522 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.402 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 161.81 -177.57 38.01 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.85 -154.73 16.48 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.361 -1.67 . . . . 0.0 109.6 -0.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.58 78.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.953 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -75.09 -30.51 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 96' ' ' ILE . 18.4 m-85 -68.78 -50.65 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -64.21 -23.16 67.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.615 -0.678 . . . . 0.0 109.558 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.32 -52.11 37.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.6 -0.688 . . . . 0.0 109.615 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -86.46 6.16 31.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.567 -0.708 . . . . 0.0 110.037 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -66.04 -23.55 66.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -68.37 -42.43 79.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.598 -0.689 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.73 38.19 2.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.611 -0.68 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -79.97 152.76 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.583 -0.698 . . . . 0.0 109.342 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.15 -68.87 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.692 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -85.57 161.44 19.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.635 -0.665 . . . . 0.0 109.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.41 ' CD1' ' CE2' ' A' ' 136' ' ' PHE . 23.7 mt -141.63 88.32 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.549 -0.719 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.0 mt -89.44 120.65 30.95 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -132.63 142.77 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.7 m -109.98 103.17 11.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 0.0 109.329 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -85.71 132.22 34.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.0 109.603 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.9 132.73 53.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.371 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.9 -31.68 72.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.439 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.98 131.95 14.65 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.5 p -85.15 142.01 29.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.605 -0.938 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -144.86 126.26 14.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.604 -0.685 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -90.01 146.42 24.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.76 -128.89 2.02 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -143.62 -34.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.995 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.9 m -98.68 127.89 44.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 109.55 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -104.81 170.86 7.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.23 145.35 25.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.0 pt -66.91 164.78 31.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.505 -0.747 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.23 109.23 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.105 3.87 . . . . 0.0 109.891 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.08 149.42 21.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -84.46 86.35 7.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -73.36 -16.95 61.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.632 -0.668 . . . . 0.0 109.768 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.08 9.83 1.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.961 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -131.87 28.42 4.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' A' ' 113' ' ' LEU . 54.5 m-85 -138.48 179.86 6.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.45 122.01 7.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.505 -0.747 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -70.25 121.3 17.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.11 -37.4 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.478 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.4 p -158.62 169.33 24.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.545 -0.722 . . . . 0.0 109.528 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 81.4 p -158.35 129.63 6.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.607 -0.683 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -97.18 116.24 29.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.685 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.4 m -93.95 152.08 19.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.36 130.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -102.38 123.22 45.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.511 -0.743 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.45 -165.95 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.7 p -73.99 -39.9 63.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 0.0 109.604 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -99.85 137.57 20.19 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.25 -39.88 34.9 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 124.773 3.649 . . . . 0.0 110.015 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.07 -29.58 60.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.693 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.84 8.36 2.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.566 -0.709 . . . . 0.0 109.981 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.3 p -78.45 159.0 28.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.476 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -171.97 170.74 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.539 -0.725 . . . . 0.0 109.603 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.9 m -140.44 133.84 29.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -86.64 95.95 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 109.383 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -78.14 144.41 36.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.627 -0.671 . . . . 0.0 109.483 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 t -133.65 99.55 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 31.5 m95 -96.86 166.95 11.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.615 -0.678 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -146.0 138.82 25.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -68.5 102.01 1.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.715 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -149.62 117.25 6.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.483 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.28 107.05 14.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.446 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 3.7 m-85 -80.98 155.97 26.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.624 -0.673 . . . . 0.0 109.416 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.5 tp -168.78 121.56 0.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 44.0 p90 -147.31 130.1 16.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.508 -0.745 . . . . 0.0 109.584 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.91 109.77 18.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.266 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 6.6 pt20 -131.26 160.87 33.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.704 . . . . 0.0 109.72 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -109.86 169.45 8.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.672 -0.642 . . . . 0.0 109.465 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -60.72 -17.56 49.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.57 15.26 0.83 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.715 . . . . 0.0 109.798 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.25 33.75 87.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.8 tp -113.69 161.31 17.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.638 -0.919 . . . . 0.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.1 pt -134.21 -30.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.46 -174.45 38.5 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -166.38 124.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.91 32.48 21.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 109.752 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.19 -61.71 3.93 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -74.97 174.77 8.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.586 -0.949 . . . . 0.0 109.5 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 47.8 mt -89.7 156.02 47.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 109.426 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -79.59 -26.55 4.7 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 124.955 3.77 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HD2' ' A' ' 20' ' ' PRO . 36.7 p90 -108.59 165.76 11.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -115.13 101.5 9.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -122.76 79.23 48.87 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.84 -38.01 17.35 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 125.165 3.91 . . . . 0.0 110.197 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.83 -46.51 87.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.559 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -64.19 -36.9 85.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.59 -24.99 67.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.664 . . . . 0.0 109.459 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -84.12 -29.35 26.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.605 -0.685 . . . . 0.0 109.437 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -71.73 -28.12 63.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.584 -0.697 . . . . 0.0 109.4 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -67.62 -44.96 76.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.554 -0.716 . . . . 0.0 109.518 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -66.0 -31.0 71.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -30.94 60.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.693 . . . . 0.0 109.437 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -97.9 33.25 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.3 p -139.55 -30.03 0.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.608 -0.682 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.63 128.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.38 69.94 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -145.67 165.79 27.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.565 -0.962 . . . . 0.0 109.449 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.8 mt -92.11 101.0 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.428 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.7 ttp -80.7 103.33 10.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.555 -0.715 . . . . 0.0 109.457 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.85 121.43 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.24 168.33 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.624 -0.673 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.67 -165.28 39.38 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -78.87 -43.49 24.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.936 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.493 HH22 HE21 ' A' ' 101' ' ' GLN . 10.8 ptp85 -68.73 -30.99 69.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 0.0 109.461 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -79.91 -29.15 39.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.68 -31.81 72.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.629 -0.669 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -94.18 -18.07 22.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.694 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -62.26 -23.43 66.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -66.43 159.77 70.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.15 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.066 3.844 . . . . 0.0 109.953 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.92 112.8 24.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.498 -0.751 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -108.46 158.64 33.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.518 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.69 -165.51 4.57 Favored 'Cis proline' 0 N--CA 1.509 2.382 0 O-C-N 123.372 1.196 . . . . 0.0 109.897 -0.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HB2' HD22 ' A' ' 59' ' ' ASN . 87.9 mt -114.97 94.4 38.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.585 -0.697 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -74.97 -175.89 2.59 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 124.819 3.679 . . . . 0.0 109.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 61.51 27.93 17.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.77 . . . . 0.0 109.52 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.23 -169.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -119.39 115.23 23.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.583 -0.698 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.454 HD22 ' HB2' ' A' ' 54' ' ' LEU . 1.7 m-80 -92.77 103.79 16.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.722 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -104.62 99.94 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.481 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.3 t -87.03 123.89 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.4 tp -101.11 115.83 31.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.651 -0.656 . . . . 0.0 109.502 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -145.98 146.61 31.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.705 -0.622 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -101.43 31.54 3.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.585 -0.697 . . . . 0.0 109.562 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -134.2 126.51 30.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -85.1 29.53 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.17 -35.65 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 109.515 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -69.55 157.76 36.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.62 -0.675 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -147.52 140.89 25.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.527 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.5 11.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.584 -0.698 . . . . 0.0 109.475 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -84.83 133.68 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.581 -0.7 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.74 41.21 35.13 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.02 159.82 36.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.928 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -94.07 94.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.612 -0.68 . . . . 0.0 109.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.7 t -79.01 99.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.363 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -97.21 159.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.458 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -139.23 28.68 2.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.695 . . . . 0.0 109.511 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -161.49 147.56 14.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.466 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.412 HG12 ' CE1' ' A' ' 106' ' ' PHE . 31.3 t -67.81 -33.64 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.722 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.31 73.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.653 -0.655 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.08 79.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 t -67.2 -46.57 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.591 -0.693 . . . . 0.0 109.463 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.91 -27.27 63.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.672 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.29 -36.89 85.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.558 -0.714 . . . . 0.0 109.437 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.21 -34.29 68.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 109.525 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.21 67.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -65.55 -42.39 91.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.22 -29.84 70.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.579 -0.7 . . . . 0.0 109.543 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -119.74 89.86 42.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.58 -0.7 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.99 -23.16 6.85 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.148 3.899 . . . . 0.0 109.943 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.07 -26.42 65.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.49 172.49 7.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -130.94 169.13 16.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tp -93.58 131.94 38.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -128.03 127.12 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.463 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 103' ' ' PHE . 40.0 mm -103.41 118.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.54 -25.37 11.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.498 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.74 -179.04 40.83 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.85 -157.08 28.5 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.328 -1.689 . . . . 0.0 109.542 -0.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.97 -30.53 71.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.623 -0.928 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.493 HE21 HH22 ' A' ' 44' ' ' ARG . 46.0 mt-30 -73.24 -32.76 64.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.441 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -70.28 -36.87 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.552 -0.717 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE1' HG21 ' A' ' 96' ' ' ILE . 25.5 m-85 -63.77 -56.65 13.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -62.47 -16.05 53.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.604 -0.685 . . . . 0.0 109.83 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.42 -23.23 32.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.412 ' CE1' HG12 ' A' ' 79' ' ' VAL . 35.4 m-85 -121.06 18.12 11.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.809 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -66.27 -31.36 72.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.554 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.0 26.65 0.42 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.694 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.05 34.13 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.542 -0.724 . . . . 0.0 109.485 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -102.23 159.37 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -141.83 -50.43 0.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.674 -0.641 . . . . 0.0 109.345 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -105.75 109.28 21.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 0.0 109.335 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.1 mt -93.61 110.26 21.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.585 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.8 mt -105.74 101.96 11.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.596 -0.69 . . . . 0.0 109.298 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -107.71 132.74 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.669 -0.645 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.406 HG22 ' CE1' ' A' ' 155' ' ' TYR . 20.5 m -106.91 96.51 6.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.564 -0.71 . . . . 0.0 109.244 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -82.39 150.16 27.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.648 -0.658 . . . . 0.0 109.704 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.35 142.39 50.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.634 -0.666 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.69 -34.83 62.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.556 -0.715 . . . . 0.0 109.453 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.41 136.29 22.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.9 p -86.7 143.63 27.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.994 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -144.92 138.62 27.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.3 152.96 18.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.546 -0.721 . . . . 0.0 109.52 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.97 -128.76 1.04 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.05 -34.37 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.946 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -89.85 149.52 22.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.624 -0.673 . . . . 0.0 109.521 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -130.89 167.85 18.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 11.4 tpt -88.14 151.57 22.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.54 -0.725 . . . . 0.0 109.479 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.3 pt -76.06 163.62 65.47 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.595 -0.69 . . . . 0.0 109.509 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.16 104.78 1.69 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.172 3.915 . . . . 0.0 109.902 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.2 mt -97.43 144.5 27.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.16 88.44 7.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -67.15 -14.97 63.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.575 -0.703 . . . . 0.0 109.831 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.58 -26.02 68.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.478 -0.764 . . . . 0.0 109.531 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.65 30.46 2.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -143.84 171.3 14.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.533 -0.73 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.9 m -144.34 136.38 26.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.545 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -74.12 150.26 40.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.38 -35.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.56 -0.712 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -142.37 165.64 26.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.6 t -164.43 119.65 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.48 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -99.56 106.07 18.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.528 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 m -93.14 141.05 28.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.671 . . . . 0.0 109.42 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.402 ' CG1' ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -150.32 135.03 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.94 125.4 54.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.2 -165.94 0.95 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.4 p -70.85 -38.32 73.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.554 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.26 137.71 19.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.598 -0.689 . . . . 0.0 109.37 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.74 -44.14 27.21 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 124.829 3.686 . . . . 0.0 110.065 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.32 72.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.68 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.2 mt -80.74 21.1 0.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.569 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 38.0 m -91.74 142.67 27.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.39 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.402 ' NE2' ' CG1' ' A' ' 144' ' ' VAL . 35.9 p-80 -155.45 168.95 25.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -141.95 131.35 23.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 109.419 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.406 ' CE1' HG22 ' A' ' 116' ' ' THR . 99.7 m-85 -91.12 95.21 9.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.732 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.457 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 22.5 mt-10 -78.2 130.76 36.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.608 -0.683 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.1 t -115.39 110.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.457 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 36.8 m95 -108.48 165.67 11.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.584 -0.698 . . . . 0.0 109.458 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -143.36 138.87 29.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.651 -0.656 . . . . 0.0 109.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.74 95.97 4.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.417 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -93.09 120.6 33.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.571 -0.705 . . . . 0.0 109.532 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.449 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.407 ' H2 ' ' HG1' ' A' ' 1' ' ' THR . 6.3 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.47 130.96 23.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 110' ' ' VAL . 7.7 m-85 -96.37 162.14 13.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.733 . . . . 0.0 109.479 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.6 tp -168.97 107.33 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.597 -0.689 . . . . 0.0 109.301 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.421 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.04 143.14 31.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.55 -0.719 . . . . 0.0 109.811 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.09 112.5 24.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.648 -0.658 . . . . 0.0 109.245 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -134.16 149.79 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -98.7 170.17 8.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.499 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -60.96 -17.26 50.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.558 -0.714 . . . . 0.0 109.943 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -76.83 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.493 -0.754 . . . . 0.0 109.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.21 36.43 92.99 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 tp -111.59 162.36 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 13' ' ' ILE . 32.3 pt -137.13 -30.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.508 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.12 -172.8 34.74 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -168.98 124.96 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.933 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.08 28.04 17.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.01 -63.55 1.47 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -75.45 -171.65 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.602 -0.94 . . . . 0.0 109.468 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 31.5 mt -92.58 156.89 40.81 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.58 -0.7 . . . . 0.0 109.423 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.1 Cg_endo -80.22 -28.67 2.91 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.015 3.81 . . . . 0.0 109.882 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.42 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 36.7 p90 -106.75 -172.27 2.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -138.65 94.8 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.614 -0.679 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.3 tp -116.12 83.36 12.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.56 -38.34 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.123 3.882 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.99 -40.97 99.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -69.25 -28.4 66.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.457 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.24 -23.47 57.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.621 -0.674 . . . . 0.0 109.542 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -86.82 -28.87 22.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.729 . . . . 0.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -71.04 -27.08 63.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -64.35 -47.8 77.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.627 -0.67 . . . . 0.0 109.47 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -66.6 -5.27 10.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.611 -0.681 . . . . 0.0 109.974 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.08 -34.47 12.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.512 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -106.28 35.48 2.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.466 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.6 p -133.37 -32.8 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.527 -0.733 . . . . 0.0 109.493 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.7 129.58 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 37.3 57.15 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -155.15 164.94 38.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.484 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -92.37 110.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.3 ttp -88.81 107.6 19.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -94.57 119.42 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.468 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.95 164.49 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.718 . . . . 0.0 109.5 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.38 -165.36 40.42 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtm105 -80.52 -38.43 29.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.95 . . . . 0.0 109.471 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -70.05 -32.98 71.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.58 -0.7 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 m -79.17 -28.5 42.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.465 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.65 -34.19 77.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.471 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -86.7 -25.48 24.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -62.89 -23.23 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -62.92 162.83 19.18 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.18 -63.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.125 3.883 . . . . 0.0 109.922 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -124.12 111.55 16.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.543 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -108.52 157.37 36.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.405 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.83 146.51 72.18 Favored 'Cis proline' 0 N--CA 1.508 2.36 0 O-C-N 123.396 1.208 . . . . 0.0 109.982 0.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.447 ' HB2' HD22 ' A' ' 59' ' ' ASN . 68.6 mt -67.51 112.93 11.61 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.368 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -78.24 179.91 6.06 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 124.793 3.662 . . . . 0.0 109.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 61.22 27.65 17.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.665 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -177.13 -173.32 0.45 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.493 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -116.16 120.11 37.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.711 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.447 HD22 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -95.53 107.72 19.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.668 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.1 116.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.424 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -102.1 122.7 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.606 -0.684 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 tp -99.22 110.93 23.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.74 142.82 31.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -97.65 30.98 2.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -125.81 138.39 53.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.71 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.75 29.84 2.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.31 -40.18 5.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.611 -0.681 . . . . 0.0 109.454 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -73.17 136.98 44.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -141.48 102.88 4.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.75 117.43 23.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -76.92 133.28 39.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.571 -0.705 . . . . 0.0 109.424 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 37.52 59.55 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.47 142.83 19.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.965 . . . . 0.0 109.494 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -75.4 95.96 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.0 t -80.22 102.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.528 -0.732 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.33 158.7 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.488 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -139.68 29.56 2.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.693 . . . . 0.0 109.459 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -162.18 147.29 12.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 106' ' ' PHE . 31.1 t -67.97 -35.3 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.454 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.58 70.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.53 81.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.473 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.0 t -68.34 -40.72 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -75.67 -30.24 59.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -36.96 84.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.56 -41.92 75.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.622 -0.674 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 109.48 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -65.12 -45.31 85.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.57 -0.706 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -67.48 -27.08 66.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.469 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.82 89.82 39.02 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.678 . . . . 0.0 109.463 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.93 -23.14 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 125.06 3.84 . . . . 0.0 109.893 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.69 -26.79 66.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -91.27 179.94 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.34 150.64 46.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.7 tp -93.67 126.4 38.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 t -133.16 127.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.716 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.42 HG21 ' CE1' ' A' ' 103' ' ' PHE . 39.7 mm -91.42 127.64 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.85 -23.83 10.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.562 -0.711 . . . . 0.0 109.59 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.92 -178.15 37.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.493 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -82.6 -154.37 14.92 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 120.389 -1.654 . . . . 0.0 109.587 -0.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.53 77.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.579 -0.954 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -73.15 -27.2 61.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.493 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -73.94 -35.44 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.723 . . . . 0.0 109.479 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 96' ' ' ILE . 24.1 m-85 -63.26 -53.71 48.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -62.71 -21.98 66.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.59 -0.694 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.91 -30.84 67.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.741 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CE1' HG11 ' A' ' 79' ' ' VAL . 59.9 m-85 -116.06 16.89 16.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -22.85 64.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.651 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -70.19 -45.51 66.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -97.04 40.3 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.456 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 3' ' ' PHE . 9.0 p -89.38 143.95 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -128.53 -65.63 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.668 . . . . 0.0 109.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.5 m -89.86 164.58 14.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 33.4 mt -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.564 -0.71 . . . . 0.0 109.58 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.9 mt -91.21 104.25 16.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.421 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -115.47 137.99 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -107.77 102.69 11.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.68 . . . . 0.0 109.336 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mmm-85 -88.23 135.22 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.99 140.69 42.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.69 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.62 -29.63 61.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.416 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.93 126.08 8.65 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 p -72.57 143.25 48.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.939 . . . . 0.0 109.452 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -148.98 121.55 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 109.432 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -96.51 149.25 21.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.54 -120.78 1.13 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -145.95 -33.94 0.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.631 -0.923 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.2 m -93.9 146.28 24.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -125.53 174.32 8.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.6 tpt -97.55 152.14 19.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.2 pt -74.67 163.9 65.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.14 94.18 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.115 3.876 . . . . 0.0 109.873 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.57 154.28 28.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.6 -0.688 . . . . 0.0 109.486 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -87.14 86.08 7.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.587 -0.696 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.401 ' C ' ' H ' ' A' ' 135' ' ' ASP . 96.7 m95 -71.47 -18.49 62.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.6 -0.688 . . . . 0.0 109.725 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -74.12 10.08 1.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 133' ' ' TRP . 9.2 t70 -132.68 29.62 4.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.0 109.472 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -138.95 -180.0 6.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.629 -0.669 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -148.59 125.5 11.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 109.441 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -78.44 126.36 30.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.07 -35.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.612 -0.68 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.2 t -162.31 -177.79 5.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 98.3 p -163.88 132.56 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -95.73 100.74 12.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.4 m -82.72 148.79 27.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.58 131.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.313 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -108.36 120.22 41.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.451 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.01 -165.3 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 p -72.99 -42.96 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.61 -0.681 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -100.01 137.97 20.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.4 -47.62 17.19 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 124.832 3.688 . . . . 0.0 110.092 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.02 70.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.569 -0.707 . . . . 0.0 109.664 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.8 mt -78.82 17.58 0.7 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 109.741 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.5 m -90.54 144.36 25.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.755 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -159.68 170.14 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.56 -0.712 . . . . 0.0 109.574 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.5 m -139.92 135.66 33.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.39 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -91.32 92.02 8.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.564 -0.71 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.463 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 44.0 mt-10 -77.1 128.36 34.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.544 -0.722 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.8 t -114.76 99.49 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.484 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.463 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 35.5 m95 -95.03 164.31 12.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.7 . . . . 0.0 109.445 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -148.66 136.11 20.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -65.58 126.31 27.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.724 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.99 99.15 2.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.64 -0.662 . . . . 0.0 109.483 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.449 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.401 ' C17' HN52 ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.73 127.76 33.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.557 -0.714 . . . . 0.0 109.467 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.445 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.5 m-85 -100.18 143.93 29.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.532 -0.73 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.4 ' CD1' ' CB ' ' A' ' 114' ' ' LEU . 7.7 tp -156.59 111.51 2.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.33 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.417 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.93 141.22 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.545 -0.722 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.97 112.81 24.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.207 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.89 157.82 44.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -107.53 170.01 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 109.46 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -60.89 -18.31 55.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.551 -0.718 . . . . 0.0 109.871 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.42 15.09 0.82 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.77 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 35.77 91.9 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 tp -111.34 162.01 15.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.978 . . . . 0.0 109.535 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 13' ' ' ILE . 31.9 pt -136.28 -30.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.493 -0.754 . . . . 0.0 109.58 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.34 -170.28 31.04 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -168.8 117.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.584 -0.951 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.1 30.74 20.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.698 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.83 -61.85 2.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -75.03 165.15 25.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.975 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.9 mt -78.09 156.9 79.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.721 . . . . 0.0 109.421 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.7 Cg_endo -80.34 -28.58 2.88 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 124.996 3.797 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.421 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 34.2 p90 -107.53 -170.94 1.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -140.68 96.96 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -117.09 81.11 12.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.76 -40.85 19.59 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 125.095 3.863 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -62.48 -52.25 64.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 109.63 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.1 -35.94 81.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.0 mt -63.12 -23.8 67.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.539 -0.726 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -85.52 -29.16 24.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 12.4 t80 -64.78 -25.72 68.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.647 -0.658 . . . . 0.0 109.528 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.64 -46.05 84.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.591 -0.693 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -65.12 -31.84 73.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 109.465 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.93 -29.03 58.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.565 -0.709 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 22.4 mm100 -100.4 34.17 2.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.4 p -140.46 -34.87 0.51 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.581 -0.699 . . . . 0.0 109.525 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -70.98 124.94 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.687 -0.633 . . . . 0.0 109.508 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.21 34.4 20.73 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.442 ' HZ1' ' HB2' ' A' ' 93' ' ' GLU . 44.2 mttm -156.29 168.23 27.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.498 -1.001 . . . . 0.0 109.516 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.5 mt -90.54 104.61 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.649 -0.657 . . . . 0.0 109.469 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 tmm? -77.22 120.58 22.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 t -126.81 122.57 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.524 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 m -135.12 -174.28 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.79 -170.33 26.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -77.59 -40.01 43.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.525 -0.985 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.19 -36.3 74.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.638 -0.664 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -73.09 -28.12 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -63.7 -47.45 81.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HA ' HH21 ' A' ' 52' ' ' ARG . 25.1 mt-10 -71.97 -25.73 61.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -62.51 -21.64 65.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.571 -0.705 . . . . 0.0 109.587 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -62.44 164.37 11.87 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.03 -65.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.167 3.911 . . . . 0.0 110.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -128.33 103.97 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.523 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -88.92 157.38 48.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.653 . . . . 0.0 109.421 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.35 -168.95 7.07 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.361 1.19 . . . . 0.0 110.035 0.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.2 mt -112.96 96.32 37.76 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.421 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -69.54 176.48 6.54 Favored 'Trans proline' 0 N--CA 1.505 2.206 0 C-N-CA 124.592 3.528 . . . . 0.0 109.831 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 62.04 21.79 12.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.533 -0.729 . . . . 0.0 109.639 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -177.52 156.6 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.72 . . . . 0.0 109.458 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -79.46 152.36 30.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 109.54 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -130.32 114.76 16.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -116.52 103.98 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.654 -0.654 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.6 123.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 tp -94.99 108.69 20.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.416 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.418 HG21 ' CE1' ' A' ' 77' ' ' HIS . 3.9 t -136.56 152.8 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.46 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -104.44 -22.73 13.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.69 -0.631 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.88 134.31 48.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.686 . . . . 0.0 109.419 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.38 31.9 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.637 -0.664 . . . . 0.0 109.455 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -121.56 -30.6 4.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -67.79 144.44 55.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.742 . . . . 0.0 109.395 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -147.97 102.67 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.524 -0.735 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.42 117.96 25.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -78.19 133.77 37.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.685 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.69 35.95 44.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -159.22 151.48 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.611 -0.934 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -81.38 95.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.72 . . . . 0.0 109.439 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -76.7 97.72 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.55 170.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.579 -0.701 . . . . 0.0 109.501 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.418 ' CE1' HG21 ' A' ' 63' ' ' THR . 75.9 m-70 -146.15 30.23 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -168.3 144.7 3.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 t -66.48 -33.2 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.84 74.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.64 -0.662 . . . . 0.0 109.469 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.19 -35.63 78.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.629 -0.669 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.3 t -67.11 -42.28 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.635 -0.666 . . . . 0.0 109.519 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -68.94 -29.63 67.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.47 82.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.09 -33.62 72.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.57 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.641 -0.662 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.88 -40.93 92.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -67.36 -31.12 71.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -120.19 90.03 44.07 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.12 -22.98 6.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.104 3.869 . . . . 0.0 109.893 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.33 -25.29 64.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.718 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -103.72 141.09 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.442 ' HB2' ' HZ1' ' A' ' 37' ' ' LYS . 36.9 mt-10 -97.36 164.79 12.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.629 -0.669 . . . . 0.0 109.478 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.6 tp -93.17 132.1 37.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.53 -0.731 . . . . 0.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -134.5 126.81 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.458 HG22 HD11 ' A' ' 96' ' ' ILE . 41.1 mm -99.67 127.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.672 -0.643 . . . . 0.0 109.429 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.5 -22.36 12.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.586 -0.696 . . . . 0.0 109.611 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.3 -176.51 39.48 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.495 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.98 -154.23 18.49 Favored Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.353 -1.675 . . . . 0.0 109.533 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.9 77.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 109.502 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -72.49 -26.01 61.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.581 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.495 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -74.68 -36.56 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.555 -0.716 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -63.21 -51.0 68.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 m -63.17 -24.31 67.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.704 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.49 75.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.678 . . . . 0.0 109.487 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -102.13 12.62 36.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.606 -0.684 . . . . 0.0 109.759 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -70.75 -28.75 64.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.464 -0.773 . . . . 0.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -65.65 -31.6 72.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.715 . . . . 0.0 109.569 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -119.49 37.95 4.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.49 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.445 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -84.78 156.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.34 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.25 -68.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.597 -0.689 . . . . 0.0 109.482 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -88.55 161.9 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' A' ' 136' ' ' PHE . 26.9 mt -143.5 92.38 2.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.634 -0.666 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.4 ' CB ' ' CD1' ' A' ' 4' ' ' LEU . 50.8 mt -90.52 112.53 24.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.0 109.401 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.417 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -118.69 133.51 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.426 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -104.94 96.7 6.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.697 . . . . 0.0 109.321 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -82.42 138.73 34.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.7 . . . . 0.0 109.578 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.8 134.55 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.41 87.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.533 -0.729 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.78 126.22 23.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.2 p -79.29 143.44 35.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.947 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -145.83 128.61 16.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.581 -0.699 . . . . 0.0 109.506 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.82 153.58 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.718 . . . . 0.0 109.495 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.64 -135.49 1.96 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -30.39 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 m -94.54 143.51 26.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 109.553 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.66 168.95 13.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.639 -0.663 . . . . 0.0 109.485 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.4 tpt -93.38 152.4 19.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.512 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -71.83 164.4 58.73 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.618 -0.677 . . . . 0.0 109.502 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 95.2 1.0 Allowed 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 125.165 3.91 . . . . 0.0 109.889 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.67 138.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.655 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -81.15 84.15 6.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.429 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -67.83 -15.92 63.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.785 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.48 -25.93 68.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.46 -33.95 20.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.662 -0.649 . . . . 0.0 109.443 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.417 ' CD2' HD11 ' A' ' 113' ' ' LEU . 96.3 m-85 -84.29 166.56 17.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.8 m -136.45 131.63 34.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -71.65 113.6 8.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.678 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.46 -38.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 109.494 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.1 m -153.37 166.37 32.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.563 -0.711 . . . . 0.0 109.494 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.9 p -160.8 134.24 6.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.583 -0.698 . . . . 0.0 109.44 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -100.41 113.4 26.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.9 m -94.81 142.39 27.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.697 . . . . 0.0 109.489 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -151.1 147.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.697 . . . . 0.0 109.352 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.27 132.76 48.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.441 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.58 -171.38 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -64.25 -34.96 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.649 . . . . 0.0 109.45 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -95.89 152.96 39.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.68 . . . . 0.0 109.293 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.08 -22.52 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.858 3.705 . . . . 0.0 109.909 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.93 -23.25 27.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.548 -0.72 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.8 mt -84.2 -1.32 54.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.503 -0.748 . . . . 0.0 109.99 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.7 m -63.35 146.07 54.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.485 -0.759 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -157.79 165.31 35.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.65 -0.656 . . . . 0.0 109.483 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.3 m -137.57 133.87 34.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.45 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -91.66 94.44 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.91 139.16 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.8 t -126.46 103.86 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.523 -0.736 . . . . 0.0 109.536 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -99.78 165.3 11.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -144.63 138.0 27.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -73.19 114.12 11.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.726 . . . . 0.0 109.483 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -150.42 107.91 3.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.505 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.468 -179.972 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.4 HN51 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.9 108.33 7.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 0.0 109.416 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.445 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.1 m-85 -84.44 123.88 30.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.438 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tp -138.58 112.97 8.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.573 -0.705 . . . . 0.0 109.274 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.414 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -142.25 140.53 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 0.0 109.801 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.58 112.47 23.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.527 -0.733 . . . . 0.0 109.287 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.23 152.88 51.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.509 -0.744 . . . . 0.0 109.717 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -102.85 170.41 8.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLY . 11.5 ptm180 -60.78 -18.44 55.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.626 -0.671 . . . . 0.0 109.896 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 14.22 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.501 -0.749 . . . . 0.0 109.838 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' ARG . . . 62.28 37.05 93.94 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 4.6 tp -111.48 165.88 11.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.956 . . . . 0.0 109.487 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.448 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 2.5 pp -138.14 -41.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.506 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.67 -179.31 37.95 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -162.11 125.92 3.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.947 . . . . 0.0 109.471 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 59.75 30.8 20.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.534 -0.729 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.57 -60.49 4.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -75.22 168.17 20.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.951 . . . . 0.0 109.503 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 25.0 mt -81.74 156.4 70.33 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.21 -29.39 2.56 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.012 3.808 . . . . 0.0 109.847 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 32.8 p90 -107.25 173.85 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 109.521 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -124.05 106.06 10.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 tp -126.77 81.18 69.51 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.24 -39.36 15.71 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 125.213 3.942 . . . . 0.0 110.253 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.92 -47.17 84.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.516 -0.74 . . . . 0.0 109.491 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -64.58 -31.46 72.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.71 . . . . 0.0 109.496 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.75 -24.44 63.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -86.65 -29.68 22.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.468 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -69.81 -24.43 63.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.612 -0.68 . . . . 0.0 109.536 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -63.35 -45.82 89.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -65.2 -29.21 70.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.525 -0.734 . . . . 0.0 109.461 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.52 -29.39 56.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.358 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -100.74 34.8 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -143.33 -35.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.634 -0.666 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.66 124.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.496 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.31 33.96 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -156.32 166.93 32.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.954 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.63 99.68 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.343 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -72.57 134.39 45.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 t -138.32 117.8 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.579 -0.701 . . . . 0.0 109.46 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.67 -174.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.558 -0.714 . . . . 0.0 109.427 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.93 -168.32 32.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -81.78 -34.32 30.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -71.29 -38.52 71.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.597 -0.689 . . . . 0.0 109.399 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -75.43 -27.68 59.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 40.3 t80 -64.89 -42.4 94.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -75.09 -23.3 57.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.4 m -63.24 -26.13 68.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.89 161.66 44.67 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.72 -61.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.082 3.855 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -125.55 103.14 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.449 ' H ' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -104.73 154.79 38.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.439 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.6 154.71 88.74 Favored 'Cis proline' 0 N--CA 1.508 2.362 0 O-C-N 123.388 1.204 . . . . 0.0 109.827 0.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.1 mt -72.73 131.26 84.42 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -80.11 170.25 16.64 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.687 3.591 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.04 27.31 17.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -177.47 155.1 1.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.525 -0.734 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -84.92 134.22 34.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -105.6 105.08 14.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.546 -0.721 . . . . 0.0 109.465 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.9 147.54 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.435 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 t -137.15 119.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 109.476 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.7 tp -98.95 116.84 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.06 140.02 39.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.401 ' CD2' ' HG3' ' A' ' 65' ' ' GLN . 12.4 p-80 -81.63 -27.33 34.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.561 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.401 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 59.4 mt-30 -71.51 137.51 48.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.649 -0.657 . . . . 0.0 109.426 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -94.28 31.69 1.67 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.686 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -121.79 -31.37 3.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.536 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -67.94 138.7 56.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -144.47 158.57 43.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.632 -0.667 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' H ' HG23 ' A' ' 75' ' ' VAL . . . -137.59 129.67 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -84.53 136.5 33.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.583 -0.698 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.7 36.8 75.98 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.91 158.82 38.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.599 -0.942 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 t -95.06 92.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.613 -0.679 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 70' ' ' ALA . 29.1 t -74.4 104.83 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.474 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.7 153.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.493 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -136.14 28.41 3.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -161.27 149.55 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.708 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.414 HG11 ' CE1' ' A' ' 106' ' ' PHE . 31.0 t -68.92 -35.24 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.555 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.99 65.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.572 -0.705 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.99 86.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.9 t -68.15 -45.08 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.525 -0.735 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.95 -29.25 66.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.628 -0.67 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.01 82.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.4 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -71.33 -33.94 70.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.606 -0.684 . . . . 0.0 109.455 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.29 67.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.596 -0.69 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -65.92 -39.35 90.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.661 -0.65 . . . . 0.0 109.502 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.8 -32.11 72.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.523 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -121.71 89.49 47.72 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 -22.36 7.02 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.094 3.863 . . . . 0.0 109.891 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -65.53 -26.49 67.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -97.95 179.16 4.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.659 -0.65 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -137.32 150.1 47.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.3 tp -76.31 134.98 39.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.577 -0.702 . . . . 0.0 109.473 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.24 122.8 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.581 -0.7 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 96' ' ' ILE . 41.3 mm -97.02 142.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.641 . . . . 0.0 109.402 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -121.28 -30.95 4.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.713 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.56 178.78 37.5 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.86 -151.9 20.87 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.364 -1.668 . . . . 0.0 109.534 0.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.52 -26.51 65.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.963 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -68.94 -31.97 71.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 109.541 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.2 -40.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.689 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.414 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 31.3 m-85 -63.06 -47.18 84.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.96 -23.59 66.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.554 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.75 -29.6 51.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE1' HG11 ' A' ' 79' ' ' VAL . 43.7 m-85 -114.5 20.26 15.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -63.1 -36.74 84.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.605 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -81.11 29.72 0.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.603 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -160.01 33.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.585 -0.697 . . . . 0.0 109.486 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.445 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.1 p -94.7 153.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.714 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.58 -61.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.308 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -96.42 111.75 23.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.603 -0.686 . . . . 0.0 109.342 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.1 mt -95.66 98.43 10.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.573 -0.705 . . . . 0.0 109.626 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.3 mt -99.21 104.48 16.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 109.214 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.414 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -111.57 140.79 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.598 -0.689 . . . . 0.0 109.565 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.6 m -110.17 97.7 7.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 109.245 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -80.44 151.13 29.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mp -127.53 136.16 51.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.242 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.72 -32.77 71.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.05 128.88 10.25 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.7 p -81.38 144.44 31.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -147.27 121.74 9.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.619 -0.676 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.99 149.8 27.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.705 . . . . 0.0 109.522 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.05 -141.26 3.42 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.7 -30.76 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.558 -0.966 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.1 m -102.97 130.22 49.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.581 -0.699 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -108.43 175.23 5.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.573 -0.704 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -93.93 152.47 18.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.6 pt -75.19 164.29 62.2 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.78 98.08 1.11 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.178 3.919 . . . . 0.0 109.844 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.85 145.32 27.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.612 -0.68 . . . . 0.0 109.507 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -85.07 87.03 7.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.614 -0.679 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -73.26 -9.94 59.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.58 -31.26 72.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.4 36.7 1.44 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -143.28 167.81 21.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.536 -0.728 . . . . 0.0 109.452 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -144.76 145.84 31.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 109.45 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -75.28 152.66 38.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.28 -32.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -149.6 154.92 39.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 t -157.1 110.49 2.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.585 -0.697 . . . . 0.0 109.498 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -100.68 110.88 23.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.6 m -92.07 146.43 23.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.671 . . . . 0.0 109.402 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -150.47 132.1 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.552 -0.717 . . . . 0.0 109.329 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -107.61 123.47 48.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.685 . . . . 0.0 109.478 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.35 -165.52 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.583 -0.698 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -71.19 -39.55 71.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.89 137.7 19.36 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.551 -0.718 . . . . 0.0 109.408 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.39 -46.64 22.62 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 124.755 3.637 . . . . 0.0 110.052 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.92 69.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.73 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -80.2 20.53 0.66 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.711 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.7 m -89.45 141.32 28.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.408 -0.807 . . . . 0.0 109.354 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.418 ' CE1' HG12 ' A' ' 144' ' ' VAL . 34.9 p-80 -152.87 164.88 37.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.559 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.7 m -137.73 132.63 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.15 93.03 9.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.623 -0.673 . . . . 0.0 109.483 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.46 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 56.0 mm-40 -78.51 130.76 36.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.2 t -119.94 112.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.582 -0.699 . . . . 0.0 109.475 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.46 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.9 m95 -110.84 157.5 19.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.518 -0.739 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -141.38 143.06 33.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -75.3 113.17 12.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.603 -0.685 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 141.63 24.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.571 -0.706 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.491 -179.984 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.05 101.45 8.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CD1' ' CG2' ' A' ' 110' ' ' VAL . 6.7 m-85 -74.73 126.89 31.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.513 -0.742 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.3 tp -140.11 112.99 8.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 109.313 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.407 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.7 p90 -142.67 141.92 31.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 0.0 109.731 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.81 112.53 24.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.576 -0.702 . . . . 0.0 109.213 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.13 149.42 52.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.607 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -97.41 170.14 9.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.619 -0.676 . . . . 0.0 109.452 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.55 -18.58 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.872 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.38 15.4 0.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 0.0 109.855 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.1 34.38 88.83 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 13' ' ' ILE . 4.5 tp -107.54 165.25 11.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.596 -0.944 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.439 HG22 HD11 ' A' ' 13' ' ' ILE . 31.8 pt -138.61 -29.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.476 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.71 -168.85 33.05 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -174.43 124.35 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.49 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 60.03 33.56 21.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.51 -0.744 . . . . 0.0 109.735 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.35 4.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -76.03 176.11 8.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.548 -0.972 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.409 HD21 ' CZ2' ' A' ' 21' ' ' TRP . 19.3 mt -86.92 156.59 55.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.707 . . . . 0.0 109.41 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -80.59 -31.51 1.5 Allowed 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.0 3.8 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 31.4 p90 -104.96 167.11 9.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.56 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -117.79 100.27 7.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.606 -0.684 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.7 tp -122.02 81.76 43.44 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.25 -38.89 15.38 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 125.181 3.92 . . . . 0.0 110.307 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.78 -41.34 99.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.528 -0.732 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.63 -31.58 72.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.642 -0.661 . . . . 0.0 109.422 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.05 -23.7 61.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.589 -0.695 . . . . 0.0 109.531 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -86.81 -29.8 22.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.567 -0.708 . . . . 0.0 109.452 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -70.97 -25.94 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -65.42 -45.23 84.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.661 . . . . 0.0 109.446 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -64.98 -29.3 70.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.475 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.69 51.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.642 -0.661 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -97.77 33.13 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.3 p -137.37 -34.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.6 m -68.62 126.17 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.557 -0.714 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 36.28 23.58 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -153.24 166.21 33.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.521 -0.988 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.42 102.0 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.598 -0.689 . . . . 0.0 109.447 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.1 tmm? -70.38 125.72 27.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.58 -0.7 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 t -131.9 115.5 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.631 -0.668 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.7 m -135.45 -177.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.702 . . . . 0.0 109.458 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.3 -178.62 35.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -72.27 -31.86 66.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.576 -0.955 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.22 -48.23 62.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -68.64 -25.95 65.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -68.54 -33.92 74.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.708 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.14 -26.15 19.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 t -74.9 10.11 1.59 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -81.76 166.42 37.7 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.83 -73.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.103 3.868 . . . . 0.0 109.968 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -118.23 71.94 0.85 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.55 -0.719 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -72.19 156.82 90.25 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.12 -175.86 17.48 Favored 'Cis proline' 0 N--CA 1.508 2.378 0 O-C-N 123.377 1.198 . . . . 0.0 109.946 0.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.415 ' HB2' HD22 ' A' ' 59' ' ' ASN . 84.2 mt -107.73 104.25 52.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -74.56 179.83 5.55 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 124.645 3.564 . . . . 0.0 109.813 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.95 28.06 17.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.572 -0.705 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -176.1 178.76 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.416 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 m -98.47 117.47 32.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.464 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.415 HD22 ' HB2' ' A' ' 54' ' ' LEU . 21.3 m120 -88.78 105.99 18.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -114.9 141.37 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 109.438 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -131.94 123.49 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.2 tp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.523 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.65 140.13 34.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.63 -0.669 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -94.74 29.74 2.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -147.56 142.46 26.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 109.442 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -88.65 30.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.703 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.57 -35.15 9.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -77.18 134.57 38.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.515 -0.74 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -146.29 116.41 7.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.47 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' H ' HG23 ' A' ' 75' ' ' VAL . . . -106.68 131.98 53.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.473 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -84.66 138.42 32.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.562 -0.711 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.17 38.05 59.36 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.5 144.25 16.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.529 -0.983 . . . . 0.0 109.553 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -79.84 95.66 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.587 -0.696 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 70' ' ' ALA . 30.0 t -79.99 106.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.88 150.82 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -131.65 30.03 4.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.679 . . . . 0.0 109.464 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -163.87 144.55 8.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.454 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG12 ' CE1' ' A' ' 106' ' ' PHE . 29.8 t -67.57 -32.95 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.585 -0.697 . . . . 0.0 109.476 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -32.96 72.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.667 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.86 75.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.0 t -69.19 -44.14 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.42 -30.2 65.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.565 -0.71 . . . . 0.0 109.426 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.15 79.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.681 -0.637 . . . . 0.0 109.474 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -71.3 -33.45 69.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.553 -0.717 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.47 -31.16 65.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.92 -45.91 69.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.594 -0.692 . . . . 0.0 109.484 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -66.19 -26.79 67.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.552 -0.717 . . . . 0.0 109.509 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -118.94 89.75 39.38 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 -22.49 6.98 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.126 3.884 . . . . 0.0 109.984 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -65.82 -26.02 67.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.603 -0.686 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -104.24 179.46 4.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.512 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -140.36 150.61 44.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.653 -0.654 . . . . 0.0 109.462 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.6 tp -75.28 137.84 41.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 109.486 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -144.24 116.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.656 -0.652 . . . . 0.0 109.473 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 96' ' ' ILE . 40.5 mm -91.74 128.73 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.698 . . . . 0.0 109.379 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.13 -31.03 8.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.86 178.83 38.49 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.52 -151.71 21.81 Favored Glycine 0 N--CA 1.499 2.855 0 O-C-N 120.362 -1.67 . . . . 0.0 109.632 0.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.5 68.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.965 . . . . 0.0 109.519 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -70.51 -30.6 67.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -76.01 -37.75 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.533 -0.729 . . . . 0.0 109.494 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.411 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 28.9 m-85 -63.64 -50.02 70.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.399 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 -24.92 68.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.656 -0.653 . . . . 0.0 109.497 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.19 69.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.406 ' CE1' HG12 ' A' ' 79' ' ' VAL . 77.6 m-85 -116.44 19.28 14.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -27.74 65.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.69 20.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.695 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -160.09 36.85 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.546 -0.721 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.441 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -96.99 141.31 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.589 -0.695 . . . . 0.0 109.473 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -122.03 -47.46 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.384 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.7 m -100.9 152.62 20.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.391 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.0 mt -136.12 96.95 3.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.624 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.2 mt -100.49 109.3 21.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.722 . . . . 0.0 109.292 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.407 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -119.23 141.98 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.0 m -109.21 103.08 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.58 -0.7 . . . . 0.0 109.267 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -88.22 138.88 31.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.702 . . . . 0.0 109.561 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.63 141.47 47.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.291 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.94 -32.35 63.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.503 -0.748 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.74 133.73 19.52 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.0 m -82.7 142.29 31.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.62 -0.929 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -148.04 119.22 7.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.668 . . . . 0.0 109.482 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -87.53 145.23 26.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.586 -0.697 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.72 -127.68 2.36 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -143.19 -32.59 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.951 . . . . 0.0 109.438 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.3 m -105.1 136.94 43.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -113.14 175.5 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.605 -0.684 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.6 tpt -92.13 152.61 19.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.528 -0.732 . . . . 0.0 109.558 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 pt -72.55 164.75 57.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.71 98.38 1.14 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 125.112 3.875 . . . . 0.0 109.919 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.56 147.0 26.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -84.45 84.81 7.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.558 -0.714 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -67.83 -19.31 65.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.718 . . . . 0.0 109.684 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -24.97 67.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -97.42 29.35 3.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -143.57 175.2 10.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -149.47 144.28 26.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -84.43 114.75 22.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.47 -34.0 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.523 -0.736 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -155.41 171.45 19.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.726 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 t -164.51 127.64 2.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -98.7 111.91 24.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.556 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 m -91.29 145.38 24.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -149.24 125.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.509 -0.744 . . . . 0.0 109.345 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -104.79 121.32 43.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.61 -0.681 . . . . 0.0 109.436 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.56 -165.11 0.81 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.3 p -73.32 -40.7 64.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.723 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -103.45 137.58 19.29 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.61 -44.34 26.11 Favored 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 124.826 3.684 . . . . 0.0 110.093 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.7 71.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.631 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.97 19.43 1.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 109.66 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.4 m -91.13 134.29 34.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.543 -0.723 . . . . 0.0 109.437 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.41 ' CE1' HG12 ' A' ' 144' ' ' VAL . 37.4 p-80 -150.01 167.23 27.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -137.32 136.48 38.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -89.44 95.45 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.446 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.6 mt-10 -76.67 135.6 39.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.552 -0.717 . . . . 0.0 109.453 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.9 t -126.19 97.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.565 -0.709 . . . . 0.0 109.511 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.446 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 30.5 m95 -96.46 163.0 13.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.637 -0.664 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -143.31 144.77 32.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.62 -0.675 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -67.48 104.17 1.49 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -140.8 115.37 9.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.508 179.976 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' TMQ . . . . . 0.405 ' C17' HN52 ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.657 HG23 HD23 ' A' ' 94' ' ' LEU . 6.8 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.49 134.0 44.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.849 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.2 m-85 -104.76 153.99 20.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.701 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.2 tp -164.57 109.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.1 146.61 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.533 -0.729 . . . . 0.0 109.655 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.78 110.05 22.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.285 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -129.12 149.31 50.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.64 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -99.34 171.76 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 0.0 109.411 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.447 HH11 ' HB2' ' A' ' 9' ' ' ARG . 1.8 ptp180 -61.56 -19.53 62.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.641 -0.662 . . . . 0.0 109.806 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.53 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.16 37.0 93.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.447 HD23 ' CG ' ' A' ' 20' ' ' PRO . 5.5 tp -105.58 167.81 9.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.528 -0.983 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' A' ' 126' ' ' THR . 2.6 pp -144.92 -26.19 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.487 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -170.59 -170.97 35.48 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -172.65 120.28 0.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.575 -0.956 . . . . 0.0 109.442 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.92 33.42 21.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.506 -0.746 . . . . 0.0 109.706 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.98 3.68 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -77.24 178.27 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.506 -0.996 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.626 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.7 mt -83.7 155.5 65.21 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.447 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.6 Cg_endo -80.16 -30.92 1.92 Allowed 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 124.993 3.795 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.626 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 31.7 p90 -105.76 168.11 9.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.545 -0.722 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -115.19 107.61 15.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.675 . . . . 0.0 109.376 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.77 HD23 ' HB2' ' A' ' 26' ' ' ASP . 13.0 tp -129.31 80.49 72.18 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.578 -0.701 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.29 -40.05 16.46 Favored 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 125.162 3.908 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.67 -49.77 73.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.55 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.77 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.3 t0 -63.04 -31.35 72.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.32 -24.73 61.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -86.74 -23.83 25.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.505 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.0 t80 -75.02 -24.63 58.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.507 ' O ' HG23 ' A' ' 34' ' ' THR . 53.4 t80 -63.24 -44.98 93.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.576 -0.703 . . . . 0.0 109.472 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -63.6 -26.15 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.566 -0.709 . . . . 0.0 109.463 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.56 -28.34 33.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.548 -0.72 . . . . 0.0 109.419 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 17.3 mm100 -103.06 34.12 3.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 30' ' ' PHE . 22.1 p -140.59 -34.73 0.51 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.2 m -77.29 131.16 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.419 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.07 7.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -111.37 167.6 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.603 -0.939 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.501 HG23 ' HB ' ' A' ' 58' ' ' THR . 58.8 mt -85.12 126.03 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 109.431 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.443 ' CE ' HD12 ' A' ' 54' ' ' LEU . 41.6 ttp -92.12 107.66 19.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.49 122.04 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.56 163.13 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.95 -164.28 39.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 23.6 ptt180 -82.28 -38.64 24.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.987 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.44 -33.33 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.623 -0.673 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -79.42 -27.55 41.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 109.459 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -65.51 -58.35 6.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.02 -26.71 68.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -62.7 -21.85 66.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.722 . . . . 0.0 109.694 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -62.77 161.1 31.18 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.523 -0.736 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.17 -71.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 125.119 3.879 . . . . 0.0 109.901 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -115.77 75.74 0.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -78.39 156.48 78.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.04 166.86 75.92 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.423 1.223 . . . . 0.0 109.994 0.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.443 HD12 ' CE ' ' A' ' 39' ' ' MET . 53.6 mt -90.09 118.03 68.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.736 . . . . 0.0 109.315 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.65 174.3 12.49 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 124.765 3.644 . . . . 0.0 109.969 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.48 27.03 16.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.63 -0.668 . . . . 0.0 109.641 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -177.41 155.0 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.499 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.501 ' HB ' HG23 ' A' ' 38' ' ' ILE . 9.2 m -76.39 144.7 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -120.48 96.91 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.593 -0.692 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -100.34 151.57 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.69 120.2 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.697 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.506 HD12 HG23 ' A' ' 76' ' ' VAL . 17.0 tp -96.61 117.61 31.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.598 -0.689 . . . . 0.0 109.458 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -151.05 144.14 24.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.569 -0.707 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -103.06 31.14 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -124.24 132.31 53.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.629 -0.669 . . . . 0.0 109.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.2 30.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.39 -30.69 5.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.589 -0.694 . . . . 0.0 109.513 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -66.58 142.56 57.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -137.58 142.45 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.91 117.65 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -84.04 122.1 28.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.716 -0.615 . . . . 0.0 109.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.68 41.59 12.67 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.41 145.4 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.99 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -83.07 97.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.564 -0.71 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.561 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.7 t -76.8 100.35 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.56 -0.713 . . . . 0.0 109.443 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.506 HG23 HD12 ' A' ' 62' ' ' LEU . 27.9 m -91.16 153.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.457 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.561 ' NE2' HG12 ' A' ' 75' ' ' VAL . 88.3 m-70 -135.35 30.34 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.566 -0.708 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -166.88 148.23 6.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.47 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.7 -33.33 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.94 -32.9 72.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.59 -36.07 80.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.65 -0.656 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 76' ' ' VAL . 31.7 t -69.8 -39.78 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.436 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -76.84 -31.43 56.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.643 -0.661 . . . . 0.0 109.52 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.08 78.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -72.98 -33.66 65.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.21 68.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.21 -42.54 83.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.639 -0.663 . . . . 0.0 109.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.18 -27.84 68.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.507 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -119.33 89.93 41.14 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.713 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.63 -22.99 7.44 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 125.112 3.875 . . . . 0.0 109.922 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -68.15 -26.9 66.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.415 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -97.9 179.89 4.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -139.47 165.7 26.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.657 HD23 HG23 ' A' ' 1' ' ' THR . 11.7 tp -96.59 128.75 43.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 t -132.08 133.57 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.542 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.4 mm -104.07 124.46 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.69 -27.96 9.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.22 -179.57 38.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.87 -154.8 19.55 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.317 -1.696 . . . . 0.0 109.554 -0.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.84 -32.27 73.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.937 . . . . 0.0 109.486 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -71.04 -31.83 68.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.99 -36.0 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.542 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.2 m-85 -63.21 -55.63 23.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.582 -0.699 . . . . 0.0 109.554 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -62.55 -21.38 65.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.626 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.93 -36.87 78.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CE1' HG13 ' A' ' 79' ' ' VAL . 69.5 m-85 -113.41 18.7 17.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.609 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -66.98 -23.81 65.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 109.58 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.49 -45.42 59.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.08 38.84 1.12 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.607 -0.683 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.849 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -88.95 151.75 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -132.84 -61.85 0.83 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.6 m -93.55 159.82 15.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.433 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.43 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 34.3 mt -140.17 95.77 2.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.701 ' CB ' HD12 ' A' ' 4' ' ' LEU . 34.4 mt -95.08 103.36 15.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.316 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -109.24 136.18 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.725 . . . . 0.0 109.452 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 m -107.39 102.95 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.388 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.9 146.49 26.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.78 132.1 51.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.623 -0.673 . . . . 0.0 109.272 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.88 -34.17 73.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.613 -0.679 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.86 130.59 27.95 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 t -79.82 139.85 37.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.58 -0.953 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.413 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.3 m-85 -146.78 126.55 13.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.715 . . . . 0.0 109.506 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.05 146.52 26.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.36 -124.01 1.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -145.04 -30.08 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.61 -0.935 . . . . 0.0 109.49 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.423 ' HB ' HD11 ' A' ' 13' ' ' ILE . 4.3 m -100.79 142.45 32.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.705 . . . . 0.0 109.509 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -118.02 176.05 5.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.572 -0.705 . . . . 0.0 109.461 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.428 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.597 -0.689 . . . . 0.0 109.5 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.3 pt -69.37 163.68 56.08 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.562 -0.711 . . . . 0.0 109.516 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.88 102.35 1.45 Allowed 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 125.047 3.831 . . . . 0.0 109.851 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.24 144.74 26.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -81.15 85.62 6.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.692 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -71.74 -14.1 61.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.852 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.05 10.05 1.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.897 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.86 31.73 3.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 0.0 109.417 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.43 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 66.3 m-85 -141.47 174.13 10.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.399 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -147.44 137.35 22.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -71.1 156.56 39.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.746 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.73 -36.02 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.701 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.7 m -148.2 163.63 36.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.8 t -158.86 157.63 31.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -142.92 101.09 3.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.488 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.475 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.7 m -85.52 143.22 28.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.432 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.424 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.9 p -147.18 129.18 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.541 -0.725 . . . . 0.0 109.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -105.25 121.34 43.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.563 -0.711 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.32 -166.21 1.01 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.4 p -70.23 -39.63 74.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.596 -0.69 . . . . 0.0 109.61 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -105.35 137.84 19.38 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.647 -0.658 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -47.98 -45.54 24.66 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 C-N-CA 124.842 3.694 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.98 70.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.689 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.1 mt -81.07 20.83 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.6 m -91.37 137.99 31.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.424 ' NE2' HG11 ' A' ' 144' ' ' VAL . 34.5 p-80 -151.85 169.01 23.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 143' ' ' THR . 23.0 m -142.73 132.51 24.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -89.61 101.0 13.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.5 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 38.2 mt-10 -85.9 128.98 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.602 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.8 t -114.96 112.7 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.534 -0.729 . . . . 0.0 109.51 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 31.2 m95 -109.32 164.06 12.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -139.92 136.4 33.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.615 -0.678 . . . . 0.0 109.429 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 73.4 tttt . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.518 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 2' ' ' ALA . 14.7 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 1' ' ' THR . . . -135.59 121.24 19.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.815 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -91.62 149.24 21.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 114' ' ' LEU . 11.0 tp -159.79 110.39 1.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.696 . . . . 0.0 109.401 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.43 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -143.77 147.99 34.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.749 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.23 111.88 23.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.538 -0.726 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.451 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.8 pt20 -132.43 149.47 52.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.537 -0.727 . . . . 0.0 109.637 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -100.43 170.44 8.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.684 . . . . 0.0 109.458 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.25 -17.32 52.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.785 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.72 14.4 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 109.846 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.41 36.89 93.76 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.659 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.9 tp -112.23 166.55 11.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.549 -0.971 . . . . 0.0 109.526 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.657 HD11 HG22 ' A' ' 126' ' ' THR . 32.2 pt -139.8 -29.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.496 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -171.73 -168.18 32.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -170.23 119.72 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.636 -0.92 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.95 29.81 19.36 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.566 -0.709 . . . . 0.0 109.742 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.89 -61.69 2.65 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -73.83 169.77 16.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.923 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.697 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 40.3 mt -84.84 155.92 61.3 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.616 -0.677 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.4 Cg_endo -79.52 -28.08 3.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.046 3.831 . . . . 0.0 109.958 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.697 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.1 p90 -106.77 167.67 9.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -118.57 93.53 4.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.557 -0.714 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.793 HD23 ' HB2' ' A' ' 26' ' ' ASP . 18.5 tp -114.97 80.73 6.99 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.27 -38.67 15.19 Favored 'Trans proline' 0 N--CA 1.507 2.273 0 C-N-CA 125.139 3.893 . . . . 0.0 110.25 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.7 -44.25 96.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.698 . . . . 0.0 109.59 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.793 ' HB2' HD23 ' A' ' 23' ' ' LEU . 32.4 t70 -64.24 -41.07 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.741 . . . . 0.0 109.436 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.02 -23.72 67.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -85.0 -29.48 24.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.631 -0.668 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -70.8 -25.75 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.458 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.34 -52.2 59.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.545 -0.722 . . . . 0.0 109.453 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -68.32 2.09 2.51 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.601 -0.687 . . . . 0.0 110.022 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.15 12.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -0.832 . . . . 0.0 109.451 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -114.91 35.09 4.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.568 -0.707 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 p -132.91 -27.53 1.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.741 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.0 m -75.5 127.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.91 23.62 51.88 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.25 164.98 29.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.522 -0.987 . . . . 0.0 109.5 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -91.37 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.462 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.8 ttp -82.92 108.33 16.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.54 -0.725 . . . . 0.0 109.559 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.478 HG21 HD11 ' A' ' 94' ' ' LEU . 30.0 t -96.59 118.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.503 -0.748 . . . . 0.0 109.385 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 29.4 m -131.47 166.92 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.41 -160.71 36.59 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.7 -35.54 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.617 -0.931 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -69.5 -37.79 77.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -77.4 -27.23 52.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -65.51 -34.55 78.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -89.61 -24.03 21.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -62.91 -22.18 66.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.735 . . . . 0.0 109.601 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.501 ' HZ ' HG11 ' A' ' 41' ' ' VAL . 39.4 m-85 -62.73 159.8 41.23 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -72.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.093 3.862 . . . . 0.0 109.89 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.3 pttm -108.07 74.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.423 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -78.73 156.03 77.89 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.489 -0.757 . . . . 0.0 109.528 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.18 171.09 63.39 Favored 'Cis proline' 0 N--CA 1.507 2.317 0 O-C-N 123.407 1.214 . . . . 0.0 109.957 0.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.462 HD12 ' CE ' ' A' ' 39' ' ' MET . 67.4 mt -94.58 115.39 65.25 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.55 -0.719 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.0 -178.28 4.53 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.808 3.672 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 60.65 28.21 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -176.68 179.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.5 m -112.42 111.17 21.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.607 -0.683 . . . . 0.0 109.487 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.491 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -86.0 107.83 17.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.488 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 t -102.3 112.66 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.588 -0.695 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.4 t -95.71 125.16 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.453 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.537 HD12 HG23 ' A' ' 76' ' ' VAL . 14.4 tp -104.56 114.79 29.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.42 140.89 33.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -89.16 30.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -137.65 125.05 21.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.7 29.83 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.03 -37.46 6.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.601 -0.687 . . . . 0.0 109.55 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -70.83 143.7 51.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 109.518 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.75 101.45 3.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.61 118.57 28.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.439 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -73.83 136.38 43.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.546 -0.722 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 37.43 57.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.99 145.93 18.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.973 . . . . 0.0 109.515 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.78 98.91 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 0.0 109.501 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.607 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.3 t -80.42 99.41 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.537 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -99.97 158.57 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.61 -0.681 . . . . 0.0 109.433 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.607 ' NE2' HG12 ' A' ' 75' ' ' VAL . 81.0 m-70 -138.8 29.82 2.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.548 -0.72 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -167.85 148.75 5.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.6 t -68.06 -31.69 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.612 -0.68 . . . . 0.0 109.475 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.53 -33.68 76.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.5 -0.75 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.41 75.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.683 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 t -67.81 -43.92 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -73.19 -30.13 63.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.486 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.68 83.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.597 -0.689 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -71.51 -34.02 69.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.5 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.0 -30.82 69.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.602 -0.686 . . . . 0.0 109.405 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -67.19 -34.63 77.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.534 -0.728 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.43 -36.58 76.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -120.92 87.26 42.88 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.45 20.22 0.98 Allowed 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.169 3.912 . . . . 0.0 109.952 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -100.96 -30.12 11.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -94.51 178.23 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.558 -0.713 . . . . 0.0 109.443 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -127.88 151.62 48.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.626 -0.671 . . . . 0.0 109.466 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.478 HD11 HG21 ' A' ' 40' ' ' VAL . 13.1 tp -83.17 108.26 16.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.629 -0.669 . . . . 0.0 109.483 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -113.91 131.42 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.553 -0.717 . . . . 0.0 109.419 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.528 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.9 mm -98.28 125.68 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.707 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.13 -27.52 10.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.503 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 160.85 -179.94 36.0 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.29 -152.26 17.54 Favored Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.315 -1.697 . . . . 0.0 109.585 0.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.4 73.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.582 -0.952 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -70.85 -30.45 66.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.76 -34.89 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.563 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.528 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.1 m-85 -64.39 -56.79 11.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.713 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.463 ' OG1' HD13 ' A' ' 129' ' ' ILE . 2.6 m -62.53 -21.18 65.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.661 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.93 73.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.528 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' CE1' HG13 ' A' ' 79' ' ' VAL . 69.9 m-85 -113.1 17.24 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.526 -0.734 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.64 ' O ' HG12 ' A' ' 110' ' ' VAL . 1.2 pptp? -67.06 -23.17 65.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.521 -0.737 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -66.77 -45.44 78.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.516 -0.74 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.23 44.97 1.0 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.815 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -93.96 147.83 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 0.0 109.442 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -136.94 -68.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -84.65 120.04 25.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 3' ' ' PHE . 19.1 mt -107.7 94.95 5.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.631 -0.668 . . . . 0.0 109.609 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.604 ' CB ' HD12 ' A' ' 4' ' ' LEU . 39.0 mt -91.33 115.51 28.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.645 -0.659 . . . . 0.0 109.343 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.43 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -124.31 138.71 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.705 . . . . 0.0 109.509 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.9 m -109.87 101.4 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.564 -0.71 . . . . 0.0 109.234 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -87.68 139.81 30.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 109.614 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.73 140.15 47.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.331 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.81 -33.27 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.05 139.06 25.45 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.2 m -86.91 143.13 27.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.516 -0.991 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.621 ' O ' HD22 ' A' ' 12' ' ' LEU . 96.2 m-85 -148.45 108.73 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -80.1 147.04 31.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.531 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.659 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -144.46 -126.77 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -141.79 -41.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.949 . . . . 0.0 109.482 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.657 HG22 HD11 ' A' ' 13' ' ' ILE . 6.8 m -90.52 126.98 36.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.509 -0.745 . . . . 0.0 109.435 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -104.53 172.22 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.412 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -91.82 145.09 24.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.462 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.463 HD13 ' OG1' ' A' ' 104' ' ' THR . 24.4 pt -66.79 165.37 26.17 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.519 -0.738 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.52 108.83 2.19 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 125.173 3.915 . . . . 0.0 109.961 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -98.67 145.22 27.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -86.09 87.15 7.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -69.88 -17.25 63.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.82 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.86 -27.19 69.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.477 -0.764 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -93.3 30.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -149.91 164.15 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -139.07 136.18 34.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.698 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -70.12 149.17 47.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.631 -0.668 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.6 -31.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.469 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -143.87 153.3 42.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.522 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.2 p -155.48 113.3 3.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.544 -0.723 . . . . 0.0 109.501 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 tpt85 -91.24 103.31 16.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.482 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.7 m -85.55 141.4 29.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -146.72 129.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.597 -0.69 . . . . 0.0 109.322 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -108.3 120.7 43.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.4 -166.04 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.3 p -71.17 -42.77 68.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.717 . . . . 0.0 109.588 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.18 137.75 19.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.573 -0.705 . . . . 0.0 109.428 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.87 -43.1 30.33 Favored 'Trans proline' 0 N--CA 1.508 2.333 0 C-N-CA 124.781 3.654 . . . . 0.0 110.126 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.48 73.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.565 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 151' ' ' LEU . 47.9 mt -80.91 20.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.629 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.6 m -90.85 141.93 28.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 109.473 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.549 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.5 p-80 -158.12 167.29 30.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.496 -0.752 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.1 m -138.63 141.03 39.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.638 . . . . 0.0 109.417 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.36 97.75 9.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.667 . . . . 0.0 109.467 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.44 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 21.8 mt-10 -81.36 139.46 35.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.578 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -124.97 107.29 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.44 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 31.4 m95 -103.97 165.13 11.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.685 . . . . 0.0 109.454 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -148.87 144.18 26.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.482 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.81 128.59 35.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 109.412 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.808 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -95.8 160.06 14.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.562 -0.711 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.619 HD12 ' CB ' ' A' ' 114' ' ' LEU . 12.1 tp -170.86 108.92 0.32 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.698 . . . . 0.0 109.335 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.433 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.39 151.21 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.31 114.12 26.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.4 pt20 -135.61 150.65 49.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -100.86 170.73 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.526 -0.734 . . . . 0.0 109.366 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -61.17 -17.85 55.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.579 -0.701 . . . . 0.0 109.887 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.72 14.05 0.89 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.501 -0.749 . . . . 0.0 109.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.16 39.01 97.1 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.572 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.0 tp -112.25 163.95 13.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.95 . . . . 0.0 109.515 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.469 HD11 ' CG2' ' A' ' 126' ' ' THR . 2.5 pp -139.75 -27.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.518 -0.738 . . . . 0.0 109.514 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.16 -176.85 40.59 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -166.42 120.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.958 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.88 32.74 21.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -61.73 3.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -76.34 171.3 14.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.96 . . . . 0.0 109.493 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.594 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.1 mt -84.8 155.85 61.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 9.8 Cg_endo -78.9 -26.99 5.0 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 125.069 3.846 . . . . 0.0 109.97 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.594 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.5 p90 -108.37 167.31 10.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -118.83 97.6 5.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 26' ' ' ASP . 21.5 tp -118.63 80.09 16.77 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 109.428 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.28 -37.82 14.3 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 125.193 3.928 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -63.02 -43.51 98.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.505 -0.747 . . . . 0.0 109.503 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.812 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.6 t0 -64.4 -35.0 79.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.396 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.68 -25.3 63.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.67 -0.644 . . . . 0.0 109.516 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -83.8 -28.51 28.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.435 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.441 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.7 t80 -74.01 -25.53 59.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.541 -0.725 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 34' ' ' THR . 53.2 t80 -65.01 -45.82 83.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.452 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.442 ' O ' HG13 ' A' ' 35' ' ' VAL . 41.4 ttp85 -65.69 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.85 56.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 41.5 mm-40 -99.59 32.27 2.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 109.506 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.5 p -139.55 -31.33 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -67.88 129.22 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.456 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.09 56.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -155.35 170.35 22.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.561 -0.964 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' CG2' HG21 ' A' ' 60' ' ' VAL . 58.1 mt -99.62 111.66 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.435 ' CE ' HD12 ' A' ' 54' ' ' LEU . 38.4 ttp -87.05 106.87 18.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.522 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.56 119.46 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.43 160.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.562 -0.711 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.34 -170.2 46.69 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.12 -33.71 59.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.598 -0.943 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -67.67 -47.32 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 109.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -70.1 -26.03 63.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.686 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -63.9 -43.54 95.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.573 -0.704 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.9 -22.96 33.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.531 -0.73 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t -62.97 -23.9 67.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.721 . . . . 0.0 109.621 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.98 160.23 48.93 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.725 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.83 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.124 3.882 . . . . 0.0 109.942 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -105.81 89.59 3.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.377 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -96.78 157.03 35.86 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.593 -0.692 . . . . 0.0 109.507 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.87 142.32 57.68 Favored 'Cis proline' 0 N--CA 1.509 2.4 0 O-C-N 123.325 1.171 . . . . 0.0 109.964 -0.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.435 HD12 ' CE ' ' A' ' 39' ' ' MET . 82.3 mt -61.85 111.17 4.02 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.577 -0.702 . . . . 0.0 109.413 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.43 -178.05 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.732 3.621 . . . . 0.0 109.949 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 60.96 29.21 18.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.588 -0.695 . . . . 0.0 109.56 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -177.24 177.42 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -100.2 119.32 38.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -93.18 104.53 16.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.568 -0.707 . . . . 0.0 109.511 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.445 HG21 ' CG2' ' A' ' 38' ' ' ILE . 30.4 t -105.75 120.81 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.495 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -106.5 127.38 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.731 . . . . 0.0 109.408 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.736 HD12 HG23 ' A' ' 76' ' ' VAL . 17.1 tp -102.34 120.75 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.654 -0.654 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.11 155.41 44.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.396 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -86.24 -61.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.617 -0.677 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.37 145.54 37.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.655 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.38 30.95 0.59 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.72 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.55 -31.3 19.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -69.58 124.75 24.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -104.56 131.56 51.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.66 -0.65 . . . . 0.0 109.374 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.76 112.32 8.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.507 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -90.47 142.93 27.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 34.74 61.03 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.49 141.93 15.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.955 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.11 96.92 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.45 HG12 ' NE2' ' A' ' 77' ' ' HIS . 28.8 t -73.55 96.57 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.481 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 62' ' ' LEU . 28.6 m -91.23 160.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.717 . . . . 0.0 109.471 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.45 ' NE2' HG12 ' A' ' 75' ' ' VAL . 80.1 m-70 -137.53 29.74 2.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.581 -0.699 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.65 146.39 2.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.549 HG13 ' CE2' ' A' ' 106' ' ' PHE . 30.4 t -68.17 -32.92 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -33.83 75.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.485 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.19 -37.35 83.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.498 -0.751 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.456 HG22 HG21 ' A' ' 76' ' ' VAL . 30.9 t -69.03 -38.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.606 -0.684 . . . . 0.0 109.449 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -73.07 -30.75 63.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.74 86.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.61 -32.78 71.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.83 -31.03 68.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -65.64 -40.55 92.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -67.61 -32.13 72.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.546 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.82 89.75 42.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.59 -0.693 . . . . 0.0 109.521 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.08 -21.6 7.89 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 125.12 3.88 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 -26.74 67.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.545 -0.722 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.01 -179.99 5.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.576 -0.703 . . . . 0.0 109.427 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -138.16 144.81 40.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.2 tp -86.07 132.59 34.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -139.29 131.04 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 109.504 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.562 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.6 mm -97.1 125.79 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.01 -25.13 10.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.504 -0.748 . . . . 0.0 109.474 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.29 -176.14 36.12 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.476 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.28 -152.4 9.12 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.259 -1.73 . . . . 0.0 109.546 0.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.84 82.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.946 . . . . 0.0 109.707 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.434 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 13.6 pm0 -66.1 -23.05 66.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.61 -0.681 . . . . 0.0 109.765 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.476 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.5 mm -77.31 -35.42 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.521 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' CE1' HG22 ' A' ' 96' ' ' ILE . 25.5 m-85 -64.0 -50.39 68.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 109.507 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.06 -26.22 68.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.03 83.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.545 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 79' ' ' VAL . 55.3 m-85 -103.02 11.8 36.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.513 -0.742 . . . . 0.0 109.951 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.522 ' O ' HG12 ' A' ' 110' ' ' VAL . 44.9 tttm -71.54 -24.26 61.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.779 . . . . 0.0 109.526 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 -41.54 92.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.722 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -110.77 37.41 2.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.582 -0.699 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.808 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -79.72 151.89 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 0.0 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.2 -68.79 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.66 -0.65 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -88.68 163.03 15.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.459 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.451 HD12 ' CD2' ' A' ' 136' ' ' PHE . 22.0 mt -142.19 89.74 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' CB ' HD12 ' A' ' 4' ' ' LEU . 43.9 mt -89.34 117.02 27.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.272 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.433 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -126.72 137.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.598 -0.689 . . . . 0.0 109.54 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.1 m -107.89 102.44 11.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.281 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -87.46 132.9 33.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.574 -0.704 . . . . 0.0 109.585 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.81 135.53 49.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.05 77.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.712 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 130.11 25.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 p -77.99 143.01 37.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.592 -0.946 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.552 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.3 m-85 -147.99 113.32 5.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.51 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.65 149.63 25.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.532 -0.73 . . . . 0.0 109.442 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.572 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -150.25 -127.86 1.52 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.52 -32.64 0.58 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.633 -0.922 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.469 ' CG2' HD11 ' A' ' 13' ' ' ILE . 2.7 m -93.93 147.44 23.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.698 . . . . 0.0 109.574 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -128.07 173.05 10.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.7 tpt -98.01 151.09 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.496 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.5 pt -72.46 164.61 58.41 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.433 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.07 97.55 1.07 Allowed 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 125.106 3.87 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -88.11 137.71 32.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.708 . . . . 0.0 109.474 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -80.32 85.38 5.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.715 . . . . 0.0 109.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.92 -16.92 63.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.751 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.73 -24.91 67.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.745 . . . . 0.0 109.508 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.67 -29.44 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.451 ' CD2' HD12 ' A' ' 113' ' ' LEU . 91.7 m-85 -87.89 169.56 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.563 -0.711 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.2 m -138.97 134.82 33.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.632 -0.668 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -69.16 148.62 49.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 -34.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.1 p -149.53 157.91 43.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -157.62 122.37 4.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.48 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.29 100.2 11.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 109.479 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.543 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.2 m -82.07 146.48 29.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.699 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.407 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -148.88 131.24 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.625 -0.672 . . . . 0.0 109.315 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.477 ' OE2' HG22 ' A' ' 143' ' ' THR . 5.9 mp0 -111.88 118.4 35.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 0.0 109.49 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.46 -174.25 4.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.551 -0.718 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.5 p -63.31 -44.06 96.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -89.34 156.13 48.55 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.145 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.76 -22.03 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 124.827 3.685 . . . . 0.0 109.943 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.28 -23.39 30.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.548 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -89.28 18.97 4.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.605 -0.684 . . . . 0.0 109.708 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.414 HG23 ' HG3' ' A' ' 145' ' ' GLU . 16.8 m -85.6 141.88 29.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.642 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.9 p-80 -158.48 168.26 27.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.543 HG23 ' HA ' ' A' ' 143' ' ' THR . 20.0 m -136.93 134.84 37.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.638 -0.664 . . . . 0.0 109.39 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.55 91.2 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.579 -0.701 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -71.79 145.28 48.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.685 . . . . 0.0 109.418 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.602 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.0 t -133.56 104.3 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.659 . . . . 0.0 109.497 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.6 m95 -101.34 168.25 9.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -144.78 140.55 28.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.618 -0.676 . . . . 0.0 109.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 109.449 179.954 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.62 103.23 11.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.7 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -72.73 140.65 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.436 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.58 HD12 ' CB ' ' A' ' 114' ' ' LEU . 11.9 tp -154.42 111.87 3.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.305 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -142.79 141.88 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.585 -0.697 . . . . 0.0 109.757 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.21 110.5 21.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.577 -0.702 . . . . 0.0 109.294 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.521 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.3 pt20 -130.26 150.72 51.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.698 . . . . 0.0 109.676 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -98.9 169.66 9.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -60.93 -17.47 51.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.42 0.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.589 -0.694 . . . . 0.0 109.759 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 33.8 87.19 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.9 tp -109.45 164.0 12.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.947 . . . . 0.0 109.537 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 7' ' ' GLN . 31.0 pt -137.94 -30.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.532 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -168.82 -176.96 39.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -162.54 124.59 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.969 . . . . 0.0 109.431 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.89 29.77 19.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 109.694 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.25 -64.13 1.67 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -75.42 -179.51 4.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.581 -0.952 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 55.3 mt -88.74 155.96 50.22 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -80.12 -26.93 3.99 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.994 3.796 . . . . 0.0 109.887 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.593 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.8 p90 -108.09 170.89 7.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.562 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -122.54 100.2 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.673 -0.642 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.778 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.4 tp -121.3 82.47 38.65 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.623 -0.673 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 27' ' ' LEU . 7.9 Cg_exo -45.22 -39.04 15.35 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 125.142 3.894 . . . . 0.0 110.253 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.9 -49.7 73.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.778 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.2 t0 -63.35 -29.52 70.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 24' ' ' PRO . 83.0 mt -72.71 -23.45 60.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.554 -0.716 . . . . 0.0 109.595 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -88.4 -26.38 22.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.447 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 19.8 t80 -70.41 -25.9 63.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.568 -0.707 . . . . 0.0 109.464 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' THR . 60.9 t80 -63.19 -46.82 85.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.595 -0.691 . . . . 0.0 109.456 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 35' ' ' VAL . 53.4 ttt-85 -63.51 -29.87 71.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.707 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.54 -30.24 57.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.516 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 20.6 mm100 -99.18 33.74 2.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' PHE . 19.9 p -142.65 -32.49 0.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.426 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.5 m -69.98 126.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.69 . . . . 0.0 109.502 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.32 34.53 25.83 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -155.84 171.35 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.949 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.68 98.53 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.597 -0.689 . . . . 0.0 109.419 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.708 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.2 tmm? -70.03 132.23 45.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 t -137.2 118.91 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.581 -0.699 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.708 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.8 m -133.82 179.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 109.474 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.38 -168.34 41.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -80.69 -39.59 26.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -73.86 -32.31 63.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -76.23 -30.48 57.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 52' ' ' ARG . 27.9 t80 -64.27 -58.4 6.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.511 -0.743 . . . . 0.0 109.428 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -64.52 -15.65 61.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.535 -0.728 . . . . 0.0 109.793 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -62.4 -28.73 69.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.775 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -66.61 162.69 48.47 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.72 -69.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 125.129 3.886 . . . . 0.0 109.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -104.86 143.41 33.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.472 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HD2' ' CE2' ' A' ' 46' ' ' TYR . 21.3 mtm105 -144.82 161.96 40.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.73 148.54 76.11 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.449 1.236 . . . . 0.0 109.894 -0.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.516 HD12 ' CE ' ' A' ' 39' ' ' MET . 75.0 mt -62.17 111.33 4.41 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.559 -0.713 . . . . 0.0 109.444 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.62 174.03 12.29 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.873 3.715 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 61.73 24.87 14.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.543 -0.723 . . . . 0.0 109.606 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -177.18 148.45 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.688 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -79.21 126.27 30.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.499 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.495 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.4 m-80 -100.2 117.61 34.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.54 -0.725 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -114.31 146.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.621 -0.675 . . . . 0.0 109.45 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.38 118.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.493 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 76' ' ' VAL . 12.5 tp -97.56 107.03 19.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.72 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.401 HG23 ' CE1' ' A' ' 77' ' ' HIS . 4.0 t -137.71 155.59 48.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.686 . . . . 0.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -98.41 -30.67 12.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.27 124.46 25.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -84.03 29.9 0.54 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.618 -0.676 . . . . 0.0 109.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -102.4 -34.79 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -71.96 140.45 49.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -144.18 104.19 4.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.476 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.82 118.37 27.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -79.24 123.88 27.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.549 -0.72 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.5 37.44 10.75 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.4 144.95 19.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 109.534 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.74 93.23 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.509 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.9 t -77.11 102.11 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.524 HG21 HG22 ' A' ' 82' ' ' VAL . 27.9 m -97.68 155.05 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.509 ' NE2' HG12 ' A' ' 75' ' ' VAL . 61.6 m-70 -135.01 29.33 3.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.63 -0.669 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -159.77 141.65 13.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.627 -0.671 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.8 t -67.6 -34.31 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.544 -0.723 . . . . 0.0 109.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.83 67.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.58 80.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.592 -0.693 . . . . 0.0 109.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -68.15 -40.23 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.66 -31.91 65.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.721 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.46 -34.9 78.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.66 -0.65 . . . . 0.0 109.565 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -69.48 -35.21 75.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 109.488 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -68.27 -34.54 76.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.706 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -69.63 -32.4 71.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -120.6 87.95 42.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.685 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.39 20.1 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 125.116 3.878 . . . . 0.0 109.939 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.66 -30.02 12.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.565 -0.71 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.68 178.41 4.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.595 -0.691 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -127.02 155.8 42.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.624 -0.673 . . . . 0.0 109.452 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.8 tp -81.46 123.0 28.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.559 -0.713 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -124.64 120.07 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.429 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.3 mm -97.67 125.25 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.636 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -104.7 -24.82 12.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.17 -175.86 40.2 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.483 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.06 -155.72 22.16 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.283 -1.716 . . . . 0.0 109.588 -0.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.42 75.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.647 -0.914 . . . . 0.0 109.525 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.12 -28.18 62.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.557 -0.715 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.483 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -71.72 -37.61 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.696 . . . . 0.0 109.56 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 96' ' ' ILE . 30.3 m-85 -63.02 -47.57 82.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.607 -0.683 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.5 m -63.07 -24.47 67.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.538 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.77 60.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 79' ' ' VAL . 58.8 m-85 -103.97 21.05 17.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.583 -0.698 . . . . 0.0 109.646 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -23.59 53.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.498 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.82 18.7 0.58 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.499 -0.751 . . . . 0.0 109.745 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -160.08 38.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.416 -0.803 . . . . 0.0 109.419 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.7 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -93.56 152.84 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.87 -45.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 109.396 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.5 m -106.54 122.61 46.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.669 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.448 HD12 ' CD1' ' A' ' 136' ' ' PHE . 30.8 mt -108.57 101.48 10.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.646 -0.658 . . . . 0.0 109.626 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.58 ' CB ' HD12 ' A' ' 4' ' ' LEU . 43.7 mt -102.47 106.31 17.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -114.3 140.1 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.505 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -110.4 100.97 9.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -84.62 144.3 28.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.566 -0.708 . . . . 0.0 109.58 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -119.65 136.06 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.78 -35.54 77.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.437 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.23 126.79 13.64 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.6 p -79.75 143.2 34.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.569 -0.959 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.613 ' O ' HD22 ' A' ' 12' ' ' LEU . 99.8 m-85 -148.01 112.4 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.602 -0.686 . . . . 0.0 109.43 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.38 149.24 31.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.626 -0.671 . . . . 0.0 109.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.63 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.02 -129.29 1.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.56 -29.03 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.479 HG22 HD11 ' A' ' 13' ' ' ILE . 2.6 m -98.38 145.99 26.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -127.49 170.68 12.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.605 -0.684 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.3 tpt -93.15 151.9 19.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.4 pt -72.45 164.64 58.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.674 . . . . 0.0 109.508 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.03 93.41 1.06 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.168 3.912 . . . . 0.0 109.914 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 71.7 mt -80.51 144.56 32.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -84.82 85.79 7.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.405 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -71.48 -7.84 50.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.57 -31.82 72.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.357 -0.84 . . . . 0.0 109.587 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.63 32.35 2.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.448 ' CD1' HD12 ' A' ' 113' ' ' LEU . 27.6 m-85 -138.9 169.5 17.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.434 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -150.15 147.06 27.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.547 -0.721 . . . . 0.0 109.446 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -86.08 116.41 24.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.41 -35.42 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -149.89 172.95 14.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.67 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t -165.78 123.51 1.5 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.459 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -100.66 105.5 16.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.592 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.5 m -86.87 152.25 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 109.395 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.423 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -154.87 133.06 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.16 123.19 49.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.94 -174.3 5.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.9 p -63.3 -40.55 97.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.634 -0.667 . . . . 0.0 109.451 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -91.97 155.0 43.53 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -77.87 -24.68 8.31 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.887 3.725 . . . . 0.0 109.865 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.63 -23.25 31.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.536 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.0 mt -88.4 20.29 3.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.7 m -82.51 144.68 30.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.367 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.551 ' CE1' HD21 ' A' ' 23' ' ' LEU . 30.1 p-80 -158.54 162.74 37.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.727 . . . . 0.0 109.615 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.3 m -135.46 137.54 42.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.671 -0.643 . . . . 0.0 109.443 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.77 98.45 11.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.509 -0.744 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 1.2 mp0 -80.44 134.28 35.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.448 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.1 t -123.84 99.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.443 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 34.2 m95 -97.5 164.46 12.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.579 -0.701 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -140.38 145.49 37.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.447 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.5 132.32 29.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.818 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.0 m-85 -97.07 162.56 13.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.653 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.9 tp -171.18 107.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 109.269 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -141.75 147.66 37.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.524 -0.735 . . . . 0.0 109.711 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.84 115.18 26.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.588 -0.695 . . . . 0.0 109.179 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.0 pt20 -136.21 151.99 50.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.685 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -101.74 170.38 8.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.59 -0.694 . . . . 0.0 109.373 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -60.89 -17.48 50.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 109.946 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.94 14.33 0.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.718 . . . . 0.0 109.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.19 36.66 93.3 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.621 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.7 tp -112.26 164.4 13.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.916 . . . . 0.0 109.578 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 7' ' ' GLN . 31.6 pt -138.69 -29.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -169.17 -165.92 27.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -173.8 122.46 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.959 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 57.9 35.01 24.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.624 -0.673 . . . . 0.0 109.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -62.81 3.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -76.17 171.95 13.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.564 -0.962 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.557 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 16.9 mt -86.65 157.89 54.68 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.97 -27.18 3.96 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.03 3.82 . . . . 0.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.557 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.0 p90 -108.37 163.35 13.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.513 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -115.55 89.59 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.8 tp -107.7 79.57 0.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.68 -37.96 16.48 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 125.114 3.876 . . . . 0.0 110.251 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.79 -45.8 90.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.554 -0.716 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.3 t0 -62.71 -38.99 92.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 0.0 109.442 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.82 -24.0 67.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.668 . . . . 0.0 109.468 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -83.7 -27.84 28.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.625 -0.672 . . . . 0.0 109.48 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.0 t80 -76.76 -26.04 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.493 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 34' ' ' THR . 61.1 t80 -67.02 -45.31 77.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.453 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -64.76 -29.43 70.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.74 -28.74 44.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 78.3 mm-40 -101.44 33.5 2.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.506 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.5 p -137.69 -33.76 0.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.73 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.576 -0.703 . . . . 0.0 109.47 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -29.49 12.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 165.17 12.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.545 -0.973 . . . . 0.0 109.495 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.5 mt -80.84 121.85 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.62 -0.675 . . . . 0.0 109.48 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.434 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.8 ttp -90.88 107.33 19.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.602 -0.686 . . . . 0.0 109.517 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 HD21 ' A' ' 94' ' ' LEU . 30.6 t -96.48 124.47 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.62 -0.675 . . . . 0.0 109.468 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.82 166.07 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.02 -169.24 44.47 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -77.7 -34.18 52.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.565 -0.962 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.78 -45.14 72.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.7 m -71.07 -25.94 62.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.695 . . . . 0.0 109.533 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -63.96 -38.73 92.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -87.75 -20.24 26.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.4 m -62.78 -25.58 68.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.621 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -66.58 160.6 66.19 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.62 -0.675 . . . . 0.0 109.412 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.29 -73.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.125 3.883 . . . . 0.0 109.821 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -103.51 92.32 4.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 3.8 ptm180 -99.25 154.53 37.25 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.97 151.07 83.46 Favored 'Cis proline' 0 N--CA 1.51 2.463 0 O-C-N 123.309 1.163 . . . . 0.0 109.952 -0.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.434 HD12 ' CE ' ' A' ' 39' ' ' MET . 77.8 mt -69.25 123.84 89.17 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.653 . . . . 0.0 109.289 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.28 176.85 9.25 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.676 3.584 . . . . 0.0 109.937 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.04 28.66 18.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.585 -0.697 . . . . 0.0 109.729 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.28 170.52 2.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.548 -0.72 . . . . 0.0 109.496 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 m -105.93 118.76 37.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.597 -0.689 . . . . 0.0 109.514 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.468 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -85.73 101.54 12.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -99.22 100.38 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.429 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -86.42 135.99 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.803 HD12 HG23 ' A' ' 76' ' ' VAL . 15.4 tp -110.51 113.7 26.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.676 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.59 145.53 36.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.641 -0.662 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.21 -26.87 14.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -70.43 136.9 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.654 -0.654 . . . . 0.0 109.44 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.1 29.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.728 . . . . 0.0 109.508 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -111.44 -28.81 8.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.592 -0.693 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.34 140.87 58.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.536 -0.727 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -140.86 104.55 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -97.51 126.06 42.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 0.0 109.549 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -92.03 131.93 36.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.11 39.89 62.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.52 141.58 17.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.627 -0.926 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.7 95.62 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.611 -0.681 . . . . 0.0 109.448 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 70' ' ' ALA . 30.8 t -81.47 98.39 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 62' ' ' LEU . 27.9 m -92.76 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.653 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -140.73 30.68 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -169.14 142.74 2.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 106' ' ' PHE . 30.4 t -67.06 -35.04 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.18 -31.25 69.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -35.93 80.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 76' ' ' VAL . 30.0 t -68.45 -38.37 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.476 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -69.24 -31.31 69.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.602 -0.686 . . . . 0.0 109.491 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.9 -36.83 83.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.683 -0.636 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -69.58 -31.69 70.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.673 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.23 -27.13 60.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 109.429 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -64.21 -44.31 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.618 -0.676 . . . . 0.0 109.519 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.77 -30.27 70.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.578 -0.701 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -119.16 89.98 40.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.663 -0.648 . . . . 0.0 109.455 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -22.08 7.51 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.118 3.879 . . . . 0.0 109.874 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.67 -27.24 67.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 109.415 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -95.22 -180.0 4.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -138.44 169.3 18.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.532 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 95' ' ' VAL . 4.1 tt -104.02 121.58 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.646 -0.659 . . . . 0.0 109.497 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.472 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.5 t -122.3 133.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.458 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.567 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.3 mm -102.24 120.68 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.56 -25.45 10.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.675 . . . . 0.0 109.489 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.64 -178.37 38.42 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.83 -153.21 18.79 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.223 -1.751 . . . . 0.0 109.565 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.51 73.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.949 . . . . 0.0 109.502 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.36 -27.71 60.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.412 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.9 mm -76.07 -34.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.713 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.567 ' CE1' HG22 ' A' ' 96' ' ' ILE . 21.3 m-85 -63.04 -52.37 63.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.569 HG23 HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -64.9 -23.42 67.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.531 -0.731 . . . . 0.0 109.548 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.57 77.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 79' ' ' VAL . 71.3 m-85 -104.28 14.4 30.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.559 -0.713 . . . . 0.0 109.908 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 110' ' ' VAL . 31.6 ttmt -70.05 -24.68 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.802 . . . . 0.0 109.53 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.37 -44.21 79.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -101.42 38.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.644 -0.66 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.818 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -83.97 147.6 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.688 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.38 -63.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.591 -0.693 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.49 164.12 13.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 41.8 mt -143.15 93.22 2.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.653 ' CB ' HD12 ' A' ' 4' ' ' LEU . 45.1 mt -91.71 114.16 26.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -122.05 138.18 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.551 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.3 m -109.31 98.17 7.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.642 -0.661 . . . . 0.0 109.282 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -84.0 134.11 34.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.95 142.65 36.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.622 -0.674 . . . . 0.0 109.314 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.453 ' HB3' ' OG1' ' A' ' 152' ' ' THR . . . -73.53 -38.76 65.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.505 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.64 136.44 26.07 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.6 p -85.67 145.79 27.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 109.476 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.426 ' O ' HD22 ' A' ' 12' ' ' LEU . 99.4 m-85 -147.82 122.69 9.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.584 -0.698 . . . . 0.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 123' ' ' GLU . 10.4 pt-20 -81.68 161.2 23.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.608 -0.683 . . . . 0.0 109.519 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.621 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -162.79 -134.87 1.71 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -142.1 -34.58 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.984 . . . . 0.0 109.449 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.489 HG22 HD11 ' A' ' 13' ' ' ILE . 4.1 m -95.82 143.08 27.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -122.26 173.68 7.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.605 -0.684 . . . . 0.0 109.403 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -93.3 152.02 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.536 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.569 HD13 HG23 ' A' ' 104' ' ' THR . 30.6 pt -73.58 164.06 63.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.627 -0.671 . . . . 0.0 109.511 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.11 99.53 1.19 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.137 3.891 . . . . 0.0 109.878 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.42 144.52 27.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.63 -0.669 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -77.5 83.21 3.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -71.89 -18.58 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.654 . . . . 0.0 109.693 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.04 10.07 1.34 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.488 -0.758 . . . . 0.0 110.017 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -123.93 -31.75 3.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.498 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.524 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 86.1 m-85 -81.27 173.59 12.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.541 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.5 m -142.34 121.06 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.622 -0.674 . . . . 0.0 109.514 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -66.75 154.74 39.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.566 -0.709 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.5 -34.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 0.0 109.481 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.8 t -148.94 165.97 29.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 109.479 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 t -158.76 119.86 3.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.7 ttt-85 -93.14 108.65 20.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.529 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.6 m -90.76 143.07 27.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -144.88 134.61 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.462 ' HA ' HG22 ' A' ' 152' ' ' THR . 44.2 mt-10 -112.52 120.06 40.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.591 -0.693 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -81.49 -173.19 4.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.71 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.0 p -63.29 -41.37 98.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.584 -0.698 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.23 154.96 44.84 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.576 -0.703 . . . . 0.0 109.23 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.52 -25.79 7.79 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.819 3.679 . . . . 0.0 109.844 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -22.81 31.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -87.39 18.92 3.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 145' ' ' GLU . 7.3 p -85.23 146.62 26.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.403 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.501 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.8 p-80 -159.13 171.56 19.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.644 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.529 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.7 m -140.76 133.43 28.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.686 -0.634 . . . . 0.0 109.371 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -89.6 97.4 11.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.13 143.7 37.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.429 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.551 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.7 t -128.49 104.81 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 109.532 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.414 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 28.3 m95 -102.79 166.72 10.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -144.42 138.5 27.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.616 -0.677 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.5 tttt . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.14 122.17 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.55 -0.719 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.792 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -93.75 151.72 19.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.641 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.3 tp -163.15 110.92 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.592 -0.693 . . . . 0.0 109.331 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -141.85 140.01 32.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.517 -0.739 . . . . 0.0 109.743 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.94 109.4 20.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.409 ' HB3' HG22 ' A' ' 13' ' ' ILE . 8.0 pt20 -130.0 147.24 51.73 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.678 . . . . 0.0 109.616 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -94.68 170.16 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.617 -0.677 . . . . 0.0 109.43 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -60.84 -18.12 53.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 109.897 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.61 14.92 0.9 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.73 . . . . 0.0 109.801 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.03 36.41 92.84 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.593 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.8 tp -108.83 167.6 9.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.966 . . . . 0.0 109.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 126' ' ' THR . 30.3 pt -142.65 -30.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.25 -169.44 22.6 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -175.21 116.22 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.614 -0.933 . . . . 0.0 109.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.94 35.62 21.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.478 -0.764 . . . . 0.0 109.699 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.68 -61.11 4.42 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -79.18 170.95 15.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.525 -0.985 . . . . 0.0 109.471 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.552 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 35.4 mt -80.37 156.55 73.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.432 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -80.25 -27.44 3.59 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.061 3.84 . . . . 0.0 109.945 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.552 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 33.0 p90 -108.82 163.61 13.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 0.0 109.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -116.25 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.1 tp -107.29 80.44 0.87 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.601 -0.687 . . . . 0.0 109.47 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -45.76 -37.53 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 125.061 3.841 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.7 -45.91 90.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.786 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.0 t0 -62.85 -37.28 86.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.642 -0.661 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.22 -24.21 67.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.51 -0.744 . . . . 0.0 109.506 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -85.3 -28.93 24.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 25.9 t80 -74.87 -26.72 59.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.478 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.493 ' O ' HG23 ' A' ' 34' ' ' THR . 53.1 t80 -66.63 -45.1 80.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -65.93 -31.66 72.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.71 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.35 59.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.481 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 64.8 mm-40 -96.26 31.35 2.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.542 -0.724 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 30' ' ' PHE . 10.4 p -136.84 -35.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 129.63 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.671 . . . . 0.0 109.501 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.78 -27.56 18.4 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER -110.6 178.94 4.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.458 HG23 ' HB ' ' A' ' 58' ' ' THR . 58.1 mt -98.05 122.84 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.522 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.501 ' CE ' HD12 ' A' ' 54' ' ' LEU . 56.7 ttp -88.54 102.25 14.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.54 -0.725 . . . . 0.0 109.456 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.523 HG21 HD11 ' A' ' 94' ' ' LEU . 30.3 t -94.78 115.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.498 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.0 m -139.82 166.35 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.493 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.53 -170.18 46.65 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -79.64 -33.16 41.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.976 . . . . 0.0 109.5 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -71.63 -33.91 69.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.1 m -81.14 -30.84 34.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -66.99 -29.24 69.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.445 -0.785 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.89 -18.23 24.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.7 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.4 p -62.46 -24.38 67.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.645 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -65.21 160.77 54.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.69 -68.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.14 3.893 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.85 127.0 51.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtp-105 -123.14 157.43 60.92 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.489 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.55 -166.78 5.47 Favored 'Cis proline' 0 N--CA 1.509 2.416 0 O-C-N 123.4 1.211 . . . . 0.0 109.941 -0.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.501 HD12 ' CE ' ' A' ' 39' ' ' MET . 60.1 mt -113.34 96.17 38.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.515 -0.741 . . . . 0.0 109.441 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -72.33 -177.7 2.86 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.656 3.57 . . . . 0.0 109.755 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 61.59 25.49 15.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 109.534 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -176.3 177.32 1.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 38' ' ' ILE . 3.6 m -96.61 130.91 43.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -102.28 100.47 10.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.591 -0.693 . . . . 0.0 109.477 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 t -110.66 107.01 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.738 . . . . 0.0 109.386 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -98.97 136.92 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.632 -0.667 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.669 HD12 HG23 ' A' ' 76' ' ' VAL . 15.6 tp -102.47 125.98 49.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.719 . . . . 0.0 109.43 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -153.18 142.24 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -88.62 -42.22 12.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -71.79 133.28 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -85.93 30.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -101.19 -35.11 9.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -69.18 148.58 49.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.579 -0.7 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -147.18 152.98 39.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.689 . . . . 0.0 109.442 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.78 138.67 41.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.716 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -86.42 121.62 29.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 109.455 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.2 48.43 25.47 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.45 140.44 15.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.914 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -82.18 100.49 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 109.387 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -79.47 98.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.568 -0.708 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.669 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -87.67 164.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.645 -0.659 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -138.09 29.99 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -171.94 143.22 1.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.427 HG13 ' CZ ' ' A' ' 106' ' ' PHE . 30.5 t -66.82 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.551 -0.718 . . . . 0.0 109.418 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.53 76.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 109.48 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.32 77.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -67.99 -37.47 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -74.6 -30.42 61.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.546 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.32 90.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.49 -33.34 72.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.3 62.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.0 109.592 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -64.61 -46.23 83.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -65.0 -26.99 68.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -119.16 90.15 41.07 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.57 -0.707 . . . . 0.0 109.48 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -24.03 6.65 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.122 3.881 . . . . 0.0 109.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.38 -25.35 62.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.623 -0.673 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -96.56 131.8 42.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' H ' ' HG3' ' A' ' 37' ' ' LYS . 6.1 mm-40 -95.67 152.78 18.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.576 -0.702 . . . . 0.0 109.539 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 40' ' ' VAL . 6.8 tp -88.73 137.73 32.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.63 -0.669 . . . . 0.0 109.426 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.3 123.54 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.644 -0.66 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.585 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.2 mm -93.75 119.83 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -101.69 -29.78 11.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.534 -0.729 . . . . 0.0 109.526 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.25 -174.06 40.3 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.94 -154.53 19.11 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.379 -1.659 . . . . 0.0 109.555 0.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.55 -31.41 71.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.649 -0.912 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.79 -28.07 61.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.37 -36.5 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.63 -0.669 . . . . 0.0 109.51 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.585 ' CE1' HG22 ' A' ' 96' ' ' ILE . 27.8 m-85 -63.3 -48.11 79.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.676 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.76 73.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.427 ' CZ ' HG13 ' A' ' 79' ' ' VAL . 17.2 m-85 -102.26 11.81 37.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 109.887 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -67.65 -31.89 72.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.511 -0.743 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -78.86 17.94 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.548 -0.72 . . . . 0.0 109.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -160.08 38.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.792 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -95.37 145.91 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.06 -53.14 1.74 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.578 -0.701 . . . . 0.0 109.357 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -103.37 160.84 14.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.697 . . . . 0.0 109.374 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.488 HD11 ' CE2' ' A' ' 136' ' ' PHE . 30.4 mt -139.45 98.49 3.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.728 . . . . 0.0 109.604 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.618 ' CD2' HG22 ' A' ' 157' ' ' VAL . 41.8 mt -98.49 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.625 -0.672 . . . . 0.0 109.314 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -115.05 136.77 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 0.0 109.518 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -107.7 103.32 12.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.636 -0.665 . . . . 0.0 109.278 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -87.54 143.54 27.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.52 -0.737 . . . . 0.0 109.616 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.39 133.9 55.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.638 -0.663 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.91 78.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.674 . . . . 0.0 109.487 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.29 123.93 9.63 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -76.82 143.93 39.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.633 -0.922 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.525 ' O ' HD22 ' A' ' 12' ' ' LEU . 89.1 m-85 -148.32 117.39 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.53 145.77 27.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.593 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -144.16 -128.3 2.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -140.71 -36.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.542 -0.975 . . . . 0.0 109.56 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.536 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -95.22 142.09 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.576 -0.702 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.12 173.0 7.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.616 -0.677 . . . . 0.0 109.455 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -92.91 153.52 18.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -73.58 163.74 66.19 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.18 96.19 1.02 Allowed 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 125.135 3.89 . . . . 0.0 110.007 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.93 137.0 33.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.495 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -78.73 87.26 4.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.579 -0.701 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -68.39 -16.93 64.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.619 -0.676 . . . . 0.0 109.78 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.55 -26.22 68.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.44 29.78 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 113' ' ' LEU . 45.9 m-85 -142.97 175.35 9.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.598 -0.689 . . . . 0.0 109.455 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.47 135.42 17.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.652 -0.655 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -70.92 158.03 37.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.675 -0.64 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.15 -32.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.726 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.3 p -157.74 155.5 30.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 p -149.51 122.08 8.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -99.16 105.59 17.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.479 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.3 m -84.94 142.78 29.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.56 -0.712 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.456 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -145.14 129.89 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.659 -0.651 . . . . 0.0 109.377 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -105.92 121.07 43.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.433 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -80.32 -165.82 0.93 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.64 -39.42 64.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -101.92 138.05 19.69 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 109.418 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.66 -46.29 24.67 Favored 'Trans proline' 0 N--CA 1.505 2.202 0 C-N-CA 124.748 3.632 . . . . 0.0 110.08 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.59 69.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.518 -0.739 . . . . 0.0 109.668 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.0 18.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.733 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.1 m -87.55 140.0 29.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 109.314 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.581 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.1 p-80 -154.75 162.24 41.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.599 -0.688 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.4 m -134.46 135.51 42.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.705 . . . . 0.0 109.454 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -90.78 93.89 9.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 37.7 mt-10 -76.74 137.8 39.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.585 -0.697 . . . . 0.0 109.473 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.618 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.3 t -124.71 115.74 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.583 -0.698 . . . . 0.0 109.453 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.413 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 33.0 m95 -113.17 170.03 8.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.469 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -148.89 141.06 23.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.577 -0.702 . . . . 0.0 109.394 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.9 tttm . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.48 99.72 7.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.725 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.6 m-85 -76.11 131.43 39.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.504 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.9 tp -147.41 113.67 5.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.347 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.3 p90 -143.38 147.12 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 109.746 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.85 114.18 26.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -133.95 150.2 51.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.491 -0.755 . . . . 0.0 109.636 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -98.63 171.44 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -61.13 -19.85 61.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.803 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.66 15.05 0.88 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 109.754 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.89 38.54 96.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.7 tp -106.14 166.25 10.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.75 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -145.89 -29.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.467 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.11 -176.2 27.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -175.26 115.88 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.547 -0.972 . . . . 0.0 109.514 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.09 21.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.52 -0.737 . . . . 0.0 109.679 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.45 5.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -77.94 176.45 9.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.8 mt -77.05 157.87 80.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.38 -33.79 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 125.089 3.859 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.8 p90 -108.16 -170.59 1.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.688 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -136.53 86.89 2.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 109.446 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.763 HD23 ' HB2' ' A' ' 26' ' ' ASP . 26.6 tp -109.36 82.13 1.97 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -45.31 -38.55 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 125.172 3.915 . . . . 0.0 110.269 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -62.69 -40.19 96.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.538 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.763 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.7 t0 -66.05 -33.19 75.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.693 . . . . 0.0 109.407 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.1 -24.72 63.26 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.66 -29.56 27.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.633 -0.667 . . . . 0.0 109.399 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.32 -25.4 57.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 34' ' ' THR . 53.5 t80 -65.84 -45.74 81.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.656 -0.653 . . . . 0.0 109.449 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -65.28 -30.87 71.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.53 -30.98 57.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.523 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -97.82 32.66 2.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.432 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.6 p -140.29 -34.1 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.488 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.1 m -70.27 128.19 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.622 -0.673 . . . . 0.0 109.474 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 31.97 27.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -156.54 172.3 18.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.951 . . . . 0.0 109.481 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -90.47 112.81 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.649 -0.657 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.552 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.8 tmm? -81.51 105.01 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 94' ' ' LEU . 29.0 t -113.19 123.77 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.481 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.3 m -137.74 -175.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.435 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.6 -164.89 31.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -82.84 -41.28 19.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.625 -0.926 . . . . 0.0 109.492 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -70.2 -33.15 71.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -76.41 -29.41 57.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -67.12 -35.59 80.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.523 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -83.06 -25.27 32.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.677 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.9 p -62.91 -22.64 66.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.567 -0.708 . . . . 0.0 109.611 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.72 164.2 13.2 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.507 -0.746 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -80.91 -73.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.11 3.874 . . . . 0.0 109.949 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -114.33 103.78 11.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.547 -0.721 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.91 156.63 39.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.696 . . . . 0.0 109.415 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -81.25 169.69 65.48 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.397 1.209 . . . . 0.0 110.004 -0.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 ' CE ' ' A' ' 39' ' ' MET . 55.5 mt -89.76 113.09 55.55 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.36 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.46 -178.87 4.95 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 124.659 3.572 . . . . 0.0 109.918 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 61.54 24.29 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.546 -0.721 . . . . 0.0 109.704 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -176.61 174.41 1.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.573 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -91.64 131.28 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.539 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -98.91 105.22 17.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.8 144.23 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.2 t -134.45 124.12 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 76' ' ' VAL . 18.5 tp -97.79 117.15 31.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.538 -0.726 . . . . 0.0 109.511 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -155.43 137.8 14.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -93.12 29.43 1.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.514 -0.741 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -110.24 123.79 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -86.17 30.13 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.674 -0.641 . . . . 0.0 109.407 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -124.47 -33.39 3.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -69.13 147.29 51.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.61 -0.681 . . . . 0.0 109.508 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -146.14 156.72 43.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.23 132.22 31.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.649 -0.657 . . . . 0.0 109.491 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -87.55 119.42 27.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.21 42.59 18.66 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.41 133.33 8.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.971 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -74.32 103.57 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.634 -0.666 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.59 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.5 t -82.13 103.28 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.578 -0.702 . . . . 0.0 109.441 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -89.98 154.88 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.678 -0.639 . . . . 0.0 109.509 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.59 ' NE2' HG12 ' A' ' 75' ' ' VAL . 49.0 m-70 -136.16 29.52 3.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.451 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.404 ' O ' HG23 ' A' ' 82' ' ' VAL . 19.4 t70 -164.88 149.34 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.607 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.0 -33.41 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.48 70.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.654 . . . . 0.0 109.529 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.42 77.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 76' ' ' VAL . 31.2 t -67.55 -42.77 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 109.503 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.32 -29.27 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.616 -0.677 . . . . 0.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.83 92.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.717 . . . . 0.0 109.478 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -66.44 -42.76 87.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.13 -24.97 65.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.661 . . . . 0.0 109.51 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -41.15 97.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.592 -0.692 . . . . 0.0 109.463 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -69.47 -31.02 69.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -119.24 89.75 40.46 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.606 -0.684 . . . . 0.0 109.489 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.32 -22.71 6.77 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 125.138 3.892 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.84 -25.9 66.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.475 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -92.92 -179.93 5.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -138.76 148.56 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.669 . . . . 0.0 109.487 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 40' ' ' VAL . 12.8 tp -79.24 108.11 12.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.622 -0.673 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.38 112.92 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.631 -0.668 . . . . 0.0 109.464 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.405 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.4 mm -91.97 122.27 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 109.36 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -101.38 -28.87 12.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.529 -0.732 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.13 -175.83 40.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.92 -151.75 12.87 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.362 -1.669 . . . . 0.0 109.613 -0.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.94 -26.22 62.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -74.78 -23.69 58.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -80.32 -38.33 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.483 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CE1' HG22 ' A' ' 96' ' ' ILE . 30.9 m-85 -62.75 -48.5 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 0.0 109.396 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 t -63.6 -33.04 74.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.594 -0.691 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.607 ' CE1' HG13 ' A' ' 79' ' ' VAL . 45.8 m-85 -122.32 21.33 10.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.714 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.4 pttt -63.48 -32.83 74.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.441 -0.787 . . . . 0.0 109.586 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -81.09 31.0 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.725 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -160.08 32.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.733 . . . . 0.0 109.408 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.725 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -99.22 145.63 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.319 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -128.0 -55.83 1.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.583 -0.698 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -103.69 106.86 17.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.377 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.493 HD11 ' CE2' ' A' ' 136' ' ' PHE . 24.5 mt -90.44 100.94 13.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.568 -0.707 . . . . 0.0 109.592 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.603 ' CD2' HG22 ' A' ' 157' ' ' VAL . 42.5 mt -99.23 105.98 18.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.719 . . . . 0.0 109.21 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.43 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -111.32 136.05 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.613 -0.679 . . . . 0.0 109.523 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -108.62 97.49 7.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.652 . . . . 0.0 109.248 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -85.43 139.79 31.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.632 -0.668 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 135.07 54.4 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.84 -33.31 73.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.556 -0.715 . . . . 0.0 109.472 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.88 124.42 14.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.7 t -70.25 140.83 52.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.59 -0.947 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.628 ' O ' HD22 ' A' ' 12' ' ' LEU . 67.3 m-85 -148.38 107.2 3.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.422 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.72 146.33 28.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.63 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -145.02 -123.3 1.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -143.42 -49.87 0.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.975 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.75 HG22 HD11 ' A' ' 13' ' ' ILE . 4.4 m -81.64 141.09 33.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.632 -0.667 . . . . 0.0 109.476 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -118.46 172.94 7.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -94.47 146.97 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.47 164.69 42.01 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.469 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.29 99.96 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.113 3.876 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.39 138.07 32.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -77.74 84.81 4.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -67.23 -17.53 64.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.6 -0.688 . . . . 0.0 109.772 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -26.0 68.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.765 . . . . 0.0 109.519 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.81 30.32 2.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.718 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 113' ' ' LEU . 68.0 m-85 -145.35 177.16 9.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.515 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 m -153.54 131.41 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -72.13 115.82 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 109.475 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.1 -36.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.498 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.2 p -154.79 179.16 9.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.1 t -165.2 159.48 17.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -133.41 100.8 4.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.499 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.0 m -81.75 152.95 26.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.536 -0.727 . . . . 0.0 109.423 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 144' ' ' VAL . 8.8 p -156.17 127.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.309 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.39 121.99 44.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.58 -165.61 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.3 p -72.35 -36.38 68.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.603 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -106.13 137.88 19.52 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.86 -48.19 16.75 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 124.822 3.682 . . . . 0.0 110.076 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.83 69.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.5 mt -80.38 20.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.629 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 m -91.98 136.97 32.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.525 -0.734 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.668 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.6 p-80 -151.93 169.55 22.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.697 . . . . 0.0 109.602 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 143' ' ' THR . 19.1 m -139.76 137.74 35.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.541 -0.724 . . . . 0.0 109.451 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -95.32 94.75 8.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.517 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 23.4 mt-10 -76.24 128.84 35.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.603 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.2 t -112.9 102.91 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.502 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.517 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 42.4 m95 -101.41 163.45 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -140.14 145.96 38.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.4 tttt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.602 -0.686 . . . . 0.0 109.489 179.936 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.92 127.65 34.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.807 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -101.99 137.35 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.66 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.2 tp -149.87 111.69 4.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.602 -0.686 . . . . 0.0 109.331 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.2 p90 -142.04 151.52 42.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.711 . . . . 0.0 109.73 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 112.08 24.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -132.33 150.17 52.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.569 -0.707 . . . . 0.0 109.638 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.46 171.78 7.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -61.37 -18.69 59.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.618 -0.676 . . . . 0.0 109.763 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.37 15.14 0.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.518 -0.739 . . . . 0.0 109.775 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 37.57 94.64 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.528 HD23 ' CG ' ' A' ' 20' ' ' PRO . 7.1 tp -107.39 167.25 10.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.621 -0.929 . . . . 0.0 109.553 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.52 HD11 HG22 ' A' ' 126' ' ' THR . 31.7 pt -141.74 -30.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.575 -0.703 . . . . 0.0 109.519 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.0 28.74 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -173.28 115.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.462 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 33.83 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.466 -0.771 . . . . 0.0 109.723 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 -61.45 3.74 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -74.96 170.61 15.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -1.02 . . . . 0.0 109.455 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.659 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 24.0 mt -79.89 157.21 74.27 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.571 -0.706 . . . . 0.0 109.46 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.528 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.0 Cg_endo -79.91 -30.52 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 125.018 3.812 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.659 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.0 p90 -105.88 -171.38 1.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.547 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -138.42 103.02 4.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.705 -0.622 . . . . 0.0 109.431 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 26' ' ' ASP . 12.8 tp -124.58 81.02 60.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.587 -0.695 . . . . 0.0 109.516 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.23 -39.09 20.74 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 125.117 3.878 . . . . 0.0 110.154 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.98 -52.16 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.614 -0.679 . . . . 0.0 109.525 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.798 ' HB2' HD23 ' A' ' 23' ' ' LEU . 33.0 t70 -62.95 -36.54 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.75 -24.26 67.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.455 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -85.62 -29.91 23.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 26.9 t80 -65.44 -23.96 67.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 34' ' ' THR . 59.6 t80 -63.15 -46.5 86.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -65.15 -25.33 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.459 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.24 -26.57 39.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 66.6 mm-40 -107.47 36.38 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.709 . . . . 0.0 109.475 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' PHE . 15.0 p -138.38 -35.04 0.62 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.482 -0.761 . . . . 0.0 109.487 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.0 m -67.36 126.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.8 38.61 23.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -153.97 168.53 26.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.917 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.5 mt -93.47 104.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.423 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.605 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.8 tmm? -78.87 117.47 20.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 t -125.13 120.19 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.669 -0.644 . . . . 0.0 109.418 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.605 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.1 m -136.08 173.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.81 -167.21 42.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -84.05 -36.36 23.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.485 -1.009 . . . . 0.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -68.16 -31.81 71.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.444 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -82.41 -27.65 31.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -64.93 -35.7 82.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 109.487 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.27 -25.87 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.7 m -67.13 -15.36 63.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.664 -0.648 . . . . 0.0 109.759 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' CE1' HD11 ' A' ' 54' ' ' LEU . 23.7 m-85 -61.77 161.39 21.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 109.576 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 125.101 3.867 . . . . 0.0 109.987 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.6 73.57 0.92 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -72.78 157.36 88.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.58 172.7 55.23 Favored 'Cis proline' 0 N--CA 1.509 2.43 0 O-C-N 123.332 1.175 . . . . 0.0 110.035 0.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.54 HD12 ' CE ' ' A' ' 39' ' ' MET . 39.2 mt -97.8 110.75 56.73 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.589 -0.694 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -76.79 178.11 8.02 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.733 3.622 . . . . 0.0 109.866 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.39 29.59 18.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.58 -0.7 . . . . 0.0 109.68 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.412 HH12 ' N ' ' A' ' 35' ' ' VAL . 1.4 ptp180 -177.1 178.91 1.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 m -105.91 119.38 39.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.489 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -96.16 111.45 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.6 t -112.92 140.73 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 109.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 t -125.26 124.78 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 76' ' ' VAL . 11.3 tp -99.78 109.7 22.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.51 -0.744 . . . . 0.0 109.487 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 t -139.93 142.54 36.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.562 -0.712 . . . . 0.0 109.474 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -93.86 31.6 1.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.665 -0.647 . . . . 0.0 109.568 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.9 128.64 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.584 -0.698 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -88.89 29.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.41 -33.03 6.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -69.63 152.18 45.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -152.3 110.11 3.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.727 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.431 ' H ' HG21 ' A' ' 75' ' ' VAL . . . -98.1 125.18 42.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.618 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -80.57 133.05 35.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.639 -0.663 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.32 37.81 70.87 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.76 133.26 9.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.609 -0.936 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -73.52 99.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.578 -0.701 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.519 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.9 t -79.35 102.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.708 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.498 HG21 HG22 ' A' ' 82' ' ' VAL . 27.5 m -90.12 159.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 0.0 109.455 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.519 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.3 m-70 -139.35 29.98 2.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.44 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -164.26 144.93 8.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 106' ' ' PHE . 29.4 t -68.2 -33.68 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.0 109.511 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.28 70.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 109.49 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.48 81.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.647 -0.658 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -68.42 -35.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.392 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.45 -33.02 62.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.41 70.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -71.31 -37.26 71.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.706 . . . . 0.0 109.419 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.03 -26.27 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.711 . . . . 0.0 109.526 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -70.22 -38.54 75.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.77 -24.68 65.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -115.74 93.42 37.39 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.622 -0.674 . . . . 0.0 109.483 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.99 -19.96 13.43 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 124.838 3.692 . . . . 0.0 109.957 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -81.44 -25.0 36.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.54 -0.725 . . . . 0.0 109.496 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.15 179.99 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.517 -0.739 . . . . 0.0 109.492 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -142.37 148.18 37.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 95' ' ' VAL . 3.1 tt -80.65 123.32 28.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.556 -0.715 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.569 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.3 t -128.59 129.46 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 109.441 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -102.55 129.75 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.55 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -108.57 -24.09 11.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 109.599 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.76 -178.34 40.56 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.481 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.66 -155.22 19.96 Favored Glycine 0 N--CA 1.5 2.92 0 O-C-N 120.321 -1.693 . . . . 0.0 109.518 0.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.93 75.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -72.88 -25.44 61.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.531 -0.731 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.481 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.7 mm -74.61 -36.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.45 -49.9 71.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.511 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.2 t -62.88 -34.82 78.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.534 -0.729 . . . . 0.0 109.595 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.42 76.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.644 -0.66 . . . . 0.0 109.688 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 79' ' ' VAL . 41.8 m-85 -105.47 13.6 29.92 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.532 -0.73 . . . . 0.0 109.847 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -23.57 56.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.478 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -65.01 -22.22 66.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.649 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -130.3 41.43 3.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.53 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.807 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -86.05 156.98 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.416 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -136.54 -69.08 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 m -84.92 159.9 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.612 HD11 ' CE2' ' A' ' 136' ' ' PHE . 26.5 mt -142.01 96.27 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.632 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.66 ' CB ' HD12 ' A' ' 4' ' ' LEU . 51.5 mt -97.82 110.48 23.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.245 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -117.6 141.0 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.625 -0.672 . . . . 0.0 109.537 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -111.12 102.17 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.597 -0.689 . . . . 0.0 109.346 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 118' ' ' LEU . 25.7 mmt180 -85.22 151.28 24.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 117' ' ' ARG . 4.1 mp -128.6 133.81 48.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 109.279 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.51 -30.87 68.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.586 -0.696 . . . . 0.0 109.51 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.02 128.05 11.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.6 p -79.53 141.44 36.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.53 -0.982 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.479 ' O ' HD22 ' A' ' 12' ' ' LEU . 94.6 m-85 -148.63 128.28 13.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.677 . . . . 0.0 109.457 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.8 163.46 14.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -159.83 -138.38 2.44 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.69 10.04 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.96 . . . . 0.0 109.865 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.52 HG22 HD11 ' A' ' 13' ' ' ILE . 3.4 m -147.28 130.39 16.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.386 -0.821 . . . . 0.0 109.5 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -105.88 176.52 5.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.593 -0.692 . . . . 0.0 109.399 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.441 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -93.33 148.31 22.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.473 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.6 pt -66.83 165.57 25.04 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.536 -0.728 . . . . 0.0 109.477 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.18 109.32 2.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.11 3.873 . . . . 0.0 109.994 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.45 139.81 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.565 -0.709 . . . . 0.0 109.501 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 83.57 4.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.52 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.18 -20.02 64.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -62.72 -23.6 67.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.527 -0.733 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -97.78 28.73 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.612 ' CE2' HD11 ' A' ' 113' ' ' LEU . 54.2 m-85 -142.16 174.23 10.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.2 m -149.62 136.41 19.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.554 -0.716 . . . . 0.0 109.526 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -70.39 155.96 39.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.636 -0.665 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.61 -32.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.677 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 t -147.89 146.0 28.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.455 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -144.81 110.42 5.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -95.32 102.68 14.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.423 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.467 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.1 m -86.06 147.14 26.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.541 -0.725 . . . . 0.0 109.466 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.89 133.7 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.299 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.94 123.87 49.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.47 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -80.43 -165.1 0.8 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 p -71.47 -38.56 71.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.649 -0.657 . . . . 0.0 109.58 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -105.03 137.65 19.28 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.06 -46.19 22.98 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 124.815 3.677 . . . . 0.0 110.069 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.15 68.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.612 -0.68 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.55 19.9 0.97 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.704 . . . . 0.0 109.677 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 50.6 m -87.54 140.73 29.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.275 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.613 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.3 p-80 -152.63 167.27 29.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 143' ' ' THR . 20.5 m -140.57 130.52 24.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.594 -0.692 . . . . 0.0 109.434 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.46 93.81 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.54 139.37 38.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.423 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.536 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.6 t -128.81 113.51 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -111.71 166.38 11.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.508 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -142.94 143.06 31.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 41.4 tttt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.531 HG23 HD23 ' A' ' 94' ' ' LEU . 9.3 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.35 103.39 5.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.497 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.745 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.8 m-85 -75.42 141.29 43.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.4 tp -153.42 112.53 3.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 0.0 109.299 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 8.9 p90 -145.38 146.49 31.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.528 -0.733 . . . . 0.0 109.756 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 115.5 29.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 109.323 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.622 ' HB3' HG22 ' A' ' 13' ' ' ILE . 8.1 pt20 -133.86 161.32 35.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -108.72 169.64 8.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.643 -0.661 . . . . 0.0 109.406 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.476 HH11 ' HB2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -60.8 -15.86 34.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.61 -0.681 . . . . 0.0 109.88 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 15.02 0.84 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 109.763 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.59 86.17 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.526 HD21 ' HA3' ' A' ' 124' ' ' GLY . 9.3 tp -117.21 151.55 36.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -120.48 -41.36 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.577 -0.702 . . . . 0.0 109.558 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.665 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -162.87 -170.13 27.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -163.04 124.19 2.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.928 . . . . 0.0 109.454 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.91 32.66 21.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.542 -0.724 . . . . 0.0 109.717 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 -62.5 3.55 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -73.2 173.19 9.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.965 . . . . 0.0 109.499 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.57 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 9.0 mt -93.4 155.54 40.77 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.533 -0.73 . . . . 0.0 109.469 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -79.96 -24.92 5.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 125.045 3.83 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.57 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 30.4 p90 -106.72 163.13 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.624 -0.672 . . . . 0.0 109.574 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -115.55 100.96 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.677 -0.64 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 26' ' ' ASP . 17.6 tp -119.68 80.27 23.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.613 -0.679 . . . . 0.0 109.47 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.91 -37.36 16.87 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 125.133 3.889 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.93 -46.88 85.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.53 -0.731 . . . . 0.0 109.57 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.4 t0 -62.83 -37.61 87.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.59 -23.94 67.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.725 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -86.97 -29.7 21.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.565 -0.709 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.9 t80 -73.36 -24.43 60.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.528 -0.733 . . . . 0.0 109.547 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 34' ' ' THR . 52.6 t80 -63.33 -45.35 91.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttp-105 -64.84 -29.29 70.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.477 -0.764 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.84 -29.09 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 82.3 mm-40 -101.13 34.91 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.704 . . . . 0.0 109.46 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.0 p -141.67 -34.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.508 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 m -68.98 126.82 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.639 -0.663 . . . . 0.0 109.456 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.35 35.14 24.13 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -156.94 166.48 33.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.581 -0.952 . . . . 0.0 109.441 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.3 mt -90.66 103.36 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.546 -0.721 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.678 ' SD ' HG13 ' A' ' 41' ' ' VAL . 9.8 tmm? -71.96 131.48 43.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 94' ' ' LEU . 31.3 t -135.55 116.04 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.678 HG13 ' SD ' ' A' ' 39' ' ' MET . 27.6 m -133.86 -177.57 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.659 -0.65 . . . . 0.0 109.458 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 -174.06 43.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -76.17 -38.33 56.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.936 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -69.07 -41.87 76.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 m -69.97 -26.45 64.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.35 -46.03 85.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.534 -0.728 . . . . 0.0 109.487 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.86 -23.96 36.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.515 -0.741 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -62.83 -21.13 65.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -62.07 161.35 24.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.493 -0.755 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 125.103 3.869 . . . . 0.0 109.886 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -108.55 91.98 3.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.623 -0.673 . . . . 0.0 109.488 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -99.76 157.3 34.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.723 . . . . 0.0 109.458 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.5 159.06 85.8 Favored 'Cis proline' 0 N--CA 1.509 2.386 0 O-C-N 123.384 1.202 . . . . 0.0 109.953 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.98 114.17 46.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.15 179.31 6.57 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.761 3.64 . . . . 0.0 109.947 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 61.05 29.64 19.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.612 -0.68 . . . . 0.0 109.662 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.03 173.55 1.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 m -93.98 118.94 32.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -89.71 99.17 12.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.8 t -107.11 143.35 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.62 125.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.426 HD12 HG23 ' A' ' 76' ' ' VAL . 11.8 tp -95.9 112.46 24.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.615 -0.678 . . . . 0.0 109.541 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -140.26 150.78 44.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.574 -0.704 . . . . 0.0 109.401 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -91.24 -34.14 15.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -76.15 123.73 26.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.611 -0.68 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -83.52 29.59 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -100.46 -34.75 9.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 109.5 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -69.35 136.33 51.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.702 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -141.54 104.52 4.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.728 . . . . 0.0 109.48 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.36 119.71 26.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.551 -0.718 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -70.85 127.25 31.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.41 38.66 24.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.66 146.81 19.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.598 -0.942 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.28 98.03 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.511 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.8 t -77.19 98.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.478 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.51 HG21 HG22 ' A' ' 82' ' ' VAL . 27.2 m -85.13 156.86 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.511 ' NE2' HG12 ' A' ' 75' ' ' VAL . 67.1 m-70 -136.78 30.0 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.507 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -169.8 148.82 3.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.475 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.2 t -68.34 -34.13 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.88 -31.05 67.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.681 . . . . 0.0 109.46 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.22 -37.29 83.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.542 -0.724 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -69.59 -40.7 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 109.379 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -72.54 -29.54 63.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.88 84.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.633 -0.667 . . . . 0.0 109.515 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.28 -40.44 81.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.737 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.71 68.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.39 -36.59 83.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.573 -0.704 . . . . 0.0 109.492 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.9 -27.77 61.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.679 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -119.61 88.05 38.24 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.36 20.21 0.97 Allowed 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.133 3.888 . . . . 0.0 109.967 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -106.86 -31.7 8.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -94.48 178.54 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.556 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -133.03 153.86 51.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.491 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.531 HD23 HG23 ' A' ' 1' ' ' THR . 11.1 tp -84.64 133.63 34.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.712 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.6 t -134.47 114.45 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.48 127.39 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.494 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.645 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.74 -24.51 10.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.579 -0.701 . . . . 0.0 109.517 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.3 -179.67 36.58 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.53 -155.47 20.18 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 120.287 -1.714 . . . . 0.0 109.583 0.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.45 72.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.572 -0.957 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -69.88 -31.09 68.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.511 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.14 -37.7 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.524 -0.735 . . . . 0.0 109.528 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -62.88 -46.1 89.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.557 -0.715 . . . . 0.0 109.483 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.627 HG23 HD13 ' A' ' 129' ' ' ILE . 0.7 OUTLIER -67.96 -21.78 65.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.581 -0.7 . . . . 0.0 109.605 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.87 -37.1 62.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.475 ' CE1' HG13 ' A' ' 79' ' ' VAL . 73.9 m-85 -106.4 14.78 26.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.695 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -29.75 66.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.772 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.2 -27.24 69.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.07 58.86 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.745 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -105.2 151.69 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -135.29 -68.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 127.51 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.643 HD11 ' CE2' ' A' ' 136' ' ' PHE . 37.2 mt -111.7 87.76 2.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.646 ' CB ' HD12 ' A' ' 4' ' ' LEU . 40.6 mt -89.27 121.78 31.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.527 -0.733 . . . . 0.0 109.264 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -134.49 145.09 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.647 -0.658 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -111.39 107.86 17.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.234 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -88.65 128.79 35.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.3 141.2 37.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.84 62.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.1 137.46 24.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -87.4 143.49 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.533 -0.981 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.46 124.42 14.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.638 -0.664 . . . . 0.0 109.419 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.9 140.03 30.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.514 -0.741 . . . . 0.0 109.474 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.526 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -146.04 -131.65 2.3 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -144.11 -27.31 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.961 . . . . 0.0 109.476 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -94.21 118.64 31.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.571 -0.706 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -103.31 166.39 10.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.38 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -92.94 144.36 25.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.634 -0.666 . . . . 0.0 109.411 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.627 HD13 HG23 ' A' ' 104' ' ' THR . 22.1 pt -66.13 164.63 27.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.523 -0.736 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.37 104.34 1.62 Allowed 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 125.109 3.873 . . . . 0.0 109.896 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.441 ' ND2' ' OD2' ' A' ' 135' ' ' ASP . 39.7 t30 -81.76 86.92 6.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 0.0 109.488 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -68.58 -17.76 64.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.648 -0.658 . . . . 0.0 109.707 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.45 -29.48 70.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.586 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.441 ' OD2' ' ND2' ' A' ' 132' ' ' ASN . 1.7 m-20 -92.32 29.45 1.68 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.605 -0.684 . . . . 0.0 109.435 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.643 ' CE2' HD11 ' A' ' 113' ' ' LEU . 34.0 m-85 -140.61 173.75 11.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.523 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -146.08 135.95 23.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -72.15 156.24 39.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.52 -31.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.619 -0.675 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -147.2 154.09 40.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.561 -0.712 . . . . 0.0 109.383 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -158.03 109.75 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -93.09 107.3 19.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.644 -0.66 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.542 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -85.62 150.08 24.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.488 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 144' ' ' VAL . 8.8 p -152.74 126.27 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.454 ' HA ' HG23 ' A' ' 152' ' ' THR . 28.0 mt-10 -103.6 118.26 36.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.668 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.12 -166.03 0.96 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.7 p -73.68 -43.25 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.695 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -103.1 137.82 19.37 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.318 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -46.38 -42.16 22.64 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 124.878 3.719 . . . . 0.0 110.184 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.16 85.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.3 mt -76.27 12.64 1.13 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.632 -0.667 . . . . 0.0 109.902 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 145' ' ' GLU . 21.2 m -87.14 137.2 32.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.484 -0.76 . . . . 0.0 109.349 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.556 ' CE1' HD21 ' A' ' 23' ' ' LEU . 33.0 p-80 -155.6 175.05 14.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.64 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.542 HG23 ' HA ' ' A' ' 143' ' ' THR . 24.0 m -141.83 137.82 31.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.58 95.71 9.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.679 -0.638 . . . . 0.0 109.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.86 146.41 37.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.619 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.5 t -138.76 102.86 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.694 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 158' ' ' TRP . 27.9 m95 -104.46 162.53 13.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.563 -0.71 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -148.64 143.42 26.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.716 . . . . 0.0 109.462 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.461 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.502 HG23 HD23 ' A' ' 94' ' ' LEU . 4.0 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.76 103.73 5.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.498 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.753 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -78.53 147.53 33.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.631 -0.668 . . . . 0.0 109.43 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.499 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.7 tp -158.84 111.23 2.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.564 -0.71 . . . . 0.0 109.239 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.43 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.2 p90 -142.39 143.95 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.777 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.87 116.16 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.656 . . . . 0.0 109.281 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.39 156.31 49.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.678 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -104.4 171.14 7.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.419 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.04 -20.16 62.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.852 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.47 14.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.765 . . . . 0.0 109.756 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.86 40.12 98.42 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.5 tp -108.93 162.64 14.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.545 -0.974 . . . . 0.0 109.577 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.722 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -142.85 -29.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.69 . . . . 0.0 109.491 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.89 -175.62 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -174.66 116.33 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.564 -0.962 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.95 34.2 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 0.0 109.662 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -61.42 3.92 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -80.05 -175.95 5.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.622 -0.928 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.539 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 17.9 mt -86.08 156.88 57.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 109.461 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.7 Cg_endo -80.35 -31.15 1.74 Allowed 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 125.049 3.832 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.539 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 29.3 p90 -106.91 170.2 8.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.673 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.5 88.2 2.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.482 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.778 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.3 tp -107.24 80.5 0.86 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.526 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.04 -37.36 17.48 Favored 'Trans proline' 0 N--CA 1.506 2.234 0 C-N-CA 125.056 3.838 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -62.94 -44.89 94.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.778 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -63.03 -38.71 92.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.607 -0.683 . . . . 0.0 109.423 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.89 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -88.3 -28.83 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.695 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -73.02 -25.66 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 34' ' ' THR . 59.2 t80 -64.48 -44.73 90.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' VAL . 32.5 ttp180 -66.7 -26.23 66.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.85 -29.86 50.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.561 -0.712 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -102.61 36.25 2.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.704 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 30' ' ' PHE . 20.5 p -144.68 -28.96 0.47 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.584 -0.698 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -68.95 128.59 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.17 32.94 46.52 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -156.35 165.26 36.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.939 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.3 107.69 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.392 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.446 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.2 ttp -82.63 104.16 12.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.87 126.84 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.533 -0.729 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.5 m -140.75 164.55 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.662 . . . . 0.0 109.432 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.65 -161.01 36.87 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -84.78 -36.6 21.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.568 -0.96 . . . . 0.0 109.45 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -69.6 -37.25 76.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.525 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -75.9 -29.7 58.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 32.2 t80 -66.8 -33.69 76.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.489 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -82.19 -23.04 35.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -63.14 -27.78 69.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -65.24 163.53 30.95 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.736 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.2 -66.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.175 3.917 . . . . 0.0 109.894 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -121.02 103.19 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.618 -0.676 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -94.07 154.19 40.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.0 109.45 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.69 164.57 78.54 Favored 'Cis proline' 0 N--CA 1.508 2.364 0 O-C-N 123.467 1.246 . . . . 0.0 109.844 -0.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.446 HD12 ' CE ' ' A' ' 39' ' ' MET . 81.3 mt -81.61 128.35 69.7 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.556 -0.715 . . . . 0.0 109.297 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.62 172.09 14.83 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 124.798 3.665 . . . . 0.0 109.965 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 61.37 27.75 17.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.574 -0.704 . . . . 0.0 109.8 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -177.2 178.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -105.27 147.29 28.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.62 -0.675 . . . . 0.0 109.519 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -114.92 97.89 6.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -102.67 101.81 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.58 -0.7 . . . . 0.0 109.489 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 120.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.608 -0.682 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.592 HD12 HG23 ' A' ' 76' ' ' VAL . 15.2 tp -101.51 106.4 17.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.425 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -138.86 151.71 47.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.713 . . . . 0.0 109.519 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -97.02 -29.69 13.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.66 -0.65 . . . . 0.0 109.512 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -72.68 124.25 24.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.624 -0.672 . . . . 0.0 109.458 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -82.8 30.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.722 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -34.85 9.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.736 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.75 143.98 45.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.638 -0.664 . . . . 0.0 109.462 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -145.58 101.92 3.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.627 -0.67 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.19 119.95 30.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.612 -0.68 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -83.0 136.27 34.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.458 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.88 39.07 39.82 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.43 155.8 29.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.965 . . . . 0.0 109.52 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.94 95.75 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.611 -0.681 . . . . 0.0 109.483 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.508 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.1 t -80.28 100.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.541 -0.724 . . . . 0.0 109.437 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.592 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -98.7 160.34 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.663 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.508 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.4 m-70 -139.65 30.76 2.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.628 -0.67 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -165.68 146.91 7.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.566 -0.709 . . . . 0.0 109.436 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.49 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -68.39 -34.1 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.697 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -32.31 72.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.28 -37.05 82.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.602 -0.686 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.496 HG22 HG21 ' A' ' 76' ' ' VAL . 29.9 t -67.68 -38.34 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.39 -32.31 66.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.683 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.37 91.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.497 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -68.26 -36.48 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.574 -0.704 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.46 70.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -66.99 -42.79 84.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.33 5.72 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 109.943 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -144.2 87.87 7.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.492 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.11 -23.6 6.35 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.113 3.876 . . . . 0.0 109.856 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.48 -24.91 61.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -100.67 178.58 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.58 -0.7 . . . . 0.0 109.481 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -136.91 172.98 12.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 1' ' ' THR . 12.4 tp -103.94 130.16 51.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.511 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.63 129.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.549 -0.719 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.581 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -98.53 124.42 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.699 . . . . 0.0 109.425 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.6 -24.24 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.634 -0.666 . . . . 0.0 109.542 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.36 -176.46 37.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.48 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.93 -155.12 14.61 Favored Glycine 0 N--CA 1.5 2.904 0 O-C-N 120.235 -1.744 . . . . 0.0 109.589 0.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.9 76.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.565 -0.962 . . . . 0.0 109.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -73.37 -27.74 61.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.48 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -72.62 -35.61 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.545 -0.722 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.581 ' CE1' HG22 ' A' ' 96' ' ' ILE . 27.2 m-85 -63.8 -51.58 64.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.501 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -62.44 -22.65 66.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.58 -49.85 43.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.545 -0.722 . . . . 0.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 79' ' ' VAL . 70.5 m-85 -93.17 13.93 19.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.528 -0.732 . . . . 0.0 109.906 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -67.22 -23.1 65.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.745 . . . . 0.0 109.591 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.53 14.99 0.87 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.541 -0.724 . . . . 0.0 109.839 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.17 38.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.457 -0.777 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.753 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.44 154.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.52 -0.737 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -138.45 -60.06 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.513 -0.742 . . . . 0.0 109.418 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -97.1 111.39 23.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.434 HD11 ' CE2' ' A' ' 136' ' ' PHE . 21.9 mt -96.13 96.38 8.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.55 -0.719 . . . . 0.0 109.586 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.666 ' CD2' HG22 ' A' ' 157' ' ' VAL . 27.5 mt -93.39 116.46 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.589 -0.694 . . . . 0.0 109.287 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.42 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -124.94 141.45 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.705 . . . . 0.0 109.455 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 m -109.49 100.46 9.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.631 -0.668 . . . . 0.0 109.26 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -83.73 133.78 34.78 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.641 -0.662 . . . . 0.0 109.657 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.16 135.92 50.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.3 -37.03 74.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.562 -0.711 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.63 124.88 16.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.8 p -77.69 148.21 35.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.969 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' O ' HD22 ' A' ' 12' ' ' LEU . 93.7 m-85 -148.27 128.25 13.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -86.12 148.59 25.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -154.28 -137.6 2.47 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -145.31 -33.02 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.652 -0.911 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.722 HG22 HD11 ' A' ' 13' ' ' ILE . 2.6 m -92.07 124.2 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -106.35 168.76 8.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.43 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -90.96 147.77 22.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.2 pt -67.73 165.07 33.98 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.42 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 104.7 1.71 Allowed 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 125.138 3.892 . . . . 0.0 109.978 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.5 mt -94.38 133.52 37.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -77.47 85.24 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.602 -0.686 . . . . 0.0 109.469 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.36 -14.21 62.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.582 -0.698 . . . . 0.0 109.815 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.34 -27.14 68.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.78 30.08 2.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.543 -0.723 . . . . 0.0 109.416 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 113' ' ' LEU . 86.7 m-85 -144.95 172.11 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.665 -0.647 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -146.8 131.81 18.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.607 -0.683 . . . . 0.0 109.49 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -74.01 120.51 19.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.554 -0.716 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.08 -34.29 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.651 -0.656 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.1 p -164.12 163.73 22.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.659 -0.65 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.8 p -150.8 133.94 16.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -99.6 113.67 26.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.692 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.526 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.8 m -90.57 150.74 21.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 109.482 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 144' ' ' VAL . 8.8 p -154.07 128.6 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.379 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -107.32 120.46 42.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.579 -0.7 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -80.43 -165.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.8 p -73.9 -39.29 63.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.593 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.66 137.58 19.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.77 -47.32 18.87 Favored 'Trans proline' 0 N--CA 1.507 2.267 0 C-N-CA 124.744 3.629 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.25 70.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.607 -0.683 . . . . 0.0 109.68 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 151' ' ' LEU . 54.6 mt -79.47 18.42 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 109.66 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.3 m -91.64 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.715 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.535 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.9 p-80 -153.08 168.51 25.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.574 -0.704 . . . . 0.0 109.596 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 143' ' ' THR . 13.5 m -135.54 135.85 40.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.562 -0.711 . . . . 0.0 109.41 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -90.16 97.86 11.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.07 143.42 32.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.53 -0.731 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.666 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.1 t -132.4 107.56 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.424 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 30.2 m95 -105.51 169.28 8.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -147.73 145.14 28.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.507 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.3 tttt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.715 . . . . 0.0 109.451 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.02 116.4 16.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.747 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.8 m-85 -90.25 157.74 17.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.68 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.677 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.0 tp -169.51 109.65 0.44 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -140.93 140.29 34.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.564 -0.71 . . . . 0.0 109.68 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.11 111.11 22.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.284 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.5 153.31 48.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.16 170.91 7.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -60.54 -20.08 59.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.508 -0.745 . . . . 0.0 109.851 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.37 14.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.491 -0.755 . . . . 0.0 109.784 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.77 38.11 95.41 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.647 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.2 tp -108.82 168.14 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.944 . . . . 0.0 109.549 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 126' ' ' THR . 30.9 pt -144.1 -29.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.722 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.61 -172.38 26.71 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.59 115.53 0.3 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.585 -0.95 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.07 32.19 20.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.569 -0.707 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.1 -61.38 3.33 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -78.78 171.93 14.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.594 -0.945 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.64 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.4 mt -79.7 154.49 75.95 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.554 -0.716 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.75 -29.86 2.62 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.932 3.754 . . . . 0.0 109.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.64 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.2 p90 -106.34 -177.65 3.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.698 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -134.87 97.89 3.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.759 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.0 tp -118.71 80.25 17.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.499 -0.751 . . . . 0.0 109.486 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -45.78 -40.02 19.04 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 C-N-CA 125.13 3.887 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.45 -43.99 97.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 109.624 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.759 ' HB2' HD23 ' A' ' 23' ' ' LEU . 35.8 t70 -66.15 -38.72 88.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.577 -0.702 . . . . 0.0 109.409 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.45 -23.9 67.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.516 -0.74 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -82.3 -29.24 31.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.2 t80 -72.14 -26.92 62.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 109.422 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 34' ' ' THR . 46.8 t80 -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.441 ' HD3' HH12 ' A' ' 57' ' ' ARG . 10.5 tpp85 -63.71 -28.26 69.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.584 -0.697 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.39 -28.13 34.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.9 mm100 -101.57 34.95 2.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.404 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 30' ' ' PHE . 9.6 p -137.66 -34.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 35' ' ' VAL . 27.3 m -80.59 128.59 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.484 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.96 -31.01 9.14 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -113.92 164.15 14.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -79.83 122.03 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.51 -0.744 . . . . 0.0 109.377 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.481 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.3 ttp -91.28 105.63 17.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.442 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG21 HD11 ' A' ' 94' ' ' LEU . 30.4 t -94.26 130.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.433 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.1 m -146.77 164.33 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.6 -0.688 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.82 -163.8 38.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -84.34 -36.37 22.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.974 . . . . 0.0 109.553 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.1 ttp85 -68.08 -37.84 81.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -75.81 -28.93 58.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 0.0 109.501 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -36.43 83.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.66 -26.16 26.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.7 p -63.93 -19.51 65.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.13 161.21 25.4 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.11 -71.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.162 3.908 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -115.21 94.77 4.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.64 -0.662 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -98.0 157.27 34.84 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.78 147.22 73.88 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 O-C-N 123.347 1.183 . . . . 0.0 110.007 0.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.481 HD12 ' CE ' ' A' ' 39' ' ' MET . 74.9 mt -69.62 113.63 18.57 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.353 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.11 179.38 6.5 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.766 3.644 . . . . 0.0 109.899 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 61.28 26.39 16.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.459 -0.776 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.441 HH12 ' HD3' ' A' ' 31' ' ' ARG . 11.6 ptp180 -176.63 176.91 1.48 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.534 -0.729 . . . . 0.0 109.462 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -107.29 121.66 45.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.473 HD21 ' HB2' ' A' ' 54' ' ' LEU . 2.2 m-80 -97.57 111.53 23.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.9 t -107.08 112.48 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.45 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -95.95 128.27 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.674 HD12 HG23 ' A' ' 76' ' ' VAL . 14.4 tp -105.66 119.3 38.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -152.22 133.94 14.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.651 -0.656 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -92.37 30.52 1.47 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.729 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -111.15 130.41 55.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.698 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.04 31.61 0.78 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.683 . . . . 0.0 109.427 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -131.13 -25.81 2.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.671 . . . . 0.0 109.448 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -64.49 145.34 56.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.488 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.22 140.09 35.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.63 -0.669 . . . . 0.0 109.469 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . . . -137.83 122.85 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -90.66 135.0 33.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.635 -0.666 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.71 36.68 67.01 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.67 138.35 14.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.566 -0.961 . . . . 0.0 109.468 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.4 94.58 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.596 -0.69 . . . . 0.0 109.444 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.648 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.5 t -74.86 100.41 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.556 -0.715 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.674 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -91.82 155.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.565 -0.709 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.648 ' NE2' HG12 ' A' ' 75' ' ' VAL . 49.8 m-70 -136.31 29.96 2.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.97 152.1 2.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.658 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.32 -33.8 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -31.13 69.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.567 -0.708 . . . . 0.0 109.501 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.21 79.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.633 -0.667 . . . . 0.0 109.476 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 76' ' ' VAL . 31.4 t -69.14 -42.56 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -71.23 -29.02 64.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.76 86.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -69.55 -35.96 75.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.31 -26.52 64.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.472 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -64.36 -43.91 93.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.56 -0.712 . . . . 0.0 109.467 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.98 -30.38 69.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.592 -0.692 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -119.71 89.9 42.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.09 -23.21 6.69 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 125.024 3.816 . . . . 0.0 109.96 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -68.75 -25.77 64.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.91 -179.91 5.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -138.15 161.81 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.579 -0.701 . . . . 0.0 109.518 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.433 HD11 HG21 ' A' ' 40' ' ' VAL . 11.8 tp -99.6 133.29 44.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.561 -0.712 . . . . 0.0 109.476 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.0 136.32 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.565 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.7 mm -102.24 120.02 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.452 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -107.25 -26.59 10.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.486 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.26 -176.71 38.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.417 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.41 -153.18 14.12 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 120.361 -1.67 . . . . 0.0 109.604 0.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.24 -32.38 73.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.605 -0.938 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.28 -27.74 60.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.417 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.6 mm -74.88 -34.75 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.565 ' CE1' HG22 ' A' ' 96' ' ' ILE . 23.6 m-85 -63.48 -54.29 38.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.448 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 m -63.16 -24.59 67.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.76 76.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CE1' HG13 ' A' ' 79' ' ' VAL . 49.8 m-85 -106.14 13.13 29.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.581 -0.699 . . . . 0.0 109.84 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -71.32 -25.41 62.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 0.0 109.549 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.93 13.83 0.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.65 -0.657 . . . . 0.0 109.857 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.09 36.83 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.747 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.28 149.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -126.27 -49.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 m -107.49 158.24 17.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.8 mt -137.23 104.84 5.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.677 ' CB ' HD12 ' A' ' 4' ' ' LEU . 44.4 mt -103.55 105.06 15.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.497 -0.752 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.8 p -111.81 136.32 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 109.495 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -108.3 99.85 9.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -83.37 149.04 26.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.637 -0.665 . . . . 0.0 109.5 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.54 132.14 52.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.605 -0.684 . . . . 0.0 109.305 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.22 77.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.555 -0.715 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.85 128.75 17.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 p -83.69 141.94 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.627 -0.925 . . . . 0.0 109.436 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -145.88 126.27 14.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.717 . . . . 0.0 109.39 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -89.16 148.04 23.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 109.508 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.647 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -149.39 -136.03 2.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -138.4 -31.44 0.75 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.92 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.611 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -97.7 143.2 28.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -122.87 176.96 5.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.58 -0.7 . . . . 0.0 109.486 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.8 tpt -97.92 152.56 19.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.556 -0.715 . . . . 0.0 109.468 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.9 pt -72.0 163.41 67.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.677 -0.639 . . . . 0.0 109.525 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.14 96.87 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 125.162 3.908 . . . . 0.0 109.91 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.1 mt -85.96 134.9 33.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.705 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -79.97 86.59 5.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.528 -0.733 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -67.32 -14.84 63.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.562 -0.711 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.26 -27.65 69.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.452 -0.78 . . . . 0.0 109.509 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.65 29.57 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.557 -0.715 . . . . 0.0 109.449 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -142.08 179.79 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.528 -0.732 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 m -153.88 139.45 17.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 0.0 109.487 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -77.85 156.45 30.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.696 . . . . 0.0 109.509 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.09 -32.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -151.65 153.14 33.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.7 p -150.15 122.45 8.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 109.5 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -97.3 98.86 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 0.0 109.472 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.4 m -84.15 139.86 32.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.602 -0.686 . . . . 0.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.42 HG13 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -148.51 136.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.9 123.87 50.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.677 . . . . 0.0 109.419 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -79.96 -165.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.1 p -72.67 -40.79 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.548 -0.72 . . . . 0.0 109.638 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.437 ' HB3' HD12 ' A' ' 151' ' ' LEU . 28.4 t-20 -100.63 138.13 20.04 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.684 . . . . 0.0 109.494 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.52 -46.48 23.58 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 124.717 3.611 . . . . 0.0 109.983 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.69 -27.66 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.733 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 148' ' ' ASN . 28.1 mt -79.98 18.36 0.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.9 m -86.61 143.71 27.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.403 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.563 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.8 p-80 -155.9 163.82 39.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.672 . . . . 0.0 109.547 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 143' ' ' THR . 23.2 m -137.69 134.55 35.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 109.472 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.38 96.39 10.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -81.99 136.66 35.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.54 -0.725 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.643 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.8 t -125.47 109.07 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.0 m95 -103.88 169.26 8.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -143.57 140.61 30.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 48.2 tttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.493 -0.754 . . . . 0.0 109.467 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.86 95.67 3.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.734 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -68.38 134.05 49.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.54 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.9 tp -148.53 113.03 5.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.373 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -143.98 145.47 32.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.499 -0.751 . . . . 0.0 109.711 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.64 107.27 19.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 0.0 109.26 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HB3' HG22 ' A' ' 13' ' ' ILE . 9.3 pt20 -127.1 157.7 38.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.643 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -97.65 170.08 9.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -61.23 -17.54 53.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.67 14.17 0.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.728 . . . . 0.0 109.865 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.11 39.21 97.33 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.496 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.8 tp -126.02 151.51 47.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.624 -0.927 . . . . 0.0 109.413 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 126' ' ' THR . 30.5 pt -111.39 -32.02 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.649 -0.657 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.02 -150.29 18.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -169.99 147.59 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.61 -0.935 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.402 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 0.4 OUTLIER 60.63 8.11 1.62 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.22 -48.77 1.54 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' A' ' 16' ' ' ASP . 22.0 p80 -72.15 165.73 23.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.494 -1.004 . . . . 0.0 109.566 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.728 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 13.6 mt -87.35 147.7 42.8 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.678 . . . . 0.0 109.52 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -82.01 -31.81 0.92 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 124.987 3.791 . . . . 0.0 109.767 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.728 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 26.3 p90 -101.26 157.36 16.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.727 -0.608 . . . . 0.0 109.497 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -106.09 98.13 7.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.5 tp -121.04 79.8 34.06 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.424 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.47 -39.03 16.66 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 125.142 3.894 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.95 -42.55 99.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.692 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.795 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.0 t0 -68.02 -29.78 68.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.567 -0.708 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -84.8 -29.71 25.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 18.2 t80 -71.09 -27.0 63.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 34' ' ' THR . 57.4 t80 -65.17 -45.58 84.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.624 -0.672 . . . . 0.0 109.461 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -66.15 -30.05 70.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.505 -0.747 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.98 -31.53 56.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.2 mm100 -97.07 32.32 2.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.55 -0.719 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.5 p -137.89 -34.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.449 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.9 m -69.25 125.91 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.64 -0.663 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.87 34.89 23.35 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -152.69 174.38 14.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.591 -0.946 . . . . 0.0 109.416 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.77 100.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 109.401 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.675 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.7 tmm? -71.81 131.79 43.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 109.451 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.524 HG21 HD11 ' A' ' 94' ' ' LEU . 30.2 t -135.25 117.98 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.499 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.675 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.7 m -134.43 -173.3 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.524 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.97 -173.89 29.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -76.28 -35.31 58.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.61 -0.935 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -69.71 -39.39 76.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 m -76.33 -27.24 56.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.433 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' CD1' HG22 ' A' ' 61' ' ' VAL . 34.2 t80 -63.34 -39.82 95.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -87.34 -22.93 24.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.632 -0.668 . . . . 0.0 109.594 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 m -62.87 -22.66 66.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -62.1 162.22 19.39 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.542 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -73.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.159 3.906 . . . . 0.0 109.897 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.47 90.42 3.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.439 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt85 -93.66 157.13 38.83 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.644 -0.66 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.8 -174.79 15.18 Favored 'Cis proline' 0 N--CA 1.508 2.353 0 O-C-N 123.447 1.235 . . . . 0.0 110.035 0.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.65 105.99 52.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 109.374 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -75.05 -178.7 4.37 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 124.602 3.534 . . . . 0.0 109.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.55 23.41 13.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -176.27 175.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.435 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -95.84 143.89 26.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.46 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -116.9 117.62 30.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.47 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.07 103.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.403 HG22 ' CD1' ' A' ' 46' ' ' TYR . 30.6 t -91.64 136.45 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.484 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD12 HG23 ' A' ' 76' ' ' VAL . 14.3 tp -104.04 115.22 30.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -143.11 146.92 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.691 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -93.58 -35.16 13.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -73.46 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.639 -0.663 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.16 30.1 0.54 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.71 -35.75 8.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -71.31 139.6 49.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.532 -0.73 . . . . 0.0 109.477 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -142.67 100.13 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.42 117.69 24.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.9 131.63 42.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 38.85 34.6 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.74 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.555 -0.968 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 t -75.09 98.27 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.432 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.2 t -78.84 99.06 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.46 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.602 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -90.11 164.93 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.432 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.9 m-70 -141.46 27.93 1.86 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.44 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -174.9 153.42 1.69 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.68 -30.84 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.641 -0.662 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.99 69.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.649 -0.657 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.49 58.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.517 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -68.18 -46.35 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.493 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -71.72 -28.84 63.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.83 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.644 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -72.44 -33.7 67.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.87 -30.9 68.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -66.84 -40.75 88.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -67.27 -30.3 70.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.469 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -119.84 89.87 42.68 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.22 -22.43 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.196 3.93 . . . . 0.0 109.947 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -66.98 -26.6 66.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.52 -0.738 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -96.22 -179.86 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.514 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -137.53 154.63 49.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.43 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 40' ' ' VAL . 9.1 tp -86.65 141.33 29.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.586 -0.696 . . . . 0.0 109.445 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -146.93 118.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.55 -0.719 . . . . 0.0 109.488 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.7 mm -91.76 125.88 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.465 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.447 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -100.93 -34.93 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.97 -178.45 39.37 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.01 -152.26 16.81 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 120.356 -1.673 . . . . 0.0 109.529 0.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.14 65.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.948 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -69.62 -33.44 72.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -75.3 -38.54 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.537 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 28.9 m-85 -63.08 -51.51 66.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -62.87 -23.98 67.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.603 -0.686 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.18 61.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.567 ' CE1' HG13 ' A' ' 79' ' ' VAL . 57.3 m-85 -111.74 17.36 19.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.695 -0.628 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -27.0 65.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.82 18.69 0.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.55 -0.719 . . . . 0.0 109.703 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.15 36.32 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -91.39 150.76 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.505 -0.747 . . . . 0.0 109.366 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -132.36 -55.97 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.413 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 m -102.06 125.66 48.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.706 . . . . 0.0 109.375 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.476 HD11 ' CE2' ' A' ' 136' ' ' PHE . 31.9 mt -108.71 96.55 6.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.605 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.569 ' CD2' HG22 ' A' ' 157' ' ' VAL . 40.2 mt -95.13 105.7 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 109.298 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -111.85 143.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.631 -0.668 . . . . 0.0 109.505 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.8 m -117.69 99.58 7.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.251 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 mtt85 -85.19 141.67 29.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.01 138.72 49.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.611 -0.681 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.92 72.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.602 -0.686 . . . . 0.0 109.433 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.52 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -75.34 132.48 13.4 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.6 m -85.32 142.52 29.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.966 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -143.13 135.24 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -97.68 155.29 17.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.541 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -159.69 -139.54 2.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.58 -26.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.48 HG22 HD11 ' A' ' 13' ' ' ILE . 18.8 m -97.82 116.83 30.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.488 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -100.77 167.71 10.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.448 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -85.65 149.97 24.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.468 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.39 164.78 58.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.608 -0.683 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 101.79 1.37 Allowed 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 125.104 3.87 . . . . 0.0 109.871 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.19 157.25 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -88.64 86.55 7.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -73.45 -17.5 61.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.783 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.19 9.88 1.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.541 -0.724 . . . . 0.0 109.848 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -132.34 29.16 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.732 . . . . 0.0 109.392 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.476 ' CE2' HD11 ' A' ' 113' ' ' LEU . 66.2 m-85 -144.33 178.82 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.606 -0.684 . . . . 0.0 109.507 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.4 m -151.69 138.71 19.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.631 -0.668 . . . . 0.0 109.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -79.69 120.59 24.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.45 -32.93 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.549 -0.719 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.8 t -150.73 176.0 11.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -163.48 116.61 1.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 109.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -95.09 108.2 20.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.546 -0.721 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.2 m -92.33 144.58 25.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.44 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -146.83 127.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 152' ' ' THR . 13.1 mp0 -101.89 119.13 38.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 109.422 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.07 -168.66 1.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.59 -0.694 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.3 p -72.18 -43.07 65.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.588 -0.695 . . . . 0.0 109.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -101.77 137.85 19.67 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.41 -48.38 11.76 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 124.996 3.797 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.52 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -62.38 -35.09 78.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.572 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 151' ' ' LEU . 35.2 mt -72.06 6.31 2.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 109.868 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.0 m -80.67 146.19 31.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.36 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.537 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.4 p-80 -160.79 167.87 25.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.569 -0.707 . . . . 0.0 109.55 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 143' ' ' THR . 26.0 m -140.13 139.34 35.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.578 -0.701 . . . . 0.0 109.335 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.52 99.38 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.52 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.9 mt-10 -80.9 130.97 35.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.475 -0.766 . . . . 0.0 109.438 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.569 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -115.16 103.53 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.695 . . . . 0.0 109.45 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.52 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 34.1 m95 -101.01 165.26 11.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.511 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -147.57 145.3 29.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.565 -0.71 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 56.9 tttt . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.519 179.979 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.474 HG23 HD23 ' A' ' 94' ' ' LEU . 5.8 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.473 ' H ' HG22 ' A' ' 1' ' ' THR . . . -137.5 133.15 34.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.548 -0.72 . . . . 0.0 109.466 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -100.95 160.87 14.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.701 . . . . 0.0 109.437 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.9 tp -169.55 109.06 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.68 . . . . 0.0 109.35 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.3 p90 -140.91 146.66 37.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.4 112.22 24.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.2 pt20 -132.61 149.85 52.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.58 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -99.13 170.8 8.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -61.3 -18.7 59.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.818 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' CG ' ' HG ' ' A' ' 121' ' ' SER . 2.0 m-20 -77.46 15.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.445 -0.784 . . . . 0.0 109.858 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.37 35.32 91.5 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 122' ' ' PHE . 5.9 tp -107.34 167.12 10.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 126' ' ' THR . 31.2 pt -141.86 -30.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.521 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -166.43 -167.41 27.06 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -172.49 121.22 0.42 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.627 -0.925 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 57.99 34.0 23.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.706 . . . . 0.0 109.923 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.92 -63.69 2.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -76.26 177.46 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.54 -0.977 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.584 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 29.4 mt -84.94 156.9 60.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.576 -0.703 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.26 -28.38 3.05 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 125.055 3.836 . . . . 0.0 109.923 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.584 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 33.3 p90 -108.09 176.02 5.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -126.55 98.85 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.693 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 18.8 tp -118.23 80.44 15.69 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 109.51 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -45.88 -37.74 17.21 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 125.051 3.834 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.63 -45.51 92.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.5 t0 -63.09 -39.66 95.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.474 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.77 -23.62 67.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -86.07 -28.54 24.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.365 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -71.67 -26.51 62.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.672 . . . . 0.0 109.476 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 34' ' ' THR . 49.6 t80 -65.27 -46.33 80.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.547 -0.72 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -71.09 2.72 4.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.643 . . . . 0.0 109.994 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.02 -33.06 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.831 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -107.99 30.46 6.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.51 HG21 ' CE2' ' A' ' 30' ' ' PHE . 19.0 p -126.63 -30.59 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.483 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.13 134.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.573 -0.704 . . . . 0.0 109.445 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.18 34.29 64.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -156.92 165.78 35.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.954 . . . . 0.0 109.511 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.8 mt -92.51 111.61 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.594 -0.691 . . . . 0.0 109.465 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.0 ttp -87.83 111.7 21.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 94' ' ' LEU . 29.0 t -98.87 122.48 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.42 161.54 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.652 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.81 -177.61 52.03 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -72.35 -38.36 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.457 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.8 mtm-85 -68.23 -34.08 75.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -78.68 -28.82 45.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.579 -0.701 . . . . 0.0 109.459 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 35.7 t80 -68.17 -29.22 68.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.541 -0.725 . . . . 0.0 109.496 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -85.8 -24.62 26.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.537 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p -63.6 -25.34 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.635 -0.666 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -63.98 161.26 40.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.542 -0.724 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.81 -61.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.084 3.856 . . . . 0.0 109.878 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -126.37 77.01 1.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.394 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -79.87 150.73 72.69 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 0.0 109.588 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.41 161.64 87.09 Favored 'Cis proline' 0 N--CA 1.51 2.466 0 O-C-N 123.445 1.234 . . . . 0.0 109.859 0.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.5 mt -78.53 142.93 62.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -80.58 162.62 21.78 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 124.914 3.742 . . . . 0.0 110.037 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.08 28.46 18.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.544 -0.723 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -177.83 146.36 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.555 -0.715 . . . . 0.0 109.629 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.41 ' C ' HD22 ' A' ' 59' ' ' ASN . 3.3 m -78.43 152.42 32.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.589 -0.694 . . . . 0.0 109.455 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.428 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 1.9 m-80 -123.79 97.67 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.695 . . . . 0.0 109.5 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -91.62 149.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -136.03 120.72 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.445 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 76' ' ' VAL . 15.1 tp -96.21 119.52 34.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 109.492 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.37 146.07 36.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -100.57 31.21 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -150.95 137.17 18.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.635 -0.666 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -87.74 32.19 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -95.14 -38.04 10.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.668 -0.645 . . . . 0.0 109.475 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -73.56 158.18 35.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -151.73 101.52 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.45 115.33 27.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.544 -0.722 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -80.36 124.5 28.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.63 -0.669 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.82 40.38 12.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -156.47 153.82 29.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.598 -0.942 . . . . 0.0 109.558 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -86.29 94.29 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.586 -0.696 . . . . 0.0 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.507 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.4 t -75.55 103.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.63 -0.669 . . . . 0.0 109.444 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -96.57 157.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.519 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.507 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.0 m-70 -135.95 30.68 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.482 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -169.98 146.46 3.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.613 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -67.95 -32.37 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.638 -0.664 . . . . 0.0 109.476 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.79 70.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.738 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.46 -35.21 78.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -68.45 -33.31 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.45 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.15 -31.22 39.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.661 -0.649 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.46 67.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.458 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.53 -25.32 22.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.635 -0.665 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.17 -33.18 50.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.83 -31.51 72.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.546 -0.721 . . . . 0.0 109.5 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.36 -26.12 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.674 -0.641 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.37 90.28 42.01 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.465 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.25 -22.46 8.33 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.077 3.852 . . . . 0.0 109.95 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.94 -27.18 65.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -96.99 -179.99 4.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -138.02 150.68 47.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.474 HD23 HG23 ' A' ' 1' ' ' THR . 9.3 tp -88.08 130.2 35.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.6 t -128.83 129.86 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.525 -0.734 . . . . 0.0 109.435 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.543 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.9 mm -96.64 116.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.613 -0.68 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -104.08 -29.97 10.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.66 -175.51 39.06 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.05 -151.86 11.02 Favored Glycine 0 N--CA 1.5 2.902 0 O-C-N 120.298 -1.707 . . . . 0.0 109.567 -0.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.12 -30.64 69.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.606 -0.938 . . . . 0.0 109.483 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.73 -27.56 60.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 0.0 109.425 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -77.26 -33.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.543 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.0 m-85 -63.38 -58.19 7.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.483 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -62.91 -21.92 66.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.596 -0.69 . . . . 0.0 109.617 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.55 -29.13 64.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.613 ' CE1' HG13 ' A' ' 79' ' ' VAL . 54.5 m-85 -117.35 16.55 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.707 . . . . 0.0 109.778 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.642 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -69.43 -23.03 63.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.636 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.05 -39.01 83.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.569 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.8 41.28 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.866 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -91.17 151.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.748 . . . . 0.0 109.315 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -134.57 -66.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.581 -0.699 . . . . 0.0 109.441 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -90.03 161.92 15.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 136' ' ' PHE . 59.3 mt -140.78 96.85 3.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.557 -0.714 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.632 ' CB ' HD12 ' A' ' 4' ' ' LEU . 42.4 mt -95.69 104.44 16.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.322 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.0 p -111.23 137.43 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.2 m -109.19 99.16 8.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.337 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -85.07 139.62 31.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.04 140.05 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.294 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.28 -34.33 68.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.575 -0.703 . . . . 0.0 109.487 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.67 128.77 18.26 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.408 ' HG ' ' CG ' ' A' ' 10' ' ' ASP . 31.2 t -77.35 137.33 38.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.632 -0.923 . . . . 0.0 109.493 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.526 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.8 m-85 -144.09 117.78 9.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.608 -0.683 . . . . 0.0 109.522 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -93.06 145.29 24.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.461 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -142.8 -120.21 1.52 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.06 -36.35 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.674 -0.898 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.677 HG22 HD11 ' A' ' 13' ' ' ILE . 4.8 m -93.14 144.38 25.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.625 -0.672 . . . . 0.0 109.584 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -122.78 176.42 5.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.692 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -91.74 150.95 20.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.695 . . . . 0.0 109.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.9 pt -73.67 165.55 52.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.705 . . . . 0.0 109.456 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.95 92.72 1.09 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.123 3.882 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -77.87 149.73 34.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.595 -0.69 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -81.63 81.83 7.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -70.14 -13.92 62.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 9.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.386 -0.821 . . . . 0.0 109.904 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -136.82 30.26 2.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 113' ' ' LEU . 60.2 m-85 -139.41 177.03 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.711 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -153.69 143.56 21.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.659 -0.651 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -76.22 157.04 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.582 -0.699 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.29 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.502 -0.749 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 t -147.13 159.52 43.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.632 -0.667 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.9 t -157.12 111.06 2.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.68 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -95.88 106.82 19.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.455 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.0 m -90.19 143.37 26.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -147.29 131.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.405 ' HA ' HG23 ' A' ' 152' ' ' THR . 25.0 mt-10 -109.39 121.85 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.687 . . . . 0.0 109.48 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.33 -171.59 3.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.9 p -63.2 -45.05 93.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.313 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.46 158.91 42.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -78.81 -23.09 8.4 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 124.915 3.743 . . . . 0.0 109.819 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.76 -23.02 29.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.513 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 mt -86.01 16.84 3.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.715 . . . . 0.0 109.817 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 145' ' ' GLU . 15.0 m -82.62 146.25 29.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.49 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.8 p-80 -160.26 166.45 29.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 109.544 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 143' ' ' THR . 19.6 m -138.67 138.65 37.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.586 -0.696 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -93.69 92.19 7.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 39.0 mm-40 -74.43 126.23 30.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -110.89 112.15 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.484 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.532 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 33.4 m95 -109.22 168.34 9.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -147.1 141.08 25.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.698 . . . . 0.0 109.452 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.31 113.27 13.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.558 -0.714 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.726 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -86.92 153.39 21.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.511 HD12 ' CB ' ' A' ' 114' ' ' LEU . 16.6 tp -163.28 109.85 1.16 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 0.0 109.359 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.3 p90 -141.2 146.12 36.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.546 -0.721 . . . . 0.0 109.708 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.78 113.04 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.587 -0.696 . . . . 0.0 109.245 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 152.45 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.543 -0.723 . . . . 0.0 109.66 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -102.97 171.21 7.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 -60.92 -19.45 60.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.554 -0.716 . . . . 0.0 109.808 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.45 14.86 0.88 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.491 -0.756 . . . . 0.0 109.736 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.17 36.89 93.63 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 122' ' ' PHE . 5.6 tp -106.65 167.33 9.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.936 . . . . 0.0 109.473 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.559 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -142.57 -29.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -176.15 -176.56 44.46 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -164.19 124.1 2.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.942 . . . . 0.0 109.53 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 29.18 18.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.517 -0.739 . . . . 0.0 109.754 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -62.42 2.51 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -72.4 -179.78 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.94 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.684 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.7 mt -91.4 157.83 41.76 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.464 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.463 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.34 -30.24 2.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.063 3.842 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.684 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.9 p90 -105.44 -175.45 2.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.585 -0.697 . . . . 0.0 109.527 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -134.28 103.06 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.361 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.767 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.8 tp -124.74 82.39 60.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HA ' HD12 ' A' ' 27' ' ' LEU . 7.6 Cg_exo -45.44 -38.78 16.22 Favored 'Trans proline' 0 N--CA 1.508 2.329 0 C-N-CA 125.066 3.844 . . . . 0.0 110.21 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.79 -47.37 83.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.472 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.767 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.5 t0 -64.47 -28.95 70.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.512 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 24' ' ' PRO . 83.9 mt -72.72 -23.69 60.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -87.18 -27.83 22.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.581 -0.7 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -69.68 -28.44 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 34' ' ' THR . 59.9 t80 -67.59 -45.7 74.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -67.12 -26.25 66.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.65 -0.656 . . . . 0.0 109.46 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.7 -28.07 40.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.549 -0.719 . . . . 0.0 109.462 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -104.72 35.71 2.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 30' ' ' PHE . 13.9 p -139.26 -27.01 0.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.694 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -68.29 124.26 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.64 . . . . 0.0 109.501 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 37.84 61.54 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -146.93 164.12 33.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.529 -0.983 . . . . 0.0 109.534 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.1 103.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.432 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.415 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.3 ttp -86.49 105.17 16.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.64 -0.663 . . . . 0.0 109.481 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 t -94.24 124.54 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.5 166.26 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 109.489 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.31 -164.25 40.08 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -81.85 -37.49 26.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.62 -0.929 . . . . 0.0 109.441 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -66.99 -42.3 85.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.643 -0.66 . . . . 0.0 109.486 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -72.27 -26.11 61.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.612 -0.68 . . . . 0.0 109.456 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -64.32 -41.3 96.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.442 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -85.37 -21.18 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.63 -0.668 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -62.71 -24.26 67.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.739 . . . . 0.0 109.608 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -62.83 161.06 31.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.98 -72.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.194 3.929 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -107.36 94.46 5.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -99.01 157.18 34.55 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.77 153.46 83.03 Favored 'Cis proline' 0 N--CA 1.508 2.35 0 O-C-N 123.37 1.195 . . . . 0.0 109.967 0.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.415 HD12 ' CE ' ' A' ' 39' ' ' MET . 84.7 mt -76.45 114.06 34.78 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.636 -0.665 . . . . 0.0 109.282 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.28 -179.16 5.17 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 124.791 3.66 . . . . 0.0 109.906 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 60.81 32.13 20.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.714 . . . . 0.0 109.666 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -177.11 -171.59 0.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.764 . . . . 0.0 109.544 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -118.06 113.09 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.601 -0.687 . . . . 0.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.435 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -83.49 103.67 13.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 0.0 109.417 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.62 92.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.582 -0.699 . . . . 0.0 109.461 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -79.66 136.86 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.779 HD12 HG23 ' A' ' 76' ' ' VAL . 14.6 tp -108.65 109.75 21.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.677 -0.64 . . . . 0.0 109.499 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -137.51 151.69 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.461 ' CD2' ' HG2' ' A' ' 65' ' ' GLN . 37.2 p-80 -95.76 -33.9 12.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.461 ' HG2' ' CD2' ' A' ' 64' ' ' HIS . 10.1 mm-40 -77.22 128.81 35.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.386 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 13.9 pt-20 -85.16 30.36 0.6 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.714 . . . . 0.0 109.522 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -98.43 -36.37 9.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.692 . . . . 0.0 109.579 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -71.04 146.76 49.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -143.96 103.4 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.33 117.61 26.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -74.62 127.37 32.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.63 -0.669 . . . . 0.0 109.487 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.28 38.06 35.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.8 144.47 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.958 . . . . 0.0 109.417 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -79.69 104.45 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.6 t -85.65 94.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.555 -0.715 . . . . 0.0 109.414 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.779 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -88.6 171.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.451 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -143.95 29.96 1.33 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.493 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -171.22 142.86 1.81 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.559 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.5 t -66.55 -33.64 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.85 74.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.659 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.02 79.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.627 -0.671 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -67.06 -40.25 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.89 -29.55 66.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.42 77.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.665 . . . . 0.0 109.529 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -72.39 -34.14 67.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.513 -0.742 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.79 -30.49 68.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -65.81 -40.4 91.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -65.69 -29.63 70.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.619 -0.676 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -118.99 90.06 40.33 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.01 -23.54 6.52 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.061 3.841 . . . . 0.0 109.828 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.56 -25.31 63.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.676 -0.64 . . . . 0.0 109.495 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 1.4 tp60 -94.6 179.85 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 28.4 mt-10 -136.52 155.61 49.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.598 -0.689 . . . . 0.0 109.468 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -97.4 147.81 23.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.606 -0.684 . . . . 0.0 109.462 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -145.92 139.12 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.585 -0.697 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.541 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.9 mm -105.21 120.55 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.429 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -101.97 -29.1 12.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 109.415 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 156.67 -174.41 34.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.97 -150.14 9.06 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.266 -1.726 . . . . 0.0 109.58 -0.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.17 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.962 . . . . 0.0 109.53 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.51 -28.06 65.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.601 -0.687 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -79.44 -36.12 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.541 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.4 m-85 -63.3 -52.96 59.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.478 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.773 HG23 HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -63.13 -28.04 69.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.61 -0.681 . . . . 0.0 109.535 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.46 79.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.679 . . . . 0.0 109.534 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.61 8.78 41.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.503 -0.748 . . . . 0.0 109.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HE2' HD22 ' A' ' 131' ' ' LEU . 19.9 tptp -66.07 -30.67 71.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.56 14.45 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.0 109.873 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -160.1 37.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.741 . . . . 0.0 109.402 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.726 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -95.77 153.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.596 -0.69 . . . . 0.0 109.442 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -130.94 -52.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -102.29 158.69 16.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.675 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.539 HD11 ' CE2' ' A' ' 136' ' ' PHE . 32.8 mt -139.49 107.7 5.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.539 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.558 ' CD2' HG22 ' A' ' 157' ' ' VAL . 37.8 mt -104.66 102.51 12.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.242 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -108.27 137.92 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.526 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -109.09 99.82 9.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -81.98 147.66 29.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.712 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -126.33 131.92 51.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.554 -0.716 . . . . 0.0 109.277 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.69 71.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.464 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.8 127.47 13.48 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.4 p -79.16 140.66 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.934 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.483 ' O ' HD22 ' A' ' 12' ' ' LEU . 96.1 m-85 -147.95 129.53 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.462 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -99.35 151.03 21.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.535 -0.728 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -147.56 -122.38 1.32 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -146.27 -36.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.599 -0.942 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.559 HG22 HD11 ' A' ' 13' ' ' ILE . 3.2 m -99.42 135.74 40.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.416 ' O ' HD13 ' A' ' 13' ' ' ILE . 52.2 mtpt -110.32 179.95 3.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.435 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.15 144.73 25.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 109.548 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.773 HD13 HG23 ' A' ' 104' ' ' THR . 28.8 pt -67.27 163.5 45.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.632 -0.668 . . . . 0.0 109.534 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.79 94.85 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 125.137 3.891 . . . . 0.0 109.945 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.471 HD22 ' HE2' ' A' ' 107' ' ' LYS . 50.1 mt -77.91 147.29 35.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.523 -0.736 . . . . 0.0 109.388 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -79.67 86.75 5.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -73.94 -11.76 60.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.953 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.01 10.11 1.31 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -138.56 30.73 2.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 113' ' ' LEU . 55.2 m-85 -143.21 176.96 8.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.504 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.3 m -156.69 140.14 15.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HE3' ' CZ2' ' A' ' 158' ' ' TRP . 31.2 ttmt -81.95 120.87 25.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.567 -0.708 . . . . 0.0 109.492 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.02 -35.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.724 . . . . 0.0 109.51 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.4 p -148.64 170.26 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.1 p -157.49 113.64 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.36 104.1 16.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.538 -0.726 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.451 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.3 m -86.02 147.09 26.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.401 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -151.74 132.49 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.586 -0.696 . . . . 0.0 109.38 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -107.6 128.91 54.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.81 -166.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -69.96 -39.0 76.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -105.38 137.7 19.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.42 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -48.53 -43.7 32.44 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 124.775 3.65 . . . . 0.0 110.059 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.88 -29.06 69.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.537 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.7 mt -80.71 21.2 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.6 m -89.06 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.501 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.6 p-80 -153.76 168.23 26.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.451 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.4 m -141.67 128.25 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 109.42 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -84.52 95.83 8.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.493 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 25.7 mt-10 -81.12 130.4 35.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.7 t -117.6 106.06 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.509 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.493 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.5 m95 -100.48 166.81 10.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.721 . . . . 0.0 109.481 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -142.49 147.14 35.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttm . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.695 . . . . 0.0 109.501 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.414 HG23 HD22 ' A' ' 94' ' ' LEU . 6.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.37 20.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.817 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.8 m-85 -87.92 135.03 33.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.587 -0.696 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.603 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.4 tp -150.08 112.91 4.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.722 . . . . 0.0 109.467 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -144.23 138.79 28.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.536 -0.727 . . . . 0.0 109.735 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.84 111.19 22.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -129.75 157.64 41.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.515 -0.74 . . . . 0.0 109.68 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -101.32 168.44 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.559 -0.713 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -60.77 -23.88 65.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 109.713 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.71 -1.44 3.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.636 -0.665 . . . . 0.0 109.907 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.75 44.79 19.1 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.633 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.9 tp -124.55 152.32 43.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.562 -0.963 . . . . 0.0 109.53 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.902 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -128.01 -33.87 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.569 -0.707 . . . . 0.0 109.81 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.422 ' H ' HD13 ' A' ' 13' ' ' ILE . . . -146.01 178.84 23.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -172.03 116.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.624 -0.927 . . . . 0.0 109.543 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.86 31.18 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.507 -0.745 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.55 -59.57 4.04 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -81.95 179.99 7.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.598 -0.943 . . . . 0.0 109.503 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.737 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.2 mt -88.57 155.1 51.09 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.0 109.4 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.0 Cg_endo -79.28 -29.46 3.1 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 124.946 3.764 . . . . 0.0 109.892 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.737 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.5 p90 -105.06 167.24 9.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.639 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -123.37 83.77 2.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 109.394 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 26' ' ' ASP . 20.2 tp -106.76 81.4 0.88 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -45.01 -39.06 14.24 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 125.262 3.974 . . . . 0.0 110.22 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.91 -38.33 90.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.446 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.787 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -70.91 -32.32 69.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.528 -0.732 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.3 mt -72.47 -24.23 61.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.737 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -82.15 -30.32 31.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.593 -0.692 . . . . 0.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -70.47 -25.11 63.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.571 -0.705 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 34' ' ' THR . 56.0 t80 -63.39 -45.43 91.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.584 -0.698 . . . . 0.0 109.401 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -64.45 -28.71 69.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -28.71 46.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.527 -0.733 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -101.96 33.65 2.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.541 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 30' ' ' PHE . 18.8 p -140.05 -34.45 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.4 m -68.59 126.04 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.557 -0.714 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.53 36.8 25.45 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -154.49 175.29 13.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.654 -0.909 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 99.97 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.557 -0.714 . . . . 0.0 109.415 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.659 ' SD ' HG13 ' A' ' 41' ' ' VAL . 9.7 tmm? -72.62 125.77 28.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -132.55 118.55 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.659 HG13 ' SD ' ' A' ' 39' ' ' MET . 28.1 m -134.35 -176.17 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.87 -169.39 33.74 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -80.01 -35.69 36.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.929 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -70.22 -40.86 74.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 m -73.1 -26.08 61.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -63.67 -45.09 91.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.629 -0.67 . . . . 0.0 109.502 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -77.48 -23.31 50.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.626 -0.671 . . . . 0.0 109.568 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.9 m -63.05 -24.16 67.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.509 -0.745 . . . . 0.0 109.607 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.43 160.59 58.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.583 -0.698 . . . . 0.0 109.471 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.96 -72.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 125.075 3.85 . . . . 0.0 109.955 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -109.22 94.81 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -99.54 157.26 34.3 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 9.3 Cg_endo -80.75 154.09 83.61 Favored 'Cis proline' 0 N--CA 1.509 2.419 0 O-C-N 123.313 1.165 . . . . 0.0 109.923 0.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.438 HD12 ' CE ' ' A' ' 39' ' ' MET . 69.2 mt -73.88 115.61 44.0 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.642 -0.661 . . . . 0.0 109.277 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.96 178.86 7.04 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 124.741 3.627 . . . . 0.0 109.934 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 61.34 29.32 18.52 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.595 -0.69 . . . . 0.0 109.608 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.0 167.61 2.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.702 . . . . 0.0 109.465 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.452 HG21 ' CE1' ' A' ' 85' ' ' TYR . 3.1 m -88.26 117.06 26.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' A' ' 53' ' ' PRO . 83.1 m-20 -91.85 101.61 14.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 109.462 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.22 145.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -134.93 116.43 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.587 -0.696 . . . . 0.0 109.417 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 82' ' ' VAL . 17.5 tp -96.2 119.54 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.573 -0.705 . . . . 0.0 109.485 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.537 HG23 ' CD2' ' A' ' 77' ' ' HIS . 4.0 t -138.51 152.61 48.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.454 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -93.79 -37.24 11.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.529 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -72.34 133.64 45.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 109.46 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -88.48 29.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -102.6 -38.61 7.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.53 141.41 48.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.681 -0.637 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -149.91 101.52 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.604 -0.685 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.88 115.02 20.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -76.84 135.01 38.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.43 35.09 34.07 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.16 147.81 19.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.553 -0.969 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.66 94.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -96.8 124.4 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 109.426 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 82' ' ' VAL . 27.4 m -134.23 174.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.682 . . . . 0.0 109.514 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.537 ' CD2' HG23 ' A' ' 63' ' ' THR . 56.1 m80 -138.86 31.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 109.452 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -153.67 143.69 22.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.717 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -66.96 -32.76 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.718 . . . . 0.0 109.442 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.62 -34.15 76.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.715 . . . . 0.0 109.44 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.97 90.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 76' ' ' VAL . 32.9 t -66.83 -39.37 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.63 -28.55 63.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.48 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.18 90.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 0.0 109.533 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CE1' HG21 ' A' ' 58' ' ' THR . 39.0 t80 -69.36 -37.42 77.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.541 -0.725 . . . . 0.0 109.45 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.3 68.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.595 -0.69 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -67.18 -43.74 81.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -65.46 -28.84 69.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -119.42 90.02 41.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.77 -20.59 9.01 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.14 3.893 . . . . 0.0 109.944 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.12 -28.31 69.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.479 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -105.55 165.54 11.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.6 -0.687 . . . . 0.0 109.498 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -122.01 143.66 49.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 95' ' ' VAL . 2.1 tt -67.18 132.93 48.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.636 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.9 t -135.31 120.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.426 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.2 mm -96.09 140.64 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 109.438 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.605 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -114.78 -36.1 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.705 . . . . 0.0 109.546 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.17 179.58 36.89 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 -155.44 28.06 Favored Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.335 -1.685 . . . . 0.0 109.591 0.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' A' ' 129' ' ' ILE . . . -62.78 -23.43 67.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.649 -0.912 . . . . 0.0 109.669 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.05 -38.55 75.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.1 mm -72.14 -39.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.552 -0.718 . . . . 0.0 109.585 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 29.1 m-85 -62.93 -41.69 99.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.552 -0.717 . . . . 0.0 109.415 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.629 HG23 HD13 ' A' ' 129' ' ' ILE . 0.7 OUTLIER -71.74 -19.06 62.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.669 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.15 -25.8 47.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.554 -0.716 . . . . 0.0 109.544 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.717 ' CE1' HG13 ' A' ' 79' ' ' VAL . 82.1 m-85 -124.53 19.85 8.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.584 -0.698 . . . . 0.0 109.748 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -63.41 -29.99 71.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 109.625 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -80.85 26.02 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.617 -0.677 . . . . 0.0 109.73 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -159.99 34.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.817 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -91.68 150.66 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.49 -0.756 . . . . 0.0 109.436 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -132.35 -58.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.683 -0.636 . . . . 0.0 109.307 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -102.22 112.04 24.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.569 -0.707 . . . . 0.0 109.353 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.571 HD11 ' CE2' ' A' ' 136' ' ' PHE . 30.0 mt -94.64 99.26 11.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.637 ' CD2' HG22 ' A' ' 157' ' ' VAL . 20.0 mt -100.63 104.41 15.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.667 . . . . 0.0 109.22 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -112.38 143.65 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.602 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.0 m -113.5 99.98 8.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -83.64 142.12 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.682 . . . . 0.0 109.611 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.1 131.54 56.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.685 . . . . 0.0 109.243 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.47 75.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.41 9.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 p -76.92 142.89 39.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.443 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -147.82 109.44 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.33 153.19 28.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.633 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -151.12 -126.2 1.29 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.55 -46.9 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.907 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.443 HG22 HD11 ' A' ' 13' ' ' ILE . 3.2 m -85.8 139.84 30.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 109.515 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 13' ' ' ILE . 48.3 mttp -116.54 160.72 20.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.634 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.45 ' HG2' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -76.61 147.61 37.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.546 -0.721 . . . . 0.0 109.476 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.645 HG23 ' HB1' ' A' ' 100' ' ' ALA . 19.7 pt -70.37 163.83 59.13 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.695 . . . . 0.0 109.479 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.34 101.03 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.139 3.893 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.3 153.08 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.686 . . . . 0.0 109.485 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.2 88.52 7.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 109.461 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -73.9 -15.16 61.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.0 109.82 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.95 9.86 1.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 109.933 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -134.48 30.62 3.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.823 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.571 ' CE2' HD11 ' A' ' 113' ' ' LEU . 60.9 m-85 -140.59 179.59 6.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -150.77 134.29 16.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.638 -0.664 . . . . 0.0 109.43 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -78.63 118.55 20.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -95.25 -33.56 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.6 m -157.47 174.28 15.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 t -161.69 122.73 2.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -95.67 107.22 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.482 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.7 m -90.13 149.52 22.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 109.427 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.417 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.7 p -154.43 129.57 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.363 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -107.73 120.79 43.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.533 -0.73 . . . . 0.0 109.479 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.19 -165.97 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.589 -0.695 . . . . 0.0 109.519 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.6 p -71.52 -39.19 70.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.599 -0.688 . . . . 0.0 109.525 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -105.63 137.59 19.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.547 -0.721 . . . . 0.0 109.41 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.99 -44.84 26.74 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 C-N-CA 124.762 3.641 . . . . 0.0 110.072 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.15 71.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.718 . . . . 0.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 151' ' ' LEU . 43.3 mt -80.78 20.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.682 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.2 m -92.33 142.06 27.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.36 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.697 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.6 p-80 -156.93 166.62 32.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.5 m -138.33 133.44 33.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.411 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.91 92.97 9.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.439 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 31.3 mt-10 -74.06 139.84 44.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.637 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.8 t -128.91 106.74 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.597 -0.69 . . . . 0.0 109.506 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.1 m95 -106.83 168.56 9.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -145.21 142.31 29.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.32 100.68 7.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.582 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.8 m-85 -71.66 139.03 49.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.512 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.6 tp -153.91 113.38 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.324 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 p90 -146.05 151.01 37.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.736 . . . . 0.0 109.909 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.59 118.24 36.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.282 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HB3' HG22 ' A' ' 13' ' ' ILE . 9.1 pt20 -138.04 152.81 49.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.48 -0.762 . . . . 0.0 109.588 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.38 171.07 7.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 109.498 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -61.1 -19.05 61.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.604 -0.685 . . . . 0.0 109.864 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -76.61 13.95 0.89 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.493 -0.754 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.24 39.63 97.95 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.512 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.6 tp -112.02 165.79 11.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.624 -0.927 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 126' ' ' THR . 32.4 pt -142.21 -30.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.577 -0.702 . . . . 0.0 109.545 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.18 -169.43 30.75 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -172.13 117.78 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.631 -0.923 . . . . 0.0 109.44 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.0 21.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.577 -0.702 . . . . 0.0 109.613 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.68 -61.74 4.08 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.401 ' CD2' ' H ' ' A' ' 18' ' ' HIS . 19.1 p80 -76.89 166.56 23.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.445 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.558 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 15.6 mt -79.91 157.54 73.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.662 -0.649 . . . . 0.0 109.439 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -80.24 -27.98 3.28 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.08 3.853 . . . . 0.0 109.971 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.558 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.4 p90 -108.25 -179.29 3.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.534 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -131.34 102.35 5.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 26' ' ' ASP . 20.7 tp -121.51 80.16 38.39 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.606 -0.684 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.63 -37.6 15.77 Favored 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 125.167 3.912 . . . . 0.0 110.178 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -62.89 -42.79 99.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.562 -0.711 . . . . 0.0 109.509 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.798 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.2 t0 -65.42 -38.1 88.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.622 -0.674 . . . . 0.0 109.38 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.35 -24.42 67.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.579 -0.7 . . . . 0.0 109.519 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -83.63 -30.82 26.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.614 -0.679 . . . . 0.0 109.407 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 19.0 t80 -73.83 -25.62 60.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 34' ' ' THR . 48.4 t80 -63.42 -45.74 89.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.51 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -63.58 -30.12 71.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.624 -0.672 . . . . 0.0 109.44 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.83 -29.21 50.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 76.5 mm-40 -100.77 32.54 3.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.3 p -136.82 -35.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.588 -0.695 . . . . 0.0 109.54 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 35' ' ' VAL . 27.8 m -79.42 128.86 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.705 . . . . 0.0 109.496 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.88 -25.75 26.36 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.36 -170.58 1.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.927 . . . . 0.0 109.511 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.407 HG23 ' HB ' ' A' ' 58' ' ' THR . 59.1 mt -103.99 112.05 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.459 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.565 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.7 tmm? -73.72 110.99 8.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.26 122.88 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.713 . . . . 0.0 109.464 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.565 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.8 m -136.66 178.05 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.498 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.94 -177.58 34.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -70.36 -39.58 74.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.963 . . . . 0.0 109.416 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -68.94 -40.53 78.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.616 -0.678 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -72.46 -25.72 61.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.31 -44.49 87.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.661 -0.65 . . . . 0.0 109.462 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -77.33 -26.84 52.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.1 p -62.67 -21.79 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.64 -0.663 . . . . 0.0 109.697 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.427 ' HE2' HG21 ' A' ' 41' ' ' VAL . 20.3 m-85 -62.45 162.96 16.37 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.547 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -81.22 -74.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 125.227 3.952 . . . . 0.0 110.037 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -113.7 82.65 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.465 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -84.42 157.24 62.01 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.371 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.87 152.14 76.88 Favored 'Cis proline' 0 N--CA 1.509 2.383 0 O-C-N 123.415 1.219 . . . . 0.0 109.995 0.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.474 HD12 ' CE ' ' A' ' 39' ' ' MET . 97.1 mt -73.4 113.86 26.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.707 . . . . 0.0 109.27 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.44 179.24 6.68 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.761 3.641 . . . . 0.0 109.942 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 61.03 32.03 19.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.525 -0.734 . . . . 0.0 109.64 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.29 -178.62 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 38' ' ' ILE . 19.7 m -100.98 119.83 39.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 109.339 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -94.24 117.16 29.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.653 -0.654 . . . . 0.0 109.484 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -125.83 143.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.59 -0.693 . . . . 0.0 109.398 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 t -127.97 132.62 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.602 -0.686 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.48 HD12 HG23 ' A' ' 76' ' ' VAL . 12.8 tp -104.2 112.02 24.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -137.88 153.5 49.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.7 . . . . 0.0 109.464 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -89.68 -47.82 7.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 0.0 109.548 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -72.74 157.97 36.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.604 -0.685 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -102.45 8.11 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.593 -0.692 . . . . 0.0 109.859 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.99 -28.01 57.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.28 153.56 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.492 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -143.72 143.59 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.601 -0.687 . . . . 0.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -136.0 125.4 24.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -87.6 123.39 32.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.16 41.6 59.77 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -154.42 148.84 26.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.617 -0.931 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.64 99.63 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.469 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.8 t -75.88 97.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.652 -0.655 . . . . 0.0 109.467 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -89.19 162.98 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.469 ' NE2' HG12 ' A' ' 75' ' ' VAL . 61.2 m-70 -140.07 30.39 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.41 146.48 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.607 -0.683 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.518 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.6 t -68.18 -33.36 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.528 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.53 70.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.506 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.39 80.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.54 -0.725 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -69.13 -36.57 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.645 -0.659 . . . . 0.0 109.473 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.6 -30.34 64.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.75 -36.92 83.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.83 -38.75 83.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.581 -0.7 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.51 -24.49 64.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -63.87 -43.73 95.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -67.45 -29.11 68.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -120.77 89.76 45.58 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.13 -23.53 6.38 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.165 3.91 . . . . 0.0 109.86 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.57 -24.92 64.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.536 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -90.44 179.97 5.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -138.31 154.06 49.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.45 ' CD2' HD11 ' A' ' 96' ' ' ILE . 2.6 tt -91.16 109.58 20.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -110.62 122.6 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.45 HD11 ' CD2' ' A' ' 94' ' ' LEU . 41.7 mm -97.3 127.76 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.532 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.57 -23.44 11.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.599 -0.688 . . . . 0.0 109.578 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.38 -177.05 40.88 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.453 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -80.5 -157.0 14.34 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.341 -1.682 . . . . 0.0 109.54 -0.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.56 87.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.588 -0.948 . . . . 0.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.31 -26.29 66.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.548 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.453 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.5 mm -74.88 -32.17 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.6 -0.688 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.68 -42.65 81.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -69.89 -35.09 74.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.581 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.77 88.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.664 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.518 ' CE1' HG13 ' A' ' 79' ' ' VAL . 33.6 m-85 -95.14 3.49 54.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -70.8 -22.72 62.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.568 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -62.93 -23.87 67.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.71 58.97 1.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -105.98 149.51 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -130.37 -50.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -95.2 142.72 27.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.589 -0.694 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 136' ' ' PHE . 17.3 mt -129.52 87.15 2.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.573 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.652 ' CD2' HG22 ' A' ' 157' ' ' VAL . 61.1 mt -90.37 123.97 34.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.347 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -135.59 147.28 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 0.0 109.543 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.5 m -113.51 105.95 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.64 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -88.27 127.97 35.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.44 133.66 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 109.387 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.58 63.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 0.0 109.425 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.04 129.06 12.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 p -78.05 143.69 37.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.988 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.475 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.0 m-85 -148.45 125.79 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.634 -0.667 . . . . 0.0 109.517 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.57 160.77 16.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.512 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.37 -132.17 1.32 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -143.83 -41.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.664 -0.903 . . . . 0.0 109.451 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.615 HG22 HD11 ' A' ' 13' ' ' ILE . 4.2 m -89.46 134.94 33.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.518 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -113.33 173.39 6.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.419 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.408 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -90.84 143.56 26.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.485 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.2 pt -67.34 164.62 35.61 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.564 -0.71 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.4 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.147 3.898 . . . . 0.0 109.883 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.66 155.15 18.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -87.04 85.34 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.588 -0.695 . . . . 0.0 109.418 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -74.64 -15.17 60.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.669 -0.644 . . . . 0.0 109.871 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.09 9.97 1.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.513 -0.742 . . . . 0.0 109.877 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -134.05 29.7 3.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.534 ' CE2' HD11 ' A' ' 113' ' ' LEU . 47.8 m-85 -141.13 176.01 9.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -150.39 134.24 16.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 109.42 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -70.65 153.19 43.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.553 -0.717 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.09 -31.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.612 -0.68 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.2 m -139.33 144.01 38.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -143.84 99.09 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -86.71 97.56 10.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.708 . . . . 0.0 109.462 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.569 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.2 m -77.2 147.87 36.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.54 129.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.351 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.75 120.65 42.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.736 . . . . 0.0 109.477 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.08 -165.9 0.93 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.7 p -74.89 -41.96 58.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.22 137.8 20.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.733 . . . . 0.0 109.434 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.65 -48.45 15.69 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 124.804 3.669 . . . . 0.0 110.143 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.88 70.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.658 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.32 15.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.788 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.0 m -86.58 139.36 30.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.339 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.578 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.0 p-80 -156.01 173.25 17.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.571 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.569 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.3 m -139.23 135.56 34.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -86.46 92.13 8.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.46 147.52 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.2 t -139.05 99.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.461 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -94.59 166.19 12.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.395 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -148.84 141.34 24.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.1 tttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 179.989 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.82 124.31 20.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.71 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.798 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -94.86 152.77 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.561 -0.712 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.571 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.7 tp -163.2 110.05 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.33 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.0 p90 -144.78 150.1 36.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.75 117.3 31.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 109.223 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' HB3' HG22 ' A' ' 13' ' ' ILE . 2.2 pt20 -138.48 152.8 48.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.723 . . . . 0.0 109.691 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -104.07 170.99 7.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.68 -17.38 55.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.805 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.85 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.36 38.22 95.91 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 122' ' ' PHE . 6.2 tp -113.03 163.97 14.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.551 -0.97 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 126' ' ' THR . 31.7 pt -138.16 -30.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.435 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -167.49 -166.87 27.29 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -171.79 118.2 0.42 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.902 . . . . 0.0 109.501 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 59.98 32.24 21.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.72 -62.8 2.63 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -75.35 172.84 11.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.615 -0.932 . . . . 0.0 109.454 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.575 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 31.1 mt -85.18 156.36 60.12 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.84 -26.66 4.4 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 125.021 3.814 . . . . 0.0 109.944 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.575 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.4 p90 -108.77 167.74 9.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.511 -0.743 . . . . 0.0 109.491 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -117.57 101.31 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.61 -0.682 . . . . 0.0 109.45 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.1 tp -121.38 80.41 37.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.59 -38.99 17.29 Favored 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 125.171 3.914 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.48 -41.35 98.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.625 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.788 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.3 t0 -65.87 -36.99 84.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.15 -23.25 64.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -86.1 -28.23 24.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.65 -0.656 . . . . 0.0 109.461 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.8 t80 -75.23 -25.49 58.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.507 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 34' ' ' THR . 50.4 t80 -63.82 -48.98 74.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -65.66 -25.7 67.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.566 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.08 -25.72 43.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.542 -0.724 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.0 mm100 -109.07 36.77 2.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' PHE . 20.6 p -142.06 -29.3 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.32 132.49 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.592 -0.692 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.37 34.82 60.39 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -155.98 164.31 38.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.532 -0.981 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.87 117.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.44 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.455 ' CE ' HD12 ' A' ' 54' ' ' LEU . 39.6 ttp -97.6 108.34 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' CG2' HD11 ' A' ' 94' ' ' LEU . 30.4 t -93.67 120.08 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.47 161.78 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.512 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.73 -162.85 37.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 ptt85 -83.55 -35.8 24.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.956 . . . . 0.0 109.428 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -69.59 -38.66 77.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.697 -0.627 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.497 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 10.7 m -74.14 -28.64 61.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.483 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.49 -58.44 7.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -66.32 -21.58 66.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.586 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.6 m -63.1 -29.36 70.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.743 . . . . 0.0 109.543 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.497 ' CZ ' HG22 ' A' ' 45' ' ' THR . 35.7 m-85 -64.83 161.64 44.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.86 -73.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 125.126 3.884 . . . . 0.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -107.03 95.57 5.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.625 -0.672 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 25.3 ptt-85 -101.23 157.32 33.89 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.641 -0.662 . . . . 0.0 109.443 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.27 145.7 72.09 Favored 'Cis proline' 0 N--CA 1.508 2.365 0 O-C-N 123.385 1.203 . . . . 0.0 109.903 0.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.455 HD12 ' CE ' ' A' ' 39' ' ' MET . 50.2 mt -62.59 116.1 21.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.289 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.92 178.47 7.51 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 124.762 3.641 . . . . 0.0 109.929 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 61.02 29.44 18.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.516 -0.74 . . . . 0.0 109.638 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.11 -169.27 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.706 . . . . 0.0 109.527 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -118.06 130.19 56.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.525 -0.735 . . . . 0.0 109.437 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -107.61 100.56 9.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.491 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -99.55 105.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.56 -0.713 . . . . 0.0 109.449 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.42 122.05 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.599 HD12 HG23 ' A' ' 76' ' ' VAL . 12.3 tp -101.38 118.16 36.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.624 -0.673 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.469 HG23 ' CE1' ' A' ' 77' ' ' HIS . 3.9 t -144.32 154.37 42.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.479 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -95.11 -38.87 10.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.579 -0.7 . . . . 0.0 109.479 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -72.1 131.61 43.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.613 -0.68 . . . . 0.0 109.433 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.97 30.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -103.21 -33.21 9.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -69.69 143.3 53.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -142.14 146.09 34.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.69 . . . . 0.0 109.48 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.98 124.31 20.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -83.0 130.21 35.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.38 38.85 37.57 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.74 139.4 12.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.991 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -77.37 104.46 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.61 100.71 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.599 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -102.47 -176.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.469 ' CE1' HG23 ' A' ' 63' ' ' THR . 64.0 m-70 -142.93 30.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.489 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -161.06 142.54 11.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 t -65.18 -31.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.06 -34.54 78.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.05 81.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.643 -0.661 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 76' ' ' VAL . 34.1 t -66.73 -41.22 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.42 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -71.94 -30.07 64.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.603 -0.686 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.42 87.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.71 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -71.44 -33.03 69.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.583 -0.698 . . . . 0.0 109.521 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.32 -29.98 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -66.42 -42.45 87.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.517 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -66.54 -28.41 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -119.21 90.01 40.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.643 -0.66 . . . . 0.0 109.453 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 -23.67 6.51 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 125.103 3.869 . . . . 0.0 109.843 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.58 -26.4 66.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -102.44 133.67 47.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -92.29 151.63 20.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.71 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.483 HD11 ' CG2' ' A' ' 40' ' ' VAL . 9.7 tp -87.43 143.93 26.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.555 -0.716 . . . . 0.0 109.497 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -144.43 130.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.431 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.554 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -94.65 125.36 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.94 -28.32 9.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.522 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 161.81 -177.57 38.01 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.85 -154.73 16.48 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.361 -1.67 . . . . 0.0 109.6 -0.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.58 78.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.953 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -75.09 -30.51 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.554 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.4 m-85 -68.78 -50.65 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -64.21 -23.16 67.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.615 -0.678 . . . . 0.0 109.558 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.32 -52.11 37.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.6 -0.688 . . . . 0.0 109.615 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -86.46 6.16 31.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.567 -0.708 . . . . 0.0 110.037 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 110' ' ' VAL . 32.2 ttpt -66.04 -23.55 66.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 109.586 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -68.37 -42.43 79.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.598 -0.689 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.73 38.19 2.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.611 -0.68 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.798 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -79.97 152.76 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.583 -0.698 . . . . 0.0 109.342 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.15 -68.87 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.692 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -85.57 161.44 19.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.635 -0.665 . . . . 0.0 109.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.583 HD11 ' CE2' ' A' ' 136' ' ' PHE . 23.7 mt -141.63 88.32 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.549 -0.719 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.571 ' CB ' HD12 ' A' ' 4' ' ' LEU . 54.0 mt -89.44 120.65 30.95 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -132.63 142.77 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.7 m -109.98 103.17 11.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 0.0 109.329 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -85.71 132.22 34.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.0 109.603 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.9 132.73 53.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.371 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.9 -31.68 72.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.439 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.443 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -73.98 131.95 14.65 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.5 p -85.15 142.01 29.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.605 -0.938 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.59 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.3 m-85 -144.86 126.26 14.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.604 -0.685 . . . . 0.0 109.456 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -90.01 146.42 24.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.561 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -145.76 -128.89 2.02 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -143.62 -34.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.995 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.49 HG22 HD11 ' A' ' 13' ' ' ILE . 2.9 m -98.68 127.89 44.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 109.55 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -104.81 170.86 7.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.23 145.35 25.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.0 pt -66.91 164.78 31.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.505 -0.747 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.23 109.23 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.105 3.87 . . . . 0.0 109.891 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.08 149.42 21.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -84.46 86.35 7.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -73.36 -16.95 61.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.632 -0.668 . . . . 0.0 109.768 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.08 9.83 1.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.961 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -131.87 28.42 4.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.583 ' CE2' HD11 ' A' ' 113' ' ' LEU . 54.5 m-85 -138.48 179.86 6.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.45 122.01 7.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.505 -0.747 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -70.25 121.3 17.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 140' ' ' SER . 28.1 m -96.11 -37.4 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.478 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.406 ' N ' HG23 ' A' ' 139' ' ' VAL . 57.4 p -158.62 169.33 24.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.545 -0.722 . . . . 0.0 109.528 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 81.4 p -158.35 129.63 6.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.607 -0.683 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -97.18 116.24 29.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.685 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.564 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.4 m -93.95 152.08 19.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.36 130.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -102.38 123.22 45.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.511 -0.743 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.45 -165.95 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.7 p -73.99 -39.9 63.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 0.0 109.604 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -99.85 137.57 20.19 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.25 -39.88 34.9 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 124.773 3.649 . . . . 0.0 110.015 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.443 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -75.07 -29.58 60.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.693 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.84 8.36 2.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.566 -0.709 . . . . 0.0 109.981 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.3 p -78.45 159.0 28.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.476 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.584 ' CE1' HD21 ' A' ' 23' ' ' LEU . 39.4 p-80 -171.97 170.74 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.539 -0.725 . . . . 0.0 109.603 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 143' ' ' THR . 16.9 m -140.44 133.84 29.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -86.64 95.95 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 109.383 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -78.14 144.41 36.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.627 -0.671 . . . . 0.0 109.483 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.555 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.3 t -133.65 99.55 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 31.5 m95 -96.86 166.95 11.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.615 -0.678 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -146.0 138.82 25.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.4 tttp . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.715 . . . . 0.0 109.405 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.28 107.05 14.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CD1' HG23 ' A' ' 110' ' ' VAL . 3.7 m-85 -80.98 155.97 26.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.624 -0.673 . . . . 0.0 109.416 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.707 HD12 ' CB ' ' A' ' 114' ' ' LEU . 6.5 tp -168.78 121.56 0.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.451 ' NE1' HG23 ' A' ' 115' ' ' VAL . 44.0 p90 -147.31 130.1 16.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.508 -0.745 . . . . 0.0 109.584 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.91 109.77 18.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.266 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.653 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.6 pt20 -131.26 160.87 33.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.704 . . . . 0.0 109.72 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -109.86 169.45 8.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.672 -0.642 . . . . 0.0 109.465 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -60.72 -17.56 49.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.57 15.26 0.83 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.715 . . . . 0.0 109.798 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.25 33.75 87.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.608 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.8 tp -113.69 161.31 17.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.638 -0.919 . . . . 0.0 109.469 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.653 HG22 ' HB3' ' A' ' 7' ' ' GLN . 30.1 pt -134.21 -30.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -170.46 -174.45 38.5 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -166.38 124.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.91 32.48 21.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 109.752 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.19 -61.71 3.93 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -74.97 174.77 8.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.586 -0.949 . . . . 0.0 109.5 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.575 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 47.8 mt -89.7 156.02 47.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 109.426 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -79.59 -26.55 4.7 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 124.955 3.77 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.575 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.7 p90 -108.59 165.76 11.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -115.13 101.5 9.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.776 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.6 tp -122.76 79.23 48.87 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.84 -38.01 17.35 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 125.165 3.91 . . . . 0.0 110.197 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.83 -46.51 87.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.559 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.776 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.8 t0 -64.19 -36.9 85.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.59 -24.99 67.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.664 . . . . 0.0 109.459 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -84.12 -29.35 26.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.605 -0.685 . . . . 0.0 109.437 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -71.73 -28.12 63.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.584 -0.697 . . . . 0.0 109.4 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 34' ' ' THR . 46.6 t80 -67.62 -44.96 76.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.554 -0.716 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -66.0 -31.0 71.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -30.94 60.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.693 . . . . 0.0 109.437 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -97.9 33.25 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.3 p -139.55 -30.03 0.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.608 -0.682 . . . . 0.0 109.493 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.5 m -68.63 128.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 109.513 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.38 69.94 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -145.67 165.79 27.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.565 -0.962 . . . . 0.0 109.449 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.417 HG23 ' HB ' ' A' ' 58' ' ' THR . 59.8 mt -92.11 101.0 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.428 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.619 ' CE ' HD12 ' A' ' 54' ' ' LEU . 43.7 ttp -80.7 103.33 10.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.555 -0.715 . . . . 0.0 109.457 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.85 121.43 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.24 168.33 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.624 -0.673 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.67 -165.28 39.38 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -78.87 -43.49 24.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.936 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -68.73 -30.99 69.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -79.91 -29.15 39.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.68 -31.81 72.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.629 -0.669 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -94.18 -18.07 22.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.694 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -62.26 -23.43 66.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -66.43 159.77 70.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.15 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.066 3.844 . . . . 0.0 109.953 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.92 112.8 24.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.498 -0.751 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -108.46 158.64 33.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.518 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.69 -165.51 4.57 Favored 'Cis proline' 0 N--CA 1.509 2.382 0 O-C-N 123.372 1.196 . . . . 0.0 109.897 -0.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.619 HD12 ' CE ' ' A' ' 39' ' ' MET . 87.9 mt -114.97 94.4 38.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.585 -0.697 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -74.97 -175.89 2.59 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 124.819 3.679 . . . . 0.0 109.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 61.51 27.93 17.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.77 . . . . 0.0 109.52 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.23 -169.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 38' ' ' ILE . 1.3 m -119.39 115.23 23.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.583 -0.698 . . . . 0.0 109.49 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.496 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.7 m-80 -92.77 103.79 16.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.722 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -104.62 99.94 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.481 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.3 t -87.03 123.89 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.492 HD12 HG23 ' A' ' 76' ' ' VAL . 18.4 tp -101.11 115.83 31.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.651 -0.656 . . . . 0.0 109.502 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -145.98 146.61 31.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.705 -0.622 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -101.43 31.54 3.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.585 -0.697 . . . . 0.0 109.562 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -134.2 126.51 30.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -85.1 29.53 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.17 -35.65 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 109.515 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -69.55 157.76 36.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.62 -0.675 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -147.52 140.89 25.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.527 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.5 11.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.584 -0.698 . . . . 0.0 109.475 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -84.83 133.68 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.581 -0.7 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.74 41.21 35.13 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.02 159.82 36.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.928 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -94.07 94.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.612 -0.68 . . . . 0.0 109.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.629 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.7 t -79.01 99.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.363 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.492 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -97.21 159.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.458 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.629 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.5 m-70 -139.23 28.68 2.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.695 . . . . 0.0 109.511 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -161.49 147.56 14.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.466 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.512 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.3 t -67.81 -33.64 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.722 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.31 73.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.653 -0.655 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.08 79.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 76' ' ' VAL . 30.2 t -67.2 -46.57 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.591 -0.693 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.91 -27.27 63.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.672 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.29 -36.89 85.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.558 -0.714 . . . . 0.0 109.437 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.21 -34.29 68.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 109.525 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.21 67.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -65.55 -42.39 91.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.22 -29.84 70.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.579 -0.7 . . . . 0.0 109.543 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -119.74 89.86 42.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.58 -0.7 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.99 -23.16 6.85 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.148 3.899 . . . . 0.0 109.943 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.07 -26.42 65.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.49 172.49 7.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -130.94 169.13 16.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tp -93.58 131.94 38.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -128.03 127.12 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.463 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.615 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.0 mm -103.41 118.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.54 -25.37 11.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.498 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.74 -179.04 40.83 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.85 -157.08 28.5 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.328 -1.689 . . . . 0.0 109.542 -0.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.97 -30.53 71.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.623 -0.928 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -73.24 -32.76 64.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -70.28 -36.87 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.552 -0.717 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.615 ' CE1' HG22 ' A' ' 96' ' ' ILE . 25.5 m-85 -63.77 -56.65 13.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -62.47 -16.05 53.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.604 -0.685 . . . . 0.0 109.83 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.42 -23.23 32.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.512 ' CE1' HG13 ' A' ' 79' ' ' VAL . 35.4 m-85 -121.06 18.12 11.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.809 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -66.27 -31.36 72.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.554 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.0 26.65 0.42 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.694 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.05 34.13 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.542 -0.724 . . . . 0.0 109.485 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.683 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -102.23 159.37 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.429 ' N ' HG22 ' A' ' 110' ' ' VAL . 7.7 t0 -141.83 -50.43 0.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.674 -0.641 . . . . 0.0 109.345 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -105.75 109.28 21.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 0.0 109.335 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.407 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 23.1 mt -93.61 110.26 21.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.585 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.707 ' CB ' HD12 ' A' ' 4' ' ' LEU . 21.8 mt -105.74 101.96 11.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.596 -0.69 . . . . 0.0 109.298 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.451 HG23 ' NE1' ' A' ' 5' ' ' TRP . 9.5 p -107.71 132.74 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.669 -0.645 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.5 m -106.91 96.51 6.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.564 -0.71 . . . . 0.0 109.244 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -82.39 150.16 27.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.648 -0.658 . . . . 0.0 109.704 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.35 142.39 50.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.634 -0.666 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.69 -34.83 62.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.556 -0.715 . . . . 0.0 109.453 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.41 136.29 22.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.9 p -86.7 143.63 27.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.994 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -144.92 138.62 27.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.3 152.96 18.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.546 -0.721 . . . . 0.0 109.52 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.608 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -157.97 -128.76 1.04 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.05 -34.37 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.946 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.475 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -89.85 149.52 22.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.624 -0.673 . . . . 0.0 109.521 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -130.89 167.85 18.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 11.4 tpt -88.14 151.57 22.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.54 -0.725 . . . . 0.0 109.479 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.3 pt -76.06 163.62 65.47 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.595 -0.69 . . . . 0.0 109.509 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.16 104.78 1.69 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.172 3.915 . . . . 0.0 109.902 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.2 mt -97.43 144.5 27.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -87.16 88.44 7.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -67.15 -14.97 63.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.575 -0.703 . . . . 0.0 109.831 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.58 -26.02 68.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.478 -0.764 . . . . 0.0 109.531 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.65 30.46 2.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 67.2 m-85 -143.84 171.3 14.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.533 -0.73 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.9 m -144.34 136.38 26.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.545 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -74.12 150.26 40.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.38 -35.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.56 -0.712 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -142.37 165.64 26.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.6 t -164.43 119.65 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.48 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -99.56 106.07 18.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.528 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 m -93.14 141.05 28.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.671 . . . . 0.0 109.42 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.402 ' CG1' ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -150.32 135.03 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.94 125.4 54.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.2 -165.94 0.95 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.4 p -70.85 -38.32 73.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.554 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.26 137.71 19.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.598 -0.689 . . . . 0.0 109.37 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.74 -44.14 27.21 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 124.829 3.686 . . . . 0.0 110.065 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.32 72.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.68 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 151' ' ' LEU . 34.2 mt -80.74 21.1 0.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 38.0 m -91.74 142.67 27.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.39 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.402 ' NE2' ' CG1' ' A' ' 144' ' ' VAL . 35.9 p-80 -155.45 168.95 25.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -141.95 131.35 23.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 109.419 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -91.12 95.21 9.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.732 . . . . 0.0 109.516 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.514 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 22.5 mt-10 -78.2 130.76 36.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.608 -0.683 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.607 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.1 t -115.39 110.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.514 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 36.8 m95 -108.48 165.67 11.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.584 -0.698 . . . . 0.0 109.458 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -143.36 138.87 29.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.651 -0.656 . . . . 0.0 109.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.617 HG23 HD23 ' A' ' 94' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 1' ' ' THR . . . -141.47 130.96 23.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.498 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.834 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.7 m-85 -96.37 162.14 13.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.733 . . . . 0.0 109.479 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 114' ' ' LEU . 8.6 tp -168.97 107.33 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.597 -0.689 . . . . 0.0 109.301 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.04 143.14 31.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.55 -0.719 . . . . 0.0 109.811 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.09 112.5 24.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.648 -0.658 . . . . 0.0 109.245 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.485 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.5 pt20 -134.16 149.79 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.637 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -98.7 170.17 8.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.499 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -60.96 -17.26 50.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.558 -0.714 . . . . 0.0 109.943 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -76.83 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.493 -0.754 . . . . 0.0 109.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.21 36.43 92.99 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.2 tp -111.59 162.36 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.534 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.528 HD11 HG22 ' A' ' 126' ' ' THR . 32.3 pt -137.13 -30.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.508 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -167.12 -172.8 34.74 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -168.98 124.96 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.933 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.08 28.04 17.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.01 -63.55 1.47 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -75.45 -171.65 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.602 -0.94 . . . . 0.0 109.468 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.706 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 31.5 mt -92.58 156.89 40.81 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.58 -0.7 . . . . 0.0 109.423 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.1 Cg_endo -80.22 -28.67 2.91 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.015 3.81 . . . . 0.0 109.882 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.706 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.7 p90 -106.75 -172.27 2.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -138.65 94.8 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.614 -0.679 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.774 HD23 ' HB2' ' A' ' 26' ' ' ASP . 22.3 tp -116.12 83.36 12.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.56 -38.34 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.123 3.882 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.99 -40.97 99.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.774 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -69.25 -28.4 66.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.24 -23.47 57.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.621 -0.674 . . . . 0.0 109.542 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -86.82 -28.87 22.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.729 . . . . 0.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -71.04 -27.08 63.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CE2' HG21 ' A' ' 34' ' ' THR . 48.1 t80 -64.35 -47.8 77.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.627 -0.67 . . . . 0.0 109.47 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -66.6 -5.27 10.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.611 -0.681 . . . . 0.0 109.974 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.08 -34.47 12.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.512 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -106.28 35.48 2.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.466 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.474 HG21 ' CE2' ' A' ' 30' ' ' PHE . 20.6 p -133.37 -32.8 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.527 -0.733 . . . . 0.0 109.493 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.7 129.58 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 37.3 57.15 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -155.15 164.94 38.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.484 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -92.37 110.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.469 ' CE ' HD12 ' A' ' 54' ' ' LEU . 36.3 ttp -88.81 107.6 19.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 94' ' ' LEU . 30.7 t -94.57 119.42 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.456 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 27.3 m -132.95 164.49 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.718 . . . . 0.0 109.5 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.38 -165.36 40.42 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtm105 -80.52 -38.43 29.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.95 . . . . 0.0 109.471 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -70.05 -32.98 71.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.58 -0.7 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 m -79.17 -28.5 42.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.465 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.65 -34.19 77.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.471 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -86.7 -25.48 24.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -62.89 -23.23 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HZ ' HG11 ' A' ' 41' ' ' VAL . 44.4 m-85 -62.92 162.83 19.18 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.18 -63.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.125 3.883 . . . . 0.0 109.922 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -124.12 111.55 16.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.543 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -108.52 157.37 36.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.405 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.83 146.51 72.18 Favored 'Cis proline' 0 N--CA 1.508 2.36 0 O-C-N 123.396 1.208 . . . . 0.0 109.982 0.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.484 ' HB2' HD21 ' A' ' 59' ' ' ASN . 68.6 mt -67.51 112.93 11.61 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.368 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -78.24 179.91 6.06 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 124.793 3.662 . . . . 0.0 109.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 61.22 27.65 17.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.665 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -177.13 -173.32 0.45 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.493 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -116.16 120.11 37.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.711 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.484 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -95.53 107.72 19.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.668 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.1 116.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.424 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -102.1 122.7 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.606 -0.684 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.509 HD12 HG23 ' A' ' 76' ' ' VAL . 15.3 tp -99.22 110.93 23.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.74 142.82 31.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -97.65 30.98 2.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -125.81 138.39 53.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.71 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.75 29.84 2.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.31 -40.18 5.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.611 -0.681 . . . . 0.0 109.454 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -73.17 136.98 44.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -141.48 102.88 4.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.75 117.43 23.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -76.92 133.28 39.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.571 -0.705 . . . . 0.0 109.424 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 37.52 59.55 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.47 142.83 19.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.965 . . . . 0.0 109.494 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -75.4 95.96 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.622 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.0 t -80.22 102.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.528 -0.732 . . . . 0.0 109.437 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.509 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -94.33 158.7 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.622 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.8 m-70 -139.68 29.56 2.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.693 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -162.18 147.29 12.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 t -67.97 -35.3 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.454 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.58 70.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.53 81.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.473 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.508 HG22 HG21 ' A' ' 76' ' ' VAL . 31.0 t -68.34 -40.72 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -75.67 -30.24 59.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -36.96 84.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.56 -41.92 75.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.622 -0.674 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 109.48 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -65.12 -45.31 85.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.57 -0.706 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -67.48 -27.08 66.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.469 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.82 89.82 39.02 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.678 . . . . 0.0 109.463 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.93 -23.14 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 125.06 3.84 . . . . 0.0 109.893 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.69 -26.79 66.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -91.27 179.94 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.34 150.64 46.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.617 HD23 HG23 ' A' ' 1' ' ' THR . 11.7 tp -93.67 126.4 38.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 t -133.16 127.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.716 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.558 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.7 mm -91.42 127.64 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.85 -23.83 10.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.562 -0.711 . . . . 0.0 109.59 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.92 -178.15 37.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.48 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -82.6 -154.37 14.92 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 120.389 -1.654 . . . . 0.0 109.587 -0.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.53 77.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.579 -0.954 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -73.15 -27.2 61.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.48 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -73.94 -35.44 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.723 . . . . 0.0 109.479 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 96' ' ' ILE . 24.1 m-85 -63.26 -53.71 48.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -62.71 -21.98 66.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.59 -0.694 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.91 -30.84 67.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.741 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -116.06 16.89 16.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.767 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.621 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -68.04 -22.85 64.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.651 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -70.19 -45.51 66.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -97.04 40.3 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.456 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.834 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -89.38 143.95 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -128.53 -65.63 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.668 . . . . 0.0 109.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.5 m -89.86 164.58 14.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.533 HD11 ' CE2' ' A' ' 136' ' ' PHE . 33.4 mt -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.564 -0.71 . . . . 0.0 109.58 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.65 ' HB2' HD12 ' A' ' 4' ' ' LEU . 35.9 mt -91.21 104.25 16.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -115.47 137.99 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -107.77 102.69 11.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.68 . . . . 0.0 109.336 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mmm-85 -88.23 135.22 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.99 140.69 42.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.69 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.62 -29.63 61.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.416 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.464 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -74.93 126.08 8.65 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 p -72.57 143.25 48.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.939 . . . . 0.0 109.452 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.424 ' O ' HD22 ' A' ' 12' ' ' LEU . 66.7 m-85 -148.98 121.55 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -96.51 149.25 21.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.54 -120.78 1.13 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -145.95 -33.94 0.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.631 -0.923 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.528 HG22 HD11 ' A' ' 13' ' ' ILE . 2.2 m -93.9 146.28 24.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -125.53 174.32 8.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.6 tpt -97.55 152.14 19.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.2 pt -74.67 163.9 65.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.14 94.18 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.115 3.876 . . . . 0.0 109.873 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.57 154.28 28.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.6 -0.688 . . . . 0.0 109.486 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -87.14 86.08 7.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.587 -0.696 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -71.47 -18.49 62.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.6 -0.688 . . . . 0.0 109.725 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -74.12 10.08 1.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -132.68 29.62 4.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.533 ' CE2' HD11 ' A' ' 113' ' ' LEU . 44.5 m-85 -138.95 -180.0 6.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.629 -0.669 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -148.59 125.5 11.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 109.441 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -78.44 126.36 30.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.07 -35.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.612 -0.68 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.2 t -162.31 -177.79 5.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 98.3 p -163.88 132.56 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -95.73 100.74 12.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.531 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.4 m -82.72 148.79 27.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.58 131.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.313 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -108.36 120.22 41.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.451 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.01 -165.3 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 p -72.99 -42.96 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.61 -0.681 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -100.01 137.97 20.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.4 -47.62 17.19 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 124.832 3.688 . . . . 0.0 110.092 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.464 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -62.23 -30.02 70.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.569 -0.707 . . . . 0.0 109.664 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.8 mt -78.82 17.58 0.7 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 109.741 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.5 m -90.54 144.36 25.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.755 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.721 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.3 p-80 -159.68 170.14 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.56 -0.712 . . . . 0.0 109.574 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.531 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.5 m -139.92 135.66 33.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.39 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -91.32 92.02 8.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.564 -0.71 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.518 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 44.0 mt-10 -77.1 128.36 34.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.544 -0.722 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.617 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.8 t -114.76 99.49 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.484 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.518 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 35.5 m95 -95.03 164.31 12.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.7 . . . . 0.0 109.445 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -148.66 136.11 20.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.0 tttt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.724 . . . . 0.0 109.45 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.503 HG23 HD23 ' A' ' 94' ' ' LEU . 3.9 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.73 127.76 33.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.557 -0.714 . . . . 0.0 109.467 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.791 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -100.18 143.93 29.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.532 -0.73 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.677 HD12 ' CB ' ' A' ' 114' ' ' LEU . 7.7 tp -156.59 111.51 2.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.33 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.93 141.22 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.545 -0.722 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.97 112.81 24.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.207 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -132.89 157.82 44.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -107.53 170.01 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 109.46 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -60.89 -18.31 55.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.551 -0.718 . . . . 0.0 109.871 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.42 15.09 0.82 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.77 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 35.77 91.9 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.647 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.5 tp -111.34 162.01 15.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.978 . . . . 0.0 109.535 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.63 HD11 HG22 ' A' ' 126' ' ' THR . 31.9 pt -136.28 -30.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.493 -0.754 . . . . 0.0 109.58 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.439 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -166.34 -170.28 31.04 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -168.8 117.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.584 -0.951 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.1 30.74 20.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.698 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.83 -61.85 2.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -75.03 165.15 25.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.975 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.618 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 32.9 mt -78.09 156.9 79.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.721 . . . . 0.0 109.421 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.432 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.7 Cg_endo -80.34 -28.58 2.88 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 124.996 3.797 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.618 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.2 p90 -107.53 -170.94 1.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -140.68 96.96 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 26' ' ' ASP . 11.6 tp -117.09 81.11 12.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.76 -40.85 19.59 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 125.095 3.863 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -62.48 -52.25 64.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 109.63 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.788 ' HB2' HD23 ' A' ' 23' ' ' LEU . 30.6 t70 -63.1 -35.94 81.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 27' ' ' LEU . 43.0 mt -63.12 -23.8 67.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.539 -0.726 . . . . 0.0 109.554 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -85.52 -29.16 24.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 12.4 t80 -64.78 -25.72 68.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.647 -0.658 . . . . 0.0 109.528 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 34' ' ' THR . 49.6 t80 -64.64 -46.05 84.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.591 -0.693 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -65.12 -31.84 73.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 109.465 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.93 -29.03 58.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.565 -0.709 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 22.4 mm100 -100.4 34.17 2.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.4 p -140.46 -34.87 0.51 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.581 -0.699 . . . . 0.0 109.525 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -70.98 124.94 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.687 -0.633 . . . . 0.0 109.508 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.21 34.4 20.73 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -156.29 168.23 27.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.498 -1.001 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.5 mt -90.54 104.61 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.649 -0.657 . . . . 0.0 109.469 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.609 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.6 tmm? -77.22 120.58 22.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 0.0 109.484 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 94' ' ' LEU . 28.2 t -126.81 122.57 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.524 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.609 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.8 m -135.12 -174.28 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.79 -170.33 26.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -77.59 -40.01 43.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.525 -0.985 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.19 -36.3 74.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.638 -0.664 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -73.09 -28.12 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -63.7 -47.45 81.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HA ' HH21 ' A' ' 52' ' ' ARG . 25.1 mt-10 -71.97 -25.73 61.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -62.51 -21.64 65.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.571 -0.705 . . . . 0.0 109.587 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -62.44 164.37 11.87 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.03 -65.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.167 3.911 . . . . 0.0 110.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -128.33 103.97 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.523 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.453 HH21 ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -88.92 157.38 48.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.653 . . . . 0.0 109.421 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.35 -168.95 7.07 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.361 1.19 . . . . 0.0 110.035 0.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.589 HD12 ' CE ' ' A' ' 39' ' ' MET . 93.2 mt -112.96 96.32 37.76 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.421 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -69.54 176.48 6.54 Favored 'Trans proline' 0 N--CA 1.505 2.206 0 C-N-CA 124.592 3.528 . . . . 0.0 109.831 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 62.04 21.79 12.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.533 -0.729 . . . . 0.0 109.639 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -177.52 156.6 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.72 . . . . 0.0 109.458 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -79.46 152.36 30.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 109.54 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -130.32 114.76 16.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.454 ' HB ' HG22 ' A' ' 40' ' ' VAL . 30.1 t -116.52 103.98 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.654 -0.654 . . . . 0.0 109.522 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.6 123.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 76' ' ' VAL . 16.4 tp -94.99 108.69 20.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.416 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.478 HG23 ' CE1' ' A' ' 77' ' ' HIS . 3.9 t -136.56 152.8 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.46 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -104.44 -22.73 13.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.69 -0.631 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.88 134.31 48.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.686 . . . . 0.0 109.419 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.38 31.9 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.637 -0.664 . . . . 0.0 109.455 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -121.56 -30.6 4.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -67.79 144.44 55.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.742 . . . . 0.0 109.395 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -147.97 102.67 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.524 -0.735 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.42 117.96 25.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -78.19 133.77 37.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.685 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.69 35.95 44.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -159.22 151.48 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.611 -0.934 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -81.38 95.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.72 . . . . 0.0 109.439 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.404 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.3 t -76.7 97.72 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.466 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -94.55 170.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.579 -0.701 . . . . 0.0 109.501 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.478 ' CE1' HG23 ' A' ' 63' ' ' THR . 75.9 m-70 -146.15 30.23 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -168.3 144.7 3.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.569 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.2 t -66.48 -33.2 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.84 74.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.64 -0.662 . . . . 0.0 109.469 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.19 -35.63 78.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.629 -0.669 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.419 HG22 HG21 ' A' ' 76' ' ' VAL . 31.3 t -67.11 -42.28 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.635 -0.666 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -68.94 -29.63 67.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.47 82.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.09 -33.62 72.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.57 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.641 -0.662 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.88 -40.93 92.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -67.36 -31.12 71.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -120.19 90.03 44.07 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.12 -22.98 6.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.104 3.869 . . . . 0.0 109.893 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.33 -25.29 64.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.718 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -103.72 141.09 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.36 164.79 12.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.629 -0.669 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 40' ' ' VAL . 9.6 tp -93.17 132.1 37.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.53 -0.731 . . . . 0.0 109.457 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -134.5 126.81 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.1 mm -99.67 127.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.672 -0.643 . . . . 0.0 109.429 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.537 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -106.5 -22.36 12.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.586 -0.696 . . . . 0.0 109.611 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.3 -176.51 39.48 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.484 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.98 -154.23 18.49 Favored Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.353 -1.675 . . . . 0.0 109.533 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.9 77.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 109.502 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -72.49 -26.01 61.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.581 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.484 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -74.68 -36.56 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.555 -0.716 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -63.21 -51.0 68.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 m -63.17 -24.31 67.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.704 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.49 75.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.678 . . . . 0.0 109.487 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.569 ' CE1' HG13 ' A' ' 79' ' ' VAL . 65.8 m-85 -102.13 12.62 36.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.606 -0.684 . . . . 0.0 109.759 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 110' ' ' VAL . 70.2 tttt -70.75 -28.75 64.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.464 -0.773 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -65.65 -31.6 72.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.715 . . . . 0.0 109.569 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -119.49 37.95 4.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.49 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.791 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -84.78 156.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.34 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.25 -68.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.597 -0.689 . . . . 0.0 109.482 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -88.55 161.9 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 3' ' ' PHE . 26.9 mt -143.5 92.38 2.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.634 -0.666 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.677 ' CB ' HD12 ' A' ' 4' ' ' LEU . 50.8 mt -90.52 112.53 24.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.0 109.401 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -118.69 133.51 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.426 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -104.94 96.7 6.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.697 . . . . 0.0 109.321 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -82.42 138.73 34.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.7 . . . . 0.0 109.578 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.8 134.55 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.41 87.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.533 -0.729 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.78 126.22 23.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.2 p -79.29 143.44 35.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.947 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -145.83 128.61 16.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.581 -0.699 . . . . 0.0 109.506 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.82 153.58 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.718 . . . . 0.0 109.495 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.647 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -156.64 -135.49 1.96 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -30.39 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.63 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -94.54 143.51 26.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 109.553 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.66 168.95 13.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.639 -0.663 . . . . 0.0 109.485 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.4 tpt -93.38 152.4 19.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.512 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -71.83 164.4 58.73 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.618 -0.677 . . . . 0.0 109.502 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 95.2 1.0 Allowed 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 125.165 3.91 . . . . 0.0 109.889 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.67 138.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.655 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -81.15 84.15 6.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.429 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -67.83 -15.92 63.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.785 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.48 -25.93 68.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.46 -33.95 20.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.662 -0.649 . . . . 0.0 109.443 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 113' ' ' LEU . 96.3 m-85 -84.29 166.56 17.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.8 m -136.45 131.63 34.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -71.65 113.6 8.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.678 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 140' ' ' SER . 27.4 m -93.46 -38.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 109.494 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.424 ' N ' HG23 ' A' ' 139' ' ' VAL . 47.1 m -153.37 166.37 32.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.563 -0.711 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.9 p -160.8 134.24 6.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.583 -0.698 . . . . 0.0 109.44 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -100.41 113.4 26.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.448 ' HA ' HG23 ' A' ' 154' ' ' THR . 9.9 m -94.81 142.39 27.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.697 . . . . 0.0 109.489 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -151.1 147.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.697 . . . . 0.0 109.352 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.496 ' HA ' HG23 ' A' ' 152' ' ' THR . 10.4 pt-20 -128.27 132.76 48.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.441 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.58 -171.38 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -64.25 -34.96 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.649 . . . . 0.0 109.45 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.418 ' HB2' HD12 ' A' ' 151' ' ' LEU . 7.0 t30 -95.89 152.96 39.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.68 . . . . 0.0 109.293 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.08 -22.52 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.858 3.705 . . . . 0.0 109.909 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.93 -23.25 27.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.548 -0.72 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' A' ' 148' ' ' ASN . 46.8 mt -84.2 -1.32 54.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.503 -0.748 . . . . 0.0 109.99 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 145' ' ' GLU . 3.7 m -63.35 146.07 54.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.485 -0.759 . . . . 0.0 109.434 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.409 ' CE1' HG13 ' A' ' 144' ' ' VAL . 27.2 p-80 -157.79 165.31 35.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.65 -0.656 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.3 m -137.57 133.87 34.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.45 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -91.66 94.44 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.91 139.16 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.586 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.8 t -126.46 103.86 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.523 -0.736 . . . . 0.0 109.536 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -99.78 165.3 11.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -144.63 138.0 27.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 tttp . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.726 . . . . 0.0 109.483 -179.981 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.493 HG23 HD23 ' A' ' 94' ' ' LEU . 9.4 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.9 108.33 7.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 0.0 109.416 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.794 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.1 m-85 -84.44 123.88 30.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.438 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.675 HD12 ' CB ' ' A' ' 114' ' ' LEU . 6.9 tp -138.58 112.97 8.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.573 -0.705 . . . . 0.0 109.274 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -142.25 140.53 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 0.0 109.801 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.58 112.47 23.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.527 -0.733 . . . . 0.0 109.287 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.23 152.88 51.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.509 -0.744 . . . . 0.0 109.717 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -102.85 170.41 8.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -60.78 -18.44 55.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.626 -0.671 . . . . 0.0 109.896 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 14.22 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.501 -0.749 . . . . 0.0 109.838 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.28 37.05 93.94 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.67 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.6 tp -111.48 165.88 11.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.956 . . . . 0.0 109.487 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -138.14 -41.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.506 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.66 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -163.67 -179.31 37.95 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -162.11 125.92 3.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.947 . . . . 0.0 109.471 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 59.75 30.8 20.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.534 -0.729 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.57 -60.49 4.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -75.22 168.17 20.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.951 . . . . 0.0 109.503 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.618 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.0 mt -81.74 156.4 70.33 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.21 -29.39 2.56 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.012 3.808 . . . . 0.0 109.847 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.618 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 32.8 p90 -107.25 173.85 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 109.521 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -124.05 106.06 10.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.9 tp -126.77 81.18 69.51 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.24 -39.36 15.71 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 125.213 3.942 . . . . 0.0 110.253 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.92 -47.17 84.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.516 -0.74 . . . . 0.0 109.491 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.9 t0 -64.58 -31.46 72.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.71 . . . . 0.0 109.496 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.75 -24.44 63.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -86.65 -29.68 22.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.468 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 26.3 t80 -69.81 -24.43 63.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.612 -0.68 . . . . 0.0 109.536 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -63.35 -45.82 89.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -65.2 -29.21 70.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.525 -0.734 . . . . 0.0 109.461 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.52 -29.39 56.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.358 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.419 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 12.5 mm100 -100.74 34.8 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -143.33 -35.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.634 -0.666 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.8 m -70.66 124.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.496 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.31 33.96 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -156.32 166.93 32.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.954 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.63 99.68 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.343 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.711 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.9 tmm? -72.57 134.39 45.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.421 HG21 HD11 ' A' ' 94' ' ' LEU . 27.7 t -138.32 117.8 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.579 -0.701 . . . . 0.0 109.46 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.711 HG13 ' SD ' ' A' ' 39' ' ' MET . 27.0 m -132.67 -174.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.558 -0.714 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.93 -168.32 32.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 34.8 ptt180 -81.78 -34.32 30.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.523 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -71.29 -38.52 71.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.597 -0.689 . . . . 0.0 109.399 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -75.43 -27.68 59.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 40.3 t80 -64.89 -42.4 94.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -75.09 -23.3 57.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.4 m -63.24 -26.13 68.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.89 161.66 44.67 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.72 -61.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.082 3.855 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -125.55 103.14 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -104.73 154.79 38.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.439 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.6 154.71 88.74 Favored 'Cis proline' 0 N--CA 1.508 2.362 0 O-C-N 123.388 1.204 . . . . 0.0 109.827 0.025 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.1 mt -72.73 131.26 84.42 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -80.11 170.25 16.64 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.687 3.591 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.04 27.31 17.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -177.47 155.1 1.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.525 -0.734 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -84.92 134.22 34.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -105.6 105.08 14.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.546 -0.721 . . . . 0.0 109.465 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.9 147.54 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.435 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 t -137.15 119.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 109.476 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.559 HD12 HG23 ' A' ' 76' ' ' VAL . 12.7 tp -98.95 116.84 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.06 140.02 39.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.426 ' CD2' ' HG3' ' A' ' 65' ' ' GLN . 12.4 p-80 -81.63 -27.33 34.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.561 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.426 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 59.4 mt-30 -71.51 137.51 48.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.649 -0.657 . . . . 0.0 109.426 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -94.28 31.69 1.67 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.686 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -121.79 -31.37 3.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.536 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -67.94 138.7 56.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -144.47 158.57 43.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.632 -0.667 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' H ' HG21 ' A' ' 75' ' ' VAL . . . -137.59 129.67 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -84.53 136.5 33.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.583 -0.698 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.7 36.8 75.98 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.91 158.82 38.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.599 -0.942 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 t -95.06 92.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.613 -0.679 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.692 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.1 t -74.4 104.83 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.474 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 82' ' ' VAL . 27.6 m -94.7 153.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.692 ' NE2' HG12 ' A' ' 75' ' ' VAL . 55.8 m-70 -136.14 28.41 3.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -161.27 149.55 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.708 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.414 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.0 t -68.92 -35.24 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.555 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.99 65.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.572 -0.705 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.99 86.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.562 HG22 HG21 ' A' ' 76' ' ' VAL . 30.9 t -68.15 -45.08 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.525 -0.735 . . . . 0.0 109.431 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.95 -29.25 66.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.628 -0.67 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.01 82.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.4 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -71.33 -33.94 70.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.606 -0.684 . . . . 0.0 109.455 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.29 67.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.596 -0.69 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -65.92 -39.35 90.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.661 -0.65 . . . . 0.0 109.502 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.8 -32.11 72.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.523 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -121.71 89.49 47.72 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 -22.36 7.02 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.094 3.863 . . . . 0.0 109.891 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -65.53 -26.49 67.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -97.95 179.16 4.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.659 -0.65 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -137.32 150.1 47.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.493 HD23 HG23 ' A' ' 1' ' ' THR . 12.3 tp -76.31 134.98 39.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.577 -0.702 . . . . 0.0 109.473 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.24 122.8 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.581 -0.7 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.414 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.3 mm -97.02 142.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.641 . . . . 0.0 109.402 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.628 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -121.28 -30.95 4.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.713 . . . . 0.0 109.484 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.56 178.78 37.5 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.86 -151.9 20.87 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.364 -1.668 . . . . 0.0 109.534 0.027 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.52 -26.51 65.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.963 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -68.94 -31.97 71.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 109.541 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.2 -40.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.689 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 31.3 m-85 -63.06 -47.18 84.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.96 -23.59 66.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.554 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.75 -29.6 51.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 82' ' ' VAL . 43.7 m-85 -114.5 20.26 15.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -63.1 -36.74 84.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.605 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -81.11 29.72 0.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.603 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -160.01 33.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.585 -0.697 . . . . 0.0 109.486 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.1 p -94.7 153.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.714 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.58 -61.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.308 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -96.42 111.75 23.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.603 -0.686 . . . . 0.0 109.342 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 136' ' ' PHE . 34.1 mt -95.66 98.43 10.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.573 -0.705 . . . . 0.0 109.626 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.675 ' CB ' HD12 ' A' ' 4' ' ' LEU . 30.3 mt -99.21 104.48 16.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 109.214 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -111.57 140.79 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.598 -0.689 . . . . 0.0 109.565 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.6 m -110.17 97.7 7.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 109.245 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.406 ' O ' HD12 ' A' ' 118' ' ' LEU . 61.2 mtt180 -80.44 151.13 29.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 117' ' ' ARG . 3.0 mp -127.53 136.16 51.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.242 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.72 -32.77 71.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.05 128.88 10.25 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.7 p -81.38 144.44 31.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.465 ' O ' HD22 ' A' ' 12' ' ' LEU . 98.3 m-85 -147.27 121.74 9.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.619 -0.676 . . . . 0.0 109.418 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.99 149.8 27.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.705 . . . . 0.0 109.522 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.67 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -149.05 -141.26 3.42 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.7 -30.76 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.558 -0.966 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.1 m -102.97 130.22 49.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.581 -0.699 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -108.43 175.23 5.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.573 -0.704 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -93.93 152.47 18.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.6 pt -75.19 164.29 62.2 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.78 98.08 1.11 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.178 3.919 . . . . 0.0 109.844 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.85 145.32 27.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.612 -0.68 . . . . 0.0 109.507 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -85.07 87.03 7.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.614 -0.679 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -73.26 -9.94 59.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.58 -31.26 72.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.4 36.7 1.44 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.48 ' CE2' HD11 ' A' ' 113' ' ' LEU . 40.4 m-85 -143.28 167.81 21.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.536 -0.728 . . . . 0.0 109.452 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -144.76 145.84 31.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 109.45 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HE3' ' CZ2' ' A' ' 158' ' ' TRP . 31.8 ttmt -75.28 152.66 38.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.28 -32.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -149.6 154.92 39.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 t -157.1 110.49 2.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.585 -0.697 . . . . 0.0 109.498 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -100.68 110.88 23.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.6 m -92.07 146.43 23.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.671 . . . . 0.0 109.402 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.411 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -150.47 132.1 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.552 -0.717 . . . . 0.0 109.329 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -107.61 123.47 48.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.685 . . . . 0.0 109.478 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.35 -165.52 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.583 -0.698 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -71.19 -39.55 71.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.89 137.7 19.36 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.551 -0.718 . . . . 0.0 109.408 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.39 -46.64 22.62 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 124.755 3.637 . . . . 0.0 110.052 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.92 69.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.73 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -80.2 20.53 0.66 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.711 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.7 m -89.45 141.32 28.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.408 -0.807 . . . . 0.0 109.354 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.443 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.9 p-80 -152.87 164.88 37.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.559 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.7 m -137.73 132.63 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.15 93.03 9.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.623 -0.673 . . . . 0.0 109.483 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 56.0 mm-40 -78.51 130.76 36.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.62 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.2 t -119.94 112.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.582 -0.699 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.521 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.9 m95 -110.84 157.5 19.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.518 -0.739 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -141.38 143.06 33.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.3 tttp . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.603 -0.685 . . . . 0.0 109.489 -179.989 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.462 HG23 HD23 ' A' ' 94' ' ' LEU . 2.8 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.05 101.45 8.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -74.73 126.89 31.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.513 -0.742 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.587 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.3 tp -140.11 112.99 8.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 109.313 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 9.7 p90 -142.67 141.92 31.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 0.0 109.731 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.81 112.53 24.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.576 -0.702 . . . . 0.0 109.213 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.13 149.42 52.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.607 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -97.41 170.14 9.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.619 -0.676 . . . . 0.0 109.452 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.55 -18.58 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.872 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.38 15.4 0.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 0.0 109.855 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.1 34.38 88.83 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.611 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.5 tp -107.54 165.25 11.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.596 -0.944 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 126' ' ' THR . 31.8 pt -138.61 -29.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.476 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.71 -168.85 33.05 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -174.43 124.35 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.49 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 60.03 33.56 21.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.51 -0.744 . . . . 0.0 109.735 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.35 4.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -76.03 176.11 8.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.548 -0.972 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.645 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 19.3 mt -86.92 156.59 55.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.707 . . . . 0.0 109.41 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -80.59 -31.51 1.5 Allowed 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.0 3.8 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.645 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 31.4 p90 -104.96 167.11 9.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.56 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -117.79 100.27 7.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.606 -0.684 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 21.7 tp -122.02 81.76 43.44 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.361 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.25 -38.89 15.38 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 125.181 3.92 . . . . 0.0 110.307 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.78 -41.34 99.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.528 -0.732 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.9 t0 -66.63 -31.58 72.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.642 -0.661 . . . . 0.0 109.422 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.05 -23.7 61.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.589 -0.695 . . . . 0.0 109.531 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -86.81 -29.8 22.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.567 -0.708 . . . . 0.0 109.452 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -70.97 -25.94 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 34' ' ' THR . 51.9 t80 -65.42 -45.23 84.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.661 . . . . 0.0 109.446 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -64.98 -29.3 70.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.475 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.69 51.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.642 -0.661 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -97.77 33.13 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 30' ' ' PHE . 10.3 p -137.37 -34.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' VAL . 26.6 m -68.62 126.17 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.557 -0.714 . . . . 0.0 109.433 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 36.28 23.58 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -153.24 166.21 33.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.521 -0.988 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.42 102.0 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.598 -0.689 . . . . 0.0 109.447 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.64 ' SD ' HG13 ' A' ' 41' ' ' VAL . 8.1 tmm? -70.38 125.72 27.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.58 -0.7 . . . . 0.0 109.435 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 94' ' ' LEU . 29.8 t -131.9 115.5 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.631 -0.668 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.64 HG13 ' SD ' ' A' ' 39' ' ' MET . 24.7 m -135.45 -177.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.702 . . . . 0.0 109.458 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.3 -178.62 35.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -72.27 -31.86 66.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.576 -0.955 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.22 -48.23 62.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -68.64 -25.95 65.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -68.54 -33.92 74.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.708 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.14 -26.15 19.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 t -74.9 10.11 1.59 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -81.76 166.42 37.7 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.83 -73.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.103 3.868 . . . . 0.0 109.968 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -118.23 71.94 0.85 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.55 -0.719 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -72.19 156.82 90.25 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.12 -175.86 17.48 Favored 'Cis proline' 0 N--CA 1.508 2.378 0 O-C-N 123.377 1.198 . . . . 0.0 109.946 0.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.5 HD12 ' CE ' ' A' ' 39' ' ' MET . 84.2 mt -107.73 104.25 52.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -74.56 179.83 5.55 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 124.645 3.564 . . . . 0.0 109.813 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.95 28.06 17.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.572 -0.705 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -176.1 178.76 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.416 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 m -98.47 117.47 32.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.464 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -88.78 105.99 18.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -114.9 141.37 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 109.438 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -131.94 123.49 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 76' ' ' VAL . 15.2 tp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.523 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.65 140.13 34.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.63 -0.669 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -94.74 29.74 2.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -147.56 142.46 26.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 109.442 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -88.65 30.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.703 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.57 -35.15 9.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -77.18 134.57 38.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.515 -0.74 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -146.29 116.41 7.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.47 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.68 131.98 53.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -84.66 138.42 32.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.562 -0.711 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.17 38.05 59.36 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.5 144.25 16.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.529 -0.983 . . . . 0.0 109.553 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -79.84 95.66 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.587 -0.696 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.593 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.0 t -79.99 106.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.509 HG21 HG22 ' A' ' 82' ' ' VAL . 28.0 m -94.88 150.82 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.593 ' NE2' HG12 ' A' ' 75' ' ' VAL . 31.8 m-70 -131.65 30.03 4.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.679 . . . . 0.0 109.464 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -163.87 144.55 8.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.454 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 106' ' ' PHE . 29.8 t -67.57 -32.95 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.585 -0.697 . . . . 0.0 109.476 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -32.96 72.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.667 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.86 75.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 76' ' ' VAL . 31.0 t -69.19 -44.14 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.42 -30.2 65.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.565 -0.71 . . . . 0.0 109.426 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.15 79.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.681 -0.637 . . . . 0.0 109.474 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -71.3 -33.45 69.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.553 -0.717 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.47 -31.16 65.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.92 -45.91 69.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.594 -0.692 . . . . 0.0 109.484 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -66.19 -26.79 67.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.552 -0.717 . . . . 0.0 109.509 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -118.94 89.75 39.38 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 -22.49 6.98 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.126 3.884 . . . . 0.0 109.984 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -65.82 -26.02 67.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.603 -0.686 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -104.24 179.46 4.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.512 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -140.36 150.61 44.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.653 -0.654 . . . . 0.0 109.462 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 40' ' ' VAL . 12.6 tp -75.28 137.84 41.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 109.486 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -144.24 116.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.656 -0.652 . . . . 0.0 109.473 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.516 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.5 mm -91.74 128.73 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.698 . . . . 0.0 109.379 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -107.13 -31.03 8.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.49 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.86 178.83 38.49 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.52 -151.71 21.81 Favored Glycine 0 N--CA 1.499 2.855 0 O-C-N 120.362 -1.67 . . . . 0.0 109.632 0.035 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.5 68.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.965 . . . . 0.0 109.519 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -70.51 -30.6 67.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -76.01 -37.75 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.533 -0.729 . . . . 0.0 109.494 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.516 ' CE1' HG22 ' A' ' 96' ' ' ILE . 28.9 m-85 -63.64 -50.02 70.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.399 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 -24.92 68.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.656 -0.653 . . . . 0.0 109.497 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.19 69.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 79' ' ' VAL . 77.6 m-85 -116.44 19.28 14.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -27.74 65.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.69 20.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.695 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -160.09 36.85 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.546 -0.721 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.661 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -96.99 141.31 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.589 -0.695 . . . . 0.0 109.473 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -122.03 -47.46 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.384 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.7 m -100.9 152.62 20.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.391 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.507 HD11 ' CE2' ' A' ' 136' ' ' PHE . 22.0 mt -136.12 96.95 3.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.624 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.624 ' CD2' HG22 ' A' ' 157' ' ' VAL . 38.2 mt -100.49 109.3 21.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.722 . . . . 0.0 109.292 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -119.23 141.98 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.0 m -109.21 103.08 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.58 -0.7 . . . . 0.0 109.267 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -88.22 138.88 31.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.702 . . . . 0.0 109.561 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.63 141.47 47.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.291 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.94 -32.35 63.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.503 -0.748 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.74 133.73 19.52 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.0 m -82.7 142.29 31.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.62 -0.929 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.546 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.6 m-85 -148.04 119.22 7.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.668 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -87.53 145.23 26.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.586 -0.697 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.611 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -140.72 -127.68 2.36 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -143.19 -32.59 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.951 . . . . 0.0 109.438 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.536 HG22 HD11 ' A' ' 13' ' ' ILE . 8.3 m -105.1 136.94 43.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -113.14 175.5 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.605 -0.684 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.6 tpt -92.13 152.61 19.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.528 -0.732 . . . . 0.0 109.558 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 pt -72.55 164.75 57.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.71 98.38 1.14 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 125.112 3.875 . . . . 0.0 109.919 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.56 147.0 26.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -84.45 84.81 7.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.558 -0.714 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -67.83 -19.31 65.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.718 . . . . 0.0 109.684 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -24.97 67.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -97.42 29.35 3.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.507 ' CE2' HD11 ' A' ' 113' ' ' LEU . 40.7 m-85 -143.57 175.2 10.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -149.47 144.28 26.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -84.43 114.75 22.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.47 -34.0 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.523 -0.736 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -155.41 171.45 19.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.726 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 t -164.51 127.64 2.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -98.7 111.91 24.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.556 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.528 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.2 m -91.29 145.38 24.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.484 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -149.24 125.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.509 -0.744 . . . . 0.0 109.345 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -104.79 121.32 43.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.61 -0.681 . . . . 0.0 109.436 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.56 -165.11 0.81 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.3 p -73.32 -40.7 64.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.723 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -103.45 137.58 19.29 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.61 -44.34 26.11 Favored 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 124.826 3.684 . . . . 0.0 110.093 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.7 71.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.631 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.97 19.43 1.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 109.66 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.4 m -91.13 134.29 34.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.543 -0.723 . . . . 0.0 109.437 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.609 ' CE1' HD21 ' A' ' 23' ' ' LEU . 37.4 p-80 -150.01 167.23 27.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 143' ' ' THR . 16.1 m -137.32 136.48 38.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -89.44 95.45 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.494 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.6 mt-10 -76.67 135.6 39.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.552 -0.717 . . . . 0.0 109.453 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 114' ' ' LEU . 27.9 t -126.19 97.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.565 -0.709 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.494 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 30.5 m95 -96.46 163.0 13.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.637 -0.664 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -143.31 144.77 32.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.62 -0.675 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 0.0 109.461 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.657 HG23 HD23 ' A' ' 94' ' ' LEU . 6.8 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.49 134.0 44.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.849 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.2 m-85 -104.76 153.99 20.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.701 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.2 tp -164.57 109.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.1 146.61 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.533 -0.729 . . . . 0.0 109.655 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.78 110.05 22.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.285 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -129.12 149.31 50.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.64 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -99.34 171.76 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 0.0 109.411 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.447 HH11 ' HB2' ' A' ' 9' ' ' ARG . 1.8 ptp180 -61.56 -19.53 62.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.641 -0.662 . . . . 0.0 109.806 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.53 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.16 37.0 93.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.447 HD23 ' CG ' ' A' ' 20' ' ' PRO . 5.5 tp -105.58 167.81 9.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.528 -0.983 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' A' ' 126' ' ' THR . 2.6 pp -144.92 -26.19 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.487 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -170.59 -170.97 35.48 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -172.65 120.28 0.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.575 -0.956 . . . . 0.0 109.442 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.92 33.42 21.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.506 -0.746 . . . . 0.0 109.706 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.98 3.68 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -77.24 178.27 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.506 -0.996 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.626 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.7 mt -83.7 155.5 65.21 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.447 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.6 Cg_endo -80.16 -30.92 1.92 Allowed 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 124.993 3.795 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.626 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 31.7 p90 -105.76 168.11 9.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.545 -0.722 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -115.19 107.61 15.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.675 . . . . 0.0 109.376 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.77 HD23 ' HB2' ' A' ' 26' ' ' ASP . 13.0 tp -129.31 80.49 72.18 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.578 -0.701 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.29 -40.05 16.46 Favored 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 125.162 3.908 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.67 -49.77 73.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.55 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.77 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.3 t0 -63.04 -31.35 72.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.631 HD22 H223 ' A' ' 170' ' ' TMQ . 96.1 mt -72.32 -24.73 61.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -86.74 -23.83 25.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.505 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.0 t80 -75.02 -24.63 58.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.507 ' O ' HG23 ' A' ' 34' ' ' THR . 53.4 t80 -63.24 -44.98 93.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.576 -0.703 . . . . 0.0 109.472 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -63.6 -26.15 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.566 -0.709 . . . . 0.0 109.463 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.56 -28.34 33.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.548 -0.72 . . . . 0.0 109.419 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 17.3 mm100 -103.06 34.12 3.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 30' ' ' PHE . 22.1 p -140.59 -34.73 0.51 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.2 m -77.29 131.16 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.419 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.07 7.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -111.37 167.6 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.603 -0.939 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.501 HG23 ' HB ' ' A' ' 58' ' ' THR . 58.8 mt -85.12 126.03 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 109.431 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.443 ' CE ' HD12 ' A' ' 54' ' ' LEU . 41.6 ttp -92.12 107.66 19.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.49 122.04 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.56 163.13 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.95 -164.28 39.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 23.6 ptt180 -82.28 -38.64 24.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.987 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.44 -33.33 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.623 -0.673 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -79.42 -27.55 41.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 109.459 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -65.51 -58.35 6.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.02 -26.71 68.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -62.7 -21.85 66.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.722 . . . . 0.0 109.694 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -62.77 161.1 31.18 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.523 -0.736 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.17 -71.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 125.119 3.879 . . . . 0.0 109.901 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -115.77 75.74 0.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -78.39 156.48 78.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.04 166.86 75.92 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.423 1.223 . . . . 0.0 109.994 0.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.443 HD12 ' CE ' ' A' ' 39' ' ' MET . 53.6 mt -90.09 118.03 68.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.736 . . . . 0.0 109.315 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.65 174.3 12.49 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 124.765 3.644 . . . . 0.0 109.969 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.48 27.03 16.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.63 -0.668 . . . . 0.0 109.641 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -177.41 155.0 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.499 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.501 ' HB ' HG23 ' A' ' 38' ' ' ILE . 9.2 m -76.39 144.7 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -120.48 96.91 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.593 -0.692 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -100.34 151.57 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.69 120.2 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.697 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.506 HD12 HG23 ' A' ' 76' ' ' VAL . 17.0 tp -96.61 117.61 31.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.598 -0.689 . . . . 0.0 109.458 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -151.05 144.14 24.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.569 -0.707 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -103.06 31.14 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -124.24 132.31 53.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.629 -0.669 . . . . 0.0 109.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.2 30.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.39 -30.69 5.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.589 -0.694 . . . . 0.0 109.513 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -66.58 142.56 57.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -137.58 142.45 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.91 117.65 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -84.04 122.1 28.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.716 -0.615 . . . . 0.0 109.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.68 41.59 12.67 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.41 145.4 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.99 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -83.07 97.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.564 -0.71 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.561 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.7 t -76.8 100.35 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.56 -0.713 . . . . 0.0 109.443 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.506 HG23 HD12 ' A' ' 62' ' ' LEU . 27.9 m -91.16 153.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.457 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.561 ' NE2' HG12 ' A' ' 75' ' ' VAL . 88.3 m-70 -135.35 30.34 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.566 -0.708 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -166.88 148.23 6.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.47 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.7 -33.33 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.94 -32.9 72.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.59 -36.07 80.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.65 -0.656 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 76' ' ' VAL . 31.7 t -69.8 -39.78 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.436 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -76.84 -31.43 56.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.643 -0.661 . . . . 0.0 109.52 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.08 78.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -72.98 -33.66 65.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.21 68.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.21 -42.54 83.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.639 -0.663 . . . . 0.0 109.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.18 -27.84 68.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.507 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -119.33 89.93 41.14 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.713 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.63 -22.99 7.44 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 125.112 3.875 . . . . 0.0 109.922 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -68.15 -26.9 66.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.415 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -97.9 179.89 4.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -139.47 165.7 26.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.657 HD23 HG23 ' A' ' 1' ' ' THR . 11.7 tp -96.59 128.75 43.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 t -132.08 133.57 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.542 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.4 mm -104.07 124.46 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.549 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -109.69 -27.96 9.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.22 -179.57 38.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.87 -154.8 19.55 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.317 -1.696 . . . . 0.0 109.554 -0.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.84 -32.27 73.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.937 . . . . 0.0 109.486 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -71.04 -31.83 68.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.99 -36.0 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.542 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.2 m-85 -63.21 -55.63 23.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.582 -0.699 . . . . 0.0 109.554 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -62.55 -21.38 65.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.626 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.93 -36.87 78.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CE1' HG13 ' A' ' 79' ' ' VAL . 69.5 m-85 -113.41 18.7 17.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.609 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -66.98 -23.81 65.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 109.58 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.49 -45.42 59.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.08 38.84 1.12 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.607 -0.683 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.849 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -88.95 151.75 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -132.84 -61.85 0.83 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.6 m -93.55 159.82 15.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.433 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.43 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 34.3 mt -140.17 95.77 2.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.701 ' CB ' HD12 ' A' ' 4' ' ' LEU . 34.4 mt -95.08 103.36 15.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.316 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -109.24 136.18 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.725 . . . . 0.0 109.452 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 m -107.39 102.95 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.388 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.9 146.49 26.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.78 132.1 51.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.623 -0.673 . . . . 0.0 109.272 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.88 -34.17 73.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.613 -0.679 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.86 130.59 27.95 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 t -79.82 139.85 37.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.58 -0.953 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.413 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.3 m-85 -146.78 126.55 13.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.715 . . . . 0.0 109.506 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.05 146.52 26.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.36 -124.01 1.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -145.04 -30.08 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.61 -0.935 . . . . 0.0 109.49 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.423 ' HB ' HD11 ' A' ' 13' ' ' ILE . 4.3 m -100.79 142.45 32.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.705 . . . . 0.0 109.509 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -118.02 176.05 5.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.572 -0.705 . . . . 0.0 109.461 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.428 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.597 -0.689 . . . . 0.0 109.5 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.3 pt -69.37 163.68 56.08 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.562 -0.711 . . . . 0.0 109.516 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.88 102.35 1.45 Allowed 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 125.047 3.831 . . . . 0.0 109.851 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.24 144.74 26.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -81.15 85.62 6.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.692 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -71.74 -14.1 61.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.852 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.05 10.05 1.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.897 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.86 31.73 3.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 0.0 109.417 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.43 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 66.3 m-85 -141.47 174.13 10.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.399 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -147.44 137.35 22.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -71.1 156.56 39.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.746 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.73 -36.02 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.701 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.7 m -148.2 163.63 36.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.8 t -158.86 157.63 31.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -142.92 101.09 3.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.488 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.475 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.7 m -85.52 143.22 28.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.432 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.424 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.9 p -147.18 129.18 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.541 -0.725 . . . . 0.0 109.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -105.25 121.34 43.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.563 -0.711 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.32 -166.21 1.01 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.4 p -70.23 -39.63 74.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.596 -0.69 . . . . 0.0 109.61 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -105.35 137.84 19.38 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.647 -0.658 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -47.98 -45.54 24.66 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 C-N-CA 124.842 3.694 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.98 70.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.689 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.1 mt -81.07 20.83 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.6 m -91.37 137.99 31.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.424 ' NE2' HG11 ' A' ' 144' ' ' VAL . 34.5 p-80 -151.85 169.01 23.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 143' ' ' THR . 23.0 m -142.73 132.51 24.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -89.61 101.0 13.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.5 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 38.2 mt-10 -85.9 128.98 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.602 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.8 t -114.96 112.7 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.534 -0.729 . . . . 0.0 109.51 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 31.2 m95 -109.32 164.06 12.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -139.92 136.4 33.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.615 -0.678 . . . . 0.0 109.429 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -72.78 140.35 47.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.518 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -141.65 127.46 19.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.607 -0.683 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.432 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.631 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 2' ' ' ALA . 14.7 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 1' ' ' THR . . . -135.59 121.24 19.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.815 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -91.62 149.24 21.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 114' ' ' LEU . 11.0 tp -159.79 110.39 1.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.696 . . . . 0.0 109.401 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.43 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -143.77 147.99 34.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.749 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.23 111.88 23.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.538 -0.726 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.451 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.8 pt20 -132.43 149.47 52.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.537 -0.727 . . . . 0.0 109.637 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -100.43 170.44 8.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.684 . . . . 0.0 109.458 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.25 -17.32 52.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.785 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.72 14.4 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 109.846 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.41 36.89 93.76 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.659 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.9 tp -112.23 166.55 11.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.549 -0.971 . . . . 0.0 109.526 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.657 HD11 HG22 ' A' ' 126' ' ' THR . 32.2 pt -139.8 -29.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.496 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -171.73 -168.18 32.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -170.23 119.72 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.636 -0.92 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.95 29.81 19.36 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.566 -0.709 . . . . 0.0 109.742 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.89 -61.69 2.65 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -73.83 169.77 16.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.923 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.697 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 40.3 mt -84.84 155.92 61.3 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.616 -0.677 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.4 Cg_endo -79.52 -28.08 3.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.046 3.831 . . . . 0.0 109.958 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.697 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.1 p90 -106.77 167.67 9.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -118.57 93.53 4.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.557 -0.714 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.793 HD23 ' HB2' ' A' ' 26' ' ' ASP . 18.5 tp -114.97 80.73 6.99 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.27 -38.67 15.19 Favored 'Trans proline' 0 N--CA 1.507 2.273 0 C-N-CA 125.139 3.893 . . . . 0.0 110.25 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.7 -44.25 96.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.698 . . . . 0.0 109.59 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.793 ' HB2' HD23 ' A' ' 23' ' ' LEU . 32.4 t70 -64.24 -41.07 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.741 . . . . 0.0 109.436 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.661 HD22 ' C22' ' A' ' 170' ' ' TMQ . 95.0 mt -63.02 -23.72 67.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -85.0 -29.48 24.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.631 -0.668 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -70.8 -25.75 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.458 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.34 -52.2 59.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.545 -0.722 . . . . 0.0 109.453 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -68.32 2.09 2.51 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.601 -0.687 . . . . 0.0 110.022 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.15 12.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -0.832 . . . . 0.0 109.451 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -114.91 35.09 4.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.568 -0.707 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 p -132.91 -27.53 1.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.741 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.0 m -75.5 127.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.91 23.62 51.88 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.25 164.98 29.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.522 -0.987 . . . . 0.0 109.5 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -91.37 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.462 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.8 ttp -82.92 108.33 16.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.54 -0.725 . . . . 0.0 109.559 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.478 HG21 HD11 ' A' ' 94' ' ' LEU . 30.0 t -96.59 118.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.503 -0.748 . . . . 0.0 109.385 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 29.4 m -131.47 166.92 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.41 -160.71 36.59 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.7 -35.54 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.617 -0.931 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -69.5 -37.79 77.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -77.4 -27.23 52.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -65.51 -34.55 78.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -89.61 -24.03 21.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -62.91 -22.18 66.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.735 . . . . 0.0 109.601 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.501 ' HZ ' HG11 ' A' ' 41' ' ' VAL . 39.4 m-85 -62.73 159.8 41.23 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -72.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.093 3.862 . . . . 0.0 109.89 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.3 pttm -108.07 74.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.423 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -78.73 156.03 77.89 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.489 -0.757 . . . . 0.0 109.528 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.18 171.09 63.39 Favored 'Cis proline' 0 N--CA 1.507 2.317 0 O-C-N 123.407 1.214 . . . . 0.0 109.957 0.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.462 HD12 ' CE ' ' A' ' 39' ' ' MET . 67.4 mt -94.58 115.39 65.25 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.55 -0.719 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.0 -178.28 4.53 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.808 3.672 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 60.65 28.21 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -176.68 179.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.5 m -112.42 111.17 21.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.607 -0.683 . . . . 0.0 109.487 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.491 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -86.0 107.83 17.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.488 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 t -102.3 112.66 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.588 -0.695 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.4 t -95.71 125.16 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.453 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.537 HD12 HG23 ' A' ' 76' ' ' VAL . 14.4 tp -104.56 114.79 29.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.42 140.89 33.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -89.16 30.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -137.65 125.05 21.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.7 29.83 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.03 -37.46 6.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.601 -0.687 . . . . 0.0 109.55 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -70.83 143.7 51.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 109.518 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.75 101.45 3.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.61 118.57 28.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.439 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -73.83 136.38 43.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.546 -0.722 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 37.43 57.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.99 145.93 18.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.973 . . . . 0.0 109.515 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.78 98.91 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 0.0 109.501 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.607 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.3 t -80.42 99.41 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.537 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -99.97 158.57 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.61 -0.681 . . . . 0.0 109.433 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.607 ' NE2' HG12 ' A' ' 75' ' ' VAL . 81.0 m-70 -138.8 29.82 2.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.548 -0.72 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -167.85 148.75 5.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.6 t -68.06 -31.69 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.612 -0.68 . . . . 0.0 109.475 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.53 -33.68 76.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.5 -0.75 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.41 75.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.683 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 t -67.81 -43.92 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -73.19 -30.13 63.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.486 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.68 83.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.597 -0.689 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -71.51 -34.02 69.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.5 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.0 -30.82 69.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.602 -0.686 . . . . 0.0 109.405 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -67.19 -34.63 77.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.534 -0.728 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.43 -36.58 76.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -120.92 87.26 42.88 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.45 20.22 0.98 Allowed 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.169 3.912 . . . . 0.0 109.952 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -100.96 -30.12 11.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -94.51 178.23 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.558 -0.713 . . . . 0.0 109.443 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -127.88 151.62 48.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.626 -0.671 . . . . 0.0 109.466 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.478 HD11 HG21 ' A' ' 40' ' ' VAL . 13.1 tp -83.17 108.26 16.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.629 -0.669 . . . . 0.0 109.483 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -113.91 131.42 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.553 -0.717 . . . . 0.0 109.419 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.528 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.9 mm -98.28 125.68 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.707 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.56 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -108.13 -27.52 10.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.503 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 160.85 -179.94 36.0 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.29 -152.26 17.54 Favored Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.315 -1.697 . . . . 0.0 109.585 0.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.4 73.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.582 -0.952 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -70.85 -30.45 66.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.76 -34.89 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.563 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.528 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.1 m-85 -64.39 -56.79 11.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.713 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.463 ' OG1' HD13 ' A' ' 129' ' ' ILE . 2.6 m -62.53 -21.18 65.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.661 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.93 73.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.528 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' CE1' HG13 ' A' ' 79' ' ' VAL . 69.9 m-85 -113.1 17.24 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.526 -0.734 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.64 ' O ' HG12 ' A' ' 110' ' ' VAL . 1.2 pptp? -67.06 -23.17 65.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.521 -0.737 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -66.77 -45.44 78.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.516 -0.74 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.23 44.97 1.0 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.815 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -93.96 147.83 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 0.0 109.442 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -136.94 -68.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -84.65 120.04 25.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 3' ' ' PHE . 19.1 mt -107.7 94.95 5.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.631 -0.668 . . . . 0.0 109.609 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.604 ' CB ' HD12 ' A' ' 4' ' ' LEU . 39.0 mt -91.33 115.51 28.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.645 -0.659 . . . . 0.0 109.343 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.43 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -124.31 138.71 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.705 . . . . 0.0 109.509 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.9 m -109.87 101.4 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.564 -0.71 . . . . 0.0 109.234 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -87.68 139.81 30.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 109.614 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.73 140.15 47.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.331 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.81 -33.27 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.05 139.06 25.45 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.2 m -86.91 143.13 27.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.516 -0.991 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.621 ' O ' HD22 ' A' ' 12' ' ' LEU . 96.2 m-85 -148.45 108.73 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -80.1 147.04 31.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.531 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.659 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -144.46 -126.77 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -141.79 -41.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.949 . . . . 0.0 109.482 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.657 HG22 HD11 ' A' ' 13' ' ' ILE . 6.8 m -90.52 126.98 36.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.509 -0.745 . . . . 0.0 109.435 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -104.53 172.22 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.412 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -91.82 145.09 24.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.462 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.463 HD13 ' OG1' ' A' ' 104' ' ' THR . 24.4 pt -66.79 165.37 26.17 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.519 -0.738 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.52 108.83 2.19 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 125.173 3.915 . . . . 0.0 109.961 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -98.67 145.22 27.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -86.09 87.15 7.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -69.88 -17.25 63.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.82 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.86 -27.19 69.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.477 -0.764 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -93.3 30.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -149.91 164.15 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -139.07 136.18 34.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.698 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -70.12 149.17 47.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.631 -0.668 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.6 -31.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.469 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -143.87 153.3 42.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.522 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.2 p -155.48 113.3 3.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.544 -0.723 . . . . 0.0 109.501 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 tpt85 -91.24 103.31 16.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.482 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.7 m -85.55 141.4 29.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -146.72 129.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.597 -0.69 . . . . 0.0 109.322 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -108.3 120.7 43.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.4 -166.04 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.3 p -71.17 -42.77 68.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.717 . . . . 0.0 109.588 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.18 137.75 19.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.573 -0.705 . . . . 0.0 109.428 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.87 -43.1 30.33 Favored 'Trans proline' 0 N--CA 1.508 2.333 0 C-N-CA 124.781 3.654 . . . . 0.0 110.126 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.48 73.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.565 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 151' ' ' LEU . 47.9 mt -80.91 20.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.629 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.6 m -90.85 141.93 28.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 109.473 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.549 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.5 p-80 -158.12 167.29 30.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.496 -0.752 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.1 m -138.63 141.03 39.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.638 . . . . 0.0 109.417 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.36 97.75 9.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.667 . . . . 0.0 109.467 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 21.8 mt-10 -81.36 139.46 35.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.578 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -124.97 107.29 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.44 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 31.4 m95 -103.97 165.13 11.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.685 . . . . 0.0 109.454 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -148.87 144.18 26.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.482 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -69.01 113.81 6.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -146.89 139.25 24.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.632 -0.667 . . . . 0.0 109.507 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.504 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.661 ' C22' HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.81 128.59 35.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 109.412 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.808 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -95.8 160.06 14.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.562 -0.711 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.619 HD12 ' CB ' ' A' ' 114' ' ' LEU . 12.1 tp -170.86 108.92 0.32 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.698 . . . . 0.0 109.335 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.433 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.39 151.21 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.31 114.12 26.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.4 pt20 -135.61 150.65 49.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -100.86 170.73 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.526 -0.734 . . . . 0.0 109.366 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -61.17 -17.85 55.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.579 -0.701 . . . . 0.0 109.887 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.72 14.05 0.89 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.501 -0.749 . . . . 0.0 109.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.16 39.01 97.1 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.572 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.0 tp -112.25 163.95 13.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.95 . . . . 0.0 109.515 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.469 HD11 ' CG2' ' A' ' 126' ' ' THR . 2.5 pp -139.75 -27.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.518 -0.738 . . . . 0.0 109.514 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.16 -176.85 40.59 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -166.42 120.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.958 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.88 32.74 21.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -61.73 3.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -76.34 171.3 14.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.96 . . . . 0.0 109.493 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.594 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.1 mt -84.8 155.85 61.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 9.8 Cg_endo -78.9 -26.99 5.0 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 125.069 3.846 . . . . 0.0 109.97 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.594 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.5 p90 -108.37 167.31 10.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -118.83 97.6 5.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 26' ' ' ASP . 21.5 tp -118.63 80.09 16.77 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 109.428 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.28 -37.82 14.3 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 125.193 3.928 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -63.02 -43.51 98.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.505 -0.747 . . . . 0.0 109.503 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.812 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.6 t0 -64.4 -35.0 79.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.396 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.68 -25.3 63.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.67 -0.644 . . . . 0.0 109.516 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -83.8 -28.51 28.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.435 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.441 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.7 t80 -74.01 -25.53 59.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.541 -0.725 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 34' ' ' THR . 53.2 t80 -65.01 -45.82 83.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.452 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' O ' HG13 ' A' ' 35' ' ' VAL . 41.4 ttp85 -65.69 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.85 56.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 41.5 mm-40 -99.59 32.27 2.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 109.506 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.5 p -139.55 -31.33 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -67.88 129.22 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.456 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.09 56.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -155.35 170.35 22.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.561 -0.964 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' CG2' HG21 ' A' ' 60' ' ' VAL . 58.1 mt -99.62 111.66 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.435 ' CE ' HD12 ' A' ' 54' ' ' LEU . 38.4 ttp -87.05 106.87 18.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.522 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.56 119.46 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.43 160.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.562 -0.711 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.34 -170.2 46.69 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.12 -33.71 59.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.598 -0.943 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -67.67 -47.32 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 109.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -70.1 -26.03 63.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.686 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -63.9 -43.54 95.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.573 -0.704 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.9 -22.96 33.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.531 -0.73 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t -62.97 -23.9 67.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.721 . . . . 0.0 109.621 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.98 160.23 48.93 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.725 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.83 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.124 3.882 . . . . 0.0 109.942 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -105.81 89.59 3.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.377 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -96.78 157.03 35.86 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.593 -0.692 . . . . 0.0 109.507 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.87 142.32 57.68 Favored 'Cis proline' 0 N--CA 1.509 2.4 0 O-C-N 123.325 1.171 . . . . 0.0 109.964 -0.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.435 HD12 ' CE ' ' A' ' 39' ' ' MET . 82.3 mt -61.85 111.17 4.02 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.577 -0.702 . . . . 0.0 109.413 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.43 -178.05 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.732 3.621 . . . . 0.0 109.949 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 60.96 29.21 18.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.588 -0.695 . . . . 0.0 109.56 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -177.24 177.42 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -100.2 119.32 38.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -93.18 104.53 16.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.568 -0.707 . . . . 0.0 109.511 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG21 ' CG2' ' A' ' 38' ' ' ILE . 30.4 t -105.75 120.81 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.495 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -106.5 127.38 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.731 . . . . 0.0 109.408 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.736 HD12 HG23 ' A' ' 76' ' ' VAL . 17.1 tp -102.34 120.75 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.654 -0.654 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.11 155.41 44.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.396 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -86.24 -61.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.617 -0.677 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.37 145.54 37.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.655 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.38 30.95 0.59 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.72 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.55 -31.3 19.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -69.58 124.75 24.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -104.56 131.56 51.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.66 -0.65 . . . . 0.0 109.374 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.76 112.32 8.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.507 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -90.47 142.93 27.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 34.74 61.03 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.49 141.93 15.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.955 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.11 96.92 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.45 HG12 ' NE2' ' A' ' 77' ' ' HIS . 28.8 t -73.55 96.57 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.481 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 62' ' ' LEU . 28.6 m -91.23 160.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.717 . . . . 0.0 109.471 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.45 ' NE2' HG12 ' A' ' 75' ' ' VAL . 80.1 m-70 -137.53 29.74 2.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.581 -0.699 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.65 146.39 2.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.549 HG13 ' CE2' ' A' ' 106' ' ' PHE . 30.4 t -68.17 -32.92 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -33.83 75.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.485 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.19 -37.35 83.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.498 -0.751 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.456 HG22 HG21 ' A' ' 76' ' ' VAL . 30.9 t -69.03 -38.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.606 -0.684 . . . . 0.0 109.449 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -73.07 -30.75 63.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.74 86.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.61 -32.78 71.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.83 -31.03 68.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -65.64 -40.55 92.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -67.61 -32.13 72.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.546 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.82 89.75 42.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.59 -0.693 . . . . 0.0 109.521 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.08 -21.6 7.89 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 125.12 3.88 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 -26.74 67.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.545 -0.722 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.01 -179.99 5.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.576 -0.703 . . . . 0.0 109.427 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -138.16 144.81 40.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.2 tp -86.07 132.59 34.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -139.29 131.04 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 109.504 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.562 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.6 mm -97.1 125.79 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.524 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -109.01 -25.13 10.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.504 -0.748 . . . . 0.0 109.474 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.29 -176.14 36.12 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.476 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.28 -152.4 9.12 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.259 -1.73 . . . . 0.0 109.546 0.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.84 82.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.946 . . . . 0.0 109.707 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.434 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 13.6 pm0 -66.1 -23.05 66.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.61 -0.681 . . . . 0.0 109.765 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.476 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.5 mm -77.31 -35.42 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.521 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' CE1' HG22 ' A' ' 96' ' ' ILE . 25.5 m-85 -64.0 -50.39 68.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 109.507 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.06 -26.22 68.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.03 83.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.545 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 79' ' ' VAL . 55.3 m-85 -103.02 11.8 36.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.513 -0.742 . . . . 0.0 109.951 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.522 ' O ' HG12 ' A' ' 110' ' ' VAL . 44.9 tttm -71.54 -24.26 61.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.779 . . . . 0.0 109.526 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 -41.54 92.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.722 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -110.77 37.41 2.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.582 -0.699 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.808 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -79.72 151.89 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 0.0 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.2 -68.79 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.66 -0.65 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -88.68 163.03 15.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.459 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.451 HD12 ' CD2' ' A' ' 136' ' ' PHE . 22.0 mt -142.19 89.74 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' CB ' HD12 ' A' ' 4' ' ' LEU . 43.9 mt -89.34 117.02 27.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.272 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.433 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -126.72 137.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.598 -0.689 . . . . 0.0 109.54 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.1 m -107.89 102.44 11.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.281 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -87.46 132.9 33.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.574 -0.704 . . . . 0.0 109.585 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.81 135.53 49.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.05 77.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.712 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 130.11 25.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 p -77.99 143.01 37.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.592 -0.946 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.552 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.3 m-85 -147.99 113.32 5.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.51 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.65 149.63 25.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.532 -0.73 . . . . 0.0 109.442 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.572 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -150.25 -127.86 1.52 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.52 -32.64 0.58 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.633 -0.922 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.469 ' CG2' HD11 ' A' ' 13' ' ' ILE . 2.7 m -93.93 147.44 23.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.698 . . . . 0.0 109.574 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -128.07 173.05 10.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.7 tpt -98.01 151.09 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.496 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.5 pt -72.46 164.61 58.41 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.433 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.07 97.55 1.07 Allowed 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 125.106 3.87 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -88.11 137.71 32.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.708 . . . . 0.0 109.474 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -80.32 85.38 5.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.715 . . . . 0.0 109.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.92 -16.92 63.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.751 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.73 -24.91 67.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.745 . . . . 0.0 109.508 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.67 -29.44 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.451 ' CD2' HD12 ' A' ' 113' ' ' LEU . 91.7 m-85 -87.89 169.56 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.563 -0.711 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.2 m -138.97 134.82 33.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.632 -0.668 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -69.16 148.62 49.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 -34.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.1 p -149.53 157.91 43.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -157.62 122.37 4.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.48 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.29 100.2 11.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 109.479 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.543 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.2 m -82.07 146.48 29.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.699 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.407 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -148.88 131.24 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.625 -0.672 . . . . 0.0 109.315 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.477 ' OE2' HG22 ' A' ' 143' ' ' THR . 5.9 mp0 -111.88 118.4 35.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 0.0 109.49 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.46 -174.25 4.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.551 -0.718 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.5 p -63.31 -44.06 96.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -89.34 156.13 48.55 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.145 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.76 -22.03 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 124.827 3.685 . . . . 0.0 109.943 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.28 -23.39 30.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.548 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -89.28 18.97 4.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.605 -0.684 . . . . 0.0 109.708 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.414 HG23 ' HG3' ' A' ' 145' ' ' GLU . 16.8 m -85.6 141.88 29.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.642 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.9 p-80 -158.48 168.26 27.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.543 HG23 ' HA ' ' A' ' 143' ' ' THR . 20.0 m -136.93 134.84 37.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.638 -0.664 . . . . 0.0 109.39 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.55 91.2 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.579 -0.701 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -71.79 145.28 48.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.685 . . . . 0.0 109.418 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.602 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.0 t -133.56 104.3 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.659 . . . . 0.0 109.497 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.6 m95 -101.34 168.25 9.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -144.78 140.55 28.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.618 -0.676 . . . . 0.0 109.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -69.87 108.51 4.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -152.55 151.56 30.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.568 -0.707 . . . . 0.0 109.457 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.469 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.524 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.62 103.23 11.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.7 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -72.73 140.65 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.436 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.58 HD12 ' CB ' ' A' ' 114' ' ' LEU . 11.9 tp -154.42 111.87 3.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.305 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -142.79 141.88 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.585 -0.697 . . . . 0.0 109.757 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.21 110.5 21.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.577 -0.702 . . . . 0.0 109.294 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.521 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.3 pt20 -130.26 150.72 51.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.698 . . . . 0.0 109.676 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -98.9 169.66 9.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -60.93 -17.47 51.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.42 0.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.589 -0.694 . . . . 0.0 109.759 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 33.8 87.19 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.9 tp -109.45 164.0 12.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.947 . . . . 0.0 109.537 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 7' ' ' GLN . 31.0 pt -137.94 -30.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.532 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -168.82 -176.96 39.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -162.54 124.59 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.969 . . . . 0.0 109.431 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.89 29.77 19.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 109.694 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.25 -64.13 1.67 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -75.42 -179.51 4.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.581 -0.952 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 55.3 mt -88.74 155.96 50.22 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -80.12 -26.93 3.99 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.994 3.796 . . . . 0.0 109.887 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.593 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.8 p90 -108.09 170.89 7.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.562 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -122.54 100.2 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.673 -0.642 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.778 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.4 tp -121.3 82.47 38.65 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.623 -0.673 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 27' ' ' LEU . 7.9 Cg_exo -45.22 -39.04 15.35 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 125.142 3.894 . . . . 0.0 110.253 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.9 -49.7 73.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.778 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.2 t0 -63.35 -29.52 70.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.654 HD22 H223 ' A' ' 170' ' ' TMQ . 83.0 mt -72.71 -23.45 60.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.554 -0.716 . . . . 0.0 109.595 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -88.4 -26.38 22.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.447 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 19.8 t80 -70.41 -25.9 63.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.568 -0.707 . . . . 0.0 109.464 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' THR . 60.9 t80 -63.19 -46.82 85.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.595 -0.691 . . . . 0.0 109.456 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 35' ' ' VAL . 53.4 ttt-85 -63.51 -29.87 71.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.707 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.54 -30.24 57.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.516 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 20.6 mm100 -99.18 33.74 2.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' PHE . 19.9 p -142.65 -32.49 0.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.426 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.5 m -69.98 126.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.69 . . . . 0.0 109.502 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.32 34.53 25.83 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -155.84 171.35 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.949 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.68 98.53 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.597 -0.689 . . . . 0.0 109.419 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.708 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.2 tmm? -70.03 132.23 45.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 t -137.2 118.91 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.581 -0.699 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.708 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.8 m -133.82 179.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 109.474 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.38 -168.34 41.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -80.69 -39.59 26.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -73.86 -32.31 63.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -76.23 -30.48 57.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 52' ' ' ARG . 27.9 t80 -64.27 -58.4 6.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.511 -0.743 . . . . 0.0 109.428 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -64.52 -15.65 61.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.535 -0.728 . . . . 0.0 109.793 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -62.4 -28.73 69.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.775 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -66.61 162.69 48.47 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.72 -69.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 125.129 3.886 . . . . 0.0 109.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -104.86 143.41 33.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.472 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HD2' ' CE2' ' A' ' 46' ' ' TYR . 21.3 mtm105 -144.82 161.96 40.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.73 148.54 76.11 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.449 1.236 . . . . 0.0 109.894 -0.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.516 HD12 ' CE ' ' A' ' 39' ' ' MET . 75.0 mt -62.17 111.33 4.41 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.559 -0.713 . . . . 0.0 109.444 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.62 174.03 12.29 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.873 3.715 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 61.73 24.87 14.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.543 -0.723 . . . . 0.0 109.606 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -177.18 148.45 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.688 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -79.21 126.27 30.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.499 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.495 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.4 m-80 -100.2 117.61 34.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.54 -0.725 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -114.31 146.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.621 -0.675 . . . . 0.0 109.45 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.38 118.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.493 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 76' ' ' VAL . 12.5 tp -97.56 107.03 19.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.72 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.401 HG23 ' CE1' ' A' ' 77' ' ' HIS . 4.0 t -137.71 155.59 48.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.686 . . . . 0.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -98.41 -30.67 12.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.27 124.46 25.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -84.03 29.9 0.54 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.618 -0.676 . . . . 0.0 109.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -102.4 -34.79 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -71.96 140.45 49.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -144.18 104.19 4.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.476 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.82 118.37 27.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -79.24 123.88 27.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.549 -0.72 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.5 37.44 10.75 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.4 144.95 19.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 109.534 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.74 93.23 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.509 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.9 t -77.11 102.11 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.524 HG21 HG22 ' A' ' 82' ' ' VAL . 27.9 m -97.68 155.05 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.509 ' NE2' HG12 ' A' ' 75' ' ' VAL . 61.6 m-70 -135.01 29.33 3.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.63 -0.669 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -159.77 141.65 13.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.627 -0.671 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.8 t -67.6 -34.31 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.544 -0.723 . . . . 0.0 109.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.83 67.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.58 80.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.592 -0.693 . . . . 0.0 109.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -68.15 -40.23 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.66 -31.91 65.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.721 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.46 -34.9 78.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.66 -0.65 . . . . 0.0 109.565 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -69.48 -35.21 75.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 109.488 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -68.27 -34.54 76.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.706 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -69.63 -32.4 71.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -120.6 87.95 42.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.685 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.39 20.1 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 125.116 3.878 . . . . 0.0 109.939 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.66 -30.02 12.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.565 -0.71 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.68 178.41 4.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.595 -0.691 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -127.02 155.8 42.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.624 -0.673 . . . . 0.0 109.452 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.8 tp -81.46 123.0 28.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.559 -0.713 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -124.64 120.07 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.3 mm -97.67 125.25 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.636 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -104.7 -24.82 12.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.17 -175.86 40.2 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.483 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.06 -155.72 22.16 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.283 -1.716 . . . . 0.0 109.588 -0.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.42 75.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.647 -0.914 . . . . 0.0 109.525 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.12 -28.18 62.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.557 -0.715 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.483 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -71.72 -37.61 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.696 . . . . 0.0 109.56 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 96' ' ' ILE . 30.3 m-85 -63.02 -47.57 82.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.607 -0.683 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.5 m -63.07 -24.47 67.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.538 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.77 60.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 79' ' ' VAL . 58.8 m-85 -103.97 21.05 17.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.583 -0.698 . . . . 0.0 109.646 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -23.59 53.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.498 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.82 18.7 0.58 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.499 -0.751 . . . . 0.0 109.745 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -160.08 38.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.416 -0.803 . . . . 0.0 109.419 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.7 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -93.56 152.84 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.87 -45.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 109.396 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.5 m -106.54 122.61 46.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.669 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.448 HD12 ' CD1' ' A' ' 136' ' ' PHE . 30.8 mt -108.57 101.48 10.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.646 -0.658 . . . . 0.0 109.626 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.58 ' CB ' HD12 ' A' ' 4' ' ' LEU . 43.7 mt -102.47 106.31 17.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -114.3 140.1 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.505 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -110.4 100.97 9.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -84.62 144.3 28.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.566 -0.708 . . . . 0.0 109.58 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -119.65 136.06 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.78 -35.54 77.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.437 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.23 126.79 13.64 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.6 p -79.75 143.2 34.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.569 -0.959 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.613 ' O ' HD22 ' A' ' 12' ' ' LEU . 99.8 m-85 -148.01 112.4 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.602 -0.686 . . . . 0.0 109.43 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.38 149.24 31.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.626 -0.671 . . . . 0.0 109.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.63 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.02 -129.29 1.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.56 -29.03 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.479 HG22 HD11 ' A' ' 13' ' ' ILE . 2.6 m -98.38 145.99 26.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -127.49 170.68 12.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.605 -0.684 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.3 tpt -93.15 151.9 19.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.4 pt -72.45 164.64 58.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.674 . . . . 0.0 109.508 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.03 93.41 1.06 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.168 3.912 . . . . 0.0 109.914 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 71.7 mt -80.51 144.56 32.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -84.82 85.79 7.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.405 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -71.48 -7.84 50.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.57 -31.82 72.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.357 -0.84 . . . . 0.0 109.587 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.63 32.35 2.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.448 ' CD1' HD12 ' A' ' 113' ' ' LEU . 27.6 m-85 -138.9 169.5 17.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.434 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -150.15 147.06 27.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.547 -0.721 . . . . 0.0 109.446 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -86.08 116.41 24.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.41 -35.42 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -149.89 172.95 14.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.67 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t -165.78 123.51 1.5 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.459 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -100.66 105.5 16.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.592 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.5 m -86.87 152.25 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 109.395 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.423 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -154.87 133.06 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.16 123.19 49.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.94 -174.3 5.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.9 p -63.3 -40.55 97.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.634 -0.667 . . . . 0.0 109.451 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -91.97 155.0 43.53 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -77.87 -24.68 8.31 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.887 3.725 . . . . 0.0 109.865 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.63 -23.25 31.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.536 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.0 mt -88.4 20.29 3.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.7 m -82.51 144.68 30.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.367 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.551 ' CE1' HD21 ' A' ' 23' ' ' LEU . 30.1 p-80 -158.54 162.74 37.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.727 . . . . 0.0 109.615 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.3 m -135.46 137.54 42.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.671 -0.643 . . . . 0.0 109.443 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.77 98.45 11.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.509 -0.744 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 1.2 mp0 -80.44 134.28 35.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.448 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.1 t -123.84 99.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.443 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 34.2 m95 -97.5 164.46 12.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.579 -0.701 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -140.38 145.49 37.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -67.07 115.64 7.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.447 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -152.81 151.91 30.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.563 -0.711 . . . . 0.0 109.469 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.489 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.654 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.5 132.32 29.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.818 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.0 m-85 -97.07 162.56 13.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.653 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.9 tp -171.18 107.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 109.269 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -141.75 147.66 37.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.524 -0.735 . . . . 0.0 109.711 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.84 115.18 26.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.588 -0.695 . . . . 0.0 109.179 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.0 pt20 -136.21 151.99 50.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.685 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -101.74 170.38 8.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.59 -0.694 . . . . 0.0 109.373 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -60.89 -17.48 50.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 109.946 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.94 14.33 0.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.718 . . . . 0.0 109.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.19 36.66 93.3 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.621 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.7 tp -112.26 164.4 13.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.916 . . . . 0.0 109.578 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 7' ' ' GLN . 31.6 pt -138.69 -29.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -169.17 -165.92 27.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -173.8 122.46 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.959 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 57.9 35.01 24.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.624 -0.673 . . . . 0.0 109.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -62.81 3.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -76.17 171.95 13.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.564 -0.962 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.557 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 16.9 mt -86.65 157.89 54.68 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.97 -27.18 3.96 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.03 3.82 . . . . 0.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.557 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.0 p90 -108.37 163.35 13.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.513 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -115.55 89.59 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.8 tp -107.7 79.57 0.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.68 -37.96 16.48 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 125.114 3.876 . . . . 0.0 110.251 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.79 -45.8 90.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.554 -0.716 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.3 t0 -62.71 -38.99 92.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 0.0 109.442 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.82 -24.0 67.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.668 . . . . 0.0 109.468 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -83.7 -27.84 28.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.625 -0.672 . . . . 0.0 109.48 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.0 t80 -76.76 -26.04 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.493 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 34' ' ' THR . 61.1 t80 -67.02 -45.31 77.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.453 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -64.76 -29.43 70.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.74 -28.74 44.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 78.3 mm-40 -101.44 33.5 2.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.506 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.5 p -137.69 -33.76 0.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.73 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.576 -0.703 . . . . 0.0 109.47 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -29.49 12.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 165.17 12.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.545 -0.973 . . . . 0.0 109.495 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.5 mt -80.84 121.85 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.62 -0.675 . . . . 0.0 109.48 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.434 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.8 ttp -90.88 107.33 19.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.602 -0.686 . . . . 0.0 109.517 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 HD21 ' A' ' 94' ' ' LEU . 30.6 t -96.48 124.47 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.62 -0.675 . . . . 0.0 109.468 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.82 166.07 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.02 -169.24 44.47 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -77.7 -34.18 52.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.565 -0.962 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.78 -45.14 72.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.7 m -71.07 -25.94 62.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.695 . . . . 0.0 109.533 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -63.96 -38.73 92.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -87.75 -20.24 26.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.4 m -62.78 -25.58 68.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.621 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -66.58 160.6 66.19 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.62 -0.675 . . . . 0.0 109.412 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.29 -73.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.125 3.883 . . . . 0.0 109.821 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -103.51 92.32 4.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 3.8 ptm180 -99.25 154.53 37.25 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.97 151.07 83.46 Favored 'Cis proline' 0 N--CA 1.51 2.463 0 O-C-N 123.309 1.163 . . . . 0.0 109.952 -0.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.434 HD12 ' CE ' ' A' ' 39' ' ' MET . 77.8 mt -69.25 123.84 89.17 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.653 . . . . 0.0 109.289 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.28 176.85 9.25 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.676 3.584 . . . . 0.0 109.937 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.04 28.66 18.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.585 -0.697 . . . . 0.0 109.729 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.28 170.52 2.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.548 -0.72 . . . . 0.0 109.496 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 m -105.93 118.76 37.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.597 -0.689 . . . . 0.0 109.514 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.468 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -85.73 101.54 12.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -99.22 100.38 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.429 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -86.42 135.99 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.803 HD12 HG23 ' A' ' 76' ' ' VAL . 15.4 tp -110.51 113.7 26.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.676 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.59 145.53 36.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.641 -0.662 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.21 -26.87 14.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -70.43 136.9 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.654 -0.654 . . . . 0.0 109.44 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.1 29.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.728 . . . . 0.0 109.508 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -111.44 -28.81 8.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.592 -0.693 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.34 140.87 58.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.536 -0.727 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -140.86 104.55 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -97.51 126.06 42.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 0.0 109.549 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -92.03 131.93 36.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.11 39.89 62.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.52 141.58 17.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.627 -0.926 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.7 95.62 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.611 -0.681 . . . . 0.0 109.448 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 70' ' ' ALA . 30.8 t -81.47 98.39 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 62' ' ' LEU . 27.9 m -92.76 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.653 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -140.73 30.68 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -169.14 142.74 2.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 106' ' ' PHE . 30.4 t -67.06 -35.04 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.18 -31.25 69.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -35.93 80.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 76' ' ' VAL . 30.0 t -68.45 -38.37 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.476 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -69.24 -31.31 69.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.602 -0.686 . . . . 0.0 109.491 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.9 -36.83 83.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.683 -0.636 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -69.58 -31.69 70.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.673 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.23 -27.13 60.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 109.429 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -64.21 -44.31 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.618 -0.676 . . . . 0.0 109.519 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.77 -30.27 70.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.578 -0.701 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -119.16 89.98 40.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.663 -0.648 . . . . 0.0 109.455 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -22.08 7.51 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.118 3.879 . . . . 0.0 109.874 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.67 -27.24 67.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 109.415 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -95.22 -180.0 4.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -138.44 169.3 18.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.532 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 95' ' ' VAL . 4.1 tt -104.02 121.58 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.646 -0.659 . . . . 0.0 109.497 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.472 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.5 t -122.3 133.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.458 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.567 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.3 mm -102.24 120.68 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.581 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -108.56 -25.45 10.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.675 . . . . 0.0 109.489 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.64 -178.37 38.42 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.83 -153.21 18.79 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.223 -1.751 . . . . 0.0 109.565 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.51 73.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.949 . . . . 0.0 109.502 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.36 -27.71 60.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.412 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.9 mm -76.07 -34.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.713 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.567 ' CE1' HG22 ' A' ' 96' ' ' ILE . 21.3 m-85 -63.04 -52.37 63.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.569 HG23 HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -64.9 -23.42 67.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.531 -0.731 . . . . 0.0 109.548 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.57 77.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 79' ' ' VAL . 71.3 m-85 -104.28 14.4 30.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.559 -0.713 . . . . 0.0 109.908 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 110' ' ' VAL . 31.6 ttmt -70.05 -24.68 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.802 . . . . 0.0 109.53 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.37 -44.21 79.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -101.42 38.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.644 -0.66 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.818 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -83.97 147.6 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.688 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.38 -63.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.591 -0.693 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.49 164.12 13.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 41.8 mt -143.15 93.22 2.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.653 ' CB ' HD12 ' A' ' 4' ' ' LEU . 45.1 mt -91.71 114.16 26.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -122.05 138.18 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.551 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.3 m -109.31 98.17 7.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.642 -0.661 . . . . 0.0 109.282 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -84.0 134.11 34.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.95 142.65 36.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.622 -0.674 . . . . 0.0 109.314 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.453 ' HB3' ' OG1' ' A' ' 152' ' ' THR . . . -73.53 -38.76 65.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.505 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.64 136.44 26.07 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.6 p -85.67 145.79 27.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 109.476 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.426 ' O ' HD22 ' A' ' 12' ' ' LEU . 99.4 m-85 -147.82 122.69 9.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.584 -0.698 . . . . 0.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 123' ' ' GLU . 10.4 pt-20 -81.68 161.2 23.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.608 -0.683 . . . . 0.0 109.519 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.621 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -162.79 -134.87 1.71 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -142.1 -34.58 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.984 . . . . 0.0 109.449 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.489 HG22 HD11 ' A' ' 13' ' ' ILE . 4.1 m -95.82 143.08 27.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -122.26 173.68 7.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.605 -0.684 . . . . 0.0 109.403 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -93.3 152.02 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.536 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.569 HD13 HG23 ' A' ' 104' ' ' THR . 30.6 pt -73.58 164.06 63.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.627 -0.671 . . . . 0.0 109.511 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.11 99.53 1.19 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.137 3.891 . . . . 0.0 109.878 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.42 144.52 27.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.63 -0.669 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -77.5 83.21 3.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -71.89 -18.58 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.654 . . . . 0.0 109.693 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.04 10.07 1.34 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.488 -0.758 . . . . 0.0 110.017 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -123.93 -31.75 3.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.498 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.524 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 86.1 m-85 -81.27 173.59 12.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.541 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.5 m -142.34 121.06 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.622 -0.674 . . . . 0.0 109.514 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -66.75 154.74 39.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.566 -0.709 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.5 -34.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 0.0 109.481 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.8 t -148.94 165.97 29.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 109.479 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 t -158.76 119.86 3.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.7 ttt-85 -93.14 108.65 20.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.529 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.6 m -90.76 143.07 27.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -144.88 134.61 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.462 ' HA ' HG22 ' A' ' 152' ' ' THR . 44.2 mt-10 -112.52 120.06 40.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.591 -0.693 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -81.49 -173.19 4.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.71 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.0 p -63.29 -41.37 98.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.584 -0.698 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.23 154.96 44.84 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.576 -0.703 . . . . 0.0 109.23 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.52 -25.79 7.79 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.819 3.679 . . . . 0.0 109.844 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -22.81 31.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -87.39 18.92 3.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 145' ' ' GLU . 7.3 p -85.23 146.62 26.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.403 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.501 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.8 p-80 -159.13 171.56 19.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.644 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.529 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.7 m -140.76 133.43 28.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.686 -0.634 . . . . 0.0 109.371 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -89.6 97.4 11.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.13 143.7 37.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.429 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.551 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.7 t -128.49 104.81 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 109.532 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.414 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 28.3 m95 -102.79 166.72 10.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -144.42 138.5 27.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.616 -0.677 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -73.93 106.15 5.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -159.36 154.74 25.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.588 -0.695 . . . . 0.0 109.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.485 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.581 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.14 122.17 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.55 -0.719 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.792 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -93.75 151.72 19.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.641 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.3 tp -163.15 110.92 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.592 -0.693 . . . . 0.0 109.331 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -141.85 140.01 32.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.517 -0.739 . . . . 0.0 109.743 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.94 109.4 20.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' HB3' HG22 ' A' ' 13' ' ' ILE . 8.0 pt20 -130.0 147.24 51.73 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.678 . . . . 0.0 109.616 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -94.68 170.16 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.617 -0.677 . . . . 0.0 109.43 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -60.84 -18.12 53.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 109.897 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.61 14.92 0.9 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.73 . . . . 0.0 109.801 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.03 36.41 92.84 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.593 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.8 tp -108.83 167.6 9.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.966 . . . . 0.0 109.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 126' ' ' THR . 30.3 pt -142.65 -30.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.25 -169.44 22.6 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -175.21 116.22 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.614 -0.933 . . . . 0.0 109.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.94 35.62 21.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.478 -0.764 . . . . 0.0 109.699 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.68 -61.11 4.42 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -79.18 170.95 15.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.525 -0.985 . . . . 0.0 109.471 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.552 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 35.4 mt -80.37 156.55 73.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.432 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -80.25 -27.44 3.59 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.061 3.84 . . . . 0.0 109.945 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.552 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 33.0 p90 -108.82 163.61 13.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 0.0 109.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -116.25 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.1 tp -107.29 80.44 0.87 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.601 -0.687 . . . . 0.0 109.47 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -45.76 -37.53 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 125.061 3.841 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.7 -45.91 90.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.786 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.0 t0 -62.85 -37.28 86.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.642 -0.661 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.22 -24.21 67.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.51 -0.744 . . . . 0.0 109.506 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -85.3 -28.93 24.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 25.9 t80 -74.87 -26.72 59.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.478 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.493 ' O ' HG23 ' A' ' 34' ' ' THR . 53.1 t80 -66.63 -45.1 80.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -65.93 -31.66 72.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.71 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.35 59.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.481 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 64.8 mm-40 -96.26 31.35 2.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.542 -0.724 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 30' ' ' PHE . 10.4 p -136.84 -35.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 129.63 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.671 . . . . 0.0 109.501 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.78 -27.56 18.4 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER -110.6 178.94 4.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.458 HG23 ' HB ' ' A' ' 58' ' ' THR . 58.1 mt -98.05 122.84 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.522 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.501 ' CE ' HD12 ' A' ' 54' ' ' LEU . 56.7 ttp -88.54 102.25 14.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.54 -0.725 . . . . 0.0 109.456 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG21 HD11 ' A' ' 94' ' ' LEU . 30.3 t -94.78 115.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.498 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.0 m -139.82 166.35 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.493 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.53 -170.18 46.65 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -79.64 -33.16 41.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.976 . . . . 0.0 109.5 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -71.63 -33.91 69.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.1 m -81.14 -30.84 34.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -66.99 -29.24 69.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.445 -0.785 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.89 -18.23 24.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.7 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.4 p -62.46 -24.38 67.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.645 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -65.21 160.77 54.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.69 -68.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.14 3.893 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.85 127.0 51.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtp-105 -123.14 157.43 60.92 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.489 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.55 -166.78 5.47 Favored 'Cis proline' 0 N--CA 1.509 2.416 0 O-C-N 123.4 1.211 . . . . 0.0 109.941 -0.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.501 HD12 ' CE ' ' A' ' 39' ' ' MET . 60.1 mt -113.34 96.17 38.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.515 -0.741 . . . . 0.0 109.441 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -72.33 -177.7 2.86 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.656 3.57 . . . . 0.0 109.755 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 61.59 25.49 15.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 109.534 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -176.3 177.32 1.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 38' ' ' ILE . 3.6 m -96.61 130.91 43.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -102.28 100.47 10.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.591 -0.693 . . . . 0.0 109.477 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 t -110.66 107.01 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.738 . . . . 0.0 109.386 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -98.97 136.92 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.632 -0.667 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.669 HD12 HG23 ' A' ' 76' ' ' VAL . 15.6 tp -102.47 125.98 49.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.719 . . . . 0.0 109.43 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -153.18 142.24 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -88.62 -42.22 12.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -71.79 133.28 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -85.93 30.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -101.19 -35.11 9.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -69.18 148.58 49.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.579 -0.7 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -147.18 152.98 39.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.689 . . . . 0.0 109.442 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.78 138.67 41.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.716 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -86.42 121.62 29.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 109.455 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.2 48.43 25.47 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.45 140.44 15.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.914 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -82.18 100.49 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 109.387 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -79.47 98.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.568 -0.708 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.669 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -87.67 164.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.645 -0.659 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -138.09 29.99 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -171.94 143.22 1.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.427 HG13 ' CZ ' ' A' ' 106' ' ' PHE . 30.5 t -66.82 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.551 -0.718 . . . . 0.0 109.418 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.53 76.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 109.48 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.32 77.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -67.99 -37.47 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -74.6 -30.42 61.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.546 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.32 90.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.49 -33.34 72.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.3 62.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.0 109.592 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -64.61 -46.23 83.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -65.0 -26.99 68.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -119.16 90.15 41.07 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.57 -0.707 . . . . 0.0 109.48 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -24.03 6.65 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.122 3.881 . . . . 0.0 109.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.38 -25.35 62.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.623 -0.673 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -96.56 131.8 42.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' H ' ' HG3' ' A' ' 37' ' ' LYS . 6.1 mm-40 -95.67 152.78 18.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.576 -0.702 . . . . 0.0 109.539 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 40' ' ' VAL . 6.8 tp -88.73 137.73 32.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.63 -0.669 . . . . 0.0 109.426 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.3 123.54 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.644 -0.66 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.585 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.2 mm -93.75 119.83 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -101.69 -29.78 11.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.534 -0.729 . . . . 0.0 109.526 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.25 -174.06 40.3 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.94 -154.53 19.11 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.379 -1.659 . . . . 0.0 109.555 0.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.55 -31.41 71.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.649 -0.912 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.79 -28.07 61.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.37 -36.5 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.63 -0.669 . . . . 0.0 109.51 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.585 ' CE1' HG22 ' A' ' 96' ' ' ILE . 27.8 m-85 -63.3 -48.11 79.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.676 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.76 73.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.427 ' CZ ' HG13 ' A' ' 79' ' ' VAL . 17.2 m-85 -102.26 11.81 37.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 109.887 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -67.65 -31.89 72.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.511 -0.743 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -78.86 17.94 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.548 -0.72 . . . . 0.0 109.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -160.08 38.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.792 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -95.37 145.91 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.06 -53.14 1.74 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.578 -0.701 . . . . 0.0 109.357 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -103.37 160.84 14.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.697 . . . . 0.0 109.374 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.488 HD11 ' CE2' ' A' ' 136' ' ' PHE . 30.4 mt -139.45 98.49 3.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.728 . . . . 0.0 109.604 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.618 ' CD2' HG22 ' A' ' 157' ' ' VAL . 41.8 mt -98.49 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.625 -0.672 . . . . 0.0 109.314 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -115.05 136.77 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 0.0 109.518 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -107.7 103.32 12.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.636 -0.665 . . . . 0.0 109.278 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -87.54 143.54 27.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.52 -0.737 . . . . 0.0 109.616 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.39 133.9 55.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.638 -0.663 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.91 78.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.674 . . . . 0.0 109.487 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.29 123.93 9.63 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -76.82 143.93 39.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.633 -0.922 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.525 ' O ' HD22 ' A' ' 12' ' ' LEU . 89.1 m-85 -148.32 117.39 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.53 145.77 27.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.593 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -144.16 -128.3 2.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -140.71 -36.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.542 -0.975 . . . . 0.0 109.56 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.536 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -95.22 142.09 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.576 -0.702 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.12 173.0 7.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.616 -0.677 . . . . 0.0 109.455 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -92.91 153.52 18.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -73.58 163.74 66.19 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.18 96.19 1.02 Allowed 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 125.135 3.89 . . . . 0.0 110.007 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.93 137.0 33.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.495 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -78.73 87.26 4.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.579 -0.701 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -68.39 -16.93 64.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.619 -0.676 . . . . 0.0 109.78 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.55 -26.22 68.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.44 29.78 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 113' ' ' LEU . 45.9 m-85 -142.97 175.35 9.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.598 -0.689 . . . . 0.0 109.455 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.47 135.42 17.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.652 -0.655 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -70.92 158.03 37.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.675 -0.64 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.15 -32.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.726 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.3 p -157.74 155.5 30.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 p -149.51 122.08 8.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -99.16 105.59 17.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.479 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.3 m -84.94 142.78 29.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.56 -0.712 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.456 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -145.14 129.89 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.659 -0.651 . . . . 0.0 109.377 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -105.92 121.07 43.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.433 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -80.32 -165.82 0.93 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.64 -39.42 64.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -101.92 138.05 19.69 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 109.418 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.66 -46.29 24.67 Favored 'Trans proline' 0 N--CA 1.505 2.202 0 C-N-CA 124.748 3.632 . . . . 0.0 110.08 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.59 69.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.518 -0.739 . . . . 0.0 109.668 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.0 18.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.733 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.1 m -87.55 140.0 29.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 109.314 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.581 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.1 p-80 -154.75 162.24 41.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.599 -0.688 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.4 m -134.46 135.51 42.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.705 . . . . 0.0 109.454 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -90.78 93.89 9.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 37.7 mt-10 -76.74 137.8 39.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.585 -0.697 . . . . 0.0 109.473 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.618 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.3 t -124.71 115.74 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.583 -0.698 . . . . 0.0 109.453 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.413 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 33.0 m95 -113.17 170.03 8.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.469 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -148.89 141.06 23.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.577 -0.702 . . . . 0.0 109.394 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -72.18 116.23 12.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -160.57 102.87 1.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.662 -0.649 . . . . 0.0 109.484 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.498 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.44 HN52 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.48 99.72 7.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.725 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.6 m-85 -76.11 131.43 39.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.504 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.9 tp -147.41 113.67 5.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.347 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.3 p90 -143.38 147.12 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 109.746 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.85 114.18 26.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -133.95 150.2 51.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.491 -0.755 . . . . 0.0 109.636 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -98.63 171.44 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -61.13 -19.85 61.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.803 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.66 15.05 0.88 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 109.754 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.89 38.54 96.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.7 tp -106.14 166.25 10.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.75 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -145.89 -29.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.467 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.11 -176.2 27.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -175.26 115.88 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.547 -0.972 . . . . 0.0 109.514 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.09 21.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.52 -0.737 . . . . 0.0 109.679 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.45 5.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -77.94 176.45 9.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.527 HD11 ' C7 ' ' A' ' 170' ' ' TMQ . 11.8 mt -77.05 157.87 80.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.38 -33.79 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 125.089 3.859 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.8 p90 -108.16 -170.59 1.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.688 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -136.53 86.89 2.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 109.446 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.763 HD23 ' HB2' ' A' ' 26' ' ' ASP . 26.6 tp -109.36 82.13 1.97 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -45.31 -38.55 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 125.172 3.915 . . . . 0.0 110.269 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -62.69 -40.19 96.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.538 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.763 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.7 t0 -66.05 -33.19 75.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.693 . . . . 0.0 109.407 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.1 -24.72 63.26 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.66 -29.56 27.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.633 -0.667 . . . . 0.0 109.399 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.32 -25.4 57.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 34' ' ' THR . 53.5 t80 -65.84 -45.74 81.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.656 -0.653 . . . . 0.0 109.449 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -65.28 -30.87 71.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.53 -30.98 57.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.523 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -97.82 32.66 2.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.432 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.6 p -140.29 -34.1 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.488 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.1 m -70.27 128.19 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.622 -0.673 . . . . 0.0 109.474 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 31.97 27.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -156.54 172.3 18.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.951 . . . . 0.0 109.481 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -90.47 112.81 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.649 -0.657 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.552 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.8 tmm? -81.51 105.01 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 94' ' ' LEU . 29.0 t -113.19 123.77 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.481 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.3 m -137.74 -175.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.435 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.6 -164.89 31.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -82.84 -41.28 19.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.625 -0.926 . . . . 0.0 109.492 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -70.2 -33.15 71.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -76.41 -29.41 57.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -67.12 -35.59 80.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.523 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -83.06 -25.27 32.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.677 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.9 p -62.91 -22.64 66.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.567 -0.708 . . . . 0.0 109.611 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.72 164.2 13.2 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.507 -0.746 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -80.91 -73.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.11 3.874 . . . . 0.0 109.949 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -114.33 103.78 11.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.547 -0.721 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.91 156.63 39.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.696 . . . . 0.0 109.415 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -81.25 169.69 65.48 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.397 1.209 . . . . 0.0 110.004 -0.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 ' CE ' ' A' ' 39' ' ' MET . 55.5 mt -89.76 113.09 55.55 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.36 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.46 -178.87 4.95 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 124.659 3.572 . . . . 0.0 109.918 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 61.54 24.29 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.546 -0.721 . . . . 0.0 109.704 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -176.61 174.41 1.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.573 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -91.64 131.28 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.539 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -98.91 105.22 17.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.8 144.23 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.2 t -134.45 124.12 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 76' ' ' VAL . 18.5 tp -97.79 117.15 31.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.538 -0.726 . . . . 0.0 109.511 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -155.43 137.8 14.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -93.12 29.43 1.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.514 -0.741 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -110.24 123.79 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -86.17 30.13 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.674 -0.641 . . . . 0.0 109.407 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -124.47 -33.39 3.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -69.13 147.29 51.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.61 -0.681 . . . . 0.0 109.508 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -146.14 156.72 43.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.23 132.22 31.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.649 -0.657 . . . . 0.0 109.491 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -87.55 119.42 27.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.21 42.59 18.66 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.41 133.33 8.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.971 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -74.32 103.57 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.634 -0.666 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.59 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.5 t -82.13 103.28 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.578 -0.702 . . . . 0.0 109.441 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -89.98 154.88 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.678 -0.639 . . . . 0.0 109.509 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.59 ' NE2' HG12 ' A' ' 75' ' ' VAL . 49.0 m-70 -136.16 29.52 3.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.451 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.404 ' O ' HG23 ' A' ' 82' ' ' VAL . 19.4 t70 -164.88 149.34 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.607 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.0 -33.41 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.48 70.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.654 . . . . 0.0 109.529 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.42 77.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 76' ' ' VAL . 31.2 t -67.55 -42.77 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 109.503 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.32 -29.27 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.616 -0.677 . . . . 0.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.83 92.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.717 . . . . 0.0 109.478 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -66.44 -42.76 87.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.13 -24.97 65.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.661 . . . . 0.0 109.51 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -41.15 97.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.592 -0.692 . . . . 0.0 109.463 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -69.47 -31.02 69.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -119.24 89.75 40.46 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.606 -0.684 . . . . 0.0 109.489 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.32 -22.71 6.77 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 125.138 3.892 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.84 -25.9 66.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.475 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -92.92 -179.93 5.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -138.76 148.56 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.669 . . . . 0.0 109.487 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 40' ' ' VAL . 12.8 tp -79.24 108.11 12.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.622 -0.673 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.38 112.92 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.631 -0.668 . . . . 0.0 109.464 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.405 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.4 mm -91.97 122.27 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 109.36 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -101.38 -28.87 12.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.529 -0.732 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.13 -175.83 40.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.92 -151.75 12.87 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.362 -1.669 . . . . 0.0 109.613 -0.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.94 -26.22 62.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -74.78 -23.69 58.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -80.32 -38.33 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.483 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CE1' HG22 ' A' ' 96' ' ' ILE . 30.9 m-85 -62.75 -48.5 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 0.0 109.396 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 t -63.6 -33.04 74.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.594 -0.691 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.607 ' CE1' HG13 ' A' ' 79' ' ' VAL . 45.8 m-85 -122.32 21.33 10.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.714 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.4 pttt -63.48 -32.83 74.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.441 -0.787 . . . . 0.0 109.586 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -81.09 31.0 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.725 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -160.08 32.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.733 . . . . 0.0 109.408 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.725 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -99.22 145.63 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.319 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -128.0 -55.83 1.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.583 -0.698 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -103.69 106.86 17.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.377 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.493 HD11 ' CE2' ' A' ' 136' ' ' PHE . 24.5 mt -90.44 100.94 13.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.568 -0.707 . . . . 0.0 109.592 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.603 ' CD2' HG22 ' A' ' 157' ' ' VAL . 42.5 mt -99.23 105.98 18.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.719 . . . . 0.0 109.21 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.43 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -111.32 136.05 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.613 -0.679 . . . . 0.0 109.523 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -108.62 97.49 7.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.652 . . . . 0.0 109.248 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -85.43 139.79 31.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.632 -0.668 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 135.07 54.4 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.84 -33.31 73.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.556 -0.715 . . . . 0.0 109.472 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.88 124.42 14.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.7 t -70.25 140.83 52.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.59 -0.947 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.628 ' O ' HD22 ' A' ' 12' ' ' LEU . 67.3 m-85 -148.38 107.2 3.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.422 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.72 146.33 28.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.63 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -145.02 -123.3 1.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -143.42 -49.87 0.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.975 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.75 HG22 HD11 ' A' ' 13' ' ' ILE . 4.4 m -81.64 141.09 33.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.632 -0.667 . . . . 0.0 109.476 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -118.46 172.94 7.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -94.47 146.97 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.47 164.69 42.01 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.469 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.29 99.96 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.113 3.876 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.39 138.07 32.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -77.74 84.81 4.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -67.23 -17.53 64.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.6 -0.688 . . . . 0.0 109.772 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -26.0 68.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.765 . . . . 0.0 109.519 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.81 30.32 2.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.718 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 113' ' ' LEU . 68.0 m-85 -145.35 177.16 9.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.515 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 m -153.54 131.41 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -72.13 115.82 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 109.475 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.1 -36.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.498 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.2 p -154.79 179.16 9.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.1 t -165.2 159.48 17.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -133.41 100.8 4.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.499 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.0 m -81.75 152.95 26.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.536 -0.727 . . . . 0.0 109.423 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 144' ' ' VAL . 8.8 p -156.17 127.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.309 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.39 121.99 44.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.58 -165.61 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.3 p -72.35 -36.38 68.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.603 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -106.13 137.88 19.52 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.86 -48.19 16.75 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 124.822 3.682 . . . . 0.0 110.076 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.83 69.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.5 mt -80.38 20.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.629 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 m -91.98 136.97 32.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.525 -0.734 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.668 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.6 p-80 -151.93 169.55 22.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.697 . . . . 0.0 109.602 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 143' ' ' THR . 19.1 m -139.76 137.74 35.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.541 -0.724 . . . . 0.0 109.451 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -95.32 94.75 8.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.517 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 23.4 mt-10 -76.24 128.84 35.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.603 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.2 t -112.9 102.91 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.502 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.517 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 42.4 m95 -101.41 163.45 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -140.14 145.96 38.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -66.71 116.33 7.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.602 -0.686 . . . . 0.0 109.489 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -165.22 114.52 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.678 . . . . 0.0 109.455 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.475 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.527 ' C7 ' HD11 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.92 127.65 34.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.807 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -101.99 137.35 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.66 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.2 tp -149.87 111.69 4.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.602 -0.686 . . . . 0.0 109.331 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.2 p90 -142.04 151.52 42.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.711 . . . . 0.0 109.73 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 112.08 24.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -132.33 150.17 52.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.569 -0.707 . . . . 0.0 109.638 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.46 171.78 7.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -61.37 -18.69 59.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.618 -0.676 . . . . 0.0 109.763 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.37 15.14 0.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.518 -0.739 . . . . 0.0 109.775 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 37.57 94.64 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.528 HD23 ' CG ' ' A' ' 20' ' ' PRO . 7.1 tp -107.39 167.25 10.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.621 -0.929 . . . . 0.0 109.553 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.52 HD11 HG22 ' A' ' 126' ' ' THR . 31.7 pt -141.74 -30.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.575 -0.703 . . . . 0.0 109.519 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.0 28.74 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -173.28 115.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.462 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 33.83 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.466 -0.771 . . . . 0.0 109.723 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 -61.45 3.74 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -74.96 170.61 15.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -1.02 . . . . 0.0 109.455 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.659 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 24.0 mt -79.89 157.21 74.27 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.571 -0.706 . . . . 0.0 109.46 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.528 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.0 Cg_endo -79.91 -30.52 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 125.018 3.812 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.659 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.0 p90 -105.88 -171.38 1.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.547 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -138.42 103.02 4.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.705 -0.622 . . . . 0.0 109.431 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 26' ' ' ASP . 12.8 tp -124.58 81.02 60.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.587 -0.695 . . . . 0.0 109.516 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.23 -39.09 20.74 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 125.117 3.878 . . . . 0.0 110.154 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.98 -52.16 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.614 -0.679 . . . . 0.0 109.525 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.798 ' HB2' HD23 ' A' ' 23' ' ' LEU . 33.0 t70 -62.95 -36.54 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.547 HD22 H223 ' A' ' 170' ' ' TMQ . 79.8 mt -63.75 -24.26 67.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.455 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -85.62 -29.91 23.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 26.9 t80 -65.44 -23.96 67.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 34' ' ' THR . 59.6 t80 -63.15 -46.5 86.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -65.15 -25.33 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.459 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.24 -26.57 39.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 66.6 mm-40 -107.47 36.38 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.709 . . . . 0.0 109.475 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' PHE . 15.0 p -138.38 -35.04 0.62 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.482 -0.761 . . . . 0.0 109.487 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.0 m -67.36 126.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.8 38.61 23.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -153.97 168.53 26.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.917 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.5 mt -93.47 104.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.423 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.605 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.8 tmm? -78.87 117.47 20.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 t -125.13 120.19 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.669 -0.644 . . . . 0.0 109.418 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.605 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.1 m -136.08 173.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.81 -167.21 42.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -84.05 -36.36 23.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.485 -1.009 . . . . 0.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -68.16 -31.81 71.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.444 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -82.41 -27.65 31.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -64.93 -35.7 82.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 109.487 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.27 -25.87 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.7 m -67.13 -15.36 63.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.664 -0.648 . . . . 0.0 109.759 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' CE1' HD11 ' A' ' 54' ' ' LEU . 23.7 m-85 -61.77 161.39 21.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 109.576 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 125.101 3.867 . . . . 0.0 109.987 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.6 73.57 0.92 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -72.78 157.36 88.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.58 172.7 55.23 Favored 'Cis proline' 0 N--CA 1.509 2.43 0 O-C-N 123.332 1.175 . . . . 0.0 110.035 0.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.54 HD12 ' CE ' ' A' ' 39' ' ' MET . 39.2 mt -97.8 110.75 56.73 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.589 -0.694 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -76.79 178.11 8.02 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.733 3.622 . . . . 0.0 109.866 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.39 29.59 18.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.58 -0.7 . . . . 0.0 109.68 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.412 HH12 ' N ' ' A' ' 35' ' ' VAL . 1.4 ptp180 -177.1 178.91 1.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 m -105.91 119.38 39.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.489 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -96.16 111.45 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.6 t -112.92 140.73 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 109.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 t -125.26 124.78 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 76' ' ' VAL . 11.3 tp -99.78 109.7 22.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.51 -0.744 . . . . 0.0 109.487 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 t -139.93 142.54 36.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.562 -0.712 . . . . 0.0 109.474 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -93.86 31.6 1.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.665 -0.647 . . . . 0.0 109.568 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.9 128.64 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.584 -0.698 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -88.89 29.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.41 -33.03 6.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -69.63 152.18 45.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -152.3 110.11 3.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.727 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.431 ' H ' HG21 ' A' ' 75' ' ' VAL . . . -98.1 125.18 42.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.618 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -80.57 133.05 35.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.639 -0.663 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.32 37.81 70.87 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.76 133.26 9.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.609 -0.936 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -73.52 99.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.578 -0.701 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.519 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.9 t -79.35 102.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.708 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.498 HG21 HG22 ' A' ' 82' ' ' VAL . 27.5 m -90.12 159.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 0.0 109.455 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.519 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.3 m-70 -139.35 29.98 2.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.44 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -164.26 144.93 8.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 106' ' ' PHE . 29.4 t -68.2 -33.68 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.0 109.511 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.28 70.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 109.49 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.48 81.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.647 -0.658 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -68.42 -35.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.392 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.45 -33.02 62.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.41 70.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -71.31 -37.26 71.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.706 . . . . 0.0 109.419 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.03 -26.27 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.711 . . . . 0.0 109.526 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -70.22 -38.54 75.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.77 -24.68 65.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -115.74 93.42 37.39 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.622 -0.674 . . . . 0.0 109.483 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.99 -19.96 13.43 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 124.838 3.692 . . . . 0.0 109.957 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -81.44 -25.0 36.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.54 -0.725 . . . . 0.0 109.496 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.15 179.99 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.517 -0.739 . . . . 0.0 109.492 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -142.37 148.18 37.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 95' ' ' VAL . 3.1 tt -80.65 123.32 28.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.556 -0.715 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.569 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.3 t -128.59 129.46 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 109.441 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -102.55 129.75 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.55 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -108.57 -24.09 11.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 109.599 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.76 -178.34 40.56 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.481 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.66 -155.22 19.96 Favored Glycine 0 N--CA 1.5 2.92 0 O-C-N 120.321 -1.693 . . . . 0.0 109.518 0.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.93 75.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -72.88 -25.44 61.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.531 -0.731 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.481 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.7 mm -74.61 -36.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.45 -49.9 71.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.511 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.2 t -62.88 -34.82 78.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.534 -0.729 . . . . 0.0 109.595 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.42 76.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.644 -0.66 . . . . 0.0 109.688 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 79' ' ' VAL . 41.8 m-85 -105.47 13.6 29.92 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.532 -0.73 . . . . 0.0 109.847 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -23.57 56.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.478 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -65.01 -22.22 66.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.649 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -130.3 41.43 3.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.53 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.807 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -86.05 156.98 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.416 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -136.54 -69.08 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 m -84.92 159.9 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.612 HD11 ' CE2' ' A' ' 136' ' ' PHE . 26.5 mt -142.01 96.27 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.632 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.66 ' CB ' HD12 ' A' ' 4' ' ' LEU . 51.5 mt -97.82 110.48 23.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.245 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -117.6 141.0 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.625 -0.672 . . . . 0.0 109.537 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -111.12 102.17 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.597 -0.689 . . . . 0.0 109.346 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 118' ' ' LEU . 25.7 mmt180 -85.22 151.28 24.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 117' ' ' ARG . 4.1 mp -128.6 133.81 48.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 109.279 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.51 -30.87 68.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.586 -0.696 . . . . 0.0 109.51 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.02 128.05 11.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.6 p -79.53 141.44 36.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.53 -0.982 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.479 ' O ' HD22 ' A' ' 12' ' ' LEU . 94.6 m-85 -148.63 128.28 13.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.677 . . . . 0.0 109.457 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.8 163.46 14.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -159.83 -138.38 2.44 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.69 10.04 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.96 . . . . 0.0 109.865 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.52 HG22 HD11 ' A' ' 13' ' ' ILE . 3.4 m -147.28 130.39 16.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.386 -0.821 . . . . 0.0 109.5 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -105.88 176.52 5.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.593 -0.692 . . . . 0.0 109.399 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.441 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -93.33 148.31 22.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.473 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.6 pt -66.83 165.57 25.04 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.536 -0.728 . . . . 0.0 109.477 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.18 109.32 2.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.11 3.873 . . . . 0.0 109.994 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.45 139.81 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.565 -0.709 . . . . 0.0 109.501 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 83.57 4.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.52 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.18 -20.02 64.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -62.72 -23.6 67.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.527 -0.733 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -97.78 28.73 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.612 ' CE2' HD11 ' A' ' 113' ' ' LEU . 54.2 m-85 -142.16 174.23 10.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.2 m -149.62 136.41 19.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.554 -0.716 . . . . 0.0 109.526 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -70.39 155.96 39.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.636 -0.665 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.61 -32.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.677 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 t -147.89 146.0 28.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.455 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -144.81 110.42 5.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -95.32 102.68 14.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.423 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.467 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.1 m -86.06 147.14 26.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.541 -0.725 . . . . 0.0 109.466 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.89 133.7 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.299 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.94 123.87 49.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.47 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -80.43 -165.1 0.8 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 p -71.47 -38.56 71.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.649 -0.657 . . . . 0.0 109.58 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -105.03 137.65 19.28 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.06 -46.19 22.98 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 124.815 3.677 . . . . 0.0 110.069 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.15 68.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.612 -0.68 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.55 19.9 0.97 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.704 . . . . 0.0 109.677 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 50.6 m -87.54 140.73 29.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.275 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.613 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.3 p-80 -152.63 167.27 29.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 143' ' ' THR . 20.5 m -140.57 130.52 24.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.594 -0.692 . . . . 0.0 109.434 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.46 93.81 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.54 139.37 38.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.423 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.536 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.6 t -128.81 113.51 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -111.71 166.38 11.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.508 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -142.94 143.06 31.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -68.01 127.52 33.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -150.53 147.0 26.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.496 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.644 ' H8 ' HD11 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.531 HG23 HD23 ' A' ' 94' ' ' LEU . 9.3 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.35 103.39 5.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.497 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.745 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.8 m-85 -75.42 141.29 43.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.4 tp -153.42 112.53 3.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 0.0 109.299 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 8.9 p90 -145.38 146.49 31.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.528 -0.733 . . . . 0.0 109.756 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 115.5 29.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 109.323 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.622 ' HB3' HG22 ' A' ' 13' ' ' ILE . 8.1 pt20 -133.86 161.32 35.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -108.72 169.64 8.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.643 -0.661 . . . . 0.0 109.406 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.476 HH11 ' HB2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -60.8 -15.86 34.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.61 -0.681 . . . . 0.0 109.88 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 15.02 0.84 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 109.763 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.59 86.17 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.526 HD21 ' HA3' ' A' ' 124' ' ' GLY . 9.3 tp -117.21 151.55 36.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -120.48 -41.36 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.577 -0.702 . . . . 0.0 109.558 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.665 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -162.87 -170.13 27.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -163.04 124.19 2.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.928 . . . . 0.0 109.454 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.91 32.66 21.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.542 -0.724 . . . . 0.0 109.717 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 -62.5 3.55 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -73.2 173.19 9.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.965 . . . . 0.0 109.499 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.57 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 9.0 mt -93.4 155.54 40.77 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.533 -0.73 . . . . 0.0 109.469 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -79.96 -24.92 5.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 125.045 3.83 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.57 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 30.4 p90 -106.72 163.13 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.624 -0.672 . . . . 0.0 109.574 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -115.55 100.96 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.677 -0.64 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 26' ' ' ASP . 17.6 tp -119.68 80.27 23.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.613 -0.679 . . . . 0.0 109.47 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.91 -37.36 16.87 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 125.133 3.889 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.93 -46.88 85.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.53 -0.731 . . . . 0.0 109.57 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.4 t0 -62.83 -37.61 87.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.59 -23.94 67.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.725 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -86.97 -29.7 21.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.565 -0.709 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.9 t80 -73.36 -24.43 60.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.528 -0.733 . . . . 0.0 109.547 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 34' ' ' THR . 52.6 t80 -63.33 -45.35 91.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttp-105 -64.84 -29.29 70.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.477 -0.764 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.84 -29.09 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 82.3 mm-40 -101.13 34.91 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.704 . . . . 0.0 109.46 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.0 p -141.67 -34.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.508 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 m -68.98 126.82 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.639 -0.663 . . . . 0.0 109.456 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.35 35.14 24.13 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -156.94 166.48 33.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.581 -0.952 . . . . 0.0 109.441 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.3 mt -90.66 103.36 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.546 -0.721 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.678 ' SD ' HG13 ' A' ' 41' ' ' VAL . 9.8 tmm? -71.96 131.48 43.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 94' ' ' LEU . 31.3 t -135.55 116.04 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.678 HG13 ' SD ' ' A' ' 39' ' ' MET . 27.6 m -133.86 -177.57 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.659 -0.65 . . . . 0.0 109.458 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 -174.06 43.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -76.17 -38.33 56.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.936 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -69.07 -41.87 76.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 m -69.97 -26.45 64.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.35 -46.03 85.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.534 -0.728 . . . . 0.0 109.487 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.86 -23.96 36.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.515 -0.741 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -62.83 -21.13 65.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -62.07 161.35 24.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.493 -0.755 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 125.103 3.869 . . . . 0.0 109.886 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -108.55 91.98 3.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.623 -0.673 . . . . 0.0 109.488 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -99.76 157.3 34.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.723 . . . . 0.0 109.458 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.5 159.06 85.8 Favored 'Cis proline' 0 N--CA 1.509 2.386 0 O-C-N 123.384 1.202 . . . . 0.0 109.953 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.98 114.17 46.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.15 179.31 6.57 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.761 3.64 . . . . 0.0 109.947 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 61.05 29.64 19.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.612 -0.68 . . . . 0.0 109.662 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.03 173.55 1.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 m -93.98 118.94 32.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -89.71 99.17 12.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.8 t -107.11 143.35 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.62 125.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.426 HD12 HG23 ' A' ' 76' ' ' VAL . 11.8 tp -95.9 112.46 24.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.615 -0.678 . . . . 0.0 109.541 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -140.26 150.78 44.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.574 -0.704 . . . . 0.0 109.401 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -91.24 -34.14 15.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -76.15 123.73 26.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.611 -0.68 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -83.52 29.59 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -100.46 -34.75 9.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 109.5 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -69.35 136.33 51.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.702 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -141.54 104.52 4.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.728 . . . . 0.0 109.48 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.36 119.71 26.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.551 -0.718 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -70.85 127.25 31.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.41 38.66 24.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.66 146.81 19.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.598 -0.942 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.28 98.03 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.8 t -77.19 98.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.478 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.51 HG21 HG22 ' A' ' 82' ' ' VAL . 27.2 m -85.13 156.86 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.511 ' NE2' HG12 ' A' ' 75' ' ' VAL . 67.1 m-70 -136.78 30.0 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.507 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -169.8 148.82 3.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.475 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.2 t -68.34 -34.13 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.88 -31.05 67.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.681 . . . . 0.0 109.46 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.22 -37.29 83.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.542 -0.724 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -69.59 -40.7 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 109.379 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -72.54 -29.54 63.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.88 84.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.633 -0.667 . . . . 0.0 109.515 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.28 -40.44 81.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.737 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.71 68.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.39 -36.59 83.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.573 -0.704 . . . . 0.0 109.492 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.9 -27.77 61.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.679 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -119.61 88.05 38.24 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.36 20.21 0.97 Allowed 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.133 3.888 . . . . 0.0 109.967 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -106.86 -31.7 8.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -94.48 178.54 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.556 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -133.03 153.86 51.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.491 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD23 HG23 ' A' ' 1' ' ' THR . 11.1 tp -84.64 133.63 34.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.712 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.6 t -134.47 114.45 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.48 127.39 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.494 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.645 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.74 -24.51 10.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.579 -0.701 . . . . 0.0 109.517 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.3 -179.67 36.58 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.53 -155.47 20.18 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 120.287 -1.714 . . . . 0.0 109.583 0.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.45 72.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.572 -0.957 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -69.88 -31.09 68.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.511 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.14 -37.7 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.524 -0.735 . . . . 0.0 109.528 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -62.88 -46.1 89.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.557 -0.715 . . . . 0.0 109.483 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.627 HG23 HD13 ' A' ' 129' ' ' ILE . 0.7 OUTLIER -67.96 -21.78 65.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.581 -0.7 . . . . 0.0 109.605 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.87 -37.1 62.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.475 ' CE1' HG13 ' A' ' 79' ' ' VAL . 73.9 m-85 -106.4 14.78 26.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.695 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -29.75 66.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.772 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.2 -27.24 69.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.07 58.86 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.745 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -105.2 151.69 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -135.29 -68.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 127.51 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.643 HD11 ' CE2' ' A' ' 136' ' ' PHE . 37.2 mt -111.7 87.76 2.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.646 ' CB ' HD12 ' A' ' 4' ' ' LEU . 40.6 mt -89.27 121.78 31.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.527 -0.733 . . . . 0.0 109.264 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -134.49 145.09 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.647 -0.658 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -111.39 107.86 17.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.234 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -88.65 128.79 35.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.3 141.2 37.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.84 62.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.1 137.46 24.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -87.4 143.49 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.533 -0.981 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.46 124.42 14.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.638 -0.664 . . . . 0.0 109.419 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.9 140.03 30.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.514 -0.741 . . . . 0.0 109.474 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.526 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -146.04 -131.65 2.3 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -144.11 -27.31 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.961 . . . . 0.0 109.476 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -94.21 118.64 31.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.571 -0.706 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -103.31 166.39 10.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.38 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -92.94 144.36 25.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.634 -0.666 . . . . 0.0 109.411 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.627 HD13 HG23 ' A' ' 104' ' ' THR . 22.1 pt -66.13 164.63 27.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.523 -0.736 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.37 104.34 1.62 Allowed 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 125.109 3.873 . . . . 0.0 109.896 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.441 ' ND2' ' OD2' ' A' ' 135' ' ' ASP . 39.7 t30 -81.76 86.92 6.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 0.0 109.488 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -68.58 -17.76 64.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.648 -0.658 . . . . 0.0 109.707 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.45 -29.48 70.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.586 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.441 ' OD2' ' ND2' ' A' ' 132' ' ' ASN . 1.7 m-20 -92.32 29.45 1.68 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.605 -0.684 . . . . 0.0 109.435 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.643 ' CE2' HD11 ' A' ' 113' ' ' LEU . 34.0 m-85 -140.61 173.75 11.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.523 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -146.08 135.95 23.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -72.15 156.24 39.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.52 -31.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.619 -0.675 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -147.2 154.09 40.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.561 -0.712 . . . . 0.0 109.383 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -158.03 109.75 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -93.09 107.3 19.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.644 -0.66 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.542 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -85.62 150.08 24.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.488 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 144' ' ' VAL . 8.8 p -152.74 126.27 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.454 ' HA ' HG23 ' A' ' 152' ' ' THR . 28.0 mt-10 -103.6 118.26 36.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.668 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.12 -166.03 0.96 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.7 p -73.68 -43.25 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.695 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -103.1 137.82 19.37 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.318 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -46.38 -42.16 22.64 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 124.878 3.719 . . . . 0.0 110.184 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.16 85.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.3 mt -76.27 12.64 1.13 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.632 -0.667 . . . . 0.0 109.902 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 145' ' ' GLU . 21.2 m -87.14 137.2 32.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.484 -0.76 . . . . 0.0 109.349 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.556 ' CE1' HD21 ' A' ' 23' ' ' LEU . 33.0 p-80 -155.6 175.05 14.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.64 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.542 HG23 ' HA ' ' A' ' 143' ' ' THR . 24.0 m -141.83 137.82 31.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.58 95.71 9.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.679 -0.638 . . . . 0.0 109.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.86 146.41 37.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.619 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.5 t -138.76 102.86 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.694 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 158' ' ' TRP . 27.9 m95 -104.46 162.53 13.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.563 -0.71 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -148.64 143.42 26.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.716 . . . . 0.0 109.462 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -69.34 110.7 4.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -153.33 98.21 2.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.453 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.554 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.502 HG23 HD23 ' A' ' 94' ' ' LEU . 4.0 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.76 103.73 5.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.498 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.753 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -78.53 147.53 33.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.631 -0.668 . . . . 0.0 109.43 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.499 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.7 tp -158.84 111.23 2.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.564 -0.71 . . . . 0.0 109.239 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.43 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.2 p90 -142.39 143.95 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.777 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.87 116.16 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.656 . . . . 0.0 109.281 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.39 156.31 49.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.678 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -104.4 171.14 7.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.419 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.04 -20.16 62.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.852 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.47 14.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.765 . . . . 0.0 109.756 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.86 40.12 98.42 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.5 tp -108.93 162.64 14.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.545 -0.974 . . . . 0.0 109.577 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.722 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -142.85 -29.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.69 . . . . 0.0 109.491 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.89 -175.62 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -174.66 116.33 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.564 -0.962 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.95 34.2 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 0.0 109.662 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -61.42 3.92 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -80.05 -175.95 5.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.622 -0.928 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.539 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 17.9 mt -86.08 156.88 57.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 109.461 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.7 Cg_endo -80.35 -31.15 1.74 Allowed 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 125.049 3.832 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.539 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 29.3 p90 -106.91 170.2 8.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.673 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.5 88.2 2.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.482 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.778 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.3 tp -107.24 80.5 0.86 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.526 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.04 -37.36 17.48 Favored 'Trans proline' 0 N--CA 1.506 2.234 0 C-N-CA 125.056 3.838 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -62.94 -44.89 94.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.778 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -63.03 -38.71 92.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.607 -0.683 . . . . 0.0 109.423 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.89 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -88.3 -28.83 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.695 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -73.02 -25.66 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 34' ' ' THR . 59.2 t80 -64.48 -44.73 90.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' VAL . 32.5 ttp180 -66.7 -26.23 66.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.85 -29.86 50.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.561 -0.712 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -102.61 36.25 2.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.704 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 30' ' ' PHE . 20.5 p -144.68 -28.96 0.47 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.584 -0.698 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -68.95 128.59 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.17 32.94 46.52 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -156.35 165.26 36.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.939 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.3 107.69 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.392 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.446 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.2 ttp -82.63 104.16 12.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.87 126.84 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.533 -0.729 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.5 m -140.75 164.55 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.662 . . . . 0.0 109.432 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.65 -161.01 36.87 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -84.78 -36.6 21.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.568 -0.96 . . . . 0.0 109.45 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -69.6 -37.25 76.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.525 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -75.9 -29.7 58.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 32.2 t80 -66.8 -33.69 76.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.489 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -82.19 -23.04 35.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -63.14 -27.78 69.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -65.24 163.53 30.95 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.736 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.2 -66.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.175 3.917 . . . . 0.0 109.894 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -121.02 103.19 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.618 -0.676 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -94.07 154.19 40.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.0 109.45 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.69 164.57 78.54 Favored 'Cis proline' 0 N--CA 1.508 2.364 0 O-C-N 123.467 1.246 . . . . 0.0 109.844 -0.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.446 HD12 ' CE ' ' A' ' 39' ' ' MET . 81.3 mt -81.61 128.35 69.7 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.556 -0.715 . . . . 0.0 109.297 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.62 172.09 14.83 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 124.798 3.665 . . . . 0.0 109.965 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 61.37 27.75 17.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.574 -0.704 . . . . 0.0 109.8 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -177.2 178.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -105.27 147.29 28.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.62 -0.675 . . . . 0.0 109.519 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -114.92 97.89 6.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -102.67 101.81 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.58 -0.7 . . . . 0.0 109.489 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 120.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.608 -0.682 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.592 HD12 HG23 ' A' ' 76' ' ' VAL . 15.2 tp -101.51 106.4 17.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.425 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -138.86 151.71 47.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.713 . . . . 0.0 109.519 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -97.02 -29.69 13.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.66 -0.65 . . . . 0.0 109.512 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -72.68 124.25 24.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.624 -0.672 . . . . 0.0 109.458 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -82.8 30.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.722 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -34.85 9.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.736 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.75 143.98 45.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.638 -0.664 . . . . 0.0 109.462 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -145.58 101.92 3.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.627 -0.67 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.19 119.95 30.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.612 -0.68 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -83.0 136.27 34.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.458 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.88 39.07 39.82 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.43 155.8 29.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.965 . . . . 0.0 109.52 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.94 95.75 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.611 -0.681 . . . . 0.0 109.483 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.508 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.1 t -80.28 100.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.541 -0.724 . . . . 0.0 109.437 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.592 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -98.7 160.34 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.663 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.508 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.4 m-70 -139.65 30.76 2.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.628 -0.67 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -165.68 146.91 7.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.566 -0.709 . . . . 0.0 109.436 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.49 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -68.39 -34.1 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.697 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -32.31 72.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.28 -37.05 82.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.602 -0.686 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.496 HG22 HG21 ' A' ' 76' ' ' VAL . 29.9 t -67.68 -38.34 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.39 -32.31 66.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.683 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.37 91.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.497 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -68.26 -36.48 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.574 -0.704 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.46 70.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -66.99 -42.79 84.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.33 5.72 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 109.943 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -144.2 87.87 7.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.492 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.11 -23.6 6.35 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.113 3.876 . . . . 0.0 109.856 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.48 -24.91 61.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -100.67 178.58 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.58 -0.7 . . . . 0.0 109.481 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -136.91 172.98 12.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 1' ' ' THR . 12.4 tp -103.94 130.16 51.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.511 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.63 129.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.549 -0.719 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.581 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -98.53 124.42 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.699 . . . . 0.0 109.425 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.6 -24.24 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.634 -0.666 . . . . 0.0 109.542 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.36 -176.46 37.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.48 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.93 -155.12 14.61 Favored Glycine 0 N--CA 1.5 2.904 0 O-C-N 120.235 -1.744 . . . . 0.0 109.589 0.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.9 76.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.565 -0.962 . . . . 0.0 109.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -73.37 -27.74 61.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.48 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -72.62 -35.61 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.545 -0.722 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.581 ' CE1' HG22 ' A' ' 96' ' ' ILE . 27.2 m-85 -63.8 -51.58 64.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.501 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -62.44 -22.65 66.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.58 -49.85 43.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.545 -0.722 . . . . 0.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 79' ' ' VAL . 70.5 m-85 -93.17 13.93 19.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.528 -0.732 . . . . 0.0 109.906 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -67.22 -23.1 65.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.745 . . . . 0.0 109.591 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.53 14.99 0.87 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.541 -0.724 . . . . 0.0 109.839 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.17 38.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.457 -0.777 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.753 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.44 154.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.52 -0.737 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -138.45 -60.06 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.513 -0.742 . . . . 0.0 109.418 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -97.1 111.39 23.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.434 HD11 ' CE2' ' A' ' 136' ' ' PHE . 21.9 mt -96.13 96.38 8.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.55 -0.719 . . . . 0.0 109.586 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.666 ' CD2' HG22 ' A' ' 157' ' ' VAL . 27.5 mt -93.39 116.46 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.589 -0.694 . . . . 0.0 109.287 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.42 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -124.94 141.45 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.705 . . . . 0.0 109.455 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 m -109.49 100.46 9.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.631 -0.668 . . . . 0.0 109.26 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -83.73 133.78 34.78 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.641 -0.662 . . . . 0.0 109.657 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.16 135.92 50.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.3 -37.03 74.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.562 -0.711 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.63 124.88 16.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.8 p -77.69 148.21 35.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.969 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' O ' HD22 ' A' ' 12' ' ' LEU . 93.7 m-85 -148.27 128.25 13.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -86.12 148.59 25.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -154.28 -137.6 2.47 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -145.31 -33.02 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.652 -0.911 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.722 HG22 HD11 ' A' ' 13' ' ' ILE . 2.6 m -92.07 124.2 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -106.35 168.76 8.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.43 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -90.96 147.77 22.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.2 pt -67.73 165.07 33.98 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.42 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 104.7 1.71 Allowed 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 125.138 3.892 . . . . 0.0 109.978 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.5 mt -94.38 133.52 37.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -77.47 85.24 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.602 -0.686 . . . . 0.0 109.469 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.36 -14.21 62.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.582 -0.698 . . . . 0.0 109.815 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.34 -27.14 68.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.78 30.08 2.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.543 -0.723 . . . . 0.0 109.416 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 113' ' ' LEU . 86.7 m-85 -144.95 172.11 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.665 -0.647 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -146.8 131.81 18.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.607 -0.683 . . . . 0.0 109.49 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -74.01 120.51 19.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.554 -0.716 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.08 -34.29 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.651 -0.656 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.1 p -164.12 163.73 22.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.659 -0.65 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.8 p -150.8 133.94 16.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -99.6 113.67 26.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.692 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.526 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.8 m -90.57 150.74 21.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 109.482 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 144' ' ' VAL . 8.8 p -154.07 128.6 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.379 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -107.32 120.46 42.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.579 -0.7 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -80.43 -165.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.8 p -73.9 -39.29 63.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.593 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.66 137.58 19.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.77 -47.32 18.87 Favored 'Trans proline' 0 N--CA 1.507 2.267 0 C-N-CA 124.744 3.629 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.25 70.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.607 -0.683 . . . . 0.0 109.68 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 151' ' ' LEU . 54.6 mt -79.47 18.42 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 109.66 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.3 m -91.64 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.715 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.535 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.9 p-80 -153.08 168.51 25.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.574 -0.704 . . . . 0.0 109.596 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 143' ' ' THR . 13.5 m -135.54 135.85 40.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.562 -0.711 . . . . 0.0 109.41 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -90.16 97.86 11.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.07 143.42 32.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.53 -0.731 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.666 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.1 t -132.4 107.56 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.424 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 30.2 m95 -105.51 169.28 8.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -147.73 145.14 28.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.507 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -67.8 129.68 40.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.715 . . . . 0.0 109.451 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -144.78 148.41 34.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.629 -0.669 . . . . 0.0 109.566 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.497 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.44 HN52 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.02 116.4 16.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.747 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.8 m-85 -90.25 157.74 17.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.68 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.677 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.0 tp -169.51 109.65 0.44 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -140.93 140.29 34.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.564 -0.71 . . . . 0.0 109.68 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.11 111.11 22.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.284 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.5 153.31 48.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.16 170.91 7.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -60.54 -20.08 59.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.508 -0.745 . . . . 0.0 109.851 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.37 14.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.491 -0.755 . . . . 0.0 109.784 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.77 38.11 95.41 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.647 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.2 tp -108.82 168.14 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.944 . . . . 0.0 109.549 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 126' ' ' THR . 30.9 pt -144.1 -29.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.722 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.61 -172.38 26.71 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.59 115.53 0.3 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.585 -0.95 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.07 32.19 20.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.569 -0.707 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.1 -61.38 3.33 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -78.78 171.93 14.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.594 -0.945 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.64 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.4 mt -79.7 154.49 75.95 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.554 -0.716 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.75 -29.86 2.62 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.932 3.754 . . . . 0.0 109.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.64 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.2 p90 -106.34 -177.65 3.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.698 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -134.87 97.89 3.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.759 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.0 tp -118.71 80.25 17.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.499 -0.751 . . . . 0.0 109.486 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -45.78 -40.02 19.04 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 C-N-CA 125.13 3.887 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.45 -43.99 97.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 109.624 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.759 ' HB2' HD23 ' A' ' 23' ' ' LEU . 35.8 t70 -66.15 -38.72 88.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.577 -0.702 . . . . 0.0 109.409 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.681 HD22 ' C22' ' A' ' 170' ' ' TMQ . 94.8 mt -63.45 -23.9 67.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.516 -0.74 . . . . 0.0 109.515 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -82.3 -29.24 31.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.2 t80 -72.14 -26.92 62.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 109.422 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 34' ' ' THR . 46.8 t80 -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.441 ' HD3' HH12 ' A' ' 57' ' ' ARG . 10.5 tpp85 -63.71 -28.26 69.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.584 -0.697 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.39 -28.13 34.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.9 mm100 -101.57 34.95 2.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.404 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 30' ' ' PHE . 9.6 p -137.66 -34.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 35' ' ' VAL . 27.3 m -80.59 128.59 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.484 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.96 -31.01 9.14 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -113.92 164.15 14.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -79.83 122.03 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.51 -0.744 . . . . 0.0 109.377 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.481 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.3 ttp -91.28 105.63 17.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.442 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG21 HD11 ' A' ' 94' ' ' LEU . 30.4 t -94.26 130.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.433 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.1 m -146.77 164.33 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.6 -0.688 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.82 -163.8 38.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -84.34 -36.37 22.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.974 . . . . 0.0 109.553 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.1 ttp85 -68.08 -37.84 81.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -75.81 -28.93 58.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 0.0 109.501 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -36.43 83.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.66 -26.16 26.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.7 p -63.93 -19.51 65.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.13 161.21 25.4 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.11 -71.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.162 3.908 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -115.21 94.77 4.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.64 -0.662 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -98.0 157.27 34.84 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.78 147.22 73.88 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 O-C-N 123.347 1.183 . . . . 0.0 110.007 0.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.481 HD12 ' CE ' ' A' ' 39' ' ' MET . 74.9 mt -69.62 113.63 18.57 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.353 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.11 179.38 6.5 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.766 3.644 . . . . 0.0 109.899 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 61.28 26.39 16.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.459 -0.776 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.441 HH12 ' HD3' ' A' ' 31' ' ' ARG . 11.6 ptp180 -176.63 176.91 1.48 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.534 -0.729 . . . . 0.0 109.462 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -107.29 121.66 45.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.473 HD21 ' HB2' ' A' ' 54' ' ' LEU . 2.2 m-80 -97.57 111.53 23.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.9 t -107.08 112.48 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.45 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -95.95 128.27 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.674 HD12 HG23 ' A' ' 76' ' ' VAL . 14.4 tp -105.66 119.3 38.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -152.22 133.94 14.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.651 -0.656 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -92.37 30.52 1.47 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.729 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -111.15 130.41 55.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.698 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.04 31.61 0.78 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.683 . . . . 0.0 109.427 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -131.13 -25.81 2.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.671 . . . . 0.0 109.448 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -64.49 145.34 56.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.488 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.22 140.09 35.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.63 -0.669 . . . . 0.0 109.469 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . . . -137.83 122.85 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -90.66 135.0 33.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.635 -0.666 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.71 36.68 67.01 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.67 138.35 14.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.566 -0.961 . . . . 0.0 109.468 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.4 94.58 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.596 -0.69 . . . . 0.0 109.444 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.648 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.5 t -74.86 100.41 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.556 -0.715 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.674 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -91.82 155.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.565 -0.709 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.648 ' NE2' HG12 ' A' ' 75' ' ' VAL . 49.8 m-70 -136.31 29.96 2.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.97 152.1 2.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.658 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.32 -33.8 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -31.13 69.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.567 -0.708 . . . . 0.0 109.501 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.21 79.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.633 -0.667 . . . . 0.0 109.476 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 76' ' ' VAL . 31.4 t -69.14 -42.56 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -71.23 -29.02 64.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.76 86.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -69.55 -35.96 75.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.31 -26.52 64.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.472 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -64.36 -43.91 93.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.56 -0.712 . . . . 0.0 109.467 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.98 -30.38 69.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.592 -0.692 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -119.71 89.9 42.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.09 -23.21 6.69 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 125.024 3.816 . . . . 0.0 109.96 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -68.75 -25.77 64.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.91 -179.91 5.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -138.15 161.81 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.579 -0.701 . . . . 0.0 109.518 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.433 HD11 HG21 ' A' ' 40' ' ' VAL . 11.8 tp -99.6 133.29 44.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.561 -0.712 . . . . 0.0 109.476 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.0 136.32 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.565 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.7 mm -102.24 120.02 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.536 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -107.25 -26.59 10.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.486 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.26 -176.71 38.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.417 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.41 -153.18 14.12 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 120.361 -1.67 . . . . 0.0 109.604 0.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.24 -32.38 73.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.605 -0.938 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.28 -27.74 60.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.417 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.6 mm -74.88 -34.75 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.565 ' CE1' HG22 ' A' ' 96' ' ' ILE . 23.6 m-85 -63.48 -54.29 38.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.448 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 m -63.16 -24.59 67.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.76 76.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CE1' HG13 ' A' ' 79' ' ' VAL . 49.8 m-85 -106.14 13.13 29.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.581 -0.699 . . . . 0.0 109.84 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -71.32 -25.41 62.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 0.0 109.549 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.93 13.83 0.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.65 -0.657 . . . . 0.0 109.857 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.09 36.83 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.747 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.28 149.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -126.27 -49.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 m -107.49 158.24 17.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.8 mt -137.23 104.84 5.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.677 ' CB ' HD12 ' A' ' 4' ' ' LEU . 44.4 mt -103.55 105.06 15.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.497 -0.752 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.8 p -111.81 136.32 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 109.495 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -108.3 99.85 9.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -83.37 149.04 26.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.637 -0.665 . . . . 0.0 109.5 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.54 132.14 52.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.605 -0.684 . . . . 0.0 109.305 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.22 77.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.555 -0.715 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.85 128.75 17.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 p -83.69 141.94 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.627 -0.925 . . . . 0.0 109.436 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -145.88 126.27 14.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.717 . . . . 0.0 109.39 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -89.16 148.04 23.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 109.508 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.647 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -149.39 -136.03 2.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -138.4 -31.44 0.75 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.92 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.611 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -97.7 143.2 28.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -122.87 176.96 5.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.58 -0.7 . . . . 0.0 109.486 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.8 tpt -97.92 152.56 19.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.556 -0.715 . . . . 0.0 109.468 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.9 pt -72.0 163.41 67.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.677 -0.639 . . . . 0.0 109.525 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.14 96.87 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 125.162 3.908 . . . . 0.0 109.91 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.1 mt -85.96 134.9 33.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.705 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -79.97 86.59 5.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.528 -0.733 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -67.32 -14.84 63.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.562 -0.711 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.26 -27.65 69.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.452 -0.78 . . . . 0.0 109.509 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.65 29.57 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.557 -0.715 . . . . 0.0 109.449 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -142.08 179.79 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.528 -0.732 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 m -153.88 139.45 17.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 0.0 109.487 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -77.85 156.45 30.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.696 . . . . 0.0 109.509 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.09 -32.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -151.65 153.14 33.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.7 p -150.15 122.45 8.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 109.5 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -97.3 98.86 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 0.0 109.472 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.4 m -84.15 139.86 32.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.602 -0.686 . . . . 0.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.42 HG13 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -148.51 136.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.9 123.87 50.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.677 . . . . 0.0 109.419 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -79.96 -165.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.1 p -72.67 -40.79 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.548 -0.72 . . . . 0.0 109.638 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.437 ' HB3' HD12 ' A' ' 151' ' ' LEU . 28.4 t-20 -100.63 138.13 20.04 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.684 . . . . 0.0 109.494 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.52 -46.48 23.58 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 124.717 3.611 . . . . 0.0 109.983 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.69 -27.66 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.733 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 148' ' ' ASN . 28.1 mt -79.98 18.36 0.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.9 m -86.61 143.71 27.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.403 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.563 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.8 p-80 -155.9 163.82 39.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.672 . . . . 0.0 109.547 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 143' ' ' THR . 23.2 m -137.69 134.55 35.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 109.472 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.38 96.39 10.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -81.99 136.66 35.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.54 -0.725 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.643 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.8 t -125.47 109.07 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.0 m95 -103.88 169.26 8.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -143.57 140.61 30.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -81.67 131.77 35.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.493 -0.754 . . . . 0.0 109.467 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.56 179.0 7.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -0.76 . . . . 0.0 109.506 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.456 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.681 ' C22' HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.86 95.67 3.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.734 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -68.38 134.05 49.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.54 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.9 tp -148.53 113.03 5.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.373 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -143.98 145.47 32.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.499 -0.751 . . . . 0.0 109.711 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.64 107.27 19.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 0.0 109.26 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HB3' HG22 ' A' ' 13' ' ' ILE . 9.3 pt20 -127.1 157.7 38.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.643 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -97.65 170.08 9.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -61.23 -17.54 53.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.67 14.17 0.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.728 . . . . 0.0 109.865 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.11 39.21 97.33 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.496 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.8 tp -126.02 151.51 47.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.624 -0.927 . . . . 0.0 109.413 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 126' ' ' THR . 30.5 pt -111.39 -32.02 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.649 -0.657 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.02 -150.29 18.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -169.99 147.59 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.61 -0.935 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 0.4 OUTLIER 60.63 8.11 1.62 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.22 -48.77 1.54 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' A' ' 16' ' ' ASP . 22.0 p80 -72.15 165.73 23.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.494 -1.004 . . . . 0.0 109.566 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.728 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 13.6 mt -87.35 147.7 42.8 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.678 . . . . 0.0 109.52 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -82.01 -31.81 0.92 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 124.987 3.791 . . . . 0.0 109.767 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.728 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 26.3 p90 -101.26 157.36 16.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.727 -0.608 . . . . 0.0 109.497 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -106.09 98.13 7.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.5 tp -121.04 79.8 34.06 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.424 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.47 -39.03 16.66 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 125.142 3.894 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.95 -42.55 99.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.692 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.795 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.0 t0 -68.02 -29.78 68.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.567 -0.708 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -84.8 -29.71 25.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 18.2 t80 -71.09 -27.0 63.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 34' ' ' THR . 57.4 t80 -65.17 -45.58 84.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.624 -0.672 . . . . 0.0 109.461 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -66.15 -30.05 70.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.505 -0.747 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.98 -31.53 56.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.2 mm100 -97.07 32.32 2.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.55 -0.719 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.5 p -137.89 -34.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.449 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.9 m -69.25 125.91 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.64 -0.663 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.87 34.89 23.35 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -152.69 174.38 14.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.591 -0.946 . . . . 0.0 109.416 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.77 100.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 109.401 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.675 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.7 tmm? -71.81 131.79 43.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 109.451 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.524 HG21 HD11 ' A' ' 94' ' ' LEU . 30.2 t -135.25 117.98 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.499 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.675 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.7 m -134.43 -173.3 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.524 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.97 -173.89 29.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -76.28 -35.31 58.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.61 -0.935 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -69.71 -39.39 76.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 m -76.33 -27.24 56.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.433 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' CD1' HG22 ' A' ' 61' ' ' VAL . 34.2 t80 -63.34 -39.82 95.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -87.34 -22.93 24.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.632 -0.668 . . . . 0.0 109.594 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 m -62.87 -22.66 66.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -62.1 162.22 19.39 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.542 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -73.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.159 3.906 . . . . 0.0 109.897 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.47 90.42 3.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.439 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt85 -93.66 157.13 38.83 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.644 -0.66 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.8 -174.79 15.18 Favored 'Cis proline' 0 N--CA 1.508 2.353 0 O-C-N 123.447 1.235 . . . . 0.0 110.035 0.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.65 105.99 52.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 109.374 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -75.05 -178.7 4.37 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 124.602 3.534 . . . . 0.0 109.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.55 23.41 13.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -176.27 175.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.435 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -95.84 143.89 26.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.46 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -116.9 117.62 30.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.47 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.07 103.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.403 HG22 ' CD1' ' A' ' 46' ' ' TYR . 30.6 t -91.64 136.45 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.484 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD12 HG23 ' A' ' 76' ' ' VAL . 14.3 tp -104.04 115.22 30.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -143.11 146.92 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.691 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -93.58 -35.16 13.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -73.46 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.639 -0.663 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.16 30.1 0.54 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.71 -35.75 8.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -71.31 139.6 49.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.532 -0.73 . . . . 0.0 109.477 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -142.67 100.13 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.42 117.69 24.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.9 131.63 42.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 38.85 34.6 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.74 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.555 -0.968 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 t -75.09 98.27 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.432 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.2 t -78.84 99.06 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.46 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.602 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -90.11 164.93 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.432 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.9 m-70 -141.46 27.93 1.86 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.44 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -174.9 153.42 1.69 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.68 -30.84 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.641 -0.662 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.99 69.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.649 -0.657 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.49 58.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.517 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -68.18 -46.35 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.493 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -71.72 -28.84 63.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.83 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.644 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -72.44 -33.7 67.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.87 -30.9 68.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -66.84 -40.75 88.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -67.27 -30.3 70.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.469 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -119.84 89.87 42.68 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.22 -22.43 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.196 3.93 . . . . 0.0 109.947 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -66.98 -26.6 66.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.52 -0.738 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -96.22 -179.86 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.514 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -137.53 154.63 49.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.43 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 40' ' ' VAL . 9.1 tp -86.65 141.33 29.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.586 -0.696 . . . . 0.0 109.445 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -146.93 118.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.55 -0.719 . . . . 0.0 109.488 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.7 mm -91.76 125.88 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.465 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.447 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -100.93 -34.93 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.97 -178.45 39.37 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.01 -152.26 16.81 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 120.356 -1.673 . . . . 0.0 109.529 0.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.14 65.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.948 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -69.62 -33.44 72.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -75.3 -38.54 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.537 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 28.9 m-85 -63.08 -51.51 66.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -62.87 -23.98 67.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.603 -0.686 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.18 61.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.567 ' CE1' HG13 ' A' ' 79' ' ' VAL . 57.3 m-85 -111.74 17.36 19.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.695 -0.628 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -27.0 65.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.82 18.69 0.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.55 -0.719 . . . . 0.0 109.703 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.15 36.32 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -91.39 150.76 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.505 -0.747 . . . . 0.0 109.366 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -132.36 -55.97 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.413 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 m -102.06 125.66 48.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.706 . . . . 0.0 109.375 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.476 HD11 ' CE2' ' A' ' 136' ' ' PHE . 31.9 mt -108.71 96.55 6.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.605 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.569 ' CD2' HG22 ' A' ' 157' ' ' VAL . 40.2 mt -95.13 105.7 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 109.298 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -111.85 143.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.631 -0.668 . . . . 0.0 109.505 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.8 m -117.69 99.58 7.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.251 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 mtt85 -85.19 141.67 29.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.01 138.72 49.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.611 -0.681 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.92 72.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.602 -0.686 . . . . 0.0 109.433 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.52 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -75.34 132.48 13.4 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.6 m -85.32 142.52 29.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.966 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -143.13 135.24 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -97.68 155.29 17.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.541 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -159.69 -139.54 2.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.58 -26.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.48 HG22 HD11 ' A' ' 13' ' ' ILE . 18.8 m -97.82 116.83 30.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.488 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -100.77 167.71 10.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.448 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -85.65 149.97 24.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.468 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.39 164.78 58.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.608 -0.683 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 101.79 1.37 Allowed 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 125.104 3.87 . . . . 0.0 109.871 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.19 157.25 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -88.64 86.55 7.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -73.45 -17.5 61.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.783 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.19 9.88 1.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.541 -0.724 . . . . 0.0 109.848 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -132.34 29.16 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.732 . . . . 0.0 109.392 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.476 ' CE2' HD11 ' A' ' 113' ' ' LEU . 66.2 m-85 -144.33 178.82 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.606 -0.684 . . . . 0.0 109.507 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.4 m -151.69 138.71 19.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.631 -0.668 . . . . 0.0 109.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -79.69 120.59 24.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.45 -32.93 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.549 -0.719 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.8 t -150.73 176.0 11.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -163.48 116.61 1.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 109.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -95.09 108.2 20.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.546 -0.721 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.2 m -92.33 144.58 25.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.44 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -146.83 127.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 152' ' ' THR . 13.1 mp0 -101.89 119.13 38.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 109.422 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.07 -168.66 1.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.59 -0.694 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.3 p -72.18 -43.07 65.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.588 -0.695 . . . . 0.0 109.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -101.77 137.85 19.67 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.41 -48.38 11.76 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 124.996 3.797 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.52 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -62.38 -35.09 78.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.572 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 151' ' ' LEU . 35.2 mt -72.06 6.31 2.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 109.868 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.0 m -80.67 146.19 31.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.36 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.537 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.4 p-80 -160.79 167.87 25.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.569 -0.707 . . . . 0.0 109.55 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 143' ' ' THR . 26.0 m -140.13 139.34 35.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.578 -0.701 . . . . 0.0 109.335 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.52 99.38 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.52 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.9 mt-10 -80.9 130.97 35.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.475 -0.766 . . . . 0.0 109.438 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.569 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -115.16 103.53 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.695 . . . . 0.0 109.45 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.52 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 34.1 m95 -101.01 165.26 11.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.511 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -147.57 145.3 29.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.565 -0.71 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -71.11 104.36 3.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.519 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -138.06 123.28 19.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.548 -0.72 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.431 -179.971 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.428 HN52 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.474 HG23 HD23 ' A' ' 94' ' ' LEU . 5.8 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.473 ' H ' HG22 ' A' ' 1' ' ' THR . . . -137.5 133.15 34.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.548 -0.72 . . . . 0.0 109.466 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -100.95 160.87 14.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.701 . . . . 0.0 109.437 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.9 tp -169.55 109.06 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.68 . . . . 0.0 109.35 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.3 p90 -140.91 146.66 37.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.4 112.22 24.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.2 pt20 -132.61 149.85 52.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.58 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -99.13 170.8 8.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -61.3 -18.7 59.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.818 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' CG ' ' HG ' ' A' ' 121' ' ' SER . 2.0 m-20 -77.46 15.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.445 -0.784 . . . . 0.0 109.858 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.37 35.32 91.5 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 122' ' ' PHE . 5.9 tp -107.34 167.12 10.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 126' ' ' THR . 31.2 pt -141.86 -30.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.521 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -166.43 -167.41 27.06 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -172.49 121.22 0.42 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.627 -0.925 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 57.99 34.0 23.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.706 . . . . 0.0 109.923 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.92 -63.69 2.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -76.26 177.46 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.54 -0.977 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.584 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 29.4 mt -84.94 156.9 60.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.576 -0.703 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.26 -28.38 3.05 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 125.055 3.836 . . . . 0.0 109.923 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.584 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 33.3 p90 -108.09 176.02 5.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -126.55 98.85 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.693 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 18.8 tp -118.23 80.44 15.69 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 109.51 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -45.88 -37.74 17.21 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 125.051 3.834 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.63 -45.51 92.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.5 t0 -63.09 -39.66 95.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.474 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.77 -23.62 67.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -86.07 -28.54 24.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.365 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -71.67 -26.51 62.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.672 . . . . 0.0 109.476 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 34' ' ' THR . 49.6 t80 -65.27 -46.33 80.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.547 -0.72 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -71.09 2.72 4.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.643 . . . . 0.0 109.994 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.02 -33.06 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.831 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -107.99 30.46 6.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.51 HG21 ' CE2' ' A' ' 30' ' ' PHE . 19.0 p -126.63 -30.59 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.483 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.13 134.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.573 -0.704 . . . . 0.0 109.445 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.18 34.29 64.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -156.92 165.78 35.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.954 . . . . 0.0 109.511 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.8 mt -92.51 111.61 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.594 -0.691 . . . . 0.0 109.465 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.0 ttp -87.83 111.7 21.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 94' ' ' LEU . 29.0 t -98.87 122.48 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.42 161.54 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.652 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.81 -177.61 52.03 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -72.35 -38.36 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.457 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.8 mtm-85 -68.23 -34.08 75.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -78.68 -28.82 45.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.579 -0.701 . . . . 0.0 109.459 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 35.7 t80 -68.17 -29.22 68.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.541 -0.725 . . . . 0.0 109.496 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -85.8 -24.62 26.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.537 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p -63.6 -25.34 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.635 -0.666 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -63.98 161.26 40.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.542 -0.724 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.81 -61.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.084 3.856 . . . . 0.0 109.878 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -126.37 77.01 1.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.394 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -79.87 150.73 72.69 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 0.0 109.588 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.41 161.64 87.09 Favored 'Cis proline' 0 N--CA 1.51 2.466 0 O-C-N 123.445 1.234 . . . . 0.0 109.859 0.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.5 mt -78.53 142.93 62.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -80.58 162.62 21.78 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 124.914 3.742 . . . . 0.0 110.037 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.08 28.46 18.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.544 -0.723 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -177.83 146.36 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.555 -0.715 . . . . 0.0 109.629 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.41 ' C ' HD22 ' A' ' 59' ' ' ASN . 3.3 m -78.43 152.42 32.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.589 -0.694 . . . . 0.0 109.455 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.428 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 1.9 m-80 -123.79 97.67 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.695 . . . . 0.0 109.5 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -91.62 149.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -136.03 120.72 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.445 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 76' ' ' VAL . 15.1 tp -96.21 119.52 34.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 109.492 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.37 146.07 36.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -100.57 31.21 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -150.95 137.17 18.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.635 -0.666 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -87.74 32.19 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -95.14 -38.04 10.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.668 -0.645 . . . . 0.0 109.475 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -73.56 158.18 35.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -151.73 101.52 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.45 115.33 27.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.544 -0.722 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -80.36 124.5 28.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.63 -0.669 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.82 40.38 12.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -156.47 153.82 29.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.598 -0.942 . . . . 0.0 109.558 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -86.29 94.29 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.586 -0.696 . . . . 0.0 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.507 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.4 t -75.55 103.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.63 -0.669 . . . . 0.0 109.444 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -96.57 157.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.519 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.507 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.0 m-70 -135.95 30.68 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.482 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -169.98 146.46 3.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.613 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -67.95 -32.37 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.638 -0.664 . . . . 0.0 109.476 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.79 70.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.738 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.46 -35.21 78.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -68.45 -33.31 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.45 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.15 -31.22 39.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.661 -0.649 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.46 67.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.458 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.53 -25.32 22.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.635 -0.665 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.17 -33.18 50.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.83 -31.51 72.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.546 -0.721 . . . . 0.0 109.5 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.36 -26.12 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.674 -0.641 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.37 90.28 42.01 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.465 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.25 -22.46 8.33 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.077 3.852 . . . . 0.0 109.95 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.94 -27.18 65.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -96.99 -179.99 4.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -138.02 150.68 47.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.474 HD23 HG23 ' A' ' 1' ' ' THR . 9.3 tp -88.08 130.2 35.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.6 t -128.83 129.86 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.525 -0.734 . . . . 0.0 109.435 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.543 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.9 mm -96.64 116.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.613 -0.68 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.557 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -104.08 -29.97 10.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.66 -175.51 39.06 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.05 -151.86 11.02 Favored Glycine 0 N--CA 1.5 2.902 0 O-C-N 120.298 -1.707 . . . . 0.0 109.567 -0.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.12 -30.64 69.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.606 -0.938 . . . . 0.0 109.483 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.73 -27.56 60.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 0.0 109.425 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -77.26 -33.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.543 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.0 m-85 -63.38 -58.19 7.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.483 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -62.91 -21.92 66.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.596 -0.69 . . . . 0.0 109.617 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.55 -29.13 64.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.613 ' CE1' HG13 ' A' ' 79' ' ' VAL . 54.5 m-85 -117.35 16.55 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.707 . . . . 0.0 109.778 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.642 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -69.43 -23.03 63.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.636 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.05 -39.01 83.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.569 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.8 41.28 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.866 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -91.17 151.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.748 . . . . 0.0 109.315 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -134.57 -66.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.581 -0.699 . . . . 0.0 109.441 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -90.03 161.92 15.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 136' ' ' PHE . 59.3 mt -140.78 96.85 3.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.557 -0.714 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.632 ' CB ' HD12 ' A' ' 4' ' ' LEU . 42.4 mt -95.69 104.44 16.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.322 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.0 p -111.23 137.43 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.2 m -109.19 99.16 8.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.337 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -85.07 139.62 31.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.04 140.05 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.294 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.28 -34.33 68.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.575 -0.703 . . . . 0.0 109.487 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.67 128.77 18.26 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.408 ' HG ' ' CG ' ' A' ' 10' ' ' ASP . 31.2 t -77.35 137.33 38.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.632 -0.923 . . . . 0.0 109.493 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.526 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.8 m-85 -144.09 117.78 9.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.608 -0.683 . . . . 0.0 109.522 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -93.06 145.29 24.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.461 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -142.8 -120.21 1.52 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.06 -36.35 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.674 -0.898 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.677 HG22 HD11 ' A' ' 13' ' ' ILE . 4.8 m -93.14 144.38 25.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.625 -0.672 . . . . 0.0 109.584 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -122.78 176.42 5.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.692 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -91.74 150.95 20.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.695 . . . . 0.0 109.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.9 pt -73.67 165.55 52.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.705 . . . . 0.0 109.456 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.95 92.72 1.09 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.123 3.882 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -77.87 149.73 34.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.595 -0.69 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -81.63 81.83 7.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -70.14 -13.92 62.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 9.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.386 -0.821 . . . . 0.0 109.904 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -136.82 30.26 2.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 113' ' ' LEU . 60.2 m-85 -139.41 177.03 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.711 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 136' ' ' PHE . 5.6 m -153.69 143.56 21.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.659 -0.651 . . . . 0.0 109.428 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -76.22 157.04 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.582 -0.699 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.29 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.502 -0.749 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 t -147.13 159.52 43.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.632 -0.667 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.9 t -157.12 111.06 2.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.68 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -95.88 106.82 19.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.455 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.0 m -90.19 143.37 26.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -147.29 131.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.405 ' HA ' HG23 ' A' ' 152' ' ' THR . 25.0 mt-10 -109.39 121.85 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.687 . . . . 0.0 109.48 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.33 -171.59 3.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.9 p -63.2 -45.05 93.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.313 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.46 158.91 42.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -78.81 -23.09 8.4 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 124.915 3.743 . . . . 0.0 109.819 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.76 -23.02 29.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.513 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 mt -86.01 16.84 3.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.715 . . . . 0.0 109.817 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 145' ' ' GLU . 15.0 m -82.62 146.25 29.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.49 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.8 p-80 -160.26 166.45 29.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 109.544 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 143' ' ' THR . 19.6 m -138.67 138.65 37.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.586 -0.696 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -93.69 92.19 7.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 39.0 mm-40 -74.43 126.23 30.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -110.89 112.15 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.484 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.532 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 33.4 m95 -109.22 168.34 9.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -147.1 141.08 25.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.698 . . . . 0.0 109.452 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -66.47 124.81 23.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -153.54 144.02 22.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.592 -0.692 . . . . 0.0 109.434 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.434 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.557 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.31 113.27 13.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.558 -0.714 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.726 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -86.92 153.39 21.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.511 HD12 ' CB ' ' A' ' 114' ' ' LEU . 16.6 tp -163.28 109.85 1.16 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 0.0 109.359 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.3 p90 -141.2 146.12 36.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.546 -0.721 . . . . 0.0 109.708 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.78 113.04 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.587 -0.696 . . . . 0.0 109.245 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 152.45 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.543 -0.723 . . . . 0.0 109.66 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -102.97 171.21 7.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 -60.92 -19.45 60.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.554 -0.716 . . . . 0.0 109.808 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.45 14.86 0.88 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.491 -0.756 . . . . 0.0 109.736 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.17 36.89 93.63 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 122' ' ' PHE . 5.6 tp -106.65 167.33 9.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.936 . . . . 0.0 109.473 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.559 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -142.57 -29.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -176.15 -176.56 44.46 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -164.19 124.1 2.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.942 . . . . 0.0 109.53 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 29.18 18.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.517 -0.739 . . . . 0.0 109.754 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -62.42 2.51 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -72.4 -179.78 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.94 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.684 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.7 mt -91.4 157.83 41.76 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.464 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.463 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.34 -30.24 2.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.063 3.842 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.684 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.9 p90 -105.44 -175.45 2.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.585 -0.697 . . . . 0.0 109.527 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -134.28 103.06 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.361 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.767 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.8 tp -124.74 82.39 60.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HA ' HD12 ' A' ' 27' ' ' LEU . 7.6 Cg_exo -45.44 -38.78 16.22 Favored 'Trans proline' 0 N--CA 1.508 2.329 0 C-N-CA 125.066 3.844 . . . . 0.0 110.21 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.79 -47.37 83.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.472 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.767 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.5 t0 -64.47 -28.95 70.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.512 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.705 HD22 H223 ' A' ' 170' ' ' TMQ . 83.9 mt -72.72 -23.69 60.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -87.18 -27.83 22.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.581 -0.7 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -69.68 -28.44 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 34' ' ' THR . 59.9 t80 -67.59 -45.7 74.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -67.12 -26.25 66.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.65 -0.656 . . . . 0.0 109.46 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.7 -28.07 40.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.549 -0.719 . . . . 0.0 109.462 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -104.72 35.71 2.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 30' ' ' PHE . 13.9 p -139.26 -27.01 0.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.694 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -68.29 124.26 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.64 . . . . 0.0 109.501 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 37.84 61.54 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -146.93 164.12 33.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.529 -0.983 . . . . 0.0 109.534 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.1 103.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.432 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.415 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.3 ttp -86.49 105.17 16.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.64 -0.663 . . . . 0.0 109.481 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 t -94.24 124.54 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.5 166.26 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 109.489 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.31 -164.25 40.08 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -81.85 -37.49 26.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.62 -0.929 . . . . 0.0 109.441 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -66.99 -42.3 85.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.643 -0.66 . . . . 0.0 109.486 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -72.27 -26.11 61.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.612 -0.68 . . . . 0.0 109.456 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -64.32 -41.3 96.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.442 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -85.37 -21.18 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.63 -0.668 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -62.71 -24.26 67.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.739 . . . . 0.0 109.608 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -62.83 161.06 31.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.98 -72.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.194 3.929 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -107.36 94.46 5.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -99.01 157.18 34.55 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.77 153.46 83.03 Favored 'Cis proline' 0 N--CA 1.508 2.35 0 O-C-N 123.37 1.195 . . . . 0.0 109.967 0.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.415 HD12 ' CE ' ' A' ' 39' ' ' MET . 84.7 mt -76.45 114.06 34.78 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.636 -0.665 . . . . 0.0 109.282 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.28 -179.16 5.17 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 124.791 3.66 . . . . 0.0 109.906 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 60.81 32.13 20.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.714 . . . . 0.0 109.666 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -177.11 -171.59 0.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.764 . . . . 0.0 109.544 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -118.06 113.09 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.601 -0.687 . . . . 0.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.435 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -83.49 103.67 13.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 0.0 109.417 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.62 92.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.582 -0.699 . . . . 0.0 109.461 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -79.66 136.86 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.779 HD12 HG23 ' A' ' 76' ' ' VAL . 14.6 tp -108.65 109.75 21.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.677 -0.64 . . . . 0.0 109.499 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -137.51 151.69 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.461 ' CD2' ' HG2' ' A' ' 65' ' ' GLN . 37.2 p-80 -95.76 -33.9 12.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.461 ' HG2' ' CD2' ' A' ' 64' ' ' HIS . 10.1 mm-40 -77.22 128.81 35.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.386 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 13.9 pt-20 -85.16 30.36 0.6 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.714 . . . . 0.0 109.522 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -98.43 -36.37 9.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.692 . . . . 0.0 109.579 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -71.04 146.76 49.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -143.96 103.4 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.33 117.61 26.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -74.62 127.37 32.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.63 -0.669 . . . . 0.0 109.487 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.28 38.06 35.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.8 144.47 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.958 . . . . 0.0 109.417 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -79.69 104.45 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.6 t -85.65 94.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.555 -0.715 . . . . 0.0 109.414 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.779 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -88.6 171.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.451 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -143.95 29.96 1.33 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.493 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -171.22 142.86 1.81 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.559 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.5 t -66.55 -33.64 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.85 74.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.659 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.02 79.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.627 -0.671 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -67.06 -40.25 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.89 -29.55 66.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.42 77.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.665 . . . . 0.0 109.529 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -72.39 -34.14 67.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.513 -0.742 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.79 -30.49 68.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -65.81 -40.4 91.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -65.69 -29.63 70.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.619 -0.676 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -118.99 90.06 40.33 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.01 -23.54 6.52 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.061 3.841 . . . . 0.0 109.828 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.56 -25.31 63.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.676 -0.64 . . . . 0.0 109.495 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 1.4 tp60 -94.6 179.85 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 28.4 mt-10 -136.52 155.61 49.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.598 -0.689 . . . . 0.0 109.468 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -97.4 147.81 23.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.606 -0.684 . . . . 0.0 109.462 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -145.92 139.12 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.585 -0.697 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.541 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.9 mm -105.21 120.55 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.429 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -101.97 -29.1 12.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 109.415 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 156.67 -174.41 34.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.97 -150.14 9.06 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.266 -1.726 . . . . 0.0 109.58 -0.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.17 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.962 . . . . 0.0 109.53 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.51 -28.06 65.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.601 -0.687 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -79.44 -36.12 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.541 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.4 m-85 -63.3 -52.96 59.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.478 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.773 HG23 HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -63.13 -28.04 69.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.61 -0.681 . . . . 0.0 109.535 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.46 79.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.679 . . . . 0.0 109.534 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.61 8.78 41.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.503 -0.748 . . . . 0.0 109.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HE2' HD22 ' A' ' 131' ' ' LEU . 19.9 tptp -66.07 -30.67 71.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.56 14.45 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.0 109.873 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -160.1 37.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.741 . . . . 0.0 109.402 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.726 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -95.77 153.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.596 -0.69 . . . . 0.0 109.442 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -130.94 -52.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -102.29 158.69 16.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.675 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.539 HD11 ' CE2' ' A' ' 136' ' ' PHE . 32.8 mt -139.49 107.7 5.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.539 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.558 ' CD2' HG22 ' A' ' 157' ' ' VAL . 37.8 mt -104.66 102.51 12.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.242 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -108.27 137.92 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.526 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -109.09 99.82 9.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -81.98 147.66 29.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.712 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -126.33 131.92 51.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.554 -0.716 . . . . 0.0 109.277 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.69 71.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.464 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.8 127.47 13.48 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.4 p -79.16 140.66 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.934 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.483 ' O ' HD22 ' A' ' 12' ' ' LEU . 96.1 m-85 -147.95 129.53 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.462 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -99.35 151.03 21.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.535 -0.728 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -147.56 -122.38 1.32 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -146.27 -36.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.599 -0.942 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.559 HG22 HD11 ' A' ' 13' ' ' ILE . 3.2 m -99.42 135.74 40.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.416 ' O ' HD13 ' A' ' 13' ' ' ILE . 52.2 mtpt -110.32 179.95 3.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.435 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.15 144.73 25.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 109.548 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.773 HD13 HG23 ' A' ' 104' ' ' THR . 28.8 pt -67.27 163.5 45.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.632 -0.668 . . . . 0.0 109.534 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.79 94.85 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 125.137 3.891 . . . . 0.0 109.945 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.471 HD22 ' HE2' ' A' ' 107' ' ' LYS . 50.1 mt -77.91 147.29 35.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.523 -0.736 . . . . 0.0 109.388 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -79.67 86.75 5.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -73.94 -11.76 60.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.953 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.01 10.11 1.31 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -138.56 30.73 2.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 113' ' ' LEU . 55.2 m-85 -143.21 176.96 8.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.504 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.3 m -156.69 140.14 15.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HE3' ' CZ2' ' A' ' 158' ' ' TRP . 31.2 ttmt -81.95 120.87 25.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.567 -0.708 . . . . 0.0 109.492 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.02 -35.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.724 . . . . 0.0 109.51 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.4 p -148.64 170.26 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.1 p -157.49 113.64 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.36 104.1 16.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.538 -0.726 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.451 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.3 m -86.02 147.09 26.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.401 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -151.74 132.49 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.586 -0.696 . . . . 0.0 109.38 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -107.6 128.91 54.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.81 -166.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -69.96 -39.0 76.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -105.38 137.7 19.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.42 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -48.53 -43.7 32.44 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 124.775 3.65 . . . . 0.0 110.059 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.88 -29.06 69.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.537 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.7 mt -80.71 21.2 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.6 m -89.06 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.501 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.6 p-80 -153.76 168.23 26.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.451 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.4 m -141.67 128.25 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 109.42 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -84.52 95.83 8.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.493 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 25.7 mt-10 -81.12 130.4 35.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.7 t -117.6 106.06 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.509 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.493 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.5 m95 -100.48 166.81 10.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.721 . . . . 0.0 109.481 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -142.49 147.14 35.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -66.4 99.84 0.59 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.695 . . . . 0.0 109.501 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -157.79 113.85 2.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.492 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.705 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.414 HG23 HD22 ' A' ' 94' ' ' LEU . 6.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.37 20.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.817 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.8 m-85 -87.92 135.03 33.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.587 -0.696 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.603 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.4 tp -150.08 112.91 4.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.722 . . . . 0.0 109.467 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -144.23 138.79 28.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.536 -0.727 . . . . 0.0 109.735 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.84 111.19 22.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -129.75 157.64 41.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.515 -0.74 . . . . 0.0 109.68 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -101.32 168.44 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.559 -0.713 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -60.77 -23.88 65.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 109.713 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.71 -1.44 3.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.636 -0.665 . . . . 0.0 109.907 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.75 44.79 19.1 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.633 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.9 tp -124.55 152.32 43.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.562 -0.963 . . . . 0.0 109.53 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.902 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -128.01 -33.87 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.569 -0.707 . . . . 0.0 109.81 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.422 ' H ' HD13 ' A' ' 13' ' ' ILE . . . -146.01 178.84 23.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -172.03 116.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.624 -0.927 . . . . 0.0 109.543 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.86 31.18 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.507 -0.745 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.55 -59.57 4.04 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -81.95 179.99 7.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.598 -0.943 . . . . 0.0 109.503 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.737 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.2 mt -88.57 155.1 51.09 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.0 109.4 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.0 Cg_endo -79.28 -29.46 3.1 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 124.946 3.764 . . . . 0.0 109.892 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.737 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.5 p90 -105.06 167.24 9.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.639 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -123.37 83.77 2.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 109.394 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 26' ' ' ASP . 20.2 tp -106.76 81.4 0.88 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -45.01 -39.06 14.24 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 125.262 3.974 . . . . 0.0 110.22 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.91 -38.33 90.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.446 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.787 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -70.91 -32.32 69.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.528 -0.732 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.3 mt -72.47 -24.23 61.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.737 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -82.15 -30.32 31.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.593 -0.692 . . . . 0.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -70.47 -25.11 63.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.571 -0.705 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 34' ' ' THR . 56.0 t80 -63.39 -45.43 91.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.584 -0.698 . . . . 0.0 109.401 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -64.45 -28.71 69.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -28.71 46.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.527 -0.733 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -101.96 33.65 2.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.541 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 30' ' ' PHE . 18.8 p -140.05 -34.45 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.4 m -68.59 126.04 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.557 -0.714 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.53 36.8 25.45 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -154.49 175.29 13.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.654 -0.909 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 99.97 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.557 -0.714 . . . . 0.0 109.415 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.659 ' SD ' HG13 ' A' ' 41' ' ' VAL . 9.7 tmm? -72.62 125.77 28.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -132.55 118.55 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.659 HG13 ' SD ' ' A' ' 39' ' ' MET . 28.1 m -134.35 -176.17 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.87 -169.39 33.74 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -80.01 -35.69 36.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.929 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -70.22 -40.86 74.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 m -73.1 -26.08 61.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -63.67 -45.09 91.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.629 -0.67 . . . . 0.0 109.502 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -77.48 -23.31 50.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.626 -0.671 . . . . 0.0 109.568 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.9 m -63.05 -24.16 67.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.509 -0.745 . . . . 0.0 109.607 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.43 160.59 58.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.583 -0.698 . . . . 0.0 109.471 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.96 -72.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 125.075 3.85 . . . . 0.0 109.955 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -109.22 94.81 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -99.54 157.26 34.3 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 9.3 Cg_endo -80.75 154.09 83.61 Favored 'Cis proline' 0 N--CA 1.509 2.419 0 O-C-N 123.313 1.165 . . . . 0.0 109.923 0.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.438 HD12 ' CE ' ' A' ' 39' ' ' MET . 69.2 mt -73.88 115.61 44.0 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.642 -0.661 . . . . 0.0 109.277 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.96 178.86 7.04 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 124.741 3.627 . . . . 0.0 109.934 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 61.34 29.32 18.52 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.595 -0.69 . . . . 0.0 109.608 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.0 167.61 2.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.702 . . . . 0.0 109.465 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.452 HG21 ' CE1' ' A' ' 85' ' ' TYR . 3.1 m -88.26 117.06 26.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' A' ' 53' ' ' PRO . 83.1 m-20 -91.85 101.61 14.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 109.462 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.22 145.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -134.93 116.43 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.587 -0.696 . . . . 0.0 109.417 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 82' ' ' VAL . 17.5 tp -96.2 119.54 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.573 -0.705 . . . . 0.0 109.485 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.537 HG23 ' CD2' ' A' ' 77' ' ' HIS . 4.0 t -138.51 152.61 48.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.454 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -93.79 -37.24 11.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.529 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -72.34 133.64 45.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 109.46 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -88.48 29.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -102.6 -38.61 7.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.53 141.41 48.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.681 -0.637 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -149.91 101.52 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.604 -0.685 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.88 115.02 20.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -76.84 135.01 38.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.43 35.09 34.07 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.16 147.81 19.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.553 -0.969 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.66 94.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -96.8 124.4 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 109.426 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 82' ' ' VAL . 27.4 m -134.23 174.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.682 . . . . 0.0 109.514 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.537 ' CD2' HG23 ' A' ' 63' ' ' THR . 56.1 m80 -138.86 31.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 109.452 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -153.67 143.69 22.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.717 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -66.96 -32.76 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.718 . . . . 0.0 109.442 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.62 -34.15 76.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.715 . . . . 0.0 109.44 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.97 90.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 76' ' ' VAL . 32.9 t -66.83 -39.37 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.63 -28.55 63.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.48 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.18 90.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 0.0 109.533 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CE1' HG21 ' A' ' 58' ' ' THR . 39.0 t80 -69.36 -37.42 77.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.541 -0.725 . . . . 0.0 109.45 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.3 68.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.595 -0.69 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -67.18 -43.74 81.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -65.46 -28.84 69.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -119.42 90.02 41.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.77 -20.59 9.01 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.14 3.893 . . . . 0.0 109.944 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.12 -28.31 69.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.479 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -105.55 165.54 11.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.6 -0.687 . . . . 0.0 109.498 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -122.01 143.66 49.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 95' ' ' VAL . 2.1 tt -67.18 132.93 48.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.636 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.9 t -135.31 120.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.426 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.2 mm -96.09 140.64 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 109.438 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.605 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -114.78 -36.1 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.705 . . . . 0.0 109.546 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.17 179.58 36.89 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 -155.44 28.06 Favored Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.335 -1.685 . . . . 0.0 109.591 0.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' A' ' 129' ' ' ILE . . . -62.78 -23.43 67.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.649 -0.912 . . . . 0.0 109.669 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.05 -38.55 75.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.1 mm -72.14 -39.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.552 -0.718 . . . . 0.0 109.585 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 29.1 m-85 -62.93 -41.69 99.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.552 -0.717 . . . . 0.0 109.415 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.629 HG23 HD13 ' A' ' 129' ' ' ILE . 0.7 OUTLIER -71.74 -19.06 62.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.669 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.15 -25.8 47.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.554 -0.716 . . . . 0.0 109.544 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.717 ' CE1' HG13 ' A' ' 79' ' ' VAL . 82.1 m-85 -124.53 19.85 8.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.584 -0.698 . . . . 0.0 109.748 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -63.41 -29.99 71.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 109.625 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -80.85 26.02 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.617 -0.677 . . . . 0.0 109.73 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -159.99 34.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.817 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -91.68 150.66 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.49 -0.756 . . . . 0.0 109.436 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -132.35 -58.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.683 -0.636 . . . . 0.0 109.307 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -102.22 112.04 24.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.569 -0.707 . . . . 0.0 109.353 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.571 HD11 ' CE2' ' A' ' 136' ' ' PHE . 30.0 mt -94.64 99.26 11.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.637 ' CD2' HG22 ' A' ' 157' ' ' VAL . 20.0 mt -100.63 104.41 15.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.667 . . . . 0.0 109.22 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -112.38 143.65 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.602 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.0 m -113.5 99.98 8.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -83.64 142.12 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.682 . . . . 0.0 109.611 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.1 131.54 56.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.685 . . . . 0.0 109.243 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.47 75.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.41 9.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 p -76.92 142.89 39.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.443 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -147.82 109.44 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.33 153.19 28.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.633 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -151.12 -126.2 1.29 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.55 -46.9 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.907 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.443 HG22 HD11 ' A' ' 13' ' ' ILE . 3.2 m -85.8 139.84 30.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 109.515 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 13' ' ' ILE . 48.3 mttp -116.54 160.72 20.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.634 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.45 ' HG2' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -76.61 147.61 37.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.546 -0.721 . . . . 0.0 109.476 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.645 HG23 ' HB1' ' A' ' 100' ' ' ALA . 19.7 pt -70.37 163.83 59.13 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.695 . . . . 0.0 109.479 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.34 101.03 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.139 3.893 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.3 153.08 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.686 . . . . 0.0 109.485 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.2 88.52 7.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 109.461 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -73.9 -15.16 61.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.0 109.82 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.95 9.86 1.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 109.933 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -134.48 30.62 3.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.823 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.571 ' CE2' HD11 ' A' ' 113' ' ' LEU . 60.9 m-85 -140.59 179.59 6.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -150.77 134.29 16.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.638 -0.664 . . . . 0.0 109.43 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -78.63 118.55 20.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -95.25 -33.56 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.6 m -157.47 174.28 15.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 t -161.69 122.73 2.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -95.67 107.22 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.482 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.7 m -90.13 149.52 22.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 109.427 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.417 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.7 p -154.43 129.57 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.363 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -107.73 120.79 43.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.533 -0.73 . . . . 0.0 109.479 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.19 -165.97 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.589 -0.695 . . . . 0.0 109.519 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.6 p -71.52 -39.19 70.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.599 -0.688 . . . . 0.0 109.525 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -105.63 137.59 19.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.547 -0.721 . . . . 0.0 109.41 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.99 -44.84 26.74 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 C-N-CA 124.762 3.641 . . . . 0.0 110.072 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.15 71.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.718 . . . . 0.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 151' ' ' LEU . 43.3 mt -80.78 20.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.682 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.2 m -92.33 142.06 27.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.36 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.697 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.6 p-80 -156.93 166.62 32.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.5 m -138.33 133.44 33.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.411 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.91 92.97 9.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.439 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 31.3 mt-10 -74.06 139.84 44.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.637 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.8 t -128.91 106.74 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.597 -0.69 . . . . 0.0 109.506 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.1 m95 -106.83 168.56 9.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -145.21 142.31 29.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.79 122.02 19.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -141.42 136.2 31.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.566 -0.709 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.445 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.482 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.32 100.68 7.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.582 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.8 m-85 -71.66 139.03 49.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.512 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.6 tp -153.91 113.38 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.324 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 p90 -146.05 151.01 37.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.736 . . . . 0.0 109.909 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.59 118.24 36.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.282 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HB3' HG22 ' A' ' 13' ' ' ILE . 9.1 pt20 -138.04 152.81 49.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.48 -0.762 . . . . 0.0 109.588 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.38 171.07 7.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 109.498 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -61.1 -19.05 61.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.604 -0.685 . . . . 0.0 109.864 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -76.61 13.95 0.89 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.493 -0.754 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.24 39.63 97.95 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.512 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.6 tp -112.02 165.79 11.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.624 -0.927 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 126' ' ' THR . 32.4 pt -142.21 -30.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.577 -0.702 . . . . 0.0 109.545 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.18 -169.43 30.75 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -172.13 117.78 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.631 -0.923 . . . . 0.0 109.44 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.0 21.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.577 -0.702 . . . . 0.0 109.613 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.68 -61.74 4.08 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.401 ' CD2' ' H ' ' A' ' 18' ' ' HIS . 19.1 p80 -76.89 166.56 23.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.445 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.558 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 15.6 mt -79.91 157.54 73.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.662 -0.649 . . . . 0.0 109.439 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -80.24 -27.98 3.28 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.08 3.853 . . . . 0.0 109.971 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.558 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.4 p90 -108.25 -179.29 3.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.534 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -131.34 102.35 5.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 26' ' ' ASP . 20.7 tp -121.51 80.16 38.39 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.606 -0.684 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.63 -37.6 15.77 Favored 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 125.167 3.912 . . . . 0.0 110.178 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -62.89 -42.79 99.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.562 -0.711 . . . . 0.0 109.509 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.798 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.2 t0 -65.42 -38.1 88.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.622 -0.674 . . . . 0.0 109.38 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.35 -24.42 67.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.579 -0.7 . . . . 0.0 109.519 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -83.63 -30.82 26.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.614 -0.679 . . . . 0.0 109.407 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 19.0 t80 -73.83 -25.62 60.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 34' ' ' THR . 48.4 t80 -63.42 -45.74 89.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.51 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -63.58 -30.12 71.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.624 -0.672 . . . . 0.0 109.44 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.83 -29.21 50.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 76.5 mm-40 -100.77 32.54 3.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.3 p -136.82 -35.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.588 -0.695 . . . . 0.0 109.54 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 35' ' ' VAL . 27.8 m -79.42 128.86 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.705 . . . . 0.0 109.496 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.88 -25.75 26.36 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.36 -170.58 1.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.927 . . . . 0.0 109.511 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.407 HG23 ' HB ' ' A' ' 58' ' ' THR . 59.1 mt -103.99 112.05 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.459 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.565 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.7 tmm? -73.72 110.99 8.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.26 122.88 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.713 . . . . 0.0 109.464 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.565 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.8 m -136.66 178.05 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.498 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.94 -177.58 34.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -70.36 -39.58 74.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.963 . . . . 0.0 109.416 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -68.94 -40.53 78.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.616 -0.678 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -72.46 -25.72 61.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.31 -44.49 87.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.661 -0.65 . . . . 0.0 109.462 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -77.33 -26.84 52.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.1 p -62.67 -21.79 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.64 -0.663 . . . . 0.0 109.697 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.427 ' HE2' HG21 ' A' ' 41' ' ' VAL . 20.3 m-85 -62.45 162.96 16.37 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.547 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -81.22 -74.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 125.227 3.952 . . . . 0.0 110.037 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -113.7 82.65 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.465 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -84.42 157.24 62.01 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.371 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.87 152.14 76.88 Favored 'Cis proline' 0 N--CA 1.509 2.383 0 O-C-N 123.415 1.219 . . . . 0.0 109.995 0.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.474 HD12 ' CE ' ' A' ' 39' ' ' MET . 97.1 mt -73.4 113.86 26.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.707 . . . . 0.0 109.27 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.44 179.24 6.68 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.761 3.641 . . . . 0.0 109.942 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 61.03 32.03 19.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.525 -0.734 . . . . 0.0 109.64 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.29 -178.62 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 38' ' ' ILE . 19.7 m -100.98 119.83 39.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 109.339 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -94.24 117.16 29.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.653 -0.654 . . . . 0.0 109.484 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -125.83 143.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.59 -0.693 . . . . 0.0 109.398 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 t -127.97 132.62 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.602 -0.686 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.48 HD12 HG23 ' A' ' 76' ' ' VAL . 12.8 tp -104.2 112.02 24.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -137.88 153.5 49.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.7 . . . . 0.0 109.464 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -89.68 -47.82 7.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 0.0 109.548 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -72.74 157.97 36.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.604 -0.685 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -102.45 8.11 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.593 -0.692 . . . . 0.0 109.859 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.99 -28.01 57.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.28 153.56 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.492 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -143.72 143.59 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.601 -0.687 . . . . 0.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -136.0 125.4 24.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -87.6 123.39 32.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.16 41.6 59.77 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -154.42 148.84 26.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.617 -0.931 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.64 99.63 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.469 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.8 t -75.88 97.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.652 -0.655 . . . . 0.0 109.467 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -89.19 162.98 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.469 ' NE2' HG12 ' A' ' 75' ' ' VAL . 61.2 m-70 -140.07 30.39 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.41 146.48 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.607 -0.683 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.518 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.6 t -68.18 -33.36 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.528 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.53 70.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.506 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.39 80.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.54 -0.725 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -69.13 -36.57 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.645 -0.659 . . . . 0.0 109.473 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.6 -30.34 64.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.75 -36.92 83.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.83 -38.75 83.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.581 -0.7 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.51 -24.49 64.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -63.87 -43.73 95.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -67.45 -29.11 68.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -120.77 89.76 45.58 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.13 -23.53 6.38 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.165 3.91 . . . . 0.0 109.86 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.57 -24.92 64.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.536 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -90.44 179.97 5.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -138.31 154.06 49.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.45 ' CD2' HD11 ' A' ' 96' ' ' ILE . 2.6 tt -91.16 109.58 20.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -110.62 122.6 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.45 HD11 ' CD2' ' A' ' 94' ' ' LEU . 41.7 mm -97.3 127.76 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.532 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.57 -23.44 11.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.599 -0.688 . . . . 0.0 109.578 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.38 -177.05 40.88 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.453 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -80.5 -157.0 14.34 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.341 -1.682 . . . . 0.0 109.54 -0.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.56 87.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.588 -0.948 . . . . 0.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.31 -26.29 66.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.548 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.453 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.5 mm -74.88 -32.17 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.6 -0.688 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.68 -42.65 81.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -69.89 -35.09 74.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.581 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.77 88.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.664 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.518 ' CE1' HG13 ' A' ' 79' ' ' VAL . 33.6 m-85 -95.14 3.49 54.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -70.8 -22.72 62.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.568 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -62.93 -23.87 67.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.71 58.97 1.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.582 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -105.98 149.51 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -130.37 -50.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -95.2 142.72 27.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.589 -0.694 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 136' ' ' PHE . 17.3 mt -129.52 87.15 2.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.573 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.652 ' CD2' HG22 ' A' ' 157' ' ' VAL . 61.1 mt -90.37 123.97 34.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.347 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -135.59 147.28 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 0.0 109.543 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.5 m -113.51 105.95 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.64 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -88.27 127.97 35.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.44 133.66 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 109.387 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.58 63.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 0.0 109.425 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.04 129.06 12.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 p -78.05 143.69 37.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.988 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.475 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.0 m-85 -148.45 125.79 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.634 -0.667 . . . . 0.0 109.517 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.57 160.77 16.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.512 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.37 -132.17 1.32 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -143.83 -41.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.664 -0.903 . . . . 0.0 109.451 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.615 HG22 HD11 ' A' ' 13' ' ' ILE . 4.2 m -89.46 134.94 33.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.518 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -113.33 173.39 6.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.419 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.408 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -90.84 143.56 26.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.485 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.2 pt -67.34 164.62 35.61 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.564 -0.71 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.4 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.147 3.898 . . . . 0.0 109.883 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.66 155.15 18.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -87.04 85.34 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.588 -0.695 . . . . 0.0 109.418 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -74.64 -15.17 60.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.669 -0.644 . . . . 0.0 109.871 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.09 9.97 1.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.513 -0.742 . . . . 0.0 109.877 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -134.05 29.7 3.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.534 ' CE2' HD11 ' A' ' 113' ' ' LEU . 47.8 m-85 -141.13 176.01 9.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -150.39 134.24 16.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 109.42 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -70.65 153.19 43.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.553 -0.717 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.09 -31.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.612 -0.68 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.2 m -139.33 144.01 38.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -143.84 99.09 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -86.71 97.56 10.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.708 . . . . 0.0 109.462 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.569 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.2 m -77.2 147.87 36.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.54 129.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.351 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.75 120.65 42.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.736 . . . . 0.0 109.477 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.08 -165.9 0.93 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.7 p -74.89 -41.96 58.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.22 137.8 20.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.733 . . . . 0.0 109.434 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.65 -48.45 15.69 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 124.804 3.669 . . . . 0.0 110.143 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.88 70.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.658 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.32 15.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.788 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.0 m -86.58 139.36 30.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.339 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.578 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.0 p-80 -156.01 173.25 17.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.571 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.569 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.3 m -139.23 135.56 34.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -86.46 92.13 8.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.46 147.52 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.2 t -139.05 99.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.461 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -94.59 166.19 12.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.395 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -148.84 141.34 24.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -63.22 133.48 54.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -140.01 157.16 46.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.484 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.457 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.515 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.82 124.31 20.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.71 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.798 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -94.86 152.77 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.561 -0.712 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.571 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.7 tp -163.2 110.05 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.33 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.0 p90 -144.78 150.1 36.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.75 117.3 31.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 109.223 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' HB3' HG22 ' A' ' 13' ' ' ILE . 2.2 pt20 -138.48 152.8 48.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.723 . . . . 0.0 109.691 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -104.07 170.99 7.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.68 -17.38 55.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.805 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.85 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.36 38.22 95.91 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 122' ' ' PHE . 6.2 tp -113.03 163.97 14.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.551 -0.97 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 126' ' ' THR . 31.7 pt -138.16 -30.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.435 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -167.49 -166.87 27.29 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -171.79 118.2 0.42 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.902 . . . . 0.0 109.501 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 59.98 32.24 21.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.72 -62.8 2.63 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -75.35 172.84 11.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.615 -0.932 . . . . 0.0 109.454 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.575 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 31.1 mt -85.18 156.36 60.12 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.84 -26.66 4.4 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 125.021 3.814 . . . . 0.0 109.944 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.575 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.4 p90 -108.77 167.74 9.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.511 -0.743 . . . . 0.0 109.491 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -117.57 101.31 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.61 -0.682 . . . . 0.0 109.45 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.1 tp -121.38 80.41 37.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.59 -38.99 17.29 Favored 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 125.171 3.914 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.48 -41.35 98.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.625 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.788 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.3 t0 -65.87 -36.99 84.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.711 HD22 H223 ' A' ' 170' ' ' TMQ . 88.4 mt -68.15 -23.25 64.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -86.1 -28.23 24.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.65 -0.656 . . . . 0.0 109.461 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.8 t80 -75.23 -25.49 58.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.507 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 34' ' ' THR . 50.4 t80 -63.82 -48.98 74.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -65.66 -25.7 67.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.566 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.08 -25.72 43.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.542 -0.724 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.0 mm100 -109.07 36.77 2.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' PHE . 20.6 p -142.06 -29.3 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.32 132.49 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.592 -0.692 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.37 34.82 60.39 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -155.98 164.31 38.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.532 -0.981 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.87 117.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.44 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.455 ' CE ' HD12 ' A' ' 54' ' ' LEU . 39.6 ttp -97.6 108.34 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.483 ' CG2' HD11 ' A' ' 94' ' ' LEU . 30.4 t -93.67 120.08 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.47 161.78 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.512 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.73 -162.85 37.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 ptt85 -83.55 -35.8 24.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.956 . . . . 0.0 109.428 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -69.59 -38.66 77.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.697 -0.627 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.497 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 10.7 m -74.14 -28.64 61.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.483 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.49 -58.44 7.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -66.32 -21.58 66.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.586 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.6 m -63.1 -29.36 70.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.743 . . . . 0.0 109.543 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.497 ' CZ ' HG22 ' A' ' 45' ' ' THR . 35.7 m-85 -64.83 161.64 44.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.86 -73.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 125.126 3.884 . . . . 0.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -107.03 95.57 5.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.625 -0.672 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 25.3 ptt-85 -101.23 157.32 33.89 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.641 -0.662 . . . . 0.0 109.443 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.27 145.7 72.09 Favored 'Cis proline' 0 N--CA 1.508 2.365 0 O-C-N 123.385 1.203 . . . . 0.0 109.903 0.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.455 HD12 ' CE ' ' A' ' 39' ' ' MET . 50.2 mt -62.59 116.1 21.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.289 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.92 178.47 7.51 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 124.762 3.641 . . . . 0.0 109.929 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 61.02 29.44 18.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.516 -0.74 . . . . 0.0 109.638 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.11 -169.27 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.706 . . . . 0.0 109.527 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -118.06 130.19 56.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.525 -0.735 . . . . 0.0 109.437 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -107.61 100.56 9.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.491 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -99.55 105.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.56 -0.713 . . . . 0.0 109.449 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.42 122.05 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.599 HD12 HG23 ' A' ' 76' ' ' VAL . 12.3 tp -101.38 118.16 36.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.624 -0.673 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.469 HG23 ' CE1' ' A' ' 77' ' ' HIS . 3.9 t -144.32 154.37 42.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.479 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -95.11 -38.87 10.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.579 -0.7 . . . . 0.0 109.479 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -72.1 131.61 43.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.613 -0.68 . . . . 0.0 109.433 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.97 30.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -103.21 -33.21 9.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -69.69 143.3 53.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -142.14 146.09 34.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.69 . . . . 0.0 109.48 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.98 124.31 20.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -83.0 130.21 35.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.38 38.85 37.57 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.74 139.4 12.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.991 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -77.37 104.46 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.61 100.71 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.599 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -102.47 -176.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.469 ' CE1' HG23 ' A' ' 63' ' ' THR . 64.0 m-70 -142.93 30.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.489 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -161.06 142.54 11.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 t -65.18 -31.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.06 -34.54 78.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.05 81.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.643 -0.661 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 76' ' ' VAL . 34.1 t -66.73 -41.22 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.42 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -71.94 -30.07 64.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.603 -0.686 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.42 87.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.71 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -71.44 -33.03 69.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.583 -0.698 . . . . 0.0 109.521 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.32 -29.98 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -66.42 -42.45 87.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.517 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -66.54 -28.41 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -119.21 90.01 40.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.643 -0.66 . . . . 0.0 109.453 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 -23.67 6.51 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 125.103 3.869 . . . . 0.0 109.843 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.58 -26.4 66.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -102.44 133.67 47.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -92.29 151.63 20.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.71 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.483 HD11 ' CG2' ' A' ' 40' ' ' VAL . 9.7 tp -87.43 143.93 26.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.555 -0.716 . . . . 0.0 109.497 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -144.43 130.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.431 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.554 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -94.65 125.36 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.507 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -107.94 -28.32 9.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 161.81 -177.57 38.01 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.85 -154.73 16.48 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.361 -1.67 . . . . 0.0 109.6 -0.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.58 78.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.953 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -75.09 -30.51 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.554 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.4 m-85 -68.78 -50.65 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -64.21 -23.16 67.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.615 -0.678 . . . . 0.0 109.558 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.32 -52.11 37.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.6 -0.688 . . . . 0.0 109.615 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -86.46 6.16 31.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.567 -0.708 . . . . 0.0 110.037 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 110' ' ' VAL . 32.2 ttpt -66.04 -23.55 66.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 109.586 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -68.37 -42.43 79.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.598 -0.689 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.73 38.19 2.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.611 -0.68 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.798 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -79.97 152.76 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.583 -0.698 . . . . 0.0 109.342 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.15 -68.87 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.692 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -85.57 161.44 19.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.635 -0.665 . . . . 0.0 109.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.583 HD11 ' CE2' ' A' ' 136' ' ' PHE . 23.7 mt -141.63 88.32 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.549 -0.719 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.571 ' CB ' HD12 ' A' ' 4' ' ' LEU . 54.0 mt -89.44 120.65 30.95 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -132.63 142.77 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.7 m -109.98 103.17 11.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 0.0 109.329 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -85.71 132.22 34.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.0 109.603 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.9 132.73 53.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.371 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.9 -31.68 72.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.439 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.443 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -73.98 131.95 14.65 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.5 p -85.15 142.01 29.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.605 -0.938 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.59 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.3 m-85 -144.86 126.26 14.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.604 -0.685 . . . . 0.0 109.456 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -90.01 146.42 24.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.561 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -145.76 -128.89 2.02 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -143.62 -34.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.995 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.49 HG22 HD11 ' A' ' 13' ' ' ILE . 2.9 m -98.68 127.89 44.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 109.55 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -104.81 170.86 7.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.23 145.35 25.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.0 pt -66.91 164.78 31.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.505 -0.747 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.23 109.23 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.105 3.87 . . . . 0.0 109.891 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.08 149.42 21.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -84.46 86.35 7.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -73.36 -16.95 61.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.632 -0.668 . . . . 0.0 109.768 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.08 9.83 1.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.961 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -131.87 28.42 4.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.583 ' CE2' HD11 ' A' ' 113' ' ' LEU . 54.5 m-85 -138.48 179.86 6.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.45 122.01 7.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.505 -0.747 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -70.25 121.3 17.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 140' ' ' SER . 28.1 m -96.11 -37.4 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.478 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.406 ' N ' HG23 ' A' ' 139' ' ' VAL . 57.4 p -158.62 169.33 24.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.545 -0.722 . . . . 0.0 109.528 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 81.4 p -158.35 129.63 6.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.607 -0.683 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -97.18 116.24 29.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.685 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.564 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.4 m -93.95 152.08 19.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.36 130.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -102.38 123.22 45.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.511 -0.743 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.45 -165.95 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.7 p -73.99 -39.9 63.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 0.0 109.604 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -99.85 137.57 20.19 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.25 -39.88 34.9 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 124.773 3.649 . . . . 0.0 110.015 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.443 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -75.07 -29.58 60.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.693 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.84 8.36 2.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.566 -0.709 . . . . 0.0 109.981 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.3 p -78.45 159.0 28.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.476 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.584 ' CE1' HD21 ' A' ' 23' ' ' LEU . 39.4 p-80 -171.97 170.74 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.539 -0.725 . . . . 0.0 109.603 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 143' ' ' THR . 16.9 m -140.44 133.84 29.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -86.64 95.95 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 109.383 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -78.14 144.41 36.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.627 -0.671 . . . . 0.0 109.483 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.555 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.3 t -133.65 99.55 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 31.5 m95 -96.86 166.95 11.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.615 -0.678 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -146.0 138.82 25.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -68.5 102.01 1.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.715 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -149.62 117.25 6.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.483 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.711 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.28 107.05 14.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CD1' HG23 ' A' ' 110' ' ' VAL . 3.7 m-85 -80.98 155.97 26.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.624 -0.673 . . . . 0.0 109.416 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.707 HD12 ' CB ' ' A' ' 114' ' ' LEU . 6.5 tp -168.78 121.56 0.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.451 ' NE1' HG23 ' A' ' 115' ' ' VAL . 44.0 p90 -147.31 130.1 16.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.508 -0.745 . . . . 0.0 109.584 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.91 109.77 18.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.266 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.653 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.6 pt20 -131.26 160.87 33.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.704 . . . . 0.0 109.72 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -109.86 169.45 8.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.672 -0.642 . . . . 0.0 109.465 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -60.72 -17.56 49.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.57 15.26 0.83 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.715 . . . . 0.0 109.798 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.25 33.75 87.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.608 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.8 tp -113.69 161.31 17.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.638 -0.919 . . . . 0.0 109.469 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.653 HG22 ' HB3' ' A' ' 7' ' ' GLN . 30.1 pt -134.21 -30.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -170.46 -174.45 38.5 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -166.38 124.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.91 32.48 21.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 109.752 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.19 -61.71 3.93 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -74.97 174.77 8.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.586 -0.949 . . . . 0.0 109.5 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.575 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 47.8 mt -89.7 156.02 47.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 109.426 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -79.59 -26.55 4.7 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 124.955 3.77 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.575 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.7 p90 -108.59 165.76 11.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -115.13 101.5 9.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.776 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.6 tp -122.76 79.23 48.87 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.84 -38.01 17.35 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 125.165 3.91 . . . . 0.0 110.197 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.83 -46.51 87.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.559 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.776 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.8 t0 -64.19 -36.9 85.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.59 -24.99 67.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.664 . . . . 0.0 109.459 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -84.12 -29.35 26.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.605 -0.685 . . . . 0.0 109.437 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -71.73 -28.12 63.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.584 -0.697 . . . . 0.0 109.4 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 34' ' ' THR . 46.6 t80 -67.62 -44.96 76.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.554 -0.716 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -66.0 -31.0 71.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -30.94 60.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.693 . . . . 0.0 109.437 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -97.9 33.25 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.3 p -139.55 -30.03 0.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.608 -0.682 . . . . 0.0 109.493 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.5 m -68.63 128.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 109.513 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.38 69.94 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -145.67 165.79 27.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.565 -0.962 . . . . 0.0 109.449 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.417 HG23 ' HB ' ' A' ' 58' ' ' THR . 59.8 mt -92.11 101.0 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.428 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.619 ' CE ' HD12 ' A' ' 54' ' ' LEU . 43.7 ttp -80.7 103.33 10.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.555 -0.715 . . . . 0.0 109.457 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.85 121.43 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.24 168.33 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.624 -0.673 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.67 -165.28 39.38 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -78.87 -43.49 24.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.936 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -68.73 -30.99 69.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -79.91 -29.15 39.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.68 -31.81 72.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.629 -0.669 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -94.18 -18.07 22.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.694 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -62.26 -23.43 66.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -66.43 159.77 70.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.15 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.066 3.844 . . . . 0.0 109.953 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.92 112.8 24.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.498 -0.751 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -108.46 158.64 33.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.518 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.69 -165.51 4.57 Favored 'Cis proline' 0 N--CA 1.509 2.382 0 O-C-N 123.372 1.196 . . . . 0.0 109.897 -0.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.619 HD12 ' CE ' ' A' ' 39' ' ' MET . 87.9 mt -114.97 94.4 38.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.585 -0.697 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -74.97 -175.89 2.59 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 124.819 3.679 . . . . 0.0 109.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 61.51 27.93 17.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.77 . . . . 0.0 109.52 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.23 -169.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 38' ' ' ILE . 1.3 m -119.39 115.23 23.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.583 -0.698 . . . . 0.0 109.49 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.496 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.7 m-80 -92.77 103.79 16.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.722 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -104.62 99.94 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.481 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.3 t -87.03 123.89 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.492 HD12 HG23 ' A' ' 76' ' ' VAL . 18.4 tp -101.11 115.83 31.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.651 -0.656 . . . . 0.0 109.502 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -145.98 146.61 31.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.705 -0.622 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -101.43 31.54 3.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.585 -0.697 . . . . 0.0 109.562 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -134.2 126.51 30.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -85.1 29.53 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.17 -35.65 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 109.515 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -69.55 157.76 36.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.62 -0.675 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -147.52 140.89 25.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.527 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.5 11.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.584 -0.698 . . . . 0.0 109.475 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -84.83 133.68 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.581 -0.7 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.74 41.21 35.13 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.02 159.82 36.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.928 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -94.07 94.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.612 -0.68 . . . . 0.0 109.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.629 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.7 t -79.01 99.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.363 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.492 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -97.21 159.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.458 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.629 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.5 m-70 -139.23 28.68 2.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.695 . . . . 0.0 109.511 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -161.49 147.56 14.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.466 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.512 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.3 t -67.81 -33.64 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.722 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.31 73.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.653 -0.655 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.08 79.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 76' ' ' VAL . 30.2 t -67.2 -46.57 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.591 -0.693 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.91 -27.27 63.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.672 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.29 -36.89 85.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.558 -0.714 . . . . 0.0 109.437 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.21 -34.29 68.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 109.525 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.21 67.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -65.55 -42.39 91.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.22 -29.84 70.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.579 -0.7 . . . . 0.0 109.543 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -119.74 89.86 42.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.58 -0.7 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.99 -23.16 6.85 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.148 3.899 . . . . 0.0 109.943 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.07 -26.42 65.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.49 172.49 7.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -130.94 169.13 16.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tp -93.58 131.94 38.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -128.03 127.12 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.463 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.615 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.0 mm -103.41 118.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.54 -25.37 11.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.498 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.74 -179.04 40.83 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.85 -157.08 28.5 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.328 -1.689 . . . . 0.0 109.542 -0.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.97 -30.53 71.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.623 -0.928 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -73.24 -32.76 64.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -70.28 -36.87 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.552 -0.717 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.615 ' CE1' HG22 ' A' ' 96' ' ' ILE . 25.5 m-85 -63.77 -56.65 13.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -62.47 -16.05 53.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.604 -0.685 . . . . 0.0 109.83 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.42 -23.23 32.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.512 ' CE1' HG13 ' A' ' 79' ' ' VAL . 35.4 m-85 -121.06 18.12 11.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.809 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -66.27 -31.36 72.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.554 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.0 26.65 0.42 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.694 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.05 34.13 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.542 -0.724 . . . . 0.0 109.485 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.683 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -102.23 159.37 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.429 ' N ' HG22 ' A' ' 110' ' ' VAL . 7.7 t0 -141.83 -50.43 0.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.674 -0.641 . . . . 0.0 109.345 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -105.75 109.28 21.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 0.0 109.335 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.407 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 23.1 mt -93.61 110.26 21.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.585 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.707 ' CB ' HD12 ' A' ' 4' ' ' LEU . 21.8 mt -105.74 101.96 11.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.596 -0.69 . . . . 0.0 109.298 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.451 HG23 ' NE1' ' A' ' 5' ' ' TRP . 9.5 p -107.71 132.74 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.669 -0.645 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.5 m -106.91 96.51 6.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.564 -0.71 . . . . 0.0 109.244 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -82.39 150.16 27.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.648 -0.658 . . . . 0.0 109.704 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.35 142.39 50.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.634 -0.666 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.69 -34.83 62.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.556 -0.715 . . . . 0.0 109.453 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.41 136.29 22.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.9 p -86.7 143.63 27.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.994 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -144.92 138.62 27.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.3 152.96 18.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.546 -0.721 . . . . 0.0 109.52 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.608 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -157.97 -128.76 1.04 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.05 -34.37 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.946 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.475 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -89.85 149.52 22.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.624 -0.673 . . . . 0.0 109.521 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -130.89 167.85 18.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 11.4 tpt -88.14 151.57 22.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.54 -0.725 . . . . 0.0 109.479 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.3 pt -76.06 163.62 65.47 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.595 -0.69 . . . . 0.0 109.509 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.16 104.78 1.69 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.172 3.915 . . . . 0.0 109.902 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.2 mt -97.43 144.5 27.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -87.16 88.44 7.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -67.15 -14.97 63.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.575 -0.703 . . . . 0.0 109.831 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.58 -26.02 68.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.478 -0.764 . . . . 0.0 109.531 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.65 30.46 2.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 67.2 m-85 -143.84 171.3 14.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.533 -0.73 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.9 m -144.34 136.38 26.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.545 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -74.12 150.26 40.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.38 -35.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.56 -0.712 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -142.37 165.64 26.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.6 t -164.43 119.65 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.48 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -99.56 106.07 18.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.528 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 m -93.14 141.05 28.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.671 . . . . 0.0 109.42 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.402 ' CG1' ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -150.32 135.03 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.94 125.4 54.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.2 -165.94 0.95 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.4 p -70.85 -38.32 73.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.554 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.26 137.71 19.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.598 -0.689 . . . . 0.0 109.37 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.74 -44.14 27.21 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 124.829 3.686 . . . . 0.0 110.065 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.32 72.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.68 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 151' ' ' LEU . 34.2 mt -80.74 21.1 0.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 38.0 m -91.74 142.67 27.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.39 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.402 ' NE2' ' CG1' ' A' ' 144' ' ' VAL . 35.9 p-80 -155.45 168.95 25.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -141.95 131.35 23.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 109.419 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -91.12 95.21 9.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.732 . . . . 0.0 109.516 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.514 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 22.5 mt-10 -78.2 130.76 36.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.608 -0.683 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.607 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.1 t -115.39 110.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.514 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 36.8 m95 -108.48 165.67 11.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.584 -0.698 . . . . 0.0 109.458 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -143.36 138.87 29.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.651 -0.656 . . . . 0.0 109.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.74 95.97 4.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.417 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -93.09 120.6 33.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.571 -0.705 . . . . 0.0 109.532 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.449 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.43 HN52 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.617 HG23 HD23 ' A' ' 94' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 1' ' ' THR . . . -141.47 130.96 23.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.498 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.834 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.7 m-85 -96.37 162.14 13.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.733 . . . . 0.0 109.479 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 114' ' ' LEU . 8.6 tp -168.97 107.33 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.597 -0.689 . . . . 0.0 109.301 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.04 143.14 31.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.55 -0.719 . . . . 0.0 109.811 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.09 112.5 24.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.648 -0.658 . . . . 0.0 109.245 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.485 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.5 pt20 -134.16 149.79 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.637 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -98.7 170.17 8.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.499 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -60.96 -17.26 50.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.558 -0.714 . . . . 0.0 109.943 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -76.83 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.493 -0.754 . . . . 0.0 109.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.21 36.43 92.99 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.2 tp -111.59 162.36 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.534 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.528 HD11 HG22 ' A' ' 126' ' ' THR . 32.3 pt -137.13 -30.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.508 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -167.12 -172.8 34.74 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -168.98 124.96 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.933 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.08 28.04 17.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.01 -63.55 1.47 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -75.45 -171.65 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.602 -0.94 . . . . 0.0 109.468 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.706 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 31.5 mt -92.58 156.89 40.81 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.58 -0.7 . . . . 0.0 109.423 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.1 Cg_endo -80.22 -28.67 2.91 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.015 3.81 . . . . 0.0 109.882 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.706 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.7 p90 -106.75 -172.27 2.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -138.65 94.8 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.614 -0.679 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.774 HD23 ' HB2' ' A' ' 26' ' ' ASP . 22.3 tp -116.12 83.36 12.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.56 -38.34 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.123 3.882 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.99 -40.97 99.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.774 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -69.25 -28.4 66.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.683 HD22 H223 ' A' ' 170' ' ' TMQ . 80.2 mt -75.24 -23.47 57.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.621 -0.674 . . . . 0.0 109.542 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -86.82 -28.87 22.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.729 . . . . 0.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -71.04 -27.08 63.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CE2' HG21 ' A' ' 34' ' ' THR . 48.1 t80 -64.35 -47.8 77.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.627 -0.67 . . . . 0.0 109.47 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -66.6 -5.27 10.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.611 -0.681 . . . . 0.0 109.974 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.08 -34.47 12.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.512 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -106.28 35.48 2.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.466 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.474 HG21 ' CE2' ' A' ' 30' ' ' PHE . 20.6 p -133.37 -32.8 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.527 -0.733 . . . . 0.0 109.493 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.7 129.58 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 37.3 57.15 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -155.15 164.94 38.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.484 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -92.37 110.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.469 ' CE ' HD12 ' A' ' 54' ' ' LEU . 36.3 ttp -88.81 107.6 19.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 94' ' ' LEU . 30.7 t -94.57 119.42 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.456 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 27.3 m -132.95 164.49 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.718 . . . . 0.0 109.5 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.38 -165.36 40.42 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtm105 -80.52 -38.43 29.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.95 . . . . 0.0 109.471 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -70.05 -32.98 71.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.58 -0.7 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 m -79.17 -28.5 42.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.465 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.65 -34.19 77.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.471 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -86.7 -25.48 24.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -62.89 -23.23 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HZ ' HG11 ' A' ' 41' ' ' VAL . 44.4 m-85 -62.92 162.83 19.18 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.18 -63.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.125 3.883 . . . . 0.0 109.922 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -124.12 111.55 16.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.543 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -108.52 157.37 36.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.405 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.83 146.51 72.18 Favored 'Cis proline' 0 N--CA 1.508 2.36 0 O-C-N 123.396 1.208 . . . . 0.0 109.982 0.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.484 ' HB2' HD21 ' A' ' 59' ' ' ASN . 68.6 mt -67.51 112.93 11.61 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.368 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -78.24 179.91 6.06 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 124.793 3.662 . . . . 0.0 109.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 61.22 27.65 17.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.665 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -177.13 -173.32 0.45 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.493 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -116.16 120.11 37.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.711 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.484 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -95.53 107.72 19.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.668 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.1 116.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.424 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -102.1 122.7 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.606 -0.684 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.509 HD12 HG23 ' A' ' 76' ' ' VAL . 15.3 tp -99.22 110.93 23.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.74 142.82 31.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -97.65 30.98 2.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -125.81 138.39 53.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.71 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.75 29.84 2.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.31 -40.18 5.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.611 -0.681 . . . . 0.0 109.454 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -73.17 136.98 44.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -141.48 102.88 4.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.75 117.43 23.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -76.92 133.28 39.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.571 -0.705 . . . . 0.0 109.424 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 37.52 59.55 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.47 142.83 19.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.965 . . . . 0.0 109.494 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -75.4 95.96 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.622 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.0 t -80.22 102.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.528 -0.732 . . . . 0.0 109.437 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.509 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -94.33 158.7 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.622 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.8 m-70 -139.68 29.56 2.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.693 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -162.18 147.29 12.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 t -67.97 -35.3 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.454 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.58 70.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.53 81.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.473 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.508 HG22 HG21 ' A' ' 76' ' ' VAL . 31.0 t -68.34 -40.72 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -75.67 -30.24 59.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -36.96 84.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.56 -41.92 75.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.622 -0.674 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 109.48 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -65.12 -45.31 85.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.57 -0.706 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -67.48 -27.08 66.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.469 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.82 89.82 39.02 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.678 . . . . 0.0 109.463 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.93 -23.14 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 125.06 3.84 . . . . 0.0 109.893 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.69 -26.79 66.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -91.27 179.94 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.34 150.64 46.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.617 HD23 HG23 ' A' ' 1' ' ' THR . 11.7 tp -93.67 126.4 38.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 t -133.16 127.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.716 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.558 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.7 mm -91.42 127.64 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.561 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -111.85 -23.83 10.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.562 -0.711 . . . . 0.0 109.59 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.92 -178.15 37.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.48 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -82.6 -154.37 14.92 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 120.389 -1.654 . . . . 0.0 109.587 -0.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.53 77.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.579 -0.954 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -73.15 -27.2 61.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.48 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -73.94 -35.44 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.723 . . . . 0.0 109.479 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 96' ' ' ILE . 24.1 m-85 -63.26 -53.71 48.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -62.71 -21.98 66.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.59 -0.694 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.91 -30.84 67.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.741 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -116.06 16.89 16.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.767 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.621 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -68.04 -22.85 64.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.651 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -70.19 -45.51 66.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -97.04 40.3 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.456 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.834 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -89.38 143.95 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -128.53 -65.63 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.668 . . . . 0.0 109.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.5 m -89.86 164.58 14.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.533 HD11 ' CE2' ' A' ' 136' ' ' PHE . 33.4 mt -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.564 -0.71 . . . . 0.0 109.58 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.65 ' HB2' HD12 ' A' ' 4' ' ' LEU . 35.9 mt -91.21 104.25 16.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -115.47 137.99 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -107.77 102.69 11.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.68 . . . . 0.0 109.336 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mmm-85 -88.23 135.22 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.99 140.69 42.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.69 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.62 -29.63 61.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.416 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.464 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -74.93 126.08 8.65 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 p -72.57 143.25 48.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.939 . . . . 0.0 109.452 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.424 ' O ' HD22 ' A' ' 12' ' ' LEU . 66.7 m-85 -148.98 121.55 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -96.51 149.25 21.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.54 -120.78 1.13 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -145.95 -33.94 0.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.631 -0.923 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.528 HG22 HD11 ' A' ' 13' ' ' ILE . 2.2 m -93.9 146.28 24.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -125.53 174.32 8.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.6 tpt -97.55 152.14 19.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.2 pt -74.67 163.9 65.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.14 94.18 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.115 3.876 . . . . 0.0 109.873 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.57 154.28 28.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.6 -0.688 . . . . 0.0 109.486 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -87.14 86.08 7.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.587 -0.696 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -71.47 -18.49 62.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.6 -0.688 . . . . 0.0 109.725 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -74.12 10.08 1.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -132.68 29.62 4.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.533 ' CE2' HD11 ' A' ' 113' ' ' LEU . 44.5 m-85 -138.95 -180.0 6.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.629 -0.669 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -148.59 125.5 11.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 109.441 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -78.44 126.36 30.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.07 -35.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.612 -0.68 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.2 t -162.31 -177.79 5.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 98.3 p -163.88 132.56 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -95.73 100.74 12.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.531 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.4 m -82.72 148.79 27.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.58 131.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.313 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -108.36 120.22 41.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.451 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.01 -165.3 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 p -72.99 -42.96 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.61 -0.681 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -100.01 137.97 20.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.4 -47.62 17.19 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 124.832 3.688 . . . . 0.0 110.092 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.464 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -62.23 -30.02 70.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.569 -0.707 . . . . 0.0 109.664 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.8 mt -78.82 17.58 0.7 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 109.741 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.5 m -90.54 144.36 25.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.755 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.721 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.3 p-80 -159.68 170.14 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.56 -0.712 . . . . 0.0 109.574 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.531 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.5 m -139.92 135.66 33.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.39 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -91.32 92.02 8.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.564 -0.71 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.518 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 44.0 mt-10 -77.1 128.36 34.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.544 -0.722 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.617 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.8 t -114.76 99.49 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.484 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.518 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 35.5 m95 -95.03 164.31 12.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.7 . . . . 0.0 109.445 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -148.66 136.11 20.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -65.58 126.31 27.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.724 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.99 99.15 2.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.64 -0.662 . . . . 0.0 109.483 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.449 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.683 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.503 HG23 HD23 ' A' ' 94' ' ' LEU . 3.9 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.73 127.76 33.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.557 -0.714 . . . . 0.0 109.467 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.791 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -100.18 143.93 29.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.532 -0.73 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.677 HD12 ' CB ' ' A' ' 114' ' ' LEU . 7.7 tp -156.59 111.51 2.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.33 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.93 141.22 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.545 -0.722 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.97 112.81 24.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.207 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -132.89 157.82 44.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -107.53 170.01 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 109.46 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -60.89 -18.31 55.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.551 -0.718 . . . . 0.0 109.871 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.42 15.09 0.82 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.77 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 35.77 91.9 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.647 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.5 tp -111.34 162.01 15.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.978 . . . . 0.0 109.535 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.63 HD11 HG22 ' A' ' 126' ' ' THR . 31.9 pt -136.28 -30.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.493 -0.754 . . . . 0.0 109.58 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -166.34 -170.28 31.04 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -168.8 117.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.584 -0.951 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.1 30.74 20.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.698 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.83 -61.85 2.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -75.03 165.15 25.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.975 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.618 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 32.9 mt -78.09 156.9 79.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.721 . . . . 0.0 109.421 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.432 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.7 Cg_endo -80.34 -28.58 2.88 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 124.996 3.797 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.618 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.2 p90 -107.53 -170.94 1.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -140.68 96.96 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 26' ' ' ASP . 11.6 tp -117.09 81.11 12.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.76 -40.85 19.59 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 125.095 3.863 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -62.48 -52.25 64.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 109.63 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.788 ' HB2' HD23 ' A' ' 23' ' ' LEU . 30.6 t70 -63.1 -35.94 81.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.635 HD22 ' C22' ' A' ' 170' ' ' TMQ . 43.0 mt -63.12 -23.8 67.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.539 -0.726 . . . . 0.0 109.554 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -85.52 -29.16 24.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 12.4 t80 -64.78 -25.72 68.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.647 -0.658 . . . . 0.0 109.528 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 34' ' ' THR . 49.6 t80 -64.64 -46.05 84.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.591 -0.693 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -65.12 -31.84 73.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 109.465 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.93 -29.03 58.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.565 -0.709 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 22.4 mm100 -100.4 34.17 2.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.4 p -140.46 -34.87 0.51 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.581 -0.699 . . . . 0.0 109.525 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -70.98 124.94 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.687 -0.633 . . . . 0.0 109.508 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.21 34.4 20.73 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -156.29 168.23 27.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.498 -1.001 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.5 mt -90.54 104.61 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.649 -0.657 . . . . 0.0 109.469 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.609 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.6 tmm? -77.22 120.58 22.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 0.0 109.484 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 94' ' ' LEU . 28.2 t -126.81 122.57 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.524 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.609 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.8 m -135.12 -174.28 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.79 -170.33 26.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -77.59 -40.01 43.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.525 -0.985 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.19 -36.3 74.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.638 -0.664 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -73.09 -28.12 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -63.7 -47.45 81.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HA ' HH21 ' A' ' 52' ' ' ARG . 25.1 mt-10 -71.97 -25.73 61.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -62.51 -21.64 65.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.571 -0.705 . . . . 0.0 109.587 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -62.44 164.37 11.87 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.03 -65.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.167 3.911 . . . . 0.0 110.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -128.33 103.97 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.523 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.453 HH21 ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -88.92 157.38 48.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.653 . . . . 0.0 109.421 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.35 -168.95 7.07 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.361 1.19 . . . . 0.0 110.035 0.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.589 HD12 ' CE ' ' A' ' 39' ' ' MET . 93.2 mt -112.96 96.32 37.76 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.421 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -69.54 176.48 6.54 Favored 'Trans proline' 0 N--CA 1.505 2.206 0 C-N-CA 124.592 3.528 . . . . 0.0 109.831 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 62.04 21.79 12.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.533 -0.729 . . . . 0.0 109.639 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -177.52 156.6 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.72 . . . . 0.0 109.458 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -79.46 152.36 30.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 109.54 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -130.32 114.76 16.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.454 ' HB ' HG22 ' A' ' 40' ' ' VAL . 30.1 t -116.52 103.98 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.654 -0.654 . . . . 0.0 109.522 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.6 123.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 76' ' ' VAL . 16.4 tp -94.99 108.69 20.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.416 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.478 HG23 ' CE1' ' A' ' 77' ' ' HIS . 3.9 t -136.56 152.8 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.46 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -104.44 -22.73 13.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.69 -0.631 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.88 134.31 48.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.686 . . . . 0.0 109.419 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.38 31.9 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.637 -0.664 . . . . 0.0 109.455 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -121.56 -30.6 4.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -67.79 144.44 55.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.742 . . . . 0.0 109.395 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -147.97 102.67 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.524 -0.735 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.42 117.96 25.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -78.19 133.77 37.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.685 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.69 35.95 44.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -159.22 151.48 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.611 -0.934 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -81.38 95.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.72 . . . . 0.0 109.439 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.404 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.3 t -76.7 97.72 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.466 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.476 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -94.55 170.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.579 -0.701 . . . . 0.0 109.501 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.478 ' CE1' HG23 ' A' ' 63' ' ' THR . 75.9 m-70 -146.15 30.23 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -168.3 144.7 3.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.569 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.2 t -66.48 -33.2 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.84 74.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.64 -0.662 . . . . 0.0 109.469 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.19 -35.63 78.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.629 -0.669 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.419 HG22 HG21 ' A' ' 76' ' ' VAL . 31.3 t -67.11 -42.28 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.635 -0.666 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -68.94 -29.63 67.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.47 82.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.09 -33.62 72.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.57 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.641 -0.662 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.88 -40.93 92.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -67.36 -31.12 71.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -120.19 90.03 44.07 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.12 -22.98 6.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.104 3.869 . . . . 0.0 109.893 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.33 -25.29 64.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.718 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -103.72 141.09 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.36 164.79 12.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.629 -0.669 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 40' ' ' VAL . 9.6 tp -93.17 132.1 37.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.53 -0.731 . . . . 0.0 109.457 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -134.5 126.81 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.1 mm -99.67 127.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.672 -0.643 . . . . 0.0 109.429 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.563 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -106.5 -22.36 12.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.586 -0.696 . . . . 0.0 109.611 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.3 -176.51 39.48 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.484 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.98 -154.23 18.49 Favored Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.353 -1.675 . . . . 0.0 109.533 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.9 77.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 109.502 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -72.49 -26.01 61.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.581 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.484 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -74.68 -36.56 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.555 -0.716 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -63.21 -51.0 68.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 m -63.17 -24.31 67.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.704 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.49 75.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.678 . . . . 0.0 109.487 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.569 ' CE1' HG13 ' A' ' 79' ' ' VAL . 65.8 m-85 -102.13 12.62 36.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.606 -0.684 . . . . 0.0 109.759 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 110' ' ' VAL . 70.2 tttt -70.75 -28.75 64.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.464 -0.773 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -65.65 -31.6 72.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.715 . . . . 0.0 109.569 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -119.49 37.95 4.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.49 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.791 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -84.78 156.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.34 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.25 -68.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.597 -0.689 . . . . 0.0 109.482 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -88.55 161.9 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 3' ' ' PHE . 26.9 mt -143.5 92.38 2.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.634 -0.666 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.677 ' CB ' HD12 ' A' ' 4' ' ' LEU . 50.8 mt -90.52 112.53 24.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.0 109.401 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -118.69 133.51 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.426 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -104.94 96.7 6.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.697 . . . . 0.0 109.321 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -82.42 138.73 34.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.7 . . . . 0.0 109.578 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.8 134.55 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.41 87.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.533 -0.729 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.78 126.22 23.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.2 p -79.29 143.44 35.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.947 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -145.83 128.61 16.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.581 -0.699 . . . . 0.0 109.506 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.82 153.58 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.718 . . . . 0.0 109.495 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.647 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -156.64 -135.49 1.96 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -30.39 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.63 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -94.54 143.51 26.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 109.553 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.66 168.95 13.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.639 -0.663 . . . . 0.0 109.485 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.4 tpt -93.38 152.4 19.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.512 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -71.83 164.4 58.73 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.618 -0.677 . . . . 0.0 109.502 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 95.2 1.0 Allowed 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 125.165 3.91 . . . . 0.0 109.889 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.67 138.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.655 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -81.15 84.15 6.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.429 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -67.83 -15.92 63.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.785 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.48 -25.93 68.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.46 -33.95 20.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.662 -0.649 . . . . 0.0 109.443 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 113' ' ' LEU . 96.3 m-85 -84.29 166.56 17.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.8 m -136.45 131.63 34.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -71.65 113.6 8.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.678 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 140' ' ' SER . 27.4 m -93.46 -38.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 109.494 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.424 ' N ' HG23 ' A' ' 139' ' ' VAL . 47.1 m -153.37 166.37 32.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.563 -0.711 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.9 p -160.8 134.24 6.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.583 -0.698 . . . . 0.0 109.44 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -100.41 113.4 26.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.448 ' HA ' HG23 ' A' ' 154' ' ' THR . 9.9 m -94.81 142.39 27.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.697 . . . . 0.0 109.489 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -151.1 147.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.697 . . . . 0.0 109.352 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.496 ' HA ' HG23 ' A' ' 152' ' ' THR . 10.4 pt-20 -128.27 132.76 48.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.441 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.58 -171.38 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -64.25 -34.96 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.649 . . . . 0.0 109.45 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.418 ' HB2' HD12 ' A' ' 151' ' ' LEU . 7.0 t30 -95.89 152.96 39.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.68 . . . . 0.0 109.293 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.08 -22.52 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.858 3.705 . . . . 0.0 109.909 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.93 -23.25 27.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.548 -0.72 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' A' ' 148' ' ' ASN . 46.8 mt -84.2 -1.32 54.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.503 -0.748 . . . . 0.0 109.99 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 145' ' ' GLU . 3.7 m -63.35 146.07 54.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.485 -0.759 . . . . 0.0 109.434 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.409 ' CE1' HG13 ' A' ' 144' ' ' VAL . 27.2 p-80 -157.79 165.31 35.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.65 -0.656 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.3 m -137.57 133.87 34.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.45 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -91.66 94.44 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.91 139.16 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.586 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.8 t -126.46 103.86 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.523 -0.736 . . . . 0.0 109.536 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -99.78 165.3 11.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -144.63 138.0 27.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -73.19 114.12 11.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.726 . . . . 0.0 109.483 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -150.42 107.91 3.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.505 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.468 -179.972 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.635 ' C22' HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.493 HG23 HD23 ' A' ' 94' ' ' LEU . 9.4 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.9 108.33 7.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 0.0 109.416 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.794 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.1 m-85 -84.44 123.88 30.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.438 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.675 HD12 ' CB ' ' A' ' 114' ' ' LEU . 6.9 tp -138.58 112.97 8.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.573 -0.705 . . . . 0.0 109.274 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -142.25 140.53 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 0.0 109.801 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.58 112.47 23.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.527 -0.733 . . . . 0.0 109.287 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.23 152.88 51.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.509 -0.744 . . . . 0.0 109.717 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -102.85 170.41 8.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -60.78 -18.44 55.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.626 -0.671 . . . . 0.0 109.896 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 14.22 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.501 -0.749 . . . . 0.0 109.838 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.28 37.05 93.94 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.67 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.6 tp -111.48 165.88 11.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.956 . . . . 0.0 109.487 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -138.14 -41.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.506 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.66 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -163.67 -179.31 37.95 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -162.11 125.92 3.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.947 . . . . 0.0 109.471 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 59.75 30.8 20.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.534 -0.729 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.57 -60.49 4.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -75.22 168.17 20.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.951 . . . . 0.0 109.503 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.618 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.0 mt -81.74 156.4 70.33 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.21 -29.39 2.56 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.012 3.808 . . . . 0.0 109.847 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.618 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 32.8 p90 -107.25 173.85 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 109.521 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -124.05 106.06 10.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.9 tp -126.77 81.18 69.51 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.24 -39.36 15.71 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 125.213 3.942 . . . . 0.0 110.253 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.92 -47.17 84.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.516 -0.74 . . . . 0.0 109.491 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.9 t0 -64.58 -31.46 72.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.71 . . . . 0.0 109.496 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.57 HD22 H223 ' A' ' 170' ' ' TMQ . 89.3 mt -69.75 -24.44 63.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 109.527 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -86.65 -29.68 22.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.468 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 26.3 t80 -69.81 -24.43 63.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.612 -0.68 . . . . 0.0 109.536 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -63.35 -45.82 89.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -65.2 -29.21 70.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.525 -0.734 . . . . 0.0 109.461 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.52 -29.39 56.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.358 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.419 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 12.5 mm100 -100.74 34.8 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -143.33 -35.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.634 -0.666 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.8 m -70.66 124.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.496 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.31 33.96 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -156.32 166.93 32.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.954 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.63 99.68 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.343 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.711 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.9 tmm? -72.57 134.39 45.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.421 HG21 HD11 ' A' ' 94' ' ' LEU . 27.7 t -138.32 117.8 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.579 -0.701 . . . . 0.0 109.46 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.711 HG13 ' SD ' ' A' ' 39' ' ' MET . 27.0 m -132.67 -174.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.558 -0.714 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.93 -168.32 32.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 34.8 ptt180 -81.78 -34.32 30.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.523 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -71.29 -38.52 71.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.597 -0.689 . . . . 0.0 109.399 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -75.43 -27.68 59.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 40.3 t80 -64.89 -42.4 94.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -75.09 -23.3 57.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.4 m -63.24 -26.13 68.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.89 161.66 44.67 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.72 -61.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.082 3.855 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -125.55 103.14 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -104.73 154.79 38.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.439 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.6 154.71 88.74 Favored 'Cis proline' 0 N--CA 1.508 2.362 0 O-C-N 123.388 1.204 . . . . 0.0 109.827 0.025 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.1 mt -72.73 131.26 84.42 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -80.11 170.25 16.64 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.687 3.591 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.04 27.31 17.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -177.47 155.1 1.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.525 -0.734 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -84.92 134.22 34.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -105.6 105.08 14.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.546 -0.721 . . . . 0.0 109.465 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.9 147.54 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.435 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 t -137.15 119.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 109.476 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.559 HD12 HG23 ' A' ' 76' ' ' VAL . 12.7 tp -98.95 116.84 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.06 140.02 39.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.426 ' CD2' ' HG3' ' A' ' 65' ' ' GLN . 12.4 p-80 -81.63 -27.33 34.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.561 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.426 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 59.4 mt-30 -71.51 137.51 48.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.649 -0.657 . . . . 0.0 109.426 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -94.28 31.69 1.67 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.686 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -121.79 -31.37 3.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.536 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -67.94 138.7 56.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -144.47 158.57 43.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.632 -0.667 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' H ' HG21 ' A' ' 75' ' ' VAL . . . -137.59 129.67 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -84.53 136.5 33.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.583 -0.698 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.7 36.8 75.98 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.91 158.82 38.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.599 -0.942 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 t -95.06 92.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.613 -0.679 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.692 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.1 t -74.4 104.83 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.474 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 82' ' ' VAL . 27.6 m -94.7 153.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.692 ' NE2' HG12 ' A' ' 75' ' ' VAL . 55.8 m-70 -136.14 28.41 3.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -161.27 149.55 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.708 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.414 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.0 t -68.92 -35.24 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.555 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.99 65.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.572 -0.705 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.99 86.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.562 HG22 HG21 ' A' ' 76' ' ' VAL . 30.9 t -68.15 -45.08 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.525 -0.735 . . . . 0.0 109.431 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.95 -29.25 66.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.628 -0.67 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.01 82.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.4 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -71.33 -33.94 70.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.606 -0.684 . . . . 0.0 109.455 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.29 67.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.596 -0.69 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -65.92 -39.35 90.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.661 -0.65 . . . . 0.0 109.502 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.8 -32.11 72.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.523 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -121.71 89.49 47.72 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 -22.36 7.02 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.094 3.863 . . . . 0.0 109.891 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -65.53 -26.49 67.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -97.95 179.16 4.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.659 -0.65 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -137.32 150.1 47.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.493 HD23 HG23 ' A' ' 1' ' ' THR . 12.3 tp -76.31 134.98 39.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.577 -0.702 . . . . 0.0 109.473 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.24 122.8 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.581 -0.7 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.414 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.3 mm -97.02 142.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.641 . . . . 0.0 109.402 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.628 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -121.28 -30.95 4.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.713 . . . . 0.0 109.484 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.56 178.78 37.5 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.86 -151.9 20.87 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.364 -1.668 . . . . 0.0 109.534 0.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.52 -26.51 65.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.963 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -68.94 -31.97 71.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 109.541 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.2 -40.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.689 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 31.3 m-85 -63.06 -47.18 84.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.96 -23.59 66.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.554 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.75 -29.6 51.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 82' ' ' VAL . 43.7 m-85 -114.5 20.26 15.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -63.1 -36.74 84.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.605 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -81.11 29.72 0.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.603 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -160.01 33.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.585 -0.697 . . . . 0.0 109.486 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.1 p -94.7 153.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.714 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.58 -61.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.308 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -96.42 111.75 23.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.603 -0.686 . . . . 0.0 109.342 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 136' ' ' PHE . 34.1 mt -95.66 98.43 10.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.573 -0.705 . . . . 0.0 109.626 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.675 ' CB ' HD12 ' A' ' 4' ' ' LEU . 30.3 mt -99.21 104.48 16.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 109.214 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -111.57 140.79 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.598 -0.689 . . . . 0.0 109.565 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.6 m -110.17 97.7 7.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 109.245 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.406 ' O ' HD12 ' A' ' 118' ' ' LEU . 61.2 mtt180 -80.44 151.13 29.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 117' ' ' ARG . 3.0 mp -127.53 136.16 51.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.242 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.72 -32.77 71.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.05 128.88 10.25 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.7 p -81.38 144.44 31.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.465 ' O ' HD22 ' A' ' 12' ' ' LEU . 98.3 m-85 -147.27 121.74 9.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.619 -0.676 . . . . 0.0 109.418 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.99 149.8 27.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.705 . . . . 0.0 109.522 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.67 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -149.05 -141.26 3.42 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.7 -30.76 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.558 -0.966 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.1 m -102.97 130.22 49.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.581 -0.699 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -108.43 175.23 5.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.573 -0.704 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -93.93 152.47 18.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.6 pt -75.19 164.29 62.2 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.78 98.08 1.11 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.178 3.919 . . . . 0.0 109.844 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.85 145.32 27.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.612 -0.68 . . . . 0.0 109.507 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -85.07 87.03 7.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.614 -0.679 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -73.26 -9.94 59.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.58 -31.26 72.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.4 36.7 1.44 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.48 ' CE2' HD11 ' A' ' 113' ' ' LEU . 40.4 m-85 -143.28 167.81 21.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.536 -0.728 . . . . 0.0 109.452 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -144.76 145.84 31.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 109.45 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HE3' ' CZ2' ' A' ' 158' ' ' TRP . 31.8 ttmt -75.28 152.66 38.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.28 -32.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -149.6 154.92 39.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 t -157.1 110.49 2.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.585 -0.697 . . . . 0.0 109.498 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -100.68 110.88 23.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.6 m -92.07 146.43 23.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.671 . . . . 0.0 109.402 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.411 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -150.47 132.1 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.552 -0.717 . . . . 0.0 109.329 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -107.61 123.47 48.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.685 . . . . 0.0 109.478 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.35 -165.52 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.583 -0.698 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -71.19 -39.55 71.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.89 137.7 19.36 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.551 -0.718 . . . . 0.0 109.408 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.39 -46.64 22.62 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 124.755 3.637 . . . . 0.0 110.052 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.92 69.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.73 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -80.2 20.53 0.66 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.711 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.7 m -89.45 141.32 28.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.408 -0.807 . . . . 0.0 109.354 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.443 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.9 p-80 -152.87 164.88 37.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.559 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.7 m -137.73 132.63 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.15 93.03 9.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.623 -0.673 . . . . 0.0 109.483 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 56.0 mm-40 -78.51 130.76 36.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.62 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.2 t -119.94 112.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.582 -0.699 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.521 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.9 m95 -110.84 157.5 19.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.518 -0.739 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -141.38 143.06 33.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -75.3 113.17 12.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.603 -0.685 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 141.63 24.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.571 -0.706 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.491 -179.984 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.57 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.462 HG23 HD23 ' A' ' 94' ' ' LEU . 2.8 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.05 101.45 8.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -74.73 126.89 31.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.513 -0.742 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.587 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.3 tp -140.11 112.99 8.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 109.313 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 9.7 p90 -142.67 141.92 31.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 0.0 109.731 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.81 112.53 24.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.576 -0.702 . . . . 0.0 109.213 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.13 149.42 52.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.607 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -97.41 170.14 9.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.619 -0.676 . . . . 0.0 109.452 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.55 -18.58 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.872 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.38 15.4 0.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 0.0 109.855 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.1 34.38 88.83 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.611 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.5 tp -107.54 165.25 11.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.596 -0.944 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 126' ' ' THR . 31.8 pt -138.61 -29.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.476 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.71 -168.85 33.05 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -174.43 124.35 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.49 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 60.03 33.56 21.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.51 -0.744 . . . . 0.0 109.735 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.35 4.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -76.03 176.11 8.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.548 -0.972 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.645 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 19.3 mt -86.92 156.59 55.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.707 . . . . 0.0 109.41 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -80.59 -31.51 1.5 Allowed 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.0 3.8 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.645 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 31.4 p90 -104.96 167.11 9.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.56 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -117.79 100.27 7.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.606 -0.684 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 21.7 tp -122.02 81.76 43.44 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.361 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.25 -38.89 15.38 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 125.181 3.92 . . . . 0.0 110.307 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.78 -41.34 99.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.528 -0.732 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.9 t0 -66.63 -31.58 72.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.642 -0.661 . . . . 0.0 109.422 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.666 HD22 H223 ' A' ' 170' ' ' TMQ . 84.2 mt -72.05 -23.7 61.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.589 -0.695 . . . . 0.0 109.531 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -86.81 -29.8 22.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.567 -0.708 . . . . 0.0 109.452 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -70.97 -25.94 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 34' ' ' THR . 51.9 t80 -65.42 -45.23 84.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.661 . . . . 0.0 109.446 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -64.98 -29.3 70.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.475 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.69 51.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.642 -0.661 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -97.77 33.13 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 30' ' ' PHE . 10.3 p -137.37 -34.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' VAL . 26.6 m -68.62 126.17 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.557 -0.714 . . . . 0.0 109.433 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 36.28 23.58 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -153.24 166.21 33.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.521 -0.988 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.42 102.0 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.598 -0.689 . . . . 0.0 109.447 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.64 ' SD ' HG13 ' A' ' 41' ' ' VAL . 8.1 tmm? -70.38 125.72 27.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.58 -0.7 . . . . 0.0 109.435 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 94' ' ' LEU . 29.8 t -131.9 115.5 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.631 -0.668 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.64 HG13 ' SD ' ' A' ' 39' ' ' MET . 24.7 m -135.45 -177.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.702 . . . . 0.0 109.458 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.3 -178.62 35.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -72.27 -31.86 66.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.576 -0.955 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.22 -48.23 62.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -68.64 -25.95 65.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -68.54 -33.92 74.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.708 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.14 -26.15 19.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 t -74.9 10.11 1.59 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -81.76 166.42 37.7 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.83 -73.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.103 3.868 . . . . 0.0 109.968 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -118.23 71.94 0.85 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.55 -0.719 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -72.19 156.82 90.25 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.12 -175.86 17.48 Favored 'Cis proline' 0 N--CA 1.508 2.378 0 O-C-N 123.377 1.198 . . . . 0.0 109.946 0.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.5 HD12 ' CE ' ' A' ' 39' ' ' MET . 84.2 mt -107.73 104.25 52.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -74.56 179.83 5.55 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 124.645 3.564 . . . . 0.0 109.813 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.95 28.06 17.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.572 -0.705 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -176.1 178.76 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.416 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 m -98.47 117.47 32.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.464 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -88.78 105.99 18.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -114.9 141.37 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 109.438 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -131.94 123.49 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 76' ' ' VAL . 15.2 tp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.523 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.65 140.13 34.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.63 -0.669 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -94.74 29.74 2.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -147.56 142.46 26.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 109.442 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -88.65 30.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.703 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.57 -35.15 9.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -77.18 134.57 38.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.515 -0.74 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -146.29 116.41 7.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.47 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.68 131.98 53.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -84.66 138.42 32.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.562 -0.711 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.17 38.05 59.36 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.5 144.25 16.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.529 -0.983 . . . . 0.0 109.553 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -79.84 95.66 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.587 -0.696 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.593 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.0 t -79.99 106.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.509 HG21 HG22 ' A' ' 82' ' ' VAL . 28.0 m -94.88 150.82 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.593 ' NE2' HG12 ' A' ' 75' ' ' VAL . 31.8 m-70 -131.65 30.03 4.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.679 . . . . 0.0 109.464 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -163.87 144.55 8.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.454 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 106' ' ' PHE . 29.8 t -67.57 -32.95 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.585 -0.697 . . . . 0.0 109.476 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -32.96 72.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.667 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.86 75.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 76' ' ' VAL . 31.0 t -69.19 -44.14 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.42 -30.2 65.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.565 -0.71 . . . . 0.0 109.426 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.15 79.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.681 -0.637 . . . . 0.0 109.474 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -71.3 -33.45 69.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.553 -0.717 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.47 -31.16 65.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.92 -45.91 69.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.594 -0.692 . . . . 0.0 109.484 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -66.19 -26.79 67.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.552 -0.717 . . . . 0.0 109.509 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -118.94 89.75 39.38 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 -22.49 6.98 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.126 3.884 . . . . 0.0 109.984 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -65.82 -26.02 67.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.603 -0.686 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -104.24 179.46 4.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.512 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -140.36 150.61 44.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.653 -0.654 . . . . 0.0 109.462 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 40' ' ' VAL . 12.6 tp -75.28 137.84 41.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 109.486 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -144.24 116.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.656 -0.652 . . . . 0.0 109.473 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.516 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.5 mm -91.74 128.73 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.698 . . . . 0.0 109.379 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.54 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -107.13 -31.03 8.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.49 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.86 178.83 38.49 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.52 -151.71 21.81 Favored Glycine 0 N--CA 1.499 2.855 0 O-C-N 120.362 -1.67 . . . . 0.0 109.632 0.035 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.5 68.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.965 . . . . 0.0 109.519 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -70.51 -30.6 67.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -76.01 -37.75 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.533 -0.729 . . . . 0.0 109.494 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.516 ' CE1' HG22 ' A' ' 96' ' ' ILE . 28.9 m-85 -63.64 -50.02 70.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.399 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 -24.92 68.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.656 -0.653 . . . . 0.0 109.497 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.19 69.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 79' ' ' VAL . 77.6 m-85 -116.44 19.28 14.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -27.74 65.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.69 20.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.695 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -160.09 36.85 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.546 -0.721 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.661 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -96.99 141.31 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.589 -0.695 . . . . 0.0 109.473 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -122.03 -47.46 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.384 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.7 m -100.9 152.62 20.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.391 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.507 HD11 ' CE2' ' A' ' 136' ' ' PHE . 22.0 mt -136.12 96.95 3.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.624 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.624 ' CD2' HG22 ' A' ' 157' ' ' VAL . 38.2 mt -100.49 109.3 21.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.722 . . . . 0.0 109.292 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -119.23 141.98 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.0 m -109.21 103.08 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.58 -0.7 . . . . 0.0 109.267 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -88.22 138.88 31.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.702 . . . . 0.0 109.561 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.63 141.47 47.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.291 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.94 -32.35 63.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.503 -0.748 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.74 133.73 19.52 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.0 m -82.7 142.29 31.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.62 -0.929 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.546 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.6 m-85 -148.04 119.22 7.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.668 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -87.53 145.23 26.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.586 -0.697 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.611 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -140.72 -127.68 2.36 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -143.19 -32.59 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.951 . . . . 0.0 109.438 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.536 HG22 HD11 ' A' ' 13' ' ' ILE . 8.3 m -105.1 136.94 43.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -113.14 175.5 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.605 -0.684 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.6 tpt -92.13 152.61 19.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.528 -0.732 . . . . 0.0 109.558 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 pt -72.55 164.75 57.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.71 98.38 1.14 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 125.112 3.875 . . . . 0.0 109.919 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.56 147.0 26.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -84.45 84.81 7.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.558 -0.714 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -67.83 -19.31 65.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.718 . . . . 0.0 109.684 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -24.97 67.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -97.42 29.35 3.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.507 ' CE2' HD11 ' A' ' 113' ' ' LEU . 40.7 m-85 -143.57 175.2 10.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -149.47 144.28 26.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -84.43 114.75 22.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.47 -34.0 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.523 -0.736 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -155.41 171.45 19.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.726 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 t -164.51 127.64 2.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -98.7 111.91 24.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.556 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.528 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.2 m -91.29 145.38 24.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.484 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -149.24 125.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.509 -0.744 . . . . 0.0 109.345 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -104.79 121.32 43.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.61 -0.681 . . . . 0.0 109.436 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.56 -165.11 0.81 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.3 p -73.32 -40.7 64.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.723 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -103.45 137.58 19.29 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.61 -44.34 26.11 Favored 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 124.826 3.684 . . . . 0.0 110.093 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.7 71.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.631 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.97 19.43 1.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 109.66 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.4 m -91.13 134.29 34.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.543 -0.723 . . . . 0.0 109.437 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.609 ' CE1' HD21 ' A' ' 23' ' ' LEU . 37.4 p-80 -150.01 167.23 27.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 143' ' ' THR . 16.1 m -137.32 136.48 38.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -89.44 95.45 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.494 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.6 mt-10 -76.67 135.6 39.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.552 -0.717 . . . . 0.0 109.453 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 114' ' ' LEU . 27.9 t -126.19 97.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.565 -0.709 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.494 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 30.5 m95 -96.46 163.0 13.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.637 -0.664 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -143.31 144.77 32.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.62 -0.675 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -67.48 104.17 1.49 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -140.8 115.37 9.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.508 179.976 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 170' ' ' TMQ . . . . . 0.666 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.657 HG23 HD23 ' A' ' 94' ' ' LEU . 6.8 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.49 134.0 44.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.849 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.2 m-85 -104.76 153.99 20.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.701 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.2 tp -164.57 109.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.1 146.61 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.533 -0.729 . . . . 0.0 109.655 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.78 110.05 22.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.285 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -129.12 149.31 50.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.64 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -99.34 171.76 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 0.0 109.411 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.447 HH11 ' HB2' ' A' ' 9' ' ' ARG . 1.8 ptp180 -61.56 -19.53 62.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.641 -0.662 . . . . 0.0 109.806 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.53 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.16 37.0 93.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.447 HD23 ' CG ' ' A' ' 20' ' ' PRO . 5.5 tp -105.58 167.81 9.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.528 -0.983 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' A' ' 126' ' ' THR . 2.6 pp -144.92 -26.19 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.487 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -170.59 -170.97 35.48 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -172.65 120.28 0.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.575 -0.956 . . . . 0.0 109.442 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.92 33.42 21.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.506 -0.746 . . . . 0.0 109.706 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.98 3.68 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -77.24 178.27 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.506 -0.996 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.626 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.7 mt -83.7 155.5 65.21 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.447 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.6 Cg_endo -80.16 -30.92 1.92 Allowed 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 124.993 3.795 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.626 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 31.7 p90 -105.76 168.11 9.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.545 -0.722 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -115.19 107.61 15.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.675 . . . . 0.0 109.376 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.77 HD23 ' HB2' ' A' ' 26' ' ' ASP . 13.0 tp -129.31 80.49 72.18 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.578 -0.701 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.29 -40.05 16.46 Favored 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 125.162 3.908 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.67 -49.77 73.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.55 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.77 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.3 t0 -63.04 -31.35 72.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.32 -24.73 61.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -86.74 -23.83 25.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.505 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.0 t80 -75.02 -24.63 58.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.507 ' O ' HG23 ' A' ' 34' ' ' THR . 53.4 t80 -63.24 -44.98 93.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.576 -0.703 . . . . 0.0 109.472 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -63.6 -26.15 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.566 -0.709 . . . . 0.0 109.463 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.56 -28.34 33.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.548 -0.72 . . . . 0.0 109.419 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 17.3 mm100 -103.06 34.12 3.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 30' ' ' PHE . 22.1 p -140.59 -34.73 0.51 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.2 m -77.29 131.16 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.419 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.07 7.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -111.37 167.6 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.603 -0.939 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.501 HG23 ' HB ' ' A' ' 58' ' ' THR . 58.8 mt -85.12 126.03 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 109.431 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.443 ' CE ' HD12 ' A' ' 54' ' ' LEU . 41.6 ttp -92.12 107.66 19.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.49 122.04 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.56 163.13 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.95 -164.28 39.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 23.6 ptt180 -82.28 -38.64 24.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.987 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.44 -33.33 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.623 -0.673 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -79.42 -27.55 41.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 109.459 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -65.51 -58.35 6.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.02 -26.71 68.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -62.7 -21.85 66.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.722 . . . . 0.0 109.694 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -62.77 161.1 31.18 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.523 -0.736 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.17 -71.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 125.119 3.879 . . . . 0.0 109.901 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -115.77 75.74 0.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -78.39 156.48 78.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.04 166.86 75.92 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.423 1.223 . . . . 0.0 109.994 0.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.443 HD12 ' CE ' ' A' ' 39' ' ' MET . 53.6 mt -90.09 118.03 68.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.736 . . . . 0.0 109.315 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.65 174.3 12.49 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 124.765 3.644 . . . . 0.0 109.969 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.48 27.03 16.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.63 -0.668 . . . . 0.0 109.641 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -177.41 155.0 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.499 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.501 ' HB ' HG23 ' A' ' 38' ' ' ILE . 9.2 m -76.39 144.7 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -120.48 96.91 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.593 -0.692 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -100.34 151.57 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.69 120.2 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.697 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.506 HD12 HG23 ' A' ' 76' ' ' VAL . 17.0 tp -96.61 117.61 31.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.598 -0.689 . . . . 0.0 109.458 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -151.05 144.14 24.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.569 -0.707 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -103.06 31.14 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -124.24 132.31 53.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.629 -0.669 . . . . 0.0 109.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.2 30.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.39 -30.69 5.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.589 -0.694 . . . . 0.0 109.513 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -66.58 142.56 57.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -137.58 142.45 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.91 117.65 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -84.04 122.1 28.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.716 -0.615 . . . . 0.0 109.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.68 41.59 12.67 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.41 145.4 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.99 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -83.07 97.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.564 -0.71 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.561 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.7 t -76.8 100.35 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.56 -0.713 . . . . 0.0 109.443 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.506 HG23 HD12 ' A' ' 62' ' ' LEU . 27.9 m -91.16 153.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.457 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.561 ' NE2' HG12 ' A' ' 75' ' ' VAL . 88.3 m-70 -135.35 30.34 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.566 -0.708 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -166.88 148.23 6.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.47 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.7 -33.33 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.94 -32.9 72.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.59 -36.07 80.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.65 -0.656 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 76' ' ' VAL . 31.7 t -69.8 -39.78 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.436 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -76.84 -31.43 56.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.643 -0.661 . . . . 0.0 109.52 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.08 78.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -72.98 -33.66 65.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.21 68.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.21 -42.54 83.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.639 -0.663 . . . . 0.0 109.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.18 -27.84 68.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.507 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -119.33 89.93 41.14 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.713 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.63 -22.99 7.44 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 125.112 3.875 . . . . 0.0 109.922 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -68.15 -26.9 66.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.415 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -97.9 179.89 4.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -139.47 165.7 26.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.657 HD23 HG23 ' A' ' 1' ' ' THR . 11.7 tp -96.59 128.75 43.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 t -132.08 133.57 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.542 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.4 mm -104.07 124.46 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.69 -27.96 9.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.22 -179.57 38.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.87 -154.8 19.55 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.317 -1.696 . . . . 0.0 109.554 -0.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.84 -32.27 73.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.937 . . . . 0.0 109.486 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -71.04 -31.83 68.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.99 -36.0 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.542 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.2 m-85 -63.21 -55.63 23.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.582 -0.699 . . . . 0.0 109.554 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -62.55 -21.38 65.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.626 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.93 -36.87 78.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CE1' HG13 ' A' ' 79' ' ' VAL . 69.5 m-85 -113.41 18.7 17.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.609 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -66.98 -23.81 65.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 109.58 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.49 -45.42 59.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.08 38.84 1.12 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.607 -0.683 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.849 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -88.95 151.75 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -132.84 -61.85 0.83 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.515 HG23 HE21 ' A' ' 159' ' ' GLN . 7.6 m -93.55 159.82 15.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.433 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.43 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 34.3 mt -140.17 95.77 2.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.701 ' CB ' HD12 ' A' ' 4' ' ' LEU . 34.4 mt -95.08 103.36 15.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.316 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -109.24 136.18 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.725 . . . . 0.0 109.452 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 m -107.39 102.95 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.388 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.9 146.49 26.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.78 132.1 51.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.623 -0.673 . . . . 0.0 109.272 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.88 -34.17 73.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.613 -0.679 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.86 130.59 27.95 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 t -79.82 139.85 37.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.58 -0.953 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.413 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.3 m-85 -146.78 126.55 13.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.715 . . . . 0.0 109.506 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.05 146.52 26.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.36 -124.01 1.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -145.04 -30.08 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.61 -0.935 . . . . 0.0 109.49 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.423 ' HB ' HD11 ' A' ' 13' ' ' ILE . 4.3 m -100.79 142.45 32.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.705 . . . . 0.0 109.509 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -118.02 176.05 5.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.572 -0.705 . . . . 0.0 109.461 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.428 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.597 -0.689 . . . . 0.0 109.5 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.3 pt -69.37 163.68 56.08 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.562 -0.711 . . . . 0.0 109.516 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.88 102.35 1.45 Allowed 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 125.047 3.831 . . . . 0.0 109.851 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.24 144.74 26.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -81.15 85.62 6.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.692 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -71.74 -14.1 61.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.852 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.05 10.05 1.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.897 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.86 31.73 3.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 0.0 109.417 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.43 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 66.3 m-85 -141.47 174.13 10.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.399 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -147.44 137.35 22.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -71.1 156.56 39.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.746 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.73 -36.02 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.701 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.7 m -148.2 163.63 36.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.8 t -158.86 157.63 31.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -142.92 101.09 3.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.488 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.475 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.7 m -85.52 143.22 28.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.432 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.424 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.9 p -147.18 129.18 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.541 -0.725 . . . . 0.0 109.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -105.25 121.34 43.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.563 -0.711 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.32 -166.21 1.01 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.4 p -70.23 -39.63 74.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.596 -0.69 . . . . 0.0 109.61 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -105.35 137.84 19.38 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.647 -0.658 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -47.98 -45.54 24.66 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 C-N-CA 124.842 3.694 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.98 70.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.689 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.1 mt -81.07 20.83 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.6 m -91.37 137.99 31.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.424 ' NE2' HG11 ' A' ' 144' ' ' VAL . 34.5 p-80 -151.85 169.01 23.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 143' ' ' THR . 23.0 m -142.73 132.51 24.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -89.61 101.0 13.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.5 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 38.2 mt-10 -85.9 128.98 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.602 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.8 t -114.96 112.7 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.534 -0.729 . . . . 0.0 109.51 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 31.2 m95 -109.32 164.06 12.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.515 HE21 HG23 ' A' ' 112' ' ' THR . 57.0 mm-40 -139.92 136.4 33.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.615 -0.678 . . . . 0.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 73.4 tttt . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.518 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 2' ' ' ALA . 14.7 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 1' ' ' THR . . . -135.59 121.24 19.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.815 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -91.62 149.24 21.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 114' ' ' LEU . 11.0 tp -159.79 110.39 1.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.696 . . . . 0.0 109.401 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.43 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -143.77 147.99 34.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.749 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.23 111.88 23.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.538 -0.726 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.451 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.8 pt20 -132.43 149.47 52.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.537 -0.727 . . . . 0.0 109.637 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -100.43 170.44 8.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.684 . . . . 0.0 109.458 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.25 -17.32 52.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.785 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.72 14.4 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 109.846 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.41 36.89 93.76 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.659 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.9 tp -112.23 166.55 11.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.549 -0.971 . . . . 0.0 109.526 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.657 HD11 HG22 ' A' ' 126' ' ' THR . 32.2 pt -139.8 -29.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.496 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -171.73 -168.18 32.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -170.23 119.72 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.636 -0.92 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.95 29.81 19.36 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.566 -0.709 . . . . 0.0 109.742 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.89 -61.69 2.65 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -73.83 169.77 16.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.923 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.697 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 40.3 mt -84.84 155.92 61.3 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.616 -0.677 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.4 Cg_endo -79.52 -28.08 3.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.046 3.831 . . . . 0.0 109.958 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.697 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.1 p90 -106.77 167.67 9.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -118.57 93.53 4.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.557 -0.714 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.793 HD23 ' HB2' ' A' ' 26' ' ' ASP . 18.5 tp -114.97 80.73 6.99 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.27 -38.67 15.19 Favored 'Trans proline' 0 N--CA 1.507 2.273 0 C-N-CA 125.139 3.893 . . . . 0.0 110.25 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.7 -44.25 96.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.698 . . . . 0.0 109.59 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.793 ' HB2' HD23 ' A' ' 23' ' ' LEU . 32.4 t70 -64.24 -41.07 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.741 . . . . 0.0 109.436 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.02 -23.72 67.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -85.0 -29.48 24.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.631 -0.668 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -70.8 -25.75 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.458 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.34 -52.2 59.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.545 -0.722 . . . . 0.0 109.453 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -68.32 2.09 2.51 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.601 -0.687 . . . . 0.0 110.022 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.15 12.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -0.832 . . . . 0.0 109.451 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -114.91 35.09 4.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.568 -0.707 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 p -132.91 -27.53 1.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.741 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.0 m -75.5 127.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.91 23.62 51.88 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.25 164.98 29.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.522 -0.987 . . . . 0.0 109.5 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -91.37 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.462 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.8 ttp -82.92 108.33 16.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.54 -0.725 . . . . 0.0 109.559 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.478 HG21 HD11 ' A' ' 94' ' ' LEU . 30.0 t -96.59 118.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.503 -0.748 . . . . 0.0 109.385 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 29.4 m -131.47 166.92 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.41 -160.71 36.59 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.7 -35.54 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.617 -0.931 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -69.5 -37.79 77.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -77.4 -27.23 52.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -65.51 -34.55 78.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -89.61 -24.03 21.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -62.91 -22.18 66.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.735 . . . . 0.0 109.601 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.501 ' HZ ' HG11 ' A' ' 41' ' ' VAL . 39.4 m-85 -62.73 159.8 41.23 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -72.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.093 3.862 . . . . 0.0 109.89 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.3 pttm -108.07 74.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.423 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -78.73 156.03 77.89 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.489 -0.757 . . . . 0.0 109.528 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.18 171.09 63.39 Favored 'Cis proline' 0 N--CA 1.507 2.317 0 O-C-N 123.407 1.214 . . . . 0.0 109.957 0.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.462 HD12 ' CE ' ' A' ' 39' ' ' MET . 67.4 mt -94.58 115.39 65.25 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.55 -0.719 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.0 -178.28 4.53 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.808 3.672 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 60.65 28.21 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -176.68 179.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.5 m -112.42 111.17 21.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.607 -0.683 . . . . 0.0 109.487 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.491 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -86.0 107.83 17.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.488 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 t -102.3 112.66 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.588 -0.695 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.4 t -95.71 125.16 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.453 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.537 HD12 HG23 ' A' ' 76' ' ' VAL . 14.4 tp -104.56 114.79 29.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.42 140.89 33.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -89.16 30.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -137.65 125.05 21.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.7 29.83 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.03 -37.46 6.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.601 -0.687 . . . . 0.0 109.55 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -70.83 143.7 51.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 109.518 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.75 101.45 3.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.61 118.57 28.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.439 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -73.83 136.38 43.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.546 -0.722 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 37.43 57.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.99 145.93 18.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.973 . . . . 0.0 109.515 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.78 98.91 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 0.0 109.501 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.607 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.3 t -80.42 99.41 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.537 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -99.97 158.57 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.61 -0.681 . . . . 0.0 109.433 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.607 ' NE2' HG12 ' A' ' 75' ' ' VAL . 81.0 m-70 -138.8 29.82 2.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.548 -0.72 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -167.85 148.75 5.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.6 t -68.06 -31.69 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.612 -0.68 . . . . 0.0 109.475 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.53 -33.68 76.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.5 -0.75 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.41 75.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.683 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 t -67.81 -43.92 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -73.19 -30.13 63.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.486 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.68 83.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.597 -0.689 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -71.51 -34.02 69.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.5 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.0 -30.82 69.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.602 -0.686 . . . . 0.0 109.405 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -67.19 -34.63 77.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.534 -0.728 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.43 -36.58 76.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -120.92 87.26 42.88 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.45 20.22 0.98 Allowed 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.169 3.912 . . . . 0.0 109.952 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -100.96 -30.12 11.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -94.51 178.23 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.558 -0.713 . . . . 0.0 109.443 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -127.88 151.62 48.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.626 -0.671 . . . . 0.0 109.466 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.478 HD11 HG21 ' A' ' 40' ' ' VAL . 13.1 tp -83.17 108.26 16.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.629 -0.669 . . . . 0.0 109.483 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -113.91 131.42 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.553 -0.717 . . . . 0.0 109.419 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.528 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.9 mm -98.28 125.68 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.707 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.13 -27.52 10.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.503 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 160.85 -179.94 36.0 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.29 -152.26 17.54 Favored Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.315 -1.697 . . . . 0.0 109.585 0.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.4 73.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.582 -0.952 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -70.85 -30.45 66.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.76 -34.89 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.563 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.528 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.1 m-85 -64.39 -56.79 11.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.713 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.463 ' OG1' HD13 ' A' ' 129' ' ' ILE . 2.6 m -62.53 -21.18 65.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.661 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.93 73.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.528 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' CE1' HG13 ' A' ' 79' ' ' VAL . 69.9 m-85 -113.1 17.24 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.526 -0.734 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.64 ' O ' HG12 ' A' ' 110' ' ' VAL . 1.2 pptp? -67.06 -23.17 65.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.521 -0.737 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -66.77 -45.44 78.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.516 -0.74 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.23 44.97 1.0 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.815 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -93.96 147.83 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 0.0 109.442 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -136.94 -68.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -84.65 120.04 25.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 3' ' ' PHE . 19.1 mt -107.7 94.95 5.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.631 -0.668 . . . . 0.0 109.609 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.604 ' CB ' HD12 ' A' ' 4' ' ' LEU . 39.0 mt -91.33 115.51 28.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.645 -0.659 . . . . 0.0 109.343 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.43 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -124.31 138.71 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.705 . . . . 0.0 109.509 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.9 m -109.87 101.4 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.564 -0.71 . . . . 0.0 109.234 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -87.68 139.81 30.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 109.614 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.73 140.15 47.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.331 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.81 -33.27 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.05 139.06 25.45 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.2 m -86.91 143.13 27.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.516 -0.991 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.621 ' O ' HD22 ' A' ' 12' ' ' LEU . 96.2 m-85 -148.45 108.73 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -80.1 147.04 31.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.531 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.659 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -144.46 -126.77 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -141.79 -41.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.949 . . . . 0.0 109.482 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.657 HG22 HD11 ' A' ' 13' ' ' ILE . 6.8 m -90.52 126.98 36.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.509 -0.745 . . . . 0.0 109.435 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -104.53 172.22 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.412 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -91.82 145.09 24.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.462 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.463 HD13 ' OG1' ' A' ' 104' ' ' THR . 24.4 pt -66.79 165.37 26.17 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.519 -0.738 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.52 108.83 2.19 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 125.173 3.915 . . . . 0.0 109.961 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -98.67 145.22 27.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -86.09 87.15 7.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -69.88 -17.25 63.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.82 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.86 -27.19 69.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.477 -0.764 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -93.3 30.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -149.91 164.15 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -139.07 136.18 34.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.698 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -70.12 149.17 47.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.631 -0.668 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.6 -31.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.469 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -143.87 153.3 42.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.522 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.2 p -155.48 113.3 3.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.544 -0.723 . . . . 0.0 109.501 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 tpt85 -91.24 103.31 16.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.482 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.7 m -85.55 141.4 29.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -146.72 129.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.597 -0.69 . . . . 0.0 109.322 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -108.3 120.7 43.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.4 -166.04 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.3 p -71.17 -42.77 68.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.717 . . . . 0.0 109.588 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.18 137.75 19.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.573 -0.705 . . . . 0.0 109.428 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.87 -43.1 30.33 Favored 'Trans proline' 0 N--CA 1.508 2.333 0 C-N-CA 124.781 3.654 . . . . 0.0 110.126 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.48 73.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.565 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 151' ' ' LEU . 47.9 mt -80.91 20.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.629 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.6 m -90.85 141.93 28.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 109.473 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.549 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.5 p-80 -158.12 167.29 30.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.496 -0.752 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.1 m -138.63 141.03 39.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.638 . . . . 0.0 109.417 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.36 97.75 9.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.667 . . . . 0.0 109.467 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.44 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 21.8 mt-10 -81.36 139.46 35.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.578 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -124.97 107.29 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.44 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 31.4 m95 -103.97 165.13 11.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.685 . . . . 0.0 109.454 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -148.87 144.18 26.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.482 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.81 128.59 35.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 109.412 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.808 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -95.8 160.06 14.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.562 -0.711 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.619 HD12 ' CB ' ' A' ' 114' ' ' LEU . 12.1 tp -170.86 108.92 0.32 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.698 . . . . 0.0 109.335 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.433 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.39 151.21 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.31 114.12 26.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.4 pt20 -135.61 150.65 49.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -100.86 170.73 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.526 -0.734 . . . . 0.0 109.366 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -61.17 -17.85 55.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.579 -0.701 . . . . 0.0 109.887 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.72 14.05 0.89 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.501 -0.749 . . . . 0.0 109.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.16 39.01 97.1 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.572 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.0 tp -112.25 163.95 13.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.95 . . . . 0.0 109.515 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.469 HD11 ' CG2' ' A' ' 126' ' ' THR . 2.5 pp -139.75 -27.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.518 -0.738 . . . . 0.0 109.514 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.16 -176.85 40.59 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -166.42 120.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.958 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.88 32.74 21.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -61.73 3.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -76.34 171.3 14.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.96 . . . . 0.0 109.493 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.594 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.1 mt -84.8 155.85 61.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 9.8 Cg_endo -78.9 -26.99 5.0 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 125.069 3.846 . . . . 0.0 109.97 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.594 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.5 p90 -108.37 167.31 10.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -118.83 97.6 5.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 26' ' ' ASP . 21.5 tp -118.63 80.09 16.77 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 109.428 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.28 -37.82 14.3 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 125.193 3.928 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -63.02 -43.51 98.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.505 -0.747 . . . . 0.0 109.503 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.812 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.6 t0 -64.4 -35.0 79.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.396 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.68 -25.3 63.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.67 -0.644 . . . . 0.0 109.516 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -83.8 -28.51 28.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.435 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.441 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.7 t80 -74.01 -25.53 59.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.541 -0.725 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 34' ' ' THR . 53.2 t80 -65.01 -45.82 83.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.452 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.442 ' O ' HG13 ' A' ' 35' ' ' VAL . 41.4 ttp85 -65.69 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.85 56.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 41.5 mm-40 -99.59 32.27 2.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 109.506 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.5 p -139.55 -31.33 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -67.88 129.22 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.456 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.09 56.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -155.35 170.35 22.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.561 -0.964 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' CG2' HG21 ' A' ' 60' ' ' VAL . 58.1 mt -99.62 111.66 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.435 ' CE ' HD12 ' A' ' 54' ' ' LEU . 38.4 ttp -87.05 106.87 18.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.522 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.56 119.46 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.43 160.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.562 -0.711 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.34 -170.2 46.69 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.12 -33.71 59.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.598 -0.943 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -67.67 -47.32 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 109.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -70.1 -26.03 63.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.686 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -63.9 -43.54 95.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.573 -0.704 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.9 -22.96 33.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.531 -0.73 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t -62.97 -23.9 67.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.721 . . . . 0.0 109.621 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.98 160.23 48.93 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.725 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.83 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.124 3.882 . . . . 0.0 109.942 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -105.81 89.59 3.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.377 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -96.78 157.03 35.86 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.593 -0.692 . . . . 0.0 109.507 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.87 142.32 57.68 Favored 'Cis proline' 0 N--CA 1.509 2.4 0 O-C-N 123.325 1.171 . . . . 0.0 109.964 -0.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.435 HD12 ' CE ' ' A' ' 39' ' ' MET . 82.3 mt -61.85 111.17 4.02 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.577 -0.702 . . . . 0.0 109.413 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.43 -178.05 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.732 3.621 . . . . 0.0 109.949 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 60.96 29.21 18.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.588 -0.695 . . . . 0.0 109.56 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -177.24 177.42 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -100.2 119.32 38.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -93.18 104.53 16.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.568 -0.707 . . . . 0.0 109.511 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.445 HG21 ' CG2' ' A' ' 38' ' ' ILE . 30.4 t -105.75 120.81 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.495 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -106.5 127.38 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.731 . . . . 0.0 109.408 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.736 HD12 HG23 ' A' ' 76' ' ' VAL . 17.1 tp -102.34 120.75 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.654 -0.654 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.11 155.41 44.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.396 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -86.24 -61.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.617 -0.677 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.37 145.54 37.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.655 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.38 30.95 0.59 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.72 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.55 -31.3 19.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -69.58 124.75 24.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -104.56 131.56 51.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.66 -0.65 . . . . 0.0 109.374 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.76 112.32 8.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.507 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -90.47 142.93 27.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 34.74 61.03 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.49 141.93 15.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.955 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.11 96.92 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.45 HG12 ' NE2' ' A' ' 77' ' ' HIS . 28.8 t -73.55 96.57 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.481 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 62' ' ' LEU . 28.6 m -91.23 160.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.717 . . . . 0.0 109.471 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.45 ' NE2' HG12 ' A' ' 75' ' ' VAL . 80.1 m-70 -137.53 29.74 2.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.581 -0.699 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.65 146.39 2.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.549 HG13 ' CE2' ' A' ' 106' ' ' PHE . 30.4 t -68.17 -32.92 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -33.83 75.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.485 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.19 -37.35 83.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.498 -0.751 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.456 HG22 HG21 ' A' ' 76' ' ' VAL . 30.9 t -69.03 -38.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.606 -0.684 . . . . 0.0 109.449 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -73.07 -30.75 63.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.74 86.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.61 -32.78 71.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.83 -31.03 68.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -65.64 -40.55 92.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -67.61 -32.13 72.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.546 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.82 89.75 42.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.59 -0.693 . . . . 0.0 109.521 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.08 -21.6 7.89 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 125.12 3.88 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 -26.74 67.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.545 -0.722 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.01 -179.99 5.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.576 -0.703 . . . . 0.0 109.427 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -138.16 144.81 40.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.2 tp -86.07 132.59 34.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -139.29 131.04 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 109.504 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.562 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.6 mm -97.1 125.79 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.01 -25.13 10.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.504 -0.748 . . . . 0.0 109.474 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.29 -176.14 36.12 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.476 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.28 -152.4 9.12 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.259 -1.73 . . . . 0.0 109.546 0.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.84 82.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.946 . . . . 0.0 109.707 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.434 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 13.6 pm0 -66.1 -23.05 66.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.61 -0.681 . . . . 0.0 109.765 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.476 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.5 mm -77.31 -35.42 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.521 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' CE1' HG22 ' A' ' 96' ' ' ILE . 25.5 m-85 -64.0 -50.39 68.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 109.507 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.06 -26.22 68.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.03 83.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.545 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 79' ' ' VAL . 55.3 m-85 -103.02 11.8 36.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.513 -0.742 . . . . 0.0 109.951 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.522 ' O ' HG12 ' A' ' 110' ' ' VAL . 44.9 tttm -71.54 -24.26 61.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.779 . . . . 0.0 109.526 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 -41.54 92.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.722 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -110.77 37.41 2.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.582 -0.699 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.808 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -79.72 151.89 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 0.0 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.2 -68.79 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.66 -0.65 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -88.68 163.03 15.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.459 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.451 HD12 ' CD2' ' A' ' 136' ' ' PHE . 22.0 mt -142.19 89.74 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' CB ' HD12 ' A' ' 4' ' ' LEU . 43.9 mt -89.34 117.02 27.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.272 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.433 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -126.72 137.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.598 -0.689 . . . . 0.0 109.54 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.1 m -107.89 102.44 11.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.281 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -87.46 132.9 33.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.574 -0.704 . . . . 0.0 109.585 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.81 135.53 49.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.05 77.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.712 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 130.11 25.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 p -77.99 143.01 37.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.592 -0.946 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.552 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.3 m-85 -147.99 113.32 5.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.51 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.65 149.63 25.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.532 -0.73 . . . . 0.0 109.442 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.572 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -150.25 -127.86 1.52 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.52 -32.64 0.58 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.633 -0.922 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.469 ' CG2' HD11 ' A' ' 13' ' ' ILE . 2.7 m -93.93 147.44 23.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.698 . . . . 0.0 109.574 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -128.07 173.05 10.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.7 tpt -98.01 151.09 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.496 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.5 pt -72.46 164.61 58.41 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.433 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.07 97.55 1.07 Allowed 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 125.106 3.87 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -88.11 137.71 32.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.708 . . . . 0.0 109.474 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -80.32 85.38 5.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.715 . . . . 0.0 109.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.92 -16.92 63.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.751 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.73 -24.91 67.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.745 . . . . 0.0 109.508 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.67 -29.44 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.451 ' CD2' HD12 ' A' ' 113' ' ' LEU . 91.7 m-85 -87.89 169.56 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.563 -0.711 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.2 m -138.97 134.82 33.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.632 -0.668 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -69.16 148.62 49.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 -34.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.1 p -149.53 157.91 43.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -157.62 122.37 4.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.48 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.29 100.2 11.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 109.479 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.543 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.2 m -82.07 146.48 29.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.699 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.407 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -148.88 131.24 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.625 -0.672 . . . . 0.0 109.315 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.477 ' OE2' HG22 ' A' ' 143' ' ' THR . 5.9 mp0 -111.88 118.4 35.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 0.0 109.49 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.46 -174.25 4.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.551 -0.718 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.5 p -63.31 -44.06 96.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -89.34 156.13 48.55 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.145 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.76 -22.03 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 124.827 3.685 . . . . 0.0 109.943 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.28 -23.39 30.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.548 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -89.28 18.97 4.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.605 -0.684 . . . . 0.0 109.708 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.414 HG23 ' HG3' ' A' ' 145' ' ' GLU . 16.8 m -85.6 141.88 29.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.642 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.9 p-80 -158.48 168.26 27.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.543 HG23 ' HA ' ' A' ' 143' ' ' THR . 20.0 m -136.93 134.84 37.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.638 -0.664 . . . . 0.0 109.39 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.55 91.2 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.579 -0.701 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -71.79 145.28 48.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.685 . . . . 0.0 109.418 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.602 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.0 t -133.56 104.3 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.659 . . . . 0.0 109.497 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.6 m95 -101.34 168.25 9.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -144.78 140.55 28.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.618 -0.676 . . . . 0.0 109.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 109.449 179.954 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.62 103.23 11.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.7 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -72.73 140.65 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.436 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.58 HD12 ' CB ' ' A' ' 114' ' ' LEU . 11.9 tp -154.42 111.87 3.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.305 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -142.79 141.88 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.585 -0.697 . . . . 0.0 109.757 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.21 110.5 21.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.577 -0.702 . . . . 0.0 109.294 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.521 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.3 pt20 -130.26 150.72 51.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.698 . . . . 0.0 109.676 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -98.9 169.66 9.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -60.93 -17.47 51.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.42 0.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.589 -0.694 . . . . 0.0 109.759 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 33.8 87.19 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.9 tp -109.45 164.0 12.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.947 . . . . 0.0 109.537 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 7' ' ' GLN . 31.0 pt -137.94 -30.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.532 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -168.82 -176.96 39.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -162.54 124.59 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.969 . . . . 0.0 109.431 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.89 29.77 19.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 109.694 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.25 -64.13 1.67 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -75.42 -179.51 4.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.581 -0.952 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 55.3 mt -88.74 155.96 50.22 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -80.12 -26.93 3.99 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.994 3.796 . . . . 0.0 109.887 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.593 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.8 p90 -108.09 170.89 7.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.562 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -122.54 100.2 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.673 -0.642 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.778 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.4 tp -121.3 82.47 38.65 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.623 -0.673 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 27' ' ' LEU . 7.9 Cg_exo -45.22 -39.04 15.35 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 125.142 3.894 . . . . 0.0 110.253 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.9 -49.7 73.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.778 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.2 t0 -63.35 -29.52 70.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 24' ' ' PRO . 83.0 mt -72.71 -23.45 60.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.554 -0.716 . . . . 0.0 109.595 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -88.4 -26.38 22.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.447 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 19.8 t80 -70.41 -25.9 63.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.568 -0.707 . . . . 0.0 109.464 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' THR . 60.9 t80 -63.19 -46.82 85.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.595 -0.691 . . . . 0.0 109.456 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 35' ' ' VAL . 53.4 ttt-85 -63.51 -29.87 71.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.707 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.54 -30.24 57.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.516 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 20.6 mm100 -99.18 33.74 2.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' PHE . 19.9 p -142.65 -32.49 0.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.426 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.5 m -69.98 126.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.69 . . . . 0.0 109.502 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.32 34.53 25.83 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -155.84 171.35 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.949 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.68 98.53 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.597 -0.689 . . . . 0.0 109.419 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.708 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.2 tmm? -70.03 132.23 45.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 t -137.2 118.91 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.581 -0.699 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.708 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.8 m -133.82 179.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 109.474 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.38 -168.34 41.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -80.69 -39.59 26.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -73.86 -32.31 63.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -76.23 -30.48 57.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 52' ' ' ARG . 27.9 t80 -64.27 -58.4 6.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.511 -0.743 . . . . 0.0 109.428 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -64.52 -15.65 61.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.535 -0.728 . . . . 0.0 109.793 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -62.4 -28.73 69.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.775 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -66.61 162.69 48.47 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.72 -69.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 125.129 3.886 . . . . 0.0 109.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -104.86 143.41 33.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.472 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HD2' ' CE2' ' A' ' 46' ' ' TYR . 21.3 mtm105 -144.82 161.96 40.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.73 148.54 76.11 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.449 1.236 . . . . 0.0 109.894 -0.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.516 HD12 ' CE ' ' A' ' 39' ' ' MET . 75.0 mt -62.17 111.33 4.41 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.559 -0.713 . . . . 0.0 109.444 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.62 174.03 12.29 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.873 3.715 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 61.73 24.87 14.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.543 -0.723 . . . . 0.0 109.606 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -177.18 148.45 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.688 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -79.21 126.27 30.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.499 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.495 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.4 m-80 -100.2 117.61 34.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.54 -0.725 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -114.31 146.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.621 -0.675 . . . . 0.0 109.45 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.38 118.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.493 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 76' ' ' VAL . 12.5 tp -97.56 107.03 19.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.72 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.401 HG23 ' CE1' ' A' ' 77' ' ' HIS . 4.0 t -137.71 155.59 48.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.686 . . . . 0.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -98.41 -30.67 12.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.27 124.46 25.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -84.03 29.9 0.54 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.618 -0.676 . . . . 0.0 109.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -102.4 -34.79 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -71.96 140.45 49.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -144.18 104.19 4.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.476 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.82 118.37 27.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -79.24 123.88 27.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.549 -0.72 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.5 37.44 10.75 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.4 144.95 19.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 109.534 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.74 93.23 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.509 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.9 t -77.11 102.11 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.524 HG21 HG22 ' A' ' 82' ' ' VAL . 27.9 m -97.68 155.05 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.509 ' NE2' HG12 ' A' ' 75' ' ' VAL . 61.6 m-70 -135.01 29.33 3.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.63 -0.669 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -159.77 141.65 13.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.627 -0.671 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.8 t -67.6 -34.31 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.544 -0.723 . . . . 0.0 109.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.83 67.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.58 80.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.592 -0.693 . . . . 0.0 109.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -68.15 -40.23 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.66 -31.91 65.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.721 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.46 -34.9 78.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.66 -0.65 . . . . 0.0 109.565 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -69.48 -35.21 75.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 109.488 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -68.27 -34.54 76.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.706 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -69.63 -32.4 71.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -120.6 87.95 42.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.685 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.39 20.1 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 125.116 3.878 . . . . 0.0 109.939 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.66 -30.02 12.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.565 -0.71 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.68 178.41 4.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.595 -0.691 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -127.02 155.8 42.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.624 -0.673 . . . . 0.0 109.452 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.8 tp -81.46 123.0 28.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.559 -0.713 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -124.64 120.07 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.429 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.3 mm -97.67 125.25 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.636 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -104.7 -24.82 12.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.17 -175.86 40.2 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.483 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.06 -155.72 22.16 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.283 -1.716 . . . . 0.0 109.588 -0.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.42 75.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.647 -0.914 . . . . 0.0 109.525 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.12 -28.18 62.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.557 -0.715 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.483 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -71.72 -37.61 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.696 . . . . 0.0 109.56 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 96' ' ' ILE . 30.3 m-85 -63.02 -47.57 82.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.607 -0.683 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.5 m -63.07 -24.47 67.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.538 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.77 60.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 79' ' ' VAL . 58.8 m-85 -103.97 21.05 17.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.583 -0.698 . . . . 0.0 109.646 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -23.59 53.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.498 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.82 18.7 0.58 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.499 -0.751 . . . . 0.0 109.745 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -160.08 38.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.416 -0.803 . . . . 0.0 109.419 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.7 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -93.56 152.84 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.87 -45.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 109.396 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.526 HG23 HE21 ' A' ' 159' ' ' GLN . 27.5 m -106.54 122.61 46.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.669 . . . . 0.0 109.326 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.448 HD12 ' CD1' ' A' ' 136' ' ' PHE . 30.8 mt -108.57 101.48 10.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.646 -0.658 . . . . 0.0 109.626 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.58 ' CB ' HD12 ' A' ' 4' ' ' LEU . 43.7 mt -102.47 106.31 17.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -114.3 140.1 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.505 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -110.4 100.97 9.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -84.62 144.3 28.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.566 -0.708 . . . . 0.0 109.58 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -119.65 136.06 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.78 -35.54 77.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.437 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.23 126.79 13.64 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.6 p -79.75 143.2 34.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.569 -0.959 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.613 ' O ' HD22 ' A' ' 12' ' ' LEU . 99.8 m-85 -148.01 112.4 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.602 -0.686 . . . . 0.0 109.43 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.38 149.24 31.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.626 -0.671 . . . . 0.0 109.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.63 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.02 -129.29 1.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.56 -29.03 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.479 HG22 HD11 ' A' ' 13' ' ' ILE . 2.6 m -98.38 145.99 26.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -127.49 170.68 12.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.605 -0.684 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.3 tpt -93.15 151.9 19.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.4 pt -72.45 164.64 58.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.674 . . . . 0.0 109.508 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.03 93.41 1.06 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.168 3.912 . . . . 0.0 109.914 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 71.7 mt -80.51 144.56 32.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -84.82 85.79 7.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.405 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -71.48 -7.84 50.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.57 -31.82 72.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.357 -0.84 . . . . 0.0 109.587 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.63 32.35 2.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.448 ' CD1' HD12 ' A' ' 113' ' ' LEU . 27.6 m-85 -138.9 169.5 17.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.434 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -150.15 147.06 27.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.547 -0.721 . . . . 0.0 109.446 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -86.08 116.41 24.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.41 -35.42 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -149.89 172.95 14.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.67 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t -165.78 123.51 1.5 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.459 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -100.66 105.5 16.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.592 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.5 m -86.87 152.25 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 109.395 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.423 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -154.87 133.06 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.16 123.19 49.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.94 -174.3 5.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.9 p -63.3 -40.55 97.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.634 -0.667 . . . . 0.0 109.451 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -91.97 155.0 43.53 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -77.87 -24.68 8.31 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.887 3.725 . . . . 0.0 109.865 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.63 -23.25 31.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.536 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.0 mt -88.4 20.29 3.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.7 m -82.51 144.68 30.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.367 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.551 ' CE1' HD21 ' A' ' 23' ' ' LEU . 30.1 p-80 -158.54 162.74 37.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.727 . . . . 0.0 109.615 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.3 m -135.46 137.54 42.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.671 -0.643 . . . . 0.0 109.443 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.77 98.45 11.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.509 -0.744 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 1.2 mp0 -80.44 134.28 35.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.448 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.1 t -123.84 99.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.443 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 34.2 m95 -97.5 164.46 12.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.579 -0.701 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.526 HE21 HG23 ' A' ' 112' ' ' THR . 55.1 mm-40 -140.38 145.49 37.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.447 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.5 132.32 29.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.818 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.0 m-85 -97.07 162.56 13.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.653 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.9 tp -171.18 107.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 109.269 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -141.75 147.66 37.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.524 -0.735 . . . . 0.0 109.711 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.84 115.18 26.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.588 -0.695 . . . . 0.0 109.179 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.0 pt20 -136.21 151.99 50.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.685 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -101.74 170.38 8.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.59 -0.694 . . . . 0.0 109.373 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -60.89 -17.48 50.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 109.946 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.94 14.33 0.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.718 . . . . 0.0 109.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.19 36.66 93.3 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.621 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.7 tp -112.26 164.4 13.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.916 . . . . 0.0 109.578 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 7' ' ' GLN . 31.6 pt -138.69 -29.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -169.17 -165.92 27.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -173.8 122.46 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.959 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 57.9 35.01 24.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.624 -0.673 . . . . 0.0 109.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -62.81 3.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -76.17 171.95 13.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.564 -0.962 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.557 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 16.9 mt -86.65 157.89 54.68 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.97 -27.18 3.96 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.03 3.82 . . . . 0.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.557 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.0 p90 -108.37 163.35 13.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.513 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -115.55 89.59 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.8 tp -107.7 79.57 0.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.68 -37.96 16.48 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 125.114 3.876 . . . . 0.0 110.251 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.79 -45.8 90.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.554 -0.716 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.3 t0 -62.71 -38.99 92.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 0.0 109.442 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.82 -24.0 67.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.668 . . . . 0.0 109.468 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -83.7 -27.84 28.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.625 -0.672 . . . . 0.0 109.48 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.0 t80 -76.76 -26.04 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.493 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 34' ' ' THR . 61.1 t80 -67.02 -45.31 77.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.453 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -64.76 -29.43 70.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.74 -28.74 44.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 78.3 mm-40 -101.44 33.5 2.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.506 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.5 p -137.69 -33.76 0.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.73 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.576 -0.703 . . . . 0.0 109.47 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -29.49 12.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 165.17 12.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.545 -0.973 . . . . 0.0 109.495 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.5 mt -80.84 121.85 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.62 -0.675 . . . . 0.0 109.48 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.434 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.8 ttp -90.88 107.33 19.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.602 -0.686 . . . . 0.0 109.517 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 HD21 ' A' ' 94' ' ' LEU . 30.6 t -96.48 124.47 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.62 -0.675 . . . . 0.0 109.468 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.82 166.07 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.02 -169.24 44.47 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -77.7 -34.18 52.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.565 -0.962 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.78 -45.14 72.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.7 m -71.07 -25.94 62.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.695 . . . . 0.0 109.533 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -63.96 -38.73 92.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -87.75 -20.24 26.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.4 m -62.78 -25.58 68.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.621 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -66.58 160.6 66.19 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.62 -0.675 . . . . 0.0 109.412 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.29 -73.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.125 3.883 . . . . 0.0 109.821 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -103.51 92.32 4.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 3.8 ptm180 -99.25 154.53 37.25 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.97 151.07 83.46 Favored 'Cis proline' 0 N--CA 1.51 2.463 0 O-C-N 123.309 1.163 . . . . 0.0 109.952 -0.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.434 HD12 ' CE ' ' A' ' 39' ' ' MET . 77.8 mt -69.25 123.84 89.17 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.653 . . . . 0.0 109.289 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.28 176.85 9.25 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.676 3.584 . . . . 0.0 109.937 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.04 28.66 18.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.585 -0.697 . . . . 0.0 109.729 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.28 170.52 2.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.548 -0.72 . . . . 0.0 109.496 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 m -105.93 118.76 37.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.597 -0.689 . . . . 0.0 109.514 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.468 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -85.73 101.54 12.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -99.22 100.38 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.429 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -86.42 135.99 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.803 HD12 HG23 ' A' ' 76' ' ' VAL . 15.4 tp -110.51 113.7 26.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.676 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.59 145.53 36.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.641 -0.662 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.21 -26.87 14.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -70.43 136.9 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.654 -0.654 . . . . 0.0 109.44 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.1 29.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.728 . . . . 0.0 109.508 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -111.44 -28.81 8.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.592 -0.693 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.34 140.87 58.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.536 -0.727 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -140.86 104.55 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -97.51 126.06 42.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 0.0 109.549 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -92.03 131.93 36.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.11 39.89 62.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.52 141.58 17.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.627 -0.926 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.7 95.62 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.611 -0.681 . . . . 0.0 109.448 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 70' ' ' ALA . 30.8 t -81.47 98.39 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 62' ' ' LEU . 27.9 m -92.76 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.653 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -140.73 30.68 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -169.14 142.74 2.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 106' ' ' PHE . 30.4 t -67.06 -35.04 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.18 -31.25 69.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -35.93 80.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 76' ' ' VAL . 30.0 t -68.45 -38.37 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.476 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -69.24 -31.31 69.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.602 -0.686 . . . . 0.0 109.491 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.9 -36.83 83.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.683 -0.636 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -69.58 -31.69 70.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.673 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.23 -27.13 60.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 109.429 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -64.21 -44.31 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.618 -0.676 . . . . 0.0 109.519 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.77 -30.27 70.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.578 -0.701 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -119.16 89.98 40.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.663 -0.648 . . . . 0.0 109.455 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -22.08 7.51 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.118 3.879 . . . . 0.0 109.874 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.67 -27.24 67.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 109.415 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -95.22 -180.0 4.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -138.44 169.3 18.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.532 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 95' ' ' VAL . 4.1 tt -104.02 121.58 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.646 -0.659 . . . . 0.0 109.497 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.472 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.5 t -122.3 133.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.458 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.567 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.3 mm -102.24 120.68 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.56 -25.45 10.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.675 . . . . 0.0 109.489 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.64 -178.37 38.42 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.412 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.83 -153.21 18.79 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.223 -1.751 . . . . 0.0 109.565 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.51 73.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.949 . . . . 0.0 109.502 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.36 -27.71 60.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.412 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.9 mm -76.07 -34.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.713 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.567 ' CE1' HG22 ' A' ' 96' ' ' ILE . 21.3 m-85 -63.04 -52.37 63.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.569 HG23 HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -64.9 -23.42 67.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.531 -0.731 . . . . 0.0 109.548 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.57 77.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 79' ' ' VAL . 71.3 m-85 -104.28 14.4 30.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.559 -0.713 . . . . 0.0 109.908 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 110' ' ' VAL . 31.6 ttmt -70.05 -24.68 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.802 . . . . 0.0 109.53 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.37 -44.21 79.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -101.42 38.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.644 -0.66 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.818 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -83.97 147.6 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.688 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.38 -63.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.591 -0.693 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.49 164.12 13.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 41.8 mt -143.15 93.22 2.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.653 ' CB ' HD12 ' A' ' 4' ' ' LEU . 45.1 mt -91.71 114.16 26.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -122.05 138.18 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.551 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.3 m -109.31 98.17 7.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.642 -0.661 . . . . 0.0 109.282 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -84.0 134.11 34.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.95 142.65 36.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.622 -0.674 . . . . 0.0 109.314 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.453 ' HB3' ' OG1' ' A' ' 152' ' ' THR . . . -73.53 -38.76 65.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.505 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.64 136.44 26.07 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.6 p -85.67 145.79 27.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 109.476 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.426 ' O ' HD22 ' A' ' 12' ' ' LEU . 99.4 m-85 -147.82 122.69 9.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.584 -0.698 . . . . 0.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 123' ' ' GLU . 10.4 pt-20 -81.68 161.2 23.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.608 -0.683 . . . . 0.0 109.519 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.621 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -162.79 -134.87 1.71 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -142.1 -34.58 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.984 . . . . 0.0 109.449 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.489 HG22 HD11 ' A' ' 13' ' ' ILE . 4.1 m -95.82 143.08 27.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -122.26 173.68 7.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.605 -0.684 . . . . 0.0 109.403 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -93.3 152.02 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.536 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.569 HD13 HG23 ' A' ' 104' ' ' THR . 30.6 pt -73.58 164.06 63.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.627 -0.671 . . . . 0.0 109.511 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.11 99.53 1.19 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.137 3.891 . . . . 0.0 109.878 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.42 144.52 27.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.63 -0.669 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.5 83.21 3.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -71.89 -18.58 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.654 . . . . 0.0 109.693 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.04 10.07 1.34 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.488 -0.758 . . . . 0.0 110.017 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -123.93 -31.75 3.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.498 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.524 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 86.1 m-85 -81.27 173.59 12.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.541 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.5 m -142.34 121.06 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.622 -0.674 . . . . 0.0 109.514 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -66.75 154.74 39.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.566 -0.709 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.5 -34.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 0.0 109.481 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.8 t -148.94 165.97 29.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 109.479 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 t -158.76 119.86 3.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.7 ttt-85 -93.14 108.65 20.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.529 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.6 m -90.76 143.07 27.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -144.88 134.61 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.462 ' HA ' HG22 ' A' ' 152' ' ' THR . 44.2 mt-10 -112.52 120.06 40.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.591 -0.693 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -81.49 -173.19 4.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.71 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.0 p -63.29 -41.37 98.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.584 -0.698 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.23 154.96 44.84 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.576 -0.703 . . . . 0.0 109.23 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.52 -25.79 7.79 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.819 3.679 . . . . 0.0 109.844 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -22.81 31.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -87.39 18.92 3.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 145' ' ' GLU . 7.3 p -85.23 146.62 26.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.403 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.501 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.8 p-80 -159.13 171.56 19.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.644 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.529 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.7 m -140.76 133.43 28.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.686 -0.634 . . . . 0.0 109.371 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -89.6 97.4 11.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.13 143.7 37.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.429 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.551 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.7 t -128.49 104.81 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 109.532 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.414 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 28.3 m95 -102.79 166.72 10.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -144.42 138.5 27.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.616 -0.677 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.5 tttt . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.14 122.17 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.55 -0.719 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.792 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -93.75 151.72 19.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.641 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.3 tp -163.15 110.92 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.592 -0.693 . . . . 0.0 109.331 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -141.85 140.01 32.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.517 -0.739 . . . . 0.0 109.743 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.94 109.4 20.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.409 ' HB3' HG22 ' A' ' 13' ' ' ILE . 8.0 pt20 -130.0 147.24 51.73 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.678 . . . . 0.0 109.616 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -94.68 170.16 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.617 -0.677 . . . . 0.0 109.43 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -60.84 -18.12 53.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 109.897 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.61 14.92 0.9 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.73 . . . . 0.0 109.801 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.03 36.41 92.84 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.593 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.8 tp -108.83 167.6 9.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.966 . . . . 0.0 109.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 126' ' ' THR . 30.3 pt -142.65 -30.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.25 -169.44 22.6 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -175.21 116.22 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.614 -0.933 . . . . 0.0 109.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.94 35.62 21.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.478 -0.764 . . . . 0.0 109.699 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.68 -61.11 4.42 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -79.18 170.95 15.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.525 -0.985 . . . . 0.0 109.471 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.552 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 35.4 mt -80.37 156.55 73.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.432 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -80.25 -27.44 3.59 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.061 3.84 . . . . 0.0 109.945 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.552 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 33.0 p90 -108.82 163.61 13.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 0.0 109.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -116.25 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.1 tp -107.29 80.44 0.87 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.601 -0.687 . . . . 0.0 109.47 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -45.76 -37.53 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 125.061 3.841 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.7 -45.91 90.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.786 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.0 t0 -62.85 -37.28 86.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.642 -0.661 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.22 -24.21 67.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.51 -0.744 . . . . 0.0 109.506 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -85.3 -28.93 24.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 25.9 t80 -74.87 -26.72 59.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.478 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.493 ' O ' HG23 ' A' ' 34' ' ' THR . 53.1 t80 -66.63 -45.1 80.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -65.93 -31.66 72.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.71 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.35 59.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.481 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 64.8 mm-40 -96.26 31.35 2.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.542 -0.724 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 30' ' ' PHE . 10.4 p -136.84 -35.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 129.63 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.671 . . . . 0.0 109.501 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.78 -27.56 18.4 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER -110.6 178.94 4.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.458 HG23 ' HB ' ' A' ' 58' ' ' THR . 58.1 mt -98.05 122.84 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.522 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.501 ' CE ' HD12 ' A' ' 54' ' ' LEU . 56.7 ttp -88.54 102.25 14.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.54 -0.725 . . . . 0.0 109.456 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.523 HG21 HD11 ' A' ' 94' ' ' LEU . 30.3 t -94.78 115.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.498 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.0 m -139.82 166.35 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.493 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.53 -170.18 46.65 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -79.64 -33.16 41.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.976 . . . . 0.0 109.5 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -71.63 -33.91 69.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.1 m -81.14 -30.84 34.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -66.99 -29.24 69.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.445 -0.785 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.89 -18.23 24.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.7 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.4 p -62.46 -24.38 67.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.645 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -65.21 160.77 54.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.69 -68.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.14 3.893 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.85 127.0 51.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtp-105 -123.14 157.43 60.92 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.489 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.55 -166.78 5.47 Favored 'Cis proline' 0 N--CA 1.509 2.416 0 O-C-N 123.4 1.211 . . . . 0.0 109.941 -0.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.501 HD12 ' CE ' ' A' ' 39' ' ' MET . 60.1 mt -113.34 96.17 38.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.515 -0.741 . . . . 0.0 109.441 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -72.33 -177.7 2.86 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.656 3.57 . . . . 0.0 109.755 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 61.59 25.49 15.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 109.534 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -176.3 177.32 1.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 38' ' ' ILE . 3.6 m -96.61 130.91 43.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -102.28 100.47 10.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.591 -0.693 . . . . 0.0 109.477 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 t -110.66 107.01 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.738 . . . . 0.0 109.386 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -98.97 136.92 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.632 -0.667 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.669 HD12 HG23 ' A' ' 76' ' ' VAL . 15.6 tp -102.47 125.98 49.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.719 . . . . 0.0 109.43 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -153.18 142.24 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -88.62 -42.22 12.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -71.79 133.28 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -85.93 30.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -101.19 -35.11 9.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -69.18 148.58 49.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.579 -0.7 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -147.18 152.98 39.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.689 . . . . 0.0 109.442 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.78 138.67 41.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.716 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -86.42 121.62 29.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 109.455 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.2 48.43 25.47 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.45 140.44 15.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.914 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -82.18 100.49 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 109.387 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -79.47 98.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.568 -0.708 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.669 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -87.67 164.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.645 -0.659 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -138.09 29.99 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -171.94 143.22 1.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.427 HG13 ' CZ ' ' A' ' 106' ' ' PHE . 30.5 t -66.82 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.551 -0.718 . . . . 0.0 109.418 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.53 76.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 109.48 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.32 77.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -67.99 -37.47 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -74.6 -30.42 61.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.546 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.32 90.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.49 -33.34 72.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.3 62.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.0 109.592 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -64.61 -46.23 83.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -65.0 -26.99 68.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -119.16 90.15 41.07 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.57 -0.707 . . . . 0.0 109.48 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -24.03 6.65 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.122 3.881 . . . . 0.0 109.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.38 -25.35 62.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.623 -0.673 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -96.56 131.8 42.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' H ' ' HG3' ' A' ' 37' ' ' LYS . 6.1 mm-40 -95.67 152.78 18.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.576 -0.702 . . . . 0.0 109.539 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 40' ' ' VAL . 6.8 tp -88.73 137.73 32.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.63 -0.669 . . . . 0.0 109.426 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.3 123.54 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.644 -0.66 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.585 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.2 mm -93.75 119.83 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -101.69 -29.78 11.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.534 -0.729 . . . . 0.0 109.526 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.25 -174.06 40.3 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.94 -154.53 19.11 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.379 -1.659 . . . . 0.0 109.555 0.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.55 -31.41 71.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.649 -0.912 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.79 -28.07 61.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.37 -36.5 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.63 -0.669 . . . . 0.0 109.51 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.585 ' CE1' HG22 ' A' ' 96' ' ' ILE . 27.8 m-85 -63.3 -48.11 79.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.676 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.76 73.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.427 ' CZ ' HG13 ' A' ' 79' ' ' VAL . 17.2 m-85 -102.26 11.81 37.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 109.887 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -67.65 -31.89 72.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.511 -0.743 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -78.86 17.94 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.548 -0.72 . . . . 0.0 109.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -160.08 38.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.792 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -95.37 145.91 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.06 -53.14 1.74 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.578 -0.701 . . . . 0.0 109.357 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -103.37 160.84 14.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.697 . . . . 0.0 109.374 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.488 HD11 ' CE2' ' A' ' 136' ' ' PHE . 30.4 mt -139.45 98.49 3.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.728 . . . . 0.0 109.604 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.618 ' CD2' HG22 ' A' ' 157' ' ' VAL . 41.8 mt -98.49 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.625 -0.672 . . . . 0.0 109.314 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -115.05 136.77 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 0.0 109.518 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -107.7 103.32 12.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.636 -0.665 . . . . 0.0 109.278 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -87.54 143.54 27.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.52 -0.737 . . . . 0.0 109.616 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.39 133.9 55.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.638 -0.663 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.91 78.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.674 . . . . 0.0 109.487 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.29 123.93 9.63 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -76.82 143.93 39.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.633 -0.922 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.525 ' O ' HD22 ' A' ' 12' ' ' LEU . 89.1 m-85 -148.32 117.39 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.53 145.77 27.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.593 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -144.16 -128.3 2.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -140.71 -36.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.542 -0.975 . . . . 0.0 109.56 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.536 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -95.22 142.09 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.576 -0.702 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.12 173.0 7.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.616 -0.677 . . . . 0.0 109.455 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -92.91 153.52 18.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -73.58 163.74 66.19 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.18 96.19 1.02 Allowed 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 125.135 3.89 . . . . 0.0 110.007 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.93 137.0 33.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.495 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -78.73 87.26 4.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.579 -0.701 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -68.39 -16.93 64.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.619 -0.676 . . . . 0.0 109.78 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.55 -26.22 68.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.44 29.78 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 113' ' ' LEU . 45.9 m-85 -142.97 175.35 9.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.598 -0.689 . . . . 0.0 109.455 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.47 135.42 17.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.652 -0.655 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -70.92 158.03 37.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.675 -0.64 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.15 -32.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.726 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.3 p -157.74 155.5 30.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 p -149.51 122.08 8.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -99.16 105.59 17.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.479 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.3 m -84.94 142.78 29.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.56 -0.712 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.456 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -145.14 129.89 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.659 -0.651 . . . . 0.0 109.377 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -105.92 121.07 43.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.433 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -80.32 -165.82 0.93 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.64 -39.42 64.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -101.92 138.05 19.69 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 109.418 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.66 -46.29 24.67 Favored 'Trans proline' 0 N--CA 1.505 2.202 0 C-N-CA 124.748 3.632 . . . . 0.0 110.08 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.59 69.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.518 -0.739 . . . . 0.0 109.668 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.0 18.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.733 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.1 m -87.55 140.0 29.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 109.314 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.581 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.1 p-80 -154.75 162.24 41.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.599 -0.688 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.4 m -134.46 135.51 42.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.705 . . . . 0.0 109.454 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -90.78 93.89 9.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 37.7 mt-10 -76.74 137.8 39.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.585 -0.697 . . . . 0.0 109.473 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.618 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.3 t -124.71 115.74 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.583 -0.698 . . . . 0.0 109.453 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.413 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 33.0 m95 -113.17 170.03 8.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.469 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -148.89 141.06 23.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.577 -0.702 . . . . 0.0 109.394 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.9 tttm . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.48 99.72 7.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.725 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.6 m-85 -76.11 131.43 39.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.504 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.9 tp -147.41 113.67 5.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.347 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.3 p90 -143.38 147.12 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 109.746 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.85 114.18 26.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -133.95 150.2 51.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.491 -0.755 . . . . 0.0 109.636 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -98.63 171.44 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -61.13 -19.85 61.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.803 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.66 15.05 0.88 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 109.754 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.89 38.54 96.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.7 tp -106.14 166.25 10.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.75 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -145.89 -29.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.467 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.11 -176.2 27.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -175.26 115.88 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.547 -0.972 . . . . 0.0 109.514 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.09 21.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.52 -0.737 . . . . 0.0 109.679 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.45 5.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -77.94 176.45 9.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.8 mt -77.05 157.87 80.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.38 -33.79 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 125.089 3.859 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.8 p90 -108.16 -170.59 1.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.688 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -136.53 86.89 2.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 109.446 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.763 HD23 ' HB2' ' A' ' 26' ' ' ASP . 26.6 tp -109.36 82.13 1.97 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -45.31 -38.55 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 125.172 3.915 . . . . 0.0 110.269 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -62.69 -40.19 96.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.538 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.763 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.7 t0 -66.05 -33.19 75.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.693 . . . . 0.0 109.407 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.1 -24.72 63.26 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.66 -29.56 27.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.633 -0.667 . . . . 0.0 109.399 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.32 -25.4 57.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 34' ' ' THR . 53.5 t80 -65.84 -45.74 81.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.656 -0.653 . . . . 0.0 109.449 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -65.28 -30.87 71.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.53 -30.98 57.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.523 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' A' ' 33' ' ' GLN . 6.7 mm-40 -97.82 32.66 2.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.6 p -140.29 -34.1 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.488 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.1 m -70.27 128.19 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.622 -0.673 . . . . 0.0 109.474 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 31.97 27.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -156.54 172.3 18.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.951 . . . . 0.0 109.481 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -90.47 112.81 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.649 -0.657 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.552 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.8 tmm? -81.51 105.01 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 94' ' ' LEU . 29.0 t -113.19 123.77 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.481 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.3 m -137.74 -175.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.435 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.6 -164.89 31.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -82.84 -41.28 19.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.625 -0.926 . . . . 0.0 109.492 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -70.2 -33.15 71.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -76.41 -29.41 57.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -67.12 -35.59 80.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.523 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -83.06 -25.27 32.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.677 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.9 p -62.91 -22.64 66.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.567 -0.708 . . . . 0.0 109.611 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.72 164.2 13.2 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.507 -0.746 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -80.91 -73.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.11 3.874 . . . . 0.0 109.949 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -114.33 103.78 11.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.547 -0.721 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.91 156.63 39.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.696 . . . . 0.0 109.415 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -81.25 169.69 65.48 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.397 1.209 . . . . 0.0 110.004 -0.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 ' CE ' ' A' ' 39' ' ' MET . 55.5 mt -89.76 113.09 55.55 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.36 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.46 -178.87 4.95 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 124.659 3.572 . . . . 0.0 109.918 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 61.54 24.29 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.546 -0.721 . . . . 0.0 109.704 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -176.61 174.41 1.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.573 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -91.64 131.28 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.539 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -98.91 105.22 17.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.8 144.23 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.2 t -134.45 124.12 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 76' ' ' VAL . 18.5 tp -97.79 117.15 31.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.538 -0.726 . . . . 0.0 109.511 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -155.43 137.8 14.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -93.12 29.43 1.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.514 -0.741 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -110.24 123.79 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -86.17 30.13 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.674 -0.641 . . . . 0.0 109.407 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -124.47 -33.39 3.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -69.13 147.29 51.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.61 -0.681 . . . . 0.0 109.508 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -146.14 156.72 43.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.23 132.22 31.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.649 -0.657 . . . . 0.0 109.491 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -87.55 119.42 27.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.21 42.59 18.66 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.41 133.33 8.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.971 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -74.32 103.57 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.634 -0.666 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.59 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.5 t -82.13 103.28 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.578 -0.702 . . . . 0.0 109.441 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -89.98 154.88 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.678 -0.639 . . . . 0.0 109.509 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.59 ' NE2' HG12 ' A' ' 75' ' ' VAL . 49.0 m-70 -136.16 29.52 3.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.451 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.404 ' O ' HG23 ' A' ' 82' ' ' VAL . 19.4 t70 -164.88 149.34 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.607 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.0 -33.41 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.48 70.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.654 . . . . 0.0 109.529 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.42 77.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 76' ' ' VAL . 31.2 t -67.55 -42.77 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 109.503 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.32 -29.27 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.616 -0.677 . . . . 0.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.83 92.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.717 . . . . 0.0 109.478 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -66.44 -42.76 87.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.13 -24.97 65.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.661 . . . . 0.0 109.51 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -41.15 97.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.592 -0.692 . . . . 0.0 109.463 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -69.47 -31.02 69.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -119.24 89.75 40.46 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.606 -0.684 . . . . 0.0 109.489 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.32 -22.71 6.77 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 125.138 3.892 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.84 -25.9 66.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.475 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -92.92 -179.93 5.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -138.76 148.56 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.669 . . . . 0.0 109.487 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 40' ' ' VAL . 12.8 tp -79.24 108.11 12.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.622 -0.673 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.38 112.92 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.631 -0.668 . . . . 0.0 109.464 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.405 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.4 mm -91.97 122.27 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 109.36 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -101.38 -28.87 12.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.529 -0.732 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.13 -175.83 40.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.92 -151.75 12.87 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.362 -1.669 . . . . 0.0 109.613 -0.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.94 -26.22 62.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -74.78 -23.69 58.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -80.32 -38.33 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.483 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CE1' HG22 ' A' ' 96' ' ' ILE . 30.9 m-85 -62.75 -48.5 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 0.0 109.396 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 t -63.6 -33.04 74.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.594 -0.691 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.607 ' CE1' HG13 ' A' ' 79' ' ' VAL . 45.8 m-85 -122.32 21.33 10.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.714 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.4 pttt -63.48 -32.83 74.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.441 -0.787 . . . . 0.0 109.586 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -81.09 31.0 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.725 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -160.08 32.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.733 . . . . 0.0 109.408 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.725 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -99.22 145.63 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.319 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -128.0 -55.83 1.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.583 -0.698 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -103.69 106.86 17.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.377 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.493 HD11 ' CE2' ' A' ' 136' ' ' PHE . 24.5 mt -90.44 100.94 13.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.568 -0.707 . . . . 0.0 109.592 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.603 ' CD2' HG22 ' A' ' 157' ' ' VAL . 42.5 mt -99.23 105.98 18.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.719 . . . . 0.0 109.21 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.43 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -111.32 136.05 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.613 -0.679 . . . . 0.0 109.523 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -108.62 97.49 7.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.652 . . . . 0.0 109.248 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -85.43 139.79 31.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.632 -0.668 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 135.07 54.4 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.84 -33.31 73.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.556 -0.715 . . . . 0.0 109.472 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.88 124.42 14.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.7 t -70.25 140.83 52.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.59 -0.947 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.628 ' O ' HD22 ' A' ' 12' ' ' LEU . 67.3 m-85 -148.38 107.2 3.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.422 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.72 146.33 28.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.63 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -145.02 -123.3 1.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -143.42 -49.87 0.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.975 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.75 HG22 HD11 ' A' ' 13' ' ' ILE . 4.4 m -81.64 141.09 33.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.632 -0.667 . . . . 0.0 109.476 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -118.46 172.94 7.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -94.47 146.97 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.47 164.69 42.01 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.469 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.29 99.96 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.113 3.876 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.39 138.07 32.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -77.74 84.81 4.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -67.23 -17.53 64.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.6 -0.688 . . . . 0.0 109.772 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -26.0 68.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.765 . . . . 0.0 109.519 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.81 30.32 2.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.718 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 113' ' ' LEU . 68.0 m-85 -145.35 177.16 9.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.515 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 m -153.54 131.41 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -72.13 115.82 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 109.475 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.1 -36.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.498 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.2 p -154.79 179.16 9.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.1 t -165.2 159.48 17.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -133.41 100.8 4.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.499 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.0 m -81.75 152.95 26.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.536 -0.727 . . . . 0.0 109.423 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 144' ' ' VAL . 8.8 p -156.17 127.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.309 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.39 121.99 44.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.58 -165.61 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.3 p -72.35 -36.38 68.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.603 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -106.13 137.88 19.52 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.86 -48.19 16.75 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 124.822 3.682 . . . . 0.0 110.076 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.83 69.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.5 mt -80.38 20.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.629 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 m -91.98 136.97 32.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.525 -0.734 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.668 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.6 p-80 -151.93 169.55 22.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.697 . . . . 0.0 109.602 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 143' ' ' THR . 19.1 m -139.76 137.74 35.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.541 -0.724 . . . . 0.0 109.451 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -95.32 94.75 8.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.517 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 23.4 mt-10 -76.24 128.84 35.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.603 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.2 t -112.9 102.91 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.502 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.517 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 42.4 m95 -101.41 163.45 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -140.14 145.96 38.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.4 tttt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.602 -0.686 . . . . 0.0 109.489 179.936 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.92 127.65 34.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.807 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -101.99 137.35 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.66 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.2 tp -149.87 111.69 4.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.602 -0.686 . . . . 0.0 109.331 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.2 p90 -142.04 151.52 42.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.711 . . . . 0.0 109.73 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 112.08 24.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -132.33 150.17 52.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.569 -0.707 . . . . 0.0 109.638 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.46 171.78 7.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -61.37 -18.69 59.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.618 -0.676 . . . . 0.0 109.763 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.37 15.14 0.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.518 -0.739 . . . . 0.0 109.775 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 37.57 94.64 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.528 HD23 ' CG ' ' A' ' 20' ' ' PRO . 7.1 tp -107.39 167.25 10.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.621 -0.929 . . . . 0.0 109.553 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.52 HD11 HG22 ' A' ' 126' ' ' THR . 31.7 pt -141.74 -30.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.575 -0.703 . . . . 0.0 109.519 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.0 28.74 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -173.28 115.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.462 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 33.83 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.466 -0.771 . . . . 0.0 109.723 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 -61.45 3.74 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -74.96 170.61 15.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -1.02 . . . . 0.0 109.455 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.659 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 24.0 mt -79.89 157.21 74.27 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.571 -0.706 . . . . 0.0 109.46 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.528 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.0 Cg_endo -79.91 -30.52 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 125.018 3.812 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.659 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.0 p90 -105.88 -171.38 1.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.547 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -138.42 103.02 4.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.705 -0.622 . . . . 0.0 109.431 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 26' ' ' ASP . 12.8 tp -124.58 81.02 60.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.587 -0.695 . . . . 0.0 109.516 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.23 -39.09 20.74 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 125.117 3.878 . . . . 0.0 110.154 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.98 -52.16 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.614 -0.679 . . . . 0.0 109.525 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.798 ' HB2' HD23 ' A' ' 23' ' ' LEU . 33.0 t70 -62.95 -36.54 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.8 mt -63.75 -24.26 67.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.455 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -85.62 -29.91 23.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 26.9 t80 -65.44 -23.96 67.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 34' ' ' THR . 59.6 t80 -63.15 -46.5 86.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -65.15 -25.33 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.459 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.24 -26.57 39.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 21.8 mm100 -107.47 36.38 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.709 . . . . 0.0 109.475 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' PHE . 15.0 p -138.38 -35.04 0.62 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.482 -0.761 . . . . 0.0 109.487 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.0 m -67.36 126.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.8 38.61 23.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -153.97 168.53 26.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.917 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.5 mt -93.47 104.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.423 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.605 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.8 tmm? -78.87 117.47 20.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 t -125.13 120.19 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.669 -0.644 . . . . 0.0 109.418 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.605 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.1 m -136.08 173.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.81 -167.21 42.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -84.05 -36.36 23.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.485 -1.009 . . . . 0.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -68.16 -31.81 71.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.444 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -82.41 -27.65 31.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -64.93 -35.7 82.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 109.487 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.27 -25.87 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.7 m -67.13 -15.36 63.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.664 -0.648 . . . . 0.0 109.759 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' CE1' HD11 ' A' ' 54' ' ' LEU . 23.7 m-85 -61.77 161.39 21.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 109.576 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 125.101 3.867 . . . . 0.0 109.987 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.6 73.57 0.92 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -72.78 157.36 88.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.58 172.7 55.23 Favored 'Cis proline' 0 N--CA 1.509 2.43 0 O-C-N 123.332 1.175 . . . . 0.0 110.035 0.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.54 HD12 ' CE ' ' A' ' 39' ' ' MET . 39.2 mt -97.8 110.75 56.73 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.589 -0.694 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -76.79 178.11 8.02 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.733 3.622 . . . . 0.0 109.866 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.39 29.59 18.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.58 -0.7 . . . . 0.0 109.68 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.412 HH12 ' N ' ' A' ' 35' ' ' VAL . 1.4 ptp180 -177.1 178.91 1.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 m -105.91 119.38 39.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.489 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -96.16 111.45 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.6 t -112.92 140.73 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 109.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 t -125.26 124.78 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 76' ' ' VAL . 11.3 tp -99.78 109.7 22.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.51 -0.744 . . . . 0.0 109.487 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 t -139.93 142.54 36.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.562 -0.712 . . . . 0.0 109.474 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.515 ' H ' ' CD2' ' A' ' 64' ' ' HIS . 10.6 p80 -93.86 31.6 1.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.665 -0.647 . . . . 0.0 109.568 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.9 128.64 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.584 -0.698 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -88.89 29.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.41 -33.03 6.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -69.63 152.18 45.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -152.3 110.11 3.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.727 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.431 ' H ' HG21 ' A' ' 75' ' ' VAL . . . -98.1 125.18 42.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.618 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -80.57 133.05 35.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.639 -0.663 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.32 37.81 70.87 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.76 133.26 9.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.609 -0.936 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -73.52 99.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.578 -0.701 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.519 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.9 t -79.35 102.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.708 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.498 HG21 HG22 ' A' ' 82' ' ' VAL . 27.5 m -90.12 159.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 0.0 109.455 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.519 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.3 m-70 -139.35 29.98 2.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.44 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -164.26 144.93 8.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 106' ' ' PHE . 29.4 t -68.2 -33.68 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.0 109.511 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.28 70.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 109.49 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.48 81.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.647 -0.658 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -68.42 -35.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.392 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.45 -33.02 62.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.41 70.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -71.31 -37.26 71.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.706 . . . . 0.0 109.419 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.03 -26.27 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.711 . . . . 0.0 109.526 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -70.22 -38.54 75.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.77 -24.68 65.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -115.74 93.42 37.39 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.622 -0.674 . . . . 0.0 109.483 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.99 -19.96 13.43 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 124.838 3.692 . . . . 0.0 109.957 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -81.44 -25.0 36.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.54 -0.725 . . . . 0.0 109.496 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.15 179.99 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.517 -0.739 . . . . 0.0 109.492 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -142.37 148.18 37.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 95' ' ' VAL . 3.1 tt -80.65 123.32 28.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.556 -0.715 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.569 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.3 t -128.59 129.46 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 109.441 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -102.55 129.75 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.55 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -108.57 -24.09 11.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 109.599 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.76 -178.34 40.56 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.481 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.66 -155.22 19.96 Favored Glycine 0 N--CA 1.5 2.92 0 O-C-N 120.321 -1.693 . . . . 0.0 109.518 0.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.93 75.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -72.88 -25.44 61.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.531 -0.731 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.481 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.7 mm -74.61 -36.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.45 -49.9 71.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.511 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.2 t -62.88 -34.82 78.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.534 -0.729 . . . . 0.0 109.595 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.42 76.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.644 -0.66 . . . . 0.0 109.688 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 79' ' ' VAL . 41.8 m-85 -105.47 13.6 29.92 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.532 -0.73 . . . . 0.0 109.847 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -23.57 56.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.478 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -65.01 -22.22 66.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.649 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -130.3 41.43 3.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.53 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.807 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -86.05 156.98 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.416 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -136.54 -69.08 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 m -84.92 159.9 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.612 HD11 ' CE2' ' A' ' 136' ' ' PHE . 26.5 mt -142.01 96.27 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.632 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.66 ' CB ' HD12 ' A' ' 4' ' ' LEU . 51.5 mt -97.82 110.48 23.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.245 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -117.6 141.0 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.625 -0.672 . . . . 0.0 109.537 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -111.12 102.17 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.597 -0.689 . . . . 0.0 109.346 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 118' ' ' LEU . 25.7 mmt180 -85.22 151.28 24.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 117' ' ' ARG . 4.1 mp -128.6 133.81 48.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 109.279 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.51 -30.87 68.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.586 -0.696 . . . . 0.0 109.51 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.02 128.05 11.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.6 p -79.53 141.44 36.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.53 -0.982 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.479 ' O ' HD22 ' A' ' 12' ' ' LEU . 94.6 m-85 -148.63 128.28 13.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.677 . . . . 0.0 109.457 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.8 163.46 14.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -159.83 -138.38 2.44 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.69 10.04 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.96 . . . . 0.0 109.865 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.52 HG22 HD11 ' A' ' 13' ' ' ILE . 3.4 m -147.28 130.39 16.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.386 -0.821 . . . . 0.0 109.5 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -105.88 176.52 5.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.593 -0.692 . . . . 0.0 109.399 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.441 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -93.33 148.31 22.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.473 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.6 pt -66.83 165.57 25.04 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.536 -0.728 . . . . 0.0 109.477 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.18 109.32 2.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.11 3.873 . . . . 0.0 109.994 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.45 139.81 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.565 -0.709 . . . . 0.0 109.501 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 83.57 4.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.52 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.18 -20.02 64.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -62.72 -23.6 67.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.527 -0.733 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -97.78 28.73 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.612 ' CE2' HD11 ' A' ' 113' ' ' LEU . 54.2 m-85 -142.16 174.23 10.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.2 m -149.62 136.41 19.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.554 -0.716 . . . . 0.0 109.526 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -70.39 155.96 39.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.636 -0.665 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.61 -32.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.677 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 t -147.89 146.0 28.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.455 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -144.81 110.42 5.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -95.32 102.68 14.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.423 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.467 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.1 m -86.06 147.14 26.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.541 -0.725 . . . . 0.0 109.466 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.89 133.7 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.299 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.94 123.87 49.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.47 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -80.43 -165.1 0.8 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 p -71.47 -38.56 71.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.649 -0.657 . . . . 0.0 109.58 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -105.03 137.65 19.28 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.06 -46.19 22.98 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 124.815 3.677 . . . . 0.0 110.069 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.15 68.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.612 -0.68 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.55 19.9 0.97 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.704 . . . . 0.0 109.677 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 50.6 m -87.54 140.73 29.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.275 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.613 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.3 p-80 -152.63 167.27 29.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 143' ' ' THR . 20.5 m -140.57 130.52 24.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.594 -0.692 . . . . 0.0 109.434 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.46 93.81 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.54 139.37 38.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.423 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.536 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.6 t -128.81 113.51 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -111.71 166.38 11.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.508 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -142.94 143.06 31.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 41.4 tttt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.531 HG23 HD23 ' A' ' 94' ' ' LEU . 9.3 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.35 103.39 5.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.497 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.745 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.8 m-85 -75.42 141.29 43.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.4 tp -153.42 112.53 3.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 0.0 109.299 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 8.9 p90 -145.38 146.49 31.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.528 -0.733 . . . . 0.0 109.756 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 115.5 29.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 109.323 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.622 ' HB3' HG22 ' A' ' 13' ' ' ILE . 8.1 pt20 -133.86 161.32 35.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -108.72 169.64 8.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.643 -0.661 . . . . 0.0 109.406 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.476 HH11 ' HB2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -60.8 -15.86 34.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.61 -0.681 . . . . 0.0 109.88 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 15.02 0.84 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 109.763 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.59 86.17 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.526 HD21 ' HA3' ' A' ' 124' ' ' GLY . 9.3 tp -117.21 151.55 36.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -120.48 -41.36 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.577 -0.702 . . . . 0.0 109.558 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.665 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -162.87 -170.13 27.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -163.04 124.19 2.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.928 . . . . 0.0 109.454 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.91 32.66 21.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.542 -0.724 . . . . 0.0 109.717 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 -62.5 3.55 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -73.2 173.19 9.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.965 . . . . 0.0 109.499 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.57 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 9.0 mt -93.4 155.54 40.77 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.533 -0.73 . . . . 0.0 109.469 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -79.96 -24.92 5.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 125.045 3.83 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.57 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 30.4 p90 -106.72 163.13 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.624 -0.672 . . . . 0.0 109.574 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -115.55 100.96 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.677 -0.64 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 26' ' ' ASP . 17.6 tp -119.68 80.27 23.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.613 -0.679 . . . . 0.0 109.47 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.91 -37.36 16.87 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 125.133 3.889 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.93 -46.88 85.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.53 -0.731 . . . . 0.0 109.57 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.4 t0 -62.83 -37.61 87.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.59 -23.94 67.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.725 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -86.97 -29.7 21.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.565 -0.709 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.9 t80 -73.36 -24.43 60.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.528 -0.733 . . . . 0.0 109.547 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 34' ' ' THR . 52.6 t80 -63.33 -45.35 91.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttp-105 -64.84 -29.29 70.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.477 -0.764 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.84 -29.09 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 82.3 mm-40 -101.13 34.91 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.704 . . . . 0.0 109.46 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.0 p -141.67 -34.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.508 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 m -68.98 126.82 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.639 -0.663 . . . . 0.0 109.456 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.35 35.14 24.13 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -156.94 166.48 33.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.581 -0.952 . . . . 0.0 109.441 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.3 mt -90.66 103.36 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.546 -0.721 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.678 ' SD ' HG13 ' A' ' 41' ' ' VAL . 9.8 tmm? -71.96 131.48 43.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 94' ' ' LEU . 31.3 t -135.55 116.04 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.678 HG13 ' SD ' ' A' ' 39' ' ' MET . 27.6 m -133.86 -177.57 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.659 -0.65 . . . . 0.0 109.458 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 -174.06 43.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -76.17 -38.33 56.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.936 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -69.07 -41.87 76.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 m -69.97 -26.45 64.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.35 -46.03 85.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.534 -0.728 . . . . 0.0 109.487 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.86 -23.96 36.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.515 -0.741 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -62.83 -21.13 65.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -62.07 161.35 24.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.493 -0.755 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 125.103 3.869 . . . . 0.0 109.886 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -108.55 91.98 3.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.623 -0.673 . . . . 0.0 109.488 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -99.76 157.3 34.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.723 . . . . 0.0 109.458 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.5 159.06 85.8 Favored 'Cis proline' 0 N--CA 1.509 2.386 0 O-C-N 123.384 1.202 . . . . 0.0 109.953 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.98 114.17 46.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.15 179.31 6.57 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.761 3.64 . . . . 0.0 109.947 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 61.05 29.64 19.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.612 -0.68 . . . . 0.0 109.662 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.03 173.55 1.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 m -93.98 118.94 32.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -89.71 99.17 12.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.8 t -107.11 143.35 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.62 125.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.426 HD12 HG23 ' A' ' 76' ' ' VAL . 11.8 tp -95.9 112.46 24.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.615 -0.678 . . . . 0.0 109.541 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -140.26 150.78 44.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.574 -0.704 . . . . 0.0 109.401 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -91.24 -34.14 15.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -76.15 123.73 26.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.611 -0.68 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -83.52 29.59 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -100.46 -34.75 9.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 109.5 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -69.35 136.33 51.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.702 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -141.54 104.52 4.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.728 . . . . 0.0 109.48 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.36 119.71 26.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.551 -0.718 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -70.85 127.25 31.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.41 38.66 24.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.66 146.81 19.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.598 -0.942 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.28 98.03 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.511 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.8 t -77.19 98.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.478 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.51 HG21 HG22 ' A' ' 82' ' ' VAL . 27.2 m -85.13 156.86 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.511 ' NE2' HG12 ' A' ' 75' ' ' VAL . 67.1 m-70 -136.78 30.0 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.507 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -169.8 148.82 3.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.475 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.2 t -68.34 -34.13 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.88 -31.05 67.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.681 . . . . 0.0 109.46 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.22 -37.29 83.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.542 -0.724 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -69.59 -40.7 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 109.379 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -72.54 -29.54 63.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.88 84.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.633 -0.667 . . . . 0.0 109.515 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.28 -40.44 81.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.737 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.71 68.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.39 -36.59 83.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.573 -0.704 . . . . 0.0 109.492 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.9 -27.77 61.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.679 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -119.61 88.05 38.24 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.36 20.21 0.97 Allowed 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.133 3.888 . . . . 0.0 109.967 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -106.86 -31.7 8.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -94.48 178.54 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.556 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -133.03 153.86 51.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.491 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.531 HD23 HG23 ' A' ' 1' ' ' THR . 11.1 tp -84.64 133.63 34.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.712 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.6 t -134.47 114.45 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.48 127.39 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.494 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.645 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.74 -24.51 10.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.579 -0.701 . . . . 0.0 109.517 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.3 -179.67 36.58 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.53 -155.47 20.18 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 120.287 -1.714 . . . . 0.0 109.583 0.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.45 72.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.572 -0.957 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -69.88 -31.09 68.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.511 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.14 -37.7 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.524 -0.735 . . . . 0.0 109.528 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -62.88 -46.1 89.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.557 -0.715 . . . . 0.0 109.483 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.627 HG23 HD13 ' A' ' 129' ' ' ILE . 0.7 OUTLIER -67.96 -21.78 65.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.581 -0.7 . . . . 0.0 109.605 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.87 -37.1 62.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.475 ' CE1' HG13 ' A' ' 79' ' ' VAL . 73.9 m-85 -106.4 14.78 26.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.695 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -29.75 66.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.772 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.2 -27.24 69.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.07 58.86 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.745 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -105.2 151.69 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -135.29 -68.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 127.51 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.643 HD11 ' CE2' ' A' ' 136' ' ' PHE . 37.2 mt -111.7 87.76 2.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.646 ' CB ' HD12 ' A' ' 4' ' ' LEU . 40.6 mt -89.27 121.78 31.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.527 -0.733 . . . . 0.0 109.264 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -134.49 145.09 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.647 -0.658 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -111.39 107.86 17.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.234 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -88.65 128.79 35.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.3 141.2 37.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.84 62.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.1 137.46 24.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -87.4 143.49 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.533 -0.981 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.46 124.42 14.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.638 -0.664 . . . . 0.0 109.419 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.9 140.03 30.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.514 -0.741 . . . . 0.0 109.474 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.526 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -146.04 -131.65 2.3 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -144.11 -27.31 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.961 . . . . 0.0 109.476 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -94.21 118.64 31.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.571 -0.706 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -103.31 166.39 10.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.38 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -92.94 144.36 25.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.634 -0.666 . . . . 0.0 109.411 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.627 HD13 HG23 ' A' ' 104' ' ' THR . 22.1 pt -66.13 164.63 27.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.523 -0.736 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.37 104.34 1.62 Allowed 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 125.109 3.873 . . . . 0.0 109.896 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.76 86.92 6.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 0.0 109.488 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -68.58 -17.76 64.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.648 -0.658 . . . . 0.0 109.707 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.45 -29.48 70.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.586 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.32 29.45 1.68 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.605 -0.684 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.643 ' CE2' HD11 ' A' ' 113' ' ' LEU . 34.0 m-85 -140.61 173.75 11.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.523 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -146.08 135.95 23.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -72.15 156.24 39.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.52 -31.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.619 -0.675 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -147.2 154.09 40.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.561 -0.712 . . . . 0.0 109.383 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -158.03 109.75 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -93.09 107.3 19.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.644 -0.66 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.542 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -85.62 150.08 24.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.488 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 144' ' ' VAL . 8.8 p -152.74 126.27 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.454 ' HA ' HG23 ' A' ' 152' ' ' THR . 28.0 mt-10 -103.6 118.26 36.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.668 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.12 -166.03 0.96 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.7 p -73.68 -43.25 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.695 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -103.1 137.82 19.37 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.318 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -46.38 -42.16 22.64 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 124.878 3.719 . . . . 0.0 110.184 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.16 85.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.3 mt -76.27 12.64 1.13 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.632 -0.667 . . . . 0.0 109.902 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 145' ' ' GLU . 21.2 m -87.14 137.2 32.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.484 -0.76 . . . . 0.0 109.349 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.556 ' CE1' HD21 ' A' ' 23' ' ' LEU . 33.0 p-80 -155.6 175.05 14.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.64 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.542 HG23 ' HA ' ' A' ' 143' ' ' THR . 24.0 m -141.83 137.82 31.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.58 95.71 9.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.679 -0.638 . . . . 0.0 109.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.86 146.41 37.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.619 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.5 t -138.76 102.86 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.694 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 158' ' ' TRP . 27.9 m95 -104.46 162.53 13.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.563 -0.71 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -148.64 143.42 26.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.716 . . . . 0.0 109.462 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.461 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.502 HG23 HD23 ' A' ' 94' ' ' LEU . 4.0 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.76 103.73 5.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.498 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.753 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -78.53 147.53 33.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.631 -0.668 . . . . 0.0 109.43 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.499 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.7 tp -158.84 111.23 2.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.564 -0.71 . . . . 0.0 109.239 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.43 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.2 p90 -142.39 143.95 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.777 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.87 116.16 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.656 . . . . 0.0 109.281 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -135.39 156.31 49.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -104.4 171.14 7.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.419 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.04 -20.16 62.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.852 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.47 14.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.765 . . . . 0.0 109.756 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.86 40.12 98.42 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.5 tp -108.93 162.64 14.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.545 -0.974 . . . . 0.0 109.577 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.722 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -142.85 -29.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.69 . . . . 0.0 109.491 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.89 -175.62 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -174.66 116.33 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.564 -0.962 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.95 34.2 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 0.0 109.662 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -61.42 3.92 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -80.05 -175.95 5.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.622 -0.928 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.539 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 17.9 mt -86.08 156.88 57.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 109.461 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.7 Cg_endo -80.35 -31.15 1.74 Allowed 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 125.049 3.832 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.539 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 29.3 p90 -106.91 170.2 8.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.673 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.5 88.2 2.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.482 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.778 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.3 tp -107.24 80.5 0.86 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.526 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.04 -37.36 17.48 Favored 'Trans proline' 0 N--CA 1.506 2.234 0 C-N-CA 125.056 3.838 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -62.94 -44.89 94.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.778 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -63.03 -38.71 92.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.607 -0.683 . . . . 0.0 109.423 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.89 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -88.3 -28.83 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.695 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -73.02 -25.66 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 34' ' ' THR . 59.2 t80 -64.48 -44.73 90.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' VAL . 32.5 ttp180 -66.7 -26.23 66.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.85 -29.86 50.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.561 -0.712 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.477 ' NE2' HD22 ' A' ' 4' ' ' LEU . 6.8 mt-30 -102.61 36.25 2.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.704 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 30' ' ' PHE . 20.5 p -144.68 -28.96 0.47 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.584 -0.698 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -68.95 128.59 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.17 32.94 46.52 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -156.35 165.26 36.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.939 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.3 107.69 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.392 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.446 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.2 ttp -82.63 104.16 12.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.87 126.84 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.533 -0.729 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.5 m -140.75 164.55 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.662 . . . . 0.0 109.432 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.65 -161.01 36.87 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -84.78 -36.6 21.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.568 -0.96 . . . . 0.0 109.45 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -69.6 -37.25 76.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.525 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -75.9 -29.7 58.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 32.2 t80 -66.8 -33.69 76.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.489 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -82.19 -23.04 35.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -63.14 -27.78 69.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -65.24 163.53 30.95 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.736 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.2 -66.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.175 3.917 . . . . 0.0 109.894 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -121.02 103.19 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.618 -0.676 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -94.07 154.19 40.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.0 109.45 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.69 164.57 78.54 Favored 'Cis proline' 0 N--CA 1.508 2.364 0 O-C-N 123.467 1.246 . . . . 0.0 109.844 -0.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.446 HD12 ' CE ' ' A' ' 39' ' ' MET . 81.3 mt -81.61 128.35 69.7 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.556 -0.715 . . . . 0.0 109.297 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.62 172.09 14.83 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 124.798 3.665 . . . . 0.0 109.965 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 61.37 27.75 17.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.574 -0.704 . . . . 0.0 109.8 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -177.2 178.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -105.27 147.29 28.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.62 -0.675 . . . . 0.0 109.519 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -114.92 97.89 6.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -102.67 101.81 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.58 -0.7 . . . . 0.0 109.489 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 120.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.608 -0.682 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.592 HD12 HG23 ' A' ' 76' ' ' VAL . 15.2 tp -101.51 106.4 17.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.425 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -138.86 151.71 47.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.713 . . . . 0.0 109.519 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 65' ' ' GLN . 9.5 p-80 -97.02 -29.69 13.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.66 -0.65 . . . . 0.0 109.512 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.406 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 11.5 tt0 -72.68 124.25 24.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.624 -0.672 . . . . 0.0 109.458 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -82.8 30.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.722 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -34.85 9.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.736 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.75 143.98 45.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.638 -0.664 . . . . 0.0 109.462 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -145.58 101.92 3.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.627 -0.67 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.19 119.95 30.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.612 -0.68 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -83.0 136.27 34.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.458 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.88 39.07 39.82 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.43 155.8 29.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.965 . . . . 0.0 109.52 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.94 95.75 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.611 -0.681 . . . . 0.0 109.483 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.508 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.1 t -80.28 100.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.541 -0.724 . . . . 0.0 109.437 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.592 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -98.7 160.34 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.663 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.508 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.4 m-70 -139.65 30.76 2.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.628 -0.67 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -165.68 146.91 7.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.566 -0.709 . . . . 0.0 109.436 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.49 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -68.39 -34.1 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.697 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -32.31 72.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.28 -37.05 82.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.602 -0.686 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.496 HG22 HG21 ' A' ' 76' ' ' VAL . 29.9 t -67.68 -38.34 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.39 -32.31 66.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.683 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.37 91.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.497 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -68.26 -36.48 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.574 -0.704 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.46 70.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -66.99 -42.79 84.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.33 5.72 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 109.943 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -144.2 87.87 7.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.492 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.11 -23.6 6.35 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.113 3.876 . . . . 0.0 109.856 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.48 -24.91 61.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -100.67 178.58 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.58 -0.7 . . . . 0.0 109.481 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -136.91 172.98 12.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 1' ' ' THR . 12.4 tp -103.94 130.16 51.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.511 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.63 129.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.549 -0.719 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.581 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -98.53 124.42 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.699 . . . . 0.0 109.425 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.6 -24.24 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.634 -0.666 . . . . 0.0 109.542 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.36 -176.46 37.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.48 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.93 -155.12 14.61 Favored Glycine 0 N--CA 1.5 2.904 0 O-C-N 120.235 -1.744 . . . . 0.0 109.589 0.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.9 76.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.565 -0.962 . . . . 0.0 109.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -73.37 -27.74 61.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.48 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -72.62 -35.61 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.545 -0.722 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.581 ' CE1' HG22 ' A' ' 96' ' ' ILE . 27.2 m-85 -63.8 -51.58 64.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.501 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -62.44 -22.65 66.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.58 -49.85 43.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.545 -0.722 . . . . 0.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 79' ' ' VAL . 70.5 m-85 -93.17 13.93 19.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.528 -0.732 . . . . 0.0 109.906 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -67.22 -23.1 65.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.745 . . . . 0.0 109.591 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.53 14.99 0.87 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.541 -0.724 . . . . 0.0 109.839 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.17 38.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.457 -0.777 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.753 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.44 154.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.52 -0.737 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -138.45 -60.06 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.513 -0.742 . . . . 0.0 109.418 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -97.1 111.39 23.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.434 HD11 ' CE2' ' A' ' 136' ' ' PHE . 21.9 mt -96.13 96.38 8.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.55 -0.719 . . . . 0.0 109.586 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.666 ' CD2' HG22 ' A' ' 157' ' ' VAL . 27.5 mt -93.39 116.46 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.589 -0.694 . . . . 0.0 109.287 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.42 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -124.94 141.45 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.705 . . . . 0.0 109.455 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 m -109.49 100.46 9.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.631 -0.668 . . . . 0.0 109.26 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -83.73 133.78 34.78 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.641 -0.662 . . . . 0.0 109.657 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.16 135.92 50.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.3 -37.03 74.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.562 -0.711 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.63 124.88 16.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.8 p -77.69 148.21 35.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.969 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' O ' HD22 ' A' ' 12' ' ' LEU . 93.7 m-85 -148.27 128.25 13.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -86.12 148.59 25.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -154.28 -137.6 2.47 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -145.31 -33.02 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.652 -0.911 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.722 HG22 HD11 ' A' ' 13' ' ' ILE . 2.6 m -92.07 124.2 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -106.35 168.76 8.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.43 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -90.96 147.77 22.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.2 pt -67.73 165.07 33.98 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.42 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 104.7 1.71 Allowed 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 125.138 3.892 . . . . 0.0 109.978 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.5 mt -94.38 133.52 37.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -77.47 85.24 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.602 -0.686 . . . . 0.0 109.469 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.36 -14.21 62.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.582 -0.698 . . . . 0.0 109.815 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.34 -27.14 68.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.78 30.08 2.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.543 -0.723 . . . . 0.0 109.416 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 113' ' ' LEU . 86.7 m-85 -144.95 172.11 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.665 -0.647 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -146.8 131.81 18.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.607 -0.683 . . . . 0.0 109.49 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -74.01 120.51 19.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.554 -0.716 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.622 HG11 HE21 ' A' ' 159' ' ' GLN . 27.1 m -97.08 -34.29 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.651 -0.656 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.1 p -164.12 163.73 22.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.659 -0.65 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.8 p -150.8 133.94 16.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -99.6 113.67 26.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.692 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.526 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.8 m -90.57 150.74 21.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 109.482 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 144' ' ' VAL . 8.8 p -154.07 128.6 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.379 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -107.32 120.46 42.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.579 -0.7 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -80.43 -165.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.8 p -73.9 -39.29 63.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.593 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.66 137.58 19.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.77 -47.32 18.87 Favored 'Trans proline' 0 N--CA 1.507 2.267 0 C-N-CA 124.744 3.629 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.25 70.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.607 -0.683 . . . . 0.0 109.68 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 151' ' ' LEU . 54.6 mt -79.47 18.42 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 109.66 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.3 m -91.64 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.715 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.535 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.9 p-80 -153.08 168.51 25.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.574 -0.704 . . . . 0.0 109.596 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 143' ' ' THR . 13.5 m -135.54 135.85 40.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.562 -0.711 . . . . 0.0 109.41 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -90.16 97.86 11.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.07 143.42 32.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.53 -0.731 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.666 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.1 t -132.4 107.56 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.424 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 30.2 m95 -105.51 169.28 8.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.622 HE21 HG11 ' A' ' 139' ' ' VAL . 26.5 mt-30 -147.73 145.14 28.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.3 tttt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.715 . . . . 0.0 109.451 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.02 116.4 16.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.747 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.8 m-85 -90.25 157.74 17.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.68 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.677 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.0 tp -169.51 109.65 0.44 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -140.93 140.29 34.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.564 -0.71 . . . . 0.0 109.68 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.11 111.11 22.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.284 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.5 153.31 48.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.16 170.91 7.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -60.54 -20.08 59.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.508 -0.745 . . . . 0.0 109.851 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.37 14.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.491 -0.755 . . . . 0.0 109.784 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.77 38.11 95.41 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.647 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.2 tp -108.82 168.14 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.944 . . . . 0.0 109.549 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 126' ' ' THR . 30.9 pt -144.1 -29.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.722 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.61 -172.38 26.71 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.59 115.53 0.3 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.585 -0.95 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.07 32.19 20.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.569 -0.707 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.1 -61.38 3.33 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -78.78 171.93 14.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.594 -0.945 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.64 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.4 mt -79.7 154.49 75.95 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.554 -0.716 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.75 -29.86 2.62 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.932 3.754 . . . . 0.0 109.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.64 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.2 p90 -106.34 -177.65 3.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.698 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -134.87 97.89 3.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.759 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.0 tp -118.71 80.25 17.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.499 -0.751 . . . . 0.0 109.486 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -45.78 -40.02 19.04 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 C-N-CA 125.13 3.887 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.45 -43.99 97.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 109.624 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.759 ' HB2' HD23 ' A' ' 23' ' ' LEU . 35.8 t70 -66.15 -38.72 88.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.577 -0.702 . . . . 0.0 109.409 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.45 -23.9 67.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.516 -0.74 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -82.3 -29.24 31.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.2 t80 -72.14 -26.92 62.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 109.422 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 34' ' ' THR . 46.8 t80 -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.441 ' HD3' HH12 ' A' ' 57' ' ' ARG . 10.5 tpp85 -63.71 -28.26 69.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.584 -0.697 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.39 -28.13 34.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.9 mm100 -101.57 34.95 2.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.404 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 30' ' ' PHE . 9.6 p -137.66 -34.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 35' ' ' VAL . 27.3 m -80.59 128.59 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.484 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.96 -31.01 9.14 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -113.92 164.15 14.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -79.83 122.03 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.51 -0.744 . . . . 0.0 109.377 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.481 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.3 ttp -91.28 105.63 17.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.442 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG21 HD11 ' A' ' 94' ' ' LEU . 30.4 t -94.26 130.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.433 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.1 m -146.77 164.33 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.6 -0.688 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.82 -163.8 38.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -84.34 -36.37 22.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.974 . . . . 0.0 109.553 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.1 ttp85 -68.08 -37.84 81.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -75.81 -28.93 58.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 0.0 109.501 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -36.43 83.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.66 -26.16 26.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.7 p -63.93 -19.51 65.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.13 161.21 25.4 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.11 -71.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.162 3.908 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -115.21 94.77 4.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.64 -0.662 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -98.0 157.27 34.84 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.78 147.22 73.88 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 O-C-N 123.347 1.183 . . . . 0.0 110.007 0.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.481 HD12 ' CE ' ' A' ' 39' ' ' MET . 74.9 mt -69.62 113.63 18.57 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.353 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.11 179.38 6.5 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.766 3.644 . . . . 0.0 109.899 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 61.28 26.39 16.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.459 -0.776 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.441 HH12 ' HD3' ' A' ' 31' ' ' ARG . 11.6 ptp180 -176.63 176.91 1.48 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.534 -0.729 . . . . 0.0 109.462 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -107.29 121.66 45.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.473 HD21 ' HB2' ' A' ' 54' ' ' LEU . 2.2 m-80 -97.57 111.53 23.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.9 t -107.08 112.48 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.45 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -95.95 128.27 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.674 HD12 HG23 ' A' ' 76' ' ' VAL . 14.4 tp -105.66 119.3 38.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -152.22 133.94 14.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.651 -0.656 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -92.37 30.52 1.47 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.729 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -111.15 130.41 55.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.698 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.04 31.61 0.78 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.683 . . . . 0.0 109.427 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -131.13 -25.81 2.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.671 . . . . 0.0 109.448 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -64.49 145.34 56.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.488 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.22 140.09 35.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.63 -0.669 . . . . 0.0 109.469 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . . . -137.83 122.85 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.66 135.0 33.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.635 -0.666 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.71 36.68 67.01 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.67 138.35 14.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.566 -0.961 . . . . 0.0 109.468 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.4 94.58 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.596 -0.69 . . . . 0.0 109.444 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.648 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.5 t -74.86 100.41 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.556 -0.715 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.674 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -91.82 155.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.565 -0.709 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.648 ' NE2' HG12 ' A' ' 75' ' ' VAL . 49.8 m-70 -136.31 29.96 2.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.97 152.1 2.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.658 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.32 -33.8 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -31.13 69.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.567 -0.708 . . . . 0.0 109.501 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.21 79.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.633 -0.667 . . . . 0.0 109.476 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 76' ' ' VAL . 31.4 t -69.14 -42.56 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -71.23 -29.02 64.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.76 86.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -69.55 -35.96 75.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.31 -26.52 64.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.472 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -64.36 -43.91 93.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.56 -0.712 . . . . 0.0 109.467 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.98 -30.38 69.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.592 -0.692 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -119.71 89.9 42.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.09 -23.21 6.69 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 125.024 3.816 . . . . 0.0 109.96 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -68.75 -25.77 64.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.91 -179.91 5.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -138.15 161.81 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.579 -0.701 . . . . 0.0 109.518 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.433 HD11 HG21 ' A' ' 40' ' ' VAL . 11.8 tp -99.6 133.29 44.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.561 -0.712 . . . . 0.0 109.476 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.0 136.32 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.565 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.7 mm -102.24 120.02 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.452 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -107.25 -26.59 10.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.486 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.26 -176.71 38.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.417 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.41 -153.18 14.12 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 120.361 -1.67 . . . . 0.0 109.604 0.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.24 -32.38 73.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.605 -0.938 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.28 -27.74 60.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.417 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.6 mm -74.88 -34.75 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.565 ' CE1' HG22 ' A' ' 96' ' ' ILE . 23.6 m-85 -63.48 -54.29 38.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.448 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 m -63.16 -24.59 67.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.76 76.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CE1' HG13 ' A' ' 79' ' ' VAL . 49.8 m-85 -106.14 13.13 29.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.581 -0.699 . . . . 0.0 109.84 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -71.32 -25.41 62.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 0.0 109.549 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.93 13.83 0.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.65 -0.657 . . . . 0.0 109.857 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.09 36.83 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.747 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.28 149.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -126.27 -49.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 m -107.49 158.24 17.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.8 mt -137.23 104.84 5.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.677 ' CB ' HD12 ' A' ' 4' ' ' LEU . 44.4 mt -103.55 105.06 15.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.497 -0.752 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.8 p -111.81 136.32 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 109.495 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -108.3 99.85 9.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -83.37 149.04 26.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.637 -0.665 . . . . 0.0 109.5 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.54 132.14 52.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.605 -0.684 . . . . 0.0 109.305 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.22 77.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.555 -0.715 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.85 128.75 17.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 p -83.69 141.94 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.627 -0.925 . . . . 0.0 109.436 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -145.88 126.27 14.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.717 . . . . 0.0 109.39 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -89.16 148.04 23.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 109.508 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.647 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -149.39 -136.03 2.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -138.4 -31.44 0.75 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.92 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.611 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -97.7 143.2 28.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -122.87 176.96 5.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.58 -0.7 . . . . 0.0 109.486 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.8 tpt -97.92 152.56 19.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.556 -0.715 . . . . 0.0 109.468 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.9 pt -72.0 163.41 67.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.677 -0.639 . . . . 0.0 109.525 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.14 96.87 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 125.162 3.908 . . . . 0.0 109.91 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.1 mt -85.96 134.9 33.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.705 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -79.97 86.59 5.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.528 -0.733 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -67.32 -14.84 63.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.562 -0.711 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.26 -27.65 69.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.452 -0.78 . . . . 0.0 109.509 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.65 29.57 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.557 -0.715 . . . . 0.0 109.449 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -142.08 179.79 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.528 -0.732 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 m -153.88 139.45 17.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 0.0 109.487 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -77.85 156.45 30.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.696 . . . . 0.0 109.509 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.09 -32.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -151.65 153.14 33.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.7 p -150.15 122.45 8.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 109.5 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -97.3 98.86 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 0.0 109.472 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.4 m -84.15 139.86 32.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.602 -0.686 . . . . 0.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.42 HG13 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -148.51 136.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.9 123.87 50.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.677 . . . . 0.0 109.419 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -79.96 -165.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.1 p -72.67 -40.79 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.548 -0.72 . . . . 0.0 109.638 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.437 ' HB3' HD12 ' A' ' 151' ' ' LEU . 28.4 t-20 -100.63 138.13 20.04 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.684 . . . . 0.0 109.494 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.52 -46.48 23.58 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 124.717 3.611 . . . . 0.0 109.983 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.69 -27.66 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.733 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 148' ' ' ASN . 28.1 mt -79.98 18.36 0.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.9 m -86.61 143.71 27.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.403 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.563 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.8 p-80 -155.9 163.82 39.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.672 . . . . 0.0 109.547 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 143' ' ' THR . 23.2 m -137.69 134.55 35.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 109.472 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.38 96.39 10.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -81.99 136.66 35.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.54 -0.725 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.643 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.8 t -125.47 109.07 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.0 m95 -103.88 169.26 8.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -143.57 140.61 30.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 48.2 tttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.493 -0.754 . . . . 0.0 109.467 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.86 95.67 3.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.734 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -68.38 134.05 49.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.54 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.9 tp -148.53 113.03 5.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.373 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -143.98 145.47 32.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.499 -0.751 . . . . 0.0 109.711 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.64 107.27 19.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 0.0 109.26 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HB3' HG22 ' A' ' 13' ' ' ILE . 9.3 pt20 -127.1 157.7 38.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.643 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -97.65 170.08 9.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -61.23 -17.54 53.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.67 14.17 0.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.728 . . . . 0.0 109.865 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.11 39.21 97.33 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.496 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.8 tp -126.02 151.51 47.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.624 -0.927 . . . . 0.0 109.413 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 126' ' ' THR . 30.5 pt -111.39 -32.02 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.649 -0.657 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.02 -150.29 18.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -169.99 147.59 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.61 -0.935 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.402 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 0.4 OUTLIER 60.63 8.11 1.62 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.22 -48.77 1.54 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' A' ' 16' ' ' ASP . 22.0 p80 -72.15 165.73 23.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.494 -1.004 . . . . 0.0 109.566 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.728 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 13.6 mt -87.35 147.7 42.8 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.678 . . . . 0.0 109.52 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -82.01 -31.81 0.92 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 124.987 3.791 . . . . 0.0 109.767 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.728 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 26.3 p90 -101.26 157.36 16.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.727 -0.608 . . . . 0.0 109.497 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -106.09 98.13 7.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.5 tp -121.04 79.8 34.06 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.424 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.47 -39.03 16.66 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 125.142 3.894 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.95 -42.55 99.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.692 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.795 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.0 t0 -68.02 -29.78 68.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.567 -0.708 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -84.8 -29.71 25.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 18.2 t80 -71.09 -27.0 63.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 34' ' ' THR . 57.4 t80 -65.17 -45.58 84.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.624 -0.672 . . . . 0.0 109.461 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -66.15 -30.05 70.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.505 -0.747 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.98 -31.53 56.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.2 mm100 -97.07 32.32 2.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.55 -0.719 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.5 p -137.89 -34.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.449 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.9 m -69.25 125.91 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.64 -0.663 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.87 34.89 23.35 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -152.69 174.38 14.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.591 -0.946 . . . . 0.0 109.416 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.77 100.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 109.401 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.675 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.7 tmm? -71.81 131.79 43.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 109.451 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.524 HG21 HD11 ' A' ' 94' ' ' LEU . 30.2 t -135.25 117.98 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.499 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.675 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.7 m -134.43 -173.3 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.524 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.97 -173.89 29.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -76.28 -35.31 58.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.61 -0.935 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -69.71 -39.39 76.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 m -76.33 -27.24 56.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.433 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' CD1' HG22 ' A' ' 61' ' ' VAL . 34.2 t80 -63.34 -39.82 95.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -87.34 -22.93 24.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.632 -0.668 . . . . 0.0 109.594 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 m -62.87 -22.66 66.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -62.1 162.22 19.39 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.542 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -73.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.159 3.906 . . . . 0.0 109.897 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.47 90.42 3.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.439 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt85 -93.66 157.13 38.83 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.644 -0.66 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.8 -174.79 15.18 Favored 'Cis proline' 0 N--CA 1.508 2.353 0 O-C-N 123.447 1.235 . . . . 0.0 110.035 0.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.65 105.99 52.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 109.374 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -75.05 -178.7 4.37 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 124.602 3.534 . . . . 0.0 109.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.55 23.41 13.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -176.27 175.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.435 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -95.84 143.89 26.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.46 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -116.9 117.62 30.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.47 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.07 103.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.403 HG22 ' CD1' ' A' ' 46' ' ' TYR . 30.6 t -91.64 136.45 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.484 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD12 HG23 ' A' ' 76' ' ' VAL . 14.3 tp -104.04 115.22 30.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -143.11 146.92 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.691 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -93.58 -35.16 13.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -73.46 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.639 -0.663 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.16 30.1 0.54 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.71 -35.75 8.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -71.31 139.6 49.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.532 -0.73 . . . . 0.0 109.477 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -142.67 100.13 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.42 117.69 24.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.9 131.63 42.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 38.85 34.6 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.74 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.555 -0.968 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 t -75.09 98.27 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.432 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.2 t -78.84 99.06 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.46 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.602 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -90.11 164.93 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.432 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.9 m-70 -141.46 27.93 1.86 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.44 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -174.9 153.42 1.69 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.68 -30.84 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.641 -0.662 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.99 69.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.649 -0.657 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.49 58.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.517 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -68.18 -46.35 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.493 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -71.72 -28.84 63.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.83 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.644 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -72.44 -33.7 67.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.87 -30.9 68.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -66.84 -40.75 88.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -67.27 -30.3 70.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.469 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -119.84 89.87 42.68 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.22 -22.43 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.196 3.93 . . . . 0.0 109.947 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -66.98 -26.6 66.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.52 -0.738 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -96.22 -179.86 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.514 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -137.53 154.63 49.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.43 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 40' ' ' VAL . 9.1 tp -86.65 141.33 29.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.586 -0.696 . . . . 0.0 109.445 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -146.93 118.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.55 -0.719 . . . . 0.0 109.488 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.7 mm -91.76 125.88 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.465 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.447 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -100.93 -34.93 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.97 -178.45 39.37 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.01 -152.26 16.81 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 120.356 -1.673 . . . . 0.0 109.529 0.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.14 65.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.948 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -69.62 -33.44 72.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -75.3 -38.54 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.537 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 28.9 m-85 -63.08 -51.51 66.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -62.87 -23.98 67.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.603 -0.686 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.18 61.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.567 ' CE1' HG13 ' A' ' 79' ' ' VAL . 57.3 m-85 -111.74 17.36 19.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.695 -0.628 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -27.0 65.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.82 18.69 0.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.55 -0.719 . . . . 0.0 109.703 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.15 36.32 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -91.39 150.76 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.505 -0.747 . . . . 0.0 109.366 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -132.36 -55.97 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.413 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 m -102.06 125.66 48.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.706 . . . . 0.0 109.375 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.476 HD11 ' CE2' ' A' ' 136' ' ' PHE . 31.9 mt -108.71 96.55 6.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.605 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.569 ' CD2' HG22 ' A' ' 157' ' ' VAL . 40.2 mt -95.13 105.7 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 109.298 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -111.85 143.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.631 -0.668 . . . . 0.0 109.505 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.8 m -117.69 99.58 7.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.251 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 mtt85 -85.19 141.67 29.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.01 138.72 49.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.611 -0.681 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.92 72.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.602 -0.686 . . . . 0.0 109.433 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.52 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -75.34 132.48 13.4 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.6 m -85.32 142.52 29.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.966 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -143.13 135.24 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -97.68 155.29 17.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.541 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -159.69 -139.54 2.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.58 -26.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.48 HG22 HD11 ' A' ' 13' ' ' ILE . 18.8 m -97.82 116.83 30.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.488 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -100.77 167.71 10.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.448 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -85.65 149.97 24.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.468 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.39 164.78 58.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.608 -0.683 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 101.79 1.37 Allowed 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 125.104 3.87 . . . . 0.0 109.871 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.19 157.25 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.64 86.55 7.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -73.45 -17.5 61.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.783 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.19 9.88 1.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.541 -0.724 . . . . 0.0 109.848 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -132.34 29.16 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.732 . . . . 0.0 109.392 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.476 ' CE2' HD11 ' A' ' 113' ' ' LEU . 66.2 m-85 -144.33 178.82 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.606 -0.684 . . . . 0.0 109.507 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.4 m -151.69 138.71 19.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.631 -0.668 . . . . 0.0 109.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -79.69 120.59 24.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.45 -32.93 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.549 -0.719 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.8 t -150.73 176.0 11.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -163.48 116.61 1.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 109.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -95.09 108.2 20.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.546 -0.721 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.2 m -92.33 144.58 25.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.44 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -146.83 127.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 152' ' ' THR . 13.1 mp0 -101.89 119.13 38.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 109.422 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.07 -168.66 1.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.59 -0.694 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.3 p -72.18 -43.07 65.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.588 -0.695 . . . . 0.0 109.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -101.77 137.85 19.67 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.41 -48.38 11.76 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 124.996 3.797 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.52 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -62.38 -35.09 78.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.572 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 151' ' ' LEU . 35.2 mt -72.06 6.31 2.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 109.868 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.0 m -80.67 146.19 31.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.36 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.537 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.4 p-80 -160.79 167.87 25.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.569 -0.707 . . . . 0.0 109.55 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 143' ' ' THR . 26.0 m -140.13 139.34 35.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.578 -0.701 . . . . 0.0 109.335 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.52 99.38 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.52 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.9 mt-10 -80.9 130.97 35.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.475 -0.766 . . . . 0.0 109.438 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.569 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -115.16 103.53 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.695 . . . . 0.0 109.45 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.52 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 34.1 m95 -101.01 165.26 11.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.511 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -147.57 145.3 29.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.565 -0.71 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 56.9 tttt . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.519 179.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.474 HG23 HD23 ' A' ' 94' ' ' LEU . 5.8 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.473 ' H ' HG22 ' A' ' 1' ' ' THR . . . -137.5 133.15 34.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.548 -0.72 . . . . 0.0 109.466 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -100.95 160.87 14.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.701 . . . . 0.0 109.437 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.9 tp -169.55 109.06 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.68 . . . . 0.0 109.35 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.3 p90 -140.91 146.66 37.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.4 112.22 24.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.2 pt20 -132.61 149.85 52.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.58 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -99.13 170.8 8.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -61.3 -18.7 59.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.818 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' CG ' ' HG ' ' A' ' 121' ' ' SER . 2.0 m-20 -77.46 15.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.445 -0.784 . . . . 0.0 109.858 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.37 35.32 91.5 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 122' ' ' PHE . 5.9 tp -107.34 167.12 10.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 126' ' ' THR . 31.2 pt -141.86 -30.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.521 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -166.43 -167.41 27.06 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -172.49 121.22 0.42 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.627 -0.925 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 57.99 34.0 23.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.706 . . . . 0.0 109.923 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.92 -63.69 2.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -76.26 177.46 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.54 -0.977 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.584 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 29.4 mt -84.94 156.9 60.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.576 -0.703 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.26 -28.38 3.05 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 125.055 3.836 . . . . 0.0 109.923 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.584 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 33.3 p90 -108.09 176.02 5.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -126.55 98.85 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.693 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 18.8 tp -118.23 80.44 15.69 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 109.51 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -45.88 -37.74 17.21 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 125.051 3.834 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.63 -45.51 92.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.5 t0 -63.09 -39.66 95.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.474 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.77 -23.62 67.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -86.07 -28.54 24.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.365 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.432 ' CZ ' ' NE2' ' A' ' 33' ' ' GLN . 20.6 t80 -71.67 -26.51 62.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.672 . . . . 0.0 109.476 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 34' ' ' THR . 49.6 t80 -65.27 -46.33 80.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.547 -0.72 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -71.09 2.72 4.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.643 . . . . 0.0 109.994 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.02 -33.06 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.831 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.432 ' NE2' ' CZ ' ' A' ' 29' ' ' TYR . 3.5 mp0 -107.99 30.46 6.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.51 HG21 ' CE2' ' A' ' 30' ' ' PHE . 19.0 p -126.63 -30.59 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.483 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.13 134.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.573 -0.704 . . . . 0.0 109.445 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.18 34.29 64.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -156.92 165.78 35.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.954 . . . . 0.0 109.511 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.8 mt -92.51 111.61 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.594 -0.691 . . . . 0.0 109.465 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.0 ttp -87.83 111.7 21.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 94' ' ' LEU . 29.0 t -98.87 122.48 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.42 161.54 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.652 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.81 -177.61 52.03 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -72.35 -38.36 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.457 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.8 mtm-85 -68.23 -34.08 75.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -78.68 -28.82 45.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.579 -0.701 . . . . 0.0 109.459 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 35.7 t80 -68.17 -29.22 68.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.541 -0.725 . . . . 0.0 109.496 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -85.8 -24.62 26.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.537 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p -63.6 -25.34 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.635 -0.666 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -63.98 161.26 40.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.542 -0.724 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.81 -61.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.084 3.856 . . . . 0.0 109.878 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -126.37 77.01 1.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.394 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -79.87 150.73 72.69 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 0.0 109.588 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.41 161.64 87.09 Favored 'Cis proline' 0 N--CA 1.51 2.466 0 O-C-N 123.445 1.234 . . . . 0.0 109.859 0.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.5 mt -78.53 142.93 62.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -80.58 162.62 21.78 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 124.914 3.742 . . . . 0.0 110.037 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.08 28.46 18.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.544 -0.723 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -177.83 146.36 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.555 -0.715 . . . . 0.0 109.629 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.41 ' C ' HD22 ' A' ' 59' ' ' ASN . 3.3 m -78.43 152.42 32.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.589 -0.694 . . . . 0.0 109.455 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.428 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 1.9 m-80 -123.79 97.67 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.695 . . . . 0.0 109.5 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -91.62 149.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -136.03 120.72 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.445 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 76' ' ' VAL . 15.1 tp -96.21 119.52 34.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 109.492 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.37 146.07 36.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -100.57 31.21 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -150.95 137.17 18.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.635 -0.666 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -87.74 32.19 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -95.14 -38.04 10.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.668 -0.645 . . . . 0.0 109.475 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -73.56 158.18 35.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -151.73 101.52 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.45 115.33 27.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.544 -0.722 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -80.36 124.5 28.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.63 -0.669 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.82 40.38 12.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -156.47 153.82 29.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.598 -0.942 . . . . 0.0 109.558 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -86.29 94.29 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.586 -0.696 . . . . 0.0 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.507 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.4 t -75.55 103.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.63 -0.669 . . . . 0.0 109.444 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -96.57 157.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.519 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.507 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.0 m-70 -135.95 30.68 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.482 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -169.98 146.46 3.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.613 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -67.95 -32.37 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.638 -0.664 . . . . 0.0 109.476 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.79 70.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.738 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.46 -35.21 78.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -68.45 -33.31 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.45 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.15 -31.22 39.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.661 -0.649 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.46 67.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.458 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.53 -25.32 22.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.635 -0.665 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.17 -33.18 50.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.83 -31.51 72.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.546 -0.721 . . . . 0.0 109.5 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.36 -26.12 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.674 -0.641 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.37 90.28 42.01 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.465 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.25 -22.46 8.33 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.077 3.852 . . . . 0.0 109.95 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.94 -27.18 65.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -96.99 -179.99 4.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -138.02 150.68 47.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.474 HD23 HG23 ' A' ' 1' ' ' THR . 9.3 tp -88.08 130.2 35.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.6 t -128.83 129.86 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.525 -0.734 . . . . 0.0 109.435 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.543 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.9 mm -96.64 116.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.613 -0.68 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -104.08 -29.97 10.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.66 -175.51 39.06 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.05 -151.86 11.02 Favored Glycine 0 N--CA 1.5 2.902 0 O-C-N 120.298 -1.707 . . . . 0.0 109.567 -0.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.12 -30.64 69.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.606 -0.938 . . . . 0.0 109.483 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.73 -27.56 60.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 0.0 109.425 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -77.26 -33.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.543 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.0 m-85 -63.38 -58.19 7.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.483 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -62.91 -21.92 66.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.596 -0.69 . . . . 0.0 109.617 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.55 -29.13 64.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.613 ' CE1' HG13 ' A' ' 79' ' ' VAL . 54.5 m-85 -117.35 16.55 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.707 . . . . 0.0 109.778 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.642 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -69.43 -23.03 63.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.636 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.05 -39.01 83.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.569 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.8 41.28 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.866 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -91.17 151.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.748 . . . . 0.0 109.315 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -134.57 -66.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.581 -0.699 . . . . 0.0 109.441 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -90.03 161.92 15.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 136' ' ' PHE . 59.3 mt -140.78 96.85 3.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.557 -0.714 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.632 ' CB ' HD12 ' A' ' 4' ' ' LEU . 42.4 mt -95.69 104.44 16.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.322 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.0 p -111.23 137.43 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.2 m -109.19 99.16 8.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.337 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -85.07 139.62 31.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.04 140.05 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.294 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.28 -34.33 68.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.575 -0.703 . . . . 0.0 109.487 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.67 128.77 18.26 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.408 ' HG ' ' CG ' ' A' ' 10' ' ' ASP . 31.2 t -77.35 137.33 38.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.632 -0.923 . . . . 0.0 109.493 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.526 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.8 m-85 -144.09 117.78 9.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.608 -0.683 . . . . 0.0 109.522 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -93.06 145.29 24.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.461 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -142.8 -120.21 1.52 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.06 -36.35 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.674 -0.898 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.677 HG22 HD11 ' A' ' 13' ' ' ILE . 4.8 m -93.14 144.38 25.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.625 -0.672 . . . . 0.0 109.584 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -122.78 176.42 5.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.692 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -91.74 150.95 20.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.695 . . . . 0.0 109.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.9 pt -73.67 165.55 52.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.705 . . . . 0.0 109.456 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.95 92.72 1.09 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.123 3.882 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -77.87 149.73 34.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.595 -0.69 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -81.63 81.83 7.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -70.14 -13.92 62.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 9.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.386 -0.821 . . . . 0.0 109.904 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -136.82 30.26 2.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 113' ' ' LEU . 60.2 m-85 -139.41 177.03 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.711 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -153.69 143.56 21.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.659 -0.651 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -76.22 157.04 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.582 -0.699 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.472 HG11 HE21 ' A' ' 159' ' ' GLN . 28.0 m -148.29 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.502 -0.749 . . . . 0.0 109.443 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 t -147.13 159.52 43.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.632 -0.667 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.9 t -157.12 111.06 2.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.68 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -95.88 106.82 19.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.455 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.0 m -90.19 143.37 26.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -147.29 131.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.405 ' HA ' HG23 ' A' ' 152' ' ' THR . 25.0 mt-10 -109.39 121.85 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.687 . . . . 0.0 109.48 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.33 -171.59 3.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.9 p -63.2 -45.05 93.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.313 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.46 158.91 42.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -78.81 -23.09 8.4 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 124.915 3.743 . . . . 0.0 109.819 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.76 -23.02 29.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.513 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 mt -86.01 16.84 3.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.715 . . . . 0.0 109.817 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 145' ' ' GLU . 15.0 m -82.62 146.25 29.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.49 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.8 p-80 -160.26 166.45 29.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 109.544 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 143' ' ' THR . 19.6 m -138.67 138.65 37.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.586 -0.696 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -93.69 92.19 7.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 39.0 mm-40 -74.43 126.23 30.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -110.89 112.15 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.484 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.532 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 33.4 m95 -109.22 168.34 9.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.472 HE21 HG11 ' A' ' 139' ' ' VAL . 25.8 mt-30 -147.1 141.08 25.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.698 . . . . 0.0 109.452 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.31 113.27 13.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.558 -0.714 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.726 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -86.92 153.39 21.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.511 HD12 ' CB ' ' A' ' 114' ' ' LEU . 16.6 tp -163.28 109.85 1.16 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 0.0 109.359 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.3 p90 -141.2 146.12 36.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.546 -0.721 . . . . 0.0 109.708 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.78 113.04 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.587 -0.696 . . . . 0.0 109.245 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -131.87 152.45 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.543 -0.723 . . . . 0.0 109.66 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -102.97 171.21 7.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 -60.92 -19.45 60.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.554 -0.716 . . . . 0.0 109.808 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.45 14.86 0.88 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.491 -0.756 . . . . 0.0 109.736 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.17 36.89 93.63 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 122' ' ' PHE . 5.6 tp -106.65 167.33 9.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.936 . . . . 0.0 109.473 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.559 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -142.57 -29.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -176.15 -176.56 44.46 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -164.19 124.1 2.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.942 . . . . 0.0 109.53 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 29.18 18.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.517 -0.739 . . . . 0.0 109.754 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -62.42 2.51 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -72.4 -179.78 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.94 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.684 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.7 mt -91.4 157.83 41.76 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.464 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.463 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.34 -30.24 2.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.063 3.842 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.684 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.9 p90 -105.44 -175.45 2.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.585 -0.697 . . . . 0.0 109.527 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -134.28 103.06 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.361 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.767 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.8 tp -124.74 82.39 60.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HA ' HD12 ' A' ' 27' ' ' LEU . 7.6 Cg_exo -45.44 -38.78 16.22 Favored 'Trans proline' 0 N--CA 1.508 2.329 0 C-N-CA 125.066 3.844 . . . . 0.0 110.21 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.79 -47.37 83.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.472 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.767 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.5 t0 -64.47 -28.95 70.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.512 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 24' ' ' PRO . 83.9 mt -72.72 -23.69 60.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -87.18 -27.83 22.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.581 -0.7 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -69.68 -28.44 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 34' ' ' THR . 59.9 t80 -67.59 -45.7 74.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -67.12 -26.25 66.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.65 -0.656 . . . . 0.0 109.46 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.7 -28.07 40.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.549 -0.719 . . . . 0.0 109.462 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -104.72 35.71 2.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 30' ' ' PHE . 13.9 p -139.26 -27.01 0.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.694 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -68.29 124.26 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.64 . . . . 0.0 109.501 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 37.84 61.54 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -146.93 164.12 33.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.529 -0.983 . . . . 0.0 109.534 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.1 103.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.432 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.415 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.3 ttp -86.49 105.17 16.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.64 -0.663 . . . . 0.0 109.481 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 t -94.24 124.54 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.5 166.26 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 109.489 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.31 -164.25 40.08 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -81.85 -37.49 26.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.62 -0.929 . . . . 0.0 109.441 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -66.99 -42.3 85.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.643 -0.66 . . . . 0.0 109.486 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -72.27 -26.11 61.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.612 -0.68 . . . . 0.0 109.456 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -64.32 -41.3 96.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.442 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -85.37 -21.18 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.63 -0.668 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -62.71 -24.26 67.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.739 . . . . 0.0 109.608 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -62.83 161.06 31.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.98 -72.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.194 3.929 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -107.36 94.46 5.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -99.01 157.18 34.55 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.77 153.46 83.03 Favored 'Cis proline' 0 N--CA 1.508 2.35 0 O-C-N 123.37 1.195 . . . . 0.0 109.967 0.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.415 HD12 ' CE ' ' A' ' 39' ' ' MET . 84.7 mt -76.45 114.06 34.78 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.636 -0.665 . . . . 0.0 109.282 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.28 -179.16 5.17 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 124.791 3.66 . . . . 0.0 109.906 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 60.81 32.13 20.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.714 . . . . 0.0 109.666 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -177.11 -171.59 0.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.764 . . . . 0.0 109.544 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -118.06 113.09 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.601 -0.687 . . . . 0.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.435 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -83.49 103.67 13.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 0.0 109.417 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.62 92.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.582 -0.699 . . . . 0.0 109.461 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -79.66 136.86 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.779 HD12 HG23 ' A' ' 76' ' ' VAL . 14.6 tp -108.65 109.75 21.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.677 -0.64 . . . . 0.0 109.499 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -137.51 151.69 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.534 ' H ' ' CD2' ' A' ' 64' ' ' HIS . 9.3 p80 -95.76 -33.9 12.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -77.22 128.81 35.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 13.9 pt-20 -85.16 30.36 0.6 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.714 . . . . 0.0 109.522 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -98.43 -36.37 9.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.692 . . . . 0.0 109.579 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -71.04 146.76 49.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -143.96 103.4 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.33 117.61 26.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -74.62 127.37 32.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.63 -0.669 . . . . 0.0 109.487 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.28 38.06 35.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.8 144.47 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.958 . . . . 0.0 109.417 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -79.69 104.45 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.6 t -85.65 94.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.555 -0.715 . . . . 0.0 109.414 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.779 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -88.6 171.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.451 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -143.95 29.96 1.33 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.493 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -171.22 142.86 1.81 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.559 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.5 t -66.55 -33.64 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.85 74.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.659 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.02 79.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.627 -0.671 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -67.06 -40.25 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.89 -29.55 66.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.42 77.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.665 . . . . 0.0 109.529 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -72.39 -34.14 67.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.513 -0.742 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.79 -30.49 68.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -65.81 -40.4 91.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -65.69 -29.63 70.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.619 -0.676 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -118.99 90.06 40.33 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.01 -23.54 6.52 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.061 3.841 . . . . 0.0 109.828 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.56 -25.31 63.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.676 -0.64 . . . . 0.0 109.495 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 1.4 tp60 -94.6 179.85 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 28.4 mt-10 -136.52 155.61 49.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.598 -0.689 . . . . 0.0 109.468 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -97.4 147.81 23.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.606 -0.684 . . . . 0.0 109.462 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -145.92 139.12 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.585 -0.697 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.541 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.9 mm -105.21 120.55 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.429 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -101.97 -29.1 12.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 109.415 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 156.67 -174.41 34.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.97 -150.14 9.06 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.266 -1.726 . . . . 0.0 109.58 -0.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.17 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.962 . . . . 0.0 109.53 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.51 -28.06 65.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.601 -0.687 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -79.44 -36.12 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.541 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.4 m-85 -63.3 -52.96 59.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.478 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.773 HG23 HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -63.13 -28.04 69.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.61 -0.681 . . . . 0.0 109.535 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.46 79.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.679 . . . . 0.0 109.534 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.61 8.78 41.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.503 -0.748 . . . . 0.0 109.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HE2' HD22 ' A' ' 131' ' ' LEU . 19.9 tptp -66.07 -30.67 71.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.56 14.45 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.0 109.873 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -160.1 37.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.741 . . . . 0.0 109.402 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.726 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -95.77 153.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.596 -0.69 . . . . 0.0 109.442 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -130.94 -52.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -102.29 158.69 16.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.675 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.539 HD11 ' CE2' ' A' ' 136' ' ' PHE . 32.8 mt -139.49 107.7 5.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.539 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.558 ' CD2' HG22 ' A' ' 157' ' ' VAL . 37.8 mt -104.66 102.51 12.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.242 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -108.27 137.92 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.526 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -109.09 99.82 9.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -81.98 147.66 29.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.712 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -126.33 131.92 51.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.554 -0.716 . . . . 0.0 109.277 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.69 71.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.464 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.8 127.47 13.48 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.4 p -79.16 140.66 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.934 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.483 ' O ' HD22 ' A' ' 12' ' ' LEU . 96.1 m-85 -147.95 129.53 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.462 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -99.35 151.03 21.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.535 -0.728 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -147.56 -122.38 1.32 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -146.27 -36.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.599 -0.942 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.559 HG22 HD11 ' A' ' 13' ' ' ILE . 3.2 m -99.42 135.74 40.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.416 ' O ' HD13 ' A' ' 13' ' ' ILE . 52.2 mtpt -110.32 179.95 3.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.435 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.15 144.73 25.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 109.548 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.773 HD13 HG23 ' A' ' 104' ' ' THR . 28.8 pt -67.27 163.5 45.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.632 -0.668 . . . . 0.0 109.534 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.79 94.85 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 125.137 3.891 . . . . 0.0 109.945 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.471 HD22 ' HE2' ' A' ' 107' ' ' LYS . 50.1 mt -77.91 147.29 35.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.523 -0.736 . . . . 0.0 109.388 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -79.67 86.75 5.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -73.94 -11.76 60.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.953 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.01 10.11 1.31 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -138.56 30.73 2.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 113' ' ' LEU . 55.2 m-85 -143.21 176.96 8.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.504 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.3 m -156.69 140.14 15.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HE3' ' CZ2' ' A' ' 158' ' ' TRP . 31.2 ttmt -81.95 120.87 25.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.567 -0.708 . . . . 0.0 109.492 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.02 -35.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.724 . . . . 0.0 109.51 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.4 p -148.64 170.26 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.1 p -157.49 113.64 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.36 104.1 16.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.538 -0.726 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.451 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.3 m -86.02 147.09 26.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.401 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -151.74 132.49 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.586 -0.696 . . . . 0.0 109.38 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -107.6 128.91 54.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.81 -166.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -69.96 -39.0 76.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -105.38 137.7 19.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.42 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -48.53 -43.7 32.44 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 124.775 3.65 . . . . 0.0 110.059 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.88 -29.06 69.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.537 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.7 mt -80.71 21.2 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.6 m -89.06 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.501 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.6 p-80 -153.76 168.23 26.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.451 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.4 m -141.67 128.25 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 109.42 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -84.52 95.83 8.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.493 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 25.7 mt-10 -81.12 130.4 35.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.7 t -117.6 106.06 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.509 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.493 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.5 m95 -100.48 166.81 10.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.721 . . . . 0.0 109.481 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -142.49 147.14 35.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttm . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.695 . . . . 0.0 109.501 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.414 HG23 HD22 ' A' ' 94' ' ' LEU . 6.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.37 20.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.817 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.8 m-85 -87.92 135.03 33.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.587 -0.696 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.603 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.4 tp -150.08 112.91 4.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.722 . . . . 0.0 109.467 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -144.23 138.79 28.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.536 -0.727 . . . . 0.0 109.735 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.84 111.19 22.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 13' ' ' ILE . 2.4 pp0? -129.75 157.64 41.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.515 -0.74 . . . . 0.0 109.68 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -101.32 168.44 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.559 -0.713 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -60.77 -23.88 65.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 109.713 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.71 -1.44 3.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.636 -0.665 . . . . 0.0 109.907 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.75 44.79 19.1 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.633 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.9 tp -124.55 152.32 43.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.562 -0.963 . . . . 0.0 109.53 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.902 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -128.01 -33.87 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.569 -0.707 . . . . 0.0 109.81 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.422 ' H ' HD13 ' A' ' 13' ' ' ILE . . . -146.01 178.84 23.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -172.03 116.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.624 -0.927 . . . . 0.0 109.543 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.86 31.18 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.507 -0.745 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.55 -59.57 4.04 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -81.95 179.99 7.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.598 -0.943 . . . . 0.0 109.503 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.737 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.2 mt -88.57 155.1 51.09 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.0 109.4 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.0 Cg_endo -79.28 -29.46 3.1 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 124.946 3.764 . . . . 0.0 109.892 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.737 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.5 p90 -105.06 167.24 9.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.639 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -123.37 83.77 2.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 109.394 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 26' ' ' ASP . 20.2 tp -106.76 81.4 0.88 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -45.01 -39.06 14.24 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 125.262 3.974 . . . . 0.0 110.22 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.91 -38.33 90.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.446 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.787 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -70.91 -32.32 69.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.528 -0.732 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.3 mt -72.47 -24.23 61.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.737 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -82.15 -30.32 31.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.593 -0.692 . . . . 0.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -70.47 -25.11 63.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.571 -0.705 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 34' ' ' THR . 56.0 t80 -63.39 -45.43 91.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.584 -0.698 . . . . 0.0 109.401 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -64.45 -28.71 69.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -28.71 46.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.527 -0.733 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -101.96 33.65 2.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.541 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 30' ' ' PHE . 18.8 p -140.05 -34.45 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.4 m -68.59 126.04 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.557 -0.714 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.53 36.8 25.45 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -154.49 175.29 13.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.654 -0.909 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 99.97 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.557 -0.714 . . . . 0.0 109.415 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.659 ' SD ' HG13 ' A' ' 41' ' ' VAL . 9.7 tmm? -72.62 125.77 28.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -132.55 118.55 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.659 HG13 ' SD ' ' A' ' 39' ' ' MET . 28.1 m -134.35 -176.17 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.87 -169.39 33.74 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -80.01 -35.69 36.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.929 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -70.22 -40.86 74.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 m -73.1 -26.08 61.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -63.67 -45.09 91.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.629 -0.67 . . . . 0.0 109.502 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -77.48 -23.31 50.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.626 -0.671 . . . . 0.0 109.568 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.9 m -63.05 -24.16 67.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.509 -0.745 . . . . 0.0 109.607 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.43 160.59 58.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.583 -0.698 . . . . 0.0 109.471 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.96 -72.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 125.075 3.85 . . . . 0.0 109.955 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -109.22 94.81 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -99.54 157.26 34.3 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.75 154.09 83.61 Favored 'Cis proline' 0 N--CA 1.509 2.419 0 O-C-N 123.313 1.165 . . . . 0.0 109.923 0.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.438 HD12 ' CE ' ' A' ' 39' ' ' MET . 69.2 mt -73.88 115.61 44.0 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.642 -0.661 . . . . 0.0 109.277 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.96 178.86 7.04 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 124.741 3.627 . . . . 0.0 109.934 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 61.34 29.32 18.52 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.595 -0.69 . . . . 0.0 109.608 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.0 167.61 2.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.702 . . . . 0.0 109.465 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.452 HG21 ' CE1' ' A' ' 85' ' ' TYR . 3.1 m -88.26 117.06 26.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.42 HD21 ' HB2' ' A' ' 54' ' ' LEU . 25.8 m120 -91.85 101.61 14.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 109.462 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.22 145.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -134.93 116.43 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.587 -0.696 . . . . 0.0 109.417 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 82' ' ' VAL . 17.5 tp -96.2 119.54 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.573 -0.705 . . . . 0.0 109.485 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.571 HG23 ' CE1' ' A' ' 77' ' ' HIS . 4.0 t -138.51 152.61 48.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.454 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -93.79 -37.24 11.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.529 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -72.34 133.64 45.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 109.46 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -88.48 29.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -102.6 -38.61 7.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.53 141.41 48.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.681 -0.637 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -149.91 101.52 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.604 -0.685 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.88 115.02 20.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -76.84 135.01 38.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.43 35.09 34.07 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.16 147.81 19.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.553 -0.969 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.66 94.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -96.8 124.4 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 109.426 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 82' ' ' VAL . 27.4 m -134.23 174.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.682 . . . . 0.0 109.514 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.571 ' CE1' HG23 ' A' ' 63' ' ' THR . 47.9 m-70 -138.86 31.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 109.452 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -153.67 143.69 22.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.717 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -66.96 -32.76 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.718 . . . . 0.0 109.442 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.62 -34.15 76.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.715 . . . . 0.0 109.44 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.97 90.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 76' ' ' VAL . 32.9 t -66.83 -39.37 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.63 -28.55 63.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.48 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.18 90.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 0.0 109.533 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CE1' HG21 ' A' ' 58' ' ' THR . 39.0 t80 -69.36 -37.42 77.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.541 -0.725 . . . . 0.0 109.45 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.3 68.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.595 -0.69 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -67.18 -43.74 81.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -65.46 -28.84 69.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -119.42 90.02 41.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.77 -20.59 9.01 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.14 3.893 . . . . 0.0 109.944 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.12 -28.31 69.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.479 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -105.55 165.54 11.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.6 -0.687 . . . . 0.0 109.498 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -122.01 143.66 49.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 95' ' ' VAL . 2.1 tt -67.18 132.93 48.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.636 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.9 t -135.31 120.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.426 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.2 mm -96.09 140.64 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 109.438 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.605 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -114.78 -36.1 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.705 . . . . 0.0 109.546 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.17 179.58 36.89 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 -155.44 28.06 Favored Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.335 -1.685 . . . . 0.0 109.591 0.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' A' ' 129' ' ' ILE . . . -62.78 -23.43 67.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.649 -0.912 . . . . 0.0 109.669 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.05 -38.55 75.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.1 mm -72.14 -39.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.552 -0.718 . . . . 0.0 109.585 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 29.1 m-85 -62.93 -41.69 99.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.552 -0.717 . . . . 0.0 109.415 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.629 HG23 HD13 ' A' ' 129' ' ' ILE . 0.7 OUTLIER -71.74 -19.06 62.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.669 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.15 -25.8 47.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.554 -0.716 . . . . 0.0 109.544 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.717 ' CE1' HG13 ' A' ' 79' ' ' VAL . 82.1 m-85 -124.53 19.85 8.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.584 -0.698 . . . . 0.0 109.748 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -63.41 -29.99 71.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 109.625 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -80.85 26.02 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.617 -0.677 . . . . 0.0 109.73 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -159.99 34.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.817 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -91.68 150.66 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.49 -0.756 . . . . 0.0 109.436 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -132.35 -58.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.683 -0.636 . . . . 0.0 109.307 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -102.22 112.04 24.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.569 -0.707 . . . . 0.0 109.353 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.571 HD11 ' CE2' ' A' ' 136' ' ' PHE . 30.0 mt -94.64 99.26 11.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.637 ' CD2' HG22 ' A' ' 157' ' ' VAL . 20.0 mt -100.63 104.41 15.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.667 . . . . 0.0 109.22 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -112.38 143.65 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.602 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.0 m -113.5 99.98 8.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -83.64 142.12 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.682 . . . . 0.0 109.611 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.1 131.54 56.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.685 . . . . 0.0 109.243 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.47 75.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.41 9.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 p -76.92 142.89 39.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.443 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -147.82 109.44 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.33 153.19 28.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.633 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -151.12 -126.2 1.29 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.55 -46.9 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.907 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.443 HG22 HD11 ' A' ' 13' ' ' ILE . 3.2 m -85.8 139.84 30.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 109.515 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 13' ' ' ILE . 48.3 mttp -116.54 160.72 20.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.634 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.45 ' HG2' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -76.61 147.61 37.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.546 -0.721 . . . . 0.0 109.476 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.645 HG23 ' HB1' ' A' ' 100' ' ' ALA . 19.7 pt -70.37 163.83 59.13 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.695 . . . . 0.0 109.479 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.34 101.03 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.139 3.893 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.3 153.08 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.686 . . . . 0.0 109.485 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.2 88.52 7.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 109.461 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -73.9 -15.16 61.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.0 109.82 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.95 9.86 1.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 109.933 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -134.48 30.62 3.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.823 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.571 ' CE2' HD11 ' A' ' 113' ' ' LEU . 60.9 m-85 -140.59 179.59 6.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -150.77 134.29 16.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.638 -0.664 . . . . 0.0 109.43 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -78.63 118.55 20.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -95.25 -33.56 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.6 m -157.47 174.28 15.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 t -161.69 122.73 2.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -95.67 107.22 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.482 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.7 m -90.13 149.52 22.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 109.427 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.417 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.7 p -154.43 129.57 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.363 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -107.73 120.79 43.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.533 -0.73 . . . . 0.0 109.479 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.19 -165.97 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.589 -0.695 . . . . 0.0 109.519 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.6 p -71.52 -39.19 70.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.599 -0.688 . . . . 0.0 109.525 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -105.63 137.59 19.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.547 -0.721 . . . . 0.0 109.41 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.99 -44.84 26.74 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 C-N-CA 124.762 3.641 . . . . 0.0 110.072 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.15 71.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.718 . . . . 0.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 151' ' ' LEU . 43.3 mt -80.78 20.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.682 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.2 m -92.33 142.06 27.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.36 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.697 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.6 p-80 -156.93 166.62 32.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.5 m -138.33 133.44 33.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.411 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.91 92.97 9.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.439 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 31.3 mt-10 -74.06 139.84 44.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.637 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.8 t -128.91 106.74 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.597 -0.69 . . . . 0.0 109.506 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.1 m95 -106.83 168.56 9.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -145.21 142.31 29.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.32 100.68 7.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.582 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.8 m-85 -71.66 139.03 49.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.512 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.6 tp -153.91 113.38 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.324 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 p90 -146.05 151.01 37.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.736 . . . . 0.0 109.909 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.59 118.24 36.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.282 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HB3' HG22 ' A' ' 13' ' ' ILE . 9.1 pt20 -138.04 152.81 49.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.48 -0.762 . . . . 0.0 109.588 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.38 171.07 7.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 109.498 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -61.1 -19.05 61.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.604 -0.685 . . . . 0.0 109.864 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -76.61 13.95 0.89 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.493 -0.754 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.24 39.63 97.95 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.512 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.6 tp -112.02 165.79 11.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.624 -0.927 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 126' ' ' THR . 32.4 pt -142.21 -30.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.577 -0.702 . . . . 0.0 109.545 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.18 -169.43 30.75 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -172.13 117.78 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.631 -0.923 . . . . 0.0 109.44 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.0 21.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.577 -0.702 . . . . 0.0 109.613 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.68 -61.74 4.08 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.401 ' CD2' ' H ' ' A' ' 18' ' ' HIS . 19.1 p80 -76.89 166.56 23.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.445 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.558 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 15.6 mt -79.91 157.54 73.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.662 -0.649 . . . . 0.0 109.439 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -80.24 -27.98 3.28 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.08 3.853 . . . . 0.0 109.971 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.558 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.4 p90 -108.25 -179.29 3.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.534 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -131.34 102.35 5.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 26' ' ' ASP . 20.7 tp -121.51 80.16 38.39 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.606 -0.684 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.63 -37.6 15.77 Favored 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 125.167 3.912 . . . . 0.0 110.178 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -62.89 -42.79 99.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.562 -0.711 . . . . 0.0 109.509 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.798 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.2 t0 -65.42 -38.1 88.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.622 -0.674 . . . . 0.0 109.38 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.35 -24.42 67.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.579 -0.7 . . . . 0.0 109.519 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -83.63 -30.82 26.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.614 -0.679 . . . . 0.0 109.407 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 19.0 t80 -73.83 -25.62 60.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 34' ' ' THR . 48.4 t80 -63.42 -45.74 89.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.51 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -63.58 -30.12 71.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.624 -0.672 . . . . 0.0 109.44 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.83 -29.21 50.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 76.5 mm-40 -100.77 32.54 3.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.3 p -136.82 -35.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.588 -0.695 . . . . 0.0 109.54 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 35' ' ' VAL . 27.8 m -79.42 128.86 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.705 . . . . 0.0 109.496 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.88 -25.75 26.36 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.36 -170.58 1.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.927 . . . . 0.0 109.511 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.407 HG23 ' HB ' ' A' ' 58' ' ' THR . 59.1 mt -103.99 112.05 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.459 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.565 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.7 tmm? -73.72 110.99 8.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.26 122.88 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.713 . . . . 0.0 109.464 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.565 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.8 m -136.66 178.05 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.498 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.94 -177.58 34.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -70.36 -39.58 74.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.963 . . . . 0.0 109.416 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -68.94 -40.53 78.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.616 -0.678 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -72.46 -25.72 61.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.31 -44.49 87.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.661 -0.65 . . . . 0.0 109.462 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -77.33 -26.84 52.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.1 p -62.67 -21.79 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.64 -0.663 . . . . 0.0 109.697 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.427 ' HE2' HG21 ' A' ' 41' ' ' VAL . 20.3 m-85 -62.45 162.96 16.37 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.547 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -81.22 -74.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 125.227 3.952 . . . . 0.0 110.037 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -113.7 82.65 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.465 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -84.42 157.24 62.01 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.371 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.87 152.14 76.88 Favored 'Cis proline' 0 N--CA 1.509 2.383 0 O-C-N 123.415 1.219 . . . . 0.0 109.995 0.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.474 HD12 ' CE ' ' A' ' 39' ' ' MET . 97.1 mt -73.4 113.86 26.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.707 . . . . 0.0 109.27 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.44 179.24 6.68 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.761 3.641 . . . . 0.0 109.942 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 61.03 32.03 19.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.525 -0.734 . . . . 0.0 109.64 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.29 -178.62 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 38' ' ' ILE . 19.7 m -100.98 119.83 39.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 109.339 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -94.24 117.16 29.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.653 -0.654 . . . . 0.0 109.484 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -125.83 143.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.59 -0.693 . . . . 0.0 109.398 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 t -127.97 132.62 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.602 -0.686 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.48 HD12 HG23 ' A' ' 76' ' ' VAL . 12.8 tp -104.2 112.02 24.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -137.88 153.5 49.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.7 . . . . 0.0 109.464 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -89.68 -47.82 7.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 0.0 109.548 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -72.74 157.97 36.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.604 -0.685 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -102.45 8.11 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.593 -0.692 . . . . 0.0 109.859 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.99 -28.01 57.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.28 153.56 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.492 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -143.72 143.59 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.601 -0.687 . . . . 0.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -136.0 125.4 24.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -87.6 123.39 32.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.16 41.6 59.77 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -154.42 148.84 26.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.617 -0.931 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.64 99.63 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.469 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.8 t -75.88 97.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.652 -0.655 . . . . 0.0 109.467 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -89.19 162.98 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.469 ' NE2' HG12 ' A' ' 75' ' ' VAL . 61.2 m-70 -140.07 30.39 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.41 146.48 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.607 -0.683 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.518 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.6 t -68.18 -33.36 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.528 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.53 70.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.506 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.39 80.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.54 -0.725 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -69.13 -36.57 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.645 -0.659 . . . . 0.0 109.473 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.6 -30.34 64.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.75 -36.92 83.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.83 -38.75 83.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.581 -0.7 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.51 -24.49 64.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -63.87 -43.73 95.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -67.45 -29.11 68.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -120.77 89.76 45.58 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.13 -23.53 6.38 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.165 3.91 . . . . 0.0 109.86 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.57 -24.92 64.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.536 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -90.44 179.97 5.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -138.31 154.06 49.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.45 ' CD2' HD11 ' A' ' 96' ' ' ILE . 2.6 tt -91.16 109.58 20.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -110.62 122.6 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.45 HD11 ' CD2' ' A' ' 94' ' ' LEU . 41.7 mm -97.3 127.76 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.532 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.57 -23.44 11.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.599 -0.688 . . . . 0.0 109.578 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.38 -177.05 40.88 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.453 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -80.5 -157.0 14.34 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.341 -1.682 . . . . 0.0 109.54 -0.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.56 87.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.588 -0.948 . . . . 0.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.31 -26.29 66.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.548 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.453 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.5 mm -74.88 -32.17 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.6 -0.688 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.68 -42.65 81.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -69.89 -35.09 74.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.581 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.77 88.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.664 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.518 ' CE1' HG13 ' A' ' 79' ' ' VAL . 33.6 m-85 -95.14 3.49 54.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -70.8 -22.72 62.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.568 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -62.93 -23.87 67.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.71 58.97 1.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -105.98 149.51 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -130.37 -50.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -95.2 142.72 27.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.589 -0.694 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 136' ' ' PHE . 17.3 mt -129.52 87.15 2.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.573 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.652 ' CD2' HG22 ' A' ' 157' ' ' VAL . 61.1 mt -90.37 123.97 34.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.347 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -135.59 147.28 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 0.0 109.543 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.5 m -113.51 105.95 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.64 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -88.27 127.97 35.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.44 133.66 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 109.387 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.58 63.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 0.0 109.425 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.04 129.06 12.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 p -78.05 143.69 37.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.988 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.475 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.0 m-85 -148.45 125.79 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.634 -0.667 . . . . 0.0 109.517 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.57 160.77 16.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.512 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.37 -132.17 1.32 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -143.83 -41.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.664 -0.903 . . . . 0.0 109.451 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.615 HG22 HD11 ' A' ' 13' ' ' ILE . 4.2 m -89.46 134.94 33.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.518 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -113.33 173.39 6.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.419 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.408 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -90.84 143.56 26.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.485 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.2 pt -67.34 164.62 35.61 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.564 -0.71 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.4 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.147 3.898 . . . . 0.0 109.883 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.66 155.15 18.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -87.04 85.34 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.588 -0.695 . . . . 0.0 109.418 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -74.64 -15.17 60.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.669 -0.644 . . . . 0.0 109.871 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.09 9.97 1.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.513 -0.742 . . . . 0.0 109.877 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -134.05 29.7 3.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.534 ' CE2' HD11 ' A' ' 113' ' ' LEU . 47.8 m-85 -141.13 176.01 9.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -150.39 134.24 16.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 109.42 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -70.65 153.19 43.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.553 -0.717 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.09 -31.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.612 -0.68 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.2 m -139.33 144.01 38.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -143.84 99.09 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -86.71 97.56 10.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.708 . . . . 0.0 109.462 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.569 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.2 m -77.2 147.87 36.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.54 129.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.351 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.75 120.65 42.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.736 . . . . 0.0 109.477 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.08 -165.9 0.93 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.7 p -74.89 -41.96 58.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.22 137.8 20.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.733 . . . . 0.0 109.434 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.65 -48.45 15.69 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 124.804 3.669 . . . . 0.0 110.143 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.88 70.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.658 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.32 15.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.788 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.0 m -86.58 139.36 30.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.339 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.578 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.0 p-80 -156.01 173.25 17.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.571 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.569 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.3 m -139.23 135.56 34.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -86.46 92.13 8.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.46 147.52 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.2 t -139.05 99.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.461 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -94.59 166.19 12.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.395 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -148.84 141.34 24.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.1 tttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 179.989 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.82 124.31 20.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.71 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.798 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -94.86 152.77 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.561 -0.712 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.571 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.7 tp -163.2 110.05 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.33 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.0 p90 -144.78 150.1 36.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.75 117.3 31.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 109.223 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' HB3' HG22 ' A' ' 13' ' ' ILE . 2.2 pt20 -138.48 152.8 48.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.723 . . . . 0.0 109.691 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -104.07 170.99 7.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.68 -17.38 55.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.805 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.85 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.36 38.22 95.91 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 122' ' ' PHE . 6.2 tp -113.03 163.97 14.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.551 -0.97 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 126' ' ' THR . 31.7 pt -138.16 -30.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.435 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -167.49 -166.87 27.29 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -171.79 118.2 0.42 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.902 . . . . 0.0 109.501 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 59.98 32.24 21.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.72 -62.8 2.63 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -75.35 172.84 11.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.615 -0.932 . . . . 0.0 109.454 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.575 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 31.1 mt -85.18 156.36 60.12 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.84 -26.66 4.4 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 125.021 3.814 . . . . 0.0 109.944 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.575 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.4 p90 -108.77 167.74 9.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.511 -0.743 . . . . 0.0 109.491 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -117.57 101.31 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.61 -0.682 . . . . 0.0 109.45 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.1 tp -121.38 80.41 37.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.59 -38.99 17.29 Favored 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 125.171 3.914 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.48 -41.35 98.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.625 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.788 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.3 t0 -65.87 -36.99 84.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.15 -23.25 64.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -86.1 -28.23 24.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.65 -0.656 . . . . 0.0 109.461 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.8 t80 -75.23 -25.49 58.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.507 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 34' ' ' THR . 50.4 t80 -63.82 -48.98 74.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -65.66 -25.7 67.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.566 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.08 -25.72 43.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.542 -0.724 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.0 mm100 -109.07 36.77 2.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' PHE . 20.6 p -142.06 -29.3 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.32 132.49 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.592 -0.692 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.37 34.82 60.39 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -155.98 164.31 38.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.532 -0.981 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.87 117.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.44 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.455 ' CE ' HD12 ' A' ' 54' ' ' LEU . 39.6 ttp -97.6 108.34 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' CG2' HD11 ' A' ' 94' ' ' LEU . 30.4 t -93.67 120.08 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.47 161.78 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.512 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.73 -162.85 37.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 ptt85 -83.55 -35.8 24.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.956 . . . . 0.0 109.428 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -69.59 -38.66 77.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.697 -0.627 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.497 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 10.7 m -74.14 -28.64 61.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.483 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.49 -58.44 7.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -66.32 -21.58 66.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.586 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.6 m -63.1 -29.36 70.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.743 . . . . 0.0 109.543 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.497 ' CZ ' HG22 ' A' ' 45' ' ' THR . 35.7 m-85 -64.83 161.64 44.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.86 -73.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 125.126 3.884 . . . . 0.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -107.03 95.57 5.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.625 -0.672 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 25.3 ptt-85 -101.23 157.32 33.89 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.641 -0.662 . . . . 0.0 109.443 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.27 145.7 72.09 Favored 'Cis proline' 0 N--CA 1.508 2.365 0 O-C-N 123.385 1.203 . . . . 0.0 109.903 0.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.455 HD12 ' CE ' ' A' ' 39' ' ' MET . 50.2 mt -62.59 116.1 21.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.289 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.92 178.47 7.51 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 124.762 3.641 . . . . 0.0 109.929 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 61.02 29.44 18.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.516 -0.74 . . . . 0.0 109.638 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.11 -169.27 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.706 . . . . 0.0 109.527 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -118.06 130.19 56.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.525 -0.735 . . . . 0.0 109.437 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -107.61 100.56 9.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.491 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -99.55 105.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.56 -0.713 . . . . 0.0 109.449 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.42 122.05 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.599 HD12 HG23 ' A' ' 76' ' ' VAL . 12.3 tp -101.38 118.16 36.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.624 -0.673 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.469 HG23 ' CE1' ' A' ' 77' ' ' HIS . 3.9 t -144.32 154.37 42.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.479 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -95.11 -38.87 10.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.579 -0.7 . . . . 0.0 109.479 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -72.1 131.61 43.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.613 -0.68 . . . . 0.0 109.433 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.97 30.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -103.21 -33.21 9.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -69.69 143.3 53.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -142.14 146.09 34.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.69 . . . . 0.0 109.48 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.98 124.31 20.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -83.0 130.21 35.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.38 38.85 37.57 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.74 139.4 12.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.991 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -77.37 104.46 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.61 100.71 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.599 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -102.47 -176.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.469 ' CE1' HG23 ' A' ' 63' ' ' THR . 64.0 m-70 -142.93 30.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.489 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -161.06 142.54 11.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 t -65.18 -31.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.06 -34.54 78.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.05 81.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.643 -0.661 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 76' ' ' VAL . 34.1 t -66.73 -41.22 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.42 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -71.94 -30.07 64.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.603 -0.686 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.42 87.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.71 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -71.44 -33.03 69.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.583 -0.698 . . . . 0.0 109.521 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.32 -29.98 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -66.42 -42.45 87.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.517 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -66.54 -28.41 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -119.21 90.01 40.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.643 -0.66 . . . . 0.0 109.453 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 -23.67 6.51 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 125.103 3.869 . . . . 0.0 109.843 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.58 -26.4 66.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -102.44 133.67 47.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -92.29 151.63 20.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.71 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.483 HD11 ' CG2' ' A' ' 40' ' ' VAL . 9.7 tp -87.43 143.93 26.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.555 -0.716 . . . . 0.0 109.497 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -144.43 130.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.431 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.554 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -94.65 125.36 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.94 -28.32 9.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.522 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 161.81 -177.57 38.01 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.85 -154.73 16.48 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.361 -1.67 . . . . 0.0 109.6 -0.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.58 78.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.953 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -75.09 -30.51 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.554 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.4 m-85 -68.78 -50.65 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -64.21 -23.16 67.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.615 -0.678 . . . . 0.0 109.558 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.32 -52.11 37.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.6 -0.688 . . . . 0.0 109.615 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -86.46 6.16 31.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.567 -0.708 . . . . 0.0 110.037 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 110' ' ' VAL . 32.2 ttpt -66.04 -23.55 66.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 109.586 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -68.37 -42.43 79.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.598 -0.689 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.73 38.19 2.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.611 -0.68 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.798 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -79.97 152.76 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.583 -0.698 . . . . 0.0 109.342 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.15 -68.87 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.692 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -85.57 161.44 19.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.635 -0.665 . . . . 0.0 109.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.583 HD11 ' CE2' ' A' ' 136' ' ' PHE . 23.7 mt -141.63 88.32 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.549 -0.719 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.571 ' CB ' HD12 ' A' ' 4' ' ' LEU . 54.0 mt -89.44 120.65 30.95 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -132.63 142.77 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.7 m -109.98 103.17 11.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 0.0 109.329 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -85.71 132.22 34.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.0 109.603 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.9 132.73 53.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.371 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.9 -31.68 72.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.439 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.443 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -73.98 131.95 14.65 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.5 p -85.15 142.01 29.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.605 -0.938 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.59 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.3 m-85 -144.86 126.26 14.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.604 -0.685 . . . . 0.0 109.456 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -90.01 146.42 24.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.561 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -145.76 -128.89 2.02 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -143.62 -34.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.995 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.49 HG22 HD11 ' A' ' 13' ' ' ILE . 2.9 m -98.68 127.89 44.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 109.55 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -104.81 170.86 7.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.23 145.35 25.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.0 pt -66.91 164.78 31.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.505 -0.747 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.23 109.23 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.105 3.87 . . . . 0.0 109.891 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.08 149.42 21.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -84.46 86.35 7.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -73.36 -16.95 61.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.632 -0.668 . . . . 0.0 109.768 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.08 9.83 1.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.961 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -131.87 28.42 4.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.583 ' CE2' HD11 ' A' ' 113' ' ' LEU . 54.5 m-85 -138.48 179.86 6.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.45 122.01 7.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.505 -0.747 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -70.25 121.3 17.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 140' ' ' SER . 28.1 m -96.11 -37.4 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.478 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.406 ' N ' HG23 ' A' ' 139' ' ' VAL . 57.4 p -158.62 169.33 24.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.545 -0.722 . . . . 0.0 109.528 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 81.4 p -158.35 129.63 6.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.607 -0.683 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -97.18 116.24 29.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.685 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.564 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.4 m -93.95 152.08 19.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.36 130.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -102.38 123.22 45.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.511 -0.743 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.45 -165.95 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.7 p -73.99 -39.9 63.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 0.0 109.604 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -99.85 137.57 20.19 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.25 -39.88 34.9 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 124.773 3.649 . . . . 0.0 110.015 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.443 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -75.07 -29.58 60.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.693 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.84 8.36 2.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.566 -0.709 . . . . 0.0 109.981 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.3 p -78.45 159.0 28.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.476 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.584 ' CE1' HD21 ' A' ' 23' ' ' LEU . 39.4 p-80 -171.97 170.74 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.539 -0.725 . . . . 0.0 109.603 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 143' ' ' THR . 16.9 m -140.44 133.84 29.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -86.64 95.95 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 109.383 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -78.14 144.41 36.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.627 -0.671 . . . . 0.0 109.483 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.555 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.3 t -133.65 99.55 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 31.5 m95 -96.86 166.95 11.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.615 -0.678 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -146.0 138.82 25.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.4 tttp . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.715 . . . . 0.0 109.405 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.28 107.05 14.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CD1' HG23 ' A' ' 110' ' ' VAL . 3.7 m-85 -80.98 155.97 26.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.624 -0.673 . . . . 0.0 109.416 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.707 HD12 ' CB ' ' A' ' 114' ' ' LEU . 6.5 tp -168.78 121.56 0.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.451 ' NE1' HG23 ' A' ' 115' ' ' VAL . 44.0 p90 -147.31 130.1 16.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.508 -0.745 . . . . 0.0 109.584 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.91 109.77 18.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.266 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.653 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.6 pt20 -131.26 160.87 33.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.704 . . . . 0.0 109.72 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -109.86 169.45 8.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.672 -0.642 . . . . 0.0 109.465 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -60.72 -17.56 49.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.57 15.26 0.83 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.715 . . . . 0.0 109.798 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.25 33.75 87.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.608 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.8 tp -113.69 161.31 17.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.638 -0.919 . . . . 0.0 109.469 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.653 HG22 ' HB3' ' A' ' 7' ' ' GLN . 30.1 pt -134.21 -30.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -170.46 -174.45 38.5 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -166.38 124.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.91 32.48 21.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 109.752 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.19 -61.71 3.93 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -74.97 174.77 8.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.586 -0.949 . . . . 0.0 109.5 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.575 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 47.8 mt -89.7 156.02 47.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 109.426 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -79.59 -26.55 4.7 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 124.955 3.77 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.575 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.7 p90 -108.59 165.76 11.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -115.13 101.5 9.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.776 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.6 tp -122.76 79.23 48.87 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.84 -38.01 17.35 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 125.165 3.91 . . . . 0.0 110.197 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.83 -46.51 87.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.559 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.776 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.8 t0 -64.19 -36.9 85.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.59 -24.99 67.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.664 . . . . 0.0 109.459 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -84.12 -29.35 26.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.605 -0.685 . . . . 0.0 109.437 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -71.73 -28.12 63.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.584 -0.697 . . . . 0.0 109.4 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 34' ' ' THR . 46.6 t80 -67.62 -44.96 76.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.554 -0.716 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -66.0 -31.0 71.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -30.94 60.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.693 . . . . 0.0 109.437 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -97.9 33.25 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.3 p -139.55 -30.03 0.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.608 -0.682 . . . . 0.0 109.493 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.5 m -68.63 128.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 109.513 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.38 69.94 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -145.67 165.79 27.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.565 -0.962 . . . . 0.0 109.449 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.417 HG23 ' HB ' ' A' ' 58' ' ' THR . 59.8 mt -92.11 101.0 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.428 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.619 ' CE ' HD12 ' A' ' 54' ' ' LEU . 43.7 ttp -80.7 103.33 10.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.555 -0.715 . . . . 0.0 109.457 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.85 121.43 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.24 168.33 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.624 -0.673 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.67 -165.28 39.38 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -78.87 -43.49 24.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.936 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.529 HH22 HE21 ' A' ' 101' ' ' GLN . 10.8 ptp85 -68.73 -30.99 69.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 0.0 109.461 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -79.91 -29.15 39.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.68 -31.81 72.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.629 -0.669 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -94.18 -18.07 22.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.694 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -62.26 -23.43 66.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -66.43 159.77 70.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.15 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.066 3.844 . . . . 0.0 109.953 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.92 112.8 24.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.498 -0.751 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -108.46 158.64 33.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.518 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.69 -165.51 4.57 Favored 'Cis proline' 0 N--CA 1.509 2.382 0 O-C-N 123.372 1.196 . . . . 0.0 109.897 -0.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.619 HD12 ' CE ' ' A' ' 39' ' ' MET . 87.9 mt -114.97 94.4 38.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.585 -0.697 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -74.97 -175.89 2.59 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 124.819 3.679 . . . . 0.0 109.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 61.51 27.93 17.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.77 . . . . 0.0 109.52 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.23 -169.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 38' ' ' ILE . 1.3 m -119.39 115.23 23.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.583 -0.698 . . . . 0.0 109.49 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.496 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.7 m-80 -92.77 103.79 16.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.722 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -104.62 99.94 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.481 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.3 t -87.03 123.89 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.492 HD12 HG23 ' A' ' 76' ' ' VAL . 18.4 tp -101.11 115.83 31.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.651 -0.656 . . . . 0.0 109.502 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -145.98 146.61 31.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.705 -0.622 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -101.43 31.54 3.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.585 -0.697 . . . . 0.0 109.562 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -134.2 126.51 30.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -85.1 29.53 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.17 -35.65 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 109.515 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -69.55 157.76 36.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.62 -0.675 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -147.52 140.89 25.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.527 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.5 11.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.584 -0.698 . . . . 0.0 109.475 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -84.83 133.68 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.581 -0.7 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.74 41.21 35.13 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.02 159.82 36.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.928 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -94.07 94.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.612 -0.68 . . . . 0.0 109.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.629 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.7 t -79.01 99.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.363 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.492 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -97.21 159.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.458 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.629 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.5 m-70 -139.23 28.68 2.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.695 . . . . 0.0 109.511 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -161.49 147.56 14.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.466 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.512 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.3 t -67.81 -33.64 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.722 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.31 73.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.653 -0.655 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.08 79.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 76' ' ' VAL . 30.2 t -67.2 -46.57 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.591 -0.693 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.91 -27.27 63.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.672 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.29 -36.89 85.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.558 -0.714 . . . . 0.0 109.437 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.21 -34.29 68.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 109.525 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.21 67.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -65.55 -42.39 91.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.22 -29.84 70.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.579 -0.7 . . . . 0.0 109.543 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -119.74 89.86 42.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.58 -0.7 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.99 -23.16 6.85 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.148 3.899 . . . . 0.0 109.943 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.07 -26.42 65.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.49 172.49 7.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -130.94 169.13 16.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tp -93.58 131.94 38.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -128.03 127.12 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.463 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.615 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.0 mm -103.41 118.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.54 -25.37 11.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.498 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.74 -179.04 40.83 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.85 -157.08 28.5 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.328 -1.689 . . . . 0.0 109.542 -0.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.97 -30.53 71.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.623 -0.928 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.529 HE21 HH22 ' A' ' 44' ' ' ARG . 46.0 mt-30 -73.24 -32.76 64.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.441 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -70.28 -36.87 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.552 -0.717 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.615 ' CE1' HG22 ' A' ' 96' ' ' ILE . 25.5 m-85 -63.77 -56.65 13.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -62.47 -16.05 53.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.604 -0.685 . . . . 0.0 109.83 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.42 -23.23 32.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.512 ' CE1' HG13 ' A' ' 79' ' ' VAL . 35.4 m-85 -121.06 18.12 11.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.809 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -66.27 -31.36 72.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.554 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.0 26.65 0.42 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.694 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.05 34.13 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.542 -0.724 . . . . 0.0 109.485 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.683 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -102.23 159.37 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.429 ' N ' HG22 ' A' ' 110' ' ' VAL . 7.7 t0 -141.83 -50.43 0.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.674 -0.641 . . . . 0.0 109.345 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -105.75 109.28 21.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 0.0 109.335 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.407 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 23.1 mt -93.61 110.26 21.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.585 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.707 ' CB ' HD12 ' A' ' 4' ' ' LEU . 21.8 mt -105.74 101.96 11.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.596 -0.69 . . . . 0.0 109.298 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.451 HG23 ' NE1' ' A' ' 5' ' ' TRP . 9.5 p -107.71 132.74 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.669 -0.645 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.5 m -106.91 96.51 6.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.564 -0.71 . . . . 0.0 109.244 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -82.39 150.16 27.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.648 -0.658 . . . . 0.0 109.704 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.35 142.39 50.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.634 -0.666 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.69 -34.83 62.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.556 -0.715 . . . . 0.0 109.453 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.41 136.29 22.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.9 p -86.7 143.63 27.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.994 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -144.92 138.62 27.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.3 152.96 18.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.546 -0.721 . . . . 0.0 109.52 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.608 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -157.97 -128.76 1.04 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.05 -34.37 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.946 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.475 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -89.85 149.52 22.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.624 -0.673 . . . . 0.0 109.521 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -130.89 167.85 18.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 11.4 tpt -88.14 151.57 22.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.54 -0.725 . . . . 0.0 109.479 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.3 pt -76.06 163.62 65.47 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.595 -0.69 . . . . 0.0 109.509 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.16 104.78 1.69 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.172 3.915 . . . . 0.0 109.902 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.2 mt -97.43 144.5 27.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.16 88.44 7.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -67.15 -14.97 63.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.575 -0.703 . . . . 0.0 109.831 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.58 -26.02 68.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.478 -0.764 . . . . 0.0 109.531 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.65 30.46 2.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 67.2 m-85 -143.84 171.3 14.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.533 -0.73 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.9 m -144.34 136.38 26.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.545 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -74.12 150.26 40.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.38 -35.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.56 -0.712 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -142.37 165.64 26.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.6 t -164.43 119.65 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.48 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -99.56 106.07 18.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.528 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 m -93.14 141.05 28.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.671 . . . . 0.0 109.42 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.402 ' CG1' ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -150.32 135.03 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.94 125.4 54.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.2 -165.94 0.95 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.4 p -70.85 -38.32 73.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.554 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.26 137.71 19.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.598 -0.689 . . . . 0.0 109.37 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.74 -44.14 27.21 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 124.829 3.686 . . . . 0.0 110.065 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.32 72.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.68 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 151' ' ' LEU . 34.2 mt -80.74 21.1 0.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 38.0 m -91.74 142.67 27.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.39 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.402 ' NE2' ' CG1' ' A' ' 144' ' ' VAL . 35.9 p-80 -155.45 168.95 25.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -141.95 131.35 23.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 109.419 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -91.12 95.21 9.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.732 . . . . 0.0 109.516 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.514 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 22.5 mt-10 -78.2 130.76 36.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.608 -0.683 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.607 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.1 t -115.39 110.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.514 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 36.8 m95 -108.48 165.67 11.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.584 -0.698 . . . . 0.0 109.458 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -143.36 138.87 29.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.651 -0.656 . . . . 0.0 109.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.617 HG23 HD23 ' A' ' 94' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 1' ' ' THR . . . -141.47 130.96 23.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.498 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.834 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.7 m-85 -96.37 162.14 13.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.733 . . . . 0.0 109.479 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 114' ' ' LEU . 8.6 tp -168.97 107.33 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.597 -0.689 . . . . 0.0 109.301 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.04 143.14 31.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.55 -0.719 . . . . 0.0 109.811 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.09 112.5 24.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.648 -0.658 . . . . 0.0 109.245 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.485 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.5 pt20 -134.16 149.79 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.637 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -98.7 170.17 8.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.499 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -60.96 -17.26 50.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.558 -0.714 . . . . 0.0 109.943 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -76.83 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.493 -0.754 . . . . 0.0 109.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.21 36.43 92.99 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.2 tp -111.59 162.36 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.534 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.528 HD11 HG22 ' A' ' 126' ' ' THR . 32.3 pt -137.13 -30.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.508 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -167.12 -172.8 34.74 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -168.98 124.96 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.933 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.08 28.04 17.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.01 -63.55 1.47 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -75.45 -171.65 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.602 -0.94 . . . . 0.0 109.468 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.706 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 31.5 mt -92.58 156.89 40.81 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.58 -0.7 . . . . 0.0 109.423 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.1 Cg_endo -80.22 -28.67 2.91 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.015 3.81 . . . . 0.0 109.882 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.706 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.7 p90 -106.75 -172.27 2.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -138.65 94.8 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.614 -0.679 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.774 HD23 ' HB2' ' A' ' 26' ' ' ASP . 22.3 tp -116.12 83.36 12.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.56 -38.34 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.123 3.882 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.99 -40.97 99.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.774 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -69.25 -28.4 66.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.24 -23.47 57.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.621 -0.674 . . . . 0.0 109.542 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -86.82 -28.87 22.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.729 . . . . 0.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -71.04 -27.08 63.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CE2' HG21 ' A' ' 34' ' ' THR . 48.1 t80 -64.35 -47.8 77.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.627 -0.67 . . . . 0.0 109.47 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -66.6 -5.27 10.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.611 -0.681 . . . . 0.0 109.974 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.08 -34.47 12.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.512 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -106.28 35.48 2.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.466 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.474 HG21 ' CE2' ' A' ' 30' ' ' PHE . 20.6 p -133.37 -32.8 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.527 -0.733 . . . . 0.0 109.493 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.7 129.58 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 37.3 57.15 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -155.15 164.94 38.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.484 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -92.37 110.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.469 ' CE ' HD12 ' A' ' 54' ' ' LEU . 36.3 ttp -88.81 107.6 19.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 94' ' ' LEU . 30.7 t -94.57 119.42 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.456 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 27.3 m -132.95 164.49 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.718 . . . . 0.0 109.5 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.38 -165.36 40.42 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtm105 -80.52 -38.43 29.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.95 . . . . 0.0 109.471 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -70.05 -32.98 71.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.58 -0.7 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 m -79.17 -28.5 42.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.465 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.65 -34.19 77.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.471 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -86.7 -25.48 24.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -62.89 -23.23 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HZ ' HG11 ' A' ' 41' ' ' VAL . 44.4 m-85 -62.92 162.83 19.18 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.18 -63.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.125 3.883 . . . . 0.0 109.922 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -124.12 111.55 16.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.543 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -108.52 157.37 36.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.405 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.83 146.51 72.18 Favored 'Cis proline' 0 N--CA 1.508 2.36 0 O-C-N 123.396 1.208 . . . . 0.0 109.982 0.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.484 ' HB2' HD21 ' A' ' 59' ' ' ASN . 68.6 mt -67.51 112.93 11.61 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.368 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -78.24 179.91 6.06 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 124.793 3.662 . . . . 0.0 109.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 61.22 27.65 17.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.665 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -177.13 -173.32 0.45 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.493 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -116.16 120.11 37.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.711 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.484 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -95.53 107.72 19.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.668 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.1 116.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.424 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -102.1 122.7 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.606 -0.684 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.509 HD12 HG23 ' A' ' 76' ' ' VAL . 15.3 tp -99.22 110.93 23.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.74 142.82 31.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -97.65 30.98 2.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -125.81 138.39 53.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.71 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.75 29.84 2.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.31 -40.18 5.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.611 -0.681 . . . . 0.0 109.454 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -73.17 136.98 44.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -141.48 102.88 4.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.75 117.43 23.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -76.92 133.28 39.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.571 -0.705 . . . . 0.0 109.424 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 37.52 59.55 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.47 142.83 19.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.965 . . . . 0.0 109.494 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -75.4 95.96 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.622 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.0 t -80.22 102.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.528 -0.732 . . . . 0.0 109.437 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.509 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -94.33 158.7 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.622 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.8 m-70 -139.68 29.56 2.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.693 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -162.18 147.29 12.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 t -67.97 -35.3 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.454 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.58 70.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.53 81.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.473 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.508 HG22 HG21 ' A' ' 76' ' ' VAL . 31.0 t -68.34 -40.72 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -75.67 -30.24 59.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -36.96 84.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.56 -41.92 75.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.622 -0.674 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 109.48 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -65.12 -45.31 85.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.57 -0.706 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -67.48 -27.08 66.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.469 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.82 89.82 39.02 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.678 . . . . 0.0 109.463 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.93 -23.14 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 125.06 3.84 . . . . 0.0 109.893 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.69 -26.79 66.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -91.27 179.94 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.34 150.64 46.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.617 HD23 HG23 ' A' ' 1' ' ' THR . 11.7 tp -93.67 126.4 38.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 t -133.16 127.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.716 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.558 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.7 mm -91.42 127.64 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.85 -23.83 10.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.562 -0.711 . . . . 0.0 109.59 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.92 -178.15 37.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.48 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -82.6 -154.37 14.92 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 120.389 -1.654 . . . . 0.0 109.587 -0.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.53 77.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.579 -0.954 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -73.15 -27.2 61.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.48 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -73.94 -35.44 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.723 . . . . 0.0 109.479 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 96' ' ' ILE . 24.1 m-85 -63.26 -53.71 48.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -62.71 -21.98 66.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.59 -0.694 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.91 -30.84 67.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.741 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -116.06 16.89 16.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.767 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.621 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -68.04 -22.85 64.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.651 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -70.19 -45.51 66.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -97.04 40.3 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.456 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.834 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -89.38 143.95 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -128.53 -65.63 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.668 . . . . 0.0 109.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.5 m -89.86 164.58 14.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.533 HD11 ' CE2' ' A' ' 136' ' ' PHE . 33.4 mt -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.564 -0.71 . . . . 0.0 109.58 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.65 ' HB2' HD12 ' A' ' 4' ' ' LEU . 35.9 mt -91.21 104.25 16.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -115.47 137.99 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -107.77 102.69 11.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.68 . . . . 0.0 109.336 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mmm-85 -88.23 135.22 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.99 140.69 42.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.69 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.62 -29.63 61.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.416 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.464 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -74.93 126.08 8.65 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 p -72.57 143.25 48.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.939 . . . . 0.0 109.452 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.424 ' O ' HD22 ' A' ' 12' ' ' LEU . 66.7 m-85 -148.98 121.55 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -96.51 149.25 21.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.54 -120.78 1.13 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -145.95 -33.94 0.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.631 -0.923 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.528 HG22 HD11 ' A' ' 13' ' ' ILE . 2.2 m -93.9 146.28 24.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -125.53 174.32 8.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.6 tpt -97.55 152.14 19.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.2 pt -74.67 163.9 65.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.14 94.18 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.115 3.876 . . . . 0.0 109.873 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.57 154.28 28.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.6 -0.688 . . . . 0.0 109.486 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -87.14 86.08 7.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.587 -0.696 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -71.47 -18.49 62.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.6 -0.688 . . . . 0.0 109.725 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -74.12 10.08 1.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -132.68 29.62 4.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.533 ' CE2' HD11 ' A' ' 113' ' ' LEU . 44.5 m-85 -138.95 -180.0 6.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.629 -0.669 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -148.59 125.5 11.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 109.441 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -78.44 126.36 30.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.07 -35.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.612 -0.68 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.2 t -162.31 -177.79 5.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 98.3 p -163.88 132.56 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -95.73 100.74 12.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.531 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.4 m -82.72 148.79 27.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.58 131.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.313 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -108.36 120.22 41.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.451 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.01 -165.3 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 p -72.99 -42.96 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.61 -0.681 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -100.01 137.97 20.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.4 -47.62 17.19 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 124.832 3.688 . . . . 0.0 110.092 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.464 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -62.23 -30.02 70.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.569 -0.707 . . . . 0.0 109.664 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.8 mt -78.82 17.58 0.7 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 109.741 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.5 m -90.54 144.36 25.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.755 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.721 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.3 p-80 -159.68 170.14 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.56 -0.712 . . . . 0.0 109.574 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.531 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.5 m -139.92 135.66 33.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.39 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -91.32 92.02 8.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.564 -0.71 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.518 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 44.0 mt-10 -77.1 128.36 34.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.544 -0.722 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.617 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.8 t -114.76 99.49 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.484 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.518 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 35.5 m95 -95.03 164.31 12.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.7 . . . . 0.0 109.445 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -148.66 136.11 20.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.0 tttt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.724 . . . . 0.0 109.45 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.503 HG23 HD23 ' A' ' 94' ' ' LEU . 3.9 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.73 127.76 33.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.557 -0.714 . . . . 0.0 109.467 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.791 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -100.18 143.93 29.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.532 -0.73 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.677 HD12 ' CB ' ' A' ' 114' ' ' LEU . 7.7 tp -156.59 111.51 2.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.33 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.93 141.22 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.545 -0.722 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.97 112.81 24.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.207 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -132.89 157.82 44.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -107.53 170.01 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 109.46 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -60.89 -18.31 55.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.551 -0.718 . . . . 0.0 109.871 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.42 15.09 0.82 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.77 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 35.77 91.9 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.647 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.5 tp -111.34 162.01 15.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.978 . . . . 0.0 109.535 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.63 HD11 HG22 ' A' ' 126' ' ' THR . 31.9 pt -136.28 -30.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.493 -0.754 . . . . 0.0 109.58 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.439 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -166.34 -170.28 31.04 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -168.8 117.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.584 -0.951 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.1 30.74 20.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.698 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.83 -61.85 2.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -75.03 165.15 25.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.975 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.618 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 32.9 mt -78.09 156.9 79.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.721 . . . . 0.0 109.421 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.432 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.7 Cg_endo -80.34 -28.58 2.88 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 124.996 3.797 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.618 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.2 p90 -107.53 -170.94 1.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -140.68 96.96 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 26' ' ' ASP . 11.6 tp -117.09 81.11 12.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.76 -40.85 19.59 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 125.095 3.863 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -62.48 -52.25 64.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 109.63 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.788 ' HB2' HD23 ' A' ' 23' ' ' LEU . 30.6 t70 -63.1 -35.94 81.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 27' ' ' LEU . 43.0 mt -63.12 -23.8 67.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.539 -0.726 . . . . 0.0 109.554 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -85.52 -29.16 24.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 12.4 t80 -64.78 -25.72 68.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.647 -0.658 . . . . 0.0 109.528 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 34' ' ' THR . 49.6 t80 -64.64 -46.05 84.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.591 -0.693 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -65.12 -31.84 73.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 109.465 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.93 -29.03 58.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.565 -0.709 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 22.4 mm100 -100.4 34.17 2.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.4 p -140.46 -34.87 0.51 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.581 -0.699 . . . . 0.0 109.525 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -70.98 124.94 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.687 -0.633 . . . . 0.0 109.508 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.21 34.4 20.73 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -156.29 168.23 27.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.498 -1.001 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.5 mt -90.54 104.61 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.649 -0.657 . . . . 0.0 109.469 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.609 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.6 tmm? -77.22 120.58 22.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 0.0 109.484 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 94' ' ' LEU . 28.2 t -126.81 122.57 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.524 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.609 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.8 m -135.12 -174.28 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.79 -170.33 26.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -77.59 -40.01 43.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.525 -0.985 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.19 -36.3 74.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.638 -0.664 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -73.09 -28.12 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -63.7 -47.45 81.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HA ' HH21 ' A' ' 52' ' ' ARG . 25.1 mt-10 -71.97 -25.73 61.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -62.51 -21.64 65.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.571 -0.705 . . . . 0.0 109.587 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -62.44 164.37 11.87 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.03 -65.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.167 3.911 . . . . 0.0 110.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -128.33 103.97 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.523 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.453 HH21 ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -88.92 157.38 48.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.653 . . . . 0.0 109.421 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.35 -168.95 7.07 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.361 1.19 . . . . 0.0 110.035 0.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.589 HD12 ' CE ' ' A' ' 39' ' ' MET . 93.2 mt -112.96 96.32 37.76 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.421 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -69.54 176.48 6.54 Favored 'Trans proline' 0 N--CA 1.505 2.206 0 C-N-CA 124.592 3.528 . . . . 0.0 109.831 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 62.04 21.79 12.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.533 -0.729 . . . . 0.0 109.639 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -177.52 156.6 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.72 . . . . 0.0 109.458 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -79.46 152.36 30.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 109.54 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -130.32 114.76 16.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.454 ' HB ' HG22 ' A' ' 40' ' ' VAL . 30.1 t -116.52 103.98 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.654 -0.654 . . . . 0.0 109.522 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.6 123.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 76' ' ' VAL . 16.4 tp -94.99 108.69 20.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.416 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.478 HG23 ' CE1' ' A' ' 77' ' ' HIS . 3.9 t -136.56 152.8 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.46 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -104.44 -22.73 13.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.69 -0.631 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.88 134.31 48.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.686 . . . . 0.0 109.419 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.38 31.9 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.637 -0.664 . . . . 0.0 109.455 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -121.56 -30.6 4.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -67.79 144.44 55.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.742 . . . . 0.0 109.395 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -147.97 102.67 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.524 -0.735 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.42 117.96 25.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -78.19 133.77 37.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.685 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.69 35.95 44.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -159.22 151.48 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.611 -0.934 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -81.38 95.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.72 . . . . 0.0 109.439 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.404 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.3 t -76.7 97.72 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.466 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -94.55 170.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.579 -0.701 . . . . 0.0 109.501 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.478 ' CE1' HG23 ' A' ' 63' ' ' THR . 75.9 m-70 -146.15 30.23 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -168.3 144.7 3.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.569 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.2 t -66.48 -33.2 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.84 74.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.64 -0.662 . . . . 0.0 109.469 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.19 -35.63 78.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.629 -0.669 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.419 HG22 HG21 ' A' ' 76' ' ' VAL . 31.3 t -67.11 -42.28 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.635 -0.666 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -68.94 -29.63 67.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.47 82.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.09 -33.62 72.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.57 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.641 -0.662 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.88 -40.93 92.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -67.36 -31.12 71.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -120.19 90.03 44.07 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.12 -22.98 6.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.104 3.869 . . . . 0.0 109.893 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.33 -25.29 64.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.718 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -103.72 141.09 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.36 164.79 12.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.629 -0.669 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 40' ' ' VAL . 9.6 tp -93.17 132.1 37.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.53 -0.731 . . . . 0.0 109.457 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -134.5 126.81 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.1 mm -99.67 127.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.672 -0.643 . . . . 0.0 109.429 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.537 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -106.5 -22.36 12.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.586 -0.696 . . . . 0.0 109.611 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.3 -176.51 39.48 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.484 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.98 -154.23 18.49 Favored Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.353 -1.675 . . . . 0.0 109.533 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.9 77.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 109.502 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -72.49 -26.01 61.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.581 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.484 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -74.68 -36.56 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.555 -0.716 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -63.21 -51.0 68.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 m -63.17 -24.31 67.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.704 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.49 75.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.678 . . . . 0.0 109.487 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.569 ' CE1' HG13 ' A' ' 79' ' ' VAL . 65.8 m-85 -102.13 12.62 36.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.606 -0.684 . . . . 0.0 109.759 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 110' ' ' VAL . 70.2 tttt -70.75 -28.75 64.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.464 -0.773 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -65.65 -31.6 72.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.715 . . . . 0.0 109.569 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -119.49 37.95 4.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.49 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.791 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -84.78 156.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.34 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.25 -68.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.597 -0.689 . . . . 0.0 109.482 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -88.55 161.9 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 3' ' ' PHE . 26.9 mt -143.5 92.38 2.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.634 -0.666 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.677 ' CB ' HD12 ' A' ' 4' ' ' LEU . 50.8 mt -90.52 112.53 24.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.0 109.401 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -118.69 133.51 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.426 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -104.94 96.7 6.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.697 . . . . 0.0 109.321 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -82.42 138.73 34.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.7 . . . . 0.0 109.578 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.8 134.55 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.41 87.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.533 -0.729 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.78 126.22 23.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.2 p -79.29 143.44 35.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.947 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -145.83 128.61 16.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.581 -0.699 . . . . 0.0 109.506 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.82 153.58 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.718 . . . . 0.0 109.495 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.647 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -156.64 -135.49 1.96 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -30.39 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.63 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -94.54 143.51 26.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 109.553 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.66 168.95 13.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.639 -0.663 . . . . 0.0 109.485 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.4 tpt -93.38 152.4 19.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.512 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -71.83 164.4 58.73 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.618 -0.677 . . . . 0.0 109.502 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 95.2 1.0 Allowed 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 125.165 3.91 . . . . 0.0 109.889 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.67 138.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.655 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -81.15 84.15 6.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.429 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -67.83 -15.92 63.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.785 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.48 -25.93 68.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.46 -33.95 20.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.662 -0.649 . . . . 0.0 109.443 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 113' ' ' LEU . 96.3 m-85 -84.29 166.56 17.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.8 m -136.45 131.63 34.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -71.65 113.6 8.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.678 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 140' ' ' SER . 27.4 m -93.46 -38.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 109.494 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.424 ' N ' HG23 ' A' ' 139' ' ' VAL . 47.1 m -153.37 166.37 32.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.563 -0.711 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.9 p -160.8 134.24 6.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.583 -0.698 . . . . 0.0 109.44 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -100.41 113.4 26.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.448 ' HA ' HG23 ' A' ' 154' ' ' THR . 9.9 m -94.81 142.39 27.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.697 . . . . 0.0 109.489 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -151.1 147.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.697 . . . . 0.0 109.352 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.496 ' HA ' HG23 ' A' ' 152' ' ' THR . 10.4 pt-20 -128.27 132.76 48.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.441 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.58 -171.38 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -64.25 -34.96 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.649 . . . . 0.0 109.45 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.418 ' HB2' HD12 ' A' ' 151' ' ' LEU . 7.0 t30 -95.89 152.96 39.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.68 . . . . 0.0 109.293 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.08 -22.52 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.858 3.705 . . . . 0.0 109.909 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.93 -23.25 27.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.548 -0.72 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' A' ' 148' ' ' ASN . 46.8 mt -84.2 -1.32 54.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.503 -0.748 . . . . 0.0 109.99 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 145' ' ' GLU . 3.7 m -63.35 146.07 54.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.485 -0.759 . . . . 0.0 109.434 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.409 ' CE1' HG13 ' A' ' 144' ' ' VAL . 27.2 p-80 -157.79 165.31 35.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.65 -0.656 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.3 m -137.57 133.87 34.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.45 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -91.66 94.44 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.91 139.16 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.586 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.8 t -126.46 103.86 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.523 -0.736 . . . . 0.0 109.536 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -99.78 165.3 11.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -144.63 138.0 27.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 tttp . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.726 . . . . 0.0 109.483 -179.981 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.493 HG23 HD23 ' A' ' 94' ' ' LEU . 9.4 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.9 108.33 7.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 0.0 109.416 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.794 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.1 m-85 -84.44 123.88 30.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.438 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.675 HD12 ' CB ' ' A' ' 114' ' ' LEU . 6.9 tp -138.58 112.97 8.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.573 -0.705 . . . . 0.0 109.274 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -142.25 140.53 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 0.0 109.801 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.58 112.47 23.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.527 -0.733 . . . . 0.0 109.287 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.23 152.88 51.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.509 -0.744 . . . . 0.0 109.717 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -102.85 170.41 8.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -60.78 -18.44 55.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.626 -0.671 . . . . 0.0 109.896 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 14.22 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.501 -0.749 . . . . 0.0 109.838 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.28 37.05 93.94 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.67 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.6 tp -111.48 165.88 11.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.956 . . . . 0.0 109.487 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -138.14 -41.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.506 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.66 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -163.67 -179.31 37.95 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -162.11 125.92 3.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.947 . . . . 0.0 109.471 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 59.75 30.8 20.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.534 -0.729 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.57 -60.49 4.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -75.22 168.17 20.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.951 . . . . 0.0 109.503 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.618 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.0 mt -81.74 156.4 70.33 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.21 -29.39 2.56 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.012 3.808 . . . . 0.0 109.847 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.618 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 32.8 p90 -107.25 173.85 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 109.521 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -124.05 106.06 10.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.9 tp -126.77 81.18 69.51 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.24 -39.36 15.71 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 125.213 3.942 . . . . 0.0 110.253 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.92 -47.17 84.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.516 -0.74 . . . . 0.0 109.491 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.9 t0 -64.58 -31.46 72.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.71 . . . . 0.0 109.496 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.75 -24.44 63.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 109.527 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -86.65 -29.68 22.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.468 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 26.3 t80 -69.81 -24.43 63.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.612 -0.68 . . . . 0.0 109.536 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -63.35 -45.82 89.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -65.2 -29.21 70.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.525 -0.734 . . . . 0.0 109.461 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.52 -29.39 56.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.358 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.419 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 12.5 mm100 -100.74 34.8 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -143.33 -35.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.634 -0.666 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.8 m -70.66 124.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.496 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.31 33.96 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -156.32 166.93 32.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.954 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.63 99.68 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.343 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.711 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.9 tmm? -72.57 134.39 45.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.421 HG21 HD11 ' A' ' 94' ' ' LEU . 27.7 t -138.32 117.8 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.579 -0.701 . . . . 0.0 109.46 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.711 HG13 ' SD ' ' A' ' 39' ' ' MET . 27.0 m -132.67 -174.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.558 -0.714 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.93 -168.32 32.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 34.8 ptt180 -81.78 -34.32 30.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.523 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -71.29 -38.52 71.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.597 -0.689 . . . . 0.0 109.399 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -75.43 -27.68 59.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 40.3 t80 -64.89 -42.4 94.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -75.09 -23.3 57.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.4 m -63.24 -26.13 68.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.89 161.66 44.67 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.72 -61.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.082 3.855 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -125.55 103.14 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -104.73 154.79 38.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.439 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.6 154.71 88.74 Favored 'Cis proline' 0 N--CA 1.508 2.362 0 O-C-N 123.388 1.204 . . . . 0.0 109.827 0.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.1 mt -72.73 131.26 84.42 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -80.11 170.25 16.64 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.687 3.591 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.04 27.31 17.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -177.47 155.1 1.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.525 -0.734 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -84.92 134.22 34.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -105.6 105.08 14.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.546 -0.721 . . . . 0.0 109.465 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.9 147.54 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.435 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 t -137.15 119.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 109.476 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.559 HD12 HG23 ' A' ' 76' ' ' VAL . 12.7 tp -98.95 116.84 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.06 140.02 39.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.426 ' CD2' ' HG3' ' A' ' 65' ' ' GLN . 12.4 p-80 -81.63 -27.33 34.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.561 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.426 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 59.4 mt-30 -71.51 137.51 48.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.649 -0.657 . . . . 0.0 109.426 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -94.28 31.69 1.67 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.686 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -121.79 -31.37 3.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.536 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -67.94 138.7 56.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -144.47 158.57 43.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.632 -0.667 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' H ' HG21 ' A' ' 75' ' ' VAL . . . -137.59 129.67 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -84.53 136.5 33.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.583 -0.698 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.7 36.8 75.98 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.91 158.82 38.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.599 -0.942 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 t -95.06 92.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.613 -0.679 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.692 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.1 t -74.4 104.83 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.474 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 82' ' ' VAL . 27.6 m -94.7 153.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.692 ' NE2' HG12 ' A' ' 75' ' ' VAL . 55.8 m-70 -136.14 28.41 3.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -161.27 149.55 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.708 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.414 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.0 t -68.92 -35.24 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.555 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.99 65.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.572 -0.705 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.99 86.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.562 HG22 HG21 ' A' ' 76' ' ' VAL . 30.9 t -68.15 -45.08 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.525 -0.735 . . . . 0.0 109.431 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.95 -29.25 66.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.628 -0.67 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.01 82.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.4 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -71.33 -33.94 70.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.606 -0.684 . . . . 0.0 109.455 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.29 67.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.596 -0.69 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -65.92 -39.35 90.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.661 -0.65 . . . . 0.0 109.502 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.8 -32.11 72.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.523 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -121.71 89.49 47.72 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 -22.36 7.02 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.094 3.863 . . . . 0.0 109.891 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -65.53 -26.49 67.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -97.95 179.16 4.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.659 -0.65 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -137.32 150.1 47.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.493 HD23 HG23 ' A' ' 1' ' ' THR . 12.3 tp -76.31 134.98 39.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.577 -0.702 . . . . 0.0 109.473 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.24 122.8 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.581 -0.7 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.414 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.3 mm -97.02 142.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.641 . . . . 0.0 109.402 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.628 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -121.28 -30.95 4.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.713 . . . . 0.0 109.484 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.56 178.78 37.5 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.86 -151.9 20.87 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.364 -1.668 . . . . 0.0 109.534 0.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.52 -26.51 65.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.963 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -68.94 -31.97 71.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 109.541 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.2 -40.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.689 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 31.3 m-85 -63.06 -47.18 84.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.96 -23.59 66.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.554 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.75 -29.6 51.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 82' ' ' VAL . 43.7 m-85 -114.5 20.26 15.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -63.1 -36.74 84.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.605 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -81.11 29.72 0.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.603 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -160.01 33.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.585 -0.697 . . . . 0.0 109.486 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.1 p -94.7 153.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.714 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.58 -61.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.308 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -96.42 111.75 23.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.603 -0.686 . . . . 0.0 109.342 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 136' ' ' PHE . 34.1 mt -95.66 98.43 10.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.573 -0.705 . . . . 0.0 109.626 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.675 ' CB ' HD12 ' A' ' 4' ' ' LEU . 30.3 mt -99.21 104.48 16.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 109.214 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -111.57 140.79 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.598 -0.689 . . . . 0.0 109.565 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.6 m -110.17 97.7 7.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 109.245 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.406 ' O ' HD12 ' A' ' 118' ' ' LEU . 61.2 mtt180 -80.44 151.13 29.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 117' ' ' ARG . 3.0 mp -127.53 136.16 51.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.242 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.72 -32.77 71.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.05 128.88 10.25 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.7 p -81.38 144.44 31.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.465 ' O ' HD22 ' A' ' 12' ' ' LEU . 98.3 m-85 -147.27 121.74 9.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.619 -0.676 . . . . 0.0 109.418 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.99 149.8 27.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.705 . . . . 0.0 109.522 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.67 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -149.05 -141.26 3.42 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.7 -30.76 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.558 -0.966 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.1 m -102.97 130.22 49.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.581 -0.699 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -108.43 175.23 5.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.573 -0.704 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -93.93 152.47 18.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.6 pt -75.19 164.29 62.2 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.78 98.08 1.11 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.178 3.919 . . . . 0.0 109.844 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.85 145.32 27.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.612 -0.68 . . . . 0.0 109.507 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -85.07 87.03 7.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.614 -0.679 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -73.26 -9.94 59.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.58 -31.26 72.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.4 36.7 1.44 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.48 ' CE2' HD11 ' A' ' 113' ' ' LEU . 40.4 m-85 -143.28 167.81 21.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.536 -0.728 . . . . 0.0 109.452 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -144.76 145.84 31.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 109.45 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HE3' ' CZ2' ' A' ' 158' ' ' TRP . 31.8 ttmt -75.28 152.66 38.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.28 -32.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -149.6 154.92 39.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 t -157.1 110.49 2.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.585 -0.697 . . . . 0.0 109.498 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -100.68 110.88 23.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.6 m -92.07 146.43 23.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.671 . . . . 0.0 109.402 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.411 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -150.47 132.1 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.552 -0.717 . . . . 0.0 109.329 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -107.61 123.47 48.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.685 . . . . 0.0 109.478 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.35 -165.52 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.583 -0.698 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -71.19 -39.55 71.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.89 137.7 19.36 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.551 -0.718 . . . . 0.0 109.408 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.39 -46.64 22.62 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 124.755 3.637 . . . . 0.0 110.052 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.92 69.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.73 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -80.2 20.53 0.66 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.711 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.7 m -89.45 141.32 28.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.408 -0.807 . . . . 0.0 109.354 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.443 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.9 p-80 -152.87 164.88 37.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.559 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.7 m -137.73 132.63 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.15 93.03 9.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.623 -0.673 . . . . 0.0 109.483 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 56.0 mm-40 -78.51 130.76 36.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.62 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.2 t -119.94 112.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.582 -0.699 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.521 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.9 m95 -110.84 157.5 19.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.518 -0.739 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -141.38 143.06 33.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.3 tttp . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.603 -0.685 . . . . 0.0 109.489 -179.989 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.462 HG23 HD23 ' A' ' 94' ' ' LEU . 2.8 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.05 101.45 8.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -74.73 126.89 31.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.513 -0.742 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.587 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.3 tp -140.11 112.99 8.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 109.313 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 9.7 p90 -142.67 141.92 31.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 0.0 109.731 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.81 112.53 24.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.576 -0.702 . . . . 0.0 109.213 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.13 149.42 52.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.607 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -97.41 170.14 9.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.619 -0.676 . . . . 0.0 109.452 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.55 -18.58 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.872 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.38 15.4 0.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 0.0 109.855 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.1 34.38 88.83 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.611 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.5 tp -107.54 165.25 11.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.596 -0.944 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 126' ' ' THR . 31.8 pt -138.61 -29.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.476 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.71 -168.85 33.05 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -174.43 124.35 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.49 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 60.03 33.56 21.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.51 -0.744 . . . . 0.0 109.735 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.35 4.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -76.03 176.11 8.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.548 -0.972 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.645 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 19.3 mt -86.92 156.59 55.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.707 . . . . 0.0 109.41 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -80.59 -31.51 1.5 Allowed 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.0 3.8 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.645 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 31.4 p90 -104.96 167.11 9.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.56 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -117.79 100.27 7.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.606 -0.684 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 21.7 tp -122.02 81.76 43.44 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.361 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.25 -38.89 15.38 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 125.181 3.92 . . . . 0.0 110.307 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.78 -41.34 99.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.528 -0.732 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.9 t0 -66.63 -31.58 72.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.642 -0.661 . . . . 0.0 109.422 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.05 -23.7 61.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.589 -0.695 . . . . 0.0 109.531 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -86.81 -29.8 22.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.567 -0.708 . . . . 0.0 109.452 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -70.97 -25.94 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 34' ' ' THR . 51.9 t80 -65.42 -45.23 84.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.661 . . . . 0.0 109.446 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -64.98 -29.3 70.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.475 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.69 51.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.642 -0.661 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -97.77 33.13 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 30' ' ' PHE . 10.3 p -137.37 -34.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' VAL . 26.6 m -68.62 126.17 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.557 -0.714 . . . . 0.0 109.433 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 36.28 23.58 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -153.24 166.21 33.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.521 -0.988 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.42 102.0 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.598 -0.689 . . . . 0.0 109.447 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.64 ' SD ' HG13 ' A' ' 41' ' ' VAL . 8.1 tmm? -70.38 125.72 27.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.58 -0.7 . . . . 0.0 109.435 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 94' ' ' LEU . 29.8 t -131.9 115.5 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.631 -0.668 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.64 HG13 ' SD ' ' A' ' 39' ' ' MET . 24.7 m -135.45 -177.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.702 . . . . 0.0 109.458 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.3 -178.62 35.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -72.27 -31.86 66.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.576 -0.955 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.22 -48.23 62.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -68.64 -25.95 65.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -68.54 -33.92 74.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.708 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.14 -26.15 19.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 t -74.9 10.11 1.59 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -81.76 166.42 37.7 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.83 -73.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.103 3.868 . . . . 0.0 109.968 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -118.23 71.94 0.85 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.55 -0.719 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -72.19 156.82 90.25 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.12 -175.86 17.48 Favored 'Cis proline' 0 N--CA 1.508 2.378 0 O-C-N 123.377 1.198 . . . . 0.0 109.946 0.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.5 HD12 ' CE ' ' A' ' 39' ' ' MET . 84.2 mt -107.73 104.25 52.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -74.56 179.83 5.55 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 124.645 3.564 . . . . 0.0 109.813 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.95 28.06 17.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.572 -0.705 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -176.1 178.76 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.416 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 m -98.47 117.47 32.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.464 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.437 HD21 ' HB2' ' A' ' 54' ' ' LEU . 21.3 m120 -88.78 105.99 18.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -114.9 141.37 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 109.438 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -131.94 123.49 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 76' ' ' VAL . 15.2 tp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.523 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.65 140.13 34.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.63 -0.669 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -94.74 29.74 2.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -147.56 142.46 26.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 109.442 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -88.65 30.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.703 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.57 -35.15 9.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -77.18 134.57 38.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.515 -0.74 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -146.29 116.41 7.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.47 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.68 131.98 53.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -84.66 138.42 32.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.562 -0.711 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.17 38.05 59.36 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.5 144.25 16.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.529 -0.983 . . . . 0.0 109.553 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -79.84 95.66 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.587 -0.696 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.593 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.0 t -79.99 106.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.509 HG21 HG22 ' A' ' 82' ' ' VAL . 28.0 m -94.88 150.82 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.593 ' NE2' HG12 ' A' ' 75' ' ' VAL . 31.8 m-70 -131.65 30.03 4.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.679 . . . . 0.0 109.464 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -163.87 144.55 8.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.454 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 106' ' ' PHE . 29.8 t -67.57 -32.95 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.585 -0.697 . . . . 0.0 109.476 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -32.96 72.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.667 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.86 75.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 76' ' ' VAL . 31.0 t -69.19 -44.14 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.42 -30.2 65.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.565 -0.71 . . . . 0.0 109.426 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.15 79.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.681 -0.637 . . . . 0.0 109.474 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -71.3 -33.45 69.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.553 -0.717 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.47 -31.16 65.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.92 -45.91 69.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.594 -0.692 . . . . 0.0 109.484 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -66.19 -26.79 67.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.552 -0.717 . . . . 0.0 109.509 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -118.94 89.75 39.38 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 -22.49 6.98 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.126 3.884 . . . . 0.0 109.984 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -65.82 -26.02 67.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.603 -0.686 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -104.24 179.46 4.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.512 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -140.36 150.61 44.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.653 -0.654 . . . . 0.0 109.462 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 40' ' ' VAL . 12.6 tp -75.28 137.84 41.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 109.486 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -144.24 116.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.656 -0.652 . . . . 0.0 109.473 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.516 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.5 mm -91.74 128.73 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.698 . . . . 0.0 109.379 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -107.13 -31.03 8.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.49 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.86 178.83 38.49 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.52 -151.71 21.81 Favored Glycine 0 N--CA 1.499 2.855 0 O-C-N 120.362 -1.67 . . . . 0.0 109.632 0.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.5 68.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.965 . . . . 0.0 109.519 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -70.51 -30.6 67.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -76.01 -37.75 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.533 -0.729 . . . . 0.0 109.494 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.516 ' CE1' HG22 ' A' ' 96' ' ' ILE . 28.9 m-85 -63.64 -50.02 70.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.399 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 -24.92 68.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.656 -0.653 . . . . 0.0 109.497 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.19 69.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 79' ' ' VAL . 77.6 m-85 -116.44 19.28 14.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -27.74 65.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.69 20.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.695 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -160.09 36.85 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.546 -0.721 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.661 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -96.99 141.31 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.589 -0.695 . . . . 0.0 109.473 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -122.03 -47.46 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.384 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.7 m -100.9 152.62 20.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.391 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.507 HD11 ' CE2' ' A' ' 136' ' ' PHE . 22.0 mt -136.12 96.95 3.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.624 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.624 ' CD2' HG22 ' A' ' 157' ' ' VAL . 38.2 mt -100.49 109.3 21.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.722 . . . . 0.0 109.292 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -119.23 141.98 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.0 m -109.21 103.08 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.58 -0.7 . . . . 0.0 109.267 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -88.22 138.88 31.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.702 . . . . 0.0 109.561 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.63 141.47 47.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.291 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.94 -32.35 63.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.503 -0.748 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.74 133.73 19.52 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.0 m -82.7 142.29 31.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.62 -0.929 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.546 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.6 m-85 -148.04 119.22 7.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.668 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -87.53 145.23 26.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.586 -0.697 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.611 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -140.72 -127.68 2.36 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -143.19 -32.59 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.951 . . . . 0.0 109.438 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.536 HG22 HD11 ' A' ' 13' ' ' ILE . 8.3 m -105.1 136.94 43.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -113.14 175.5 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.605 -0.684 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.6 tpt -92.13 152.61 19.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.528 -0.732 . . . . 0.0 109.558 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 pt -72.55 164.75 57.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.71 98.38 1.14 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 125.112 3.875 . . . . 0.0 109.919 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.56 147.0 26.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -84.45 84.81 7.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.558 -0.714 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -67.83 -19.31 65.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.718 . . . . 0.0 109.684 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -24.97 67.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -97.42 29.35 3.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.507 ' CE2' HD11 ' A' ' 113' ' ' LEU . 40.7 m-85 -143.57 175.2 10.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -149.47 144.28 26.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -84.43 114.75 22.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.47 -34.0 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.523 -0.736 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -155.41 171.45 19.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.726 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 t -164.51 127.64 2.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -98.7 111.91 24.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.556 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.528 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.2 m -91.29 145.38 24.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.484 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -149.24 125.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.509 -0.744 . . . . 0.0 109.345 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -104.79 121.32 43.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.61 -0.681 . . . . 0.0 109.436 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.56 -165.11 0.81 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.3 p -73.32 -40.7 64.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.723 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -103.45 137.58 19.29 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.61 -44.34 26.11 Favored 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 124.826 3.684 . . . . 0.0 110.093 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.7 71.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.631 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.97 19.43 1.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 109.66 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.4 m -91.13 134.29 34.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.543 -0.723 . . . . 0.0 109.437 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.609 ' CE1' HD21 ' A' ' 23' ' ' LEU . 37.4 p-80 -150.01 167.23 27.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 143' ' ' THR . 16.1 m -137.32 136.48 38.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -89.44 95.45 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.494 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.6 mt-10 -76.67 135.6 39.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.552 -0.717 . . . . 0.0 109.453 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 114' ' ' LEU . 27.9 t -126.19 97.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.565 -0.709 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.494 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 30.5 m95 -96.46 163.0 13.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.637 -0.664 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -143.31 144.77 32.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.62 -0.675 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 72.1 tttt . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 0.0 109.461 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.657 HG23 HD23 ' A' ' 94' ' ' LEU . 6.8 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.49 134.0 44.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.849 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.2 m-85 -104.76 153.99 20.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 109.381 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.701 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.2 tp -164.57 109.45 0.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.1 146.61 35.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.533 -0.729 . . . . 0.0 109.655 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.78 110.05 22.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.285 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -129.12 149.31 50.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.64 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -99.34 171.76 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 0.0 109.411 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.447 HH11 ' HB2' ' A' ' 9' ' ' ARG . 1.8 ptp180 -61.56 -19.53 62.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.641 -0.662 . . . . 0.0 109.806 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.53 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.486 -0.759 . . . . 0.0 109.795 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.16 37.0 93.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.447 HD23 ' CG ' ' A' ' 20' ' ' PRO . 5.5 tp -105.58 167.81 9.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.528 -0.983 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' A' ' 126' ' ' THR . 2.6 pp -144.92 -26.19 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.487 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -170.59 -170.97 35.48 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -172.65 120.28 0.39 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.575 -0.956 . . . . 0.0 109.442 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.92 33.42 21.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.506 -0.746 . . . . 0.0 109.706 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.98 3.68 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -77.24 178.27 7.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.506 -0.996 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.626 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.7 mt -83.7 155.5 65.21 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.447 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.6 Cg_endo -80.16 -30.92 1.92 Allowed 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 124.993 3.795 . . . . 0.0 109.886 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.626 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 31.7 p90 -105.76 168.11 9.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.545 -0.722 . . . . 0.0 109.538 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -115.19 107.61 15.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.675 . . . . 0.0 109.376 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.77 HD23 ' HB2' ' A' ' 26' ' ' ASP . 13.0 tp -129.31 80.49 72.18 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.578 -0.701 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.29 -40.05 16.46 Favored 'Trans proline' 0 N--CA 1.507 2.312 0 C-N-CA 125.162 3.908 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.67 -49.77 73.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 109.55 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.77 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.3 t0 -63.04 -31.35 72.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.631 HD22 H223 ' A' ' 170' ' ' TMQ . 96.1 mt -72.32 -24.73 61.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -86.74 -23.83 25.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.505 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.0 t80 -75.02 -24.63 58.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.507 ' O ' HG23 ' A' ' 34' ' ' THR . 53.4 t80 -63.24 -44.98 93.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.576 -0.703 . . . . 0.0 109.472 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -63.6 -26.15 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.566 -0.709 . . . . 0.0 109.463 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.56 -28.34 33.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.548 -0.72 . . . . 0.0 109.419 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 17.3 mm100 -103.06 34.12 3.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.691 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 30' ' ' PHE . 22.1 p -140.59 -34.73 0.51 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.2 m -77.29 131.16 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 109.419 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.03 -32.07 7.51 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -111.37 167.6 10.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.603 -0.939 . . . . 0.0 109.453 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.501 HG23 ' HB ' ' A' ' 58' ' ' THR . 58.8 mt -85.12 126.03 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 109.431 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.443 ' CE ' HD12 ' A' ' 54' ' ' LEU . 41.6 ttp -92.12 107.66 19.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.55 -0.719 . . . . 0.0 109.414 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.6 t -95.49 122.04 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.56 163.13 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.95 -164.28 39.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 23.6 ptt180 -82.28 -38.64 24.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.987 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -67.44 -33.33 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.623 -0.673 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -79.42 -27.55 41.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 109.459 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -65.51 -58.35 6.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.517 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.02 -26.71 68.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -62.7 -21.85 66.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.544 -0.722 . . . . 0.0 109.694 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -62.77 161.1 31.18 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.523 -0.736 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.17 -71.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 125.119 3.879 . . . . 0.0 109.901 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 pttp -115.77 75.74 0.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -78.39 156.48 78.55 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.04 166.86 75.92 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.423 1.223 . . . . 0.0 109.994 0.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.443 HD12 ' CE ' ' A' ' 39' ' ' MET . 53.6 mt -90.09 118.03 68.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.736 . . . . 0.0 109.315 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.65 174.3 12.49 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 124.765 3.644 . . . . 0.0 109.969 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.48 27.03 16.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.63 -0.668 . . . . 0.0 109.641 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -177.41 155.0 1.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.499 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.501 ' HB ' HG23 ' A' ' 38' ' ' ILE . 9.2 m -76.39 144.7 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -120.48 96.91 5.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.593 -0.692 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 t -100.34 151.57 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.69 120.2 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.697 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.506 HD12 HG23 ' A' ' 76' ' ' VAL . 17.0 tp -96.61 117.61 31.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.598 -0.689 . . . . 0.0 109.458 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -151.05 144.14 24.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.569 -0.707 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -103.06 31.14 4.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.574 -0.704 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -124.24 132.31 53.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.629 -0.669 . . . . 0.0 109.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.2 30.34 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.39 -30.69 5.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.589 -0.694 . . . . 0.0 109.513 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -66.58 142.56 57.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -137.58 142.45 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.7 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.91 117.65 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.593 -0.692 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -84.04 122.1 28.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.716 -0.615 . . . . 0.0 109.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.68 41.59 12.67 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.41 145.4 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.99 . . . . 0.0 109.479 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -83.07 97.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.564 -0.71 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.561 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.7 t -76.8 100.35 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.56 -0.713 . . . . 0.0 109.443 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.506 HG23 HD12 ' A' ' 62' ' ' LEU . 27.9 m -91.16 153.77 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.457 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.561 ' NE2' HG12 ' A' ' 75' ' ' VAL . 88.3 m-70 -135.35 30.34 3.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.566 -0.708 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -166.88 148.23 6.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.47 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.7 -33.33 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.422 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.94 -32.9 72.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.59 -36.07 80.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.65 -0.656 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 76' ' ' VAL . 31.7 t -69.8 -39.78 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.436 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -76.84 -31.43 56.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.643 -0.661 . . . . 0.0 109.52 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.08 78.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -72.98 -33.66 65.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.572 -0.705 . . . . 0.0 109.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.21 68.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -67.21 -42.54 83.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.639 -0.663 . . . . 0.0 109.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.18 -27.84 68.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.569 -0.707 . . . . 0.0 109.507 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -119.33 89.93 41.14 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.713 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.63 -22.99 7.44 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 125.112 3.875 . . . . 0.0 109.922 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -68.15 -26.9 66.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.592 -0.693 . . . . 0.0 109.415 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -97.9 179.89 4.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -139.47 165.7 26.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.545 -0.722 . . . . 0.0 109.483 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.657 HD23 HG23 ' A' ' 1' ' ' THR . 11.7 tp -96.59 128.75 43.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 t -132.08 133.57 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.511 -0.743 . . . . 0.0 109.483 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.542 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.4 mm -104.07 124.46 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.549 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -109.69 -27.96 9.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.22 -179.57 38.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.87 -154.8 19.55 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 120.317 -1.696 . . . . 0.0 109.554 -0.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.84 -32.27 73.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.608 -0.937 . . . . 0.0 109.486 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -71.04 -31.83 68.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 109.474 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -72.99 -36.0 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.542 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.2 m-85 -63.21 -55.63 23.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.582 -0.699 . . . . 0.0 109.554 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -62.55 -21.38 65.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.617 -0.677 . . . . 0.0 109.626 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.93 -36.87 78.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CE1' HG13 ' A' ' 79' ' ' VAL . 69.5 m-85 -113.41 18.7 17.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.681 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.609 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -66.98 -23.81 65.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 109.58 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.49 -45.42 59.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.08 38.84 1.12 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.607 -0.683 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.849 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -88.95 151.75 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 109.421 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -132.84 -61.85 0.83 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.515 HG23 HE21 ' A' ' 159' ' ' GLN . 7.6 m -93.55 159.82 15.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.433 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.43 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 34.3 mt -140.17 95.77 2.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 0.0 109.536 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.701 ' CB ' HD12 ' A' ' 4' ' ' LEU . 34.4 mt -95.08 103.36 15.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.316 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -109.24 136.18 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.539 -0.725 . . . . 0.0 109.452 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.0 m -107.39 102.95 12.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 109.388 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.9 146.49 26.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.607 -0.683 . . . . 0.0 109.539 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.78 132.1 51.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.623 -0.673 . . . . 0.0 109.272 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.88 -34.17 73.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.613 -0.679 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.86 130.59 27.95 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 t -79.82 139.85 37.06 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.58 -0.953 . . . . 0.0 109.49 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.413 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.3 m-85 -146.78 126.55 13.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.555 -0.715 . . . . 0.0 109.506 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.05 146.52 26.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.36 -124.01 1.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -145.04 -30.08 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.61 -0.935 . . . . 0.0 109.49 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.423 ' HB ' HD11 ' A' ' 13' ' ' ILE . 4.3 m -100.79 142.45 32.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.705 . . . . 0.0 109.509 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -118.02 176.05 5.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.572 -0.705 . . . . 0.0 109.461 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.428 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.597 -0.689 . . . . 0.0 109.5 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.3 pt -69.37 163.68 56.08 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.562 -0.711 . . . . 0.0 109.516 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.88 102.35 1.45 Allowed 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 125.047 3.831 . . . . 0.0 109.851 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.24 144.74 26.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -81.15 85.62 6.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.692 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -71.74 -14.1 61.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.852 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.05 10.05 1.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.0 109.897 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.86 31.73 3.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.468 -0.77 . . . . 0.0 109.417 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.43 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 66.3 m-85 -141.47 174.13 10.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.399 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.6 m -147.44 137.35 22.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.584 -0.698 . . . . 0.0 109.445 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -71.1 156.56 39.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.746 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.73 -36.02 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.701 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.7 m -148.2 163.63 36.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.8 t -158.86 157.63 31.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.558 -0.714 . . . . 0.0 109.501 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -142.92 101.09 3.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.488 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.475 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.7 m -85.52 143.22 28.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.432 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.424 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.9 p -147.18 129.18 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.541 -0.725 . . . . 0.0 109.372 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -105.25 121.34 43.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.563 -0.711 . . . . 0.0 109.461 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.32 -166.21 1.01 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.4 p -70.23 -39.63 74.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.596 -0.69 . . . . 0.0 109.61 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -105.35 137.84 19.38 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.647 -0.658 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -47.98 -45.54 24.66 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 C-N-CA 124.842 3.694 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.12 -29.98 70.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.559 -0.713 . . . . 0.0 109.689 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.1 mt -81.07 20.83 0.76 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.535 -0.728 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.6 m -91.37 137.99 31.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.424 ' NE2' HG11 ' A' ' 144' ' ' VAL . 34.5 p-80 -151.85 169.01 23.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.567 -0.708 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 143' ' ' THR . 23.0 m -142.73 132.51 24.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.628 -0.67 . . . . 0.0 109.434 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -89.61 101.0 13.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.5 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 38.2 mt-10 -85.9 128.98 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.72 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.602 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.8 t -114.96 112.7 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.534 -0.729 . . . . 0.0 109.51 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 31.2 m95 -109.32 164.06 12.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.515 HE21 HG23 ' A' ' 112' ' ' THR . 57.0 mm-40 -139.92 136.4 33.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.615 -0.678 . . . . 0.0 109.429 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -72.78 140.35 47.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.487 -0.758 . . . . 0.0 109.518 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -141.65 127.46 19.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.607 -0.683 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.432 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.631 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 2' ' ' ALA . 14.7 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 1' ' ' THR . . . -135.59 121.24 19.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.815 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -91.62 149.24 21.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 114' ' ' LEU . 11.0 tp -159.79 110.39 1.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.696 . . . . 0.0 109.401 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.43 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -143.77 147.99 34.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.572 -0.705 . . . . 0.0 109.749 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.23 111.88 23.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.538 -0.726 . . . . 0.0 109.255 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.451 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.8 pt20 -132.43 149.47 52.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.537 -0.727 . . . . 0.0 109.637 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -100.43 170.44 8.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.684 . . . . 0.0 109.458 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.25 -17.32 52.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.625 -0.672 . . . . 0.0 109.785 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.72 14.4 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.438 -0.789 . . . . 0.0 109.846 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.41 36.89 93.76 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.659 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.9 tp -112.23 166.55 11.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.549 -0.971 . . . . 0.0 109.526 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.657 HD11 HG22 ' A' ' 126' ' ' THR . 32.2 pt -139.8 -29.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.541 -0.724 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.496 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -171.73 -168.18 32.93 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -170.23 119.72 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.636 -0.92 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.95 29.81 19.36 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.566 -0.709 . . . . 0.0 109.742 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.89 -61.69 2.65 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -73.83 169.77 16.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.631 -0.923 . . . . 0.0 109.472 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.697 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 40.3 mt -84.84 155.92 61.3 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.616 -0.677 . . . . 0.0 109.422 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.4 Cg_endo -79.52 -28.08 3.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.046 3.831 . . . . 0.0 109.958 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.697 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.1 p90 -106.77 167.67 9.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -118.57 93.53 4.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.557 -0.714 . . . . 0.0 109.411 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.793 HD23 ' HB2' ' A' ' 26' ' ' ASP . 18.5 tp -114.97 80.73 6.99 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.555 -0.716 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.27 -38.67 15.19 Favored 'Trans proline' 0 N--CA 1.507 2.273 0 C-N-CA 125.139 3.893 . . . . 0.0 110.25 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.7 -44.25 96.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.698 . . . . 0.0 109.59 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.793 ' HB2' HD23 ' A' ' 23' ' ' LEU . 32.4 t70 -64.24 -41.07 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.515 -0.741 . . . . 0.0 109.436 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.661 HD22 ' C22' ' A' ' 170' ' ' TMQ . 95.0 mt -63.02 -23.72 67.58 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -85.0 -29.48 24.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.631 -0.668 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -70.8 -25.75 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.458 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.34 -52.2 59.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.545 -0.722 . . . . 0.0 109.453 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -68.32 2.09 2.51 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.601 -0.687 . . . . 0.0 110.022 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.06 -29.15 12.68 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.37 -0.832 . . . . 0.0 109.451 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -114.91 35.09 4.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.568 -0.707 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 p -132.91 -27.53 1.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.741 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.0 m -75.5 127.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.91 23.62 51.88 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.25 164.98 29.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.522 -0.987 . . . . 0.0 109.5 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -91.37 104.02 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.462 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.8 ttp -82.92 108.33 16.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.54 -0.725 . . . . 0.0 109.559 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.478 HG21 HD11 ' A' ' 94' ' ' LEU . 30.0 t -96.59 118.28 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.503 -0.748 . . . . 0.0 109.385 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 29.4 m -131.47 166.92 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.713 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.41 -160.71 36.59 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.7 -35.54 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.617 -0.931 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -69.5 -37.79 77.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -77.4 -27.23 52.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.498 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -65.51 -34.55 78.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -89.61 -24.03 21.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -62.91 -22.18 66.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.735 . . . . 0.0 109.601 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.501 ' HZ ' HG11 ' A' ' 41' ' ' VAL . 39.4 m-85 -62.73 159.8 41.23 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -80.45 -72.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.093 3.862 . . . . 0.0 109.89 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.3 pttm -108.07 74.12 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.498 -0.751 . . . . 0.0 109.423 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -78.73 156.03 77.89 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.489 -0.757 . . . . 0.0 109.528 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.18 171.09 63.39 Favored 'Cis proline' 0 N--CA 1.507 2.317 0 O-C-N 123.407 1.214 . . . . 0.0 109.957 0.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.462 HD12 ' CE ' ' A' ' 39' ' ' MET . 67.4 mt -94.58 115.39 65.25 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.55 -0.719 . . . . 0.0 109.332 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.0 -178.28 4.53 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.808 3.672 . . . . 0.0 109.953 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 60.65 28.21 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.549 -0.719 . . . . 0.0 109.686 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -176.68 179.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.729 . . . . 0.0 109.546 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.5 m -112.42 111.17 21.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.607 -0.683 . . . . 0.0 109.487 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.491 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -86.0 107.83 17.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.488 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 t -102.3 112.66 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.588 -0.695 . . . . 0.0 109.4 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.4 t -95.71 125.16 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.453 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.537 HD12 HG23 ' A' ' 76' ' ' VAL . 14.4 tp -104.56 114.79 29.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.542 -0.724 . . . . 0.0 109.5 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.42 140.89 33.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.576 -0.703 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -89.16 30.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -137.65 125.05 21.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.696 . . . . 0.0 109.465 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.7 29.83 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.601 -0.687 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.03 -37.46 6.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.601 -0.687 . . . . 0.0 109.55 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -70.83 143.7 51.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 109.518 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -145.75 101.45 3.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.577 -0.702 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.61 118.57 28.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.622 -0.674 . . . . 0.0 109.439 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -73.83 136.38 43.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.546 -0.722 . . . . 0.0 109.499 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.78 37.43 57.29 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.99 145.93 18.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.973 . . . . 0.0 109.515 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.78 98.91 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.608 -0.682 . . . . 0.0 109.501 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.607 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.3 t -80.42 99.41 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.58 -0.7 . . . . 0.0 109.436 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.537 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -99.97 158.57 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.61 -0.681 . . . . 0.0 109.433 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.607 ' NE2' HG12 ' A' ' 75' ' ' VAL . 81.0 m-70 -138.8 29.82 2.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.548 -0.72 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -167.85 148.75 5.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.551 -0.718 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.6 t -68.06 -31.69 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.612 -0.68 . . . . 0.0 109.475 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.53 -33.68 76.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.5 -0.75 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.41 75.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.683 . . . . 0.0 109.517 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 t -67.81 -43.92 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -73.19 -30.13 63.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.486 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.52 -36.68 83.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.597 -0.689 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -71.51 -34.02 69.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.5 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.0 -30.82 69.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.602 -0.686 . . . . 0.0 109.405 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -67.19 -34.63 77.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.534 -0.728 . . . . 0.0 109.493 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -69.43 -36.58 76.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -120.92 87.26 42.88 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.605 -0.684 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.45 20.22 0.98 Allowed 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 125.169 3.912 . . . . 0.0 109.952 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -100.96 -30.12 11.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.554 -0.716 . . . . 0.0 109.466 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -94.51 178.23 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.558 -0.713 . . . . 0.0 109.443 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -127.88 151.62 48.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.626 -0.671 . . . . 0.0 109.466 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.478 HD11 HG21 ' A' ' 40' ' ' VAL . 13.1 tp -83.17 108.26 16.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.629 -0.669 . . . . 0.0 109.483 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -113.91 131.42 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.553 -0.717 . . . . 0.0 109.419 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.528 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.9 mm -98.28 125.68 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.707 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.56 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -108.13 -27.52 10.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.553 -0.717 . . . . 0.0 109.503 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 160.85 -179.94 36.0 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.29 -152.26 17.54 Favored Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.315 -1.697 . . . . 0.0 109.585 0.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.4 73.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.582 -0.952 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -70.85 -30.45 66.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.76 -34.89 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.556 -0.715 . . . . 0.0 109.563 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.528 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.1 m-85 -64.39 -56.79 11.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.713 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.463 ' OG1' HD13 ' A' ' 129' ' ' ILE . 2.6 m -62.53 -21.18 65.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.661 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.93 73.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.535 -0.728 . . . . 0.0 109.528 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' CE1' HG13 ' A' ' 79' ' ' VAL . 69.9 m-85 -113.1 17.24 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.526 -0.734 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.64 ' O ' HG12 ' A' ' 110' ' ' VAL . 1.2 pptp? -67.06 -23.17 65.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.521 -0.737 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -66.77 -45.44 78.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.516 -0.74 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.23 44.97 1.0 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.815 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -93.96 147.83 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 0.0 109.442 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -136.94 -68.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.39 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -84.65 120.04 25.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.316 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 3' ' ' PHE . 19.1 mt -107.7 94.95 5.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.631 -0.668 . . . . 0.0 109.609 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.604 ' CB ' HD12 ' A' ' 4' ' ' LEU . 39.0 mt -91.33 115.51 28.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.645 -0.659 . . . . 0.0 109.343 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.43 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.6 p -124.31 138.71 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.573 -0.705 . . . . 0.0 109.509 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.9 m -109.87 101.4 10.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.564 -0.71 . . . . 0.0 109.234 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -87.68 139.81 30.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.625 -0.672 . . . . 0.0 109.614 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.73 140.15 47.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.58 -0.7 . . . . 0.0 109.331 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.81 -33.27 70.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.05 139.06 25.45 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.2 m -86.91 143.13 27.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.516 -0.991 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.621 ' O ' HD22 ' A' ' 12' ' ' LEU . 96.2 m-85 -148.45 108.73 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -80.1 147.04 31.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.531 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.659 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -144.46 -126.77 1.95 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -141.79 -41.79 0.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.587 -0.949 . . . . 0.0 109.482 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.657 HG22 HD11 ' A' ' 13' ' ' ILE . 6.8 m -90.52 126.98 36.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.509 -0.745 . . . . 0.0 109.435 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -104.53 172.22 6.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.625 -0.672 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.412 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -91.82 145.09 24.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.462 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.463 HD13 ' OG1' ' A' ' 104' ' ' THR . 24.4 pt -66.79 165.37 26.17 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.519 -0.738 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -80.52 108.83 2.19 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 125.173 3.915 . . . . 0.0 109.961 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -98.67 145.22 27.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -86.09 87.15 7.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -69.88 -17.25 63.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.608 -0.683 . . . . 0.0 109.82 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.86 -27.19 69.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.477 -0.764 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -93.3 30.9 1.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -149.91 164.15 36.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -139.07 136.18 34.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.698 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -70.12 149.17 47.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.631 -0.668 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.6 -31.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.469 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -143.87 153.3 42.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.572 -0.705 . . . . 0.0 109.522 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.2 p -155.48 113.3 3.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.544 -0.723 . . . . 0.0 109.501 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 tpt85 -91.24 103.31 16.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.482 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.7 m -85.55 141.4 29.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -146.72 129.77 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.597 -0.69 . . . . 0.0 109.322 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -108.3 120.7 43.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.4 -166.04 0.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.3 p -71.17 -42.77 68.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.554 -0.717 . . . . 0.0 109.588 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.18 137.75 19.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.573 -0.705 . . . . 0.0 109.428 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.87 -43.1 30.33 Favored 'Trans proline' 0 N--CA 1.508 2.333 0 C-N-CA 124.781 3.654 . . . . 0.0 110.126 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.48 73.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.565 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 151' ' ' LEU . 47.9 mt -80.91 20.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 109.629 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 36.6 m -90.85 141.93 28.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 109.473 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.549 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.5 p-80 -158.12 167.29 30.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.496 -0.752 . . . . 0.0 109.565 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.1 m -138.63 141.03 39.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.678 -0.638 . . . . 0.0 109.417 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -96.36 97.75 9.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.667 . . . . 0.0 109.467 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 21.8 mt-10 -81.36 139.46 35.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.578 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -124.97 107.29 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.578 -0.701 . . . . 0.0 109.478 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.44 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 31.4 m95 -103.97 165.13 11.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.685 . . . . 0.0 109.454 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -148.87 144.18 26.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.482 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -69.01 113.81 6.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -146.89 139.25 24.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.632 -0.667 . . . . 0.0 109.507 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.504 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.661 ' C22' HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.81 128.59 35.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.542 -0.724 . . . . 0.0 109.412 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.808 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -95.8 160.06 14.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.562 -0.711 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.619 HD12 ' CB ' ' A' ' 114' ' ' LEU . 12.1 tp -170.86 108.92 0.32 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.582 -0.698 . . . . 0.0 109.335 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.433 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.39 151.21 40.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.31 114.12 26.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.4 pt20 -135.61 150.65 49.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.48 -0.763 . . . . 0.0 109.681 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -100.86 170.73 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.526 -0.734 . . . . 0.0 109.366 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -61.17 -17.85 55.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.579 -0.701 . . . . 0.0 109.887 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.72 14.05 0.89 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.501 -0.749 . . . . 0.0 109.833 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.16 39.01 97.1 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.572 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.0 tp -112.25 163.95 13.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.95 . . . . 0.0 109.515 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.469 HD11 ' CG2' ' A' ' 126' ' ' THR . 2.5 pp -139.75 -27.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.518 -0.738 . . . . 0.0 109.514 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.16 -176.85 40.59 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -166.42 120.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.958 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.88 32.74 21.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.77 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -61.73 3.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -76.34 171.3 14.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.96 . . . . 0.0 109.493 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.594 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.1 mt -84.8 155.85 61.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 109.416 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 9.8 Cg_endo -78.9 -26.99 5.0 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 125.069 3.846 . . . . 0.0 109.97 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.594 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.5 p90 -108.37 167.31 10.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -118.83 97.6 5.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.633 -0.667 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 26' ' ' ASP . 21.5 tp -118.63 80.09 16.77 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.637 -0.664 . . . . 0.0 109.428 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.28 -37.82 14.3 Favored 'Trans proline' 0 N--CA 1.507 2.302 0 C-N-CA 125.193 3.928 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -63.02 -43.51 98.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.505 -0.747 . . . . 0.0 109.503 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.812 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.6 t0 -64.4 -35.0 79.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 109.396 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.68 -25.3 63.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.67 -0.644 . . . . 0.0 109.516 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -83.8 -28.51 28.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.435 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.441 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.7 t80 -74.01 -25.53 59.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.541 -0.725 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 34' ' ' THR . 53.2 t80 -65.01 -45.82 83.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.535 -0.728 . . . . 0.0 109.452 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' O ' HG13 ' A' ' 35' ' ' VAL . 41.4 ttp85 -65.69 -30.19 70.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.444 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.85 56.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 41.5 mm-40 -99.59 32.27 2.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 109.506 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.5 p -139.55 -31.33 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 31' ' ' ARG . 27.5 m -67.88 129.22 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -0.757 . . . . 0.0 109.456 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.09 56.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -155.35 170.35 22.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.561 -0.964 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' CG2' HG21 ' A' ' 60' ' ' VAL . 58.1 mt -99.62 111.66 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.593 -0.692 . . . . 0.0 109.426 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.435 ' CE ' HD12 ' A' ' 54' ' ' LEU . 38.4 ttp -87.05 106.87 18.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.522 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -93.56 119.46 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.556 -0.715 . . . . 0.0 109.413 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.43 160.49 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.562 -0.711 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.34 -170.2 46.69 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.12 -33.71 59.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.598 -0.943 . . . . 0.0 109.447 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -67.67 -47.32 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 109.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 m -70.1 -26.03 63.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.686 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -63.9 -43.54 95.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.573 -0.704 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.9 -22.96 33.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.531 -0.73 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.9 t -62.97 -23.9 67.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.546 -0.721 . . . . 0.0 109.621 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -63.98 160.23 48.93 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.725 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -80.83 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 125.124 3.882 . . . . 0.0 109.942 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -105.81 89.59 3.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.571 -0.705 . . . . 0.0 109.377 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -96.78 157.03 35.86 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.593 -0.692 . . . . 0.0 109.507 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.87 142.32 57.68 Favored 'Cis proline' 0 N--CA 1.509 2.4 0 O-C-N 123.325 1.171 . . . . 0.0 109.964 -0.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.435 HD12 ' CE ' ' A' ' 39' ' ' MET . 82.3 mt -61.85 111.17 4.02 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.577 -0.702 . . . . 0.0 109.413 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -78.43 -178.05 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 124.732 3.621 . . . . 0.0 109.949 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 60.96 29.21 18.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.588 -0.695 . . . . 0.0 109.56 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -177.24 177.42 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.466 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -100.2 119.32 38.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -93.18 104.53 16.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.568 -0.707 . . . . 0.0 109.511 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG21 ' CG2' ' A' ' 38' ' ' ILE . 30.4 t -105.75 120.81 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.514 -0.741 . . . . 0.0 109.495 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -106.5 127.38 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.731 . . . . 0.0 109.408 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.736 HD12 HG23 ' A' ' 76' ' ' VAL . 17.1 tp -102.34 120.75 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.654 -0.654 . . . . 0.0 109.468 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.11 155.41 44.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.396 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -86.24 -61.71 1.68 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.617 -0.677 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.37 145.54 37.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.655 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.38 30.95 0.59 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.547 -0.72 . . . . 0.0 109.535 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.55 -31.3 19.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 0.0 109.427 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -69.58 124.75 24.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.502 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -104.56 131.56 51.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.66 -0.65 . . . . 0.0 109.374 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.76 112.32 8.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.507 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -90.47 142.93 27.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.562 -0.711 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 34.74 61.03 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.49 141.93 15.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.955 . . . . 0.0 109.485 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -77.11 96.92 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.45 HG12 ' NE2' ' A' ' 77' ' ' HIS . 28.8 t -73.55 96.57 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.741 . . . . 0.0 109.481 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 62' ' ' LEU . 28.6 m -91.23 160.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.717 . . . . 0.0 109.471 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.45 ' NE2' HG12 ' A' ' 75' ' ' VAL . 80.1 m-70 -137.53 29.74 2.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.581 -0.699 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -170.65 146.39 2.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.572 -0.705 . . . . 0.0 109.456 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.549 HG13 ' CE2' ' A' ' 106' ' ' PHE . 30.4 t -68.17 -32.92 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -33.83 75.35 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.692 . . . . 0.0 109.485 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.19 -37.35 83.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.498 -0.751 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.456 HG22 HG21 ' A' ' 76' ' ' VAL . 30.9 t -69.03 -38.11 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.606 -0.684 . . . . 0.0 109.449 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -73.07 -30.75 63.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.74 86.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.61 -32.78 71.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.83 -31.03 68.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -65.64 -40.55 92.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -67.61 -32.13 72.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.546 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.82 89.75 42.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.59 -0.693 . . . . 0.0 109.521 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.08 -21.6 7.89 Favored 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 125.12 3.88 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.86 -26.74 67.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.545 -0.722 . . . . 0.0 109.421 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.01 -179.99 5.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.576 -0.703 . . . . 0.0 109.427 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -138.16 144.81 40.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.2 tp -86.07 132.59 34.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -139.29 131.04 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.589 -0.695 . . . . 0.0 109.504 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.562 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.6 mm -97.1 125.79 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.524 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -109.01 -25.13 10.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.504 -0.748 . . . . 0.0 109.474 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.29 -176.14 36.12 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.476 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.28 -152.4 9.12 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.259 -1.73 . . . . 0.0 109.546 0.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.84 82.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.946 . . . . 0.0 109.707 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.434 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 13.6 pm0 -66.1 -23.05 66.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.61 -0.681 . . . . 0.0 109.765 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.476 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.5 mm -77.31 -35.42 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.521 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' CE1' HG22 ' A' ' 96' ' ' ILE . 25.5 m-85 -64.0 -50.39 68.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.535 -0.728 . . . . 0.0 109.507 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -64.06 -26.22 68.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.57 -0.706 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.03 83.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.545 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 79' ' ' VAL . 55.3 m-85 -103.02 11.8 36.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.513 -0.742 . . . . 0.0 109.951 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.522 ' O ' HG12 ' A' ' 110' ' ' VAL . 44.9 tttm -71.54 -24.26 61.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.453 -0.779 . . . . 0.0 109.526 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -65.7 -41.54 92.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.722 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -110.77 37.41 2.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.582 -0.699 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.808 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -79.72 151.89 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.496 -0.752 . . . . 0.0 109.285 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -130.2 -68.79 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.66 -0.65 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -88.68 163.03 15.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.459 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.451 HD12 ' CD2' ' A' ' 136' ' ' PHE . 22.0 mt -142.19 89.74 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.556 -0.715 . . . . 0.0 109.56 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' CB ' HD12 ' A' ' 4' ' ' LEU . 43.9 mt -89.34 117.02 27.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.633 -0.667 . . . . 0.0 109.272 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.433 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -126.72 137.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.598 -0.689 . . . . 0.0 109.54 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.1 m -107.89 102.44 11.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.281 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -87.46 132.9 33.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.574 -0.704 . . . . 0.0 109.585 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.81 135.53 49.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.05 77.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.712 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.6 130.11 25.54 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.5 p -77.99 143.01 37.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.592 -0.946 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.552 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.3 m-85 -147.99 113.32 5.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.596 -0.69 . . . . 0.0 109.51 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.65 149.63 25.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.532 -0.73 . . . . 0.0 109.442 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.572 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -150.25 -127.86 1.52 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.52 -32.64 0.58 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.633 -0.922 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.469 ' CG2' HD11 ' A' ' 13' ' ' ILE . 2.7 m -93.93 147.44 23.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.698 . . . . 0.0 109.574 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -128.07 173.05 10.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.54 -0.725 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.7 tpt -98.01 151.09 20.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.496 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.5 pt -72.46 164.61 58.41 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.433 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.07 97.55 1.07 Allowed 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 125.106 3.87 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.3 mt -88.11 137.71 32.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.568 -0.708 . . . . 0.0 109.474 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -80.32 85.38 5.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.715 . . . . 0.0 109.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.92 -16.92 63.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 109.751 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.73 -24.91 67.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.745 . . . . 0.0 109.508 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.67 -29.44 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.555 -0.715 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.451 ' CD2' HD12 ' A' ' 113' ' ' LEU . 91.7 m-85 -87.89 169.56 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.563 -0.711 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.2 m -138.97 134.82 33.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.632 -0.668 . . . . 0.0 109.543 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -69.16 148.62 49.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 -34.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.1 p -149.53 157.91 43.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.563 -0.711 . . . . 0.0 109.369 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -157.62 122.37 4.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.48 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.29 100.2 11.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 109.479 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.543 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.2 m -82.07 146.48 29.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.699 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.407 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -148.88 131.24 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.625 -0.672 . . . . 0.0 109.315 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.477 ' OE2' HG22 ' A' ' 143' ' ' THR . 5.9 mp0 -111.88 118.4 35.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 0.0 109.49 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.46 -174.25 4.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.551 -0.718 . . . . 0.0 109.464 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.5 p -63.31 -44.06 96.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -89.34 156.13 48.55 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.145 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.76 -22.03 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 124.827 3.685 . . . . 0.0 109.943 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.28 -23.39 30.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.535 -0.728 . . . . 0.0 109.548 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -89.28 18.97 4.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.605 -0.684 . . . . 0.0 109.708 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.414 HG23 ' HG3' ' A' ' 145' ' ' GLU . 16.8 m -85.6 141.88 29.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.642 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.9 p-80 -158.48 168.26 27.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.646 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.543 HG23 ' HA ' ' A' ' 143' ' ' THR . 20.0 m -136.93 134.84 37.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.638 -0.664 . . . . 0.0 109.39 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.55 91.2 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.579 -0.701 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -71.79 145.28 48.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.605 -0.685 . . . . 0.0 109.418 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.602 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.0 t -133.56 104.3 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.659 . . . . 0.0 109.497 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.6 m95 -101.34 168.25 9.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -144.78 140.55 28.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.618 -0.676 . . . . 0.0 109.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -69.87 108.51 4.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -152.55 151.56 30.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.568 -0.707 . . . . 0.0 109.457 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.469 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.524 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.62 103.23 11.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.7 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -72.73 140.65 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.436 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.58 HD12 ' CB ' ' A' ' 114' ' ' LEU . 11.9 tp -154.42 111.87 3.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.585 -0.697 . . . . 0.0 109.305 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -142.79 141.88 31.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.585 -0.697 . . . . 0.0 109.757 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.21 110.5 21.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.577 -0.702 . . . . 0.0 109.294 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.521 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.3 pt20 -130.26 150.72 51.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.698 . . . . 0.0 109.676 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 p30 -98.9 169.66 9.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -60.93 -17.47 51.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.52 15.42 0.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.589 -0.694 . . . . 0.0 109.759 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.27 33.8 87.19 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.9 tp -109.45 164.0 12.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.947 . . . . 0.0 109.537 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' A' ' 7' ' ' GLN . 31.0 pt -137.94 -30.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 109.532 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -168.82 -176.96 39.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -162.54 124.59 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.969 . . . . 0.0 109.431 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.89 29.77 19.33 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.486 -0.759 . . . . 0.0 109.694 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.25 -64.13 1.67 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -75.42 -179.51 4.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.581 -0.952 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 55.3 mt -88.74 155.96 50.22 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.6 Cg_endo -80.12 -26.93 3.99 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 124.994 3.796 . . . . 0.0 109.887 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.593 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.8 p90 -108.09 170.89 7.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.551 -0.718 . . . . 0.0 109.562 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -122.54 100.2 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.673 -0.642 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.778 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.4 tp -121.3 82.47 38.65 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.623 -0.673 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 27' ' ' LEU . 7.9 Cg_exo -45.22 -39.04 15.35 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 125.142 3.894 . . . . 0.0 110.253 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -62.9 -49.7 73.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.778 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.2 t0 -63.35 -29.52 70.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.576 -0.702 . . . . 0.0 109.364 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.654 HD22 H223 ' A' ' 170' ' ' TMQ . 83.0 mt -72.71 -23.45 60.86 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.554 -0.716 . . . . 0.0 109.595 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -88.4 -26.38 22.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.712 . . . . 0.0 109.447 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.418 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 19.8 t80 -70.41 -25.9 63.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.568 -0.707 . . . . 0.0 109.464 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' THR . 60.9 t80 -63.19 -46.82 85.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.595 -0.691 . . . . 0.0 109.456 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 35' ' ' VAL . 53.4 ttt-85 -63.51 -29.87 71.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.707 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.54 -30.24 57.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.516 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 20.6 mm100 -99.18 33.74 2.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' PHE . 19.9 p -142.65 -32.49 0.49 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.584 -0.698 . . . . 0.0 109.426 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.5 m -69.98 126.13 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.69 . . . . 0.0 109.502 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.32 34.53 25.83 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -155.84 171.35 20.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.949 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.68 98.53 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.597 -0.689 . . . . 0.0 109.419 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.708 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.2 tmm? -70.03 132.23 45.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.586 -0.696 . . . . 0.0 109.474 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 t -137.2 118.91 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.581 -0.699 . . . . 0.0 109.484 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.708 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.8 m -133.82 179.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 109.474 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.38 -168.34 41.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -80.69 -39.59 26.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.666 -0.902 . . . . 0.0 109.479 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -73.86 -32.31 63.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.543 -0.723 . . . . 0.0 109.457 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -76.23 -30.48 57.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 52' ' ' ARG . 27.9 t80 -64.27 -58.4 6.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.511 -0.743 . . . . 0.0 109.428 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -64.52 -15.65 61.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.535 -0.728 . . . . 0.0 109.793 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.0 t -62.4 -28.73 69.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.775 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -66.61 162.69 48.47 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.591 -0.693 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.72 -69.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 125.129 3.886 . . . . 0.0 109.934 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -104.86 143.41 33.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.71 . . . . 0.0 109.472 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HD2' ' CE2' ' A' ' 46' ' ' TYR . 21.3 mtm105 -144.82 161.96 40.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.561 -0.712 . . . . 0.0 109.491 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.73 148.54 76.11 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.449 1.236 . . . . 0.0 109.894 -0.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.516 HD12 ' CE ' ' A' ' 39' ' ' MET . 75.0 mt -62.17 111.33 4.41 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.559 -0.713 . . . . 0.0 109.444 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.62 174.03 12.29 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.873 3.715 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 61.73 24.87 14.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.543 -0.723 . . . . 0.0 109.606 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -177.18 148.45 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.688 . . . . 0.0 109.595 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 m -79.21 126.27 30.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.499 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.495 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.4 m-80 -100.2 117.61 34.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.54 -0.725 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -114.31 146.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.621 -0.675 . . . . 0.0 109.45 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.38 118.71 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.493 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 76' ' ' VAL . 12.5 tp -97.56 107.03 19.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.72 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.401 HG23 ' CE1' ' A' ' 77' ' ' HIS . 4.0 t -137.71 155.59 48.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.603 -0.686 . . . . 0.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -98.41 -30.67 12.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.27 124.46 25.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -84.03 29.9 0.54 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.618 -0.676 . . . . 0.0 109.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -102.4 -34.79 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.574 -0.704 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -71.96 140.45 49.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -144.18 104.19 4.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.476 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.82 118.37 27.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -79.24 123.88 27.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.549 -0.72 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.5 37.44 10.75 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.4 144.95 19.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.966 . . . . 0.0 109.534 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.74 93.23 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.509 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.9 t -77.11 102.11 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.604 -0.685 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.524 HG21 HG22 ' A' ' 82' ' ' VAL . 27.9 m -97.68 155.05 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.554 -0.716 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.509 ' NE2' HG12 ' A' ' 75' ' ' VAL . 61.6 m-70 -135.01 29.33 3.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.63 -0.669 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -159.77 141.65 13.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.627 -0.671 . . . . 0.0 109.546 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.8 t -67.6 -34.31 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.544 -0.723 . . . . 0.0 109.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.28 -31.83 67.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.58 80.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.592 -0.693 . . . . 0.0 109.536 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -68.15 -40.23 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -72.66 -31.91 65.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.721 . . . . 0.0 109.463 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.46 -34.9 78.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.66 -0.65 . . . . 0.0 109.565 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -69.48 -35.21 75.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.628 -0.67 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.65 68.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.499 -0.751 . . . . 0.0 109.488 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -68.27 -34.54 76.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.57 -0.706 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -69.63 -32.4 71.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -120.6 87.95 42.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.685 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.39 20.1 0.99 Allowed 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 125.116 3.878 . . . . 0.0 109.939 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.66 -30.02 12.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.565 -0.71 . . . . 0.0 109.491 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -105.68 178.41 4.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.595 -0.691 . . . . 0.0 109.466 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -127.02 155.8 42.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.624 -0.673 . . . . 0.0 109.452 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.8 tp -81.46 123.0 28.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.559 -0.713 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -124.64 120.07 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.3 mm -97.67 125.25 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.636 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -104.7 -24.82 12.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.17 -175.86 40.2 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.483 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.06 -155.72 22.16 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.283 -1.716 . . . . 0.0 109.588 -0.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.42 75.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.647 -0.914 . . . . 0.0 109.525 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -73.12 -28.18 62.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.557 -0.715 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.483 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -71.72 -37.61 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.587 -0.696 . . . . 0.0 109.56 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 96' ' ' ILE . 30.3 m-85 -63.02 -47.57 82.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.607 -0.683 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.5 m -63.07 -24.47 67.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.594 -0.691 . . . . 0.0 109.538 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -40.77 60.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 79' ' ' VAL . 58.8 m-85 -103.97 21.05 17.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.583 -0.698 . . . . 0.0 109.646 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -23.59 53.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.525 -0.734 . . . . 0.0 109.498 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.82 18.7 0.58 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.499 -0.751 . . . . 0.0 109.745 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -160.08 38.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.416 -0.803 . . . . 0.0 109.419 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.7 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -93.56 152.84 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.691 . . . . 0.0 109.404 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -138.87 -45.12 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 109.396 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.526 HG23 HE21 ' A' ' 159' ' ' GLN . 27.5 m -106.54 122.61 46.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.669 . . . . 0.0 109.326 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.448 HD12 ' CD1' ' A' ' 136' ' ' PHE . 30.8 mt -108.57 101.48 10.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.646 -0.658 . . . . 0.0 109.626 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.58 ' CB ' HD12 ' A' ' 4' ' ' LEU . 43.7 mt -102.47 106.31 17.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -114.3 140.1 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.618 -0.676 . . . . 0.0 109.505 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.8 m -110.4 100.97 9.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.601 -0.687 . . . . 0.0 109.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -84.62 144.3 28.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.566 -0.708 . . . . 0.0 109.58 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mp -119.65 136.06 54.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.705 . . . . 0.0 109.342 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.78 -35.54 77.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.437 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.23 126.79 13.64 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 63.6 p -79.75 143.2 34.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.569 -0.959 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.613 ' O ' HD22 ' A' ' 12' ' ' LEU . 99.8 m-85 -148.01 112.4 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.602 -0.686 . . . . 0.0 109.43 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.38 149.24 31.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.626 -0.671 . . . . 0.0 109.484 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.63 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.02 -129.29 1.86 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.56 -29.03 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.624 -0.927 . . . . 0.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.479 HG22 HD11 ' A' ' 13' ' ' ILE . 2.6 m -98.38 145.99 26.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -127.49 170.68 12.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.605 -0.684 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.3 tpt -93.15 151.9 19.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.4 pt -72.45 164.64 58.13 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.621 -0.674 . . . . 0.0 109.508 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.03 93.41 1.06 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.168 3.912 . . . . 0.0 109.914 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 71.7 mt -80.51 144.56 32.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.552 -0.717 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -84.82 85.79 7.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.405 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -71.48 -7.84 50.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.578 -0.701 . . . . 0.0 109.972 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.57 -31.82 72.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.357 -0.84 . . . . 0.0 109.587 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -98.63 32.35 2.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.553 -0.717 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.448 ' CD1' HD12 ' A' ' 113' ' ' LEU . 27.6 m-85 -138.9 169.5 17.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.434 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.6 m -150.15 147.06 27.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.547 -0.721 . . . . 0.0 109.446 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -86.08 116.41 24.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.725 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.41 -35.42 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.4 t -149.89 172.95 14.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.627 -0.67 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.2 t -165.78 123.51 1.5 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.459 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -100.66 105.5 16.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.592 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.5 m -86.87 152.25 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.545 -0.722 . . . . 0.0 109.395 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.423 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -154.87 133.06 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.16 123.19 49.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.94 -174.3 5.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.9 p -63.3 -40.55 97.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.634 -0.667 . . . . 0.0 109.451 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -91.97 155.0 43.53 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 109.288 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -77.87 -24.68 8.31 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 124.887 3.725 . . . . 0.0 109.865 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.63 -23.25 31.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 0.0 109.536 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.0 mt -88.4 20.29 3.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.602 -0.686 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.7 m -82.51 144.68 30.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.767 . . . . 0.0 109.367 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.551 ' CE1' HD21 ' A' ' 23' ' ' LEU . 30.1 p-80 -158.54 162.74 37.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.536 -0.727 . . . . 0.0 109.615 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 143' ' ' THR . 25.3 m -135.46 137.54 42.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.671 -0.643 . . . . 0.0 109.443 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.77 98.45 11.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.509 -0.744 . . . . 0.0 109.451 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 1.2 mp0 -80.44 134.28 35.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.448 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.1 t -123.84 99.64 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.443 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 34.2 m95 -97.5 164.46 12.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.579 -0.701 . . . . 0.0 109.523 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.526 HE21 HG23 ' A' ' 112' ' ' THR . 55.1 mm-40 -140.38 145.49 37.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.585 -0.697 . . . . 0.0 109.467 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -67.07 115.64 7.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.542 -0.724 . . . . 0.0 109.447 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -152.81 151.91 30.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.563 -0.711 . . . . 0.0 109.469 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.489 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.654 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.5 132.32 29.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.818 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.0 m-85 -97.07 162.56 13.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.617 -0.677 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.653 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.9 tp -171.18 107.81 0.27 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.537 -0.727 . . . . 0.0 109.269 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -141.75 147.66 37.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.524 -0.735 . . . . 0.0 109.711 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.84 115.18 26.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.588 -0.695 . . . . 0.0 109.179 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.0 pt20 -136.21 151.99 50.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.652 -0.655 . . . . 0.0 109.685 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -101.74 170.38 8.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.59 -0.694 . . . . 0.0 109.373 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -60.89 -17.48 50.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 109.946 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.94 14.33 0.87 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.552 -0.718 . . . . 0.0 109.876 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.19 36.66 93.3 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.621 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.7 tp -112.26 164.4 13.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.916 . . . . 0.0 109.578 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 7' ' ' GLN . 31.6 pt -138.69 -29.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -169.17 -165.92 27.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -173.8 122.46 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.959 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 57.9 35.01 24.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.624 -0.673 . . . . 0.0 109.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -62.81 3.65 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -76.17 171.95 13.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.564 -0.962 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.557 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 16.9 mt -86.65 157.89 54.68 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.97 -27.18 3.96 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.03 3.82 . . . . 0.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.557 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.0 p90 -108.37 163.35 13.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.565 -0.709 . . . . 0.0 109.513 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -115.55 89.59 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.8 tp -107.7 79.57 0.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.68 -37.96 16.48 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 125.114 3.876 . . . . 0.0 110.251 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.79 -45.8 90.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.554 -0.716 . . . . 0.0 109.58 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.3 t0 -62.71 -38.99 92.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 0.0 109.442 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.82 -24.0 67.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.632 -0.668 . . . . 0.0 109.468 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -83.7 -27.84 28.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.625 -0.672 . . . . 0.0 109.48 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.0 t80 -76.76 -26.04 54.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.493 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.518 ' O ' HG23 ' A' ' 34' ' ' THR . 61.1 t80 -67.02 -45.31 77.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.579 -0.701 . . . . 0.0 109.453 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -64.76 -29.43 70.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.74 -28.74 44.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.602 -0.686 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 78.3 mm-40 -101.44 33.5 2.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.506 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.5 p -137.69 -33.76 0.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.73 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.576 -0.703 . . . . 0.0 109.47 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -29.49 12.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.47 165.17 12.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.545 -0.973 . . . . 0.0 109.495 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.5 mt -80.84 121.85 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.62 -0.675 . . . . 0.0 109.48 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.434 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.8 ttp -90.88 107.33 19.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.602 -0.686 . . . . 0.0 109.517 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 HD21 ' A' ' 94' ' ' LEU . 30.6 t -96.48 124.47 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.62 -0.675 . . . . 0.0 109.468 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.82 166.07 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.512 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.02 -169.24 44.47 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -77.7 -34.18 52.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.565 -0.962 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.78 -45.14 72.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.59 -0.694 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.7 m -71.07 -25.94 62.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.695 . . . . 0.0 109.533 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -63.96 -38.73 92.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -87.75 -20.24 26.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.4 m -62.78 -25.58 68.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.749 . . . . 0.0 109.621 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -66.58 160.6 66.19 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.62 -0.675 . . . . 0.0 109.412 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.29 -73.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.125 3.883 . . . . 0.0 109.821 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -103.51 92.32 4.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.596 -0.69 . . . . 0.0 109.417 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 3.8 ptm180 -99.25 154.53 37.25 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.618 -0.676 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.97 151.07 83.46 Favored 'Cis proline' 0 N--CA 1.51 2.463 0 O-C-N 123.309 1.163 . . . . 0.0 109.952 -0.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.434 HD12 ' CE ' ' A' ' 39' ' ' MET . 77.8 mt -69.25 123.84 89.17 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.654 -0.653 . . . . 0.0 109.289 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.28 176.85 9.25 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.676 3.584 . . . . 0.0 109.937 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 61.04 28.66 18.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.585 -0.697 . . . . 0.0 109.729 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.28 170.52 2.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.548 -0.72 . . . . 0.0 109.496 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 m -105.93 118.76 37.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.597 -0.689 . . . . 0.0 109.514 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.468 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -85.73 101.54 12.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.597 -0.689 . . . . 0.0 109.466 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 t -99.22 100.38 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.429 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -86.42 135.99 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 109.466 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.803 HD12 HG23 ' A' ' 76' ' ' VAL . 15.4 tp -110.51 113.7 26.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.676 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.59 145.53 36.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.641 -0.662 . . . . 0.0 109.492 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -98.21 -26.87 14.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -70.43 136.9 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.654 -0.654 . . . . 0.0 109.44 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.1 29.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.728 . . . . 0.0 109.508 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -111.44 -28.81 8.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.592 -0.693 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.34 140.87 58.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.536 -0.727 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -140.86 104.55 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -97.51 126.06 42.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 0.0 109.549 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -92.03 131.93 36.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.11 39.89 62.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.52 141.58 17.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.627 -0.926 . . . . 0.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.6 t -72.7 95.62 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.611 -0.681 . . . . 0.0 109.448 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 70' ' ' ALA . 30.8 t -81.47 98.39 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 62' ' ' LEU . 27.9 m -92.76 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.653 -0.655 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -140.73 30.68 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -169.14 142.74 2.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.603 -0.686 . . . . 0.0 109.477 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 106' ' ' PHE . 30.4 t -67.06 -35.04 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.18 -31.25 69.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.55 -0.719 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.52 -35.93 80.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.549 -0.719 . . . . 0.0 109.447 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 76' ' ' VAL . 30.0 t -68.45 -38.37 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.578 -0.701 . . . . 0.0 109.476 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -69.24 -31.31 69.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.602 -0.686 . . . . 0.0 109.491 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.9 -36.83 83.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.683 -0.636 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -69.58 -31.69 70.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.673 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.23 -27.13 60.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 109.429 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.5 tttt -64.21 -44.31 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.618 -0.676 . . . . 0.0 109.519 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -65.77 -30.27 70.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.578 -0.701 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -119.16 89.98 40.7 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.663 -0.648 . . . . 0.0 109.455 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -22.08 7.51 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.118 3.879 . . . . 0.0 109.874 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.67 -27.24 67.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 109.415 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -95.22 -180.0 4.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.55 -0.719 . . . . 0.0 109.511 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -138.44 169.3 18.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.532 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 95' ' ' VAL . 4.1 tt -104.02 121.58 43.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.646 -0.659 . . . . 0.0 109.497 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.472 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.5 t -122.3 133.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.458 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.567 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.3 mm -102.24 120.68 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.581 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -108.56 -25.45 10.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.675 . . . . 0.0 109.489 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.64 -178.37 38.42 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -84.83 -153.21 18.79 Favored Glycine 0 N--CA 1.5 2.961 0 O-C-N 120.223 -1.751 . . . . 0.0 109.565 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.09 -32.51 73.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.586 -0.949 . . . . 0.0 109.502 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -74.36 -27.71 60.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.412 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.9 mm -76.07 -34.59 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.558 -0.713 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.567 ' CE1' HG22 ' A' ' 96' ' ' ILE . 21.3 m-85 -63.04 -52.37 63.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.569 HG23 HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -64.9 -23.42 67.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.531 -0.731 . . . . 0.0 109.548 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.21 -40.57 77.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 79' ' ' VAL . 71.3 m-85 -104.28 14.4 30.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.559 -0.713 . . . . 0.0 109.908 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 110' ' ' VAL . 31.6 ttmt -70.05 -24.68 63.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.418 -0.802 . . . . 0.0 109.53 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.37 -44.21 79.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -101.42 38.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.644 -0.66 . . . . 0.0 109.458 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.818 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -83.97 147.6 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.688 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -129.38 -63.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.591 -0.693 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.49 164.12 13.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 109.377 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.524 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 41.8 mt -143.15 93.22 2.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.581 -0.699 . . . . 0.0 109.597 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.653 ' CB ' HD12 ' A' ' 4' ' ' LEU . 45.1 mt -91.71 114.16 26.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -122.05 138.18 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.551 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.3 m -109.31 98.17 7.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.642 -0.661 . . . . 0.0 109.282 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -84.0 134.11 34.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.95 142.65 36.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.622 -0.674 . . . . 0.0 109.314 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.453 ' HB3' ' OG1' ' A' ' 152' ' ' THR . . . -73.53 -38.76 65.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.691 . . . . 0.0 109.505 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.64 136.44 26.07 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.6 p -85.67 145.79 27.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 109.476 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.426 ' O ' HD22 ' A' ' 12' ' ' LEU . 99.4 m-85 -147.82 122.69 9.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.584 -0.698 . . . . 0.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 123' ' ' GLU . 10.4 pt-20 -81.68 161.2 23.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.608 -0.683 . . . . 0.0 109.519 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.621 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -162.79 -134.87 1.71 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -142.1 -34.58 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.984 . . . . 0.0 109.449 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.489 HG22 HD11 ' A' ' 13' ' ' ILE . 4.1 m -95.82 143.08 27.35 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.524 -0.735 . . . . 0.0 109.505 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -122.26 173.68 7.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.605 -0.684 . . . . 0.0 109.403 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -93.3 152.02 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.536 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.569 HD13 HG23 ' A' ' 104' ' ' THR . 30.6 pt -73.58 164.06 63.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.627 -0.671 . . . . 0.0 109.511 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.11 99.53 1.19 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.137 3.891 . . . . 0.0 109.878 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.42 144.52 27.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.63 -0.669 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.5 83.21 3.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -71.89 -18.58 62.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.654 -0.654 . . . . 0.0 109.693 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.04 10.07 1.34 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.488 -0.758 . . . . 0.0 110.017 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -123.93 -31.75 3.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.498 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.524 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 86.1 m-85 -81.27 173.59 12.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.541 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.5 m -142.34 121.06 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.622 -0.674 . . . . 0.0 109.514 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -66.75 154.74 39.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.566 -0.709 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.5 -34.75 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.519 -0.738 . . . . 0.0 109.481 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.8 t -148.94 165.97 29.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 109.479 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 t -158.76 119.86 3.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.547 -0.721 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.7 ttt-85 -93.14 108.65 20.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.529 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.6 m -90.76 143.07 27.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -144.88 134.61 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.462 ' HA ' HG22 ' A' ' 152' ' ' THR . 44.2 mt-10 -112.52 120.06 40.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.591 -0.693 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -81.49 -173.19 4.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.71 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.0 p -63.29 -41.37 98.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.584 -0.698 . . . . 0.0 109.483 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.23 154.96 44.84 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.576 -0.703 . . . . 0.0 109.23 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -77.52 -25.79 7.79 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 124.819 3.679 . . . . 0.0 109.844 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.97 -22.81 31.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.562 -0.711 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -87.39 18.92 3.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 145' ' ' GLU . 7.3 p -85.23 146.62 26.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.403 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.501 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.8 p-80 -159.13 171.56 19.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.644 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.529 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.7 m -140.76 133.43 28.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.686 -0.634 . . . . 0.0 109.371 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -89.6 97.4 11.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.13 143.7 37.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 109.429 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.551 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.7 t -128.49 104.81 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.728 . . . . 0.0 109.532 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.414 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 28.3 m95 -102.79 166.72 10.32 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.614 -0.679 . . . . 0.0 109.463 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -144.42 138.5 27.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.616 -0.677 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -73.93 106.15 5.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -159.36 154.74 25.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.588 -0.695 . . . . 0.0 109.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.485 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.581 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.14 122.17 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.55 -0.719 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.792 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -93.75 151.72 19.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.641 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.506 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.3 tp -163.15 110.92 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.592 -0.693 . . . . 0.0 109.331 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -141.85 140.01 32.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.517 -0.739 . . . . 0.0 109.743 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.94 109.4 20.63 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' HB3' HG22 ' A' ' 13' ' ' ILE . 8.0 pt20 -130.0 147.24 51.73 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.678 . . . . 0.0 109.616 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -94.68 170.16 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.617 -0.677 . . . . 0.0 109.43 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -60.84 -18.12 53.92 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.587 -0.696 . . . . 0.0 109.897 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.61 14.92 0.9 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.73 . . . . 0.0 109.801 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.03 36.41 92.84 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.593 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.8 tp -108.83 167.6 9.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.558 -0.966 . . . . 0.0 109.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 126' ' ' THR . 30.3 pt -142.65 -30.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.25 -169.44 22.6 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -175.21 116.22 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.614 -0.933 . . . . 0.0 109.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.94 35.62 21.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.478 -0.764 . . . . 0.0 109.699 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.68 -61.11 4.42 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -79.18 170.95 15.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.525 -0.985 . . . . 0.0 109.471 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.552 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 35.4 mt -80.37 156.55 73.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.432 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -80.25 -27.44 3.59 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.061 3.84 . . . . 0.0 109.945 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.552 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 33.0 p90 -108.82 163.61 13.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 0.0 109.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -116.25 87.7 2.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.1 tp -107.29 80.44 0.87 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.601 -0.687 . . . . 0.0 109.47 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -45.76 -37.53 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.314 0 C-N-CA 125.061 3.841 . . . . 0.0 110.241 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.7 -45.91 90.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.592 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.786 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.0 t0 -62.85 -37.28 86.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.642 -0.661 . . . . 0.0 109.465 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.22 -24.21 67.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.51 -0.744 . . . . 0.0 109.506 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -85.3 -28.93 24.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.578 -0.701 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 25.9 t80 -74.87 -26.72 59.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.478 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.493 ' O ' HG23 ' A' ' 34' ' ' THR . 53.1 t80 -66.63 -45.1 80.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.581 -0.699 . . . . 0.0 109.486 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -65.93 -31.66 72.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.71 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.9 -31.35 59.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.481 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 64.8 mm-40 -96.26 31.35 2.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.542 -0.724 . . . . 0.0 109.439 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 30' ' ' PHE . 10.4 p -136.84 -35.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 129.63 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.671 . . . . 0.0 109.501 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.78 -27.56 18.4 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER -110.6 178.94 4.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.479 -1.012 . . . . 0.0 109.517 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.458 HG23 ' HB ' ' A' ' 58' ' ' THR . 58.1 mt -98.05 122.84 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.713 . . . . 0.0 109.522 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.501 ' CE ' HD12 ' A' ' 54' ' ' LEU . 56.7 ttp -88.54 102.25 14.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.54 -0.725 . . . . 0.0 109.456 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG21 HD11 ' A' ' 94' ' ' LEU . 30.3 t -94.78 115.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.599 -0.688 . . . . 0.0 109.498 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.0 m -139.82 166.35 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 109.493 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.53 -170.18 46.65 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -79.64 -33.16 41.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.541 -0.976 . . . . 0.0 109.5 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -71.63 -33.91 69.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.1 m -81.14 -30.84 34.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -66.99 -29.24 69.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.445 -0.785 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.89 -18.23 24.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.7 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.4 p -62.46 -24.38 67.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.5 -0.75 . . . . 0.0 109.645 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -65.21 160.77 54.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.69 -68.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.14 3.893 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.85 127.0 51.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.562 -0.711 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.9 mtp-105 -123.14 157.43 60.92 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.489 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.55 -166.78 5.47 Favored 'Cis proline' 0 N--CA 1.509 2.416 0 O-C-N 123.4 1.211 . . . . 0.0 109.941 -0.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.501 HD12 ' CE ' ' A' ' 39' ' ' MET . 60.1 mt -113.34 96.17 38.5 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.515 -0.741 . . . . 0.0 109.441 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -72.33 -177.7 2.86 Favored 'Trans proline' 0 N--CA 1.504 2.144 0 C-N-CA 124.656 3.57 . . . . 0.0 109.755 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 61.59 25.49 15.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.558 -0.714 . . . . 0.0 109.534 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -176.3 177.32 1.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 38' ' ' ILE . 3.6 m -96.61 130.91 43.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -102.28 100.47 10.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.591 -0.693 . . . . 0.0 109.477 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 t -110.66 107.01 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.738 . . . . 0.0 109.386 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.4 t -98.97 136.92 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.632 -0.667 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.669 HD12 HG23 ' A' ' 76' ' ' VAL . 15.6 tp -102.47 125.98 49.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.719 . . . . 0.0 109.43 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -153.18 142.24 21.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.639 -0.663 . . . . 0.0 109.508 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -88.62 -42.22 12.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -71.79 133.28 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -85.93 30.47 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -101.19 -35.11 9.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 0.0 109.506 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -69.18 148.58 49.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.579 -0.7 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -147.18 152.98 39.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.689 . . . . 0.0 109.442 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.78 138.67 41.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.555 -0.716 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -86.42 121.62 29.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.685 . . . . 0.0 109.455 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.2 48.43 25.47 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.45 140.44 15.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.646 -0.914 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -82.18 100.49 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 109.387 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -79.47 98.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.568 -0.708 . . . . 0.0 109.46 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.669 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -87.67 164.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.645 -0.659 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -138.09 29.99 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.577 -0.702 . . . . 0.0 109.451 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -171.94 143.22 1.57 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.427 HG13 ' CZ ' ' A' ' 106' ' ' PHE . 30.5 t -66.82 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.551 -0.718 . . . . 0.0 109.418 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.53 76.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 109.48 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.32 77.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.608 -0.682 . . . . 0.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 76' ' ' VAL . 31.5 t -67.99 -37.47 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -74.6 -30.42 61.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.644 -0.66 . . . . 0.0 109.546 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.32 90.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.69 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -69.49 -33.34 72.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.3 62.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.0 109.592 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -64.61 -46.23 83.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.422 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -65.0 -26.99 68.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.513 -0.742 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -119.16 90.15 41.07 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.57 -0.707 . . . . 0.0 109.48 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -79.55 -24.03 6.65 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.122 3.881 . . . . 0.0 109.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -71.38 -25.35 62.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.623 -0.673 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -96.56 131.8 42.81 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' H ' ' HG3' ' A' ' 37' ' ' LYS . 6.1 mm-40 -95.67 152.78 18.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.576 -0.702 . . . . 0.0 109.539 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 40' ' ' VAL . 6.8 tp -88.73 137.73 32.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.63 -0.669 . . . . 0.0 109.426 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.3 123.54 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.644 -0.66 . . . . 0.0 109.492 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.585 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.2 mm -93.75 119.83 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -101.69 -29.78 11.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.534 -0.729 . . . . 0.0 109.526 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.25 -174.06 40.3 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.94 -154.53 19.11 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 120.379 -1.659 . . . . 0.0 109.555 0.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.55 -31.41 71.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.649 -0.912 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -73.79 -28.07 61.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.37 -36.5 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.63 -0.669 . . . . 0.0 109.51 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.585 ' CE1' HG22 ' A' ' 96' ' ' ILE . 27.8 m-85 -63.3 -48.11 79.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.619 -0.676 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -28.33 69.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.71 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.76 73.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.427 ' CZ ' HG13 ' A' ' 79' ' ' VAL . 17.2 m-85 -102.26 11.81 37.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 109.887 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.4 tttt -67.65 -31.89 72.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.511 -0.743 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -78.86 17.94 0.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.548 -0.72 . . . . 0.0 109.724 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -160.08 38.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.459 -0.776 . . . . 0.0 109.408 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.792 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -95.37 145.91 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.06 -53.14 1.74 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.578 -0.701 . . . . 0.0 109.357 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 m -103.37 160.84 14.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.586 -0.697 . . . . 0.0 109.374 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.488 HD11 ' CE2' ' A' ' 136' ' ' PHE . 30.4 mt -139.45 98.49 3.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.536 -0.728 . . . . 0.0 109.604 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.618 ' CD2' HG22 ' A' ' 157' ' ' VAL . 41.8 mt -98.49 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.625 -0.672 . . . . 0.0 109.314 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -115.05 136.77 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 0.0 109.518 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -107.7 103.32 12.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.636 -0.665 . . . . 0.0 109.278 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -87.54 143.54 27.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.52 -0.737 . . . . 0.0 109.616 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.39 133.9 55.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.638 -0.663 . . . . 0.0 109.326 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.91 78.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.622 -0.674 . . . . 0.0 109.487 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.29 123.93 9.63 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 p -76.82 143.93 39.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.633 -0.922 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.525 ' O ' HD22 ' A' ' 12' ' ' LEU . 89.1 m-85 -148.32 117.39 6.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.53 145.77 27.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.586 -0.696 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.593 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -144.16 -128.3 2.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -140.71 -36.65 0.46 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.542 -0.975 . . . . 0.0 109.56 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.536 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -95.22 142.09 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.576 -0.702 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -121.12 173.0 7.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.616 -0.677 . . . . 0.0 109.455 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 13.3 tpt -92.91 153.52 18.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.491 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -73.58 163.74 66.19 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.18 96.19 1.02 Allowed 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 125.135 3.89 . . . . 0.0 110.007 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.93 137.0 33.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.709 . . . . 0.0 109.495 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -78.73 87.26 4.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.579 -0.701 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -68.39 -16.93 64.1 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.619 -0.676 . . . . 0.0 109.78 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.55 -26.22 68.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.476 -0.765 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.44 29.78 2.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 113' ' ' LEU . 45.9 m-85 -142.97 175.35 9.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.598 -0.689 . . . . 0.0 109.455 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.47 135.42 17.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.652 -0.655 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -70.92 158.03 37.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.675 -0.64 . . . . 0.0 109.498 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.15 -32.24 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.539 -0.726 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 81.3 p -157.74 155.5 30.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 p -149.51 122.08 8.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.591 -0.693 . . . . 0.0 109.441 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -99.16 105.59 17.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.618 -0.676 . . . . 0.0 109.489 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.479 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.3 m -84.94 142.78 29.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.56 -0.712 . . . . 0.0 109.441 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.456 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -145.14 129.89 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.659 -0.651 . . . . 0.0 109.377 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -105.92 121.07 43.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.433 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -80.32 -165.82 0.93 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.617 -0.677 . . . . 0.0 109.464 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -73.64 -39.42 64.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.495 -0.753 . . . . 0.0 109.561 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -101.92 138.05 19.69 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.565 -0.709 . . . . 0.0 109.418 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.66 -46.29 24.67 Favored 'Trans proline' 0 N--CA 1.505 2.202 0 C-N-CA 124.748 3.632 . . . . 0.0 110.08 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.76 -27.59 69.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.518 -0.739 . . . . 0.0 109.668 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.0 18.92 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.567 -0.708 . . . . 0.0 109.733 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.1 m -87.55 140.0 29.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.517 -0.739 . . . . 0.0 109.314 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.581 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.1 p-80 -154.75 162.24 41.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.599 -0.688 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.4 m -134.46 135.51 42.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.705 . . . . 0.0 109.454 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -90.78 93.89 9.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.611 -0.681 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 37.7 mt-10 -76.74 137.8 39.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.585 -0.697 . . . . 0.0 109.473 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.618 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.3 t -124.71 115.74 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.583 -0.698 . . . . 0.0 109.453 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.413 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 33.0 m95 -113.17 170.03 8.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.694 . . . . 0.0 109.469 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -148.89 141.06 23.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.577 -0.702 . . . . 0.0 109.394 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -72.18 116.23 12.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.456 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -160.57 102.87 1.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.662 -0.649 . . . . 0.0 109.484 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.498 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.44 HN52 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.48 99.72 7.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.725 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.6 m-85 -76.11 131.43 39.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.64 -0.662 . . . . 0.0 109.416 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.504 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.9 tp -147.41 113.67 5.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.347 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.3 p90 -143.38 147.12 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 109.746 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.85 114.18 26.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.708 . . . . 0.0 109.326 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -133.95 150.2 51.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.491 -0.755 . . . . 0.0 109.636 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -98.63 171.44 8.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -61.13 -19.85 61.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.594 -0.691 . . . . 0.0 109.803 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.66 15.05 0.88 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 109.754 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.89 38.54 96.17 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.7 tp -106.14 166.25 10.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.611 -0.935 . . . . 0.0 109.527 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.75 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -145.89 -29.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.467 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.11 -176.2 27.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -175.26 115.88 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.547 -0.972 . . . . 0.0 109.514 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.09 21.7 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.52 -0.737 . . . . 0.0 109.679 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.45 5.04 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -77.94 176.45 9.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.527 HD11 ' C7 ' ' A' ' 170' ' ' TMQ . 11.8 mt -77.05 157.87 80.78 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.38 -33.79 0.93 Allowed 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 125.089 3.859 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CE3' ' HG2' ' A' ' 20' ' ' PRO . 22.8 p90 -108.16 -170.59 1.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.688 . . . . 0.0 109.433 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -136.53 86.89 2.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.505 -0.747 . . . . 0.0 109.446 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.763 HD23 ' HB2' ' A' ' 26' ' ' ASP . 26.6 tp -109.36 82.13 1.97 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.607 -0.683 . . . . 0.0 109.506 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -45.31 -38.55 15.29 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 125.172 3.915 . . . . 0.0 110.269 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -62.69 -40.19 96.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.538 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.763 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.7 t0 -66.05 -33.19 75.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.693 . . . . 0.0 109.407 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -70.1 -24.72 63.26 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.634 -0.666 . . . . 0.0 109.489 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.66 -29.56 27.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.633 -0.667 . . . . 0.0 109.399 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.32 -25.4 57.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 34' ' ' THR . 53.5 t80 -65.84 -45.74 81.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.656 -0.653 . . . . 0.0 109.449 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -65.28 -30.87 71.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.51 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.53 -30.98 57.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.523 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' A' ' 33' ' ' GLN . 6.7 mm-40 -97.82 32.66 2.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 30' ' ' PHE . 17.6 p -140.29 -34.1 0.54 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.488 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.1 m -70.27 128.19 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.622 -0.673 . . . . 0.0 109.474 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.02 31.97 27.49 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttt -156.54 172.3 18.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.951 . . . . 0.0 109.481 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -90.47 112.81 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.649 -0.657 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.552 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.8 tmm? -81.51 105.01 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 94' ' ' LEU . 29.0 t -113.19 123.77 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.481 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.3 m -137.74 -175.92 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.694 . . . . 0.0 109.435 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.6 -164.89 31.82 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -82.84 -41.28 19.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.625 -0.926 . . . . 0.0 109.492 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -70.2 -33.15 71.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -76.41 -29.41 57.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.57 -0.706 . . . . 0.0 109.492 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -67.12 -35.59 80.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.523 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -83.06 -25.27 32.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.677 . . . . 0.0 109.423 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.9 p -62.91 -22.64 66.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.567 -0.708 . . . . 0.0 109.611 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.72 164.2 13.2 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.507 -0.746 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -80.91 -73.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.11 3.874 . . . . 0.0 109.949 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -114.33 103.78 11.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.547 -0.721 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.91 156.63 39.09 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.696 . . . . 0.0 109.415 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -81.25 169.69 65.48 Favored 'Cis proline' 0 N--CA 1.508 2.372 0 O-C-N 123.397 1.209 . . . . 0.0 110.004 -0.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 ' CE ' ' A' ' 39' ' ' MET . 55.5 mt -89.76 113.09 55.55 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 109.36 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.46 -178.87 4.95 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 124.659 3.572 . . . . 0.0 109.918 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 61.54 24.29 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.546 -0.721 . . . . 0.0 109.704 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -176.61 174.41 1.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.565 -0.709 . . . . 0.0 109.573 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -91.64 131.28 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.539 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -98.91 105.22 17.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -117.8 144.23 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.644 -0.66 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.2 t -134.45 124.12 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.666 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 76' ' ' VAL . 18.5 tp -97.79 117.15 31.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.538 -0.726 . . . . 0.0 109.511 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -155.43 137.8 14.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -93.12 29.43 1.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.514 -0.741 . . . . 0.0 109.425 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -110.24 123.79 50.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -86.17 30.13 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.674 -0.641 . . . . 0.0 109.407 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -124.47 -33.39 3.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -69.13 147.29 51.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.61 -0.681 . . . . 0.0 109.508 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -146.14 156.72 43.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.724 . . . . 0.0 109.53 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.23 132.22 31.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.649 -0.657 . . . . 0.0 109.491 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -87.55 119.42 27.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.21 42.59 18.66 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.41 133.33 8.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.971 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -74.32 103.57 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.634 -0.666 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.59 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.5 t -82.13 103.28 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.578 -0.702 . . . . 0.0 109.441 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -89.98 154.88 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.678 -0.639 . . . . 0.0 109.509 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.59 ' NE2' HG12 ' A' ' 75' ' ' VAL . 49.0 m-70 -136.16 29.52 3.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.451 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.404 ' O ' HG23 ' A' ' 82' ' ' VAL . 19.4 t70 -164.88 149.34 9.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.441 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.607 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -68.0 -33.41 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.48 70.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.654 . . . . 0.0 109.529 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.42 77.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 76' ' ' VAL . 31.2 t -67.55 -42.77 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.623 -0.673 . . . . 0.0 109.503 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.32 -29.27 59.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.616 -0.677 . . . . 0.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.83 92.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.553 -0.717 . . . . 0.0 109.478 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -66.44 -42.76 87.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.435 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.13 -24.97 65.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.661 . . . . 0.0 109.51 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -41.15 97.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.592 -0.692 . . . . 0.0 109.463 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -69.47 -31.02 69.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -119.24 89.75 40.46 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.606 -0.684 . . . . 0.0 109.489 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.32 -22.71 6.77 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 125.138 3.892 . . . . 0.0 109.905 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.84 -25.9 66.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.555 -0.715 . . . . 0.0 109.475 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -92.92 -179.93 5.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -138.76 148.56 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.629 -0.669 . . . . 0.0 109.487 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 40' ' ' VAL . 12.8 tp -79.24 108.11 12.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.622 -0.673 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -108.38 112.92 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.631 -0.668 . . . . 0.0 109.464 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.405 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.4 mm -91.97 122.27 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 109.36 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -101.38 -28.87 12.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.529 -0.732 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.13 -175.83 40.93 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.92 -151.75 12.87 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.362 -1.669 . . . . 0.0 109.613 -0.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.94 -26.22 62.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -74.78 -23.69 58.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.528 -0.732 . . . . 0.0 109.585 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -80.32 -38.33 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.496 -0.753 . . . . 0.0 109.483 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CE1' HG22 ' A' ' 96' ' ' ILE . 30.9 m-85 -62.75 -48.5 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.59 -0.694 . . . . 0.0 109.396 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 t -63.6 -33.04 74.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.594 -0.691 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.69 -0.631 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.607 ' CE1' HG13 ' A' ' 79' ' ' VAL . 45.8 m-85 -122.32 21.33 10.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.714 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.4 pttt -63.48 -32.83 74.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.441 -0.787 . . . . 0.0 109.586 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -81.09 31.0 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.725 . . . . 0.0 109.601 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -160.08 32.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.733 . . . . 0.0 109.408 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.725 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -99.22 145.63 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.319 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -128.0 -55.83 1.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.583 -0.698 . . . . 0.0 109.375 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 m -103.69 106.86 17.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.377 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.493 HD11 ' CE2' ' A' ' 136' ' ' PHE . 24.5 mt -90.44 100.94 13.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.568 -0.707 . . . . 0.0 109.592 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.603 ' CD2' HG22 ' A' ' 157' ' ' VAL . 42.5 mt -99.23 105.98 18.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.719 . . . . 0.0 109.21 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.43 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -111.32 136.05 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.613 -0.679 . . . . 0.0 109.523 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.5 m -108.62 97.49 7.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.652 . . . . 0.0 109.248 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -85.43 139.79 31.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.632 -0.668 . . . . 0.0 109.546 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.97 135.07 54.4 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.84 -33.31 73.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.556 -0.715 . . . . 0.0 109.472 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.88 124.42 14.57 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.7 t -70.25 140.83 52.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.59 -0.947 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.628 ' O ' HD22 ' A' ' 12' ' ' LEU . 67.3 m-85 -148.38 107.2 3.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.587 -0.696 . . . . 0.0 109.422 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.72 146.33 28.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.566 -0.709 . . . . 0.0 109.477 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.63 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -145.02 -123.3 1.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -143.42 -49.87 0.32 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.975 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.75 HG22 HD11 ' A' ' 13' ' ' ILE . 4.4 m -81.64 141.09 33.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.632 -0.667 . . . . 0.0 109.476 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -118.46 172.94 7.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -94.47 146.97 23.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.501 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.47 164.69 42.01 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.596 -0.69 . . . . 0.0 109.469 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.29 99.96 1.21 Allowed 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 125.113 3.876 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 73.1 mt -85.39 138.07 32.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.548 -0.72 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -77.74 84.81 4.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -67.23 -17.53 64.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.6 -0.688 . . . . 0.0 109.772 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -26.0 68.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.765 . . . . 0.0 109.519 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.81 30.32 2.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.552 -0.718 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 113' ' ' LEU . 68.0 m-85 -145.35 177.16 9.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.515 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.8 m -153.54 131.41 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.577 -0.702 . . . . 0.0 109.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -72.13 115.82 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.614 -0.679 . . . . 0.0 109.475 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.1 -36.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.705 . . . . 0.0 109.498 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.2 p -154.79 179.16 9.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.1 t -165.2 159.48 17.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.586 -0.696 . . . . 0.0 109.523 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -133.41 100.8 4.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.499 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.0 m -81.75 152.95 26.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.536 -0.727 . . . . 0.0 109.423 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 144' ' ' VAL . 8.8 p -156.17 127.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.623 -0.673 . . . . 0.0 109.309 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.39 121.99 44.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.549 -0.72 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.58 -165.61 0.91 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.3 p -72.35 -36.38 68.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.699 . . . . 0.0 109.603 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -106.13 137.88 19.52 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.86 -48.19 16.75 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 C-N-CA 124.822 3.682 . . . . 0.0 110.076 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.96 -28.83 69.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.551 -0.718 . . . . 0.0 109.768 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 35.5 mt -80.38 20.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.629 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.1 m -91.98 136.97 32.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.525 -0.734 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.668 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.6 p-80 -151.93 169.55 22.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.697 . . . . 0.0 109.602 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 143' ' ' THR . 19.1 m -139.76 137.74 35.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.541 -0.724 . . . . 0.0 109.451 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -95.32 94.75 8.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.517 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 23.4 mt-10 -76.24 128.84 35.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.603 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.2 t -112.9 102.91 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.502 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.517 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 42.4 m95 -101.41 163.45 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.617 -0.677 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -140.14 145.96 38.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -66.71 116.33 7.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.602 -0.686 . . . . 0.0 109.489 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -165.22 114.52 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.615 -0.678 . . . . 0.0 109.455 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.475 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.527 ' C7 ' HD11 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.92 127.65 34.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.807 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -101.99 137.35 40.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.535 -0.728 . . . . 0.0 109.472 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.66 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.2 tp -149.87 111.69 4.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.602 -0.686 . . . . 0.0 109.331 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.2 p90 -142.04 151.52 42.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.563 -0.711 . . . . 0.0 109.73 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 112.08 24.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.593 -0.692 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -132.33 150.17 52.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.569 -0.707 . . . . 0.0 109.638 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.46 171.78 7.25 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -61.37 -18.69 59.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.618 -0.676 . . . . 0.0 109.763 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -77.37 15.14 0.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.518 -0.739 . . . . 0.0 109.775 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 37.57 94.64 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.528 HD23 ' CG ' ' A' ' 20' ' ' PRO . 7.1 tp -107.39 167.25 10.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.621 -0.929 . . . . 0.0 109.553 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.52 HD11 HG22 ' A' ' 126' ' ' THR . 31.7 pt -141.74 -30.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.575 -0.703 . . . . 0.0 109.519 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.73 -167.0 28.74 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -173.28 115.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.462 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 33.83 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.466 -0.771 . . . . 0.0 109.723 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.94 -61.45 3.74 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -74.96 170.61 15.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -1.02 . . . . 0.0 109.455 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.659 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 24.0 mt -79.89 157.21 74.27 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.571 -0.706 . . . . 0.0 109.46 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.528 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.0 Cg_endo -79.91 -30.52 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 125.018 3.812 . . . . 0.0 109.903 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.659 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.0 p90 -105.88 -171.38 1.89 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.615 -0.678 . . . . 0.0 109.547 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -138.42 103.02 4.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.705 -0.622 . . . . 0.0 109.431 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 26' ' ' ASP . 12.8 tp -124.58 81.02 60.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.587 -0.695 . . . . 0.0 109.516 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.23 -39.09 20.74 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 125.117 3.878 . . . . 0.0 110.154 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.98 -52.16 64.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.614 -0.679 . . . . 0.0 109.525 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.798 ' HB2' HD23 ' A' ' 23' ' ' LEU . 33.0 t70 -62.95 -36.54 83.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.547 HD22 H223 ' A' ' 170' ' ' TMQ . 79.8 mt -63.75 -24.26 67.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.57 -0.706 . . . . 0.0 109.455 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -85.62 -29.91 23.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 26.9 t80 -65.44 -23.96 67.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 34' ' ' THR . 59.6 t80 -63.15 -46.5 86.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -65.15 -25.33 67.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.459 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.24 -26.57 39.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.587 -0.696 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 21.8 mm100 -107.47 36.38 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.566 -0.709 . . . . 0.0 109.475 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 30' ' ' PHE . 15.0 p -138.38 -35.04 0.62 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.482 -0.761 . . . . 0.0 109.487 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.0 m -67.36 126.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.8 38.61 23.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -153.97 168.53 26.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.641 -0.917 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.5 mt -93.47 104.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.423 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.605 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.8 tmm? -78.87 117.47 20.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.596 -0.69 . . . . 0.0 109.493 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 t -125.13 120.19 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.669 -0.644 . . . . 0.0 109.418 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.605 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.1 m -136.08 173.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 109.439 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.81 -167.21 42.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -84.05 -36.36 23.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.485 -1.009 . . . . 0.0 109.436 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -68.16 -31.81 71.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.444 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -82.41 -27.65 31.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.473 -0.767 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -64.93 -35.7 82.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 109.487 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.27 -25.87 29.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.7 m -67.13 -15.36 63.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.664 -0.648 . . . . 0.0 109.759 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' CE1' HD11 ' A' ' 54' ' ' LEU . 23.7 m-85 -61.77 161.39 21.72 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 109.576 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 125.101 3.867 . . . . 0.0 109.987 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.6 73.57 0.92 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.539 -0.726 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -72.78 157.36 88.92 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.58 172.7 55.23 Favored 'Cis proline' 0 N--CA 1.509 2.43 0 O-C-N 123.332 1.175 . . . . 0.0 110.035 0.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.54 HD12 ' CE ' ' A' ' 39' ' ' MET . 39.2 mt -97.8 110.75 56.73 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.589 -0.694 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -76.79 178.11 8.02 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.733 3.622 . . . . 0.0 109.866 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.39 29.59 18.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.58 -0.7 . . . . 0.0 109.68 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.412 HH12 ' N ' ' A' ' 35' ' ' VAL . 1.4 ptp180 -177.1 178.91 1.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 m -105.91 119.38 39.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.4 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.489 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -96.16 111.45 23.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.0 109.477 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.6 t -112.92 140.73 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.0 109.45 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 t -125.26 124.78 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.505 -0.747 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 76' ' ' VAL . 11.3 tp -99.78 109.7 22.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.51 -0.744 . . . . 0.0 109.487 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 t -139.93 142.54 36.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.562 -0.712 . . . . 0.0 109.474 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.515 ' H ' ' CD2' ' A' ' 64' ' ' HIS . 10.6 p80 -93.86 31.6 1.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.665 -0.647 . . . . 0.0 109.568 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -130.9 128.64 40.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.584 -0.698 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -88.89 29.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.41 -33.03 6.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -69.63 152.18 45.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 109.489 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -152.3 110.11 3.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.727 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.431 ' H ' HG21 ' A' ' 75' ' ' VAL . . . -98.1 125.18 42.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.618 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -80.57 133.05 35.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.639 -0.663 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.32 37.81 70.87 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.76 133.26 9.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.609 -0.936 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.5 t -73.52 99.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.578 -0.701 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.519 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.9 t -79.35 102.34 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.568 -0.708 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.498 HG21 HG22 ' A' ' 82' ' ' VAL . 27.5 m -90.12 159.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.628 -0.67 . . . . 0.0 109.455 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.519 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.3 m-70 -139.35 29.98 2.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.554 -0.716 . . . . 0.0 109.44 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -164.26 144.93 8.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.659 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 106' ' ' PHE . 29.4 t -68.2 -33.68 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.0 109.511 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.28 70.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.553 -0.717 . . . . 0.0 109.49 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.48 81.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.647 -0.658 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -68.42 -35.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.562 -0.711 . . . . 0.0 109.392 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.45 -33.02 62.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.556 -0.715 . . . . 0.0 109.557 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.41 70.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.617 -0.677 . . . . 0.0 109.507 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -71.31 -37.26 71.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.571 -0.706 . . . . 0.0 109.419 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.03 -26.27 59.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.562 -0.711 . . . . 0.0 109.526 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -70.22 -38.54 75.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.77 -24.68 65.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -115.74 93.42 37.39 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.622 -0.674 . . . . 0.0 109.483 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -76.99 -19.96 13.43 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 124.838 3.692 . . . . 0.0 109.957 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -81.44 -25.0 36.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.54 -0.725 . . . . 0.0 109.496 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.15 179.99 5.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.517 -0.739 . . . . 0.0 109.492 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -142.37 148.18 37.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.519 -0.738 . . . . 0.0 109.537 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 95' ' ' VAL . 3.1 tt -80.65 123.32 28.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.556 -0.715 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.569 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.3 t -128.59 129.46 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.56 -0.713 . . . . 0.0 109.441 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -102.55 129.75 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.55 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -108.57 -24.09 11.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.702 . . . . 0.0 109.599 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.76 -178.34 40.56 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.481 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.66 -155.22 19.96 Favored Glycine 0 N--CA 1.5 2.92 0 O-C-N 120.321 -1.693 . . . . 0.0 109.518 0.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.93 75.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.622 -0.928 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -72.88 -25.44 61.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.531 -0.731 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.481 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.7 mm -74.61 -36.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.45 -49.9 71.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.589 -0.694 . . . . 0.0 109.511 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.2 t -62.88 -34.82 78.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.534 -0.729 . . . . 0.0 109.595 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.03 -33.42 76.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.644 -0.66 . . . . 0.0 109.688 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 79' ' ' VAL . 41.8 m-85 -105.47 13.6 29.92 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.532 -0.73 . . . . 0.0 109.847 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.52 -23.57 56.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.478 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -65.01 -22.22 66.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.61 -0.682 . . . . 0.0 109.649 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -130.3 41.43 3.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.53 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.807 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.9 p -86.05 156.98 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.513 -0.742 . . . . 0.0 109.416 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -136.54 -69.08 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.653 -0.654 . . . . 0.0 109.392 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 m -84.92 159.9 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.376 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.612 HD11 ' CE2' ' A' ' 136' ' ' PHE . 26.5 mt -142.01 96.27 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.632 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.66 ' CB ' HD12 ' A' ' 4' ' ' LEU . 51.5 mt -97.82 110.48 23.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.245 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -117.6 141.0 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.625 -0.672 . . . . 0.0 109.537 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 m -111.12 102.17 10.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.597 -0.689 . . . . 0.0 109.346 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.491 ' O ' HD12 ' A' ' 118' ' ' LEU . 25.7 mmt180 -85.22 151.28 24.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.531 -0.731 . . . . 0.0 109.696 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 117' ' ' ARG . 4.1 mp -128.6 133.81 48.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 109.279 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.51 -30.87 68.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.586 -0.696 . . . . 0.0 109.51 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.02 128.05 11.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.6 p -79.53 141.44 36.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.53 -0.982 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.479 ' O ' HD22 ' A' ' 12' ' ' LEU . 94.6 m-85 -148.63 128.28 13.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.616 -0.677 . . . . 0.0 109.457 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.8 163.46 14.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -159.83 -138.38 2.44 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.69 10.04 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.96 . . . . 0.0 109.865 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.52 HG22 HD11 ' A' ' 13' ' ' ILE . 3.4 m -147.28 130.39 16.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.386 -0.821 . . . . 0.0 109.5 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -105.88 176.52 5.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.593 -0.692 . . . . 0.0 109.399 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.441 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -93.33 148.31 22.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.588 -0.695 . . . . 0.0 109.473 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.6 pt -66.83 165.57 25.04 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.536 -0.728 . . . . 0.0 109.477 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.18 109.32 2.33 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.11 3.873 . . . . 0.0 109.994 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 82.1 mt -98.45 139.81 33.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.565 -0.709 . . . . 0.0 109.501 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -77.65 83.57 4.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.52 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.18 -20.02 64.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.559 -0.713 . . . . 0.0 109.718 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -62.72 -23.6 67.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.527 -0.733 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -97.78 28.73 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.612 ' CE2' HD11 ' A' ' 113' ' ' LEU . 54.2 m-85 -142.16 174.23 10.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.556 -0.715 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.2 m -149.62 136.41 19.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.554 -0.716 . . . . 0.0 109.526 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -70.39 155.96 39.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.636 -0.665 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.61 -32.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.616 -0.677 . . . . 0.0 109.46 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 t -147.89 146.0 28.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.455 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 76.8 p -144.81 110.42 5.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.604 -0.685 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -95.32 102.68 14.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.495 -0.753 . . . . 0.0 109.423 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.467 ' HA ' HG23 ' A' ' 154' ' ' THR . 7.1 m -86.06 147.14 26.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.541 -0.725 . . . . 0.0 109.466 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.8 p -152.89 133.7 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.694 . . . . 0.0 109.299 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.94 123.87 49.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.47 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -80.43 -165.1 0.8 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.506 -0.746 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.9 p -71.47 -38.56 71.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.649 -0.657 . . . . 0.0 109.58 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -105.03 137.65 19.28 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.566 -0.709 . . . . 0.0 109.485 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.06 -46.19 22.98 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 124.815 3.677 . . . . 0.0 110.069 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.15 68.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.612 -0.68 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.55 19.9 0.97 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.573 -0.704 . . . . 0.0 109.677 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 50.6 m -87.54 140.73 29.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.486 -0.759 . . . . 0.0 109.275 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.613 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.3 p-80 -152.63 167.27 29.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.609 -0.682 . . . . 0.0 109.529 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 143' ' ' THR . 20.5 m -140.57 130.52 24.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.594 -0.692 . . . . 0.0 109.434 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.46 93.81 8.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.54 139.37 38.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.62 -0.675 . . . . 0.0 109.423 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.536 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.6 t -128.81 113.51 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -111.71 166.38 11.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.508 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -142.94 143.06 31.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.468 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -68.01 127.52 33.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.492 -0.755 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -150.53 147.0 26.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.496 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.644 ' H8 ' HD11 ' A' ' 19' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.531 HG23 HD23 ' A' ' 94' ' ' LEU . 9.3 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.35 103.39 5.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.601 -0.687 . . . . 0.0 109.497 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.745 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.8 m-85 -75.42 141.29 43.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.646 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.4 tp -153.42 112.53 3.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.629 -0.669 . . . . 0.0 109.299 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 8.9 p90 -145.38 146.49 31.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.528 -0.733 . . . . 0.0 109.756 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.95 115.5 29.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 109.323 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.622 ' HB3' HG22 ' A' ' 13' ' ' ILE . 8.1 pt20 -133.86 161.32 35.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -108.72 169.64 8.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.643 -0.661 . . . . 0.0 109.406 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.476 HH11 ' HB2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -60.8 -15.86 34.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.61 -0.681 . . . . 0.0 109.88 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.43 15.02 0.84 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 109.763 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.59 86.17 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.526 HD21 ' HA3' ' A' ' 124' ' ' GLY . 9.3 tp -117.21 151.55 36.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.574 -0.956 . . . . 0.0 109.444 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -120.48 -41.36 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.577 -0.702 . . . . 0.0 109.558 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.665 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -162.87 -170.13 27.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -163.04 124.19 2.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.928 . . . . 0.0 109.454 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 59.91 32.66 21.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.542 -0.724 . . . . 0.0 109.717 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 -62.5 3.55 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -73.2 173.19 9.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.559 -0.965 . . . . 0.0 109.499 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.57 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 9.0 mt -93.4 155.54 40.77 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.533 -0.73 . . . . 0.0 109.469 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.9 Cg_endo -79.96 -24.92 5.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 125.045 3.83 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.57 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 30.4 p90 -106.72 163.13 13.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.624 -0.672 . . . . 0.0 109.574 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -115.55 100.96 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.677 -0.64 . . . . 0.0 109.423 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 26' ' ' ASP . 17.6 tp -119.68 80.27 23.7 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.613 -0.679 . . . . 0.0 109.47 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.91 -37.36 16.87 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 125.133 3.889 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.93 -46.88 85.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.53 -0.731 . . . . 0.0 109.57 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.4 t0 -62.83 -37.61 87.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.59 -23.94 67.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.725 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -86.97 -29.7 21.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.565 -0.709 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.9 t80 -73.36 -24.43 60.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.528 -0.733 . . . . 0.0 109.547 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 34' ' ' THR . 52.6 t80 -63.33 -45.35 91.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttp-105 -64.84 -29.29 70.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.477 -0.764 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.84 -29.09 55.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 82.3 mm-40 -101.13 34.91 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.704 . . . . 0.0 109.46 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.0 p -141.67 -34.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.508 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.4 m -68.98 126.82 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.639 -0.663 . . . . 0.0 109.456 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.35 35.14 24.13 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -156.94 166.48 33.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.581 -0.952 . . . . 0.0 109.441 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.3 mt -90.66 103.36 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.546 -0.721 . . . . 0.0 109.455 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.678 ' SD ' HG13 ' A' ' 41' ' ' VAL . 9.8 tmm? -71.96 131.48 43.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 94' ' ' LEU . 31.3 t -135.55 116.04 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.54 -0.725 . . . . 0.0 109.473 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.678 HG13 ' SD ' ' A' ' 39' ' ' MET . 27.6 m -133.86 -177.57 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.659 -0.65 . . . . 0.0 109.458 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 -174.06 43.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -76.17 -38.33 56.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.936 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -69.07 -41.87 76.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 m -69.97 -26.45 64.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.35 -46.03 85.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.534 -0.728 . . . . 0.0 109.487 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.86 -23.96 36.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.515 -0.741 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -62.83 -21.13 65.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -62.07 161.35 24.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.493 -0.755 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.92 -72.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 125.103 3.869 . . . . 0.0 109.886 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -108.55 91.98 3.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.623 -0.673 . . . . 0.0 109.488 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -99.76 157.3 34.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.544 -0.723 . . . . 0.0 109.458 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.5 159.06 85.8 Favored 'Cis proline' 0 N--CA 1.509 2.386 0 O-C-N 123.384 1.202 . . . . 0.0 109.953 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.98 114.17 46.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.616 -0.677 . . . . 0.0 109.403 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.15 179.31 6.57 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 124.761 3.64 . . . . 0.0 109.947 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 61.05 29.64 19.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.612 -0.68 . . . . 0.0 109.662 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.03 173.55 1.82 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.615 -0.678 . . . . 0.0 109.512 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.0 m -93.98 118.94 32.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.705 . . . . 0.0 109.513 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -89.71 99.17 12.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.8 t -107.11 143.35 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.62 125.39 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.614 -0.679 . . . . 0.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.426 HD12 HG23 ' A' ' 76' ' ' VAL . 11.8 tp -95.9 112.46 24.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.615 -0.678 . . . . 0.0 109.541 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -140.26 150.78 44.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.574 -0.704 . . . . 0.0 109.401 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -91.24 -34.14 15.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -76.15 123.73 26.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.611 -0.68 . . . . 0.0 109.472 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -83.52 29.59 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.548 -0.72 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -100.46 -34.75 9.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.631 -0.668 . . . . 0.0 109.5 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -69.35 136.33 51.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.702 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -141.54 104.52 4.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.534 -0.728 . . . . 0.0 109.48 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.36 119.71 26.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.551 -0.718 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -70.85 127.25 31.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.41 38.66 24.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -157.66 146.81 19.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.598 -0.942 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.28 98.03 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.619 -0.676 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.8 t -77.19 98.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.478 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.51 HG21 HG22 ' A' ' 82' ' ' VAL . 27.2 m -85.13 156.86 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 0.0 109.482 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.511 ' NE2' HG12 ' A' ' 75' ' ' VAL . 67.1 m-70 -136.78 30.0 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.507 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -169.8 148.82 3.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.475 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.2 t -68.34 -34.13 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.631 -0.668 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.88 -31.05 67.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.681 . . . . 0.0 109.46 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.22 -37.29 83.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.542 -0.724 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -69.59 -40.7 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 109.379 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -72.54 -29.54 63.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.88 84.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.633 -0.667 . . . . 0.0 109.515 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.28 -40.44 81.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.737 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.71 68.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.39 -36.59 83.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.573 -0.704 . . . . 0.0 109.492 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -73.9 -27.77 61.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.679 . . . . 0.0 109.476 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -119.61 88.05 38.24 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.609 -0.682 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.36 20.21 0.97 Allowed 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 125.133 3.888 . . . . 0.0 109.967 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -106.86 -31.7 8.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.554 -0.716 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -94.48 178.54 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.556 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -133.03 153.86 51.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.491 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD23 HG23 ' A' ' 1' ' ' THR . 11.1 tp -84.64 133.63 34.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.56 -0.712 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.6 t -134.47 114.45 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.61 -0.681 . . . . 0.0 109.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.48 127.39 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.481 -0.762 . . . . 0.0 109.494 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.645 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.74 -24.51 10.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.579 -0.701 . . . . 0.0 109.517 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.3 -179.67 36.58 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.53 -155.47 20.18 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 120.287 -1.714 . . . . 0.0 109.583 0.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.45 72.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.572 -0.957 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -69.88 -31.09 68.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.593 -0.692 . . . . 0.0 109.511 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.14 -37.7 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.524 -0.735 . . . . 0.0 109.528 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -62.88 -46.1 89.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.557 -0.715 . . . . 0.0 109.483 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.627 HG23 HD13 ' A' ' 129' ' ' ILE . 0.7 OUTLIER -67.96 -21.78 65.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.581 -0.7 . . . . 0.0 109.605 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.87 -37.1 62.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 0.0 109.615 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.475 ' CE1' HG13 ' A' ' 79' ' ' VAL . 73.9 m-85 -106.4 14.78 26.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.695 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -29.75 66.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.772 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.2 -27.24 69.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.635 -0.666 . . . . 0.0 109.562 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.07 58.86 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.733 . . . . 0.0 109.409 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.745 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -105.2 151.69 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 109.305 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -135.29 -68.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 m -84.86 127.51 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.621 -0.674 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.643 HD11 ' CE2' ' A' ' 136' ' ' PHE . 37.2 mt -111.7 87.76 2.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.646 ' CB ' HD12 ' A' ' 4' ' ' LEU . 40.6 mt -89.27 121.78 31.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.527 -0.733 . . . . 0.0 109.264 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.4 p -134.49 145.09 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.647 -0.658 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -111.39 107.86 17.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.614 -0.679 . . . . 0.0 109.234 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -88.65 128.79 35.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.527 -0.733 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.3 141.2 37.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.598 -0.689 . . . . 0.0 109.379 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.84 62.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.1 137.46 24.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -87.4 143.49 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.533 -0.981 . . . . 0.0 109.496 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -143.46 124.42 14.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.638 -0.664 . . . . 0.0 109.419 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.9 140.03 30.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.514 -0.741 . . . . 0.0 109.474 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.526 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -146.04 -131.65 2.3 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -144.11 -27.31 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.566 -0.961 . . . . 0.0 109.476 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.6 m -94.21 118.64 31.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.571 -0.706 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -103.31 166.39 10.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.38 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -92.94 144.36 25.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.634 -0.666 . . . . 0.0 109.411 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.627 HD13 HG23 ' A' ' 104' ' ' THR . 22.1 pt -66.13 164.63 27.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.523 -0.736 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.37 104.34 1.62 Allowed 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 125.109 3.873 . . . . 0.0 109.896 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.76 86.92 6.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.604 -0.685 . . . . 0.0 109.488 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -68.58 -17.76 64.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.648 -0.658 . . . . 0.0 109.707 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -62.45 -29.48 70.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.586 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.32 29.45 1.68 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.605 -0.684 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.643 ' CE2' HD11 ' A' ' 113' ' ' LEU . 34.0 m-85 -140.61 173.75 11.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.523 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.0 m -146.08 135.95 23.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.643 -0.66 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -72.15 156.24 39.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.52 -31.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.619 -0.675 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -147.2 154.09 40.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.561 -0.712 . . . . 0.0 109.383 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -158.03 109.75 2.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -93.09 107.3 19.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.644 -0.66 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.542 ' HA ' HG23 ' A' ' 154' ' ' THR . 5.4 m -85.62 150.08 24.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.71 . . . . 0.0 109.488 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 144' ' ' VAL . 8.8 p -152.74 126.27 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.593 -0.692 . . . . 0.0 109.369 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.454 ' HA ' HG23 ' A' ' 152' ' ' THR . 28.0 mt-10 -103.6 118.26 36.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.668 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.12 -166.03 0.96 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.569 -0.707 . . . . 0.0 109.531 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.7 p -73.68 -43.25 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.695 . . . . 0.0 109.526 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -103.1 137.82 19.37 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.579 -0.701 . . . . 0.0 109.318 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -46.38 -42.16 22.64 Favored 'Trans proline' 0 N--CA 1.507 2.276 0 C-N-CA 124.878 3.719 . . . . 0.0 110.184 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.16 85.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.3 mt -76.27 12.64 1.13 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.632 -0.667 . . . . 0.0 109.902 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 145' ' ' GLU . 21.2 m -87.14 137.2 32.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.484 -0.76 . . . . 0.0 109.349 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.556 ' CE1' HD21 ' A' ' 23' ' ' LEU . 33.0 p-80 -155.6 175.05 14.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.64 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.542 HG23 ' HA ' ' A' ' 143' ' ' THR . 24.0 m -141.83 137.82 31.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.582 -0.699 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.58 95.71 9.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.679 -0.638 . . . . 0.0 109.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -76.86 146.41 37.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.601 -0.687 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.619 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.5 t -138.76 102.86 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.694 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 158' ' ' TRP . 27.9 m95 -104.46 162.53 13.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.563 -0.71 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -148.64 143.42 26.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.554 -0.716 . . . . 0.0 109.462 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -69.34 110.7 4.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -153.33 98.21 2.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.453 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.554 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.502 HG23 HD23 ' A' ' 94' ' ' LEU . 4.0 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.76 103.73 5.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.612 -0.68 . . . . 0.0 109.498 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.753 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -78.53 147.53 33.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.631 -0.668 . . . . 0.0 109.43 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.499 HD12 ' CB ' ' A' ' 114' ' ' LEU . 15.7 tp -158.84 111.23 2.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.564 -0.71 . . . . 0.0 109.239 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.43 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.2 p90 -142.39 143.95 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.777 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.87 116.16 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.656 . . . . 0.0 109.281 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -135.39 156.31 49.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -104.4 171.14 7.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.692 . . . . 0.0 109.419 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -61.04 -20.16 62.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.852 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.47 14.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.765 . . . . 0.0 109.756 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.86 40.12 98.42 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.5 tp -108.93 162.64 14.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.545 -0.974 . . . . 0.0 109.577 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.722 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -142.85 -29.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.69 . . . . 0.0 109.491 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.89 -175.62 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -174.66 116.33 0.18 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.564 -0.962 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.95 34.2 21.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 0.0 109.662 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -61.42 3.92 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -80.05 -175.95 5.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.622 -0.928 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.539 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 17.9 mt -86.08 156.88 57.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 109.461 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.7 Cg_endo -80.35 -31.15 1.74 Allowed 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 125.049 3.832 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.539 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 29.3 p90 -106.91 170.2 8.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.624 -0.673 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.5 88.2 2.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.619 -0.676 . . . . 0.0 109.482 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.778 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.3 tp -107.24 80.5 0.86 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.57 -0.706 . . . . 0.0 109.526 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -46.04 -37.36 17.48 Favored 'Trans proline' 0 N--CA 1.506 2.234 0 C-N-CA 125.056 3.838 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -62.94 -44.89 94.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.59 -0.694 . . . . 0.0 109.53 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.778 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -63.03 -38.71 92.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.607 -0.683 . . . . 0.0 109.423 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.89 -23.11 67.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.593 -0.692 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -88.3 -28.83 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.589 -0.695 . . . . 0.0 109.438 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -73.02 -25.66 61.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.456 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 34' ' ' THR . 59.2 t80 -64.48 -44.73 90.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.582 -0.699 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' VAL . 32.5 ttp180 -66.7 -26.23 66.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.503 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.85 -29.86 50.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.561 -0.712 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.477 ' NE2' HD22 ' A' ' 4' ' ' LEU . 6.8 mt-30 -102.61 36.25 2.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.704 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 30' ' ' PHE . 20.5 p -144.68 -28.96 0.47 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.584 -0.698 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 31' ' ' ARG . 27.3 m -68.95 128.59 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.487 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.17 32.94 46.52 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -156.35 165.26 36.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.939 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.3 107.69 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.392 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.446 ' CE ' HD12 ' A' ' 54' ' ' LEU . 40.2 ttp -82.63 104.16 12.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -95.87 126.84 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.533 -0.729 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 97' ' ' ALA . 27.5 m -140.75 164.55 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.64 -0.662 . . . . 0.0 109.432 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.65 -161.01 36.87 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -84.78 -36.6 21.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.568 -0.96 . . . . 0.0 109.45 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -69.6 -37.25 76.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.525 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 m -75.9 -29.7 58.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.427 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 52' ' ' ARG . 32.2 t80 -66.8 -33.69 76.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.489 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -82.19 -23.04 35.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -63.14 -27.78 69.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.542 -0.724 . . . . 0.0 109.514 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -65.24 163.53 30.95 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.736 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.2 -66.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.175 3.917 . . . . 0.0 109.894 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -121.02 103.19 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.618 -0.676 . . . . 0.0 109.44 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 46' ' ' TYR . 0.3 OUTLIER -94.07 154.19 40.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 0.0 109.45 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.69 164.57 78.54 Favored 'Cis proline' 0 N--CA 1.508 2.364 0 O-C-N 123.467 1.246 . . . . 0.0 109.844 -0.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.446 HD12 ' CE ' ' A' ' 39' ' ' MET . 81.3 mt -81.61 128.35 69.7 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.556 -0.715 . . . . 0.0 109.297 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.62 172.09 14.83 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 124.798 3.665 . . . . 0.0 109.965 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 61.37 27.75 17.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.574 -0.704 . . . . 0.0 109.8 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -177.2 178.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.529 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.4 m -105.27 147.29 28.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.62 -0.675 . . . . 0.0 109.519 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -114.92 97.89 6.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -102.67 101.81 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.58 -0.7 . . . . 0.0 109.489 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 120.46 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.608 -0.682 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.592 HD12 HG23 ' A' ' 76' ' ' VAL . 15.2 tp -101.51 106.4 17.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 0.0 109.425 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -138.86 151.71 47.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.713 . . . . 0.0 109.519 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 65' ' ' GLN . 9.5 p-80 -97.02 -29.69 13.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.66 -0.65 . . . . 0.0 109.512 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.406 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 11.5 tt0 -72.68 124.25 24.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.624 -0.672 . . . . 0.0 109.458 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -82.8 30.57 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.722 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.02 -34.85 9.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.523 -0.736 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.75 143.98 45.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.638 -0.664 . . . . 0.0 109.462 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -145.58 101.92 3.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.627 -0.67 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.19 119.95 30.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.612 -0.68 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -83.0 136.27 34.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.631 -0.668 . . . . 0.0 109.458 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.88 39.07 39.82 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.43 155.8 29.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.965 . . . . 0.0 109.52 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.3 t -82.94 95.75 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.611 -0.681 . . . . 0.0 109.483 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.508 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.1 t -80.28 100.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.541 -0.724 . . . . 0.0 109.437 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.592 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -98.7 160.34 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.639 -0.663 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.508 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.4 m-70 -139.65 30.76 2.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.628 -0.67 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -165.68 146.91 7.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.566 -0.709 . . . . 0.0 109.436 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.49 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -68.39 -34.1 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.584 -0.697 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.61 -32.31 72.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.28 -37.05 82.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.602 -0.686 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.496 HG22 HG21 ' A' ' 76' ' ' VAL . 29.9 t -67.68 -38.34 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.39 -32.31 66.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.683 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.37 91.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.497 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -68.26 -36.48 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.574 -0.704 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -30.46 70.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.641 -0.662 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -66.99 -42.79 84.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.574 -0.704 . . . . 0.0 109.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.33 5.72 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 109.943 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -144.2 87.87 7.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.372 -0.83 . . . . 0.0 109.492 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.11 -23.6 6.35 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 125.113 3.876 . . . . 0.0 109.856 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.48 -24.91 61.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.568 -0.708 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -100.67 178.58 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.58 -0.7 . . . . 0.0 109.481 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -136.91 172.98 12.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.592 -0.693 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 1' ' ' THR . 12.4 tp -103.94 130.16 51.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.51 -0.743 . . . . 0.0 109.511 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -136.63 129.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.549 -0.719 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.581 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -98.53 124.42 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.581 -0.699 . . . . 0.0 109.425 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.6 -24.24 11.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.634 -0.666 . . . . 0.0 109.542 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.36 -176.46 37.89 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.48 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -81.93 -155.12 14.61 Favored Glycine 0 N--CA 1.5 2.904 0 O-C-N 120.235 -1.744 . . . . 0.0 109.589 0.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.9 76.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.565 -0.962 . . . . 0.0 109.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -73.37 -27.74 61.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.48 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -72.62 -35.61 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.545 -0.722 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.581 ' CE1' HG22 ' A' ' 96' ' ' ILE . 27.2 m-85 -63.8 -51.58 64.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.501 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.3 m -62.44 -22.65 66.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.58 -49.85 43.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.545 -0.722 . . . . 0.0 109.529 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 79' ' ' VAL . 70.5 m-85 -93.17 13.93 19.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.528 -0.732 . . . . 0.0 109.906 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -67.22 -23.1 65.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.507 -0.745 . . . . 0.0 109.591 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.53 14.99 0.87 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.541 -0.724 . . . . 0.0 109.839 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -160.17 38.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.457 -0.777 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.753 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.44 154.36 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.52 -0.737 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -138.45 -60.06 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.513 -0.742 . . . . 0.0 109.418 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -97.1 111.39 23.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.573 -0.705 . . . . 0.0 109.408 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.434 HD11 ' CE2' ' A' ' 136' ' ' PHE . 21.9 mt -96.13 96.38 8.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.55 -0.719 . . . . 0.0 109.586 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.666 ' CD2' HG22 ' A' ' 157' ' ' VAL . 27.5 mt -93.39 116.46 29.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.589 -0.694 . . . . 0.0 109.287 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.42 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.9 p -124.94 141.45 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.705 . . . . 0.0 109.455 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 m -109.49 100.46 9.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.631 -0.668 . . . . 0.0 109.26 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -83.73 133.78 34.78 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.641 -0.662 . . . . 0.0 109.657 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.16 135.92 50.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.3 -37.03 74.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.562 -0.711 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.63 124.88 16.09 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.8 p -77.69 148.21 35.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.969 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' O ' HD22 ' A' ' 12' ' ' LEU . 93.7 m-85 -148.27 128.25 13.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.605 -0.685 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -86.12 148.59 25.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -154.28 -137.6 2.47 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -145.31 -33.02 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.652 -0.911 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.722 HG22 HD11 ' A' ' 13' ' ' ILE . 2.6 m -92.07 124.2 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -106.35 168.76 8.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.671 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.43 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -90.96 147.77 22.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 19.2 pt -67.73 165.07 33.98 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.42 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 104.7 1.71 Allowed 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 125.138 3.892 . . . . 0.0 109.978 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.5 mt -94.38 133.52 37.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.544 -0.722 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -77.47 85.24 3.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.602 -0.686 . . . . 0.0 109.469 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -67.36 -14.21 62.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.582 -0.698 . . . . 0.0 109.815 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.34 -27.14 68.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.511 -0.743 . . . . 0.0 109.49 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.78 30.08 2.16 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.543 -0.723 . . . . 0.0 109.416 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 113' ' ' LEU . 86.7 m-85 -144.95 172.11 13.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.665 -0.647 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.6 m -146.8 131.81 18.21 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.607 -0.683 . . . . 0.0 109.49 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -74.01 120.51 19.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.554 -0.716 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.622 HG11 HE21 ' A' ' 159' ' ' GLN . 27.1 m -97.08 -34.29 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.651 -0.656 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.1 p -164.12 163.73 22.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.659 -0.65 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.8 p -150.8 133.94 16.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -99.6 113.67 26.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.592 -0.692 . . . . 0.0 109.492 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.526 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.8 m -90.57 150.74 21.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 109.482 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 144' ' ' VAL . 8.8 p -154.07 128.6 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.379 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -107.32 120.46 42.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.579 -0.7 . . . . 0.0 109.442 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -80.43 -165.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.564 -0.71 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.8 p -73.9 -39.29 63.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.544 -0.722 . . . . 0.0 109.593 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.66 137.58 19.38 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.586 -0.696 . . . . 0.0 109.416 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.77 -47.32 18.87 Favored 'Trans proline' 0 N--CA 1.507 2.267 0 C-N-CA 124.744 3.629 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.25 70.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.607 -0.683 . . . . 0.0 109.68 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 151' ' ' LEU . 54.6 mt -79.47 18.42 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.703 . . . . 0.0 109.66 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.3 m -91.64 137.43 32.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.555 -0.715 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.535 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.9 p-80 -153.08 168.51 25.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.574 -0.704 . . . . 0.0 109.596 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 143' ' ' THR . 13.5 m -135.54 135.85 40.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.562 -0.711 . . . . 0.0 109.41 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -90.16 97.86 11.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.604 -0.685 . . . . 0.0 109.55 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.07 143.42 32.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.53 -0.731 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.666 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.1 t -132.4 107.56 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.424 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 30.2 m95 -105.51 169.28 8.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.538 -0.726 . . . . 0.0 109.457 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.622 HE21 HG11 ' A' ' 139' ' ' VAL . 26.5 mt-30 -147.73 145.14 28.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -67.8 129.68 40.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.555 -0.715 . . . . 0.0 109.451 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -144.78 148.41 34.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.629 -0.669 . . . . 0.0 109.566 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.497 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.44 HN52 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.02 116.4 16.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.747 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.8 m-85 -90.25 157.74 17.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.611 -0.68 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.677 HD12 ' CB ' ' A' ' 114' ' ' LEU . 8.0 tp -169.51 109.65 0.44 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.585 -0.697 . . . . 0.0 109.371 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -140.93 140.29 34.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.564 -0.71 . . . . 0.0 109.68 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.11 111.11 22.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.54 -0.725 . . . . 0.0 109.284 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.5 153.31 48.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.622 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -101.16 170.91 7.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.498 -0.751 . . . . 0.0 109.467 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -60.54 -20.08 59.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.508 -0.745 . . . . 0.0 109.851 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.37 14.63 0.91 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.491 -0.755 . . . . 0.0 109.784 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.77 38.11 95.41 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.647 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.2 tp -108.82 168.14 9.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.944 . . . . 0.0 109.549 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 126' ' ' THR . 30.9 pt -144.1 -29.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.545 -0.722 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.61 -172.38 26.71 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.59 115.53 0.3 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.585 -0.95 . . . . 0.0 109.472 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.07 32.19 20.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.569 -0.707 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.1 -61.38 3.33 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -78.78 171.93 14.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.594 -0.945 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.64 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.4 mt -79.7 154.49 75.95 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.554 -0.716 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -79.75 -29.86 2.62 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 124.932 3.754 . . . . 0.0 109.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.64 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.2 p90 -106.34 -177.65 3.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.584 -0.698 . . . . 0.0 109.528 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -134.87 97.89 3.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.759 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.0 tp -118.71 80.25 17.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.499 -0.751 . . . . 0.0 109.486 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -45.78 -40.02 19.04 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 C-N-CA 125.13 3.887 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.45 -43.99 97.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 109.624 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.759 ' HB2' HD23 ' A' ' 23' ' ' LEU . 35.8 t70 -66.15 -38.72 88.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.577 -0.702 . . . . 0.0 109.409 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.681 HD22 ' C22' ' A' ' 170' ' ' TMQ . 94.8 mt -63.45 -23.9 67.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.516 -0.74 . . . . 0.0 109.515 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -82.3 -29.24 31.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.534 -0.729 . . . . 0.0 109.488 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 20.2 t80 -72.14 -26.92 62.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.618 -0.676 . . . . 0.0 109.422 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 34' ' ' THR . 46.8 t80 -66.26 -45.75 79.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.441 ' HD3' HH12 ' A' ' 57' ' ' ARG . 10.5 tpp85 -63.71 -28.26 69.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.584 -0.697 . . . . 0.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.39 -28.13 34.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.475 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.9 mm100 -101.57 34.95 2.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.627 -0.671 . . . . 0.0 109.404 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 30' ' ' PHE . 9.6 p -137.66 -34.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 35' ' ' VAL . 27.3 m -80.59 128.59 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.625 -0.672 . . . . 0.0 109.484 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.96 -31.01 9.14 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -113.92 164.15 14.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.591 -0.947 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -79.83 122.03 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.51 -0.744 . . . . 0.0 109.377 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.481 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.3 ttp -91.28 105.63 17.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.57 -0.706 . . . . 0.0 109.442 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG21 HD11 ' A' ' 94' ' ' LEU . 30.4 t -94.26 130.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.433 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 97' ' ' ALA . 28.1 m -146.77 164.33 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.6 -0.688 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.82 -163.8 38.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -84.34 -36.37 22.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.543 -0.974 . . . . 0.0 109.553 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.1 ttp85 -68.08 -37.84 81.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -75.81 -28.93 58.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.591 -0.693 . . . . 0.0 109.501 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -36.43 83.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 109.465 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.66 -26.16 26.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.495 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.7 p -63.93 -19.51 65.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.13 161.21 25.4 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.569 -0.707 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -80.11 -71.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 125.162 3.908 . . . . 0.0 110.008 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -115.21 94.77 4.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.64 -0.662 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.2 ptt85 -98.0 157.27 34.84 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.566 -0.709 . . . . 0.0 109.421 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.78 147.22 73.88 Favored 'Cis proline' 0 N--CA 1.509 2.423 0 O-C-N 123.347 1.183 . . . . 0.0 110.007 0.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.481 HD12 ' CE ' ' A' ' 39' ' ' MET . 74.9 mt -69.62 113.63 18.57 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.591 -0.693 . . . . 0.0 109.353 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.11 179.38 6.5 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.766 3.644 . . . . 0.0 109.899 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 61.28 26.39 16.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.459 -0.776 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.441 HH12 ' HD3' ' A' ' 31' ' ' ARG . 11.6 ptp180 -176.63 176.91 1.48 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.534 -0.729 . . . . 0.0 109.462 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.3 m -107.29 121.66 45.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.473 HD21 ' HB2' ' A' ' 54' ' ' LEU . 2.2 m-80 -97.57 111.53 23.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 109.49 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.9 t -107.08 112.48 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.581 -0.699 . . . . 0.0 109.45 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -95.95 128.27 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.519 -0.738 . . . . 0.0 109.42 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.674 HD12 HG23 ' A' ' 76' ' ' VAL . 14.4 tp -105.66 119.3 38.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.597 -0.69 . . . . 0.0 109.533 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -152.22 133.94 14.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.651 -0.656 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -92.37 30.52 1.47 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.533 -0.729 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -111.15 130.41 55.64 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.582 -0.698 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -88.04 31.61 0.78 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.606 -0.683 . . . . 0.0 109.427 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -131.13 -25.81 2.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.671 . . . . 0.0 109.448 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -64.49 145.34 56.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.602 -0.686 . . . . 0.0 109.488 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.22 140.09 35.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.63 -0.669 . . . . 0.0 109.469 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . . . -137.83 122.85 19.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 109.48 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.66 135.0 33.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.635 -0.666 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.71 36.68 67.01 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -156.67 138.35 14.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.566 -0.961 . . . . 0.0 109.468 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.4 94.58 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.596 -0.69 . . . . 0.0 109.444 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.648 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.5 t -74.86 100.41 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.556 -0.715 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.674 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -91.82 155.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.565 -0.709 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.648 ' NE2' HG12 ' A' ' 75' ' ' VAL . 49.8 m-70 -136.31 29.96 2.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.564 -0.71 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.97 152.1 2.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.646 -0.658 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.32 -33.8 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.617 -0.677 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -31.13 69.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.567 -0.708 . . . . 0.0 109.501 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.21 79.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.633 -0.667 . . . . 0.0 109.476 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 76' ' ' VAL . 31.4 t -69.14 -42.56 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 0.0 109.418 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -71.23 -29.02 64.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.636 -0.665 . . . . 0.0 109.487 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.76 86.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -69.55 -35.96 75.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.31 -26.52 64.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.472 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -64.36 -43.91 93.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.56 -0.712 . . . . 0.0 109.467 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.98 -30.38 69.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.592 -0.692 . . . . 0.0 109.536 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -119.71 89.9 42.31 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.576 -0.703 . . . . 0.0 109.507 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.09 -23.21 6.69 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 125.024 3.816 . . . . 0.0 109.96 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -68.75 -25.77 64.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.665 -0.647 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.91 -179.91 5.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.614 -0.679 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -138.15 161.81 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.579 -0.701 . . . . 0.0 109.518 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.433 HD11 HG21 ' A' ' 40' ' ' VAL . 11.8 tp -99.6 133.29 44.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.561 -0.712 . . . . 0.0 109.476 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -134.0 136.32 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.565 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.7 mm -102.24 120.02 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.527 -0.733 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.536 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -107.25 -26.59 10.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.634 -0.666 . . . . 0.0 109.486 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.26 -176.71 38.62 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.417 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.41 -153.18 14.12 Favored Glycine 0 N--CA 1.499 2.847 0 O-C-N 120.361 -1.67 . . . . 0.0 109.604 0.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.24 -32.38 73.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.605 -0.938 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -74.28 -27.74 60.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.417 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.6 mm -74.88 -34.75 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.559 -0.713 . . . . 0.0 109.561 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.565 ' CE1' HG22 ' A' ' 96' ' ' ILE . 23.6 m-85 -63.48 -54.29 38.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.516 -0.74 . . . . 0.0 109.448 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.4 m -63.16 -24.59 67.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.76 76.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' CE1' HG13 ' A' ' 79' ' ' VAL . 49.8 m-85 -106.14 13.13 29.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.581 -0.699 . . . . 0.0 109.84 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -71.32 -25.41 62.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -0.784 . . . . 0.0 109.549 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.93 13.83 0.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.65 -0.657 . . . . 0.0 109.857 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -160.09 36.83 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.747 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -90.28 149.89 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -126.27 -49.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 m -107.49 158.24 17.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.8 mt -137.23 104.84 5.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.571 -0.706 . . . . 0.0 109.556 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.677 ' CB ' HD12 ' A' ' 4' ' ' LEU . 44.4 mt -103.55 105.06 15.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.497 -0.752 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 8.8 p -111.81 136.32 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.554 -0.716 . . . . 0.0 109.495 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -108.3 99.85 9.21 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -83.37 149.04 26.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.637 -0.665 . . . . 0.0 109.5 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.54 132.14 52.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.605 -0.684 . . . . 0.0 109.305 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.22 77.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.555 -0.715 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.85 128.75 17.66 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.0 p -83.69 141.94 31.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.627 -0.925 . . . . 0.0 109.436 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -145.88 126.27 14.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.717 . . . . 0.0 109.39 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -89.16 148.04 23.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 109.508 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.647 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -149.39 -136.03 2.57 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -138.4 -31.44 0.75 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.636 -0.92 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.611 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -97.7 143.2 28.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -122.87 176.96 5.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.58 -0.7 . . . . 0.0 109.486 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 16.8 tpt -97.92 152.56 19.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.556 -0.715 . . . . 0.0 109.468 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.9 pt -72.0 163.41 67.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.677 -0.639 . . . . 0.0 109.525 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.14 96.87 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 125.162 3.908 . . . . 0.0 109.91 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.1 mt -85.96 134.9 33.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.573 -0.705 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -79.97 86.59 5.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.528 -0.733 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -67.32 -14.84 63.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.562 -0.711 . . . . 0.0 109.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.26 -27.65 69.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.452 -0.78 . . . . 0.0 109.509 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.65 29.57 2.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.557 -0.715 . . . . 0.0 109.449 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -142.08 179.79 6.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.528 -0.732 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 m -153.88 139.45 17.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 0.0 109.487 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -77.85 156.45 30.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.586 -0.696 . . . . 0.0 109.509 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.09 -32.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.703 . . . . 0.0 109.431 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -151.65 153.14 33.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.452 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.7 p -150.15 122.45 8.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 109.5 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -97.3 98.86 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.524 -0.735 . . . . 0.0 109.472 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.454 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.4 m -84.15 139.86 32.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.602 -0.686 . . . . 0.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.42 HG13 ' CE1' ' A' ' 153' ' ' HIS . 8.6 p -148.51 136.16 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.32 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.9 123.87 50.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.677 . . . . 0.0 109.419 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -79.96 -165.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.1 p -72.67 -40.79 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.548 -0.72 . . . . 0.0 109.638 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.437 ' HB3' HD12 ' A' ' 151' ' ' LEU . 28.4 t-20 -100.63 138.13 20.04 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.605 -0.684 . . . . 0.0 109.494 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.52 -46.48 23.58 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 124.717 3.611 . . . . 0.0 109.983 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.69 -27.66 69.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.733 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 148' ' ' ASN . 28.1 mt -79.98 18.36 0.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.625 -0.672 . . . . 0.0 109.744 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.9 m -86.61 143.71 27.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.403 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.563 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.8 p-80 -155.9 163.82 39.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.672 . . . . 0.0 109.547 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 143' ' ' THR . 23.2 m -137.69 134.55 35.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 109.472 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.38 96.39 10.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.617 -0.677 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -81.99 136.66 35.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.54 -0.725 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.643 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.8 t -125.47 109.07 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.59 -0.694 . . . . 0.0 109.493 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 29.0 m95 -103.88 169.26 8.62 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -143.57 140.61 30.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.46 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -81.67 131.77 35.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.493 -0.754 . . . . 0.0 109.467 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.56 179.0 7.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -0.76 . . . . 0.0 109.506 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.456 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.681 ' C22' HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.86 95.67 3.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.436 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.734 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -68.38 134.05 49.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.68 . . . . 0.0 109.369 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.54 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.9 tp -148.53 113.03 5.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.594 -0.691 . . . . 0.0 109.373 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.5 p90 -143.98 145.47 32.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.499 -0.751 . . . . 0.0 109.711 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.64 107.27 19.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 0.0 109.26 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HB3' HG22 ' A' ' 13' ' ' ILE . 9.3 pt20 -127.1 157.7 38.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.576 -0.703 . . . . 0.0 109.643 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -97.65 170.08 9.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.6 ptt85 -61.23 -17.54 53.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.96 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.67 14.17 0.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.728 . . . . 0.0 109.865 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.11 39.21 97.33 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.496 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.8 tp -126.02 151.51 47.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.624 -0.927 . . . . 0.0 109.413 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 126' ' ' THR . 30.5 pt -111.39 -32.02 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.649 -0.657 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.02 -150.29 18.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -169.99 147.59 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.61 -0.935 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' HB2' ' NE2' ' A' ' 18' ' ' HIS . 0.4 OUTLIER 60.63 8.11 1.62 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.22 -48.77 1.54 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' A' ' 16' ' ' ASP . 22.0 p80 -72.15 165.73 23.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.494 -1.004 . . . . 0.0 109.566 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.728 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 13.6 mt -87.35 147.7 42.8 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.616 -0.678 . . . . 0.0 109.52 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -82.01 -31.81 0.92 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 124.987 3.791 . . . . 0.0 109.767 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.728 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 26.3 p90 -101.26 157.36 16.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.727 -0.608 . . . . 0.0 109.497 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -106.09 98.13 7.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.5 tp -121.04 79.8 34.06 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.704 . . . . 0.0 109.424 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -45.47 -39.03 16.66 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 125.142 3.894 . . . . 0.0 110.263 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -62.95 -42.55 99.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.592 -0.692 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.795 ' HB2' HD23 ' A' ' 23' ' ' LEU . 28.0 t0 -68.02 -29.78 68.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.567 -0.708 . . . . 0.0 109.515 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -84.8 -29.71 25.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.617 -0.677 . . . . 0.0 109.491 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 18.2 t80 -71.09 -27.0 63.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.581 -0.7 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 34' ' ' THR . 57.4 t80 -65.17 -45.58 84.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.624 -0.672 . . . . 0.0 109.461 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -66.15 -30.05 70.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.505 -0.747 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.98 -31.53 56.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.2 mm100 -97.07 32.32 2.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.55 -0.719 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.5 p -137.89 -34.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.449 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.9 m -69.25 125.91 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.64 -0.663 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.87 34.89 23.35 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -152.69 174.38 14.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.591 -0.946 . . . . 0.0 109.416 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.2 mt -101.77 100.53 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 109.401 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.675 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.7 tmm? -71.81 131.79 43.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 109.451 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.524 HG21 HD11 ' A' ' 94' ' ' LEU . 30.2 t -135.25 117.98 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.693 . . . . 0.0 109.499 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.675 HG13 ' SD ' ' A' ' 39' ' ' MET . 26.7 m -134.43 -173.3 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.58 -0.7 . . . . 0.0 109.524 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.97 -173.89 29.06 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -76.28 -35.31 58.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.61 -0.935 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.5 ttm-85 -69.71 -39.39 76.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 m -76.33 -27.24 56.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.548 -0.72 . . . . 0.0 109.433 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' CD1' HG22 ' A' ' 61' ' ' VAL . 34.2 t80 -63.34 -39.82 95.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.65 -0.656 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -87.34 -22.93 24.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.632 -0.668 . . . . 0.0 109.594 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 m -62.87 -22.66 66.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.546 -0.721 . . . . 0.0 109.651 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -62.1 162.22 19.39 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.542 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.09 -73.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.159 3.906 . . . . 0.0 109.897 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -108.47 90.42 3.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.564 -0.71 . . . . 0.0 109.439 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.0 ptt85 -93.66 157.13 38.83 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.644 -0.66 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.8 -174.79 15.18 Favored 'Cis proline' 0 N--CA 1.508 2.353 0 O-C-N 123.447 1.235 . . . . 0.0 110.035 0.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.65 105.99 52.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.618 -0.676 . . . . 0.0 109.374 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -75.05 -178.7 4.37 Favored 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 124.602 3.534 . . . . 0.0 109.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.55 23.41 13.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 109.562 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -176.27 175.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.542 -0.724 . . . . 0.0 109.435 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 m -95.84 143.89 26.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.46 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -116.9 117.62 30.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 109.47 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.6 t -121.07 103.58 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.626 -0.671 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.403 HG22 ' CD1' ' A' ' 46' ' ' TYR . 30.6 t -91.64 136.45 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.484 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD12 HG23 ' A' ' 76' ' ' VAL . 14.3 tp -104.04 115.22 30.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -143.11 146.92 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.595 -0.691 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -93.58 -35.16 13.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.569 -0.707 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -73.46 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.639 -0.663 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.16 30.1 0.54 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.37 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.71 -35.75 8.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.67 -0.644 . . . . 0.0 109.505 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -71.31 139.6 49.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.532 -0.73 . . . . 0.0 109.477 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -142.67 100.13 3.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.42 117.69 24.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.554 -0.716 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.9 131.63 42.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.468 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.96 38.85 34.6 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.74 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.555 -0.968 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 t -75.09 98.27 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.585 -0.697 . . . . 0.0 109.447 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.432 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.2 t -78.84 99.06 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.46 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.602 HG23 HD12 ' A' ' 62' ' ' LEU . 27.7 m -90.11 164.93 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.432 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.9 m-70 -141.46 27.93 1.86 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.44 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -174.9 153.42 1.69 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.609 -0.682 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.4 t -68.68 -30.84 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.641 -0.662 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.99 69.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.649 -0.657 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.49 58.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.578 -0.701 . . . . 0.0 109.517 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -68.18 -46.35 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.493 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -71.72 -28.84 63.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.83 84.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.669 -0.644 . . . . 0.0 109.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -72.44 -33.7 67.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.87 -30.9 68.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -66.84 -40.75 88.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -67.27 -30.3 70.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.469 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -119.84 89.87 42.68 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.72 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.22 -22.43 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 125.196 3.93 . . . . 0.0 109.947 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -66.98 -26.6 66.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.52 -0.738 . . . . 0.0 109.514 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -96.22 -179.86 4.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.514 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -137.53 154.63 49.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.524 -0.735 . . . . 0.0 109.43 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.524 HD11 HG21 ' A' ' 40' ' ' VAL . 9.1 tp -86.65 141.33 29.04 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.586 -0.696 . . . . 0.0 109.445 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 t -146.93 118.99 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.55 -0.719 . . . . 0.0 109.488 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.7 mm -91.76 125.88 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.554 -0.716 . . . . 0.0 109.465 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.447 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -100.93 -34.93 9.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.58 -0.7 . . . . 0.0 109.512 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.97 -178.45 39.37 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.01 -152.26 16.81 Favored Glycine 0 N--CA 1.499 2.888 0 O-C-N 120.356 -1.673 . . . . 0.0 109.529 0.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.17 -26.14 65.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.948 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -69.62 -33.44 72.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.62 -0.675 . . . . 0.0 109.483 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -75.3 -38.54 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.588 -0.695 . . . . 0.0 109.537 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 28.9 m-85 -63.08 -51.51 66.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.476 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.7 m -62.87 -23.98 67.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.603 -0.686 . . . . 0.0 109.518 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.9 -30.18 61.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.632 -0.668 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.567 ' CE1' HG13 ' A' ' 79' ' ' VAL . 57.3 m-85 -111.74 17.36 19.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.695 -0.628 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -27.0 65.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.569 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.82 18.69 0.76 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.55 -0.719 . . . . 0.0 109.703 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.15 36.32 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.734 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.5 p -91.39 150.76 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.505 -0.747 . . . . 0.0 109.366 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -132.36 -55.97 0.96 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 109.413 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 m -102.06 125.66 48.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.706 . . . . 0.0 109.375 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.476 HD11 ' CE2' ' A' ' 136' ' ' PHE . 31.9 mt -108.71 96.55 6.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.605 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.569 ' CD2' HG22 ' A' ' 157' ' ' VAL . 40.2 mt -95.13 105.7 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.614 -0.679 . . . . 0.0 109.298 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -111.85 143.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.631 -0.668 . . . . 0.0 109.505 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.8 m -117.69 99.58 7.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 109.251 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.2 mtt85 -85.19 141.67 29.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.01 138.72 49.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.611 -0.681 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.67 -31.92 72.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.602 -0.686 . . . . 0.0 109.433 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.52 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -75.34 132.48 13.4 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.6 m -85.32 142.52 29.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.558 -0.966 . . . . 0.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -143.13 135.24 27.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -97.68 155.29 17.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.541 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -159.69 -139.54 2.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -139.58 -26.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.589 -0.948 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.48 HG22 HD11 ' A' ' 13' ' ' ILE . 18.8 m -97.82 116.83 30.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.488 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -100.77 167.71 10.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.624 -0.673 . . . . 0.0 109.448 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.8 tpt -85.65 149.97 24.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.558 -0.714 . . . . 0.0 109.468 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.39 164.78 58.49 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.608 -0.683 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 101.79 1.37 Allowed 'Trans proline' 0 N--CA 1.504 2.1 0 C-N-CA 125.104 3.87 . . . . 0.0 109.871 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.3 mt -87.19 157.25 19.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.64 86.55 7.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -73.45 -17.5 61.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.508 -0.745 . . . . 0.0 109.783 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.19 9.88 1.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.541 -0.724 . . . . 0.0 109.848 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -132.34 29.16 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.732 . . . . 0.0 109.392 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.476 ' CE2' HD11 ' A' ' 113' ' ' LEU . 66.2 m-85 -144.33 178.82 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.606 -0.684 . . . . 0.0 109.507 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.4 m -151.69 138.71 19.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.631 -0.668 . . . . 0.0 109.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -79.69 120.59 24.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.515 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.45 -32.93 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.549 -0.719 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.8 t -150.73 176.0 11.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -163.48 116.61 1.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.0 109.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -95.09 108.2 20.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.546 -0.721 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.2 m -92.33 144.58 25.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.487 -0.758 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.44 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -146.83 127.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 152' ' ' THR . 13.1 mp0 -101.89 119.13 38.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 109.422 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.07 -168.66 1.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.59 -0.694 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.3 p -72.18 -43.07 65.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.588 -0.695 . . . . 0.0 109.502 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -101.77 137.85 19.67 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.41 -48.38 11.76 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 124.996 3.797 . . . . 0.0 110.228 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.52 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -62.38 -35.09 78.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.553 -0.717 . . . . 0.0 109.572 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 151' ' ' LEU . 35.2 mt -72.06 6.31 2.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 109.868 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 145' ' ' GLU . 24.0 m -80.67 146.19 31.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.36 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.537 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.4 p-80 -160.79 167.87 25.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.569 -0.707 . . . . 0.0 109.55 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 143' ' ' THR . 26.0 m -140.13 139.34 35.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.578 -0.701 . . . . 0.0 109.335 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.52 99.38 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 109.455 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.52 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.9 mt-10 -80.9 130.97 35.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.475 -0.766 . . . . 0.0 109.438 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.569 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -115.16 103.53 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.695 . . . . 0.0 109.45 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.52 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 34.1 m95 -101.01 165.26 11.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.511 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -147.57 145.3 29.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.565 -0.71 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -71.11 104.36 3.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.519 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -138.06 123.28 19.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.548 -0.72 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.431 -179.971 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.428 HN52 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.474 HG23 HD23 ' A' ' 94' ' ' LEU . 5.8 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.473 ' H ' HG22 ' A' ' 1' ' ' THR . . . -137.5 133.15 34.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.548 -0.72 . . . . 0.0 109.466 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -100.95 160.87 14.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.701 . . . . 0.0 109.437 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.9 tp -169.55 109.06 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.68 . . . . 0.0 109.35 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.3 p90 -140.91 146.66 37.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.4 112.22 24.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.353 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.2 pt20 -132.61 149.85 52.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.58 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -99.13 170.8 8.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.46 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -61.3 -18.7 59.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.58 -0.7 . . . . 0.0 109.818 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' CG ' ' HG ' ' A' ' 121' ' ' SER . 2.0 m-20 -77.46 15.51 0.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.445 -0.784 . . . . 0.0 109.858 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.37 35.32 91.5 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 122' ' ' PHE . 5.9 tp -107.34 167.12 10.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.571 -0.958 . . . . 0.0 109.533 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 126' ' ' THR . 31.2 pt -141.86 -30.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.604 -0.685 . . . . 0.0 109.521 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -166.43 -167.41 27.06 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -172.49 121.22 0.42 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.627 -0.925 . . . . 0.0 109.479 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 57.99 34.0 23.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.571 -0.706 . . . . 0.0 109.923 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.92 -63.69 2.82 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -76.26 177.46 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.54 -0.977 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.584 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 29.4 mt -84.94 156.9 60.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.576 -0.703 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.26 -28.38 3.05 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 125.055 3.836 . . . . 0.0 109.923 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.584 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 33.3 p90 -108.09 176.02 5.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.573 -0.705 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -126.55 98.85 5.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.693 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 18.8 tp -118.23 80.44 15.69 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.599 -0.688 . . . . 0.0 109.51 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -45.88 -37.74 17.21 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 125.051 3.834 . . . . 0.0 110.2 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.63 -45.51 92.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.516 -0.74 . . . . 0.0 109.55 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.5 t0 -63.09 -39.66 95.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.582 -0.699 . . . . 0.0 109.474 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.77 -23.62 67.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.57 -0.706 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -86.07 -28.54 24.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.548 -0.72 . . . . 0.0 109.365 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' CZ ' ' NE2' ' A' ' 33' ' ' GLN . 20.6 t80 -71.67 -26.51 62.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.672 . . . . 0.0 109.476 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' A' ' 34' ' ' THR . 49.6 t80 -65.27 -46.33 80.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.547 -0.72 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -71.09 2.72 4.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.643 . . . . 0.0 109.994 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.02 -33.06 10.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.831 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.432 ' NE2' ' CZ ' ' A' ' 29' ' ' TYR . 3.5 mp0 -107.99 30.46 6.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.541 -0.724 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.51 HG21 ' CE2' ' A' ' 30' ' ' PHE . 19.0 p -126.63 -30.59 2.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 109.483 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.13 134.65 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.573 -0.704 . . . . 0.0 109.445 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.18 34.29 64.51 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -156.92 165.78 35.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.954 . . . . 0.0 109.511 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 57.8 mt -92.51 111.61 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.594 -0.691 . . . . 0.0 109.465 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 43.0 ttp -87.83 111.7 21.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.681 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 94' ' ' LEU . 29.0 t -98.87 122.48 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.42 161.54 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.652 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.81 -177.61 52.03 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -72.35 -38.36 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.963 . . . . 0.0 109.457 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.8 mtm-85 -68.23 -34.08 75.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.8 m -78.68 -28.82 45.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.579 -0.701 . . . . 0.0 109.459 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 35.7 t80 -68.17 -29.22 68.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.541 -0.725 . . . . 0.0 109.496 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -85.8 -24.62 26.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.615 -0.678 . . . . 0.0 109.537 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.5 p -63.6 -25.34 68.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.635 -0.666 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -63.98 161.26 40.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.542 -0.724 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.81 -61.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 125.084 3.856 . . . . 0.0 109.878 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -126.37 77.01 1.66 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.601 -0.687 . . . . 0.0 109.394 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -79.87 150.73 72.69 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 0.0 109.588 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -79.41 161.64 87.09 Favored 'Cis proline' 0 N--CA 1.51 2.466 0 O-C-N 123.445 1.234 . . . . 0.0 109.859 0.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.5 mt -78.53 142.93 62.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -80.58 162.62 21.78 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 124.914 3.742 . . . . 0.0 110.037 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 61.08 28.46 18.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.544 -0.723 . . . . 0.0 109.903 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -177.83 146.36 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.555 -0.715 . . . . 0.0 109.629 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.41 ' C ' HD22 ' A' ' 59' ' ' ASN . 3.3 m -78.43 152.42 32.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.589 -0.694 . . . . 0.0 109.455 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.428 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 1.9 m-80 -123.79 97.67 5.47 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.695 . . . . 0.0 109.5 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -91.62 149.47 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 t -136.03 120.72 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.551 -0.718 . . . . 0.0 109.445 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 76' ' ' VAL . 15.1 tp -96.21 119.52 34.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 109.492 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -141.37 146.07 36.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -100.57 31.21 3.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.605 -0.684 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -150.95 137.17 18.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.635 -0.666 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -87.74 32.19 0.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.561 -0.712 . . . . 0.0 109.481 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -95.14 -38.04 10.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.668 -0.645 . . . . 0.0 109.475 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -73.56 158.18 35.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.554 -0.716 . . . . 0.0 109.486 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -151.73 101.52 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.674 . . . . 0.0 109.509 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.45 115.33 27.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.544 -0.722 . . . . 0.0 109.513 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -80.36 124.5 28.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.63 -0.669 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.82 40.38 12.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 59' ' ' ASN . . . -156.47 153.82 29.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.598 -0.942 . . . . 0.0 109.558 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.3 t -86.29 94.29 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.586 -0.696 . . . . 0.0 109.462 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.507 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.4 t -75.55 103.85 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.63 -0.669 . . . . 0.0 109.444 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -96.57 157.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.519 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.507 ' NE2' HG12 ' A' ' 75' ' ' VAL . 63.0 m-70 -135.95 30.68 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 109.482 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -169.98 146.46 3.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.577 -0.702 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.613 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.7 t -67.95 -32.37 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.638 -0.664 . . . . 0.0 109.476 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.47 -32.79 70.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.738 . . . . 0.0 109.5 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.46 -35.21 78.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 76' ' ' VAL . 30.5 t -68.45 -33.31 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.45 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.15 -31.22 39.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.661 -0.649 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.46 67.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.727 . . . . 0.0 109.458 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.53 -25.32 22.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.635 -0.665 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.17 -33.18 50.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.644 -0.66 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.83 -31.51 72.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.546 -0.721 . . . . 0.0 109.5 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.36 -26.12 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.674 -0.641 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -119.37 90.28 42.01 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.612 -0.68 . . . . 0.0 109.465 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.25 -22.46 8.33 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.077 3.852 . . . . 0.0 109.95 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.94 -27.18 65.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.694 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -96.99 -179.99 4.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.531 -0.731 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -138.02 150.68 47.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.506 -0.746 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.474 HD23 HG23 ' A' ' 1' ' ' THR . 9.3 tp -88.08 130.2 35.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.6 t -128.83 129.86 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.525 -0.734 . . . . 0.0 109.435 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.543 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.9 mm -96.64 116.8 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.613 -0.68 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.557 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -104.08 -29.97 10.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.476 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.66 -175.51 39.06 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.05 -151.86 11.02 Favored Glycine 0 N--CA 1.5 2.902 0 O-C-N 120.298 -1.707 . . . . 0.0 109.567 -0.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.12 -30.64 69.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.606 -0.938 . . . . 0.0 109.483 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.73 -27.56 60.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 0.0 109.425 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.1 mm -77.26 -33.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.543 ' CE1' HG22 ' A' ' 96' ' ' ILE . 20.0 m-85 -63.38 -58.19 7.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.543 -0.723 . . . . 0.0 109.483 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -62.91 -21.92 66.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.596 -0.69 . . . . 0.0 109.617 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.55 -29.13 64.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 109.484 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.613 ' CE1' HG13 ' A' ' 79' ' ' VAL . 54.5 m-85 -117.35 16.55 14.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.707 . . . . 0.0 109.778 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.642 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -69.43 -23.03 63.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.731 . . . . 0.0 109.636 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.05 -39.01 83.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.569 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -104.8 41.28 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.74 . . . . 0.0 109.457 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.866 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -91.17 151.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.748 . . . . 0.0 109.315 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -134.57 -66.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.581 -0.699 . . . . 0.0 109.441 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -90.03 161.92 15.61 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.615 -0.678 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 136' ' ' PHE . 59.3 mt -140.78 96.85 3.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.557 -0.714 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.632 ' CB ' HD12 ' A' ' 4' ' ' LEU . 42.4 mt -95.69 104.44 16.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.61 -0.681 . . . . 0.0 109.322 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.0 p -111.23 137.43 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.2 m -109.19 99.16 8.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 109.337 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -85.07 139.62 31.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.04 140.05 47.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.612 -0.68 . . . . 0.0 109.294 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.28 -34.33 68.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.575 -0.703 . . . . 0.0 109.487 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.67 128.77 18.26 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.408 ' HG ' ' CG ' ' A' ' 10' ' ' ASP . 31.2 t -77.35 137.33 38.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.632 -0.923 . . . . 0.0 109.493 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.526 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.8 m-85 -144.09 117.78 9.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.608 -0.683 . . . . 0.0 109.522 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -93.06 145.29 24.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.461 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -142.8 -120.21 1.52 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -146.06 -36.35 0.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.674 -0.898 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.677 HG22 HD11 ' A' ' 13' ' ' ILE . 4.8 m -93.14 144.38 25.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.625 -0.672 . . . . 0.0 109.584 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -122.78 176.42 5.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.592 -0.692 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.1 tpt -91.74 150.95 20.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.587 -0.695 . . . . 0.0 109.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.9 pt -73.67 165.55 52.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.571 -0.705 . . . . 0.0 109.456 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.95 92.72 1.09 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.123 3.882 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.2 mt -77.87 149.73 34.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.595 -0.69 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -81.63 81.83 7.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -70.14 -13.92 62.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.08 9.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.386 -0.821 . . . . 0.0 109.904 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -136.82 30.26 2.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 113' ' ' LEU . 60.2 m-85 -139.41 177.03 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.563 -0.711 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 136' ' ' PHE . 5.6 m -153.69 143.56 21.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.659 -0.651 . . . . 0.0 109.428 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -76.22 157.04 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.582 -0.699 . . . . 0.0 109.468 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.472 HG11 HE21 ' A' ' 159' ' ' GLN . 28.0 m -148.29 -31.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.502 -0.749 . . . . 0.0 109.443 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 t -147.13 159.52 43.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.632 -0.667 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 40.9 t -157.12 111.06 2.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.68 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -95.88 106.82 19.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.501 -0.75 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.455 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.0 m -90.19 143.37 26.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -147.29 131.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 109.317 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.405 ' HA ' HG23 ' A' ' 152' ' ' THR . 25.0 mt-10 -109.39 121.85 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.601 -0.687 . . . . 0.0 109.48 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.33 -171.59 3.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.633 -0.667 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.9 p -63.2 -45.05 93.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.55 -0.719 . . . . 0.0 109.313 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -90.46 158.91 42.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -78.81 -23.09 8.4 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 124.915 3.743 . . . . 0.0 109.819 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.76 -23.02 29.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 109.513 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 mt -86.01 16.84 3.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.715 . . . . 0.0 109.817 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 145' ' ' GLU . 15.0 m -82.62 146.25 29.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.49 ' CE1' HD21 ' A' ' 23' ' ' LEU . 32.8 p-80 -160.26 166.45 29.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.602 -0.686 . . . . 0.0 109.544 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 143' ' ' THR . 19.6 m -138.67 138.65 37.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.586 -0.696 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -93.69 92.19 7.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.606 -0.684 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 39.0 mm-40 -74.43 126.23 30.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.0 t -110.89 112.15 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.484 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.532 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 33.4 m95 -109.22 168.34 9.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.472 HE21 HG11 ' A' ' 139' ' ' VAL . 25.8 mt-30 -147.1 141.08 25.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.584 -0.698 . . . . 0.0 109.452 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -66.47 124.81 23.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.731 . . . . 0.0 109.484 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -153.54 144.02 22.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.592 -0.692 . . . . 0.0 109.434 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.434 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.557 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.31 113.27 13.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.558 -0.714 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.726 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -86.92 153.39 21.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.511 HD12 ' CB ' ' A' ' 114' ' ' LEU . 16.6 tp -163.28 109.85 1.16 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 0.0 109.359 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CD1' ' HG3' ' A' ' 128' ' ' MET . 9.3 p90 -141.2 146.12 36.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.546 -0.721 . . . . 0.0 109.708 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.78 113.04 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.587 -0.696 . . . . 0.0 109.245 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -131.87 152.45 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.543 -0.723 . . . . 0.0 109.66 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -102.97 171.21 7.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 -60.92 -19.45 60.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.554 -0.716 . . . . 0.0 109.808 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.45 14.86 0.88 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.491 -0.756 . . . . 0.0 109.736 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.17 36.89 93.63 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 122' ' ' PHE . 5.6 tp -106.65 167.33 9.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.608 -0.936 . . . . 0.0 109.473 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.559 HD11 HG22 ' A' ' 126' ' ' THR . 31.3 pt -142.57 -29.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -176.15 -176.56 44.46 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -164.19 124.1 2.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.942 . . . . 0.0 109.53 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 59.94 29.18 18.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.517 -0.739 . . . . 0.0 109.754 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.11 -62.42 2.51 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -72.4 -179.78 3.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.602 -0.94 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.684 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.7 mt -91.4 157.83 41.76 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.725 . . . . 0.0 109.464 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.463 ' CG ' HD23 ' A' ' 12' ' ' LEU . 10.5 Cg_endo -80.34 -30.24 2.12 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.063 3.842 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.684 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.9 p90 -105.44 -175.45 2.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.585 -0.697 . . . . 0.0 109.527 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -134.28 103.06 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.671 -0.643 . . . . 0.0 109.361 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.767 HD23 ' HB2' ' A' ' 26' ' ' ASP . 16.8 tp -124.74 82.39 60.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HA ' HD12 ' A' ' 27' ' ' LEU . 7.6 Cg_exo -45.44 -38.78 16.22 Favored 'Trans proline' 0 N--CA 1.508 2.329 0 C-N-CA 125.066 3.844 . . . . 0.0 110.21 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.79 -47.37 83.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 109.472 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.767 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.5 t0 -64.47 -28.95 70.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.63 -0.669 . . . . 0.0 109.512 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.705 HD22 H223 ' A' ' 170' ' ' TMQ . 83.9 mt -72.72 -23.69 60.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -87.18 -27.83 22.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.581 -0.7 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -69.68 -28.44 65.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.697 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 34' ' ' THR . 59.9 t80 -67.59 -45.7 74.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -67.12 -26.25 66.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.65 -0.656 . . . . 0.0 109.46 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.7 -28.07 40.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.549 -0.719 . . . . 0.0 109.462 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -104.72 35.71 2.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 30' ' ' PHE . 13.9 p -139.26 -27.01 0.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.589 -0.694 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -68.29 124.26 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.677 -0.64 . . . . 0.0 109.501 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.66 37.84 61.54 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -146.93 164.12 33.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.529 -0.983 . . . . 0.0 109.534 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.1 103.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.432 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.415 ' CE ' HD12 ' A' ' 54' ' ' LEU . 46.3 ttp -86.49 105.17 16.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.64 -0.663 . . . . 0.0 109.481 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.0 t -94.24 124.54 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.5 166.26 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.701 . . . . 0.0 109.489 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.31 -164.25 40.08 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -81.85 -37.49 26.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.62 -0.929 . . . . 0.0 109.441 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -66.99 -42.3 85.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.643 -0.66 . . . . 0.0 109.486 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 m -72.27 -26.11 61.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.612 -0.68 . . . . 0.0 109.456 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -64.32 -41.3 96.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.442 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -85.37 -21.18 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.63 -0.668 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -62.71 -24.26 67.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.518 -0.739 . . . . 0.0 109.608 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -62.83 161.06 31.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.98 -72.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 125.194 3.929 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.2 tttt -107.36 94.46 5.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.534 -0.729 . . . . 0.0 109.513 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.1 ptt85 -99.01 157.18 34.55 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.77 153.46 83.03 Favored 'Cis proline' 0 N--CA 1.508 2.35 0 O-C-N 123.37 1.195 . . . . 0.0 109.967 0.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.415 HD12 ' CE ' ' A' ' 39' ' ' MET . 84.7 mt -76.45 114.06 34.78 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.636 -0.665 . . . . 0.0 109.282 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.28 -179.16 5.17 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 124.791 3.66 . . . . 0.0 109.906 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 60.81 32.13 20.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.714 . . . . 0.0 109.666 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -177.11 -171.59 0.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.478 -0.764 . . . . 0.0 109.544 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -118.06 113.09 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.601 -0.687 . . . . 0.0 109.41 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.435 ' N ' HD22 ' A' ' 59' ' ' ASN . 1.5 m-80 -83.49 103.67 13.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.571 -0.706 . . . . 0.0 109.417 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.62 92.69 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.582 -0.699 . . . . 0.0 109.461 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 t -79.66 136.86 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.611 -0.681 . . . . 0.0 109.43 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.779 HD12 HG23 ' A' ' 76' ' ' VAL . 14.6 tp -108.65 109.75 21.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.677 -0.64 . . . . 0.0 109.499 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -137.51 151.69 48.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.534 ' H ' ' CD2' ' A' ' 64' ' ' HIS . 9.3 p80 -95.76 -33.9 12.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 109.531 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -77.22 128.81 35.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 13.9 pt-20 -85.16 30.36 0.6 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.714 . . . . 0.0 109.522 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -98.43 -36.37 9.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.594 -0.692 . . . . 0.0 109.579 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -71.04 146.76 49.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -143.96 103.4 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.33 117.61 26.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.522 -0.736 . . . . 0.0 109.421 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -74.62 127.37 32.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.63 -0.669 . . . . 0.0 109.487 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.28 38.06 35.09 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.8 144.47 20.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.572 -0.958 . . . . 0.0 109.417 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -79.69 104.45 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.6 t -85.65 94.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.555 -0.715 . . . . 0.0 109.414 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.779 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -88.6 171.89 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.55 -0.719 . . . . 0.0 109.451 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -143.95 29.96 1.33 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.597 -0.69 . . . . 0.0 109.493 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -171.22 142.86 1.81 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.559 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.5 t -66.55 -33.64 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.85 74.11 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.645 -0.659 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.89 -36.02 79.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.627 -0.671 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -67.06 -40.25 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -69.89 -29.55 66.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.546 -0.721 . . . . 0.0 109.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.46 -34.42 77.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.635 -0.665 . . . . 0.0 109.529 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -72.39 -34.14 67.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.513 -0.742 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.79 -30.49 68.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 0.0 109.439 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -65.81 -40.4 91.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -65.69 -29.63 70.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.619 -0.676 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -118.99 90.06 40.33 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.01 -23.54 6.52 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.061 3.841 . . . . 0.0 109.828 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -70.56 -25.31 63.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.676 -0.64 . . . . 0.0 109.495 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 93' ' ' GLU . 1.4 tp60 -94.6 179.85 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 92' ' ' GLN . 28.4 mt-10 -136.52 155.61 49.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.598 -0.689 . . . . 0.0 109.468 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.1 tp -97.4 147.81 23.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.606 -0.684 . . . . 0.0 109.462 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -145.92 139.12 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.585 -0.697 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.541 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.9 mm -105.21 120.55 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.564 -0.71 . . . . 0.0 109.429 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -101.97 -29.1 12.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.488 -0.758 . . . . 0.0 109.415 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 156.67 -174.41 34.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.97 -150.14 9.06 Favored Glycine 0 N--CA 1.499 2.857 0 O-C-N 120.266 -1.726 . . . . 0.0 109.58 -0.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.77 -32.17 71.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.564 -0.962 . . . . 0.0 109.53 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -69.51 -28.06 65.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.601 -0.687 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -79.44 -36.12 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.541 ' CE1' HG22 ' A' ' 96' ' ' ILE . 22.4 m-85 -63.3 -52.96 59.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.534 -0.729 . . . . 0.0 109.478 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.773 HG23 HD13 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -63.13 -28.04 69.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.61 -0.681 . . . . 0.0 109.535 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.46 79.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.679 . . . . 0.0 109.534 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.61 8.78 41.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.503 -0.748 . . . . 0.0 109.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.471 ' HE2' HD22 ' A' ' 131' ' ' LEU . 19.9 tptp -66.07 -30.67 71.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 109.543 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -77.56 14.45 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.0 109.873 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -160.1 37.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.741 . . . . 0.0 109.402 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.726 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -95.77 153.42 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.596 -0.69 . . . . 0.0 109.442 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -130.94 -52.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.586 -0.696 . . . . 0.0 109.379 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -102.29 158.69 16.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.675 . . . . 0.0 109.334 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.539 HD11 ' CE2' ' A' ' 136' ' ' PHE . 32.8 mt -139.49 107.7 5.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.566 -0.709 . . . . 0.0 109.539 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.558 ' CD2' HG22 ' A' ' 157' ' ' VAL . 37.8 mt -104.66 102.51 12.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.574 -0.704 . . . . 0.0 109.242 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -108.27 137.92 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.526 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 m -109.09 99.82 9.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -81.98 147.66 29.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.712 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mp -126.33 131.92 51.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.554 -0.716 . . . . 0.0 109.277 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.87 -31.69 71.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.464 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.8 127.47 13.48 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.4 p -79.16 140.66 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.613 -0.934 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.483 ' O ' HD22 ' A' ' 12' ' ' LEU . 96.1 m-85 -147.95 129.53 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.611 -0.681 . . . . 0.0 109.462 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -99.35 151.03 21.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.535 -0.728 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -147.56 -122.38 1.32 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -146.27 -36.67 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.599 -0.942 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.559 HG22 HD11 ' A' ' 13' ' ' ILE . 3.2 m -99.42 135.74 40.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.583 -0.698 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.416 ' O ' HD13 ' A' ' 13' ' ' ILE . 52.2 mtpt -110.32 179.95 3.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.435 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -95.15 144.73 25.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.539 -0.726 . . . . 0.0 109.548 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.773 HD13 HG23 ' A' ' 104' ' ' THR . 28.8 pt -67.27 163.5 45.62 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.632 -0.668 . . . . 0.0 109.534 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.79 94.85 1.03 Allowed 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 125.137 3.891 . . . . 0.0 109.945 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.471 HD22 ' HE2' ' A' ' 107' ' ' LYS . 50.1 mt -77.91 147.29 35.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.523 -0.736 . . . . 0.0 109.388 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -79.67 86.75 5.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.541 -0.724 . . . . 0.0 109.504 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -73.94 -11.76 60.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.953 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.01 10.11 1.31 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.929 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -138.56 30.73 2.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 113' ' ' LEU . 55.2 m-85 -143.21 176.96 8.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.504 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.3 m -156.69 140.14 15.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HE3' ' CZ2' ' A' ' 158' ' ' TRP . 31.2 ttmt -81.95 120.87 25.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.567 -0.708 . . . . 0.0 109.492 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.02 -35.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.724 . . . . 0.0 109.51 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.4 p -148.64 170.26 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.635 -0.666 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.1 p -157.49 113.64 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 109.445 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -93.36 104.1 16.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.538 -0.726 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.451 ' HA ' HG23 ' A' ' 154' ' ' THR . 4.3 m -86.02 147.09 26.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.618 -0.676 . . . . 0.0 109.506 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.401 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -151.74 132.49 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.586 -0.696 . . . . 0.0 109.38 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -107.6 128.91 54.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.636 -0.665 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.81 -166.05 1.41 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.675 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -69.96 -39.0 76.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.582 -0.699 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -105.38 137.7 19.35 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.488 -0.757 . . . . 0.0 109.42 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -48.53 -43.7 32.44 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 124.775 3.65 . . . . 0.0 110.059 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.88 -29.06 69.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.577 -0.702 . . . . 0.0 109.537 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 36.7 mt -80.71 21.2 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.621 -0.675 . . . . 0.0 109.652 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.6 m -89.06 142.01 28.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.501 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.6 p-80 -153.76 168.23 26.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.451 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.4 m -141.67 128.25 20.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 109.42 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -84.52 95.83 8.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.493 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 25.7 mt-10 -81.12 130.4 35.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.7 t -117.6 106.06 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.567 -0.708 . . . . 0.0 109.509 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.493 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.5 m95 -100.48 166.81 10.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.547 -0.721 . . . . 0.0 109.481 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -142.49 147.14 35.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.46 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -66.4 99.84 0.59 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.695 . . . . 0.0 109.501 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -157.79 113.85 2.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.606 -0.684 . . . . 0.0 109.442 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.492 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.705 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.414 HG23 HD22 ' A' ' 94' ' ' LEU . 6.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.37 20.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.441 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.817 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.8 m-85 -87.92 135.03 33.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.587 -0.696 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.603 HD12 ' CB ' ' A' ' 114' ' ' LEU . 9.4 tp -150.08 112.91 4.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.544 -0.722 . . . . 0.0 109.467 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -144.23 138.79 28.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.536 -0.727 . . . . 0.0 109.735 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.84 111.19 22.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 13' ' ' ILE . 2.4 pp0? -129.75 157.64 41.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.515 -0.74 . . . . 0.0 109.68 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -101.32 168.44 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.559 -0.713 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -60.77 -23.88 65.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 109.713 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.71 -1.44 3.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.636 -0.665 . . . . 0.0 109.907 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.75 44.79 19.1 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.633 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.9 tp -124.55 152.32 43.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.562 -0.963 . . . . 0.0 109.53 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.902 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -128.01 -33.87 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.569 -0.707 . . . . 0.0 109.81 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.422 ' H ' HD13 ' A' ' 13' ' ' ILE . . . -146.01 178.84 23.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -172.03 116.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.624 -0.927 . . . . 0.0 109.543 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 59.86 31.18 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.507 -0.745 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.55 -59.57 4.04 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -81.95 179.99 7.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.598 -0.943 . . . . 0.0 109.503 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.737 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 20.2 mt -88.57 155.1 51.09 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.0 109.4 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.0 Cg_endo -79.28 -29.46 3.1 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 124.946 3.764 . . . . 0.0 109.892 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.737 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 37.5 p90 -105.06 167.24 9.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.0 109.639 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -123.37 83.77 2.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 109.394 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 26' ' ' ASP . 20.2 tp -106.76 81.4 0.88 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.607 -0.683 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -45.01 -39.06 14.24 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 125.262 3.974 . . . . 0.0 110.22 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.91 -38.33 90.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.446 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.787 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -70.91 -32.32 69.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.528 -0.732 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.3 mt -72.47 -24.23 61.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.52 -0.737 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -82.15 -30.32 31.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.593 -0.692 . . . . 0.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -70.47 -25.11 63.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.571 -0.705 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 34' ' ' THR . 56.0 t80 -63.39 -45.43 91.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.584 -0.698 . . . . 0.0 109.401 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -64.45 -28.71 69.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.575 -0.703 . . . . 0.0 109.427 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.56 -28.71 46.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.527 -0.733 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -101.96 33.65 2.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.57 -0.706 . . . . 0.0 109.541 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 30' ' ' PHE . 18.8 p -140.05 -34.45 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.599 -0.688 . . . . 0.0 109.422 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.4 m -68.59 126.04 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.557 -0.714 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.53 36.8 25.45 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -154.49 175.29 13.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.654 -0.909 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 99.97 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.557 -0.714 . . . . 0.0 109.415 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.659 ' SD ' HG13 ' A' ' 41' ' ' VAL . 9.7 tmm? -72.62 125.77 28.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.633 -0.667 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -132.55 118.55 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.659 HG13 ' SD ' ' A' ' 39' ' ' MET . 28.1 m -134.35 -176.17 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.539 -0.726 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.87 -169.39 33.74 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -80.01 -35.69 36.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.62 -0.929 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -70.22 -40.86 74.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.652 -0.655 . . . . 0.0 109.419 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.1 m -73.1 -26.08 61.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.56 -0.712 . . . . 0.0 109.451 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -63.67 -45.09 91.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.629 -0.67 . . . . 0.0 109.502 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -77.48 -23.31 50.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.626 -0.671 . . . . 0.0 109.568 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.9 m -63.05 -24.16 67.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.509 -0.745 . . . . 0.0 109.607 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -65.43 160.59 58.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.583 -0.698 . . . . 0.0 109.471 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.96 -72.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 125.075 3.85 . . . . 0.0 109.955 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -109.22 94.81 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.604 -0.685 . . . . 0.0 109.533 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -99.54 157.26 34.3 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.75 154.09 83.61 Favored 'Cis proline' 0 N--CA 1.509 2.419 0 O-C-N 123.313 1.165 . . . . 0.0 109.923 0.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.438 HD12 ' CE ' ' A' ' 39' ' ' MET . 69.2 mt -73.88 115.61 44.0 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.642 -0.661 . . . . 0.0 109.277 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.96 178.86 7.04 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 124.741 3.627 . . . . 0.0 109.934 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 61.34 29.32 18.52 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.595 -0.69 . . . . 0.0 109.608 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -177.0 167.61 2.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.702 . . . . 0.0 109.465 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.452 HG21 ' CE1' ' A' ' 85' ' ' TYR . 3.1 m -88.26 117.06 26.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.591 -0.693 . . . . 0.0 109.468 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.42 HD21 ' HB2' ' A' ' 54' ' ' LEU . 25.8 m120 -91.85 101.61 14.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.548 -0.72 . . . . 0.0 109.462 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.22 145.18 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.9 t -134.93 116.43 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.587 -0.696 . . . . 0.0 109.417 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 82' ' ' VAL . 17.5 tp -96.2 119.54 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.573 -0.705 . . . . 0.0 109.485 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.571 HG23 ' CE1' ' A' ' 77' ' ' HIS . 4.0 t -138.51 152.61 48.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.62 -0.675 . . . . 0.0 109.454 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -93.79 -37.24 11.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.567 -0.708 . . . . 0.0 109.529 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -72.34 133.64 45.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 109.46 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -88.48 29.83 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.539 -0.726 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -102.6 -38.61 7.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.697 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.53 141.41 48.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.681 -0.637 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -149.91 101.52 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.604 -0.685 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.88 115.02 20.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.607 -0.683 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -76.84 135.01 38.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.599 -0.688 . . . . 0.0 109.49 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.43 35.09 34.07 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.16 147.81 19.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.553 -0.969 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.66 94.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.55 -0.719 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 t -96.8 124.4 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.628 -0.67 . . . . 0.0 109.426 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 82' ' ' VAL . 27.4 m -134.23 174.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.609 -0.682 . . . . 0.0 109.514 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.571 ' CE1' HG23 ' A' ' 63' ' ' THR . 47.9 m-70 -138.86 31.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.515 -0.741 . . . . 0.0 109.452 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -153.67 143.69 22.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.717 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.5 t -66.96 -32.76 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.552 -0.718 . . . . 0.0 109.442 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.62 -34.15 76.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.715 . . . . 0.0 109.44 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.97 90.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 76' ' ' VAL . 32.9 t -66.83 -39.37 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.63 -28.55 63.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.48 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -38.18 90.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.65 -0.656 . . . . 0.0 109.533 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' CE1' HG21 ' A' ' 58' ' ' THR . 39.0 t80 -69.36 -37.42 77.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.541 -0.725 . . . . 0.0 109.45 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.3 68.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.595 -0.69 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -67.18 -43.74 81.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -65.46 -28.84 69.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 109.477 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -119.42 90.02 41.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.77 -20.59 9.01 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 125.14 3.893 . . . . 0.0 109.944 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.12 -28.31 69.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.542 -0.724 . . . . 0.0 109.479 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -105.55 165.54 11.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.6 -0.687 . . . . 0.0 109.498 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -122.01 143.66 49.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.547 -0.721 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 95' ' ' VAL . 2.1 tt -67.18 132.93 48.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.592 -0.692 . . . . 0.0 109.459 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.636 ' N ' HD23 ' A' ' 94' ' ' LEU . 30.9 t -135.31 120.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.426 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.2 mm -96.09 140.64 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 109.438 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.605 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -114.78 -36.1 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.573 -0.705 . . . . 0.0 109.546 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 162.17 179.58 36.89 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 -155.44 28.06 Favored Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.335 -1.685 . . . . 0.0 109.591 0.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' A' ' 129' ' ' ILE . . . -62.78 -23.43 67.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.649 -0.912 . . . . 0.0 109.669 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -70.05 -38.55 75.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.54 -0.725 . . . . 0.0 109.603 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.1 mm -72.14 -39.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.552 -0.718 . . . . 0.0 109.585 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 29.1 m-85 -62.93 -41.69 99.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.552 -0.717 . . . . 0.0 109.415 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.629 HG23 HD13 ' A' ' 129' ' ' ILE . 0.7 OUTLIER -71.74 -19.06 62.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.669 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.15 -25.8 47.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.554 -0.716 . . . . 0.0 109.544 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.717 ' CE1' HG13 ' A' ' 79' ' ' VAL . 82.1 m-85 -124.53 19.85 8.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.584 -0.698 . . . . 0.0 109.748 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -63.41 -29.99 71.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 109.625 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -80.85 26.02 0.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.617 -0.677 . . . . 0.0 109.73 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -159.99 34.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.568 -0.707 . . . . 0.0 109.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.817 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -91.68 150.66 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.49 -0.756 . . . . 0.0 109.436 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -132.35 -58.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.683 -0.636 . . . . 0.0 109.307 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.7 m -102.22 112.04 24.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.569 -0.707 . . . . 0.0 109.353 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.571 HD11 ' CE2' ' A' ' 136' ' ' PHE . 30.0 mt -94.64 99.26 11.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.637 ' CD2' HG22 ' A' ' 157' ' ' VAL . 20.0 mt -100.63 104.41 15.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.632 -0.667 . . . . 0.0 109.22 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -112.38 143.65 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.723 . . . . 0.0 109.602 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.0 m -113.5 99.98 8.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -83.64 142.12 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.682 . . . . 0.0 109.611 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.1 131.54 56.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.603 -0.685 . . . . 0.0 109.243 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.47 75.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.41 9.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 p -76.92 142.89 39.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.561 -0.964 . . . . 0.0 109.443 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -147.82 109.44 4.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.33 153.19 28.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.622 -0.674 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.633 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -151.12 -126.2 1.29 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.55 -46.9 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.907 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.443 HG22 HD11 ' A' ' 13' ' ' ILE . 3.2 m -85.8 139.84 30.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.57 -0.706 . . . . 0.0 109.515 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.443 ' C ' HD12 ' A' ' 13' ' ' ILE . 48.3 mttp -116.54 160.72 20.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.685 -0.634 . . . . 0.0 109.457 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.45 ' HG2' HG21 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -76.61 147.61 37.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.546 -0.721 . . . . 0.0 109.476 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.645 HG23 ' HB1' ' A' ' 100' ' ' ALA . 19.7 pt -70.37 163.83 59.13 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.589 -0.695 . . . . 0.0 109.479 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.34 101.03 1.29 Allowed 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 125.139 3.893 . . . . 0.0 109.855 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.3 153.08 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.602 -0.686 . . . . 0.0 109.485 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.2 88.52 7.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.617 -0.677 . . . . 0.0 109.461 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -73.9 -15.16 61.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.0 109.82 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.95 9.86 1.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 109.933 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -134.48 30.62 3.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.823 . . . . 0.0 109.39 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.571 ' CE2' HD11 ' A' ' 113' ' ' LEU . 60.9 m-85 -140.59 179.59 6.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 109.525 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.3 m -150.77 134.29 16.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.638 -0.664 . . . . 0.0 109.43 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -78.63 118.55 20.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.576 -0.703 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -95.25 -33.56 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.59 -0.694 . . . . 0.0 109.533 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.6 m -157.47 174.28 15.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.541 -0.724 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 t -161.69 122.73 2.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.66 -0.65 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -95.67 107.22 19.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.482 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.7 m -90.13 149.52 22.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.696 . . . . 0.0 109.427 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.417 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.7 p -154.43 129.57 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.363 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -107.73 120.79 43.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.533 -0.73 . . . . 0.0 109.479 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.19 -165.97 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.589 -0.695 . . . . 0.0 109.519 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.6 p -71.52 -39.19 70.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.599 -0.688 . . . . 0.0 109.525 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -105.63 137.59 19.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.547 -0.721 . . . . 0.0 109.41 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.99 -44.84 26.74 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 C-N-CA 124.762 3.641 . . . . 0.0 110.072 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.15 71.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.718 . . . . 0.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 151' ' ' LEU . 43.3 mt -80.78 20.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.587 -0.695 . . . . 0.0 109.682 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.2 m -92.33 142.06 27.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 109.36 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.697 ' CE1' HD21 ' A' ' 23' ' ' LEU . 31.6 p-80 -156.93 166.62 32.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.5 m -138.33 133.44 33.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.603 -0.686 . . . . 0.0 109.411 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.91 92.97 9.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.439 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 31.3 mt-10 -74.06 139.84 44.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.637 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.8 t -128.91 106.74 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.597 -0.69 . . . . 0.0 109.506 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.1 m95 -106.83 168.56 9.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -145.21 142.31 29.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.631 -0.668 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.79 122.02 19.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 0.0 109.48 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -141.42 136.2 31.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.566 -0.709 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.445 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.482 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.32 100.68 7.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.593 -0.692 . . . . 0.0 109.499 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.582 ' CD1' HG23 ' A' ' 110' ' ' VAL . 5.8 m-85 -71.66 139.03 49.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.425 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.512 HD12 ' CB ' ' A' ' 114' ' ' LEU . 14.6 tp -153.91 113.38 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.324 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.419 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 8.7 p90 -146.05 151.01 37.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.736 . . . . 0.0 109.909 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.59 118.24 36.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.604 -0.685 . . . . 0.0 109.282 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HB3' HG22 ' A' ' 13' ' ' ILE . 9.1 pt20 -138.04 152.81 49.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.48 -0.762 . . . . 0.0 109.588 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -102.38 171.07 7.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 109.498 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -61.1 -19.05 61.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.604 -0.685 . . . . 0.0 109.864 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -76.61 13.95 0.89 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.493 -0.754 . . . . 0.0 109.87 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.24 39.63 97.95 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.512 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.6 tp -112.02 165.79 11.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.624 -0.927 . . . . 0.0 109.485 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 126' ' ' THR . 32.4 pt -142.21 -30.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.577 -0.702 . . . . 0.0 109.545 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.18 -169.43 30.75 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -172.13 117.78 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.631 -0.923 . . . . 0.0 109.44 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 35.0 21.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.577 -0.702 . . . . 0.0 109.613 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.68 -61.74 4.08 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.401 ' CD2' ' H ' ' A' ' 18' ' ' HIS . 19.1 p80 -76.89 166.56 23.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.992 . . . . 0.0 109.445 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.558 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 15.6 mt -79.91 157.54 73.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.662 -0.649 . . . . 0.0 109.439 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -80.24 -27.98 3.28 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.08 3.853 . . . . 0.0 109.971 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.558 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 35.4 p90 -108.25 -179.29 3.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.517 -0.739 . . . . 0.0 109.534 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -131.34 102.35 5.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.605 -0.684 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 26' ' ' ASP . 20.7 tp -121.51 80.16 38.39 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.606 -0.684 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.63 -37.6 15.77 Favored 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 125.167 3.912 . . . . 0.0 110.178 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -62.89 -42.79 99.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.562 -0.711 . . . . 0.0 109.509 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.798 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.2 t0 -65.42 -38.1 88.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.622 -0.674 . . . . 0.0 109.38 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.35 -24.42 67.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.579 -0.7 . . . . 0.0 109.519 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -83.63 -30.82 26.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.614 -0.679 . . . . 0.0 109.407 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 19.0 t80 -73.83 -25.62 60.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 34' ' ' THR . 48.4 t80 -63.42 -45.74 89.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.606 -0.684 . . . . 0.0 109.51 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -63.58 -30.12 71.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.624 -0.672 . . . . 0.0 109.44 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.83 -29.21 50.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.596 -0.69 . . . . 0.0 109.451 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 76.5 mm-40 -100.77 32.54 3.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.633 -0.667 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 30' ' ' PHE . 12.3 p -136.82 -35.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.588 -0.695 . . . . 0.0 109.54 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 35' ' ' VAL . 27.8 m -79.42 128.86 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.571 -0.705 . . . . 0.0 109.496 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.88 -25.75 26.36 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.36 -170.58 1.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.624 -0.927 . . . . 0.0 109.511 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.407 HG23 ' HB ' ' A' ' 58' ' ' THR . 59.1 mt -103.99 112.05 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.566 -0.709 . . . . 0.0 109.459 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.565 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.7 tmm? -73.72 110.99 8.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.26 122.88 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.56 -0.713 . . . . 0.0 109.464 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.565 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.8 m -136.66 178.05 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.498 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.94 -177.58 34.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -70.36 -39.58 74.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.963 . . . . 0.0 109.416 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -68.94 -40.53 78.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.616 -0.678 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.8 m -72.46 -25.72 61.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -65.31 -44.49 87.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.661 -0.65 . . . . 0.0 109.462 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -77.33 -26.84 52.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.528 -0.732 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.1 p -62.67 -21.79 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.64 -0.663 . . . . 0.0 109.697 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.427 ' HE2' HG21 ' A' ' 41' ' ' VAL . 20.3 m-85 -62.45 162.96 16.37 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.547 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -81.22 -74.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 125.227 3.952 . . . . 0.0 110.037 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -113.7 82.65 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.658 . . . . 0.0 109.465 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -84.42 157.24 62.01 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.575 -0.703 . . . . 0.0 109.371 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.87 152.14 76.88 Favored 'Cis proline' 0 N--CA 1.509 2.383 0 O-C-N 123.415 1.219 . . . . 0.0 109.995 0.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.474 HD12 ' CE ' ' A' ' 39' ' ' MET . 97.1 mt -73.4 113.86 26.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.707 . . . . 0.0 109.27 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.44 179.24 6.68 Favored 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 124.761 3.641 . . . . 0.0 109.942 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 61.03 32.03 19.84 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.525 -0.734 . . . . 0.0 109.64 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -177.29 -178.62 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 38' ' ' ILE . 19.7 m -100.98 119.83 39.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 109.339 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -94.24 117.16 29.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.653 -0.654 . . . . 0.0 109.484 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.8 t -125.83 143.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.59 -0.693 . . . . 0.0 109.398 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 t -127.97 132.62 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.602 -0.686 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.48 HD12 HG23 ' A' ' 76' ' ' VAL . 12.8 tp -104.2 112.02 24.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.438 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -137.88 153.5 49.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.579 -0.7 . . . . 0.0 109.464 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -89.68 -47.82 7.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.533 -0.729 . . . . 0.0 109.548 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -72.74 157.97 36.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.604 -0.685 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -102.45 8.11 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.593 -0.692 . . . . 0.0 109.859 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.99 -28.01 57.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.28 153.56 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.492 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -143.72 143.59 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.601 -0.687 . . . . 0.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 73' ' ' ALA . . . -136.0 125.4 24.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.521 -0.737 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -87.6 123.39 32.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 109.458 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.16 41.6 59.77 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . . . -154.42 148.84 26.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.617 -0.931 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.64 99.63 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.469 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.8 t -75.88 97.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.652 -0.655 . . . . 0.0 109.467 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG23 HD12 ' A' ' 62' ' ' LEU . 27.5 m -89.19 162.98 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.557 -0.714 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.469 ' NE2' HG12 ' A' ' 75' ' ' VAL . 61.2 m-70 -140.07 30.39 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.41 146.48 2.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.607 -0.683 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.518 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.6 t -68.18 -33.36 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.566 -0.709 . . . . 0.0 109.528 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.79 -31.53 70.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 0.0 109.506 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.25 -37.39 80.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.54 -0.725 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 76' ' ' VAL . 30.4 t -69.13 -36.57 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.645 -0.659 . . . . 0.0 109.473 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.6 -30.34 64.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.492 -0.755 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.75 -36.92 83.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.83 -38.75 83.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.581 -0.7 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.51 -24.49 64.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -63.87 -43.73 95.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -67.45 -29.11 68.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.574 -0.703 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -120.77 89.76 45.58 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.13 -23.53 6.38 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 125.165 3.91 . . . . 0.0 109.86 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.57 -24.92 64.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.536 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -90.44 179.97 5.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.477 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -138.31 154.06 49.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.495 -0.753 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.45 ' CD2' HD11 ' A' ' 96' ' ' ILE . 2.6 tt -91.16 109.58 20.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 t -110.62 122.6 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.474 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.45 HD11 ' CD2' ' A' ' 94' ' ' LEU . 41.7 mm -97.3 127.76 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.578 -0.701 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.532 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -109.57 -23.44 11.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.599 -0.688 . . . . 0.0 109.578 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.38 -177.05 40.88 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.453 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -80.5 -157.0 14.34 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.341 -1.682 . . . . 0.0 109.54 -0.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.9 -39.56 87.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.588 -0.948 . . . . 0.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.31 -26.29 66.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.0 109.548 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.453 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 41.5 mm -74.88 -32.17 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.6 -0.688 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.68 -42.65 81.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.699 . . . . 0.0 109.542 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -69.89 -35.09 74.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.581 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.77 88.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 109.664 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.518 ' CE1' HG13 ' A' ' 79' ' ' VAL . 33.6 m-85 -95.14 3.49 54.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -70.8 -22.72 62.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.568 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -62.93 -23.87 67.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.542 -0.724 . . . . 0.0 109.553 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.71 58.97 1.73 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.582 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -105.98 149.51 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 109.408 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -130.37 -50.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -95.2 142.72 27.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.589 -0.694 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 136' ' ' PHE . 17.3 mt -129.52 87.15 2.5 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.528 -0.732 . . . . 0.0 109.573 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.652 ' CD2' HG22 ' A' ' 157' ' ' VAL . 61.1 mt -90.37 123.97 34.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.557 -0.714 . . . . 0.0 109.347 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -135.59 147.28 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.577 -0.702 . . . . 0.0 109.543 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.5 m -113.51 105.95 13.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.64 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -88.27 127.97 35.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 0.0 109.508 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.44 133.66 50.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 109.387 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.98 -28.58 63.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.612 -0.68 . . . . 0.0 109.425 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.04 129.06 12.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 p -78.05 143.69 37.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.521 -0.988 . . . . 0.0 109.498 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.475 ' O ' HD22 ' A' ' 12' ' ' LEU . 86.0 m-85 -148.45 125.79 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.634 -0.667 . . . . 0.0 109.517 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.57 160.77 16.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.513 -0.742 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.512 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -164.37 -132.17 1.32 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -143.83 -41.24 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.664 -0.903 . . . . 0.0 109.451 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.615 HG22 HD11 ' A' ' 13' ' ' ILE . 4.2 m -89.46 134.94 33.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.534 -0.729 . . . . 0.0 109.518 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -113.33 173.39 6.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.558 -0.714 . . . . 0.0 109.419 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.408 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -90.84 143.56 26.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.562 -0.711 . . . . 0.0 109.485 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.2 pt -67.34 164.62 35.61 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.564 -0.71 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.4 106.32 1.86 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.147 3.898 . . . . 0.0 109.883 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.66 155.15 18.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -87.04 85.34 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.588 -0.695 . . . . 0.0 109.418 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -74.64 -15.17 60.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.669 -0.644 . . . . 0.0 109.871 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.09 9.97 1.39 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.513 -0.742 . . . . 0.0 109.877 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -134.05 29.7 3.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 109.414 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.534 ' CE2' HD11 ' A' ' 113' ' ' LEU . 47.8 m-85 -141.13 176.01 9.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -150.39 134.24 16.77 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.61 -0.681 . . . . 0.0 109.42 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -70.65 153.19 43.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.553 -0.717 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.09 -31.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.612 -0.68 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.2 m -139.33 144.01 38.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -143.84 99.09 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.661 . . . . 0.0 109.467 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -86.71 97.56 10.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.568 -0.708 . . . . 0.0 109.462 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.569 ' HA ' HG23 ' A' ' 154' ' ' THR . 8.2 m -77.2 147.87 36.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.54 129.18 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.351 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.75 120.65 42.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.736 . . . . 0.0 109.477 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.08 -165.9 0.93 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.7 p -74.89 -41.96 58.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.527 -0.733 . . . . 0.0 109.59 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.22 137.8 20.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.526 -0.733 . . . . 0.0 109.434 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.65 -48.45 15.69 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 124.804 3.669 . . . . 0.0 110.143 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.88 70.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.658 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.32 15.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.788 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.0 m -86.58 139.36 30.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 109.339 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.578 ' CE1' HD21 ' A' ' 23' ' ' LEU . 29.0 p-80 -156.01 173.25 17.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.571 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.569 HG23 ' HA ' ' A' ' 143' ' ' THR . 22.3 m -139.23 135.56 34.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.502 -0.749 . . . . 0.0 109.417 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -86.46 92.13 8.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.589 -0.694 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -75.46 147.52 39.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.646 -0.659 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.652 HG22 ' CD2' ' A' ' 114' ' ' LEU . 31.2 t -139.05 99.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.538 -0.726 . . . . 0.0 109.461 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 34.3 m95 -94.59 166.19 12.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.612 -0.68 . . . . 0.0 109.395 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -148.84 141.34 24.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.619 -0.676 . . . . 0.0 109.473 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -63.22 133.48 54.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.69 -0.631 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -140.01 157.16 46.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.484 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.457 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.515 HN52 ' HB1' ' A' ' 97' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.82 124.31 20.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.71 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.798 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.6 m-85 -94.86 152.77 18.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.561 -0.712 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.571 HD12 ' CB ' ' A' ' 114' ' ' LEU . 13.7 tp -163.2 110.05 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.596 -0.69 . . . . 0.0 109.33 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.0 p90 -144.78 150.1 36.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.75 117.3 31.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.579 -0.701 . . . . 0.0 109.223 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' HB3' HG22 ' A' ' 13' ' ' ILE . 2.2 pt20 -138.48 152.8 48.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.723 . . . . 0.0 109.691 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -104.07 170.99 7.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.466 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.68 -17.38 55.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.594 -0.691 . . . . 0.0 109.805 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.85 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.36 38.22 95.91 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 122' ' ' PHE . 6.2 tp -113.03 163.97 14.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.551 -0.97 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 126' ' ' THR . 31.7 pt -138.16 -30.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.511 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.435 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -167.49 -166.87 27.29 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -171.79 118.2 0.42 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.666 -0.902 . . . . 0.0 109.501 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 59.98 32.24 21.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.72 -62.8 2.63 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -75.35 172.84 11.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.615 -0.932 . . . . 0.0 109.454 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.575 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 31.1 mt -85.18 156.36 60.12 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.0 Cg_endo -79.84 -26.66 4.4 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 125.021 3.814 . . . . 0.0 109.944 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.575 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.4 p90 -108.77 167.74 9.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.511 -0.743 . . . . 0.0 109.491 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -117.57 101.31 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.61 -0.682 . . . . 0.0 109.45 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 26' ' ' ASP . 19.1 tp -121.38 80.41 37.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.534 -0.729 . . . . 0.0 109.464 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -45.59 -38.99 17.29 Favored 'Trans proline' 0 N--CA 1.506 2.233 0 C-N-CA 125.171 3.914 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.48 -41.35 98.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.614 -0.679 . . . . 0.0 109.625 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.788 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.3 t0 -65.87 -36.99 84.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.598 -0.689 . . . . 0.0 109.451 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.711 HD22 H223 ' A' ' 170' ' ' TMQ . 88.4 mt -68.15 -23.25 64.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.612 -0.68 . . . . 0.0 109.546 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -86.1 -28.23 24.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.65 -0.656 . . . . 0.0 109.461 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 27.8 t80 -75.23 -25.49 58.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.626 -0.671 . . . . 0.0 109.507 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 34' ' ' THR . 50.4 t80 -63.82 -48.98 74.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.677 -0.639 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -65.66 -25.7 67.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.566 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.08 -25.72 43.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.542 -0.724 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 14.0 mm100 -109.07 36.77 2.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.577 -0.702 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' PHE . 20.6 p -142.06 -29.3 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.571 -0.706 . . . . 0.0 109.527 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.32 132.49 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.592 -0.692 . . . . 0.0 109.526 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.37 34.82 60.39 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -155.98 164.31 38.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.532 -0.981 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.87 117.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.44 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.455 ' CE ' HD12 ' A' ' 54' ' ' LEU . 39.6 ttp -97.6 108.34 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 0.0 109.52 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.483 ' CG2' HD11 ' A' ' 94' ' ' LEU . 30.4 t -93.67 120.08 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.582 -0.699 . . . . 0.0 109.428 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.47 161.78 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 109.512 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.73 -162.85 37.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.2 ptt85 -83.55 -35.8 24.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.575 -0.956 . . . . 0.0 109.428 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -69.59 -38.66 77.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.697 -0.627 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.497 HG22 ' CZ ' ' A' ' 49' ' ' PHE . 10.7 m -74.14 -28.64 61.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.628 -0.67 . . . . 0.0 109.483 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -63.49 -58.44 7.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.634 -0.666 . . . . 0.0 109.49 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -66.32 -21.58 66.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.586 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.6 m -63.1 -29.36 70.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.512 -0.743 . . . . 0.0 109.543 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.497 ' CZ ' HG22 ' A' ' 45' ' ' THR . 35.7 m-85 -64.83 161.64 44.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.615 -0.678 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.86 -73.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 125.126 3.884 . . . . 0.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -107.03 95.57 5.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.625 -0.672 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.456 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 25.3 ptt-85 -101.23 157.32 33.89 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.641 -0.662 . . . . 0.0 109.443 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.27 145.7 72.09 Favored 'Cis proline' 0 N--CA 1.508 2.365 0 O-C-N 123.385 1.203 . . . . 0.0 109.903 0.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.455 HD12 ' CE ' ' A' ' 39' ' ' MET . 50.2 mt -62.59 116.1 21.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.58 -0.7 . . . . 0.0 109.289 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.92 178.47 7.51 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 124.762 3.641 . . . . 0.0 109.929 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 61.02 29.44 18.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.516 -0.74 . . . . 0.0 109.638 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -177.11 -169.27 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.57 -0.706 . . . . 0.0 109.527 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -118.06 130.19 56.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.525 -0.735 . . . . 0.0 109.437 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -107.61 100.56 9.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.563 -0.711 . . . . 0.0 109.491 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.1 t -99.55 105.49 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.56 -0.713 . . . . 0.0 109.449 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.8 t -88.42 122.05 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.524 -0.735 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.599 HD12 HG23 ' A' ' 76' ' ' VAL . 12.3 tp -101.38 118.16 36.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.624 -0.673 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.469 HG23 ' CE1' ' A' ' 77' ' ' HIS . 3.9 t -144.32 154.37 42.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.479 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -95.11 -38.87 10.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.579 -0.7 . . . . 0.0 109.479 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -72.1 131.61 43.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.613 -0.68 . . . . 0.0 109.433 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.97 30.69 0.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -103.21 -33.21 9.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.65 -0.656 . . . . 0.0 109.488 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -69.69 143.3 53.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -142.14 146.09 34.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.595 -0.69 . . . . 0.0 109.48 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.98 124.31 20.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -83.0 130.21 35.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.38 38.85 37.57 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.74 139.4 12.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.516 -0.991 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -77.37 104.46 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.61 100.71 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.0 109.438 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.599 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -102.47 -176.58 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.508 -0.745 . . . . 0.0 109.483 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.469 ' CE1' HG23 ' A' ' 63' ' ' THR . 64.0 m-70 -142.93 30.29 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.615 -0.678 . . . . 0.0 109.489 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -161.06 142.54 11.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.557 -0.714 . . . . 0.0 109.468 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 t -65.18 -31.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.608 -0.683 . . . . 0.0 109.466 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.06 -34.54 78.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.05 81.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.643 -0.661 . . . . 0.0 109.473 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 76' ' ' VAL . 34.1 t -66.73 -41.22 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.628 -0.67 . . . . 0.0 109.42 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -71.94 -30.07 64.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.603 -0.686 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.42 87.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.565 -0.71 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -71.44 -33.03 69.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.583 -0.698 . . . . 0.0 109.521 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.32 -29.98 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -66.42 -42.45 87.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.517 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -66.54 -28.41 68.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.479 -0.763 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -119.21 90.01 40.95 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.643 -0.66 . . . . 0.0 109.453 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.93 -23.67 6.51 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 125.103 3.869 . . . . 0.0 109.843 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.58 -26.4 66.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.572 -0.705 . . . . 0.0 109.502 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -102.44 133.67 47.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -92.29 151.63 20.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.565 -0.71 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.483 HD11 ' CG2' ' A' ' 40' ' ' VAL . 9.7 tp -87.43 143.93 26.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.555 -0.716 . . . . 0.0 109.497 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -144.43 130.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.431 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.554 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.1 mm -94.65 125.36 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.733 . . . . 0.0 109.424 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.507 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -107.94 -28.32 9.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.599 -0.688 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 161.81 -177.57 38.01 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.85 -154.73 16.48 Favored Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.361 -1.67 . . . . 0.0 109.6 -0.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.12 -34.58 78.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.58 -0.953 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.3 mm -75.09 -30.51 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.554 ' CE1' HG22 ' A' ' 96' ' ' ILE . 18.4 m-85 -68.78 -50.65 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -64.21 -23.16 67.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.615 -0.678 . . . . 0.0 109.558 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.32 -52.11 37.22 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.6 -0.688 . . . . 0.0 109.615 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -86.46 6.16 31.72 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.567 -0.708 . . . . 0.0 110.037 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 110' ' ' VAL . 32.2 ttpt -66.04 -23.55 66.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 109.586 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -68.37 -42.43 79.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.598 -0.689 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.73 38.19 2.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.611 -0.68 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.798 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -79.97 152.76 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.583 -0.698 . . . . 0.0 109.342 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.15 -68.87 0.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.594 -0.692 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -85.57 161.44 19.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.635 -0.665 . . . . 0.0 109.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.583 HD11 ' CE2' ' A' ' 136' ' ' PHE . 23.7 mt -141.63 88.32 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.549 -0.719 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.571 ' CB ' HD12 ' A' ' 4' ' ' LEU . 54.0 mt -89.44 120.65 30.95 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.3 p -132.63 142.77 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.556 -0.715 . . . . 0.0 109.471 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.7 m -109.98 103.17 11.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.545 -0.722 . . . . 0.0 109.329 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -85.71 132.22 34.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.599 -0.688 . . . . 0.0 109.603 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.9 132.73 53.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.371 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.9 -31.68 72.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.596 -0.69 . . . . 0.0 109.439 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.443 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -73.98 131.95 14.65 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.5 p -85.15 142.01 29.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.605 -0.938 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.59 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.3 m-85 -144.86 126.26 14.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.604 -0.685 . . . . 0.0 109.456 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -90.01 146.42 24.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.596 -0.69 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.561 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -145.76 -128.89 2.02 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -143.62 -34.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.995 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.49 HG22 HD11 ' A' ' 13' ' ' ILE . 2.9 m -98.68 127.89 44.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 109.55 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -104.81 170.86 7.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.595 -0.691 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.23 145.35 25.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.495 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 24.0 pt -66.91 164.78 31.5 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.505 -0.747 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -80.23 109.23 2.3 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 125.105 3.87 . . . . 0.0 109.891 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.08 149.42 21.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.583 -0.698 . . . . 0.0 109.42 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -84.46 86.35 7.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.628 -0.67 . . . . 0.0 109.445 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -73.36 -16.95 61.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.632 -0.668 . . . . 0.0 109.768 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.08 9.83 1.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.961 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -131.87 28.42 4.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.583 ' CE2' HD11 ' A' ' 113' ' ' LEU . 54.5 m-85 -138.48 179.86 6.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -150.45 122.01 7.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.505 -0.747 . . . . 0.0 109.488 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -70.25 121.3 17.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 140' ' ' SER . 28.1 m -96.11 -37.4 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 109.478 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.406 ' N ' HG23 ' A' ' 139' ' ' VAL . 57.4 p -158.62 169.33 24.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.545 -0.722 . . . . 0.0 109.528 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 81.4 p -158.35 129.63 6.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.607 -0.683 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -97.18 116.24 29.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.685 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.564 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.4 m -93.95 152.08 19.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.36 130.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.563 -0.71 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -102.38 123.22 45.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.511 -0.743 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.45 -165.95 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.615 -0.678 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.7 p -73.99 -39.9 63.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.585 -0.697 . . . . 0.0 109.604 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -99.85 137.57 20.19 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.25 -39.88 34.9 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 124.773 3.649 . . . . 0.0 110.015 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.443 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -75.07 -29.58 60.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.693 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 mt -73.84 8.36 2.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.566 -0.709 . . . . 0.0 109.981 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.3 p -78.45 159.0 28.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.476 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.584 ' CE1' HD21 ' A' ' 23' ' ' LEU . 39.4 p-80 -171.97 170.74 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.539 -0.725 . . . . 0.0 109.603 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 143' ' ' THR . 16.9 m -140.44 133.84 29.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.619 -0.676 . . . . 0.0 109.404 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -86.64 95.95 9.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 109.383 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -78.14 144.41 36.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.627 -0.671 . . . . 0.0 109.483 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.555 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.3 t -133.65 99.55 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 158' ' ' TRP . 31.5 m95 -96.86 166.95 11.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.615 -0.678 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -146.0 138.82 25.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.699 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -68.5 102.01 1.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.715 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -149.62 117.25 6.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.483 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.711 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.28 107.05 14.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CD1' HG23 ' A' ' 110' ' ' VAL . 3.7 m-85 -80.98 155.97 26.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.624 -0.673 . . . . 0.0 109.416 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.707 HD12 ' CB ' ' A' ' 114' ' ' LEU . 6.5 tp -168.78 121.56 0.81 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.451 ' NE1' HG23 ' A' ' 115' ' ' VAL . 44.0 p90 -147.31 130.1 16.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.508 -0.745 . . . . 0.0 109.584 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.91 109.77 18.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.266 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.653 ' HB3' HG22 ' A' ' 13' ' ' ILE . 6.6 pt20 -131.26 160.87 33.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.704 . . . . 0.0 109.72 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -109.86 169.45 8.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.672 -0.642 . . . . 0.0 109.465 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -60.72 -17.56 49.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.652 -0.655 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.57 15.26 0.83 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.556 -0.715 . . . . 0.0 109.798 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.25 33.75 87.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.608 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.8 tp -113.69 161.31 17.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.638 -0.919 . . . . 0.0 109.469 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.653 HG22 ' HB3' ' A' ' 7' ' ' GLN . 30.1 pt -134.21 -30.18 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -170.46 -174.45 38.5 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -166.38 124.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.91 32.48 21.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.509 -0.744 . . . . 0.0 109.752 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.19 -61.71 3.93 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -74.97 174.77 8.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.586 -0.949 . . . . 0.0 109.5 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.575 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 47.8 mt -89.7 156.02 47.72 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.61 -0.681 . . . . 0.0 109.426 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD2' ' CE3' ' A' ' 21' ' ' TRP . 10.2 Cg_endo -79.59 -26.55 4.7 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 124.955 3.77 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.575 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.7 p90 -108.59 165.76 11.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -115.13 101.5 9.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.776 HD23 ' HB2' ' A' ' 26' ' ' ASP . 15.6 tp -122.76 79.23 48.87 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.84 -38.01 17.35 Favored 'Trans proline' 0 N--CA 1.507 2.279 0 C-N-CA 125.165 3.91 . . . . 0.0 110.197 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.83 -46.51 87.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.526 -0.734 . . . . 0.0 109.559 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.776 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.8 t0 -64.19 -36.9 85.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.59 -24.99 67.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.664 . . . . 0.0 109.459 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -84.12 -29.35 26.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.605 -0.685 . . . . 0.0 109.437 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -71.73 -28.12 63.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.584 -0.697 . . . . 0.0 109.4 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 34' ' ' THR . 46.6 t80 -67.62 -44.96 76.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.554 -0.716 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -66.0 -31.0 71.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.594 -0.691 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -30.94 60.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.693 . . . . 0.0 109.437 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -97.9 33.25 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.3 p -139.55 -30.03 0.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.608 -0.682 . . . . 0.0 109.493 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.5 m -68.63 128.53 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 109.513 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.05 30.38 69.94 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -145.67 165.79 27.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.565 -0.962 . . . . 0.0 109.449 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.417 HG23 ' HB ' ' A' ' 58' ' ' THR . 59.8 mt -92.11 101.0 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.638 -0.664 . . . . 0.0 109.428 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.619 ' CE ' HD12 ' A' ' 54' ' ' LEU . 43.7 ttp -80.7 103.33 10.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.555 -0.715 . . . . 0.0 109.457 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.85 121.43 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.24 168.33 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.624 -0.673 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.67 -165.28 39.38 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -78.87 -43.49 24.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.936 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.529 HH22 HE21 ' A' ' 101' ' ' GLN . 10.8 ptp85 -68.73 -30.99 69.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.508 -0.745 . . . . 0.0 109.461 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -79.91 -29.15 39.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -66.68 -31.81 72.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.629 -0.669 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -94.18 -18.07 22.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.607 -0.683 . . . . 0.0 109.694 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -62.26 -23.43 66.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 109.638 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -66.43 159.77 70.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.574 -0.704 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.15 -73.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.066 3.844 . . . . 0.0 109.953 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -98.92 112.8 24.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.498 -0.751 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -108.46 158.64 33.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.569 -0.707 . . . . 0.0 109.518 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.69 -165.51 4.57 Favored 'Cis proline' 0 N--CA 1.509 2.382 0 O-C-N 123.372 1.196 . . . . 0.0 109.897 -0.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.619 HD12 ' CE ' ' A' ' 39' ' ' MET . 87.9 mt -114.97 94.4 38.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.585 -0.697 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -74.97 -175.89 2.59 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 124.819 3.679 . . . . 0.0 109.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 61.51 27.93 17.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.77 . . . . 0.0 109.52 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -177.23 -169.01 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 38' ' ' ILE . 1.3 m -119.39 115.23 23.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.583 -0.698 . . . . 0.0 109.49 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.496 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.7 m-80 -92.77 103.79 16.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.545 -0.722 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 t -104.62 99.94 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.594 -0.691 . . . . 0.0 109.481 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.3 t -87.03 123.89 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.492 HD12 HG23 ' A' ' 76' ' ' VAL . 18.4 tp -101.11 115.83 31.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.651 -0.656 . . . . 0.0 109.502 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -145.98 146.61 31.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.705 -0.622 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -101.43 31.54 3.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.585 -0.697 . . . . 0.0 109.562 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -134.2 126.51 30.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.555 -0.716 . . . . 0.0 109.519 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -85.1 29.53 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.439 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.17 -35.65 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 109.515 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -69.55 157.76 36.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.62 -0.675 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -147.52 140.89 25.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.527 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.34 116.5 11.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.584 -0.698 . . . . 0.0 109.475 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -84.83 133.68 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.581 -0.7 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.74 41.21 35.13 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.02 159.82 36.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.622 -0.928 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -94.07 94.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.612 -0.68 . . . . 0.0 109.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.629 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.7 t -79.01 99.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.363 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.492 HG23 HD12 ' A' ' 62' ' ' LEU . 27.8 m -97.21 159.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.555 -0.716 . . . . 0.0 109.458 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.629 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.5 m-70 -139.23 28.68 2.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.695 . . . . 0.0 109.511 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -161.49 147.56 14.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.466 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.512 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.3 t -67.81 -33.64 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.544 -0.722 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.16 -33.31 73.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.653 -0.655 . . . . 0.0 109.533 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.08 79.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 76' ' ' VAL . 30.2 t -67.2 -46.57 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.591 -0.693 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.91 -27.27 63.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.672 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.29 -36.89 85.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.558 -0.714 . . . . 0.0 109.437 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -72.21 -34.29 68.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 109.525 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -29.21 67.54 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.583 -0.698 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -65.55 -42.39 91.94 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.587 -0.696 . . . . 0.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.22 -29.84 70.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.579 -0.7 . . . . 0.0 109.543 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -119.74 89.86 42.35 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.58 -0.7 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.99 -23.16 6.85 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 125.148 3.899 . . . . 0.0 109.943 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.07 -26.42 65.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.573 -0.704 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.49 172.49 7.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -130.94 169.13 16.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.484 -0.76 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.0 tp -93.58 131.94 38.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.62 -0.675 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 t -128.03 127.12 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.542 -0.724 . . . . 0.0 109.463 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.615 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.0 mm -103.41 118.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.572 -0.705 . . . . 0.0 109.424 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -107.54 -25.37 11.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.606 -0.684 . . . . 0.0 109.498 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.74 -179.04 40.83 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.85 -157.08 28.5 Favored Glycine 0 N--CA 1.5 2.934 0 O-C-N 120.328 -1.689 . . . . 0.0 109.542 -0.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.97 -30.53 71.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.623 -0.928 . . . . 0.0 109.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.529 HE21 HH22 ' A' ' 44' ' ' ARG . 46.0 mt-30 -73.24 -32.76 64.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.636 -0.665 . . . . 0.0 109.441 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.7 mm -70.28 -36.87 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.552 -0.717 . . . . 0.0 109.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.615 ' CE1' HG22 ' A' ' 96' ' ' ILE . 25.5 m-85 -63.77 -56.65 13.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -62.47 -16.05 53.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.604 -0.685 . . . . 0.0 109.83 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.42 -23.23 32.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.512 ' CE1' HG13 ' A' ' 79' ' ' VAL . 35.4 m-85 -121.06 18.12 11.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.515 -0.741 . . . . 0.0 109.809 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -66.27 -31.36 72.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -0.766 . . . . 0.0 109.554 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.0 26.65 0.42 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.694 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -160.05 34.13 0.18 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.542 -0.724 . . . . 0.0 109.485 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.683 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.6 p -102.23 159.37 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.381 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.429 ' N ' HG22 ' A' ' 110' ' ' VAL . 7.7 t0 -141.83 -50.43 0.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.674 -0.641 . . . . 0.0 109.345 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -105.75 109.28 21.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.592 -0.693 . . . . 0.0 109.335 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.407 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 23.1 mt -93.61 110.26 21.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.585 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.707 ' CB ' HD12 ' A' ' 4' ' ' LEU . 21.8 mt -105.74 101.96 11.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.596 -0.69 . . . . 0.0 109.298 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.451 HG23 ' NE1' ' A' ' 5' ' ' TRP . 9.5 p -107.71 132.74 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.669 -0.645 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.5 m -106.91 96.51 6.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.564 -0.71 . . . . 0.0 109.244 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -82.39 150.16 27.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.648 -0.658 . . . . 0.0 109.704 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.35 142.39 50.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.634 -0.666 . . . . 0.0 109.297 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.69 -34.83 62.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.556 -0.715 . . . . 0.0 109.453 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.41 136.29 22.06 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.9 p -86.7 143.63 27.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.994 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -144.92 138.62 27.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.594 -0.691 . . . . 0.0 109.453 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -98.3 152.96 18.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.546 -0.721 . . . . 0.0 109.52 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.608 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -157.97 -128.76 1.04 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.05 -34.37 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.592 -0.946 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.475 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -89.85 149.52 22.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.624 -0.673 . . . . 0.0 109.521 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -130.89 167.85 18.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.623 -0.673 . . . . 0.0 109.449 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 11.4 tpt -88.14 151.57 22.61 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.54 -0.725 . . . . 0.0 109.479 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.3 pt -76.06 163.62 65.47 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.595 -0.69 . . . . 0.0 109.509 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.16 104.78 1.69 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 125.172 3.915 . . . . 0.0 109.902 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.2 mt -97.43 144.5 27.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.575 -0.703 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.16 88.44 7.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.697 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -67.15 -14.97 63.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.575 -0.703 . . . . 0.0 109.831 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.58 -26.02 68.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.478 -0.764 . . . . 0.0 109.531 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.65 30.46 2.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 67.2 m-85 -143.84 171.3 14.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.533 -0.73 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.9 m -144.34 136.38 26.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.545 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -74.12 150.26 40.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.558 -0.714 . . . . 0.0 109.48 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.38 -35.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.56 -0.712 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.0 t -142.37 165.64 26.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.607 -0.683 . . . . 0.0 109.444 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.6 t -164.43 119.65 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.48 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -99.56 106.07 18.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.528 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 m -93.14 141.05 28.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.671 . . . . 0.0 109.42 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.402 ' CG1' ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -150.32 135.03 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.378 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.94 125.4 54.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.569 -0.707 . . . . 0.0 109.494 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -80.2 -165.94 0.95 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.4 p -70.85 -38.32 73.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.554 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.26 137.71 19.49 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.598 -0.689 . . . . 0.0 109.37 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -47.74 -44.14 27.21 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 124.829 3.686 . . . . 0.0 110.065 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.32 72.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.567 -0.708 . . . . 0.0 109.68 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 151' ' ' LEU . 34.2 mt -80.74 21.1 0.69 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.527 -0.733 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 38.0 m -91.74 142.67 27.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.39 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.402 ' NE2' ' CG1' ' A' ' 144' ' ' VAL . 35.9 p-80 -155.45 168.95 25.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.598 -0.689 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.5 m -141.95 131.35 23.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.662 -0.649 . . . . 0.0 109.419 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -91.12 95.21 9.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.732 . . . . 0.0 109.516 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.514 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 22.5 mt-10 -78.2 130.76 36.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.608 -0.683 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.607 HG22 ' CD2' ' A' ' 114' ' ' LEU . 29.1 t -115.39 110.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.566 -0.709 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.514 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 36.8 m95 -108.48 165.67 11.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.584 -0.698 . . . . 0.0 109.458 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -143.36 138.87 29.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.651 -0.656 . . . . 0.0 109.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.74 95.97 4.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.539 -0.726 . . . . 0.0 109.417 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -93.09 120.6 33.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.571 -0.705 . . . . 0.0 109.532 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.449 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.43 HN52 ' C17' ' A' ' 170' ' ' TMQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.617 HG23 HD23 ' A' ' 94' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 1' ' ' THR . . . -141.47 130.96 23.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.498 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.834 ' CD1' HG23 ' A' ' 110' ' ' VAL . 7.7 m-85 -96.37 162.14 13.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.528 -0.733 . . . . 0.0 109.479 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 114' ' ' LEU . 8.6 tp -168.97 107.33 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.597 -0.689 . . . . 0.0 109.301 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 p90 -143.04 143.14 31.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.55 -0.719 . . . . 0.0 109.811 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.09 112.5 24.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.648 -0.658 . . . . 0.0 109.245 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.485 ' HB3' HG22 ' A' ' 13' ' ' ILE . 7.5 pt20 -134.16 149.79 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.58 -0.7 . . . . 0.0 109.637 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -98.7 170.17 8.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.67 . . . . 0.0 109.499 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -60.96 -17.26 50.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.558 -0.714 . . . . 0.0 109.943 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -76.83 14.32 0.86 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.493 -0.754 . . . . 0.0 109.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.21 36.43 92.99 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' A' ' 124' ' ' GLY . 6.2 tp -111.59 162.36 15.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.576 -0.955 . . . . 0.0 109.534 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.528 HD11 HG22 ' A' ' 126' ' ' THR . 32.3 pt -137.13 -30.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 109.508 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -167.12 -172.8 34.74 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -168.98 124.96 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.614 -0.933 . . . . 0.0 109.516 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.08 28.04 17.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.01 -63.55 1.47 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -75.45 -171.65 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.602 -0.94 . . . . 0.0 109.468 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.706 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 31.5 mt -92.58 156.89 40.81 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.58 -0.7 . . . . 0.0 109.423 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.1 Cg_endo -80.22 -28.67 2.91 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.015 3.81 . . . . 0.0 109.882 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.706 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 36.7 p90 -106.75 -172.27 2.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.583 -0.698 . . . . 0.0 109.53 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -138.65 94.8 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.614 -0.679 . . . . 0.0 109.487 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.774 HD23 ' HB2' ' A' ' 26' ' ' ASP . 22.3 tp -116.12 83.36 12.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.595 -0.691 . . . . 0.0 109.471 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -45.56 -38.34 16.32 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 125.123 3.882 . . . . 0.0 110.205 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.99 -40.97 99.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.774 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.7 t0 -69.25 -28.4 66.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.647 -0.658 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.683 HD22 H223 ' A' ' 170' ' ' TMQ . 80.2 mt -75.24 -23.47 57.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.621 -0.674 . . . . 0.0 109.542 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -86.82 -28.87 22.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.729 . . . . 0.0 109.481 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -71.04 -27.08 63.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.528 -0.733 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CE2' HG21 ' A' ' 34' ' ' THR . 48.1 t80 -64.35 -47.8 77.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.627 -0.67 . . . . 0.0 109.47 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -66.6 -5.27 10.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.611 -0.681 . . . . 0.0 109.974 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.08 -34.47 12.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.512 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -106.28 35.48 2.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 109.466 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.474 HG21 ' CE2' ' A' ' 30' ' ' PHE . 20.6 p -133.37 -32.8 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.527 -0.733 . . . . 0.0 109.493 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.7 129.58 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.493 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.83 37.3 57.15 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -155.15 164.94 38.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.612 -0.934 . . . . 0.0 109.484 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.4 mt -92.37 110.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.579 -0.701 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.469 ' CE ' HD12 ' A' ' 54' ' ' LEU . 36.3 ttp -88.81 107.6 19.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 109.466 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 94' ' ' LEU . 30.7 t -94.57 119.42 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.456 HG11 ' HZ ' ' A' ' 49' ' ' PHE . 27.3 m -132.95 164.49 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.551 -0.718 . . . . 0.0 109.5 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.38 -165.36 40.42 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.4 mtm105 -80.52 -38.43 29.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.585 -0.95 . . . . 0.0 109.471 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -70.05 -32.98 71.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.58 -0.7 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 m -79.17 -28.5 42.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.58 -0.7 . . . . 0.0 109.465 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -66.65 -34.19 77.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.592 -0.692 . . . . 0.0 109.471 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -86.7 -25.48 24.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -62.89 -23.23 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.523 -0.736 . . . . 0.0 109.605 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HZ ' HG11 ' A' ' 41' ' ' VAL . 44.4 m-85 -62.92 162.83 19.18 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.559 -0.713 . . . . 0.0 109.498 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.18 -63.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 125.125 3.883 . . . . 0.0 109.922 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -124.12 111.55 16.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.543 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -108.52 157.37 36.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.616 -0.677 . . . . 0.0 109.405 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.83 146.51 72.18 Favored 'Cis proline' 0 N--CA 1.508 2.36 0 O-C-N 123.396 1.208 . . . . 0.0 109.982 0.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.484 ' HB2' HD21 ' A' ' 59' ' ' ASN . 68.6 mt -67.51 112.93 11.61 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.368 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -78.24 179.91 6.06 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 124.793 3.662 . . . . 0.0 109.874 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 61.22 27.65 17.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.715 . . . . 0.0 109.665 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -177.13 -173.32 0.45 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.569 -0.707 . . . . 0.0 109.493 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.5 m -116.16 120.11 37.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.563 -0.711 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.484 HD21 ' HB2' ' A' ' 54' ' ' LEU . 1.6 m-80 -95.53 107.72 19.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.632 -0.668 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 t -109.1 116.89 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 109.424 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -102.1 122.7 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.606 -0.684 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.509 HD12 HG23 ' A' ' 76' ' ' VAL . 15.3 tp -99.22 110.93 23.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 t -143.74 142.82 31.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.598 -0.689 . . . . 0.0 109.449 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -97.65 30.98 2.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.568 -0.708 . . . . 0.0 109.452 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -125.81 138.39 53.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.71 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.75 29.84 2.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -109.31 -40.18 5.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.611 -0.681 . . . . 0.0 109.454 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -73.17 136.98 44.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -141.48 102.88 4.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.545 -0.722 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.75 117.43 23.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.551 -0.718 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -76.92 133.28 39.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.571 -0.705 . . . . 0.0 109.424 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.19 37.52 59.55 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.47 142.83 19.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.56 -0.965 . . . . 0.0 109.494 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.4 t -75.4 95.96 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.622 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.0 t -80.22 102.99 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.528 -0.732 . . . . 0.0 109.437 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.509 HG23 HD12 ' A' ' 62' ' ' LEU . 27.3 m -94.33 158.7 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.582 -0.699 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.622 ' NE2' HG12 ' A' ' 75' ' ' VAL . 66.8 m-70 -139.68 29.56 2.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.693 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -162.18 147.29 12.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.625 -0.672 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 t -67.97 -35.3 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.554 -0.716 . . . . 0.0 109.454 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.58 70.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.585 -0.697 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.53 81.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.52 -0.737 . . . . 0.0 109.473 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.508 HG22 HG21 ' A' ' 76' ' ' VAL . 31.0 t -68.34 -40.72 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.577 -0.702 . . . . 0.0 109.482 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -75.67 -30.24 59.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -36.96 84.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.598 -0.689 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -69.56 -41.92 75.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.622 -0.674 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.99 66.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.622 -0.674 . . . . 0.0 109.48 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -65.12 -45.31 85.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.57 -0.706 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -67.48 -27.08 66.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.618 -0.676 . . . . 0.0 109.469 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.82 89.82 39.02 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.614 -0.678 . . . . 0.0 109.463 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.93 -23.14 6.93 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 125.06 3.84 . . . . 0.0 109.893 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.69 -26.79 66.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -91.27 179.94 5.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.34 150.64 46.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.575 -0.703 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.617 HD23 HG23 ' A' ' 1' ' ' THR . 11.7 tp -93.67 126.4 38.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.8 t -133.16 127.54 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.555 -0.716 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.558 HG22 ' CE1' ' A' ' 103' ' ' PHE . 39.7 mm -91.42 127.64 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.626 -0.671 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.561 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -111.85 -23.83 10.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.562 -0.711 . . . . 0.0 109.59 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.92 -178.15 37.01 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.48 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -82.6 -154.37 14.92 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 120.389 -1.654 . . . . 0.0 109.587 -0.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.97 -34.53 77.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.579 -0.954 . . . . 0.0 109.536 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -73.15 -27.2 61.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.596 -0.69 . . . . 0.0 109.483 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.48 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 43.0 mm -73.94 -35.44 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.723 . . . . 0.0 109.479 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 96' ' ' ILE . 24.1 m-85 -63.26 -53.71 48.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.567 -0.708 . . . . 0.0 109.48 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.6 m -62.71 -21.98 66.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.59 -0.694 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.91 -30.84 67.3 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.514 -0.741 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -116.06 16.89 16.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.767 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.621 ' O ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -68.04 -22.85 64.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.651 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -70.19 -45.51 66.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -97.04 40.3 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.589 -0.694 . . . . 0.0 109.456 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.834 HG23 ' CD1' ' A' ' 3' ' ' PHE . 9.0 p -89.38 143.95 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.516 -0.74 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -128.53 -65.63 0.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.632 -0.668 . . . . 0.0 109.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.5 m -89.86 164.58 14.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.59 -0.694 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.533 HD11 ' CE2' ' A' ' 136' ' ' PHE . 33.4 mt -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.564 -0.71 . . . . 0.0 109.58 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.65 ' HB2' HD12 ' A' ' 4' ' ' LEU . 35.9 mt -91.21 104.25 16.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.521 -0.737 . . . . 0.0 109.347 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.5 p -115.47 137.99 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.612 -0.68 . . . . 0.0 109.549 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -107.77 102.69 11.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.613 -0.68 . . . . 0.0 109.336 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mmm-85 -88.23 135.22 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.99 140.69 42.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.69 . . . . 0.0 109.358 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.62 -29.63 61.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.553 -0.717 . . . . 0.0 109.416 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.464 ' HA3' ' HB1' ' A' ' 150' ' ' ALA . . . -74.93 126.08 8.65 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 p -72.57 143.25 48.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.939 . . . . 0.0 109.452 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.424 ' O ' HD22 ' A' ' 12' ' ' LEU . 66.7 m-85 -148.98 121.55 8.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -96.51 149.25 21.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.547 -0.721 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.54 -120.78 1.13 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -145.95 -33.94 0.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.631 -0.923 . . . . 0.0 109.498 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.528 HG22 HD11 ' A' ' 13' ' ' ILE . 2.2 m -93.9 146.28 24.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -125.53 174.32 8.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.578 -0.701 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 14.6 tpt -97.55 152.14 19.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.561 -0.712 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.2 pt -74.67 163.9 65.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.583 -0.698 . . . . 0.0 109.488 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.14 94.18 1.03 Allowed 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 125.115 3.876 . . . . 0.0 109.873 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.57 154.28 28.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.6 -0.688 . . . . 0.0 109.486 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -87.14 86.08 7.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.587 -0.696 . . . . 0.0 109.421 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -71.47 -18.49 62.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.6 -0.688 . . . . 0.0 109.725 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -74.12 10.08 1.36 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -132.68 29.62 4.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.533 ' CE2' HD11 ' A' ' 113' ' ' LEU . 44.5 m-85 -138.95 -180.0 6.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.629 -0.669 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 m -148.59 125.5 11.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.71 . . . . 0.0 109.441 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -78.44 126.36 30.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.596 -0.69 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.07 -35.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.612 -0.68 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.2 t -162.31 -177.79 5.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.537 -0.727 . . . . 0.0 109.476 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 98.3 p -163.88 132.56 3.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.4 ttt85 -95.73 100.74 12.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.615 -0.678 . . . . 0.0 109.453 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.531 ' HA ' HG23 ' A' ' 154' ' ' THR . 6.4 m -82.72 148.79 27.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.448 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.58 131.63 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.313 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -108.36 120.22 41.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.696 . . . . 0.0 109.451 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.01 -165.3 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.557 -0.714 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 p -72.99 -42.96 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.61 -0.681 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -100.01 137.97 20.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.51 -0.744 . . . . 0.0 109.468 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.4 -47.62 17.19 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 124.832 3.688 . . . . 0.0 110.092 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.464 ' HB1' ' HA3' ' A' ' 120' ' ' GLY . . . -62.23 -30.02 70.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.569 -0.707 . . . . 0.0 109.664 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.8 mt -78.82 17.58 0.7 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 109.741 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.5 m -90.54 144.36 25.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.491 -0.755 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.721 ' CE1' HD21 ' A' ' 23' ' ' LEU . 27.3 p-80 -159.68 170.14 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.56 -0.712 . . . . 0.0 109.574 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.531 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.5 m -139.92 135.66 33.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.613 -0.679 . . . . 0.0 109.39 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -91.32 92.02 8.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.564 -0.71 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.518 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 44.0 mt-10 -77.1 128.36 34.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.544 -0.722 . . . . 0.0 109.444 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.617 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.8 t -114.76 99.49 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.484 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.518 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 35.5 m95 -95.03 164.31 12.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.581 -0.7 . . . . 0.0 109.445 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -148.66 136.11 20.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -65.58 126.31 27.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.724 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.99 99.15 2.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.64 -0.662 . . . . 0.0 109.483 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.449 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.683 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.503 HG23 HD23 ' A' ' 94' ' ' LEU . 3.9 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.73 127.76 33.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.557 -0.714 . . . . 0.0 109.467 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.791 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.5 m-85 -100.18 143.93 29.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.532 -0.73 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.677 HD12 ' CB ' ' A' ' 114' ' ' LEU . 7.7 tp -156.59 111.51 2.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.33 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.2 p90 -142.93 141.22 31.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.545 -0.722 . . . . 0.0 109.719 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.97 112.81 24.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.207 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -132.89 157.82 44.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -107.53 170.01 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 109.46 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -60.89 -18.31 55.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.551 -0.718 . . . . 0.0 109.871 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.42 15.09 0.82 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.473 -0.767 . . . . 0.0 109.77 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.01 35.77 91.9 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.647 HD21 ' HA3' ' A' ' 124' ' ' GLY . 5.5 tp -111.34 162.01 15.47 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.537 -0.978 . . . . 0.0 109.535 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.63 HD11 HG22 ' A' ' 126' ' ' THR . 31.9 pt -136.28 -30.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.493 -0.754 . . . . 0.0 109.58 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -166.34 -170.28 31.04 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -168.8 117.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.584 -0.951 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 60.1 30.74 20.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.479 -0.763 . . . . 0.0 109.698 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.83 -61.85 2.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -75.03 165.15 25.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.542 -0.975 . . . . 0.0 109.463 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.618 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 32.9 mt -78.09 156.9 79.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.546 -0.721 . . . . 0.0 109.421 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.432 ' HG3' HD23 ' A' ' 12' ' ' LEU . 10.7 Cg_endo -80.34 -28.58 2.88 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 124.996 3.797 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.618 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 34.2 p90 -107.53 -170.94 1.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -140.68 96.96 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 26' ' ' ASP . 11.6 tp -117.09 81.11 12.35 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.662 -0.649 . . . . 0.0 109.448 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -45.76 -40.85 19.59 Favored 'Trans proline' 0 N--CA 1.507 2.291 0 C-N-CA 125.095 3.863 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -62.48 -52.25 64.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 109.63 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.788 ' HB2' HD23 ' A' ' 23' ' ' LEU . 30.6 t70 -63.1 -35.94 81.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.635 HD22 ' C22' ' A' ' 170' ' ' TMQ . 43.0 mt -63.12 -23.8 67.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.539 -0.726 . . . . 0.0 109.554 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -85.52 -29.16 24.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.543 -0.723 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 12.4 t80 -64.78 -25.72 68.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.647 -0.658 . . . . 0.0 109.528 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 34' ' ' THR . 49.6 t80 -64.64 -46.05 84.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.591 -0.693 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -65.12 -31.84 73.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 109.465 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.93 -29.03 58.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.565 -0.709 . . . . 0.0 109.454 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 22.4 mm100 -100.4 34.17 2.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.634 -0.666 . . . . 0.0 109.442 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' PHE . 14.4 p -140.46 -34.87 0.51 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.581 -0.699 . . . . 0.0 109.525 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.6 m -70.98 124.94 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.687 -0.633 . . . . 0.0 109.508 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.21 34.4 20.73 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -156.29 168.23 27.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.498 -1.001 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.5 mt -90.54 104.61 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.649 -0.657 . . . . 0.0 109.469 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.609 ' SD ' HG13 ' A' ' 41' ' ' VAL . 6.6 tmm? -77.22 120.58 22.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 0.0 109.484 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 94' ' ' LEU . 28.2 t -126.81 122.57 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.65 -0.656 . . . . 0.0 109.524 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.609 HG13 ' SD ' ' A' ' 39' ' ' MET . 23.8 m -135.12 -174.28 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.637 -0.665 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.79 -170.33 26.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -77.59 -40.01 43.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.525 -0.985 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.19 -36.3 74.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.638 -0.664 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -73.09 -28.12 62.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -63.7 -47.45 81.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.588 -0.695 . . . . 0.0 109.433 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HA ' HH21 ' A' ' 52' ' ' ARG . 25.1 mt-10 -71.97 -25.73 61.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.604 -0.685 . . . . 0.0 109.443 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -62.51 -21.64 65.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.571 -0.705 . . . . 0.0 109.587 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -62.44 164.37 11.87 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.03 -65.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 125.167 3.911 . . . . 0.0 110.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -128.33 103.97 7.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.637 -0.664 . . . . 0.0 109.523 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.453 HH21 ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -88.92 157.38 48.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.653 . . . . 0.0 109.421 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -81.35 -168.95 7.07 Favored 'Cis proline' 0 N--CA 1.509 2.391 0 O-C-N 123.361 1.19 . . . . 0.0 110.035 0.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.589 HD12 ' CE ' ' A' ' 39' ' ' MET . 93.2 mt -112.96 96.32 37.76 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.651 -0.656 . . . . 0.0 109.421 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -69.54 176.48 6.54 Favored 'Trans proline' 0 N--CA 1.505 2.206 0 C-N-CA 124.592 3.528 . . . . 0.0 109.831 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 62.04 21.79 12.62 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.533 -0.729 . . . . 0.0 109.639 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -177.52 156.6 1.18 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.72 . . . . 0.0 109.458 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 m -79.46 152.36 30.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 109.54 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -130.32 114.76 16.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.454 ' HB ' HG22 ' A' ' 40' ' ' VAL . 30.1 t -116.52 103.98 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.654 -0.654 . . . . 0.0 109.522 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.6 123.14 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.552 -0.717 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 76' ' ' VAL . 16.4 tp -94.99 108.69 20.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.588 -0.695 . . . . 0.0 109.416 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.478 HG23 ' CE1' ' A' ' 77' ' ' HIS . 3.9 t -136.56 152.8 50.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.577 -0.702 . . . . 0.0 109.46 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -104.44 -22.73 13.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.69 -0.631 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.88 134.31 48.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.603 -0.686 . . . . 0.0 109.419 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.38 31.9 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.637 -0.664 . . . . 0.0 109.455 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -121.56 -30.6 4.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.601 -0.687 . . . . 0.0 109.511 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -67.79 144.44 55.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.512 -0.742 . . . . 0.0 109.395 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -147.97 102.67 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.524 -0.735 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.42 117.96 25.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.581 -0.699 . . . . 0.0 109.409 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -78.19 133.77 37.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.685 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.69 35.95 44.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -159.22 151.48 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.611 -0.934 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -81.38 95.56 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.549 -0.72 . . . . 0.0 109.439 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.404 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.3 t -76.7 97.72 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.545 -0.722 . . . . 0.0 109.466 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.476 HG23 HD12 ' A' ' 62' ' ' LEU . 28.4 m -94.55 170.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.579 -0.701 . . . . 0.0 109.501 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.478 ' CE1' HG23 ' A' ' 63' ' ' THR . 75.9 m-70 -146.15 30.23 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.438 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -168.3 144.7 3.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.512 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.569 HG13 ' CE1' ' A' ' 106' ' ' PHE . 30.2 t -66.48 -33.2 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.599 -0.688 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.84 74.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.64 -0.662 . . . . 0.0 109.469 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.19 -35.63 78.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.629 -0.669 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.419 HG22 HG21 ' A' ' 76' ' ' VAL . 31.3 t -67.11 -42.28 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.635 -0.666 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -68.94 -29.63 67.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.533 -0.73 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.47 82.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.55 -0.719 . . . . 0.0 109.445 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.09 -33.62 72.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.623 -0.673 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -29.57 68.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.641 -0.662 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.88 -40.93 92.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.574 -0.704 . . . . 0.0 109.471 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -67.36 -31.12 71.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.546 -0.721 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -120.19 90.03 44.07 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -80.12 -22.98 6.82 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 125.104 3.869 . . . . 0.0 109.893 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.33 -25.29 64.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.551 -0.718 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -103.72 141.09 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 0.0 109.467 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.36 164.79 12.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.629 -0.669 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 40' ' ' VAL . 9.6 tp -93.17 132.1 37.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.53 -0.731 . . . . 0.0 109.457 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.3 t -134.5 126.81 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 109.445 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.1 mm -99.67 127.53 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.672 -0.643 . . . . 0.0 109.429 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.563 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -106.5 -22.36 12.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.586 -0.696 . . . . 0.0 109.611 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.3 -176.51 39.48 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.484 ' H ' ' CG1' ' A' ' 102' ' ' ILE . . . -83.98 -154.23 18.49 Favored Glycine 0 N--CA 1.498 2.824 0 O-C-N 120.353 -1.675 . . . . 0.0 109.533 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.9 77.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 109.502 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -72.49 -26.01 61.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 109.581 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.484 ' CG1' ' H ' ' A' ' 99' ' ' GLY . 42.8 mm -74.68 -36.56 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.555 -0.716 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -63.21 -51.0 68.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 m -63.17 -24.31 67.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.573 -0.704 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.49 75.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.614 -0.678 . . . . 0.0 109.487 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.569 ' CE1' HG13 ' A' ' 79' ' ' VAL . 65.8 m-85 -102.13 12.62 36.49 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.606 -0.684 . . . . 0.0 109.759 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 110' ' ' VAL . 70.2 tttt -70.75 -28.75 64.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.464 -0.773 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -65.65 -31.6 72.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.715 . . . . 0.0 109.569 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -119.49 37.95 4.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 109.49 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.791 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.7 p -84.78 156.46 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 109.34 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.25 -68.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.597 -0.689 . . . . 0.0 109.482 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -88.55 161.9 16.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.563 -0.711 . . . . 0.0 109.443 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 3' ' ' PHE . 26.9 mt -143.5 92.38 2.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.634 -0.666 . . . . 0.0 109.549 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.677 ' CB ' HD12 ' A' ' 4' ' ' LEU . 50.8 mt -90.52 112.53 24.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.629 -0.669 . . . . 0.0 109.401 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -118.69 133.51 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.426 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.8 m -104.94 96.7 6.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.697 . . . . 0.0 109.321 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -82.42 138.73 34.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.579 -0.7 . . . . 0.0 109.578 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.8 134.55 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.577 -0.702 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.41 87.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.533 -0.729 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.78 126.22 23.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.2 p -79.29 143.44 35.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.591 -0.947 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -145.83 128.61 16.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.581 -0.699 . . . . 0.0 109.506 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.82 153.58 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.552 -0.718 . . . . 0.0 109.495 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.647 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -156.64 -135.49 1.96 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -30.39 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.549 -0.971 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.63 HG22 HD11 ' A' ' 13' ' ' ILE . 2.7 m -94.54 143.51 26.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 109.553 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -125.66 168.95 13.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.639 -0.663 . . . . 0.0 109.485 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 15.4 tpt -93.38 152.4 19.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.621 -0.674 . . . . 0.0 109.512 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.1 pt -71.83 164.4 58.73 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.618 -0.677 . . . . 0.0 109.502 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 95.2 1.0 Allowed 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 125.165 3.91 . . . . 0.0 109.889 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.67 138.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.655 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -81.15 84.15 6.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.429 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -67.83 -15.92 63.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.785 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.48 -25.93 68.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.556 -0.715 . . . . 0.0 109.568 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.46 -33.95 20.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.662 -0.649 . . . . 0.0 109.443 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 113' ' ' LEU . 96.3 m-85 -84.29 166.56 17.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.8 m -136.45 131.63 34.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.488 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -71.65 113.6 8.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.616 -0.678 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 140' ' ' SER . 27.4 m -93.46 -38.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.643 -0.661 . . . . 0.0 109.494 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.424 ' N ' HG23 ' A' ' 139' ' ' VAL . 47.1 m -153.37 166.37 32.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.563 -0.711 . . . . 0.0 109.494 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.9 p -160.8 134.24 6.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.583 -0.698 . . . . 0.0 109.44 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -100.41 113.4 26.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.574 -0.704 . . . . 0.0 109.483 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.448 ' HA ' HG23 ' A' ' 154' ' ' THR . 9.9 m -94.81 142.39 27.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.697 . . . . 0.0 109.489 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 153' ' ' HIS . 8.8 p -151.1 147.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.584 -0.697 . . . . 0.0 109.352 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.496 ' HA ' HG23 ' A' ' 152' ' ' THR . 10.4 pt-20 -128.27 132.76 48.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.441 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.58 -171.38 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -64.25 -34.96 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.662 -0.649 . . . . 0.0 109.45 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.418 ' HB2' HD12 ' A' ' 151' ' ' LEU . 7.0 t30 -95.89 152.96 39.34 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.613 -0.68 . . . . 0.0 109.293 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.08 -22.52 9.87 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 124.858 3.705 . . . . 0.0 109.909 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -85.93 -23.25 27.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.548 -0.72 . . . . 0.0 109.542 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' A' ' 148' ' ' ASN . 46.8 mt -84.2 -1.32 54.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.503 -0.748 . . . . 0.0 109.99 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 145' ' ' GLU . 3.7 m -63.35 146.07 54.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.485 -0.759 . . . . 0.0 109.434 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.409 ' CE1' HG13 ' A' ' 144' ' ' VAL . 27.2 p-80 -157.79 165.31 35.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.65 -0.656 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 143' ' ' THR . 18.3 m -137.57 133.87 34.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.576 -0.702 . . . . 0.0 109.45 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -91.66 94.44 9.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.544 -0.722 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.91 139.16 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.613 -0.68 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.586 HG22 ' CD2' ' A' ' 114' ' ' LEU . 28.8 t -126.46 103.86 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.523 -0.736 . . . . 0.0 109.536 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -99.78 165.3 11.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.545 -0.722 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -144.63 138.0 27.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -73.19 114.12 11.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.726 . . . . 0.0 109.483 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -150.42 107.91 3.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.572 -0.705 . . . . 0.0 109.505 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.468 -179.972 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.635 ' C22' HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.493 HG23 HD23 ' A' ' 94' ' ' LEU . 9.4 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -134.9 108.33 7.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 0.0 109.416 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.794 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.1 m-85 -84.44 123.88 30.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.601 -0.687 . . . . 0.0 109.438 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.675 HD12 ' CB ' ' A' ' 114' ' ' LEU . 6.9 tp -138.58 112.97 8.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.573 -0.705 . . . . 0.0 109.274 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.424 ' CZ2' ' HB ' ' A' ' 115' ' ' VAL . 9.4 p90 -142.25 140.53 32.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 0.0 109.801 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.58 112.47 23.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.527 -0.733 . . . . 0.0 109.287 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.23 152.88 51.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.509 -0.744 . . . . 0.0 109.717 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -102.85 170.41 8.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -60.78 -18.44 55.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.626 -0.671 . . . . 0.0 109.896 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 14.22 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.501 -0.749 . . . . 0.0 109.838 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.28 37.05 93.94 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.67 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.6 tp -111.48 165.88 11.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.575 -0.956 . . . . 0.0 109.487 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 14' ' ' GLY . 2.5 pp -138.14 -41.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.602 -0.686 . . . . 0.0 109.506 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.66 ' N ' HD12 ' A' ' 13' ' ' ILE . . . -163.67 -179.31 37.95 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -162.11 125.92 3.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.947 . . . . 0.0 109.471 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 59.75 30.8 20.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.534 -0.729 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.57 -60.49 4.25 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -75.22 168.17 20.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.951 . . . . 0.0 109.503 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.618 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 25.0 mt -81.74 156.4 70.33 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 10.5 Cg_endo -80.21 -29.39 2.56 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 125.012 3.808 . . . . 0.0 109.847 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.618 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 32.8 p90 -107.25 173.85 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 109.521 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -124.05 106.06 10.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.574 -0.704 . . . . 0.0 109.422 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 26' ' ' ASP . 14.9 tp -126.77 81.18 69.51 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.557 -0.714 . . . . 0.0 109.447 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.24 -39.36 15.71 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 125.213 3.942 . . . . 0.0 110.253 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.92 -47.17 84.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.516 -0.74 . . . . 0.0 109.491 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 23' ' ' LEU . 27.9 t0 -64.58 -31.46 72.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.563 -0.71 . . . . 0.0 109.496 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.57 HD22 H223 ' A' ' 170' ' ' TMQ . 89.3 mt -69.75 -24.44 63.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.554 -0.716 . . . . 0.0 109.527 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -86.65 -29.68 22.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.696 . . . . 0.0 109.468 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 33' ' ' GLN . 26.3 t80 -69.81 -24.43 63.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.612 -0.68 . . . . 0.0 109.536 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -63.35 -45.82 89.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -65.2 -29.21 70.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.525 -0.734 . . . . 0.0 109.461 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.52 -29.39 56.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.358 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.419 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 12.5 mm100 -100.74 34.8 2.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.576 -0.703 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.6 p -143.33 -35.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.634 -0.666 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.8 m -70.66 124.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.496 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.31 33.96 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -156.32 166.93 32.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.954 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.63 99.68 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.567 -0.708 . . . . 0.0 109.343 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.711 ' SD ' HG13 ' A' ' 41' ' ' VAL . 11.9 tmm? -72.57 134.39 45.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.634 -0.666 . . . . 0.0 109.5 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.421 HG21 HD11 ' A' ' 94' ' ' LEU . 27.7 t -138.32 117.8 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.579 -0.701 . . . . 0.0 109.46 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.711 HG13 ' SD ' ' A' ' 39' ' ' MET . 27.0 m -132.67 -174.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.558 -0.714 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.93 -168.32 32.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.407 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 34.8 ptt180 -81.78 -34.32 30.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 0.0 109.523 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -71.29 -38.52 71.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.597 -0.689 . . . . 0.0 109.399 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.1 m -75.43 -27.68 59.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.626 -0.671 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 52' ' ' ARG . 40.3 t80 -64.89 -42.4 94.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.584 -0.698 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -75.09 -23.3 57.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.4 m -63.24 -26.13 68.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.541 -0.725 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.89 161.66 44.67 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.72 -61.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 125.082 3.855 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -125.55 103.14 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.628 -0.67 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -104.73 154.79 38.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.439 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.6 154.71 88.74 Favored 'Cis proline' 0 N--CA 1.508 2.362 0 O-C-N 123.388 1.204 . . . . 0.0 109.827 0.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.1 mt -72.73 131.26 84.42 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -80.11 170.25 16.64 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 124.687 3.591 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 61.04 27.31 17.18 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.55 -0.719 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -177.47 155.1 1.05 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.525 -0.734 . . . . 0.0 109.516 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.1 m -84.92 134.22 34.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.592 -0.693 . . . . 0.0 109.503 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -105.6 105.08 14.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.546 -0.721 . . . . 0.0 109.465 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.9 147.54 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.435 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 t -137.15 119.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.543 -0.723 . . . . 0.0 109.476 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.559 HD12 HG23 ' A' ' 76' ' ' VAL . 12.7 tp -98.95 116.84 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.56 -0.712 . . . . 0.0 109.444 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -138.06 140.02 39.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.596 -0.69 . . . . 0.0 109.507 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.426 ' CD2' ' HG3' ' A' ' 65' ' ' GLN . 12.4 p-80 -81.63 -27.33 34.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.561 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.426 ' HG3' ' CD2' ' A' ' 64' ' ' HIS . 59.4 mt-30 -71.51 137.51 48.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.649 -0.657 . . . . 0.0 109.426 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -94.28 31.69 1.67 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.603 -0.686 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -121.79 -31.37 3.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.562 -0.711 . . . . 0.0 109.536 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -67.94 138.7 56.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.591 -0.693 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -144.47 158.57 43.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.632 -0.667 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' H ' HG21 ' A' ' 75' ' ' VAL . . . -137.59 129.67 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -84.53 136.5 33.78 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.583 -0.698 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.7 36.8 75.98 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -155.91 158.82 38.61 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.599 -0.942 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.1 t -95.06 92.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.613 -0.679 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.692 HG12 ' NE2' ' A' ' 77' ' ' HIS . 29.1 t -74.4 104.83 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.474 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 82' ' ' VAL . 27.6 m -94.7 153.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.599 -0.688 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.692 ' NE2' HG12 ' A' ' 75' ' ' VAL . 55.8 m-70 -136.14 28.41 3.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.555 -0.716 . . . . 0.0 109.479 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -161.27 149.55 15.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.708 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.414 HG13 ' CE1' ' A' ' 106' ' ' PHE . 31.0 t -68.92 -35.24 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.555 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.99 65.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.572 -0.705 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.99 86.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 109.504 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.562 HG22 HG21 ' A' ' 76' ' ' VAL . 30.9 t -68.15 -45.08 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.525 -0.735 . . . . 0.0 109.431 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -69.95 -29.25 66.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.628 -0.67 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.01 82.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.678 . . . . 0.0 109.4 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -71.33 -33.94 70.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.606 -0.684 . . . . 0.0 109.455 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.29 67.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.596 -0.69 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -65.92 -39.35 90.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.661 -0.65 . . . . 0.0 109.502 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -67.8 -32.11 72.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.523 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -121.71 89.49 47.72 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.31 -22.36 7.02 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 125.094 3.863 . . . . 0.0 109.891 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -65.53 -26.49 67.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.451 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -97.95 179.16 4.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.659 -0.65 . . . . 0.0 109.402 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -137.32 150.1 47.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.564 -0.71 . . . . 0.0 109.413 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.493 HD23 HG23 ' A' ' 1' ' ' THR . 12.3 tp -76.31 134.98 39.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.577 -0.702 . . . . 0.0 109.473 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.1 t -140.24 122.8 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.581 -0.7 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.414 HG22 ' CE1' ' A' ' 103' ' ' PHE . 41.3 mm -97.02 142.84 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.674 -0.641 . . . . 0.0 109.402 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.628 ' HB3' HG12 ' A' ' 41' ' ' VAL . . . -121.28 -30.95 4.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.56 -0.713 . . . . 0.0 109.484 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 163.56 178.78 37.5 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.86 -151.9 20.87 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.364 -1.668 . . . . 0.0 109.534 0.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.52 -26.51 65.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.963 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -68.94 -31.97 71.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.661 -0.649 . . . . 0.0 109.541 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.2 -40.04 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.597 -0.689 . . . . 0.0 109.546 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' ' HA2' ' A' ' 98' ' ' GLY . 31.3 m-85 -63.06 -47.18 84.04 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.572 -0.705 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.96 -23.59 66.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.61 -0.681 . . . . 0.0 109.554 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.75 -29.6 51.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 82' ' ' VAL . 43.7 m-85 -114.5 20.26 15.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.504 -0.748 . . . . 0.0 109.682 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -63.1 -36.74 84.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.759 . . . . 0.0 109.605 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -81.11 29.72 0.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.69 . . . . 0.0 109.603 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -160.01 33.21 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.585 -0.697 . . . . 0.0 109.486 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.794 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.1 p -94.7 153.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.714 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.58 -61.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.308 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.3 m -96.42 111.75 23.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.603 -0.686 . . . . 0.0 109.342 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 136' ' ' PHE . 34.1 mt -95.66 98.43 10.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.573 -0.705 . . . . 0.0 109.626 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.675 ' CB ' HD12 ' A' ' 4' ' ' LEU . 30.3 mt -99.21 104.48 16.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.586 -0.696 . . . . 0.0 109.214 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.424 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.1 p -111.57 140.79 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.598 -0.689 . . . . 0.0 109.565 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.6 m -110.17 97.7 7.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 109.245 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.406 ' O ' HD12 ' A' ' 118' ' ' LEU . 61.2 mtt180 -80.44 151.13 29.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 117' ' ' ARG . 3.0 mp -127.53 136.16 51.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.242 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.72 -32.77 71.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.714 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.05 128.88 10.25 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.7 p -81.38 144.44 31.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.955 . . . . 0.0 109.543 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.465 ' O ' HD22 ' A' ' 12' ' ' LEU . 98.3 m-85 -147.27 121.74 9.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.619 -0.676 . . . . 0.0 109.418 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -81.99 149.8 27.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.573 -0.705 . . . . 0.0 109.522 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.67 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -149.05 -141.26 3.42 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.7 -30.76 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.558 -0.966 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.1 m -102.97 130.22 49.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.581 -0.699 . . . . 0.0 109.485 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -108.43 175.23 5.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.573 -0.704 . . . . 0.0 109.489 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.1 tpt -93.93 152.47 18.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.606 -0.684 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.6 pt -75.19 164.29 62.2 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.643 -0.66 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.78 98.08 1.11 Allowed 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 125.178 3.919 . . . . 0.0 109.844 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.85 145.32 27.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.612 -0.68 . . . . 0.0 109.507 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -85.07 87.03 7.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.614 -0.679 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -73.26 -9.94 59.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.58 -31.26 72.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.4 36.7 1.44 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.595 -0.691 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.48 ' CE2' HD11 ' A' ' 113' ' ' LEU . 40.4 m-85 -143.28 167.81 21.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.536 -0.728 . . . . 0.0 109.452 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.7 m -144.76 145.84 31.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.534 -0.729 . . . . 0.0 109.45 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HE3' ' CZ2' ' A' ' 158' ' ' TRP . 31.8 ttmt -75.28 152.66 38.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.28 -32.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.57 -0.706 . . . . 0.0 109.459 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -149.6 154.92 39.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.621 -0.674 . . . . 0.0 109.466 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.3 t -157.1 110.49 2.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.585 -0.697 . . . . 0.0 109.498 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -100.68 110.88 23.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.6 m -92.07 146.43 23.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.627 -0.671 . . . . 0.0 109.402 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.411 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.6 p -150.47 132.1 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.552 -0.717 . . . . 0.0 109.329 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -107.61 123.47 48.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.685 . . . . 0.0 109.478 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.35 -165.52 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.583 -0.698 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -71.19 -39.55 71.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.89 137.7 19.36 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.551 -0.718 . . . . 0.0 109.408 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -48.39 -46.64 22.62 Favored 'Trans proline' 0 N--CA 1.505 2.199 0 C-N-CA 124.755 3.637 . . . . 0.0 110.052 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.92 69.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 0.0 109.73 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -80.2 20.53 0.66 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.711 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.7 m -89.45 141.32 28.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.408 -0.807 . . . . 0.0 109.354 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.443 ' CE1' HD21 ' A' ' 23' ' ' LEU . 34.9 p-80 -152.87 164.88 37.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.549 -0.719 . . . . 0.0 109.559 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.7 m -137.73 132.63 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.15 93.03 9.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.623 -0.673 . . . . 0.0 109.483 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 56.0 mm-40 -78.51 130.76 36.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.575 -0.703 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.62 HG22 ' CD2' ' A' ' 114' ' ' LEU . 30.2 t -119.94 112.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.582 -0.699 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.521 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 29.9 m95 -110.84 157.5 19.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.518 -0.739 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -141.38 143.06 33.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -75.3 113.17 12.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.603 -0.685 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 141.63 24.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.571 -0.706 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.491 -179.984 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.57 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.462 HG23 HD23 ' A' ' 94' ' ' LEU . 2.8 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.05 101.45 8.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.661 ' CD1' HG23 ' A' ' 110' ' ' VAL . 6.7 m-85 -74.73 126.89 31.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.513 -0.742 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.587 HD12 ' CB ' ' A' ' 114' ' ' LEU . 10.3 tp -140.11 112.99 8.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 109.313 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.422 ' CZ3' ' HB3' ' A' ' 3' ' ' PHE . 9.7 p90 -142.67 141.92 31.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 0.0 109.731 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.81 112.53 24.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.576 -0.702 . . . . 0.0 109.213 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -132.13 149.42 52.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.622 -0.674 . . . . 0.0 109.607 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -97.41 170.14 9.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.619 -0.676 . . . . 0.0 109.452 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -60.55 -18.58 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 109.872 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.38 15.4 0.77 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 0.0 109.855 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.1 34.38 88.83 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.611 HD21 ' HA3' ' A' ' 124' ' ' GLY . 4.5 tp -107.54 165.25 11.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.596 -0.944 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 126' ' ' THR . 31.8 pt -138.61 -29.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.476 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.71 -168.85 33.05 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -174.43 124.35 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.937 . . . . 0.0 109.49 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 60.03 33.56 21.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.51 -0.744 . . . . 0.0 109.735 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.35 4.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -76.03 176.11 8.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.548 -0.972 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.645 HD22 ' CZ2' ' A' ' 21' ' ' TRP . 19.3 mt -86.92 156.59 55.15 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.568 -0.707 . . . . 0.0 109.41 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 21' ' ' TRP . 11.0 Cg_endo -80.59 -31.51 1.5 Allowed 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 125.0 3.8 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.645 ' CZ2' HD22 ' A' ' 19' ' ' LEU . 31.4 p90 -104.96 167.11 9.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.574 -0.704 . . . . 0.0 109.56 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -117.79 100.27 7.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.606 -0.684 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 26' ' ' ASP . 21.7 tp -122.02 81.76 43.44 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.598 -0.689 . . . . 0.0 109.361 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -45.25 -38.89 15.38 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 125.181 3.92 . . . . 0.0 110.307 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.78 -41.34 99.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.528 -0.732 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.79 ' HB2' HD23 ' A' ' 23' ' ' LEU . 25.9 t0 -66.63 -31.58 72.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.642 -0.661 . . . . 0.0 109.422 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.666 HD22 H223 ' A' ' 170' ' ' TMQ . 84.2 mt -72.05 -23.7 61.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.589 -0.695 . . . . 0.0 109.531 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -86.81 -29.8 22.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.567 -0.708 . . . . 0.0 109.452 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -70.97 -25.94 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 34' ' ' THR . 51.9 t80 -65.42 -45.23 84.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.661 . . . . 0.0 109.446 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -64.98 -29.3 70.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.622 -0.674 . . . . 0.0 109.475 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.69 51.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.642 -0.661 . . . . 0.0 109.453 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 mm-40 -97.77 33.13 2.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.565 -0.709 . . . . 0.0 109.409 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 30' ' ' PHE . 10.3 p -137.37 -34.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.583 -0.698 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' VAL . 26.6 m -68.62 126.17 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.557 -0.714 . . . . 0.0 109.433 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.55 36.28 23.58 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -153.24 166.21 33.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.521 -0.988 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.42 102.0 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.598 -0.689 . . . . 0.0 109.447 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.64 ' SD ' HG13 ' A' ' 41' ' ' VAL . 8.1 tmm? -70.38 125.72 27.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.58 -0.7 . . . . 0.0 109.435 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 94' ' ' LEU . 29.8 t -131.9 115.5 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.631 -0.668 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.64 HG13 ' SD ' ' A' ' 39' ' ' MET . 24.7 m -135.45 -177.25 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.702 . . . . 0.0 109.458 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.3 -178.62 35.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -72.27 -31.86 66.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.576 -0.955 . . . . 0.0 109.439 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.22 -48.23 62.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -68.64 -25.95 65.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.657 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -68.54 -33.92 74.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.708 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -91.14 -26.15 19.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 t -74.9 10.11 1.59 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -81.76 166.42 37.7 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.83 -73.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 125.103 3.868 . . . . 0.0 109.968 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -118.23 71.94 0.85 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.55 -0.719 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -72.19 156.82 90.25 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.466 -0.771 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -79.12 -175.86 17.48 Favored 'Cis proline' 0 N--CA 1.508 2.378 0 O-C-N 123.377 1.198 . . . . 0.0 109.946 0.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.5 HD12 ' CE ' ' A' ' 39' ' ' MET . 84.2 mt -107.73 104.25 52.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.565 -0.709 . . . . 0.0 109.439 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -74.56 179.83 5.55 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 124.645 3.564 . . . . 0.0 109.813 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 61.95 28.06 17.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.572 -0.705 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -176.1 178.76 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.598 -0.689 . . . . 0.0 109.416 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 m -98.47 117.47 32.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 109.464 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.437 HD21 ' HB2' ' A' ' 54' ' ' LEU . 21.3 m120 -88.78 105.99 18.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.448 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -114.9 141.37 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 0.0 109.438 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.2 t -131.94 123.49 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.437 HD12 HG23 ' A' ' 76' ' ' VAL . 15.2 tp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 109.523 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 t -140.65 140.13 34.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.63 -0.669 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -94.74 29.74 2.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.618 -0.676 . . . . 0.0 109.498 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -147.56 142.46 26.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 109.442 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -88.65 30.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.703 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.57 -35.15 9.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -77.18 134.57 38.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.515 -0.74 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -146.29 116.41 7.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.555 -0.716 . . . . 0.0 109.47 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.68 131.98 53.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -84.66 138.42 32.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.562 -0.711 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.17 38.05 59.36 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -158.5 144.25 16.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.529 -0.983 . . . . 0.0 109.553 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.7 t -79.84 95.66 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.587 -0.696 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.593 HG12 ' NE2' ' A' ' 77' ' ' HIS . 30.0 t -79.99 106.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.509 HG21 HG22 ' A' ' 82' ' ' VAL . 28.0 m -94.88 150.82 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.593 ' NE2' HG12 ' A' ' 75' ' ' VAL . 31.8 m-70 -131.65 30.03 4.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.613 -0.679 . . . . 0.0 109.464 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -163.87 144.55 8.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.454 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 106' ' ' PHE . 29.8 t -67.57 -32.95 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.585 -0.697 . . . . 0.0 109.476 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.46 -32.96 72.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.632 -0.667 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.71 -33.86 75.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 76' ' ' VAL . 31.0 t -69.19 -44.14 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.614 -0.679 . . . . 0.0 109.449 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -71.42 -30.2 65.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.565 -0.71 . . . . 0.0 109.426 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.15 79.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.681 -0.637 . . . . 0.0 109.474 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -71.3 -33.45 69.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.553 -0.717 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.47 -31.16 65.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.583 -0.698 . . . . 0.0 109.458 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.92 -45.91 69.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.594 -0.692 . . . . 0.0 109.484 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -66.19 -26.79 67.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.552 -0.717 . . . . 0.0 109.509 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -118.94 89.75 39.38 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.606 -0.684 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -80.28 -22.49 6.98 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 125.126 3.884 . . . . 0.0 109.984 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -65.82 -26.02 67.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.603 -0.686 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -104.24 179.46 4.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.657 . . . . 0.0 109.512 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -140.36 150.61 44.16 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.653 -0.654 . . . . 0.0 109.462 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 40' ' ' VAL . 12.6 tp -75.28 137.84 41.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.527 -0.733 . . . . 0.0 109.486 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 t -144.24 116.66 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.656 -0.652 . . . . 0.0 109.473 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.516 HG22 ' CE1' ' A' ' 103' ' ' PHE . 40.5 mm -91.74 128.73 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.584 -0.698 . . . . 0.0 109.379 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.54 ' HB1' HN52 ' A' ' 170' ' ' TMQ . . . -107.13 -31.03 8.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.538 -0.726 . . . . 0.0 109.49 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' CE2' ' A' ' 103' ' ' PHE . . . 164.86 178.83 38.49 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.52 -151.71 21.81 Favored Glycine 0 N--CA 1.499 2.855 0 O-C-N 120.362 -1.67 . . . . 0.0 109.632 0.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.5 68.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.56 -0.965 . . . . 0.0 109.519 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -70.51 -30.6 67.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.0 mm -76.01 -37.75 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.533 -0.729 . . . . 0.0 109.494 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.516 ' CE1' HG22 ' A' ' 96' ' ' ILE . 28.9 m-85 -63.64 -50.02 70.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.549 -0.719 . . . . 0.0 109.399 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -63.22 -24.92 68.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.656 -0.653 . . . . 0.0 109.497 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.19 69.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.415 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 79' ' ' VAL . 77.6 m-85 -116.44 19.28 14.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -27.74 65.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.69 20.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.695 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -160.09 36.85 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.546 -0.721 . . . . 0.0 109.473 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.661 HG23 ' CD1' ' A' ' 3' ' ' PHE . 8.8 p -96.99 141.31 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.589 -0.695 . . . . 0.0 109.473 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -122.03 -47.46 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.633 -0.667 . . . . 0.0 109.384 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.7 m -100.9 152.62 20.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.71 . . . . 0.0 109.391 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.507 HD11 ' CE2' ' A' ' 136' ' ' PHE . 22.0 mt -136.12 96.95 3.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.543 -0.723 . . . . 0.0 109.624 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.624 ' CD2' HG22 ' A' ' 157' ' ' VAL . 38.2 mt -100.49 109.3 21.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.544 -0.722 . . . . 0.0 109.292 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.416 ' HB ' ' CZ2' ' A' ' 5' ' ' TRP . 9.2 p -119.23 141.98 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.544 -0.723 . . . . 0.0 109.43 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.0 m -109.21 103.08 11.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.58 -0.7 . . . . 0.0 109.267 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -88.22 138.88 31.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.702 . . . . 0.0 109.561 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.63 141.47 47.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 0.0 109.291 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.94 -32.35 63.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.503 -0.748 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.74 133.73 19.52 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.0 m -82.7 142.29 31.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.62 -0.929 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.546 ' O ' HD22 ' A' ' 12' ' ' LEU . 95.6 m-85 -148.04 119.22 7.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.668 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -87.53 145.23 26.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.586 -0.697 . . . . 0.0 109.487 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.611 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -140.72 -127.68 2.36 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -143.19 -32.59 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.584 -0.951 . . . . 0.0 109.438 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.536 HG22 HD11 ' A' ' 13' ' ' ILE . 8.3 m -105.1 136.94 43.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -113.14 175.5 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.605 -0.684 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 12.6 tpt -92.13 152.61 19.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.528 -0.732 . . . . 0.0 109.558 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 pt -72.55 164.75 57.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.599 -0.688 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.71 98.38 1.14 Allowed 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 125.112 3.875 . . . . 0.0 109.919 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.56 147.0 26.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -84.45 84.81 7.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.558 -0.714 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -67.83 -19.31 65.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.718 . . . . 0.0 109.684 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -24.97 67.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -97.42 29.35 3.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.507 ' CE2' HD11 ' A' ' 113' ' ' LEU . 40.7 m-85 -143.57 175.2 10.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m -149.47 144.28 26.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -84.43 114.75 22.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 109.465 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 m -95.47 -34.0 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.523 -0.736 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -155.41 171.45 19.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.539 -0.726 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.1 t -164.51 127.64 2.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.4 tpt85 -98.7 111.91 24.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.556 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.528 ' HA ' HG23 ' A' ' 154' ' ' THR . 3.2 m -91.29 145.38 24.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 109.492 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.484 HG11 ' NE2' ' A' ' 153' ' ' HIS . 8.8 p -149.24 125.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.509 -0.744 . . . . 0.0 109.345 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -104.79 121.32 43.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.61 -0.681 . . . . 0.0 109.436 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.56 -165.11 0.81 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.676 -0.64 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.3 p -73.32 -40.7 64.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.723 . . . . 0.0 109.705 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -103.45 137.58 19.29 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -47.61 -44.34 26.11 Favored 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 124.826 3.684 . . . . 0.0 110.093 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.7 71.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.631 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.97 19.43 1.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.572 -0.705 . . . . 0.0 109.66 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 39.4 m -91.13 134.29 34.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.543 -0.723 . . . . 0.0 109.437 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.609 ' CE1' HD21 ' A' ' 23' ' ' LEU . 37.4 p-80 -150.01 167.23 27.33 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 143' ' ' THR . 16.1 m -137.32 136.48 38.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.559 -0.713 . . . . 0.0 109.456 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -89.44 95.45 10.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.555 -0.716 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.494 ' HB3' ' HE1' ' A' ' 158' ' ' TRP . 62.6 mt-10 -76.67 135.6 39.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.552 -0.717 . . . . 0.0 109.453 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 114' ' ' LEU . 27.9 t -126.19 97.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.565 -0.709 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.494 ' HE1' ' HB3' ' A' ' 156' ' ' GLU . 30.5 m95 -96.46 163.0 13.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.637 -0.664 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -143.31 144.77 32.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.62 -0.675 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -67.48 104.17 1.49 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.545 -0.722 . . . . 0.0 109.461 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -140.8 115.37 9.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.508 179.976 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' TMQ . . . . . 0.666 H223 HD22 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_